Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" ABCB11 "ABC16, BSEP, PFIC-2, PFIC2, PGY4, SPGP" ENSG00000073734 "ATP binding cassette subfamily B member 11" O95342 2 168915498-169031324 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Translocase "Disease variant, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "liver: 80.8" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 41.7;Alveolar cells type 2: 44.1;Club cells: 19.3;Early spermatids: 16.5;granulocytes: 24.0;Hepatocytes: 20.4" "Cancer enriched" "Detected in single" 87 "liver cancer: 6.7" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.6;RT4: 1.6;TIME: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA019035 Enhanced Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 62: Liver - Hemostasis" "Cluster 24: NB-4 - Immune response" "Cluster 11: Alveolar cells - Smell perception" "Nucleoplasm, Plasma membrane, Cytosol" "HPA019035: AB_1844429" "unprognostic (7.78e-2)" "unprognostic (3.92e-1)" "unprognostic (8.31e-2)" "unprognostic (2.56e-1)" "unprognostic (1.13e-1)" "unprognostic (5.10e-2)" "unprognostic (1.00e-2)" "unprognostic (9.71e-2)" "unprognostic (1.18e-1)" "unprognostic (1.72e-2)" "unprognostic (5.64e-3)" "unprognostic (3.71e-1)" "unprognostic (5.26e-6)" "unprognostic (7.12e-2)" "unprognostic (1.82e-1)" "unprognostic (1.94e-1)" 1.5 0.0 0.3 0.1 0.3 0.0 0.6 0.3 0.5 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 80.8 0.0 0.1 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.4 0.1 0.0 0.0 1.1 0.0 0.0 0.3 0.1 0.0 6.2 0.2 0.0 0.0 0.0 0.1 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.4 0.1 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.5 0.2 0.2 1.0 0.6 0.5 0.3 0.2 0.3 0.0 41.7 44.1 1.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 19.3 0.0 0.0 0.0 0.0 0.7 0.0 0.1 16.5 0.1 0.0 1.8 0.0 2.7 0.8 0.0 0.0 6.6 0.0 0.0 24.0 0.0 0.0 20.4 0.0 0.0 0.3 0.0 0.0 0.3 0.0 9.1 0.0 3.8 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.1 0.0 0.0 8.9 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 2.6 0.2 0.0 0.6 ABCF2-H2BE1 ENSG00000285292 "ABCF2-H2BE1 readthrough" Q9UG63 7 151207837-151227166 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA020091, HPA021815, HPA030388" Approved Uncertain Cytosol NA NA 51000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" Cytosol "HPA020091: AB_1844439, HPA021815: AB_1844440, HPA030388: AB_10601558" 12.0 8.1 1.1 11.1 1.6 5.5 9.0 2.1 6.2 7.4 2.9 9.5 6.7 8.4 2.9 10.1 9.0 7.6 9.8 1.5 2.0 9.7 7.4 8.6 11.4 1.5 1.6 6.0 4.6 13.9 8.3 2.3 7.2 10.3 10.0 5.4 9.5 30.7 9.0 5.7 11.9 1.9 9.5 6.0 6.8 2.1 10.2 9.5 20.9 13.8 14.4 2.8 45.0 54.8 27.0 71.0 38.7 38.6 22.4 57.1 38.5 43.7 45.1 40.5 33.8 66.4 44.1 59.7 61.1 34.7 57.9 55.3 61.0 29.9 31.8 37.1 30.6 26.6 57.8 76.5 25.8 40.8 40.8 72.5 50.5 28.6 55.4 35.8 89.1 28.4 57.6 68.1 88.9 23.1 36.5 58.4 50.1 36.5 34.6 68.3 21.9 33.8 21.9 34.8 59.5 44.0 30.3 25.1 21.2 33.9 47.5 33.4 11.4 45.2 73.6 41.6 47.5 64.7 55.4 64.7 49.0 22.5 21.3 6.0 22.5 19.1 45.7 17.5 27.9 26.3 24.8 19.9 24.8 24.3 1.6 25.5 18.5 15.4 30.2 30.3 1.1 1.6 2.1 6.2 1.5 2.0 1.5 1.6 2.3 1.9 2.1 2.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008403.1 ENSG00000268465 "Novel protein" 19 48465837-48472431 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 1.2;retina: 5.2;testis: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.1;LHCN-M2: 1.4;NB-4: 1.5;U-698: 2.2" HPA060662 Uncertain "Plasma membrane,Cytosol" NA NA "Cluster 77: Retina - Visual perception" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Plasma membrane, Cytosol" "HPA060662: AB_2732652" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.8 0.1 0.0 1.2 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 5.2 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.1 1.6 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.8 0.9 0.5 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.1 0.0 1.4 0.0 0.0 1.5 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.3 0.3 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.8 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC012254.7 ENSG00000288631 "Elongin A3" Q8NG57 18 47028202-47029842 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 44 "brain: 3.9;choroid plexus: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048971, HPA049178, HPA050086, HPA053158" Uncertain Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: " 0.0 0.0 2.0 0.0 2.8 0.0 0.0 1.5 1.8 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.9 0.0 0.0 0.0 0.0 3.9 3.8 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.8 1.5 1.8 1.6 1.9 3.9 3.8 2.7 1.1 3.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACIN1 "ACINUS, fSAP152, KIAA0670" ENSG00000100813 "Apoptotic chromatin condensation inducer 1" Q9UKV3 14 23058564-23095614 "Plasma proteins, Predicted intracellular proteins, Transporters" "Apoptosis, mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000657 Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 30000 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 60: Granulocytes - Receptor signaling" Nucleoplasm "Plasma membrane, Cytosol" "HPA000657: AB_1078091" "unprognostic (2.54e-3)" "unprognostic (1.99e-1)" "unprognostic (1.38e-2)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (4.89e-3)" "prognostic unfavorable (4.88e-5)" "unprognostic (1.49e-3)" "unprognostic (9.70e-2)" "unprognostic (4.11e-2)" "unprognostic (1.00e-2)" "unprognostic (6.64e-3)" "unprognostic (1.35e-3)" "unprognostic (4.34e-2)" "unprognostic (2.78e-2)" "unprognostic (2.28e-2)" "unprognostic (7.33e-2)" 41.5 57.7 58.3 35.0 60.2 66.7 36.6 64.3 64.6 46.1 62.7 42.6 28.6 41.5 30.1 50.9 39.3 24.3 44.1 57.5 63.4 51.3 47.5 33.8 45.2 60.9 60.6 48.7 45.1 41.4 48.5 37.2 59.9 45.8 33.2 39.0 39.1 27.8 53.0 39.5 46.0 38.9 55.7 66.4 45.3 47.6 61.6 52.8 47.1 36.5 47.4 41.9 41.3 64.4 77.1 77.6 120.0 97.7 73.3 58.5 120.2 83.8 58.8 98.9 80.0 103.8 87.8 141.8 48.4 69.7 65.0 82.6 167.4 95.6 100.7 100.2 74.3 124.5 82.9 144.8 41.8 136.6 106.4 69.0 58.0 101.5 84.8 81.0 87.9 103.4 117.2 55.1 75.7 96.5 156.1 134.6 135.1 84.6 73.3 139.7 93.0 75.8 82.9 133.3 79.7 58.6 111.2 71.7 69.1 86.7 59.2 109.0 90.7 67.3 67.3 64.7 78.5 57.9 70.2 144.0 59.9 101.8 74.8 5.3 4.0 5.1 4.2 3.5 3.2 3.8 2.9 3.2 3.4 5.4 3.8 3.7 10.8 7.5 3.2 5.5 3.5 2.6 58.3 60.2 64.3 64.6 57.5 63.4 60.9 60.6 59.9 55.7 61.6 64.4 49.8 70.5 123.0 44.4 61.6 37.3 30.2 52.7 64.9 38.1 43.4 40.8 67.9 32.9 67.2 35.0 27.1 58.0 65.0 64.4 17.6 53.4 42.5 70.5 97.6 55.5 58.3 76.2 41.0 49.3 66.8 60.3 85.1 90.1 130.6 79.4 35.0 28.8 47.1 15.2 43.6 50.1 42.7 38.1 40.8 10.9 46.0 52.5 26.6 44.0 53.4 26.1 54.6 45.8 65.6 59.4 49.7 38.4 65.4 43.5 37.7 21.6 82.6 43.3 6.6 52.4 66.9 42.1 39.2 58.5 46.5 69.2 65.2 86.1 55.8 38.4 ACP5 "HPAP, TRAP" ENSG00000102575 "Acid phosphatase 5, tartrate resistant" P13686 19 11574660-11579008 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 174.1" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 426.9;Hofbauer cells: 426.7;Macrophages: 298.2;Proximal tubular cells: 145.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 200.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 41.1;K-562: 30.4;RPMI-8226: 41.4;SK-MEL-30: 127.6;U-138 MG: 102.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB002584, HPA057655, HPA059463" Enhanced Uncertain Cytosol "Intracellular and membrane" NA NA 4000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 4: Macrophages - Innate immune response" Cytosol "CAB002584: AB_564039, HPA057655: AB_2683490, HPA059463: AB_2684028" "unprognostic (4.27e-2)" "unprognostic (2.05e-2)" "unprognostic (2.93e-1)" "unprognostic (8.60e-3)" "unprognostic (2.96e-1)" "unprognostic (1.95e-2)" "unprognostic (5.21e-2)" "unprognostic (5.17e-3)" "unprognostic (5.13e-2)" "unprognostic (3.80e-1)" "unprognostic (3.66e-3)" "unprognostic (9.09e-2)" "unprognostic (1.39e-2)" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "unprognostic (1.05e-1)" "unprognostic (1.19e-1)" 9.4 6.0 2.2 42.4 3.9 9.4 25.6 2.5 21.4 34.7 3.0 46.4 31.9 19.2 7.8 23.4 8.6 26.7 5.1 1.9 3.9 74.0 32.5 174.1 87.1 4.1 3.1 20.3 11.9 2.4 1.3 13.3 6.0 19.6 36.4 20.1 14.3 7.0 1.4 24.9 30.2 13.3 4.1 43.5 38.7 4.0 15.7 25.4 3.0 5.0 43.6 33.1 11.3 5.7 10.2 1.1 0.0 0.2 0.5 0.0 41.1 1.1 25.8 0.0 0.1 0.4 0.3 1.4 1.8 9.0 5.9 0.3 0.0 4.5 0.1 12.1 0.8 0.3 0.0 5.0 1.4 0.1 0.6 0.0 4.1 0.4 0.0 0.0 0.0 0.0 30.4 0.2 0.0 2.3 0.9 1.4 0.8 0.3 0.7 0.4 1.8 41.4 0.0 0.4 0.7 1.0 0.0 0.0 127.6 1.1 0.2 0.4 0.9 102.9 1.2 1.8 0.3 0.7 5.7 0.6 23.7 0.1 4.0 0.4 35.3 76.6 15.8 36.1 8.8 200.1 26.0 19.6 7.3 110.9 35.3 20.2 10.4 13.3 36.3 62.5 67.8 36.4 2.2 3.9 2.5 21.4 1.9 3.9 4.1 3.1 6.0 4.1 15.7 5.7 2.2 9.6 7.8 0.0 75.7 10.3 11.0 21.8 25.0 18.3 14.6 18.4 1.4 15.7 5.7 7.3 18.8 33.4 21.2 7.0 9.8 1.8 0.2 0.7 9.1 30.9 3.0 24.5 0.0 11.3 32.7 19.8 10.7 0.9 63.7 0.8 426.9 8.4 426.7 1.7 0.0 4.7 10.2 106.0 68.6 0.7 1.8 298.2 14.2 1.0 79.8 48.5 8.2 0.0 0.1 4.4 20.4 12.0 33.4 14.5 12.7 145.8 2.5 41.4 0.0 0.4 2.8 0.1 0.2 14.6 11.1 26.1 29.5 0.1 6.7 6.1 ACSF2 "ACSMW, FLJ20920" ENSG00000167107 "Acyl-CoA synthetase family member 2" Q96CM8 17 50426158-50474845 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 142.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 85.8;Proximal enterocytes: 78.2;Proximal tubular cells: 128.4;Syncytiotrophoblasts: 81.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 97.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024693 Enhanced Uncertain Nucleoplasm,Microtubules,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 15: RT4 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoplasm, Microtubules, Cytosol" "HPA024693: AB_2671654" "unprognostic (1.40e-2)" "unprognostic (1.34e-1)" "unprognostic (2.58e-1)" "unprognostic (1.53e-1)" "unprognostic (1.06e-1)" "unprognostic (2.11e-1)" "unprognostic (8.48e-2)" "unprognostic (1.14e-2)" "unprognostic (6.49e-2)" "unprognostic (7.83e-2)" "unprognostic (2.41e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (2.17e-4)" "unprognostic (1.72e-2)" "unprognostic (1.11e-1)" "unprognostic (2.45e-2)" "prognostic favorable (2.41e-4)" 24.8 71.9 7.6 5.7 8.5 3.3 21.0 7.7 10.1 18.9 8.6 26.9 22.1 6.7 15.8 7.7 9.7 10.8 25.9 7.1 7.0 142.1 36.4 17.8 8.5 8.5 7.3 19.3 6.8 9.9 2.9 15.4 8.0 15.0 17.5 1.1 15.8 16.0 41.3 22.5 20.2 5.4 8.2 8.4 18.8 4.9 7.9 5.6 42.5 25.8 8.2 17.8 13.4 7.7 24.8 8.1 6.6 15.8 68.1 12.1 38.1 5.9 8.6 12.6 24.5 32.1 47.2 15.7 12.6 7.3 11.5 14.7 4.7 29.2 15.3 19.5 11.2 27.3 3.9 58.5 11.4 3.3 24.3 54.9 44.4 15.8 2.1 45.4 17.4 20.3 3.2 8.8 13.7 31.3 8.8 11.1 1.1 47.5 11.9 20.6 4.8 41.2 4.2 97.2 21.6 11.3 11.8 17.3 12.3 13.7 15.5 22.8 12.7 22.5 6.8 3.5 1.9 15.4 3.1 8.2 9.3 17.1 1.4 0.0 2.9 15.3 2.0 7.7 1.7 8.6 1.5 2.1 16.1 2.0 0.7 0.9 0.5 1.6 7.0 6.3 5.5 2.7 7.6 8.5 7.7 10.1 7.1 7.0 8.5 7.3 8.0 8.2 7.9 7.7 3.2 28.9 24.3 27.1 7.3 6.0 23.3 17.0 25.0 0.0 20.8 16.0 25.9 11.5 19.9 3.7 0.0 85.8 1.7 59.5 11.7 13.5 0.4 4.9 3.5 4.9 10.2 1.3 0.3 4.3 11.7 6.5 21.9 7.7 22.2 24.5 4.2 44.4 21.9 0.0 0.3 20.6 2.0 9.8 11.0 1.6 26.8 11.0 3.6 17.8 12.7 6.1 5.2 3.5 0.5 5.7 53.1 14.3 2.6 3.5 78.2 128.4 14.6 0.2 0.0 2.7 5.9 0.2 2.2 5.4 7.0 81.0 4.1 12.1 25.8 14.0 ACVR1 "ACVR1A, ACVRLK2, ALK2, SKR1" ENSG00000115170 "Activin A receptor type 1" Q04771 2 157736444-157876330 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 106.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 6.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007505, HPA046514" Approved Uncertain Nucleoli,Cytosol NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 89: Fibroblasts - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 50: Fibroblasts - ECM organization" Nucleoli Cytosol "HPA007505: AB_1844752, HPA046514: AB_2732526" "unprognostic (6.99e-2)" "unprognostic (3.32e-2)" "unprognostic (3.02e-1)" "unprognostic (1.19e-2)" "unprognostic (2.73e-1)" "unprognostic (6.09e-2)" "unprognostic (3.66e-3)" "unprognostic (1.08e-1)" "unprognostic (3.99e-1)" "unprognostic (3.20e-1)" "unprognostic (2.65e-2)" "unprognostic (4.29e-2)" "unprognostic (2.42e-1)" "unprognostic (3.43e-3)" "unprognostic (3.17e-1)" "unprognostic (1.76e-2)" "prognostic unfavorable (5.17e-4)" 20.8 10.4 17.3 12.9 12.7 1.8 18.8 14.0 15.4 28.1 17.4 16.5 10.9 24.4 32.7 11.3 17.0 24.2 19.7 26.3 12.8 26.4 22.7 17.5 8.8 13.7 12.9 21.2 10.0 8.5 10.9 17.6 13.7 15.1 12.6 6.3 18.8 15.3 21.5 13.9 10.5 34.5 12.6 8.3 14.7 5.2 16.3 7.5 40.5 13.3 8.2 20.9 15.5 11.8 6.1 13.1 14.4 18.5 65.0 70.6 18.9 43.4 71.3 33.7 36.1 10.1 13.4 0.2 18.2 45.6 32.3 16.9 10.5 22.5 36.8 43.0 8.7 25.7 7.2 14.4 54.7 2.0 28.5 89.5 41.4 69.8 84.2 42.8 38.7 6.7 9.5 6.7 45.2 11.1 0.4 0.4 21.4 8.7 21.7 4.1 19.6 5.7 45.4 24.5 12.4 14.9 17.0 9.7 64.5 22.2 5.3 7.0 54.0 50.9 16.8 25.3 17.1 4.7 3.5 0.3 52.2 1.6 58.1 2.9 1.7 0.1 0.5 1.0 0.7 0.8 4.9 1.3 1.3 0.2 1.6 0.7 0.2 1.2 1.4 1.4 6.6 1.1 17.3 12.7 14.0 15.4 26.3 12.8 13.7 12.9 13.7 12.6 16.3 11.8 9.6 9.6 9.0 22.9 1.8 9.8 7.7 12.6 12.5 10.4 8.0 9.8 12.7 11.5 12.4 7.3 0.0 8.4 1.1 4.8 5.9 9.9 1.0 5.9 12.9 17.3 4.2 1.7 34.0 17.8 5.3 20.3 8.2 6.5 5.1 4.2 18.2 13.3 7.0 3.3 34.2 4.5 24.4 13.0 8.7 2.0 20.2 7.6 3.6 106.8 5.5 6.6 2.1 42.3 22.9 17.2 4.1 15.8 6.4 13.0 3.7 15.5 13.6 2.1 13.1 16.3 19.3 0.4 2.7 4.0 7.5 10.5 4.3 3.5 4.3 8.8 ADCK2 MGC20727 ENSG00000133597 "AarF domain containing kinase 2" Q7Z695 7 140672945-140696261 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 98.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036036 Approved Uncertain Centrosome,Cytosol NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 27: Brain & Skin - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 40: Granulosa cells - Unknown function" "Centrosome, Cytosol" "HPA036036: AB_10672078" "unprognostic (2.76e-1)" "unprognostic (1.79e-1)" "unprognostic (5.72e-2)" "unprognostic (5.30e-2)" "unprognostic (4.03e-3)" "unprognostic (1.52e-1)" "unprognostic (3.05e-2)" "unprognostic (7.48e-2)" "unprognostic (2.61e-1)" "unprognostic (7.10e-3)" "unprognostic (6.81e-3)" "unprognostic (9.36e-3)" "prognostic favorable (9.75e-5)" "unprognostic (1.89e-2)" "unprognostic (2.00e-1)" "unprognostic (4.13e-1)" "unprognostic (2.13e-1)" 10.4 9.1 23.7 10.2 25.1 8.8 11.3 24.6 25.9 11.9 16.5 13.4 7.4 9.7 8.9 17.5 16.0 8.3 10.7 24.3 24.2 12.4 13.3 10.8 14.8 29.1 25.6 11.8 14.4 19.5 12.8 11.2 25.9 13.2 10.9 6.3 15.6 10.7 14.1 26.3 11.0 9.0 26.3 12.2 13.1 6.5 26.4 12.4 12.8 8.4 14.1 11.9 13.7 30.2 32.6 23.2 5.6 24.9 19.3 21.5 31.7 16.5 20.0 17.2 11.2 21.7 22.5 42.4 24.0 11.7 39.4 26.3 27.5 19.0 5.1 31.3 26.1 9.2 8.8 11.1 26.5 6.2 21.8 17.7 56.8 9.9 13.5 17.3 14.8 30.9 16.1 20.9 6.1 41.0 46.4 15.3 8.2 27.0 23.1 36.3 0.3 21.0 9.9 34.9 20.6 14.5 22.7 32.7 23.3 10.1 29.2 12.2 15.6 21.3 7.3 35.0 32.0 14.2 23.2 32.4 31.3 23.9 25.7 0.0 3.0 3.0 4.2 4.1 4.0 7.0 3.8 4.3 4.8 3.0 5.8 3.7 0.1 4.4 2.6 10.1 5.4 2.0 23.7 25.1 24.6 25.9 24.3 24.2 29.1 25.6 25.9 26.3 26.4 30.2 9.0 9.6 3.6 2.3 9.8 12.4 21.3 4.4 5.7 11.4 15.3 11.7 6.4 7.2 3.5 9.2 0.0 32.9 17.8 15.0 5.9 6.3 37.9 5.6 3.4 8.8 16.8 12.2 6.5 7.5 20.2 6.2 5.1 9.3 11.4 98.0 7.1 9.9 31.5 11.8 6.7 13.5 6.1 11.4 16.1 16.4 3.4 14.3 3.6 6.5 8.4 13.3 9.2 8.0 10.8 6.1 15.8 13.5 5.1 19.6 8.3 5.7 4.8 5.9 0.0 9.5 7.2 7.0 6.4 7.3 13.9 33.8 9.6 14.9 14.0 21.2 ADGRE2 "CD312, EMR2" ENSG00000127507 "Adhesion G protein-coupled receptor E2" Q9UHX3 19 14732392-14778560 "CD markers, Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins" "Cell adhesion, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 19.4" "Group enriched" "Detected in many" 4 "granulocytes: 47.9;Kupffer cells: 69.4;Macrophages: 73.2;monocytes: 49.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 70.0;eosinophil: 74.7;intermediate monocyte: 46.9;neutrophil: 55.7;non-classical monocyte: 89.9" "Group enriched" "Detected in many" 9 "granulocytes: 74.7;monocytes: 89.9" "Cell line enhanced" "Detected in many" "HEL: 11.8;HMC-1: 18.3;NB-4: 11.5;RPMI-8226: 8.4;U-937: 14.9" "Low region specificity" "Detected in many" HPA055200 Uncertain Vesicles,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Vesicles Cytosol "HPA055200: " "unprognostic (2.46e-2)" "unprognostic (3.58e-2)" "unprognostic (2.21e-1)" "unprognostic (1.66e-1)" "unprognostic (9.10e-2)" "unprognostic (3.58e-2)" "unprognostic (2.77e-2)" "unprognostic (3.88e-2)" "unprognostic (4.28e-1)" "unprognostic (1.22e-1)" "unprognostic (2.32e-1)" "unprognostic (2.70e-2)" "prognostic unfavorable (4.35e-6)" "unprognostic (1.46e-1)" "unprognostic (2.45e-3)" "unprognostic (2.50e-1)" "unprognostic (1.01e-1)" 4.9 1.5 1.0 19.4 1.3 6.9 1.8 1.2 2.1 0.9 1.3 1.4 1.9 0.7 0.7 0.9 0.9 2.5 0.5 1.0 1.5 2.1 2.0 4.2 3.0 2.5 1.6 0.1 0.8 1.1 0.5 1.6 2.2 1.1 1.9 0.6 1.0 2.8 0.6 2.0 2.3 1.6 1.1 15.6 1.5 0.4 1.8 2.4 0.6 0.9 2.2 5.4 0.9 2.4 0.3 1.2 0.1 0.2 0.0 0.3 1.2 0.9 1.3 0.0 0.0 0.2 0.2 0.1 0.1 0.7 2.3 1.9 0.3 0.1 0.0 0.2 0.2 11.8 3.8 0.2 0.5 4.3 18.3 0.9 1.6 4.1 0.6 0.1 0.1 1.0 2.7 0.4 1.3 0.5 1.5 11.5 0.4 0.8 0.2 0.1 1.5 8.4 0.0 0.3 0.0 0.2 2.4 2.0 0.4 0.2 0.3 5.4 0.3 0.3 0.2 0.2 0.1 0.2 0.1 0.2 1.1 14.9 0.6 70.0 13.9 74.7 0.2 46.9 0.2 0.2 0.2 0.1 9.3 0.3 0.1 0.2 55.7 3.3 89.9 1.9 0.1 7.3 1.0 1.3 1.2 2.1 1.0 1.5 2.5 1.6 2.2 1.1 1.8 2.4 0.6 3.2 7.7 0.7 1.9 0.0 4.8 0.0 0.6 0.8 1.6 1.5 0.8 0.0 2.5 0.0 0.0 0.2 12.8 0.0 0.0 0.0 2.0 0.7 3.5 1.8 1.2 3.8 0.9 0.0 0.5 1.9 1.1 0.9 47.9 0.1 0.7 0.5 12.8 0.0 1.2 0.1 0.0 69.4 0.0 2.5 0.0 73.2 0.0 0.0 49.2 0.0 2.1 0.5 12.0 0.0 0.2 0.4 2.1 2.4 0.1 0.1 2.2 0.9 0.0 2.0 1.5 0.3 0.5 0.6 0.0 0.4 3.0 0.1 0.1 3.0 ADH4 ADH-2 ENSG00000198099 "Alcohol dehydrogenase 4 (class II), pi polypeptide" P08319 4 99123657-99157792 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "liver: 5151.4" "Cell type enriched" "Detected in some" 21 "Hepatocytes: 975.2" "Cancer enriched" "Detected in some" 60 "liver cancer: 230.7" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 13 "Hep G2: 22.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA020525 Enhanced Uncertain Nucleoplasm,Cytosol NA NA 20000000 "Cluster 34: Basophils - Unknown function" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" "Nucleoplasm, Cytosol" "HPA020525: AB_1844609" "unprognostic (2.75e-1)" "unprognostic (1.69e-2)" "unprognostic (1.85e-2)" "unprognostic (5.54e-3)" "unprognostic (2.14e-2)" "unprognostic (1.33e-2)" "prognostic favorable (7.08e-6)" "unprognostic (1.49e-1)" "unprognostic (1.39e-2)" "unprognostic (6.91e-2)" "unprognostic (1.88e-1)" "unprognostic (2.34e-2)" "unprognostic (7.16e-3)" "unprognostic (2.20e-1)" "unprognostic (5.89e-3)" 2.1 0.8 0.5 0.4 0.4 0.4 4.3 1.2 1.0 1.5 0.0 0.6 164.1 0.2 0.5 0.8 0.3 0.4 0.2 0.4 0.7 1.5 5151.4 0.2 0.2 0.1 0.1 0.1 0.4 0.1 0.0 0.2 0.1 0.3 0.6 0.8 2.6 0.5 0.6 0.9 22.9 0.1 0.0 0.6 0.6 1.0 0.5 0.0 0.4 2.1 0.1 0.3 3.4 0.2 0.1 0.2 0.1 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.4 0.2 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.4 0.4 22.2 0.0 1.6 0.2 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.8 0.0 0.1 0.1 0.5 0.3 0.0 0.1 0.1 1.6 0.5 0.0 0.1 0.1 0.2 1.5 0.3 0.0 0.1 0.4 0.0 0.1 0.4 0.1 0.3 0.0 0.4 0.4 0.6 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 1.2 1.0 0.4 0.7 0.1 0.1 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 21.5 0.2 1.8 0.0 0.0 0.0 0.8 0.0 0.0 26.9 0.7 0.6 1.1 0.0 45.5 0.1 0.6 0.0 1.0 0.0 0.3 0.0 0.0 16.1 975.2 0.0 0.0 0.0 1.1 0.0 27.0 0.0 3.7 0.3 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 1.9 0.0 0.8 0.0 ADORA2B ENSG00000170425 "Adenosine A2b receptor" P29275 17 15944917-15975746 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.7;urinary bladder: 14.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 73.5;Basal respiratory cells: 75.6;Langerhans cells: 31.9;Suprabasal keratinocytes: 64.4;Urothelial cells: 32.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 14.9;myeloid DC: 9.0" "Group enriched" "Detected in many" 97 "dendritic cells: 9.0;granulocytes: 14.9;monocytes: 5.0" "Cell line enhanced" "Detected in many" "GAMG: 160.8;HMC-1: 162.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073747 Uncertain Cytosol NA Yes "Cluster 10: Basophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Cytosol "HPA073747: " "unprognostic (6.04e-3)" "unprognostic (1.22e-1)" "unprognostic (8.14e-2)" "unprognostic (1.32e-2)" "unprognostic (4.68e-1)" "unprognostic (7.88e-3)" "unprognostic (2.64e-4)" "unprognostic (1.44e-1)" "unprognostic (1.84e-1)" "unprognostic (1.50e-2)" "unprognostic (2.18e-3)" "unprognostic (1.38e-1)" "unprognostic (1.66e-9)" "unprognostic (2.07e-1)" "unprognostic (3.49e-1)" "unprognostic (1.50e-2)" "unprognostic (2.84e-1)" 0.5 1.1 7.5 1.7 9.4 0.8 0.7 7.0 11.7 2.4 9.0 8.6 0.2 0.7 0.5 9.1 0.9 1.1 1.6 9.1 7.3 0.3 0.1 1.9 0.3 7.7 7.7 0.0 1.3 0.0 1.4 5.0 7.1 1.3 6.6 2.8 1.4 0.1 0.1 8.5 1.3 1.3 6.4 0.2 1.2 0.3 8.3 0.4 0.1 0.5 1.3 14.2 5.2 8.2 34.1 18.3 0.6 0.7 5.8 11.1 0.7 6.4 28.4 18.3 22.6 8.8 34.6 4.4 7.8 5.7 160.8 51.9 7.9 47.8 24.2 9.7 18.0 32.7 5.8 13.0 22.3 0.0 162.6 6.5 20.1 26.0 60.4 31.3 9.3 5.1 1.6 0.1 18.2 8.9 2.2 6.6 1.9 72.0 25.5 0.1 0.4 0.0 19.1 9.1 0.8 1.2 14.3 3.4 9.0 13.4 0.1 5.1 7.7 6.5 17.1 18.3 30.3 2.8 0.0 0.0 25.8 0.0 9.2 14.9 4.2 2.8 0.0 5.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.4 0.0 2.6 0.1 0.0 1.7 7.5 9.4 7.0 11.7 9.1 7.3 7.7 7.7 7.1 6.4 8.3 8.2 0.1 3.2 4.2 18.9 0.2 73.5 21.0 75.6 27.3 0.2 1.3 1.9 0.9 1.5 20.2 0.0 0.0 10.9 0.1 10.8 0.0 6.6 0.9 0.9 0.6 1.7 2.4 3.4 0.9 0.9 3.2 4.9 2.0 1.2 0.0 0.1 2.2 0.0 4.5 0.0 1.1 1.7 2.0 1.4 31.9 0.4 0.0 6.7 7.2 3.7 1.3 7.9 0.0 1.0 1.0 1.0 7.2 0.0 0.0 15.6 0.2 0.0 8.3 0.5 0.0 0.7 2.1 0.5 1.4 23.0 64.4 6.2 0.3 0.3 5.7 32.4 ADRB2 "ADRB2R, ADRBR, B2AR, BAR" ENSG00000169252 "Adrenoceptor beta 2" P07550 5 148826611-148828623 "FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 196.1;Basal keratinocytes: 387.5;Basal respiratory cells: 146.6;Squamous epithelial cells: 276.0;Suprabasal keratinocytes: 245.4" "Cancer enhanced" "Detected in many" "prostate cancer: 9.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 72.4;hTERT-HME1: 74.1;PC-3: 31.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003431, HPA075322" Uncertain Uncertain Cytosol NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 61: Squamous epithelial cells - Keratinization" Cytosol "HPA003431: AB_1845333, HPA075322: " "unprognostic (2.28e-2)" "unprognostic (1.50e-1)" "unprognostic (1.21e-1)" "unprognostic (1.17e-2)" "unprognostic (1.69e-1)" "unprognostic (1.17e-1)" "unprognostic (9.35e-3)" "unprognostic (5.54e-2)" "unprognostic (2.34e-1)" "unprognostic (9.85e-2)" "unprognostic (3.17e-2)" "unprognostic (2.23e-1)" "prognostic favorable (3.15e-9)" "unprognostic (1.55e-2)" "unprognostic (1.46e-1)" "unprognostic (1.49e-1)" "unprognostic (7.65e-2)" 19.5 1.6 4.5 3.2 4.7 12.5 18.7 5.1 4.4 13.5 1.8 2.3 1.9 2.3 1.7 15.1 4.1 3.8 6.7 5.3 4.2 1.1 14.2 19.5 4.1 6.0 5.6 0.9 1.2 2.2 0.3 9.9 6.2 9.0 2.8 0.6 4.2 1.5 11.7 21.8 2.1 3.7 6.2 7.9 7.5 0.5 7.1 2.7 1.0 8.6 6.0 6.8 7.2 7.6 23.3 0.1 0.1 0.0 0.8 0.2 0.0 4.3 13.2 6.0 6.7 0.0 9.7 0.1 6.1 1.3 21.5 20.0 0.0 27.9 6.9 0.0 0.6 0.0 5.1 0.0 0.6 0.1 11.0 0.1 72.4 2.0 74.1 5.0 2.8 0.0 0.1 8.3 16.0 0.0 0.0 12.9 0.4 0.2 31.2 6.7 4.1 13.0 3.2 5.8 0.1 0.1 5.4 0.4 2.0 2.5 0.0 7.0 12.3 0.0 5.0 7.2 3.5 1.9 0.0 0.2 0.0 15.1 2.6 16.5 21.8 67.8 151.4 37.1 112.3 21.5 34.3 93.0 24.7 15.6 5.8 53.3 35.4 37.2 53.3 28.4 2.3 53.4 4.5 4.7 5.1 4.4 5.3 4.2 6.0 5.6 6.2 6.2 7.1 7.6 196.1 112.2 31.6 1.6 16.5 387.5 36.6 146.6 127.5 0.5 23.3 15.2 18.6 0.0 67.4 0.0 0.0 0.4 59.2 3.7 0.0 2.4 0.5 3.2 0.5 40.3 3.0 1.3 0.0 0.2 0.3 6.2 35.7 3.0 118.6 0.1 6.8 14.1 17.7 0.0 0.0 3.1 16.2 20.8 54.9 0.7 0.0 21.1 30.2 15.9 4.0 4.1 90.6 0.0 0.1 8.6 0.1 0.0 23.2 23.5 0.1 0.1 27.8 5.0 0.0 19.8 9.6 0.7 0.1 276.0 245.4 0.5 40.1 0.1 3.5 61.5 AIF1 "AIF-1, Em:AF129756.17, IBA1, IRT-1" ENSG00000204472 "Allograft inflammatory factor 1" P55008 6 31615217-31617021 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 235.0;lymphoid tissue: 346.6" "Group enriched" "Detected in many" 22 "Hofbauer cells: 1777.1;Kupffer cells: 2140.2;Langerhans cells: 1359.1;Macrophages: 1494.0;monocytes: 1022.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 26 "classical monocyte: 3823.3;intermediate monocyte: 6550.1;myeloid DC: 2043.3;neutrophil: 2943.0;non-classical monocyte: 7744.5" "Group enriched" "Detected in all" 74 "dendritic cells: 2043.3;granulocytes: 2943.0;monocytes: 7744.5" "Group enriched" "Detected in some" 4 "HEL: 204.6;HMC-1: 329.6;NB-4: 264.7;THP-1: 184.2;U-937: 114.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049234, HPA062949" Enhanced Uncertain Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol "HPA049234: AB_2680685, HPA062949: AB_2732694" "unprognostic (3.20e-2)" "unprognostic (7.21e-3)" "unprognostic (6.11e-2)" "unprognostic (2.33e-2)" "unprognostic (2.46e-1)" "unprognostic (1.13e-1)" "unprognostic (6.98e-2)" "unprognostic (4.83e-2)" "unprognostic (2.72e-2)" "unprognostic (7.56e-2)" "unprognostic (1.41e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (2.30e-5)" "unprognostic (1.29e-1)" "unprognostic (1.02e-2)" "unprognostic (9.59e-2)" "unprognostic (4.89e-2)" 79.6 46.6 24.9 182.3 25.5 235.0 47.2 26.6 33.0 29.3 32.2 48.3 36.4 17.1 12.1 18.7 19.7 61.3 21.1 25.0 31.3 74.3 81.2 99.3 116.8 45.1 36.4 14.4 12.4 12.9 17.3 109.5 36.8 22.3 57.2 3.9 20.3 24.0 6.1 11.7 44.5 74.7 34.3 346.6 22.2 8.7 32.1 69.1 13.8 16.6 57.1 95.3 13.5 42.7 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 204.6 0.0 0.0 0.0 30.0 329.6 0.0 0.0 0.0 0.0 0.0 0.0 51.6 0.9 0.2 0.0 0.0 2.3 264.7 0.4 0.0 0.0 35.9 0.4 8.9 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 184.2 0.1 0.0 0.2 0.1 0.3 0.2 0.0 1.3 0.2 114.6 0.0 33.1 3823.3 177.9 10.2 6550.1 12.7 57.5 10.8 9.3 2043.3 6.3 33.1 26.2 2943.0 14.5 7744.5 144.2 10.7 4449.8 24.9 25.5 26.6 33.0 25.0 31.3 45.1 36.4 36.8 34.3 32.1 42.7 12.0 25.6 59.6 0.0 39.2 32.5 0.7 0.0 0.6 0.1 5.3 24.3 7.5 18.6 19.2 42.3 0.0 11.1 31.2 1.0 0.0 0.3 1.9 0.6 0.7 28.7 1.2 65.0 0.0 0.4 15.4 20.6 0.5 0.4 68.3 0.4 35.3 13.4 1777.1 0.0 0.0 0.1 0.0 2140.2 1359.1 4.9 7.5 1494.0 39.2 10.3 1022.6 0.0 32.0 0.5 0.1 0.2 11.1 0.7 7.2 0.4 0.3 4.2 10.2 0.1 52.6 4.7 6.5 0.5 1.5 2.1 28.3 22.7 46.1 1.9 0.6 0.3 AIPL1 LCA4 ENSG00000129221 "Aryl hydrocarbon receptor interacting protein like 1" Q9NZN9 17 6393693-6435199 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Disease variant, Leber congenital amaurosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 1012 "retina: 836.0" "Cell type enriched" "Detected in some" 4 "Rod photoreceptor cells: 1926.4" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.5;OE19: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA026578 Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Cluster 79: Retina - Phototransduction" "Cluster 21: OE19 - Mitochondria" "Cluster 46: Photoreceptor cells - Phototransduction" "Nucleoplasm, Cytosol" "HPA026578: AB_2671905" "unprognostic (2.42e-2)" "unprognostic (1.17e-1)" "unprognostic (2.02e-2)" "unprognostic (1.68e-3)" "unprognostic (3.24e-1)" "unprognostic (1.13e-3)" "unprognostic (3.76e-1)" "unprognostic (5.35e-2)" 0.0 0.0 0.2 0.1 0.3 0.7 0.0 0.2 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 836.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.3 2.8 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.3 0.2 0.3 0.1 0.8 0.2 0.1 0.3 0.0 0.3 0.6 0.0 3.2 1.1 0.0 0.0 0.8 1.0 0.0 0.0 139.2 0.1 0.0 0.6 0.0 1.4 0.0 412.8 0.1 0.1 0.2 0.0 0.0 7.8 0.4 0.2 8.5 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.4 0.0 0.1 1.4 0.0 0.1 65.6 0.2 0.2 0.0 0.3 1.1 1.3 0.0 0.3 1.8 0.0 0.0 256.1 0.0 0.5 0.1 0.1 0.0 0.4 0.0 0.7 0.0 0.0 0.0 1926.4 0.0 1.8 0.3 0.4 0.2 0.0 0.4 0.3 0.4 0.1 0.0 1.7 AKAP17A "721P, CCDC133, CXYorf3, DXYS155E, MGC39904, SFRS17A, XE7, XE7Y" ENSG00000197976 "A-kinase anchoring protein 17A" Q02040 X 1591604-1602520 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Theca cells: 131.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 4.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043247, HPA051020" Supported Supported "Nuclear speckles,Cytosol" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 29: U-266 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" Cytosol "HPA043247: AB_10964776, HPA051020: AB_2681314" "unprognostic (4.55e-2)" "unprognostic (1.56e-1)" "unprognostic (1.74e-1)" "prognostic favorable (3.40e-4)" "unprognostic (5.38e-2)" "unprognostic (1.59e-2)" "unprognostic (9.73e-3)" "unprognostic (6.25e-2)" "unprognostic (2.09e-1)" "unprognostic (7.91e-3)" "prognostic favorable (2.42e-4)" "unprognostic (1.55e-3)" "prognostic unfavorable (3.52e-7)" "unprognostic (1.86e-2)" "unprognostic (2.71e-1)" "unprognostic (4.03e-2)" "prognostic favorable (1.11e-5)" 35.2 46.9 13.7 33.8 15.0 44.6 37.3 12.3 15.2 45.6 15.1 38.6 30.9 35.2 20.1 38.5 39.5 16.5 34.9 13.0 11.9 39.3 70.1 51.5 36.0 16.4 14.1 73.0 66.4 12.6 46.6 17.3 13.5 50.7 9.9 7.5 41.5 15.9 17.4 35.6 49.4 7.6 12.1 83.0 41.3 31.8 16.3 27.2 62.7 9.2 20.1 32.2 38.0 20.3 23.8 29.8 23.4 26.5 11.3 14.4 57.1 25.1 10.2 19.8 16.6 33.3 21.3 35.5 15.8 12.6 27.9 20.4 14.3 12.6 11.8 29.3 49.2 44.3 32.6 31.3 24.1 17.3 71.3 12.8 22.8 14.8 16.4 23.6 13.8 17.7 28.2 21.8 11.7 15.6 38.5 74.4 35.0 5.5 25.6 28.9 27.9 30.0 13.2 16.3 26.1 38.1 19.7 31.5 31.5 19.2 20.6 31.3 26.9 30.8 14.0 26.9 22.1 93.7 17.0 49.1 12.5 27.7 8.4 4.5 0.5 0.9 0.3 0.2 0.4 0.9 0.4 0.7 0.3 0.5 0.3 0.3 1.9 0.7 0.4 0.8 0.2 0.2 13.7 15.0 12.3 15.2 13.0 11.9 16.4 14.1 13.5 12.1 16.3 20.3 41.2 25.6 25.3 1.3 53.5 44.4 36.1 10.6 36.5 24.1 41.5 29.8 12.0 12.8 19.4 12.9 10.4 25.1 67.0 39.9 13.7 21.2 52.1 29.6 32.7 35.1 22.6 14.5 0.8 15.5 32.4 31.5 39.3 41.1 25.4 49.8 32.2 21.3 22.8 16.8 0.8 38.7 12.2 25.7 54.5 18.9 38.8 37.4 40.9 0.0 38.0 21.5 54.6 2.0 2.7 24.4 35.9 31.6 65.0 41.9 22.6 7.9 14.4 15.4 0.0 28.4 23.2 20.6 27.6 31.7 47.2 72.7 51.1 131.7 28.6 46.2 AL121900.1 ENSG00000284776 "Novel protein" 20 18567453-18744216 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA040981 Uncertain Uncertain Nucleoli,Cytosol NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Nucleoli, Cytosol" "HPA040981: AB_10673268" 11.6 14.9 16.3 13.1 15.8 15.3 17.0 15.4 18.3 10.5 13.3 13.1 10.4 12.7 12.8 13.2 11.2 7.9 11.1 16.2 20.1 19.7 8.1 12.4 13.0 16.7 16.0 15.3 19.0 22.9 11.1 17.4 9.9 14.5 28.2 9.7 10.4 21.9 9.9 8.5 11.8 17.6 12.4 12.5 14.7 17.7 8.5 21.6 17.9 17.0 14.7 19.4 58.0 57.7 65.1 58.3 23.6 55.4 27.8 50.7 50.0 43.6 35.0 39.8 46.0 0.9 33.2 50.6 53.1 32.6 49.7 119.3 68.9 26.6 25.9 65.1 15.8 57.9 72.3 57.9 37.8 32.9 89.5 44.8 154.1 33.8 72.2 10.2 34.6 70.7 59.4 66.0 12.8 55.3 53.3 40.1 93.8 0.6 87.1 51.6 57.1 33.8 82.0 57.5 25.4 69.0 120.5 32.8 42.9 33.6 61.1 55.3 26.1 63.7 69.7 54.8 69.5 31.1 37.8 51.4 45.6 57.6 20.5 15.8 29.8 30.5 30.5 30.5 29.9 29.6 40.1 26.1 20.7 21.9 24.3 25.6 31.3 9.0 24.5 19.2 16.3 15.8 15.4 18.3 16.2 20.1 16.7 16.0 17.4 17.6 17.7 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALDH1B1 "ALDH5, ALDHX" ENSG00000137124 "Aldehyde dehydrogenase 1 family member B1" P30837 9 38392702-38398661 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 172.7;smooth muscle: 128.0" "Cell type enhanced" "Detected in many" "Cholangiocytes: 85.8;Ductal cells: 64.1;Hepatocytes: 128.1;Proximal tubular cells: 165.0;Theca cells: 91.7;Undifferentiated cells: 71.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 183.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021037, HPA077080" Enhanced Supported Nucleoplasm,Mitochondria,Cytosol NA NA 500000 "Cluster 27: Non-specific - Gene expression" "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "Nucleoplasm, Cytosol" "HPA021037: AB_1844724, HPA077080: " "unprognostic (4.16e-1)" "unprognostic (1.98e-2)" "unprognostic (5.84e-2)" "unprognostic (1.55e-3)" "unprognostic (2.47e-2)" "unprognostic (4.48e-3)" "unprognostic (2.84e-3)" "unprognostic (2.70e-2)" "unprognostic (1.91e-1)" "unprognostic (1.35e-1)" "unprognostic (2.09e-1)" "unprognostic (1.00e-1)" "prognostic favorable (2.05e-4)" "unprognostic (1.04e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (1.17e-5)" "unprognostic (2.89e-2)" 21.2 10.4 3.2 31.4 3.2 2.9 8.9 4.1 4.0 8.5 6.4 61.5 22.9 57.7 5.7 32.7 34.9 29.0 14.7 2.7 4.8 59.2 172.7 7.3 5.1 3.5 3.3 12.6 11.3 8.5 2.5 5.2 4.3 36.9 35.5 1.5 11.1 54.5 55.8 6.3 24.8 128.0 3.4 7.2 28.2 8.3 4.0 5.1 15.4 35.9 5.6 85.1 10.5 4.1 72.2 65.5 19.8 31.8 27.6 32.5 15.8 33.6 16.9 27.8 28.3 44.2 13.7 45.2 19.7 47.4 42.0 10.0 66.0 71.4 27.4 50.8 28.5 22.4 44.7 132.2 20.0 36.0 24.0 39.0 15.3 22.6 19.5 56.6 26.8 10.6 65.6 42.8 42.8 27.3 0.1 14.4 59.1 183.3 29.0 14.9 119.9 34.5 25.1 31.7 43.3 19.9 25.7 16.7 19.4 20.6 15.9 27.9 18.2 31.9 52.4 26.9 42.5 6.5 13.2 17.8 16.4 36.0 22.1 0.3 4.2 0.2 6.7 9.2 9.6 5.5 6.5 6.1 9.5 2.6 5.1 6.2 1.0 8.0 11.9 1.2 5.0 5.3 3.2 3.2 4.1 4.0 2.7 4.8 3.5 3.3 4.3 3.4 4.0 4.1 3.3 9.6 1.7 0.0 3.7 1.0 5.7 9.4 2.2 1.2 3.7 4.2 6.6 85.8 3.8 16.5 2.1 2.0 1.2 12.8 17.6 64.1 0.6 2.3 6.4 4.7 15.6 12.8 0.5 6.9 46.6 6.6 8.2 3.4 8.9 12.8 8.9 128.1 7.2 0.0 1.1 25.5 6.1 4.1 2.4 2.2 6.5 4.2 0.0 0.0 5.5 2.1 0.0 0.5 0.5 15.0 7.7 6.8 3.7 6.1 10.3 165.0 0.3 0.7 0.0 6.0 16.1 0.6 0.8 2.1 1.0 1.8 3.3 91.7 71.7 2.8 ALDH3A2 "ALDH10, FALDH, SLS" ENSG00000072210 "Aldehyde dehydrogenase 3 family member A2" P51648 17 19648136-19685760 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease variant, Ichthyosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 288.6" "Cell type enhanced" "Detected in all" "Basal squamous epithelial cells: 287.4;Squamous epithelial cells: 232.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 285.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014769, CAB020692" Enhanced Approved "Endoplasmic reticulum,Cytosol" NA NA 32000 "Cluster 14: Monocytes - Unknown function" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 61: Squamous epithelial cells - Keratinization" "Endoplasmic reticulum, Cytosol" "CAB020692: , HPA014769: AB_1844728" "unprognostic (1.42e-1)" "unprognostic (7.62e-2)" "unprognostic (7.77e-2)" "unprognostic (2.49e-2)" "unprognostic (4.59e-1)" "unprognostic (1.64e-1)" "unprognostic (1.59e-1)" "unprognostic (1.31e-2)" "unprognostic (2.23e-1)" "unprognostic (3.93e-3)" "unprognostic (2.40e-1)" "unprognostic (2.63e-1)" "prognostic favorable (3.85e-8)" "unprognostic (4.12e-2)" "unprognostic (1.55e-1)" "unprognostic (1.42e-2)" "unprognostic (1.26e-1)" 75.2 203.0 23.1 15.2 32.5 9.3 34.9 24.8 27.7 49.4 71.7 49.6 68.1 29.4 41.7 131.3 38.3 70.5 44.6 29.0 27.9 173.0 288.6 59.1 14.9 23.3 26.3 32.3 52.3 40.6 21.9 11.8 23.5 75.0 36.5 40.8 61.7 41.5 53.0 207.6 71.8 30.2 25.1 19.4 81.5 26.9 24.8 23.0 75.1 100.9 36.4 24.2 40.5 33.6 27.7 147.0 29.2 58.5 88.7 89.4 19.1 12.3 29.9 24.4 27.6 63.2 52.5 12.3 35.9 50.5 29.3 99.0 59.8 125.2 19.9 36.2 42.5 5.3 120.9 142.8 12.2 30.6 5.4 42.9 137.6 22.9 12.2 49.7 49.2 25.5 2.2 0.6 37.3 45.3 0.7 25.2 32.3 285.4 78.5 38.6 64.1 25.3 17.5 132.3 46.3 30.4 98.9 38.4 35.3 152.2 78.1 35.0 46.7 10.1 28.7 68.8 45.6 11.3 28.6 15.5 47.4 0.3 48.3 0.8 21.1 17.5 6.3 18.3 9.9 5.2 6.0 6.1 20.7 4.9 6.8 6.3 2.2 15.0 20.6 1.3 11.3 11.0 23.1 32.5 24.8 27.7 29.0 27.9 23.3 26.3 23.5 25.1 24.8 33.6 22.1 176.3 86.5 14.7 13.3 57.1 143.9 85.1 287.4 15.3 13.6 24.0 54.1 105.8 86.5 33.1 12.5 12.5 8.2 48.9 43.0 97.5 79.6 47.5 13.4 19.5 16.2 8.2 30.5 52.0 4.6 39.9 87.7 36.9 29.7 34.6 13.6 116.7 24.6 6.7 20.1 27.7 26.4 21.7 15.1 19.5 55.9 23.5 7.2 13.1 25.7 105.9 8.2 19.6 29.1 43.9 28.7 80.5 28.6 104.2 90.6 119.2 59.2 21.4 13.1 70.1 22.1 15.5 24.0 232.6 90.2 1.4 13.2 29.1 46.0 51.4 ALKBH5 "FLJ20308, OFOXD1" ENSG00000091542 "AlkB homolog 5, RNA demethylase" Q6P6C2 17 18183078-18209954 "Enzymes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 236.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007196 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA007196: AB_1850461" "unprognostic (1.07e-1)" "unprognostic (1.51e-1)" "unprognostic (2.23e-2)" "unprognostic (1.48e-2)" "unprognostic (1.80e-2)" "unprognostic (1.24e-1)" "unprognostic (2.23e-1)" "unprognostic (2.64e-1)" "unprognostic (1.34e-1)" "unprognostic (1.94e-2)" "prognostic favorable (3.75e-4)" "unprognostic (6.54e-2)" "unprognostic (3.99e-2)" "unprognostic (2.88e-2)" "unprognostic (3.22e-2)" "unprognostic (4.68e-3)" "prognostic unfavorable (5.69e-4)" 33.4 40.1 23.7 21.4 21.8 32.6 29.2 18.1 23.5 34.2 17.8 51.1 22.3 45.3 5.2 25.9 43.1 21.6 68.6 20.4 23.4 29.9 33.6 28.8 25.1 23.2 23.7 33.5 36.0 26.6 39.8 17.4 29.5 31.7 10.6 26.5 36.4 25.1 236.6 28.1 31.0 22.0 19.3 26.8 33.6 51.3 26.7 22.2 29.8 98.7 15.8 43.0 29.6 27.4 90.3 86.4 27.8 47.0 37.0 25.0 30.1 41.1 41.8 56.8 51.5 96.1 19.9 53.9 65.4 35.9 29.4 56.2 40.9 33.6 26.8 71.3 74.0 35.4 47.7 41.8 32.5 27.4 53.0 24.3 23.1 41.8 24.7 33.9 31.8 35.3 45.0 20.4 29.8 60.6 60.1 28.6 24.9 28.3 44.4 57.6 56.0 89.0 14.4 31.0 32.5 47.6 44.8 27.2 41.7 90.9 31.4 20.9 38.3 55.8 44.1 87.8 78.0 32.0 25.1 32.2 100.6 38.8 39.0 3.6 7.4 20.4 13.0 7.8 11.9 6.8 13.3 16.1 9.0 10.0 9.5 9.5 4.3 7.2 11.6 5.7 7.4 6.7 23.7 21.8 18.1 23.5 20.4 23.4 23.2 23.7 29.5 19.3 26.7 27.4 37.2 35.3 33.3 17.9 41.1 64.6 29.0 26.8 19.4 80.3 48.7 40.3 93.5 28.6 24.4 27.6 39.6 33.0 59.0 44.9 84.1 27.4 58.9 53.9 36.5 36.6 60.9 24.0 17.0 31.4 44.8 42.4 18.3 36.7 40.7 25.2 35.7 65.2 33.5 119.5 18.1 45.0 22.4 45.3 56.9 42.5 41.0 36.4 49.8 7.5 36.3 76.3 57.7 9.0 24.0 32.8 38.7 51.9 21.1 35.3 47.6 115.2 46.4 58.9 19.7 39.4 47.3 118.7 117.3 20.3 56.0 31.5 48.3 32.7 39.1 28.6 AMBP "EDC1, HCP, HI30, IATIL, ITI, ITIL, ITILC, UTI" ENSG00000106927 "Alpha-1-microglobulin/bikunin precursor" P02760 9 114060127-114078328 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Host-virus interaction" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 68 "liver: 10947.9" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 10517.4" "Cancer enriched" "Detected in many" 115 "liver cancer: 2620.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 173 "Hep G2: 1398.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA001497, CAB069436, HPA075585" Approved Approved "Golgi apparatus,Vesicles,Cytosol" "Secreted to blood" NA NA 47000000000 "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" Vesicles "Golgi apparatus, Cytosol" "CAB069436: AB_1611916, HPA001497: AB_1078144, HPA075585: " "unprognostic (6.92e-2)" "unprognostic (3.61e-1)" "unprognostic (4.95e-3)" "prognostic favorable (1.20e-4)" "unprognostic (9.79e-2)" "unprognostic (2.90e-1)" "unprognostic (1.04e-3)" "unprognostic (7.59e-2)" "unprognostic (2.83e-2)" "unprognostic (2.04e-1)" "unprognostic (2.14e-1)" "unprognostic (7.84e-2)" "unprognostic (4.36e-2)" "unprognostic (2.89e-3)" "unprognostic (4.66e-2)" "unprognostic (2.97e-3)" "unprognostic (9.45e-3)" 0.7 0.2 0.1 0.0 0.1 0.0 6.4 0.3 0.4 0.2 0.3 0.3 2.3 0.1 0.4 0.3 0.4 160.4 0.5 0.1 0.1 11.0 10947.9 0.3 0.0 0.1 0.1 0.2 125.3 0.0 0.2 0.4 0.1 0.2 0.5 0.2 0.1 0.0 0.2 0.3 0.7 0.0 0.1 3.1 2.6 1.0 0.1 0.1 0.4 0.0 0.2 0.1 0.2 0.0 0.0 6.7 0.1 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.0 1.8 0.0 1.8 2.1 0.2 0.9 0.5 0.0 0.0 0.0 3.2 0.0 3.0 1.0 1398.1 0.0 5.5 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.1 0.1 0.3 0.0 0.9 3.1 0.0 0.2 8.1 0.4 5.9 0.6 1.7 0.0 2.8 1.1 0.0 0.1 0.0 0.2 1.0 0.0 0.8 0.0 0.4 1.0 0.3 1.5 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.5 0.0 19.1 1.5 0.6 0.0 2.2 0.0 1.9 0.4 0.2 2585.0 0.6 1.8 0.0 0.1 0.0 0.6 3.9 216.5 30.4 0.2 0.1 10.0 2.4 219.2 0.1 28.2 0.8 0.1 0.0 1.0 0.0 0.0 181.3 10517.4 0.7 0.0 0.1 1.6 0.0 243.7 0.5 59.4 0.6 0.2 0.0 0.0 3.6 0.0 0.0 0.0 0.0 14.9 1.7 0.0 0.0 0.6 0.6 13.7 0.0 0.0 0.0 0.0 0.5 0.6 0.2 1.1 0.4 1.4 14.3 0.0 1.2 0.3 ANKRD18A "FLJ35740, KIAA2015" ENSG00000180071 "Ankyrin repeat domain 18A" Q8IVF6 9 38571358-38620596 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 18.2;brain: 21.9" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 33.3;Excitatory neurons: 24.8;Inhibitory neurons: 26.8;Oligodendrocytes: 118.1;Rod photoreceptor cells: 31.2;Spermatocytes: 53.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HL-60: 17.9" "HPA046346, HPA046695, HPA049923, HPA051288" Uncertain Uncertain "Nucleoli,Nucleoli rim,Cytosol" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 43: THP-1 - Innate immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoli, Nucleoli rim" Cytosol "HPA046346: AB_2679631, HPA046695: , HPA049923: AB_2680954, HPA051288: AB_2681421" "unprognostic (4.02e-2)" "unprognostic (1.07e-1)" "unprognostic (1.42e-3)" "unprognostic (1.69e-2)" "unprognostic (2.05e-1)" "unprognostic (2.38e-2)" "unprognostic (1.26e-1)" "unprognostic (2.37e-1)" "unprognostic (4.34e-1)" "unprognostic (1.15e-1)" "unprognostic (1.92e-2)" "unprognostic (1.94e-5)" "unprognostic (2.31e-2)" "unprognostic (1.63e-2)" "unprognostic (1.58e-2)" "unprognostic (7.03e-2)" "unprognostic (2.14e-1)" 0.0 0.1 3.0 0.3 9.1 18.2 0.4 3.6 3.7 0.4 0.0 0.5 0.3 0.2 0.2 0.8 0.5 0.4 0.6 3.1 5.1 0.9 0.7 0.3 0.2 12.6 6.0 0.0 2.2 0.6 1.0 0.1 14.3 0.9 0.7 5.0 0.4 0.1 0.0 1.3 0.7 0.2 5.1 0.1 1.0 7.2 8.4 0.3 2.2 0.0 0.1 0.2 0.4 21.9 4.8 3.7 3.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.6 0.0 1.9 0.0 0.0 0.9 3.5 3.4 0.0 0.0 5.2 0.0 5.6 2.9 0.0 17.9 0.5 0.0 2.3 0.0 3.1 1.7 0.0 7.2 1.7 0.4 0.3 4.6 0.1 0.9 3.7 6.2 2.1 0.0 6.5 6.8 2.1 2.0 1.5 3.0 2.4 0.5 0.2 7.1 2.6 8.3 4.5 0.0 1.3 0.1 0.0 0.3 0.6 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 3.0 9.1 3.6 3.7 3.1 5.1 12.6 6.0 14.3 5.1 8.4 21.9 0.1 0.0 1.5 1.0 0.1 0.6 2.0 1.5 3.4 3.8 2.3 2.4 9.4 1.5 3.7 1.8 2.1 0.0 0.1 0.8 1.9 5.4 8.0 33.3 1.7 0.2 4.2 0.0 24.8 2.4 0.9 0.2 7.7 19.2 0.0 14.7 0.0 0.5 0.1 0.0 26.8 3.3 2.0 0.0 0.3 2.2 0.6 0.2 0.0 1.0 0.4 9.2 0.0 18.1 118.1 3.9 2.6 0.4 0.1 1.9 1.6 0.3 11.0 31.2 0.0 0.0 0.3 53.5 4.3 3.8 1.7 0.0 1.4 0.3 2.3 1.4 ANKRD18B bA255A11.3 ENSG00000230453 "Ankyrin repeat domain 18B" A2A2Z9 9 33524394-33573009 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 34.5;choroid plexus: 10.6" "Cell type enhanced" "Detected in many" "Early spermatids: 34.4;Excitatory neurons: 13.8;Muller glia cells: 22.3;Spermatocytes: 41.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 27.5" "HPA046346, HPA046695, HPA049923, HPA051288" Uncertain Uncertain "Nucleoli,Nucleoli rim,Cytosol" NA NA "Cluster 70: Brain - Nervous system development" "Cluster 24: NB-4 - Immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoli, Nucleoli rim" Cytosol "HPA046346: AB_2679631, HPA046695: , HPA049923: AB_2680954, HPA051288: AB_2681421" "unprognostic (4.71e-2)" "unprognostic (1.85e-1)" "unprognostic (4.85e-3)" "unprognostic (1.00e-2)" "unprognostic (1.13e-1)" "unprognostic (1.17e-2)" "unprognostic (1.29e-4)" "unprognostic (1.45e-2)" "unprognostic (9.84e-2)" "unprognostic (8.65e-2)" "unprognostic (2.54e-4)" "unprognostic (1.01e-2)" "unprognostic (6.43e-5)" "unprognostic (4.89e-2)" "unprognostic (9.75e-4)" "unprognostic (8.25e-2)" "unprognostic (5.18e-2)" 0.4 0.2 16.8 0.0 17.5 0.1 0.1 34.5 30.1 0.2 10.6 0.0 0.0 0.1 0.1 1.9 0.2 0.4 0.0 18.2 13.6 0.0 0.0 0.1 0.1 22.3 15.7 0.0 0.0 0.0 0.4 0.2 21.4 1.2 0.0 1.9 0.1 0.0 0.7 2.2 0.0 0.0 12.7 0.3 0.0 3.9 14.5 0.0 0.2 0.1 0.1 0.7 0.9 17.0 10.0 8.8 0.6 0.1 0.2 1.5 0.9 2.1 2.1 2.7 2.9 2.1 0.2 0.2 0.4 0.3 2.9 2.2 5.9 2.1 3.6 0.1 5.2 10.2 13.1 1.5 0.0 3.5 0.6 0.8 3.6 3.7 9.3 0.7 5.0 0.0 5.5 0.5 3.0 1.7 0.0 27.5 9.1 0.2 4.8 0.0 13.0 2.0 1.6 2.4 0.3 8.5 4.2 0.3 0.4 5.5 7.5 13.4 4.6 1.5 5.8 4.4 3.9 1.5 0.8 0.0 0.8 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 17.5 34.5 30.1 18.2 13.6 22.3 15.7 21.4 12.7 14.5 17.0 0.0 0.0 0.0 0.7 0.0 2.0 5.4 2.9 1.2 8.5 0.5 0.9 3.1 4.3 2.8 1.8 0.0 0.0 0.0 0.6 0.0 0.8 34.4 12.1 0.2 0.3 0.0 0.0 13.8 0.5 0.4 0.1 0.0 4.0 0.0 12.1 0.4 0.1 0.2 0.0 9.0 2.0 4.1 0.0 0.3 3.7 0.6 0.2 0.0 1.9 0.0 22.3 0.0 4.0 0.8 0.4 1.7 0.7 0.0 2.5 0.3 0.1 9.8 5.5 0.0 0.5 0.5 41.4 2.1 6.2 3.3 0.0 0.2 0.0 1.3 3.9 ANKRD20A1 "ANKRD20A, DKFZp434A171" ENSG00000260691 "Ankyrin repeat domain 20 family member A1" Q5TYW2 9 67832765-67920552 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.3;testis: 4.4" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 5.8;Excitatory neurons: 14.8;Inhibitory neurons: 9.0;Oligodendrocyte precursor cells: 12.5;Spermatocytes: 10.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Karpas-707: 8.7;U-266/70: 8.7;U-266/84: 5.6" "HPA043239, HPA046346, HPA046695, HPA047112, HPA047167, HPA047766, HPA049923, HPA051288, HPA051753" Uncertain Uncertain "Nucleoli,Nucleoli rim,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 78: Testis - Spermatogenesis" "Cluster 2: Karpas-707 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoli, Nucleoli rim" Cytosol "HPA043239: , HPA046346: AB_2679631, HPA046695: , HPA047112: , HPA047167: , HPA047766: , HPA049923: AB_2680954, HPA051288: AB_2681421, HPA051753: AB_2681592" "unprognostic (4.92e-1)" "unprognostic (4.31e-3)" "unprognostic (3.97e-1)" "unprognostic (2.30e-2)" "unprognostic (5.94e-2)" "unprognostic (2.26e-2)" "unprognostic (1.31e-1)" "unprognostic (1.35e-2)" "unprognostic (2.32e-2)" "unprognostic (7.17e-2)" "unprognostic (1.70e-1)" "unprognostic (5.45e-2)" 0.4 0.2 0.8 0.1 2.6 0.5 0.4 0.1 3.3 0.3 0.0 0.4 0.1 0.2 0.3 0.8 0.4 0.2 0.9 1.3 0.2 0.3 0.2 0.5 0.1 0.4 0.1 0.2 1.0 0.2 0.7 0.0 0.7 0.4 0.7 0.8 0.4 0.2 0.1 0.4 0.3 0.2 0.1 0.7 0.1 4.4 0.4 0.3 0.4 0.0 0.0 0.1 0.4 2.9 0.2 0.2 1.3 0.5 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.9 1.4 0.0 0.0 0.3 0.5 0.9 0.3 0.0 0.0 0.2 1.5 0.1 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.2 0.3 1.4 0.3 8.7 0.0 0.0 0.8 0.0 0.0 0.8 0.1 0.0 0.0 0.0 1.6 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.3 0.4 0.8 8.7 5.6 0.0 0.3 0.0 1.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 2.6 0.1 3.3 1.3 0.2 0.4 0.1 0.7 0.1 0.4 2.9 0.0 3.2 2.0 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.3 1.2 0.2 0.0 0.8 0.0 0.0 14.8 1.8 0.0 0.3 1.5 0.1 1.3 0.5 0.0 0.0 0.0 0.0 9.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.6 0.0 0.0 12.5 0.3 0.5 2.5 0.0 0.0 0.0 1.8 0.0 2.2 0.0 0.0 0.0 0.2 10.3 1.9 0.7 0.0 0.0 0.4 0.0 1.3 0.1 ANKRD23 "DARP, FLJ32449, MARP3" ENSG00000163126 "Ankyrin repeat domain 23" Q86SG2 2 96824526-96857934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 39 "skeletal muscle: 1438.6;tongue: 448.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 5.0;Respiratory ciliated cells: 7.4;Rod photoreceptor cells: 5.2;Skeletal myocytes: 6.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "Karpas-707: 38.5" "Low region specificity" "Detected in many" HPA036201 Approved Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 2: Karpas-707 - Immune response" "Cluster 37: Myocytes - Muscle contraction" "Nucleoplasm, Cytosol" "Actin filaments" "HPA036201: AB_10673347" "unprognostic (2.48e-1)" "unprognostic (7.83e-4)" "unprognostic (4.93e-4)" "unprognostic (1.21e-2)" "unprognostic (4.28e-1)" "unprognostic (3.28e-1)" "unprognostic (3.27e-2)" "unprognostic (6.66e-2)" "unprognostic (2.46e-2)" "unprognostic (3.59e-2)" "unprognostic (1.81e-4)" "unprognostic (1.43e-1)" "unprognostic (2.04e-6)" "unprognostic (2.70e-1)" "unprognostic (1.39e-1)" "unprognostic (1.54e-1)" "unprognostic (2.70e-4)" 0.8 0.9 1.6 0.4 2.1 0.7 1.2 2.2 2.1 1.4 0.6 1.3 0.8 1.8 0.0 6.0 2.5 0.2 24.2 1.5 1.4 0.7 2.2 1.0 0.6 2.5 1.6 1.7 1.6 0.3 10.4 0.2 1.8 5.3 0.1 0.1 18.5 0.3 1438.6 2.5 1.3 0.2 1.5 2.3 0.7 0.7 1.9 0.6 1.1 448.6 0.4 1.2 1.1 2.3 0.5 0.7 0.4 0.8 0.0 0.2 1.1 0.3 0.1 0.2 0.1 0.1 0.2 0.4 0.2 0.1 0.3 0.3 0.3 0.3 0.2 1.1 1.0 0.5 0.8 0.2 0.1 0.8 1.8 0.3 0.3 0.6 0.0 0.2 0.1 1.5 0.9 38.5 0.3 0.9 0.5 0.8 0.4 0.1 0.3 1.4 0.0 5.0 0.2 0.9 1.4 0.2 0.3 0.7 0.0 0.2 1.1 0.0 0.3 0.5 0.6 0.7 0.1 1.7 0.7 0.3 0.4 1.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 2.1 2.2 2.1 1.5 1.4 2.5 1.6 1.8 1.5 1.9 2.3 1.1 0.0 1.1 2.0 0.5 0.8 0.5 0.4 0.6 2.6 0.8 2.3 5.0 0.0 1.5 0.0 2.1 0.4 2.1 0.9 0.0 0.3 3.3 1.3 1.9 0.8 0.0 0.4 2.8 1.1 0.2 1.3 0.5 0.7 1.3 1.1 1.4 1.2 0.2 1.7 2.7 1.0 0.0 0.6 0.3 1.8 1.5 0.6 0.0 1.0 0.2 1.1 1.0 0.5 2.9 0.1 0.3 3.0 0.4 0.3 0.6 0.2 7.4 5.2 0.0 6.1 1.6 1.3 0.4 0.4 1.3 0.3 1.1 0.7 0.9 0.2 ANKRD24 KIAA1981 ENSG00000089847 "Ankyrin repeat domain 24" Q8TF21 19 4183354-4224814 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.3;testis: 14.0" "Cell type enhanced" "Detected in some" "Astrocytes: 12.1;Excitatory neurons: 24.7;Extravillous trophoblasts: 19.1;Inhibitory neurons: 14.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 4.9;U-266/70: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041534, HPA048498" Uncertain Uncertain Microtubules,Cytosol NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Microtubules, Cytosol" "HPA041534: AB_2677537, HPA048498: AB_2680420" "unprognostic (3.70e-2)" "unprognostic (3.96e-3)" "unprognostic (5.23e-9)" "unprognostic (7.03e-2)" "unprognostic (5.01e-2)" "unprognostic (2.31e-1)" "prognostic favorable (9.13e-5)" "unprognostic (1.53e-1)" "unprognostic (3.52e-2)" "unprognostic (3.41e-2)" "unprognostic (1.19e-3)" "unprognostic (2.63e-2)" "unprognostic (1.27e-2)" "unprognostic (7.63e-2)" "unprognostic (1.61e-1)" "unprognostic (2.43e-2)" "unprognostic (1.73e-4)" 1.1 3.7 6.8 0.3 11.0 0.5 0.9 4.2 20.3 1.3 0.0 1.3 0.8 0.8 0.8 0.5 1.4 0.5 0.6 10.9 4.1 3.1 10.7 1.0 0.4 2.6 4.0 2.0 3.9 0.6 6.5 0.8 2.4 4.1 0.3 2.7 0.9 0.6 1.2 0.6 1.4 0.2 1.5 1.5 1.8 14.0 5.8 0.4 2.8 0.4 0.1 1.0 0.7 10.8 0.1 0.2 0.0 0.1 2.7 0.2 2.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.4 0.2 0.1 0.1 0.4 0.0 2.2 0.3 0.0 0.1 0.1 1.5 0.1 0.3 1.5 0.1 0.2 0.7 0.4 0.1 1.7 0.1 4.9 0.0 0.7 0.0 0.1 2.1 0.6 0.6 0.3 0.0 0.4 0.0 0.2 0.8 0.1 0.1 0.1 0.3 0.5 0.6 0.4 0.0 0.1 1.0 0.8 0.0 16.2 1.5 0.1 0.7 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 11.0 4.2 20.3 10.9 4.1 2.6 4.0 2.4 1.5 5.8 10.8 0.1 0.0 1.9 12.1 0.5 0.0 0.2 0.1 0.0 1.2 0.4 0.4 0.9 1.5 1.4 0.0 4.2 0.3 0.0 0.3 0.0 0.1 0.4 0.6 0.2 0.2 3.6 0.0 24.7 0.0 19.1 0.2 1.5 0.4 0.0 0.2 0.7 0.9 0.4 0.0 14.4 0.7 0.0 0.8 0.0 1.7 0.0 0.3 0.0 1.0 0.0 0.9 0.0 3.5 4.4 0.0 0.3 0.0 0.2 0.2 0.5 0.8 0.3 1.2 0.0 0.4 0.2 1.0 2.9 0.2 0.0 1.1 0.2 0.4 0.2 0.2 ANKRD27 "DKFZp434L0718, FLJ00040, VARP" ENSG00000105186 "Ankyrin repeat domain 27" Q96NW4 19 32597006-32676597 "Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 137.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042769 Approved Supported Vesicles,Cytosol NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 36: HEL - Hemostasis" "Cluster 59: Non-specific - Transcription" Vesicles Cytosol "HPA042769: AB_10796584" "unprognostic (2.16e-3)" "unprognostic (6.04e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (8.68e-4)" "unprognostic (1.63e-1)" "unprognostic (1.21e-2)" "prognostic unfavorable (1.21e-5)" "unprognostic (9.02e-2)" "unprognostic (1.07e-1)" "unprognostic (1.61e-2)" "unprognostic (2.90e-2)" "unprognostic (6.22e-3)" "unprognostic (3.74e-2)" "unprognostic (2.14e-1)" "unprognostic (4.94e-2)" "unprognostic (4.07e-1)" "unprognostic (2.26e-2)" 8.9 7.4 10.8 8.9 12.9 10.4 8.7 12.1 12.6 10.3 21.5 17.2 7.6 10.0 8.8 14.3 8.0 7.7 9.6 11.8 9.8 9.7 4.4 10.3 11.1 12.0 12.9 8.3 7.2 9.3 6.8 13.6 12.4 12.3 11.9 11.7 9.7 13.5 20.7 12.4 10.7 11.6 8.9 9.0 11.0 17.3 12.1 16.7 13.3 10.8 11.5 16.9 11.1 11.8 32.0 36.0 11.5 20.8 23.5 18.0 28.1 18.0 18.0 19.4 25.4 28.8 19.0 34.7 16.5 23.0 20.4 19.4 29.6 22.3 32.0 47.3 15.1 137.9 13.7 23.9 29.4 53.5 47.6 13.1 28.8 20.9 33.8 13.5 19.7 25.3 37.5 76.3 15.1 31.5 20.8 46.2 6.0 40.2 13.8 30.6 15.6 12.7 15.6 30.5 21.3 8.6 17.6 29.6 21.0 15.2 12.4 25.7 18.5 21.1 22.4 19.6 28.0 19.7 12.7 23.8 21.0 51.8 13.8 36.5 11.1 28.5 13.9 15.7 17.5 7.5 14.3 15.6 12.6 6.9 10.9 11.7 9.0 30.6 13.3 6.2 13.2 13.3 10.8 12.9 12.1 12.6 11.8 9.8 12.0 12.9 12.4 8.9 12.1 11.8 6.8 16.0 9.4 18.3 10.0 15.6 5.5 5.6 14.2 9.4 9.0 5.1 9.2 7.2 5.7 9.2 20.9 14.9 9.7 9.3 0.0 3.3 5.1 7.5 9.4 7.1 9.1 26.5 35.5 5.9 10.6 7.6 5.6 11.6 12.0 10.1 4.6 4.8 8.4 11.8 16.3 9.6 8.2 12.0 12.1 16.2 10.8 8.7 16.0 12.2 6.0 5.8 9.2 11.1 18.7 7.1 10.3 9.4 8.0 10.0 10.8 7.7 7.1 14.7 0.0 6.8 9.3 4.1 17.1 14.7 15.5 15.2 14.0 7.2 8.9 8.4 ANO6 "DKFZp313M0720, TMEM16F" ENSG00000177119 "Anoctamin 6" Q4KMQ2 12 45215987-45482280 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Lipid transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038958 Approved Approved "Plasma membrane,Cytosol" NA NA 47000 "Cluster 14: Monocytes - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 32: U-937 - Innate immune response" "Cluster 2: Hepatocytes - Metabolism" "Plasma membrane, Cytosol" "HPA038958: AB_10672835" "prognostic unfavorable (7.56e-5)" "prognostic unfavorable (3.82e-4)" "unprognostic (2.16e-1)" "unprognostic (1.75e-2)" "unprognostic (1.29e-1)" "unprognostic (9.82e-3)" "unprognostic (7.43e-2)" "unprognostic (3.01e-3)" "unprognostic (7.55e-2)" "unprognostic (2.84e-3)" "unprognostic (1.41e-3)" "unprognostic (3.02e-1)" "unprognostic (2.68e-2)" "unprognostic (1.26e-3)" "unprognostic (1.26e-1)" "unprognostic (4.20e-2)" "unprognostic (1.28e-1)" 86.4 25.9 7.4 16.8 8.0 9.8 27.5 7.9 8.4 28.9 13.8 29.9 36.2 38.9 25.6 25.0 27.2 31.6 27.7 7.2 10.5 36.2 56.9 40.2 13.4 10.4 8.5 56.6 25.3 58.8 6.9 50.5 10.1 29.9 15.0 3.6 25.4 37.1 56.0 12.0 51.4 48.4 9.0 16.0 13.8 11.8 9.1 24.9 13.2 46.3 12.8 35.0 16.0 9.3 41.5 44.3 25.7 35.4 119.1 61.7 97.4 57.4 72.5 38.4 36.3 71.9 61.5 21.1 52.2 92.0 34.9 54.0 24.1 32.3 45.6 31.4 16.9 25.0 17.8 62.1 37.8 39.5 19.4 51.7 31.9 33.0 48.7 95.4 52.6 44.5 19.3 34.0 42.7 11.2 41.5 13.2 28.6 0.0 18.0 23.4 33.3 24.4 36.9 63.1 11.7 39.9 59.9 36.8 27.9 67.7 43.3 62.8 70.6 41.2 26.1 41.8 29.3 18.3 21.5 25.8 37.3 122.8 33.4 3.1 5.9 1.4 2.4 6.9 2.5 1.4 2.2 2.0 5.5 1.2 2.0 1.3 0.6 2.3 7.1 2.7 3.0 4.2 7.4 8.0 7.9 8.4 7.2 10.5 10.4 8.5 10.1 9.0 9.1 9.3 65.1 60.9 11.8 54.9 10.0 30.5 20.3 27.7 23.3 1.1 23.0 18.7 23.4 30.0 21.5 18.4 0.0 34.0 14.5 2.5 3.9 38.4 1.3 13.3 32.1 37.5 8.4 8.0 49.8 37.4 28.0 44.2 21.4 26.0 12.7 20.2 52.5 88.3 19.9 0.0 49.0 11.5 12.2 56.3 22.9 3.5 51.3 46.0 17.8 68.4 29.1 8.2 15.5 110.6 3.0 73.3 10.0 40.6 12.2 29.5 70.3 23.4 16.5 0.3 39.5 45.9 52.1 3.5 4.3 25.1 22.0 24.6 17.3 6.7 14.6 30.5 ANXA7 ANX7 ENSG00000138279 "Annexin A7" P20073 10 73375101-73414076 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 693.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004312, HPA064290" Approved Uncertain Nucleoplasm,Cytosol NA NA 290000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 3: Monocytes - Immune response regulation" Nucleoplasm Cytosol "CAB004312: AB_626681, HPA064290: AB_2685233" "unprognostic (1.48e-1)" "unprognostic (4.70e-2)" "unprognostic (1.90e-1)" "unprognostic (2.23e-1)" "unprognostic (1.48e-1)" "unprognostic (1.66e-1)" "unprognostic (1.54e-1)" "unprognostic (2.08e-1)" "unprognostic (2.06e-2)" "unprognostic (1.17e-1)" "unprognostic (1.47e-1)" "unprognostic (2.67e-1)" "prognostic favorable (1.98e-4)" "unprognostic (1.63e-1)" "unprognostic (8.37e-2)" "unprognostic (6.93e-2)" "unprognostic (3.06e-2)" 79.0 72.1 60.1 58.6 61.1 85.2 75.5 55.9 67.8 69.9 57.1 64.3 39.4 57.6 80.5 69.3 57.0 51.8 113.4 62.6 64.8 116.4 126.0 60.4 60.8 55.4 57.0 67.1 55.9 240.7 55.6 57.2 58.1 69.2 74.4 32.3 70.2 70.6 200.1 61.2 44.9 68.4 60.8 53.4 51.7 26.3 62.5 55.4 83.1 139.6 84.1 75.2 57.4 63.9 143.4 101.4 38.8 95.3 148.9 145.2 84.3 93.2 244.7 119.9 100.6 149.2 164.8 56.6 92.2 177.2 78.8 116.9 73.2 110.9 118.1 140.8 54.5 80.4 46.5 133.9 130.6 115.7 35.4 90.8 105.7 149.2 265.1 104.7 108.0 60.8 106.2 156.4 154.4 114.5 66.1 74.4 43.5 85.1 693.9 53.9 110.1 103.4 209.3 86.5 30.9 42.8 105.1 239.4 90.3 54.3 149.7 61.0 100.8 48.5 87.9 148.1 122.5 100.5 153.2 79.5 114.4 147.4 38.4 188.6 98.1 129.8 57.5 74.9 78.9 96.5 88.8 72.2 101.3 75.1 80.0 71.4 98.0 97.2 77.5 43.2 127.8 137.2 60.1 61.1 55.9 67.8 62.6 64.8 55.4 57.0 58.1 60.8 62.5 63.9 85.0 67.3 61.8 24.8 68.4 86.2 137.9 189.8 40.9 33.0 56.7 40.9 131.9 62.9 120.6 93.8 14.6 210.6 61.2 76.2 193.7 167.2 9.7 82.9 43.8 82.4 191.8 119.3 44.8 150.9 112.0 85.3 51.5 60.4 108.3 69.0 56.4 122.7 119.9 10.1 50.7 82.8 193.3 83.0 87.3 6.5 137.0 91.4 85.4 15.0 301.5 66.4 36.0 26.7 46.2 133.1 47.5 174.5 73.0 125.3 57.9 262.8 161.1 26.3 26.3 82.1 92.9 24.0 42.3 72.5 92.5 177.3 78.4 46.9 76.9 146.1 APOBEC3F "ARP8, BK150C2.4.MRNA, KA6" ENSG00000128394 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3F" Q8IUX4 22 39040604-39055972 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 19.9" HPA073637 Uncertain Nucleoplasm,Cytosol NA NA "Cluster 37: B-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Cytosol" "HPA073637: " "unprognostic (1.38e-3)" "unprognostic (1.28e-3)" "unprognostic (4.63e-2)" "unprognostic (1.63e-2)" "unprognostic (6.16e-2)" "unprognostic (3.51e-2)" "unprognostic (3.90e-2)" "unprognostic (1.42e-1)" "unprognostic (6.03e-2)" "unprognostic (1.34e-2)" "unprognostic (1.57e-1)" "unprognostic (1.88e-1)" "unprognostic (2.06e-3)" "unprognostic (9.36e-2)" "unprognostic (3.21e-2)" "unprognostic (1.49e-1)" "prognostic favorable (8.28e-4)" 2.2 6.3 2.2 9.2 2.1 3.3 2.5 2.2 2.7 4.0 3.4 3.5 3.7 4.1 6.3 2.4 8.3 3.5 5.5 2.0 2.2 3.4 2.9 3.4 15.7 3.1 2.6 8.8 3.0 5.2 3.4 2.2 2.8 4.8 2.8 1.1 4.9 5.2 0.6 1.6 3.8 4.5 2.3 11.9 4.8 8.2 2.5 5.3 3.0 1.3 14.5 4.5 3.2 2.9 4.9 4.2 1.8 6.2 4.9 7.1 2.2 4.2 6.9 8.8 14.0 3.9 9.1 12.9 4.1 8.9 7.7 6.5 1.7 6.0 3.8 11.7 5.3 16.5 0.5 2.5 8.6 3.6 7.0 9.5 3.0 5.0 1.5 5.1 8.5 3.5 1.3 19.9 4.8 3.9 4.0 2.7 0.8 0.5 0.7 6.1 0.7 2.5 8.1 6.6 0.9 1.5 4.7 1.2 2.5 3.5 4.7 1.9 2.3 2.0 5.0 0.4 2.0 3.4 1.7 0.5 5.6 1.9 3.1 3.2 4.7 9.4 8.5 9.1 9.8 27.7 5.6 9.0 6.0 34.2 3.4 5.6 3.1 14.6 14.5 4.6 8.4 7.4 2.2 2.1 2.2 2.7 2.0 2.2 3.1 2.6 2.8 2.3 2.5 2.9 1.6 0.0 0.5 0.0 9.8 0.9 4.9 6.3 2.2 0.0 2.1 2.2 5.9 8.6 4.2 0.0 0.0 2.0 7.6 0.8 1.9 7.4 2.4 4.8 3.8 2.6 1.2 2.1 0.1 3.9 1.4 2.9 2.6 3.6 2.5 11.0 3.6 1.6 5.9 0.0 0.0 2.2 4.1 2.2 1.4 5.2 5.0 2.8 5.4 2.8 5.3 2.2 8.2 0.5 0.0 4.8 3.6 6.4 9.6 4.5 0.5 5.3 4.6 0.2 0.0 1.0 2.6 0.3 0.4 1.6 0.9 1.6 5.4 7.8 1.5 5.9 APOBEC3G "bK150C2.7, CEM15, dJ494G10.1, FLJ12740, MDS019" ENSG00000239713 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3G" Q9HC16 22 39077067-39087743 "Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 45.9" "Cell type enhanced" "Detected in many" "dendritic cells: 145.4;monocytes: 69.1;NK-cells: 251.3;Plasma cells: 69.5;T-cells: 120.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 30.0;Daudi: 38.3;HDLM-2: 31.8;Karpas-707: 44.2" "HPA001812, HPA073637" Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 16: Immune cells - Immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Cytosol" "HPA001812: AB_1078175, HPA073637: " "prognostic favorable (4.78e-4)" "prognostic favorable (4.70e-4)" "unprognostic (8.18e-3)" "prognostic favorable (6.03e-5)" "unprognostic (2.37e-1)" "unprognostic (3.43e-1)" "unprognostic (7.77e-2)" "unprognostic (2.33e-1)" "unprognostic (4.23e-1)" "unprognostic (4.13e-3)" "unprognostic (9.13e-3)" "unprognostic (1.81e-1)" "prognostic unfavorable (8.66e-13)" "unprognostic (3.41e-2)" "unprognostic (5.83e-2)" "unprognostic (2.91e-2)" "prognostic favorable (6.30e-4)" 5.5 8.1 3.3 21.7 3.2 15.9 8.6 3.4 4.6 7.7 2.9 7.6 5.5 10.3 10.4 6.1 21.1 11.1 4.3 3.0 4.0 4.1 5.7 14.5 45.9 3.9 3.7 22.7 1.7 4.8 3.5 5.0 3.9 7.8 9.4 1.4 8.5 22.4 1.2 1.6 9.6 9.6 4.0 28.2 10.0 20.1 3.4 25.9 5.8 2.7 35.1 15.7 6.4 4.5 4.5 0.1 0.0 0.0 5.0 9.7 0.3 1.0 16.8 19.9 30.0 1.6 22.6 38.3 0.5 7.3 11.6 0.1 0.2 1.3 6.0 31.8 0.1 23.1 0.0 0.2 21.8 7.1 10.1 14.3 0.5 10.9 2.4 0.0 2.4 1.2 1.9 44.2 3.1 0.0 7.6 7.7 0.6 0.0 1.7 15.3 0.0 25.8 0.0 19.6 0.0 0.0 0.5 0.0 2.0 1.7 0.0 13.2 0.0 2.8 0.2 0.0 0.0 0.0 3.5 0.5 3.2 6.9 5.0 30.7 42.3 28.7 363.8 98.1 207.6 84.9 108.8 281.7 52.4 66.1 34.3 160.2 34.8 232.2 123.0 28.1 92.3 297.8 3.3 3.2 3.4 4.6 3.0 4.0 3.9 3.7 3.9 4.0 3.4 4.5 8.4 3.2 8.9 1.0 55.7 1.8 15.5 27.0 4.6 0.4 3.0 6.6 3.7 7.2 14.4 0.0 2.1 3.9 145.4 0.6 5.9 11.7 47.2 5.7 6.4 8.9 6.0 8.6 0.1 2.3 1.1 10.0 2.0 3.9 12.6 62.5 11.4 0.9 30.6 0.0 0.1 1.9 10.2 20.4 9.8 13.7 19.0 21.3 7.2 3.7 69.1 8.1 251.3 0.5 0.0 2.2 1.8 9.1 69.5 16.0 0.1 2.1 12.1 1.2 19.7 4.7 10.1 1.3 1.6 2.0 1.3 1.0 120.5 20.3 1.5 18.0 ARGLU1 FLJ10154 ENSG00000134884 "Arginine and glutamate rich 1" Q9NWB6 13 106541673-106568137 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034962, HPA056792" Supported Enhanced Nucleoplasm,Mitochondria,Cytosol No No "Cluster 17: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Mitochondria, Cytosol" "HPA034962: AB_10611676, HPA056792: AB_2683236" "unprognostic (1.66e-2)" "unprognostic (3.10e-2)" "unprognostic (2.24e-1)" "unprognostic (2.82e-1)" "unprognostic (3.97e-2)" "unprognostic (3.00e-2)" "unprognostic (1.11e-3)" "unprognostic (3.21e-2)" "unprognostic (9.00e-2)" "unprognostic (1.52e-1)" "prognostic favorable (3.92e-5)" "unprognostic (1.43e-3)" "prognostic unfavorable (1.09e-4)" "unprognostic (2.91e-3)" "unprognostic (2.65e-1)" "unprognostic (2.87e-1)" "prognostic favorable (7.34e-5)" 35.0 25.5 17.9 4.5 18.4 11.0 36.3 19.5 25.2 43.7 13.5 41.2 3.5 43.1 6.2 30.8 47.0 2.9 31.1 17.8 16.4 28.2 22.9 46.3 6.7 15.2 15.6 50.4 29.3 3.7 34.1 6.1 15.3 34.7 4.7 8.6 35.1 4.5 28.4 32.1 42.6 6.3 15.3 40.8 38.2 23.7 16.2 7.0 36.3 7.5 5.7 35.6 37.6 18.2 10.5 9.4 26.0 6.4 9.0 4.6 9.1 10.2 6.5 9.1 6.6 16.8 8.3 21.5 6.1 9.2 8.4 6.9 17.4 9.9 11.4 24.5 12.3 18.8 9.2 11.6 9.3 36.0 8.2 5.0 6.8 6.9 7.2 9.2 8.1 13.0 13.4 11.4 11.4 7.7 16.4 13.9 18.6 23.6 4.0 17.3 19.7 8.9 10.6 7.3 7.0 13.8 9.9 12.7 6.1 17.6 5.8 27.0 9.2 7.5 6.2 5.9 10.0 11.1 14.2 27.4 10.6 15.6 6.7 44.6 24.2 17.2 15.4 17.7 14.1 30.2 13.5 12.1 17.1 32.4 15.3 14.6 45.7 18.8 14.8 34.2 15.7 12.8 17.9 18.4 19.5 25.2 17.8 16.4 15.2 15.6 15.3 15.3 16.2 18.2 342.0 141.1 230.6 198.8 242.0 261.7 268.5 179.3 186.1 222.7 153.9 104.0 88.3 90.1 204.9 114.0 135.5 141.9 329.3 195.3 99.7 120.7 42.0 201.2 308.3 298.1 187.7 160.3 208.8 113.2 137.7 204.7 355.7 290.6 168.7 331.2 280.2 81.5 101.3 304.5 155.6 218.5 148.5 90.7 186.2 34.0 255.1 142.1 128.1 161.1 182.1 223.3 301.8 200.6 367.2 145.0 173.8 217.7 194.9 251.0 153.7 58.6 190.7 271.2 216.9 179.6 196.8 199.8 125.9 164.1 262.3 185.2 257.8 280.7 193.1 316.0 ARL13B "ARL2L1, DKFZp761H079, JBTS8" ENSG00000169379 "ADP ribosylation factor like GTPase 13B" Q3SXY8 3 93980139-94055678 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 18.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 93.0;Rod photoreceptor cells: 102.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048926 Approved Uncertain Microtubules,Cytosol NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 77: Retina - Visual perception" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 46: Photoreceptor cells - Phototransduction" Microtubules Cytosol "HPA048926: AB_2680559" "unprognostic (2.29e-2)" "unprognostic (2.35e-2)" "unprognostic (1.91e-1)" "unprognostic (1.35e-1)" "unprognostic (1.94e-1)" "unprognostic (2.43e-1)" "unprognostic (1.04e-2)" "unprognostic (2.97e-1)" "unprognostic (1.05e-2)" "unprognostic (1.19e-1)" "unprognostic (2.15e-2)" "unprognostic (1.00e-1)" "unprognostic (5.42e-3)" "unprognostic (8.86e-2)" "unprognostic (2.73e-1)" "unprognostic (5.41e-2)" "unprognostic (7.50e-2)" 3.4 2.5 1.3 2.9 1.6 0.8 2.3 1.2 2.5 4.1 8.7 1.9 0.8 4.6 1.0 3.3 4.1 4.0 2.0 1.2 1.1 3.6 2.6 4.1 2.1 1.5 1.8 3.2 1.5 3.6 2.0 2.7 1.6 2.0 1.4 18.2 1.5 2.6 0.7 1.4 1.9 4.2 1.5 2.9 1.6 3.5 1.2 2.5 4.3 1.7 1.7 3.1 1.7 2.0 8.3 12.5 7.9 4.3 13.3 3.5 3.6 7.8 4.8 11.8 15.9 8.0 4.4 5.9 11.3 6.9 7.1 5.1 7.2 5.3 16.2 10.5 6.4 12.7 5.6 5.4 6.0 15.2 6.9 5.2 2.1 12.3 19.0 4.5 4.0 8.7 12.5 7.3 6.7 3.1 12.3 1.2 2.9 4.3 7.5 7.2 25.8 2.0 5.7 1.2 18.0 4.6 15.9 0.9 9.4 2.9 2.1 3.5 7.7 11.6 11.0 6.8 9.6 1.8 2.0 11.7 8.5 8.8 8.5 6.4 3.4 2.9 3.7 4.2 3.8 3.9 3.3 3.0 3.0 3.4 3.3 3.1 2.0 4.3 4.8 4.8 2.9 1.8 1.3 1.6 1.2 2.5 1.2 1.1 1.5 1.8 1.6 1.5 1.2 2.0 27.2 93.0 39.6 31.6 11.3 46.8 28.1 8.6 10.2 19.0 11.0 16.8 8.1 12.8 19.7 1.8 41.7 1.9 7.1 1.3 15.6 17.1 14.8 30.1 25.2 31.7 22.1 6.5 58.4 11.8 6.3 48.5 10.2 11.2 45.6 9.2 17.5 7.7 12.1 15.2 41.5 3.1 12.2 7.0 21.6 6.4 23.9 10.7 16.0 38.4 6.0 26.9 6.2 29.7 49.8 11.4 3.8 25.6 8.0 13.9 1.8 18.7 71.9 102.0 6.6 59.4 33.8 43.1 14.5 12.7 58.7 0.8 13.2 16.5 3.1 10.6 ARMCX5-GPRASP2 ENSG00000286237 "ARMCX5-GPRASP2 readthrough" X 102712495-102753530 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Group enriched" "Detected in some" 470 "Astrocytes: 29.7;Excitatory neurons: 67.9;Inhibitory neurons: 74.3;Microglial cells: 24.4;Oligodendrocyte precursor cells: 50.3;Oligodendrocytes: 35.6" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.9" HPA000887 Uncertain Nucleoplasm,Cytosol NA NA "Cluster 12: NES - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol Nucleoplasm "HPA000887: AB_2666130" 0.1 0.6 0.6 0.0 0.6 0.0 0.2 1.2 1.2 0.4 0.0 0.1 0.0 0.7 0.6 0.3 0.6 0.3 0.6 0.4 0.7 0.2 0.0 0.2 0.0 0.7 0.5 1.2 0.2 0.6 0.2 0.8 0.4 0.2 0.9 0.2 0.7 0.2 0.2 0.1 0.6 0.2 0.1 0.1 0.1 0.2 0.2 0.6 0.6 0.1 0.1 0.8 0.1 0.4 2.9 0.7 1.2 0.7 0.4 0.3 0.5 0.3 0.9 0.0 0.0 0.0 0.1 0.2 1.0 0.1 1.6 0.0 0.2 0.0 0.9 0.0 1.0 0.2 0.1 0.0 0.5 0.5 0.5 0.3 0.0 1.1 0.5 0.1 0.0 0.0 0.8 0.0 0.5 0.1 0.7 0.4 0.7 0.3 0.8 0.0 0.0 0.2 0.4 0.6 0.5 0.1 0.1 0.6 0.2 0.1 0.2 0.4 0.6 0.5 0.3 0.0 0.1 0.0 1.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 1.2 1.2 0.4 0.7 0.7 0.5 0.8 0.2 0.2 0.8 0.0 0.0 0.0 29.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.0 0.0 50.3 35.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARMH1 "C1orf228, MGC33556, NCRNA00082, p40" ENSG00000198520 "Armadillo like helical domain containing 1" Q6PIY5 1 44674692-44725591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 8.2;testis: 11.7" "Cell type enhanced" "Detected in some" "B-cells: 5.0;Collecting duct cells: 3.7;Endometrial ciliated cells: 13.1;Granulosa cells: 6.2;Hofbauer cells: 11.3;Macrophages: 5.1;T-cells: 5.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 8.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 6.9;MOLT-4: 4.9;NB-4: 7.5;U-937: 9.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034769 Uncertain Uncertain Cytosol NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 32: U-937 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "HPA034769: AB_10670979" "unprognostic (2.01e-5)" "unprognostic (4.28e-3)" "unprognostic (7.27e-2)" "prognostic favorable (8.64e-4)" "unprognostic (9.23e-2)" "unprognostic (7.43e-3)" "unprognostic (3.40e-1)" "unprognostic (2.16e-2)" "unprognostic (1.49e-2)" "unprognostic (9.34e-3)" "unprognostic (1.22e-2)" "unprognostic (9.38e-2)" "unprognostic (1.25e-10)" "unprognostic (1.99e-4)" "unprognostic (1.50e-1)" "unprognostic (6.77e-3)" "unprognostic (1.09e-3)" 0.4 1.1 1.7 0.2 2.2 2.2 0.7 1.1 2.6 0.8 4.5 0.5 0.2 1.7 3.5 0.5 8.2 0.7 0.2 2.3 1.3 0.9 4.2 1.0 0.6 2.6 4.0 2.6 0.5 1.9 3.3 0.3 2.1 0.8 0.3 4.2 0.7 0.6 0.1 0.8 0.3 0.3 1.8 0.3 0.7 11.7 1.9 0.4 0.6 0.0 0.3 0.3 0.3 2.2 0.2 0.3 1.8 0.1 0.5 2.1 0.5 0.0 0.2 0.5 0.3 0.4 3.8 0.2 0.2 0.8 0.9 0.5 0.0 0.0 0.0 1.0 0.2 0.9 2.6 0.6 0.2 6.9 4.1 1.7 0.2 0.7 0.0 1.3 0.2 0.3 0.1 0.7 0.2 0.0 4.9 7.5 0.1 0.5 0.0 2.7 0.1 2.2 0.7 0.0 1.2 0.8 0.0 1.2 0.9 1.2 0.3 3.6 0.0 0.3 0.3 0.3 0.0 0.3 0.1 0.2 0.3 9.9 0.4 8.7 2.1 6.1 0.2 0.7 0.1 0.6 1.1 0.8 1.0 0.9 1.6 1.5 1.0 0.4 0.0 4.8 0.0 1.4 1.7 2.2 1.1 2.6 2.3 1.3 2.6 4.0 2.1 1.8 1.9 2.2 0.5 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 1.2 1.7 0.0 0.0 0.0 3.7 0.0 0.4 1.3 0.0 1.9 0.7 0.0 13.1 0.6 0.1 0.0 0.0 0.0 0.4 0.2 0.3 0.0 0.7 0.0 6.2 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 5.2 0.9 0.0 0.0 ARSA ENSG00000100299 "Arylsulfatase A" P15289 22 50622754-50628173 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 127.5;Plasma cells: 132.0;Proximal enterocytes: 93.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 80.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005554, CAB025183" Enhanced Uncertain "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA 5600000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 71: Testis - DNA repair" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" Cytosol "CAB025183: , HPA005554: AB_1078220" "unprognostic (1.55e-1)" "unprognostic (1.97e-1)" "unprognostic (4.07e-2)" "prognostic favorable (2.96e-5)" "unprognostic (4.66e-2)" "unprognostic (4.40e-1)" "unprognostic (1.43e-2)" "unprognostic (1.15e-1)" "unprognostic (3.61e-2)" "unprognostic (2.16e-1)" "unprognostic (4.47e-2)" "unprognostic (2.76e-1)" "unprognostic (9.90e-2)" "unprognostic (1.41e-2)" "unprognostic (1.34e-1)" "unprognostic (1.87e-1)" "unprognostic (7.73e-3)" 28.8 25.1 14.4 15.6 18.0 18.4 27.2 16.8 21.8 21.3 27.5 31.3 30.8 22.4 8.6 28.1 25.1 15.7 33.0 14.9 15.2 31.4 42.8 29.1 19.8 20.0 15.9 11.3 46.7 11.7 34.7 10.9 19.1 28.9 8.2 4.4 39.6 16.2 25.3 17.5 33.8 6.5 16.3 44.5 30.3 54.0 19.4 9.8 32.3 5.1 9.5 23.9 24.7 21.0 8.5 11.0 5.3 10.9 41.8 21.8 13.5 13.0 15.9 5.7 9.3 3.3 12.9 5.3 8.2 22.9 10.8 12.8 1.2 12.3 1.0 2.7 8.0 3.4 14.3 12.5 28.3 5.2 32.7 26.0 24.4 9.5 6.3 19.9 12.8 11.5 3.5 80.4 12.1 9.6 4.6 5.8 1.7 9.0 11.2 4.0 0.4 26.7 9.9 13.5 2.5 8.2 18.2 17.2 10.1 5.1 7.7 6.6 22.1 3.8 15.1 14.9 4.1 18.4 1.9 4.5 11.7 4.3 13.6 10.4 27.7 36.1 17.3 33.3 15.1 10.4 12.4 14.2 22.7 12.5 7.3 10.0 60.4 8.9 43.2 32.1 18.2 16.3 14.4 18.0 16.8 21.8 14.9 15.2 20.0 15.9 19.1 16.3 19.4 21.0 22.8 6.4 12.9 24.5 22.2 4.7 14.0 23.8 18.8 5.3 18.9 13.1 8.0 27.1 15.5 12.9 4.2 11.5 14.0 85.4 1.9 29.4 62.4 24.4 10.3 13.4 36.7 9.7 9.4 21.3 19.9 19.6 41.3 21.3 6.3 15.3 8.2 28.6 36.8 6.7 8.6 30.6 14.2 29.0 9.5 127.5 10.8 29.2 17.8 10.3 28.7 10.3 8.2 8.0 11.9 24.2 75.2 6.0 132.0 10.8 93.9 22.7 21.2 7.2 0.0 6.6 9.9 48.3 4.1 18.3 5.5 13.3 17.2 7.2 25.0 16.1 ARSF ENSG00000062096 "Arylsulfatase F" P54793 X 3041471-3112727 "Predicted membrane proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.9;kidney: 7.6;skin 1: 5.6" "Cell type enhanced" "Detected in some" "Astrocytes: 9.4;Distal tubular cells: 1.9;Inhibitory neurons: 4.6;Oligodendrocyte precursor cells: 2.5;Proximal tubular cells: 10.5" "Cancer enhanced" "Detected in some" "glioma: 2.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA000549 Uncertain Cytosol "Secreted in other tissues" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol "HPA000549: AB_1845055" "unprognostic (2.19e-2)" "unprognostic (8.88e-2)" "unprognostic (2.87e-1)" "unprognostic (5.41e-3)" "unprognostic (3.83e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (9.72e-2)" "unprognostic (4.70e-1)" "unprognostic (6.33e-2)" "unprognostic (1.29e-1)" "unprognostic (3.05e-2)" "unprognostic (3.59e-1)" "unprognostic (1.23e-1)" "unprognostic (9.76e-2)" "unprognostic (1.48e-1)" 0.0 3.0 2.6 0.0 3.6 0.1 0.2 3.0 2.7 0.4 1.5 0.0 0.0 0.0 1.6 2.6 0.0 0.0 0.0 3.2 2.1 7.6 1.6 0.0 0.0 4.9 2.9 0.0 0.6 0.3 0.0 0.0 3.1 0.1 0.0 0.1 0.2 0.0 0.1 5.6 0.0 0.0 2.8 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.5 0.2 1.6 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.6 3.6 3.0 2.7 3.2 2.1 4.9 2.9 3.1 2.8 3.0 2.1 0.0 0.0 0.0 9.4 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 ASPN "FLJ20129, PLAP-1, SLRR1C" ENSG00000106819 Asporin Q9BXN1 9 92456205-92482506 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Biomineralization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 95.3;smooth muscle: 110.5" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 67.2;Fibroblasts: 94.6;Microglial cells: 24.4;Sertoli cells: 39.5;Smooth muscle cells: 73.5;Suprabasal keratinocytes: 27.0" "Cancer enhanced" "Detected in all" "breast cancer: 51.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 2.4" "Lineage enhanced" "Detected in single" "granulocytes: 2.4" "Cell line enhanced" "Detected in some" "ASC TERT1: 16.0;BJ hTERT+: 5.7;HHSteC: 23.2;HSkMC: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007894, HPA008435, HPA024230" Approved Uncertain Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA 2100000 "Cluster 18: Basophils - Vesicular transport" "Cluster 46: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm Cytosol "HPA007894: , HPA008435: AB_1845112, HPA024230: AB_1845113" "unprognostic (2.40e-1)" "unprognostic (1.02e-2)" "unprognostic (8.13e-3)" "unprognostic (3.51e-2)" "unprognostic (1.22e-1)" "unprognostic (1.01e-2)" "unprognostic (9.50e-3)" "unprognostic (1.17e-1)" "unprognostic (2.74e-3)" "unprognostic (6.38e-2)" "unprognostic (3.70e-2)" "unprognostic (4.70e-2)" "prognostic unfavorable (1.64e-7)" "unprognostic (1.42e-3)" "unprognostic (3.04e-2)" "unprognostic (6.27e-3)" "unprognostic (2.48e-2)" 29.6 7.6 1.2 5.7 1.7 0.1 11.8 2.3 2.0 40.9 0.9 25.5 9.6 69.6 9.7 10.1 16.9 65.9 95.3 1.2 1.2 11.2 41.1 14.3 3.0 1.3 1.2 7.1 13.4 3.8 2.5 4.3 1.6 4.7 11.3 0.2 3.2 11.7 7.8 12.1 17.6 110.5 1.0 2.3 12.0 1.2 1.8 2.5 11.1 19.8 5.5 13.4 5.0 1.7 0.1 0.0 0.0 0.0 1.4 16.0 0.2 2.6 5.7 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 23.2 0.2 0.0 4.5 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.0 1.2 1.7 2.3 2.0 1.2 1.2 1.3 1.2 1.6 1.0 1.8 1.7 12.9 0.0 1.1 0.3 0.1 67.2 0.1 0.0 0.0 0.4 0.4 0.1 8.5 0.0 0.6 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.1 4.2 6.8 0.0 0.0 2.0 0.0 0.1 94.6 0.5 0.2 1.3 0.1 13.9 0.4 0.2 0.0 1.7 0.0 0.0 0.0 13.5 0.6 5.9 0.8 14.2 24.4 0.0 0.1 0.0 1.5 1.1 0.0 0.0 1.9 0.3 0.0 0.0 0.0 0.7 0.6 39.5 4.3 73.5 0.0 0.1 0.3 27.0 0.0 1.7 0.3 0.0 0.0 ATP12A "ATP1AL1, H-K-ATPase, HK" ENSG00000075673 "ATPase H+/K+ transporting non-gastric alpha2 subunit" P54707 13 24680408-24712472 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Potassium transport, Sodium transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 11.2;kidney: 5.4;lymphoid tissue: 14.8;placenta: 5.6;skin 1: 6.2" "Group enriched" "Detected in some" 4 "Basal respiratory cells: 75.6;Club cells: 49.2" "Cancer enhanced" "Detected in many" "testis cancer: 12.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "SuSa: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA039526 Approved Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 12: NES - Nervous system development" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Plasma membrane, Actin filaments" Cytosol "HPA039526: AB_10673534" "unprognostic (8.33e-3)" "unprognostic (3.58e-2)" "unprognostic (2.93e-1)" "unprognostic (5.21e-3)" "unprognostic (2.58e-1)" "unprognostic (1.21e-2)" "unprognostic (8.03e-3)" "unprognostic (2.64e-1)" "unprognostic (1.50e-1)" "unprognostic (1.18e-1)" "unprognostic (3.39e-1)" "unprognostic (2.24e-1)" "unprognostic (1.78e-1)" "unprognostic (1.67e-1)" "unprognostic (6.80e-2)" "unprognostic (8.22e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.1 0.0 5.4 0.0 0.6 0.0 0.0 0.1 0.0 0.1 0.6 0.0 5.6 0.0 0.2 2.0 0.0 0.1 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 14.8 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.7 1.0 0.0 0.0 0.0 75.6 0.0 0.0 0.2 0.3 0.4 0.0 49.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.3 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.0 2.2 1.3 0.0 0.0 0.0 0.0 0.0 0.7 0.2 8.2 0.0 0.0 0.1 0.3 0.1 0.0 1.0 0.0 0.0 0.0 1.0 0.6 0.1 1.2 0.0 0.0 0.2 0.0 0.1 13.6 0.0 0.0 0.0 1.8 1.0 1.1 0.0 0.0 0.0 0.1 0.0 0.1 1.3 ATP6V0A1 "a1, ATP6N1, ATP6N1A, Stv1, Vph1, VPP1" ENSG00000033627 "ATPase H+ transporting V0 subunit a1" Q93050 17 42458844-42522582 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 130.7" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 294.0;Rod photoreceptor cells: 403.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022144 Enhanced Approved "Nuclear speckles,Golgi apparatus,Vesicles,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 58: Brain - Synaptic function" "Cluster 2: Karpas-707 - Immune response" "Cluster 46: Photoreceptor cells - Phototransduction" "Golgi apparatus, Vesicles" "Nuclear speckles, Cytosol" "HPA022144: AB_1845189" "unprognostic (3.93e-2)" "unprognostic (2.02e-1)" "unprognostic (4.35e-2)" "unprognostic (2.22e-2)" "unprognostic (1.60e-2)" "unprognostic (8.69e-2)" "unprognostic (1.84e-2)" "unprognostic (8.82e-2)" "unprognostic (1.47e-1)" "unprognostic (1.85e-1)" "prognostic favorable (2.05e-4)" "unprognostic (3.25e-1)" "prognostic favorable (1.28e-4)" "unprognostic (3.07e-1)" "unprognostic (3.68e-2)" "unprognostic (2.62e-2)" "prognostic unfavorable (6.90e-4)" 17.7 28.2 30.6 18.0 35.2 21.5 16.3 16.8 42.7 13.4 0.0 22.1 34.6 20.9 19.6 17.4 17.1 22.7 18.9 43.6 44.1 37.4 21.0 24.1 13.1 25.6 26.2 20.0 17.4 86.0 39.0 21.2 34.6 17.4 20.5 130.7 13.5 18.6 59.3 28.1 24.3 21.5 12.1 21.8 16.3 18.7 30.9 15.2 30.3 25.3 14.9 11.9 12.8 27.2 18.4 37.0 22.1 40.1 36.5 31.7 12.9 12.7 23.3 26.4 34.2 23.9 39.9 3.4 22.6 26.2 36.2 38.7 34.5 21.5 30.4 28.3 36.2 29.2 27.3 19.0 22.7 12.8 50.9 23.5 30.3 42.4 18.0 32.6 18.9 13.2 108.0 111.3 39.7 15.8 5.1 11.3 14.3 23.9 0.4 0.2 23.0 51.2 30.2 14.4 60.9 32.0 19.7 17.7 37.1 28.8 43.0 19.0 11.4 22.3 0.9 33.0 15.3 45.0 66.1 6.8 29.7 0.2 26.5 21.6 14.5 11.2 1.0 4.4 1.6 4.7 0.7 0.2 12.2 7.3 1.2 0.9 18.7 0.1 3.3 6.2 3.7 6.6 30.6 35.2 16.8 42.7 43.6 44.1 25.6 26.2 34.6 12.1 30.9 27.2 20.0 19.2 48.0 47.0 23.0 19.8 56.7 15.7 32.5 164.8 15.7 16.5 21.1 28.6 18.3 14.7 294.0 34.3 16.7 46.2 11.7 16.3 4.0 32.8 27.4 22.2 84.9 45.8 125.0 18.5 15.7 31.0 23.4 74.0 24.1 74.5 16.4 37.8 53.8 95.9 112.3 27.3 12.2 37.8 29.2 3.9 17.4 42.8 40.9 38.4 17.7 59.3 3.1 61.3 80.5 24.2 37.6 23.7 13.8 32.7 56.9 32.5 11.4 403.4 6.6 39.4 32.3 38.8 18.2 21.7 20.2 99.9 6.9 35.0 24.5 14.9 ATP6V0A4 "a4, ATP6N1B, ATP6N2, RDRTA2, RTA1C, RTADR, Stv1, Vph1, VPP2" ENSG00000105929 "ATPase H+ transporting V0 subunit a4" Q9HBG4 7 138706294-138799560 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "kidney: 63.6;salivary gland: 78.4" "Cell type enhanced" "Detected in some" "Collecting duct cells: 16.5;Cytotrophoblasts: 13.4;Distal tubular cells: 31.3;Ionocytes: 57.0" "Cancer enriched" "Detected in many" 8 "renal cancer: 25.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SK-BR-3: 55.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA018029, HPA064555" Enhanced Uncertain Cytosol NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" Cytosol "HPA018029: AB_1845190, HPA064555: AB_2685284" "unprognostic (1.99e-2)" "unprognostic (8.60e-3)" "unprognostic (1.12e-2)" "unprognostic (3.10e-2)" "unprognostic (1.43e-1)" "unprognostic (6.53e-2)" "unprognostic (4.63e-2)" "unprognostic (4.28e-1)" "unprognostic (1.35e-1)" "unprognostic (9.79e-3)" "unprognostic (1.73e-1)" "prognostic favorable (1.32e-6)" "unprognostic (4.35e-1)" "unprognostic (1.56e-1)" "unprognostic (1.02e-1)" "unprognostic (1.10e-2)" 0.2 0.0 0.3 0.0 0.4 0.0 4.7 0.1 0.5 3.7 3.1 0.0 0.1 0.1 1.2 4.9 0.0 0.0 0.0 0.6 0.2 63.6 0.0 0.4 0.0 0.3 0.2 0.0 0.1 1.6 0.1 2.5 0.2 0.9 0.0 0.0 78.4 1.5 0.0 10.2 0.0 0.0 0.2 0.0 0.1 0.2 0.3 0.4 0.0 0.0 3.7 0.1 0.2 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.5 0.8 0.1 0.6 0.6 1.8 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.7 5.0 1.9 0.0 0.1 0.0 0.1 0.1 0.6 0.0 4.5 0.2 0.0 0.0 0.1 55.7 1.9 2.9 0.1 0.0 0.2 0.6 1.3 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.1 0.5 0.6 0.2 0.3 0.2 0.2 0.2 0.3 0.3 0.0 0.0 1.1 0.3 0.0 0.0 1.1 0.9 0.0 0.0 2.5 1.4 0.5 0.0 1.7 16.5 2.1 13.4 0.3 0.0 31.3 0.0 2.2 0.9 0.1 0.1 0.0 0.0 1.4 0.0 0.7 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 1.2 0.0 57.0 0.0 0.0 2.8 0.3 0.0 7.2 1.0 0.0 0.0 0.0 6.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.3 4.4 0.1 0.0 0.0 0.1 0.6 0.7 0.0 0.1 5.1 0.2 0.0 0.0 1.3 ATP8B2 "ATPID, KIAA1137" ENSG00000143515 "ATPase phospholipid transporting 8B2" P98198 1 154325525-154351304 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 26.8;Excitatory neurons: 28.5;Inhibitory neurons: 31.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 6 "granulocytes: 2.8;T-cells: 3.7" "Cell line enhanced" "Detected in many" "ASC diff: 120.9;fHDF/TERT166: 112.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046680, HPA061103" Approved Supported "Nucleoli,Plasma membrane,Cytosol" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 36: Stromal cells - Cell proliferation" "Plasma membrane" "Nucleoli, Cytosol" "HPA046680: AB_2679749, HPA061103: " "unprognostic (1.68e-1)" "unprognostic (3.68e-1)" "unprognostic (8.40e-2)" "unprognostic (5.16e-2)" "unprognostic (4.52e-1)" "unprognostic (8.17e-2)" "unprognostic (2.27e-2)" "unprognostic (6.93e-3)" "unprognostic (2.57e-1)" "unprognostic (1.69e-1)" "prognostic favorable (1.60e-4)" "unprognostic (2.82e-1)" "unprognostic (1.89e-3)" "unprognostic (7.77e-3)" "unprognostic (6.58e-2)" "unprognostic (3.19e-2)" "prognostic unfavorable (5.29e-5)" 17.2 9.5 8.2 22.7 7.8 5.4 14.0 18.8 11.0 28.7 20.7 17.8 12.5 39.2 17.7 11.0 30.8 18.2 15.2 10.8 9.2 6.3 3.4 18.0 25.4 8.9 8.1 35.3 5.9 10.5 19.3 15.3 9.6 18.9 9.1 2.1 7.2 21.2 3.5 8.5 17.6 39.7 5.6 19.5 14.5 16.3 8.8 18.4 15.0 7.4 19.6 19.7 17.9 7.7 2.1 15.6 20.0 20.5 120.9 80.4 0.3 41.8 77.4 26.1 30.5 0.3 0.6 1.9 21.4 112.4 17.7 9.2 23.0 5.5 19.3 46.6 16.8 19.7 20.4 18.9 37.2 0.1 14.8 53.4 1.3 40.6 38.7 35.6 40.0 25.1 37.6 47.8 22.7 21.8 36.2 2.5 43.7 0.4 17.4 39.9 12.7 71.5 5.3 0.4 17.4 22.7 11.3 2.8 30.3 28.3 14.9 15.3 34.7 40.2 19.2 51.4 13.5 58.0 75.7 11.1 14.1 2.2 24.7 2.8 0.0 1.7 1.1 0.0 0.7 0.3 1.7 1.9 0.0 0.2 1.4 1.2 0.0 0.5 0.0 0.3 3.7 0.5 8.2 7.8 18.8 11.0 10.8 9.2 8.9 8.1 9.6 5.6 8.8 7.7 6.4 3.2 4.5 26.8 7.7 2.5 1.4 0.9 0.0 4.5 1.9 2.3 6.2 0.0 1.9 0.0 2.1 0.1 16.0 0.1 0.0 1.6 0.6 6.5 20.5 9.0 0.0 0.4 28.5 0.2 0.5 12.8 0.5 2.4 7.6 10.8 13.6 0.8 0.4 8.4 31.7 0.2 0.0 1.0 4.2 1.4 11.5 1.3 7.2 4.7 0.9 3.4 7.2 4.0 4.2 0.9 0.0 14.7 13.9 5.6 0.0 0.2 4.4 0.5 0.0 9.5 11.2 2.6 4.3 0.6 1.6 0.3 17.2 6.7 0.1 0.8 ATP8B4 "ATPIM, KIAA1939" ENSG00000104043 "ATPase phospholipid transporting 8B4 (putative)" Q8TF62 15 49858238-50182817 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "bone marrow: 78.1" "Cell type enriched" "Detected in many" 6 "Microglial cells: 248.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 15.2;NK-cell: 11.0" "Group enriched" "Detected in many" 5 "granulocytes: 15.2;NK-cells: 11.0" "Cell line enhanced" "Detected in some" "HMC-1: 40.2;NB-4: 19.2;THP-1: 26.7;U-937: 103.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA040254 Approved Uncertain Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" "Nucleoplasm, Vesicles" Cytosol "HPA040254: AB_10673028" "unprognostic (6.45e-3)" "unprognostic (3.83e-2)" "unprognostic (5.39e-2)" "unprognostic (2.96e-3)" "unprognostic (3.25e-1)" "unprognostic (6.51e-3)" "unprognostic (1.03e-1)" "unprognostic (4.87e-3)" "unprognostic (1.64e-2)" "unprognostic (5.11e-2)" "unprognostic (1.20e-1)" "unprognostic (3.74e-2)" "unprognostic (5.99e-2)" "unprognostic (5.12e-2)" "unprognostic (1.20e-2)" "unprognostic (1.53e-1)" "unprognostic (2.08e-1)" 1.4 1.1 2.3 2.5 2.4 78.1 0.7 3.5 6.5 1.5 3.0 1.1 0.7 6.4 4.2 0.5 3.1 2.2 0.4 4.5 2.9 1.2 1.6 1.1 1.0 2.5 2.6 0.4 0.5 0.2 0.3 3.5 2.8 0.6 1.7 0.1 0.5 0.8 0.1 0.3 1.3 3.1 3.1 2.6 0.6 0.4 2.4 0.5 0.1 0.1 1.0 1.4 0.4 4.9 0.1 0.6 0.0 0.0 0.0 0.7 0.2 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.5 0.5 0.2 0.0 0.2 12.2 0.0 7.3 1.7 0.1 0.0 13.6 40.2 0.7 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 19.2 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.1 1.5 0.1 1.2 0.0 0.0 0.1 0.0 26.7 0.0 0.0 0.3 1.0 0.0 0.1 0.0 0.0 1.3 103.7 0.0 15.2 2.0 3.8 0.4 1.2 0.1 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.8 11.0 0.4 0.0 0.0 0.9 2.3 2.4 3.5 6.5 4.5 2.9 2.5 2.6 2.8 3.1 2.4 4.9 1.7 0.0 1.9 1.6 0.8 1.5 0.1 0.2 0.6 0.6 0.2 0.6 1.3 0.0 0.1 0.0 0.0 5.4 12.5 0.3 0.0 0.0 27.6 0.3 1.7 1.0 0.0 12.2 20.3 0.0 1.8 8.1 3.1 0.2 19.7 0.0 1.1 3.7 16.4 0.0 17.5 0.3 2.0 37.0 17.7 25.3 1.8 27.0 1.8 248.3 6.3 0.5 15.5 1.0 2.1 0.0 0.1 0.7 4.8 2.3 0.7 1.2 0.7 0.2 0.0 1.0 7.0 0.5 0.6 0.6 0.3 2.9 13.4 1.1 0.2 0.3 AURKA "AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7" ENSG00000087586 "Aurora kinase A" O14965 20 56369389-56392337 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 22.1;testis: 30.8" "Cell type enhanced" "Detected in many" "Erythroid cells: 81.6;Extravillous trophoblasts: 67.1;granulocytes: 54.1;Spermatocytes: 168.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB001454, HPA002636" Enhanced Approved "Nucleoplasm,Mitotic spindle,Centrosome,Cytosol" Yes Yes "Cluster 7: Monocytes - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Centrosome" "Mitotic spindle, Cytosol" "CAB001454: AB_563420, HPA002636: AB_1845217" "unprognostic (7.73e-2)" "unprognostic (2.46e-2)" "unprognostic (2.76e-2)" "prognostic unfavorable (9.40e-5)" "unprognostic (1.92e-1)" "unprognostic (2.11e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (4.69e-3)" "unprognostic (2.42e-1)" "unprognostic (6.88e-2)" "prognostic unfavorable (6.13e-4)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.47e-8)" "unprognostic (1.67e-1)" "unprognostic (6.83e-2)" "unprognostic (9.00e-2)" "unprognostic (5.14e-2)" 1.3 2.3 1.3 10.4 1.6 15.3 2.2 2.4 1.4 1.4 0.6 10.8 11.7 1.5 0.8 7.5 1.2 2.0 5.3 0.8 1.0 2.3 5.0 2.2 20.9 1.7 1.2 8.4 2.0 1.8 0.6 8.1 1.4 1.1 12.9 3.0 1.9 1.3 8.7 3.5 9.3 4.9 1.3 5.2 4.9 30.8 1.6 20.2 1.4 8.2 22.1 2.9 2.6 1.3 179.9 127.2 84.5 61.2 4.9 10.8 106.3 145.2 66.8 339.7 142.9 361.4 124.8 58.4 96.2 59.2 176.2 142.2 152.4 96.4 360.0 52.4 57.5 102.6 128.9 229.8 2.8 140.4 140.4 5.1 10.1 117.3 104.5 26.7 80.7 93.2 121.8 45.3 146.9 182.1 85.3 108.9 78.3 145.6 129.8 62.9 163.4 65.9 56.0 46.8 73.9 39.6 200.5 228.8 94.2 77.3 137.9 86.1 47.1 149.7 145.3 83.0 208.6 62.3 78.9 100.5 80.5 80.9 127.0 0.2 3.5 4.3 1.2 5.9 1.8 2.5 2.0 1.1 3.7 0.8 0.9 0.9 2.3 1.4 3.4 0.8 4.7 1.7 1.3 1.6 2.4 1.4 0.8 1.0 1.7 1.2 1.4 1.3 1.6 1.3 2.5 0.0 2.8 0.3 7.4 1.1 1.2 5.6 0.6 1.0 4.3 6.2 5.6 1.5 2.3 3.7 2.1 34.5 8.3 8.3 1.9 4.0 33.9 2.0 2.3 3.1 6.0 81.6 1.1 4.9 67.1 7.0 13.7 3.4 54.1 12.3 3.6 2.6 17.5 1.7 1.5 10.8 2.0 3.5 7.6 16.3 1.5 11.7 0.0 1.0 12.0 3.7 3.1 1.0 2.0 5.2 2.8 0.4 10.1 2.0 5.1 4.2 1.5 2.7 6.6 2.2 7.7 168.2 30.8 8.3 1.1 8.2 8.0 8.7 15.5 1.5 AXIN2 "DKFZp781B0869, MGC126582" ENSG00000168646 "Axin 2" Q9Y2T1 17 65528563-65561648 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 33.7;Extravillous trophoblasts: 102.6" "Cancer enhanced" "Detected in all" "colorectal cancer: 33.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 27.2;CACO-2: 52.3;Hep G2: 78.8;OE19: 86.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012283, CAB017783" Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 89: Fibroblasts - ECM organization" "Cluster 39: CACO-2 - Unknown function" "Cluster 38: Extravillous trophoblasts - Unknown function" "Nucleoplasm, Plasma membrane" Cytosol "CAB012283: AB_2290204, CAB017783: " "unprognostic (1.31e-2)" "unprognostic (1.29e-1)" "unprognostic (1.05e-2)" "unprognostic (3.45e-3)" "unprognostic (4.48e-1)" "unprognostic (9.81e-2)" "unprognostic (1.12e-2)" "unprognostic (1.82e-1)" "unprognostic (4.57e-2)" "unprognostic (8.84e-3)" "prognostic favorable (6.58e-4)" "unprognostic (1.98e-1)" "unprognostic (1.42e-1)" "unprognostic (3.45e-2)" "unprognostic (2.10e-1)" "unprognostic (2.74e-1)" "unprognostic (1.25e-1)" 8.7 10.9 6.8 5.4 6.9 0.9 5.3 7.9 7.9 17.2 5.5 12.3 7.1 23.9 5.9 5.9 19.8 6.6 8.0 9.4 6.2 3.7 2.7 17.0 3.5 8.5 7.9 15.0 4.2 4.2 6.2 18.4 5.3 14.0 14.6 3.4 5.2 8.9 14.6 14.9 7.4 17.3 7.3 7.4 13.6 6.7 11.0 17.3 12.3 7.8 2.7 11.4 8.0 5.6 0.0 13.9 27.2 0.5 9.6 4.1 12.0 0.4 1.3 0.9 1.7 52.3 5.0 1.0 1.7 8.0 1.0 0.4 5.7 0.1 1.9 2.4 3.1 0.0 2.4 78.8 1.0 0.1 0.1 2.4 2.1 2.2 0.6 1.6 2.4 5.1 0.2 1.2 1.4 0.3 13.9 0.1 5.3 86.9 0.6 9.9 1.6 0.1 2.6 0.3 8.4 5.5 0.5 0.3 4.8 20.0 1.0 0.3 6.3 5.3 9.6 7.6 1.7 0.1 3.0 3.8 2.5 0.6 2.6 3.2 0.0 0.0 0.1 0.0 0.4 0.5 1.1 0.2 0.0 1.8 2.3 0.4 0.0 1.0 0.0 0.0 0.0 0.3 6.8 6.9 7.9 7.9 9.4 6.2 8.5 7.9 5.3 7.3 11.0 5.6 2.4 0.0 9.0 9.8 1.0 11.2 2.2 1.0 11.4 3.7 5.2 8.1 8.7 1.5 8.1 0.0 4.2 18.1 0.7 15.2 0.0 1.4 33.7 7.8 15.1 5.3 5.4 0.0 8.4 0.9 102.6 10.3 5.6 16.5 0.0 3.1 1.1 2.0 3.8 1.7 8.7 17.4 0.0 0.0 7.5 17.5 6.5 0.6 17.8 9.4 1.0 3.3 0.0 8.0 2.0 0.8 18.9 10.9 0.9 2.9 1.9 0.9 1.3 2.5 13.1 1.6 10.6 6.2 12.9 3.3 5.5 14.2 4.6 3.6 19.8 1.3 B4GALNT4 "FLJ25045, NGalNAc-T1" ENSG00000182272 "Beta-1,4-N-acetyl-galactosaminyltransferase 4" Q76KP1 11 369499-382117 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.3;ovary: 27.8" "Cell type enhanced" "Detected in many" "Astrocytes: 133.2;Bipolar cells: 23.8;Excitatory neurons: 31.2;Horizontal cells: 33.7;Inhibitory neurons: 32.3;Muller glia cells: 45.6;Oligodendrocyte precursor cells: 28.1;Oligodendrocytes: 32.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 35.4;NTERA-2: 32.0;SCLC-21H: 39.5;SH-SY5Y: 47.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043276, HPA053126" Uncertain Uncertain Nucleoplasm,Vesicles,Cytosol "Intracellular and membrane" NA No "Cluster 35: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoplasm, Cytosol" Vesicles "HPA043276: , HPA053126: AB_2682049" "unprognostic (6.11e-2)" "unprognostic (7.82e-2)" "unprognostic (1.79e-1)" "unprognostic (6.92e-3)" "unprognostic (5.36e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" "unprognostic (2.72e-2)" "unprognostic (1.33e-1)" "unprognostic (1.53e-1)" "unprognostic (1.69e-3)" "unprognostic (4.99e-3)" "unprognostic (1.52e-10)" "unprognostic (9.01e-2)" "unprognostic (2.56e-1)" "unprognostic (2.92e-4)" "unprognostic (1.25e-1)" 0.9 0.6 23.1 0.9 17.2 0.0 3.3 5.1 33.3 17.2 0.0 5.9 0.6 14.1 0.6 2.3 11.9 0.5 1.6 23.8 12.9 1.0 0.3 0.5 0.3 19.3 20.7 27.8 1.1 2.6 17.9 0.0 14.9 6.3 0.2 5.3 2.0 1.2 0.0 2.1 2.9 1.0 8.4 0.3 2.1 1.5 15.1 0.3 0.5 0.0 0.3 1.8 6.3 13.4 0.0 4.8 35.4 20.4 0.0 0.1 8.4 6.5 1.7 2.9 0.8 3.7 0.0 0.0 4.8 0.7 5.6 1.4 4.8 8.5 0.8 0.0 12.3 0.0 13.4 11.4 0.4 0.0 8.7 0.6 5.0 0.2 3.8 12.7 0.4 1.9 11.5 0.0 0.0 10.8 0.4 0.0 32.0 0.6 14.0 0.0 0.0 4.9 0.4 0.0 39.5 47.6 2.4 1.7 0.5 3.7 14.0 0.0 9.0 2.0 11.1 3.5 0.4 0.1 1.7 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 17.2 5.1 33.3 23.8 12.9 19.3 20.7 14.9 8.4 15.1 13.4 0.1 0.0 0.0 133.2 0.2 0.8 1.5 1.4 0.6 23.8 6.5 8.9 12.5 0.0 0.1 1.8 4.2 0.1 0.3 0.1 0.0 1.3 0.0 0.6 7.1 0.6 1.8 0.0 31.2 0.0 0.0 2.4 0.0 1.1 0.0 6.9 0.0 0.0 0.2 33.7 32.3 0.1 2.0 0.0 0.0 0.0 3.1 0.1 3.6 2.8 0.2 45.6 0.0 28.1 32.5 0.2 0.0 1.2 0.0 2.6 0.0 0.0 0.1 8.6 0.0 0.0 3.3 0.1 0.2 0.1 0.3 0.3 0.1 0.6 0.5 0.4 B4GALT3 beta4Gal-T3 ENSG00000158850 "Beta-1,4-galactosyltransferase 3" O60512 1 161171310-161177968 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 114.8;Syncytiotrophoblasts: 114.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 246.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010793 Approved Supported "Golgi apparatus,Cytosol" NA NA 130000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 18: Non-specific - Mitochondria" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" Cytosol "HPA010793: AB_1078256" "unprognostic (5.67e-3)" "unprognostic (7.68e-3)" "unprognostic (1.20e-2)" "unprognostic (8.15e-3)" "unprognostic (3.91e-1)" "unprognostic (1.10e-2)" "prognostic unfavorable (5.87e-5)" "unprognostic (3.11e-2)" "unprognostic (3.13e-1)" "unprognostic (4.64e-2)" "unprognostic (1.41e-1)" "unprognostic (3.69e-1)" "prognostic unfavorable (7.12e-7)" "unprognostic (1.86e-1)" "unprognostic (1.56e-1)" "unprognostic (1.66e-1)" "unprognostic (1.38e-1)" 28.4 21.9 20.0 16.0 20.5 19.0 21.6 17.9 21.1 21.8 18.6 19.4 17.2 14.7 18.3 25.1 19.0 14.4 24.9 20.5 22.0 27.7 22.5 25.1 23.4 18.4 19.3 29.0 34.0 21.9 32.5 21.7 19.1 21.8 17.5 8.0 32.3 12.3 24.6 24.6 18.6 10.6 18.2 31.2 27.6 19.4 22.9 16.9 21.9 16.3 20.7 23.7 21.4 19.3 35.2 22.3 32.8 43.6 47.5 24.7 52.5 19.2 34.7 39.6 36.3 44.8 68.4 32.2 54.2 22.1 37.8 34.3 34.9 21.7 22.8 34.1 42.5 18.6 14.2 35.8 34.1 37.0 48.6 33.7 31.1 36.5 39.6 47.0 45.2 41.3 60.3 69.3 32.2 35.4 24.1 34.4 40.9 70.3 48.0 28.5 18.2 79.4 33.5 20.9 46.6 54.7 19.7 50.4 41.7 44.2 50.7 64.8 18.9 19.5 35.4 22.4 57.7 246.6 146.5 43.0 28.5 31.2 32.0 10.7 14.9 12.6 27.0 17.2 24.3 26.2 25.9 26.0 18.0 21.2 25.0 23.2 9.7 25.9 23.3 37.4 43.1 21.0 20.0 20.5 17.9 21.1 20.5 22.0 18.4 19.3 19.1 18.2 22.9 19.3 18.1 19.2 20.0 1.6 34.7 38.5 36.6 26.2 19.9 17.3 32.8 19.9 10.2 15.7 17.7 25.8 2.1 44.8 30.3 15.3 5.9 28.7 10.1 8.2 7.8 24.4 28.8 34.5 6.2 22.9 91.7 24.7 15.3 10.9 9.5 21.0 27.8 13.2 29.7 26.9 7.1 20.7 26.4 16.6 17.9 5.7 9.6 16.2 23.2 4.7 10.2 9.4 47.4 5.0 4.5 31.4 20.0 7.2 114.8 46.1 19.0 20.9 12.4 8.6 26.3 11.1 24.7 14.9 46.9 21.7 41.9 114.2 29.5 11.8 22.7 51.4 BARX2 ENSG00000043039 "BARX homeobox 2" Q9UMQ3 11 129375848-129452279 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 158.0;salivary gland: 131.4;vagina: 72.2" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 128.5;Breast glandular cells: 50.4;Squamous epithelial cells: 136.4;Suprabasal keratinocytes: 82.5;Urothelial cells: 84.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HDLM-2: 163.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "cerebral cortex: 2.8;hippocampal formation: 1.7" "CAB033311, HPA064966, HPA068414" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 44: HDLM-2 - Immune response" "Cluster 61: Squamous epithelial cells - Keratinization" Nucleoplasm "Golgi apparatus, Cytosol" "CAB033311: AB_781574, HPA064966: , HPA068414: AB_2685984" "unprognostic (4.25e-2)" "unprognostic (2.89e-1)" "unprognostic (2.46e-1)" "unprognostic (1.22e-5)" "unprognostic (3.85e-2)" "unprognostic (9.29e-2)" "unprognostic (1.57e-1)" "unprognostic (1.43e-3)" "unprognostic (4.80e-1)" "unprognostic (1.71e-2)" "unprognostic (4.35e-3)" "unprognostic (1.15e-1)" "unprognostic (8.39e-2)" "unprognostic (3.48e-1)" "unprognostic (8.37e-2)" "unprognostic (2.14e-2)" "prognostic unfavorable (3.06e-4)" 0.3 0.0 0.1 1.3 0.3 0.0 14.9 1.1 0.3 24.2 5.5 7.0 17.9 0.1 0.2 158.0 16.7 4.7 0.2 0.3 0.4 5.4 0.0 0.3 0.7 3.0 1.6 0.0 10.3 0.3 1.7 3.6 3.2 4.8 4.9 0.2 131.4 0.6 2.2 34.8 13.0 0.2 1.8 0.0 6.4 2.4 0.4 0.4 0.3 39.3 8.8 0.4 72.2 2.9 23.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.3 0.0 1.0 20.9 0.0 5.1 0.0 163.7 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 7.1 0.0 3.9 0.0 6.2 0.0 0.0 0.0 20.6 0.9 0.0 0.0 39.8 0.0 0.3 0.2 0.0 0.0 19.4 0.1 0.4 3.8 0.1 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.1 0.3 0.3 0.4 3.0 1.6 3.2 1.8 0.4 2.9 0.2 0.0 1.1 0.3 0.5 43.1 128.5 8.7 3.4 0.6 50.4 16.9 0.5 4.3 8.0 0.0 0.0 13.4 0.8 29.4 7.9 23.7 7.2 11.3 0.6 1.2 1.8 0.0 1.8 0.7 5.8 2.7 6.6 4.6 0.0 0.0 0.0 0.2 1.9 0.0 0.3 13.4 0.0 0.3 2.2 1.6 0.0 0.7 10.6 0.0 0.1 0.7 0.0 0.0 0.3 6.2 29.8 0.4 0.9 25.6 34.0 3.4 11.8 0.3 0.0 0.6 1.7 0.1 5.3 136.4 82.5 4.2 1.7 0.0 19.4 84.8 BATF3 "JDP1, JUNDM1, SNFT" ENSG00000123685 "Basic leucine zipper ATF-like transcription factor 3" Q9NR55 1 212686417-212699840 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 9.1" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 41.0;Langerhans cells: 50.4;Macrophages: 24.4;monocytes: 65.7;Smooth muscle cells: 20.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "intermediate monocyte: 65.9;myeloid DC: 55.3;non-classical monocyte: 99.3" "Group enriched" "Detected in many" 34 "dendritic cells: 55.3;monocytes: 99.3" "Cell line enriched" "Detected in many" 11 "HDLM-2: 497.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA075858 Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 44: HDLM-2 - Immune response" "Cluster 41: Macrophages - Immune response" Nucleoli "Nucleoplasm, Cytosol" "HPA075858: " "unprognostic (3.87e-2)" "unprognostic (2.10e-2)" "unprognostic (4.29e-2)" "unprognostic (6.85e-2)" "unprognostic (6.33e-2)" "unprognostic (3.15e-2)" "unprognostic (3.84e-2)" "unprognostic (6.59e-2)" "unprognostic (3.08e-1)" "unprognostic (6.47e-2)" "unprognostic (1.28e-2)" "unprognostic (1.75e-1)" "unprognostic (6.43e-10)" "unprognostic (9.88e-2)" "unprognostic (5.19e-2)" "unprognostic (3.90e-1)" "unprognostic (7.08e-2)" 5.9 1.1 1.9 3.6 2.9 3.0 3.0 1.4 2.8 1.8 9.1 1.7 0.6 1.3 0.0 1.1 2.0 2.0 2.1 2.2 1.9 5.1 1.1 5.8 5.9 1.8 1.8 0.6 1.7 0.4 0.9 2.5 1.9 1.8 0.6 0.0 0.9 0.4 0.5 0.9 2.3 1.8 2.3 7.3 1.5 0.5 1.7 4.2 1.6 0.6 2.6 4.9 1.4 2.0 2.4 6.6 0.7 0.0 0.2 3.1 4.3 2.3 7.4 6.5 7.0 0.0 1.7 0.0 0.9 0.4 10.6 0.0 7.0 1.1 4.5 497.4 12.5 0.1 1.9 0.0 1.2 22.6 3.9 0.5 0.0 12.5 1.8 1.0 0.1 43.5 1.1 6.5 1.3 0.0 17.8 9.3 2.7 0.0 8.4 3.5 2.4 0.3 6.0 0.0 1.4 0.9 1.6 0.0 0.5 2.3 0.0 17.8 0.0 2.7 11.1 0.5 13.4 0.5 1.4 2.7 8.7 21.3 6.2 0.0 13.6 0.0 0.0 65.9 0.0 0.7 0.2 0.3 55.3 0.0 0.0 0.0 2.2 1.5 99.3 0.2 1.8 8.8 1.9 2.9 1.4 2.8 2.2 1.9 1.8 1.8 1.9 2.3 1.7 2.0 9.6 3.2 0.6 0.3 2.4 5.7 2.3 0.9 0.0 0.2 5.2 5.5 0.5 0.0 1.6 0.0 0.0 2.1 0.7 0.0 0.0 0.7 0.7 1.5 3.1 8.2 0.0 0.4 4.5 0.4 41.0 6.8 0.0 2.3 5.1 1.0 6.1 0.4 5.8 0.0 0.6 0.1 0.0 14.4 50.4 0.8 0.9 24.4 1.8 7.5 65.7 0.1 0.0 0.5 0.9 1.1 0.0 0.0 0.0 18.9 0.0 0.4 2.7 0.4 0.0 5.2 20.0 1.0 4.1 0.1 2.8 4.5 1.9 0.1 0.0 1.4 BCL2L14 "BCL-G, BCLG" ENSG00000121380 "BCL2 like 14" Q9BZR8 12 12049844-12211084 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 15.5;stomach 1: 9.4;testis: 31.4" "Group enriched" "Detected in many" 6 "Early spermatids: 385.6;Late spermatids: 863.1" "Group enriched" "Detected in many" 4 "colorectal cancer: 5.2;pancreatic cancer: 1.8;stomach cancer: 3.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.1;NTERA-2: 1.6;OE19: 2.0;RT4: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA040665, HPA059846" Enhanced Uncertain Cytosol NA NA "Cluster 35: T-regs - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 25: Spermatids - Spermatogenesis" Cytosol "HPA040665: AB_10964282, HPA059846: " "unprognostic (3.65e-4)" "unprognostic (4.95e-3)" "unprognostic (1.68e-2)" "unprognostic (2.02e-3)" "unprognostic (2.69e-1)" "unprognostic (2.70e-4)" "unprognostic (1.10e-1)" "unprognostic (2.43e-1)" "unprognostic (3.24e-2)" "unprognostic (4.59e-5)" "unprognostic (1.06e-2)" "unprognostic (1.06e-2)" "unprognostic (5.79e-6)" "unprognostic (3.83e-2)" "unprognostic (3.37e-2)" "unprognostic (2.82e-2)" "unprognostic (1.73e-8)" 0.0 0.0 0.1 2.5 0.1 0.1 0.5 0.0 0.1 0.2 0.1 10.7 13.7 0.1 0.1 0.2 0.1 1.2 0.0 0.2 0.0 0.1 0.5 0.4 1.3 0.1 0.0 0.0 5.3 0.0 0.0 0.0 0.0 1.1 15.5 0.0 0.9 0.0 0.0 0.0 12.9 0.4 0.0 0.7 9.4 31.4 0.0 1.2 0.0 0.0 0.8 1.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.3 1.6 0.2 0.4 2.9 3.2 0.0 0.3 2.5 1.3 0.7 2.8 4.5 1.8 0.0 0.1 0.2 30.1 0.0 0.3 385.6 1.2 0.2 0.7 6.7 0.0 2.1 7.5 0.0 0.5 28.5 0.8 0.0 0.1 0.0 0.3 0.2 0.0 1.4 45.0 2.0 0.3 3.8 863.1 5.6 0.9 0.0 0.0 3.8 0.1 0.0 1.5 1.1 2.6 22.9 3.8 0.5 4.0 95.0 0.0 5.0 1.0 6.6 1.2 0.6 6.5 2.8 0.0 0.4 0.1 0.6 0.1 30.6 9.4 BEX2 DJ79P11.1 ENSG00000133134 "Brain expressed X-linked 2" Q9BXY8 X 103309346-103311007 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 194.6" "Cell type enhanced" "Detected in many" "Distal tubular cells: 418.7;Muller glia cells: 285.9;Proximal tubular cells: 201.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 52.7;NK-cells: 62.0;T-cells: 68.6" "Cell line enhanced" "Detected in many" "hTCEpi: 94.7;NTERA-2: 91.4;SCLC-21H: 135.2;SH-SY5Y: 61.4" "HPA045384, HPA078630" Uncertain Uncertain Cytosol NA NA "Cluster 30: Non-specific - Translation" "Cluster 68: Epididymis - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 39: Non-specific - Basic cellular processes" Cytosol "HPA045384: AB_2679305, HPA078630: " "unprognostic (7.56e-2)" "unprognostic (7.08e-2)" "unprognostic (3.46e-2)" "prognostic unfavorable (8.54e-7)" "unprognostic (3.21e-1)" "unprognostic (1.65e-1)" "unprognostic (4.27e-2)" "prognostic favorable (1.52e-4)" "unprognostic (7.36e-3)" "unprognostic (6.82e-2)" "unprognostic (8.22e-3)" "unprognostic (6.63e-2)" "prognostic favorable (3.05e-13)" "unprognostic (4.14e-3)" "unprognostic (6.80e-2)" "unprognostic (1.40e-1)" "unprognostic (2.38e-3)" 5.8 73.6 133.5 6.8 134.9 13.7 19.4 119.0 167.3 16.4 98.2 10.2 3.4 27.6 123.8 9.9 15.5 7.6 29.5 134.4 153.2 58.7 2.5 12.7 14.2 120.7 125.6 62.8 35.5 123.1 194.6 8.0 123.7 24.2 6.0 83.5 26.7 21.0 9.1 17.1 14.0 8.7 117.7 18.5 16.7 43.1 138.6 21.0 103.3 11.5 16.9 8.7 10.7 132.2 0.0 2.8 11.3 0.1 0.2 0.0 45.5 0.3 6.1 7.7 11.3 8.4 3.8 0.0 31.6 0.0 55.4 2.0 0.1 9.4 6.6 0.1 25.4 1.4 1.4 0.4 46.0 0.1 25.4 2.8 94.7 3.7 29.1 17.8 0.5 33.6 17.4 0.7 1.0 4.2 20.1 0.2 91.4 0.0 8.4 0.1 0.0 0.2 3.8 3.7 135.2 61.4 5.9 1.4 22.2 10.7 11.2 0.1 0.0 0.1 9.0 0.3 2.1 30.8 21.6 0.1 15.3 0.0 1.3 13.4 0.4 1.1 21.8 0.4 31.0 52.7 43.8 25.7 1.6 42.3 68.6 50.0 1.4 62.0 0.1 10.0 33.7 18.4 133.5 134.9 119.0 167.3 134.4 153.2 120.7 125.6 123.7 117.7 138.6 132.2 3.7 16.0 68.5 15.0 41.6 31.6 95.6 17.4 100.7 184.7 65.8 145.5 27.0 60.1 43.4 114.0 43.8 72.2 20.9 5.0 418.7 47.5 17.9 11.6 3.3 13.7 100.5 9.4 56.7 42.7 19.9 13.1 23.0 17.0 12.7 87.6 3.6 0.9 7.0 121.1 53.0 29.6 16.2 0.3 5.3 69.4 15.8 4.6 26.6 7.5 2.5 285.9 27.8 35.2 25.8 19.8 8.4 22.2 16.5 64.5 3.7 201.3 9.0 120.5 6.6 32.0 11.4 16.8 5.8 25.7 26.7 63.8 30.2 22.3 22.3 51.1 BFSP2 "CP47, CP49, LIFL-L, phakinin" ENSG00000170819 "Beaded filament structural protein 2" Q13515 3 133400056-133475222 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Eye lens protein" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "B-cells: 6.3;Melanocytes: 5.4;Plasma cells: 10.6" "Cancer enriched" "Detected in single" 7 "testis cancer: 1.7" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 8 "T-reg: 13.4" "Lineage enriched" "Detected in single" 43 "T-cells: 13.4" "Group enriched" "Detected in some" 6 "Daudi: 2.4;U-698: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA038464, HPA062959" Enhanced Uncertain "Plasma membrane,Cytosol" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "Plasma membrane, Cytosol" "HPA038464: AB_10672746, HPA062959: AB_2684912" "unprognostic (1.58e-3)" "unprognostic (7.47e-4)" "unprognostic (1.04e-2)" "unprognostic (2.32e-1)" "unprognostic (9.59e-2)" "unprognostic (4.04e-5)" "unprognostic (8.13e-2)" "unprognostic (5.57e-2)" "unprognostic (6.71e-2)" "unprognostic (1.91e-3)" "unprognostic (1.74e-2)" "unprognostic (4.70e-2)" "unprognostic (1.68e-5)" "unprognostic (2.11e-2)" "unprognostic (1.63e-1)" "unprognostic (8.23e-2)" "unprognostic (2.21e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 2.6 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.6 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 1.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 1.8 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.4 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.9 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.3 0.1 5.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.6 0.0 1.0 0.1 0.1 0.0 BHLHE22 "Beta3, BHLHB5, CAGL85, TNRC20" ENSG00000180828 "Basic helix-loop-helix family member e22" Q8NFJ8 8 64580365-64583627 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 23.2" "Cell type enriched" "Detected in some" 14 "Bipolar cells: 64.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 23 "THP-1: 78.4" "Group enriched" "Detected in all" 5 "amygdala: 30.7;cerebellum: 30.7;cerebral cortex: 22.7;hippocampal formation: 46.3;white matter: 13.1" "HPA064128, HPA064872, HPA067500" Enhanced Approved "Nucleoplasm,Nuclear speckles,Centrosome,Cytosol" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 43: THP-1 - Innate immune response" "Cluster 56: Bipolar cells - Visual perception" "Nucleoplasm, Nuclear speckles" "Centrosome, Cytosol" "HPA064128: AB_2685195, HPA064872: AB_2685377, HPA067500: AB_2685855" "unprognostic (9.17e-2)" "unprognostic (1.11e-2)" "unprognostic (5.44e-2)" "unprognostic (2.28e-5)" "unprognostic (7.22e-3)" "unprognostic (6.47e-4)" "unprognostic (2.41e-1)" "unprognostic (1.08e-1)" "unprognostic (1.30e-1)" "unprognostic (6.58e-2)" "unprognostic (1.52e-1)" "unprognostic (3.71e-2)" "unprognostic (2.86e-7)" "unprognostic (3.20e-2)" "unprognostic (2.29e-1)" "unprognostic (6.72e-3)" "unprognostic (1.86e-1)" 2.0 0.5 8.9 1.4 6.6 0.0 1.5 12.1 22.4 2.3 0.4 1.3 0.4 0.3 0.1 0.9 0.8 0.4 0.3 23.2 1.5 0.2 0.5 2.0 0.7 5.5 1.5 0.2 0.7 0.1 1.4 0.0 2.6 0.4 0.5 4.4 0.5 2.3 0.1 0.8 1.4 0.4 1.4 1.4 0.5 0.2 1.1 0.3 0.7 0.0 0.6 1.2 2.9 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 78.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 6.6 12.1 22.4 23.2 1.5 5.5 1.5 2.6 1.4 1.1 1.8 0.3 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 64.7 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 1.2 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.1 0.0 3.4 0.2 0.0 0.0 0.6 1.5 0.0 1.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 3.0 0.0 0.2 2.9 0.0 0.4 0.1 1.6 0.0 0.1 0.0 0.0 0.0 BLM "BS, RECQ2, RECQL3" ENSG00000197299 "BLM RecQ like helicase" P54132 15 90717346-90816166 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 5.7;lymphoid tissue: 7.9;salivary gland: 7.8" "Cell type enhanced" "Detected in many" "Erythroid cells: 18.3;Oligodendrocyte precursor cells: 58.3;Plasma cells: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005689 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 46: Basophils - DNA binding" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Cytosol "HPA005689: AB_1845372" "unprognostic (2.77e-1)" "unprognostic (3.82e-3)" "unprognostic (4.03e-2)" "unprognostic (2.98e-2)" "unprognostic (4.75e-2)" "unprognostic (9.89e-2)" "unprognostic (6.12e-5)" "unprognostic (2.82e-2)" "unprognostic (4.55e-3)" "unprognostic (5.24e-3)" "unprognostic (1.80e-3)" "unprognostic (9.12e-2)" "unprognostic (1.55e-15)" "unprognostic (6.53e-3)" "unprognostic (6.55e-2)" "unprognostic (2.43e-1)" "unprognostic (1.83e-2)" 0.3 0.2 0.9 3.6 1.1 5.7 0.5 2.3 0.9 0.1 0.3 1.4 1.0 0.4 0.4 0.6 0.3 0.3 0.3 0.8 1.1 0.1 0.1 0.4 6.4 1.2 1.4 0.1 0.2 0.0 0.6 1.2 1.1 0.1 1.7 2.4 7.8 0.0 0.5 0.4 1.6 0.4 1.0 1.6 1.1 2.2 0.9 7.9 0.3 0.1 6.2 1.0 0.2 1.0 13.0 14.4 20.4 12.6 0.1 0.9 14.6 9.4 3.2 11.1 13.4 11.7 10.1 35.1 5.9 2.6 14.1 20.4 25.7 7.1 15.1 19.1 20.5 36.4 14.8 3.9 0.0 33.7 17.3 0.3 0.1 10.6 4.7 1.3 7.9 16.9 32.7 9.9 11.0 7.4 28.3 14.5 22.2 24.9 4.2 25.4 39.1 14.7 2.3 18.9 14.6 14.7 8.5 11.5 4.8 18.1 7.2 23.4 3.7 8.6 13.6 9.6 21.0 6.4 30.4 39.5 5.6 25.8 15.7 1.7 0.6 2.6 1.6 0.8 2.6 4.6 1.4 2.1 0.7 2.3 1.0 1.1 0.7 3.1 1.0 0.7 3.2 0.9 0.9 1.1 2.3 0.9 0.8 1.1 1.2 1.4 1.1 1.0 0.9 1.0 0.9 3.2 8.9 1.0 12.9 0.3 0.5 0.5 0.6 3.6 1.3 1.0 7.9 0.0 4.2 0.0 2.1 5.5 6.9 2.2 1.9 1.0 2.7 1.3 1.3 2.0 0.0 18.3 0.7 0.7 6.8 1.8 3.6 1.7 13.3 8.1 2.2 0.6 5.7 0.0 8.6 1.3 0.0 7.7 1.3 1.6 0.0 7.7 0.0 7.5 2.7 1.7 10.3 58.3 2.6 1.2 0.3 0.4 20.6 0.7 0.2 0.0 5.4 7.1 0.0 0.9 1.7 17.1 12.9 2.2 0.6 1.0 10.2 0.7 4.0 0.4 BTBD16 "C10orf87, Em:AC061711.1, FLJ25359" ENSG00000138152 "BTB domain containing 16" Q32M84 10 122271296-122338159 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 8.3;testis: 7.8;urinary bladder: 20.2" "Group enriched" "Detected in some" 9 "Early spermatids: 123.2;Late spermatids: 69.9" "Cancer enriched" "Detected in many" 14 "urothelial cancer: 18.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "RT4: 33.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA040529, HPA057638" Uncertain Uncertain Nucleoli,Cytosol Yes NA "Cluster 35: T-regs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 34: Spermatids - Unknown function" Nucleoli Cytosol "HPA040529: AB_2677022, HPA057638: " "unprognostic (1.41e-4)" "unprognostic (1.33e-1)" "unprognostic (5.97e-2)" "unprognostic (5.98e-3)" "unprognostic (2.08e-1)" "unprognostic (2.09e-3)" "unprognostic (2.88e-1)" "unprognostic (4.54e-2)" "unprognostic (1.76e-1)" "unprognostic (6.85e-2)" "unprognostic (2.48e-2)" "unprognostic (1.77e-1)" "prognostic unfavorable (1.50e-4)" "unprognostic (1.08e-1)" "unprognostic (1.60e-1)" "unprognostic (9.12e-2)" "unprognostic (9.44e-3)" 0.1 0.0 1.0 0.0 1.4 0.0 0.5 1.2 2.3 0.3 0.7 0.5 0.0 0.1 0.3 0.1 0.4 0.2 0.0 1.1 1.2 0.3 4.0 0.2 0.0 1.4 1.4 0.0 0.1 0.0 0.4 0.1 1.4 0.8 0.0 0.0 0.4 0.0 0.3 8.3 0.1 0.1 1.3 0.0 0.1 7.8 1.2 0.0 0.4 0.0 0.1 20.2 0.5 2.1 0.0 0.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 1.5 33.7 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.0 1.4 1.2 2.3 1.1 1.2 1.4 1.4 1.4 1.3 1.2 2.1 0.0 0.0 0.0 0.0 0.0 2.8 0.4 0.2 0.0 0.0 0.2 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 1.4 123.2 0.6 0.0 0.2 0.0 0.0 0.9 0.7 0.1 0.0 0.0 0.4 0.0 0.0 0.0 4.5 0.0 0.0 1.2 0.0 0.0 0.0 0.4 69.9 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.5 9.8 1.1 3.8 0.4 0.0 0.1 0.2 1.0 3.1 0.0 0.0 0.4 0.2 10.0 0.8 0.0 3.1 0.1 0.4 0.0 0.0 2.9 BTBD19 ENSG00000222009 "BTB domain containing 19" C9JJ37 1 44808482-44815585 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 9.0" "Cell type enhanced" "Detected in many" "Skeletal myocytes: 9.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 5.4;HUVEC TERT2: 5.1;TIME: 11.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042633, HPA076404" Uncertain Uncertain Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA042633: AB_2678091, HPA076404: AB_2686796" "unprognostic (4.69e-2)" "unprognostic (8.74e-3)" "unprognostic (1.82e-3)" "unprognostic (1.20e-4)" "unprognostic (5.32e-2)" "unprognostic (3.80e-2)" "unprognostic (1.11e-2)" "unprognostic (1.20e-1)" "unprognostic (3.70e-1)" "unprognostic (1.53e-2)" "unprognostic (2.76e-2)" "unprognostic (1.92e-1)" "prognostic unfavorable (4.18e-8)" "unprognostic (2.20e-3)" "unprognostic (2.78e-2)" "unprognostic (8.29e-2)" "unprognostic (1.70e-1)" 2.7 4.3 0.4 1.1 0.4 0.9 1.4 0.5 1.0 3.8 9.0 1.1 0.4 5.4 0.7 0.7 4.0 1.2 2.0 0.5 1.2 1.5 0.8 2.3 0.4 3.2 2.1 4.2 0.6 1.5 5.3 0.8 2.0 1.3 0.4 0.0 0.8 1.2 0.4 0.6 1.1 1.6 1.4 0.9 1.0 0.7 1.7 0.1 3.2 0.4 0.3 1.1 2.1 1.5 0.1 0.9 0.8 0.8 1.7 2.0 0.6 1.7 1.0 0.7 1.6 0.0 0.7 0.0 0.7 2.9 0.4 0.2 0.0 0.8 0.3 0.8 0.1 1.6 0.3 0.9 1.8 0.0 1.2 3.0 0.1 2.9 0.5 5.4 5.1 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.5 0.0 0.0 0.0 0.2 0.1 0.9 1.0 0.0 0.0 11.9 3.0 2.3 1.4 1.3 0.4 0.1 0.0 1.8 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.5 1.0 0.5 1.2 3.2 2.1 2.0 1.4 1.7 1.5 5.8 3.2 4.2 0.0 1.4 2.0 1.9 0.8 3.4 0.1 4.2 1.8 1.3 1.5 2.9 1.8 0.0 0.4 1.2 2.6 0.0 0.9 0.6 3.8 6.8 5.2 0.0 0.4 0.6 0.6 0.4 6.2 2.0 7.3 2.5 1.1 6.1 3.3 2.9 0.0 0.3 1.7 0.0 5.9 6.2 0.1 3.1 8.1 3.6 1.9 0.5 1.1 0.0 0.5 0.1 1.0 1.4 1.2 2.3 1.1 2.6 3.3 1.5 0.1 0.0 9.3 4.5 1.0 0.2 2.1 2.3 1.2 2.7 4.1 1.0 1.4 BUB1 "BUB1A, BUB1L, hBUB1" ENSG00000169679 "BUB1 mitotic checkpoint serine/threonine kinase" O43683 2 110637528-110678063 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 11.9;lymphoid tissue: 27.5;testis: 30.3" "Cell type enhanced" "Detected in many" "Erythroid cells: 24.8;Granulosa cells: 66.1;Plasma cells: 35.2;Spermatocytes: 85.6;Spermatogonia: 20.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 221.5" "Region enhanced" "Detected in single" "white matter: 1.7" "Not detected" "Not detected" HPA006123 Supported Nucleoplasm,Cytosol NA Yes "Cluster 46: Basophils - DNA binding" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 36: HEL - Hemostasis" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Cytosol "HPA006123: AB_1845498" "unprognostic (7.74e-2)" "unprognostic (3.45e-2)" "unprognostic (9.72e-3)" "prognostic unfavorable (3.65e-4)" "unprognostic (1.61e-1)" "unprognostic (5.62e-3)" "prognostic unfavorable (1.03e-5)" "prognostic unfavorable (3.94e-4)" "unprognostic (1.26e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (2.37e-5)" "unprognostic (1.76e-1)" "unprognostic (0.00e+0)" "unprognostic (2.45e-2)" "unprognostic (3.64e-1)" "unprognostic (5.01e-2)" "unprognostic (1.28e-1)" 0.5 0.4 0.1 8.4 0.3 11.9 1.2 0.1 0.1 0.9 0.0 4.3 4.0 1.0 3.5 4.7 0.5 0.9 0.6 0.1 0.1 0.3 0.6 1.2 15.9 0.1 0.6 0.4 0.2 0.7 0.0 3.2 0.3 0.3 5.7 0.1 0.9 0.1 0.1 2.7 3.5 2.2 0.0 5.6 1.9 30.3 0.4 27.5 0.4 0.2 17.0 2.4 1.6 0.3 96.0 29.4 68.5 46.8 3.8 5.3 38.8 50.9 32.9 85.6 62.3 58.3 55.0 64.7 30.9 30.1 80.1 43.2 93.9 35.0 105.7 51.4 45.6 221.5 26.2 50.6 0.8 63.5 57.0 1.7 2.8 65.2 33.1 12.7 49.8 73.2 96.8 126.5 76.8 33.7 126.3 39.0 71.2 39.4 55.3 69.3 64.2 102.7 18.3 27.0 48.3 21.4 34.2 31.4 27.2 44.1 24.0 60.6 19.1 39.7 57.5 28.8 69.0 67.3 65.5 75.4 24.2 48.6 69.8 1.1 0.0 0.2 0.2 0.0 0.3 0.5 0.9 0.5 0.1 0.5 0.6 0.4 0.0 0.5 0.0 0.9 1.5 0.3 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.6 0.3 0.0 0.4 0.3 0.2 0.0 1.5 0.0 5.5 0.5 0.5 2.0 0.6 0.0 0.9 0.8 1.1 0.0 1.6 0.0 0.0 5.8 2.5 2.4 0.0 0.3 13.5 4.5 1.5 1.1 0.0 24.8 0.2 0.0 9.8 2.2 2.0 2.2 0.0 66.1 1.8 0.3 8.1 0.0 0.2 3.1 4.1 1.6 1.4 7.5 0.3 2.0 0.0 0.0 0.6 0.0 0.0 0.5 1.0 0.1 0.0 0.4 35.2 0.5 0.3 0.1 1.8 0.0 6.6 0.2 3.7 85.6 20.0 4.0 0.4 0.7 2.9 0.5 5.9 0.9 C17orf49 "BAP18, HEPIS, MGC49942" ENSG00000258315 "Chromosome 17 open reading frame 49" Q8IXM2 17 7014495-7017525 "Predicted intracellular proteins" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 62.0;Smooth muscle cells: 41.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA022961, HPA024457" Supported Uncertain Nucleoplasm,Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 2: Karpas-707 - Immune response" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Cytosol "HPA022961: AB_1845592, HPA024457: AB_1845593" "unprognostic (1.48e-2)" "unprognostic (1.67e-3)" "unprognostic (9.09e-2)" "unprognostic (5.15e-2)" "unprognostic (4.54e-1)" "unprognostic (3.27e-2)" "unprognostic (2.38e-1)" "unprognostic (7.62e-2)" "unprognostic (2.27e-2)" "unprognostic (4.06e-2)" "unprognostic (2.25e-2)" "unprognostic (1.49e-2)" "unprognostic (1.06e-9)" "unprognostic (5.68e-2)" "unprognostic (1.74e-1)" "unprognostic (1.41e-2)" "unprognostic (4.62e-2)" 62.3 42.6 54.9 61.5 54.6 122.1 55.5 55.6 60.4 42.1 49.3 37.8 34.9 36.0 53.1 52.8 49.3 38.2 53.1 53.7 55.4 47.2 47.1 55.3 97.5 54.6 54.0 35.6 50.8 37.7 40.1 36.9 54.1 35.3 42.3 39.2 42.2 26.8 69.6 63.1 37.0 34.0 54.6 73.0 35.5 28.2 57.2 97.6 52.9 55.1 105.4 53.9 39.5 55.9 68.2 88.3 136.8 106.6 95.4 134.5 47.0 36.1 58.7 70.8 57.5 43.6 54.5 64.6 97.1 86.8 23.0 55.1 34.5 69.8 53.7 227.6 91.6 58.4 27.9 85.3 71.6 37.7 74.8 85.4 92.4 52.9 106.0 50.7 112.0 51.6 21.9 179.3 87.5 77.7 62.3 125.1 45.9 77.1 51.2 38.3 40.0 95.1 80.9 44.6 37.2 105.3 63.4 32.3 67.5 49.1 41.0 47.9 61.7 40.8 50.3 69.7 93.5 63.8 39.5 22.5 63.6 55.6 59.9 259.3 159.7 157.7 190.8 225.8 122.3 238.7 195.9 193.8 251.3 221.0 128.9 143.0 148.1 391.4 177.4 346.7 215.3 193.1 54.9 54.6 55.6 60.4 53.7 55.4 54.6 54.0 54.1 54.6 57.2 55.9 9.6 3.2 10.3 0.0 18.2 10.5 5.9 8.2 13.1 1.2 8.9 11.2 1.1 2.8 7.2 1.8 0.0 10.9 18.1 8.2 17.6 17.7 0.2 2.3 4.1 12.3 30.6 8.6 0.0 23.1 16.5 6.0 2.6 4.2 18.9 3.1 9.3 2.1 11.1 0.0 0.0 12.5 14.2 7.8 32.3 1.4 4.1 12.0 24.9 0.0 62.0 2.1 16.5 0.0 0.0 24.2 14.3 1.5 14.1 6.6 8.8 6.0 4.1 3.5 6.6 6.1 41.9 5.4 18.5 11.9 11.8 10.4 17.6 3.3 14.0 6.2 C19orf33 "H2RSP, IMUP, IMUP-1, IMUP-2" ENSG00000167644 "Chromosome 19 open reading frame 33" Q9GZP8 19 38304164-38305006 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 515.3;skin 1: 331.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 2060.3;Pancreatic endocrine cells: 2590.4;Paneth cells: 1697.3;Proximal enterocytes: 1756.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 10 "myeloid DC: 22.2" "Lineage enriched" "Detected in many" 10 "dendritic cells: 22.2" "Cell line enhanced" "Detected in many" "A-431: 745.5;A549: 1228.0;CAPAN-2: 767.1;HBEC3-KT: 744.6;hTCEpi: 799.2;OE19: 678.3;PC-3: 659.8" "Not detected" "Not detected" "HPA054406, HPA059696" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" No No 460000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 16: Pancreatic endocrine cells - Mixed function" Nucleoplasm "Plasma membrane, Cytosol" "HPA054406: AB_2682478, HPA059696: AB_2684105" "unprognostic (9.31e-2)" "unprognostic (2.06e-1)" "unprognostic (4.34e-2)" "unprognostic (1.44e-2)" "unprognostic (3.92e-3)" "unprognostic (2.37e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (5.42e-4)" "unprognostic (2.09e-1)" "unprognostic (1.74e-2)" "prognostic unfavorable (5.05e-4)" "unprognostic (6.92e-2)" "unprognostic (5.50e-2)" "unprognostic (4.82e-2)" "unprognostic (1.61e-1)" "unprognostic (3.63e-2)" "unprognostic (6.01e-2)" 43.1 5.0 2.8 17.6 3.1 3.6 25.5 2.9 4.4 82.4 2.9 187.5 186.7 6.1 0.6 515.3 91.5 49.5 32.9 2.3 2.6 28.2 1.3 91.3 0.9 3.1 3.0 4.6 8.9 0.5 12.7 7.9 3.4 26.2 104.1 0.1 123.3 18.3 3.9 331.1 189.5 4.0 2.5 10.7 151.5 1.5 3.8 4.1 18.9 4.3 30.8 102.2 224.3 2.5 745.5 1228.0 0.0 0.6 0.0 0.0 1.2 1.0 0.0 0.0 0.0 77.1 767.1 0.0 394.2 0.0 0.7 300.1 0.0 744.6 0.0 0.4 0.5 0.4 244.2 20.0 5.4 0.0 0.2 0.0 799.2 0.3 493.3 3.3 10.2 0.9 0.4 0.5 0.8 220.4 0.1 1.9 0.4 678.3 659.8 0.2 0.2 2.8 469.5 255.2 0.8 0.8 416.6 340.8 0.8 1.6 103.7 2.3 141.6 0.5 201.9 0.7 2.8 0.7 2.4 3.7 0.1 0.2 0.2 2.1 0.6 2.2 0.2 0.0 0.4 0.1 0.5 0.1 22.2 1.4 0.7 0.3 1.0 0.4 0.1 1.8 0.0 18.2 2.8 3.1 2.9 4.4 2.3 2.6 3.1 3.0 3.4 2.5 3.8 2.5 29.1 535.2 172.9 0.0 5.4 225.3 28.4 508.7 436.5 0.0 32.5 25.5 2.4 267.4 418.0 55.2 0.0 8.6 1.7 2060.3 1.9 207.7 0.7 144.3 26.0 18.4 76.1 3.6 0.1 753.8 1.3 44.7 353.7 273.2 38.2 3.7 3.6 0.4 1.3 0.0 0.0 842.0 99.7 1.4 15.1 5.1 4.1 32.9 1.8 0.0 4.9 0.0 0.0 0.0 0.0 2590.4 1697.3 0.0 5.7 35.7 1756.4 51.7 212.5 0.0 0.0 0.4 14.3 1.8 1.9 629.0 348.4 3.1 7.9 0.0 691.9 188.4 C19orf38 HIDE1 ENSG00000214212 "Chromosome 19 open reading frame 38" A8MVS5 19 10836575-10869790 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "bone marrow: 98.0" "Cell type enhanced" "Detected in many" "Kupffer cells: 90.1;Langerhans cells: 33.4;Macrophages: 59.2;monocytes: 86.7;Plasma cells: 24.7;Spermatocytes: 28.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 20 "classical monocyte: 282.3;eosinophil: 169.4;intermediate monocyte: 312.5;myeloid DC: 162.2;neutrophil: 230.1;non-classical monocyte: 392.8" "Group enriched" "Detected in all" 20 "dendritic cells: 162.2;granulocytes: 230.1;monocytes: 392.8" "Cell line enriched" "Detected in some" 4 "U-937: 50.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA012150, HPA055027" Uncertain "Golgi apparatus,Plasma membrane,Cytosol" No NA "Cluster 7: Monocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol "Golgi apparatus, Plasma membrane" "HPA012150: AB_10603448, HPA055027: " "unprognostic (6.65e-3)" "prognostic favorable (2.43e-4)" "unprognostic (6.44e-4)" "unprognostic (6.98e-2)" "unprognostic (2.19e-1)" "unprognostic (5.31e-3)" "unprognostic (3.56e-1)" "unprognostic (8.27e-2)" "unprognostic (5.60e-2)" "unprognostic (6.02e-2)" "unprognostic (9.74e-2)" "unprognostic (3.43e-2)" "prognostic unfavorable (1.75e-7)" "unprognostic (2.31e-1)" "unprognostic (4.00e-2)" "unprognostic (1.03e-2)" "unprognostic (2.11e-2)" 3.6 1.0 3.5 11.2 3.9 98.0 1.2 4.2 4.5 2.1 3.5 1.8 1.7 1.0 2.7 1.0 2.3 2.9 0.9 3.4 4.1 1.2 3.2 6.1 5.2 5.2 4.3 2.0 1.7 0.4 0.8 1.8 5.2 1.3 1.2 0.7 0.9 0.9 2.7 0.5 2.3 3.4 4.6 21.7 1.6 11.1 4.0 3.2 0.5 1.5 3.0 4.6 1.6 6.0 2.4 0.1 0.2 0.4 2.2 1.2 0.2 0.4 0.1 0.4 0.9 0.2 0.4 5.9 0.5 0.0 0.2 0.2 0.3 0.3 0.3 2.7 0.6 0.3 0.0 0.0 1.6 3.9 0.6 6.0 0.7 1.0 0.3 0.1 0.1 0.6 0.3 12.2 0.2 2.2 0.2 9.3 0.5 0.4 0.4 4.5 0.0 3.1 0.0 0.2 0.3 0.1 1.2 0.0 0.9 0.1 0.2 8.7 0.0 0.1 0.0 1.1 0.1 7.3 3.7 1.7 0.0 50.9 0.0 7.8 282.3 169.4 0.6 312.5 1.6 13.0 0.8 0.8 162.2 8.5 4.9 1.5 230.1 8.0 392.8 3.6 2.3 157.7 3.5 3.9 4.2 4.5 3.4 4.1 5.2 4.3 5.2 4.6 4.0 6.0 0.3 0.0 1.8 1.6 10.6 0.8 0.4 2.1 1.2 0.1 0.6 0.5 1.1 0.0 1.7 1.8 2.1 1.0 0.7 0.3 0.0 0.1 3.7 0.9 0.3 1.1 0.0 4.8 0.9 1.3 0.9 1.6 4.1 1.0 2.5 0.3 0.4 1.1 22.3 0.0 0.9 0.6 2.0 90.1 33.4 6.1 0.9 59.2 1.8 0.0 86.7 3.1 4.1 0.0 3.1 0.1 3.5 0.7 24.7 0.3 0.2 0.7 5.1 1.1 6.6 0.5 0.6 28.5 19.2 0.3 0.9 0.7 2.1 0.1 0.6 0.6 C1orf158 MGC35194 ENSG00000157330 "Chromosome 1 open reading frame 158" Q8N1D5 1 12746200-12763699 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "choroid plexus: 18.1;fallopian tube: 26.7;testis: 48.9" "Cell type enhanced" "Detected in some" "Early spermatids: 223.3;Endometrial ciliated cells: 50.3;Late spermatids: 92.8;Respiratory ciliated cells: 88.1;Spermatocytes: 70.7" "Group enriched" "Detected in some" 6 "endometrial cancer: 1.6;glioma: 1.0;ovarian cancer: 0.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA028396 Uncertain Cytosol NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "HPA028396: AB_10603451" "unprognostic (1.11e-2)" "unprognostic (4.94e-3)" "unprognostic (4.62e-1)" "unprognostic (8.00e-2)" "unprognostic (4.18e-1)" "unprognostic (1.03e-2)" "unprognostic (2.45e-1)" "unprognostic (3.51e-1)" "unprognostic (1.35e-1)" "unprognostic (2.68e-2)" 0.0 0.0 0.9 0.0 1.1 0.3 0.0 1.0 0.4 1.1 18.1 0.0 0.0 0.4 0.1 0.1 26.7 0.0 0.0 0.9 1.0 0.0 0.0 1.9 0.1 4.3 5.9 0.1 0.1 0.0 0.6 0.1 3.4 0.0 0.0 0.1 0.1 0.0 1.2 0.4 0.0 0.0 3.3 0.1 0.1 48.9 1.9 0.0 0.6 0.0 0.0 0.0 0.0 3.6 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.9 1.1 1.0 0.4 0.9 1.0 4.3 5.9 3.4 3.3 1.9 3.6 0.0 3.2 0.5 0.3 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.3 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 223.3 50.3 0.4 0.2 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.7 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.1 0.0 0.0 92.8 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.1 0.0 0.1 88.1 0.0 6.6 0.1 1.3 70.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 C1orf194 ENSG00000179902 "Chromosome 1 open reading frame 194" Q5T5A4 1 109105951-109113857 "Disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "fallopian tube: 106.5;testis: 147.9" "Cell type enhanced" "Detected in some" "Early spermatids: 2151.8;Endometrial ciliated cells: 931.5;Late spermatids: 3412.7;Respiratory ciliated cells: 808.8;Spermatocytes: 514.1" "Group enriched" "Detected in many" 6 "endometrial cancer: 19.1;glioma: 5.0;ovarian cancer: 5.8" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "eosinophil: 2.1" "Lineage enriched" "Detected in single" 16 "granulocytes: 2.1" "Cell line enhanced" "Detected in some" "AF22: 1.5;SCLC-21H: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031144, HPA049684" Enhanced Uncertain "Nuclear speckles,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear speckles" Cytosol "HPA031144: AB_10602109, HPA049684: AB_2680849" "unprognostic (9.91e-3)" "unprognostic (7.60e-3)" "unprognostic (2.28e-2)" "prognostic favorable (1.36e-4)" "unprognostic (3.03e-1)" "unprognostic (1.14e-2)" "unprognostic (4.53e-1)" "unprognostic (3.91e-3)" "unprognostic (5.27e-2)" "unprognostic (9.21e-3)" "unprognostic (3.98e-3)" "unprognostic (1.52e-1)" "unprognostic (6.08e-6)" "unprognostic (4.18e-2)" "unprognostic (4.53e-2)" "unprognostic (5.94e-3)" "unprognostic (3.27e-3)" 0.0 0.1 1.7 0.0 1.9 0.0 0.2 2.1 2.8 2.1 14.0 0.4 0.3 1.1 1.2 0.1 106.5 0.0 0.1 2.3 1.8 0.2 0.0 4.4 0.0 3.3 3.3 0.1 0.9 0.2 2.4 0.0 2.8 0.3 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.1 2.1 0.0 0.3 147.9 2.2 0.3 0.3 0.0 0.0 0.3 0.0 2.3 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 1.9 2.1 2.8 2.3 1.8 3.3 3.3 2.8 2.1 2.2 2.3 0.0 0.0 4.1 0.7 0.2 0.0 0.2 53.9 0.0 0.6 0.8 0.9 3.5 0.0 61.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2151.8 931.5 6.1 1.8 0.0 0.0 1.1 0.2 0.0 0.7 0.0 11.2 3.8 0.0 0.0 0.0 0.1 0.0 1.0 0.4 57.0 0.0 0.3 3412.7 21.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 18.8 0.0 2.4 0.0 0.8 808.8 0.0 6.6 0.2 9.0 514.1 20.2 0.0 0.1 0.0 1.1 0.0 0.2 0.4 C1orf43 "DKFZp586G1722, NICE-3" ENSG00000143612 "Chromosome 1 open reading frame 43" Q9BWL3 1 154206696-154220637 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010725 Approved Supported Mitochondria,Cytosol NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 80: Striated muscle - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria Cytosol "HPA010725: AB_1078341" "unprognostic (3.90e-2)" "unprognostic (1.22e-2)" "unprognostic (2.11e-1)" "unprognostic (1.12e-1)" "unprognostic (6.87e-2)" "unprognostic (6.15e-3)" "prognostic unfavorable (6.57e-4)" "unprognostic (1.72e-1)" "unprognostic (2.78e-1)" "unprognostic (2.64e-2)" "unprognostic (3.51e-2)" "unprognostic (1.10e-1)" "unprognostic (1.87e-2)" "unprognostic (1.69e-1)" "unprognostic (2.89e-1)" "unprognostic (1.75e-2)" "unprognostic (1.23e-1)" 126.7 131.9 148.0 72.6 160.4 77.3 119.7 158.9 168.6 90.5 145.1 109.3 118.4 80.7 115.3 107.7 100.5 86.7 179.7 141.7 158.3 187.7 222.0 106.3 82.0 153.0 152.6 77.1 149.7 149.6 85.7 67.6 151.6 94.9 121.2 135.7 99.1 90.2 477.6 105.8 106.1 90.6 152.4 81.6 117.2 62.0 154.2 92.0 108.7 368.2 99.0 113.9 85.7 169.3 183.5 188.4 156.5 185.1 231.1 230.7 96.2 180.2 309.4 205.0 188.4 127.7 249.8 237.9 268.1 162.9 177.5 182.4 218.5 163.3 147.2 191.1 232.1 184.9 182.6 168.1 357.9 235.4 209.6 187.1 376.6 219.8 449.7 278.6 239.9 262.6 199.1 220.1 268.4 287.5 177.4 212.1 302.3 414.8 282.3 159.8 145.8 435.9 256.0 180.6 254.8 333.5 161.1 420.8 624.9 180.8 416.6 513.5 164.4 157.9 133.6 193.3 229.7 403.5 424.1 227.6 263.4 234.4 430.9 189.9 204.8 134.3 85.9 185.4 102.4 100.3 98.7 93.3 211.5 90.0 102.8 86.8 114.9 83.3 174.6 156.2 154.3 242.7 148.0 160.4 158.9 168.6 141.7 158.3 153.0 152.6 151.6 152.4 154.2 169.3 107.2 115.4 100.8 27.1 92.1 94.2 128.4 155.3 81.4 112.6 132.9 114.4 135.8 128.7 115.4 71.7 29.2 87.2 86.8 106.1 252.4 171.5 247.1 69.6 62.1 105.4 122.0 110.0 27.3 202.0 125.1 80.2 77.5 58.1 62.1 79.5 100.6 146.9 178.9 58.9 30.8 133.9 116.0 162.5 116.1 171.8 65.0 131.5 124.5 16.9 155.4 107.0 64.9 26.2 50.5 162.8 131.6 74.9 104.1 186.1 218.3 262.1 85.7 89.5 72.3 75.8 86.6 70.7 59.2 113.9 100.6 126.1 76.7 117.4 133.6 167.5 C1R ENSG00000159403 "Complement C1r" 12 7080214-7092540 "Human disease related genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 1425.6" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 442.3;Fibroblasts: 684.4;Hepatocytes: 1444.2;Leydig cells: 1142.6;Peritubular cells: 388.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 1089.8;ASC TERT1: 546.0;BJ hTERT+: 461.9;BJ hTERT+ SV40 Large T+ RasG12V: 303.4;HSkMC: 672.1" "Low region specificity" "Detected in many" "HPA001251, HPA001551" Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Nucleoplasm, Cytosol" "HPA001251: AB_2666252, HPA001551: AB_10754818" "unprognostic (1.55e-2)" "unprognostic (8.97e-2)" "unprognostic (3.46e-2)" "unprognostic (1.92e-1)" "unprognostic (1.47e-2)" "unprognostic (2.66e-2)" "unprognostic (1.94e-2)" "unprognostic (2.05e-1)" "unprognostic (2.50e-1)" "unprognostic (1.72e-1)" "unprognostic (1.21e-1)" "unprognostic (4.16e-2)" "prognostic unfavorable (1.94e-14)" "unprognostic (3.54e-2)" "unprognostic (2.25e-2)" "unprognostic (6.13e-2)" "unprognostic (2.59e-2)" 540.6 203.6 15.8 122.4 15.9 1.1 400.6 15.9 23.3 470.5 21.7 277.3 38.3 353.8 80.8 119.0 526.3 279.1 458.7 15.4 19.6 148.9 1425.6 340.3 72.4 23.4 19.9 644.3 88.0 11.0 63.9 52.4 18.4 205.2 100.9 5.8 158.3 87.0 69.4 177.7 228.1 157.7 18.1 192.1 242.7 46.7 18.1 34.7 223.4 74.2 75.3 468.4 394.3 18.0 1.2 8.9 0.9 9.1 1089.8 546.0 0.4 108.9 461.9 143.0 303.4 1.4 2.4 0.5 4.5 108.8 11.8 2.3 11.8 5.5 18.3 18.3 1.1 0.5 4.1 3.6 226.5 0.8 2.3 672.1 3.2 74.7 4.7 121.0 2.9 0.5 0.3 20.5 21.2 0.1 8.0 0.8 3.1 0.1 0.9 8.6 3.8 0.8 0.9 5.5 0.4 2.3 95.1 3.7 2.8 1.3 0.2 0.2 0.4 38.3 6.3 152.1 0.8 1.1 3.0 0.2 53.1 1.0 5.4 0.0 0.0 0.6 0.3 0.0 0.5 0.0 0.2 0.7 0.0 0.0 0.6 0.6 0.5 0.8 0.0 0.0 0.3 0.1 15.8 15.9 15.9 23.3 15.4 19.6 23.4 19.9 18.4 18.1 18.1 18.0 45.4 22.4 90.5 3.6 7.1 54.7 58.8 76.6 33.6 0.3 5.9 30.9 20.8 183.0 22.9 18.4 2.1 4.1 1.8 0.7 3.9 280.8 4.6 13.3 442.3 45.4 0.0 40.6 0.9 44.5 3.7 684.4 16.3 11.6 10.1 24.9 114.9 1444.2 11.2 0.0 0.3 0.7 0.0 40.9 66.9 29.2 1142.6 7.0 53.4 13.1 1.6 16.0 0.0 2.5 0.1 51.1 1.3 388.1 6.2 17.7 0.3 6.1 5.3 1.4 170.9 87.5 140.4 6.8 6.7 5.6 40.1 5.2 11.5 15.2 0.7 11.2 C22orf31 "bK747E2.1, HS747E2A" ENSG00000100249 "Chromosome 22 open reading frame 31" O95567 22 29058672-29061844 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "parathyroid gland: 3.0;testis: 8.7" "Group enriched" "Detected in some" 6 "Early spermatids: 70.0;Late spermatids: 43.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA000604, HPA068522" Uncertain Approved "Nuclear membrane,Cytosol" NA NA "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 29: Early spermatids - Spermatogenesis" "Nuclear membrane" Cytosol "HPA000604: AB_1079086, HPA068522: " 0.1 0.3 1.7 0.0 2.3 0.0 0.3 2.3 2.7 0.3 1.3 0.3 0.2 0.3 0.9 0.3 0.3 0.0 0.1 1.9 1.5 0.4 0.0 0.2 0.0 1.5 1.6 0.6 0.0 3.0 0.4 0.0 1.5 0.2 0.2 0.3 0.4 0.1 0.2 0.4 0.3 0.1 1.2 0.1 0.4 8.7 1.7 1.0 0.2 0.2 0.1 0.3 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.3 2.3 2.7 1.9 1.5 1.5 1.6 1.5 1.2 1.7 1.6 0.0 0.0 0.0 8.5 0.0 0.1 0.2 0.2 0.0 0.5 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 70.0 0.3 1.6 0.1 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 43.3 0.9 0.0 1.8 1.0 0.0 3.3 0.0 0.5 0.1 0.0 0.0 0.7 0.0 0.1 0.1 0.2 0.0 0.0 0.0 3.7 0.2 1.0 0.5 0.2 0.9 0.0 0.1 1.0 0.1 0.1 C2orf50 FLJ25143 ENSG00000150873 "Chromosome 2 open reading frame 50" Q96LR7 2 11133128-11151317 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 5.7;fallopian tube: 7.4" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 8.4;Endometrial ciliated cells: 21.5;Excitatory neurons: 9.7;Respiratory ciliated cells: 27.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CAPAN-2: 1.0" "HPA062894, HPA067681" Enhanced Uncertain "Golgi apparatus,Cytosol" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" Cytosol "HPA062894: AB_2684897, HPA067681: " "unprognostic (6.29e-2)" "unprognostic (1.33e-1)" "unprognostic (3.53e-4)" "unprognostic (1.92e-3)" "unprognostic (3.35e-2)" "unprognostic (6.19e-2)" "unprognostic (3.55e-1)" "unprognostic (1.31e-1)" "unprognostic (3.32e-1)" "unprognostic (2.98e-2)" "unprognostic (2.00e-2)" "unprognostic (2.45e-1)" "unprognostic (3.97e-4)" "unprognostic (7.03e-2)" "unprognostic (2.92e-1)" "unprognostic (8.25e-3)" "unprognostic (7.36e-2)" 0.1 0.2 1.5 0.2 1.8 0.5 0.2 0.4 1.6 0.4 5.7 0.1 0.3 0.3 0.2 0.1 7.4 0.1 0.0 1.3 1.4 0.2 0.1 0.6 0.3 1.8 1.9 0.3 0.2 0.1 0.7 0.1 0.5 0.2 0.2 1.5 0.3 0.1 0.2 0.4 0.1 0.1 1.0 0.3 0.2 0.3 1.0 0.2 0.2 0.0 0.1 0.1 0.0 1.0 0.1 0.5 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 1.0 0.2 0.1 0.1 0.1 0.2 0.4 0.1 0.1 0.2 0.1 0.1 0.4 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.1 0.3 0.0 0.7 0.1 0.3 0.2 0.2 0.1 0.5 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.7 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.1 0.7 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.3 0.1 0.6 0.2 0.2 0.2 0.1 0.1 1.5 1.8 0.4 1.6 1.3 1.4 1.8 1.9 0.5 1.0 1.0 1.0 0.0 0.0 1.8 0.7 0.5 0.0 0.5 0.5 0.0 0.4 0.4 0.5 0.4 0.0 3.5 0.0 8.4 0.0 0.1 0.0 0.0 0.3 0.2 21.5 0.4 0.0 0.0 0.0 9.7 0.2 0.0 0.2 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.0 1.7 0.0 2.0 0.3 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.9 0.0 2.5 0.4 0.2 0.0 1.5 0.0 0.1 0.0 0.2 27.1 3.0 0.0 1.0 0.5 0.5 1.4 0.0 0.0 0.0 0.3 0.9 0.0 0.1 C2orf66 UNQ6411 ENSG00000187944 "Chromosome 2 open reading frame 66" 2 196804417-196809355 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 3.9;brain: 5.1;pituitary gland: 3.7" "Cell type enriched" "Detected in some" 7 "Early spermatids: 36.9" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 9.0;RT4: 2.2;TIME: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA020869 Uncertain Uncertain Nucleoplasm,Cytosol "Secreted - unknown location" NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 36: HEL - Hemostasis" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA020869: AB_1851545" "unprognostic (1.19e-1)" "unprognostic (4.85e-2)" "unprognostic (6.95e-2)" "unprognostic (1.19e-1)" "unprognostic (3.48e-2)" "unprognostic (1.61e-2)" "unprognostic (6.80e-3)" "unprognostic (3.05e-2)" "unprognostic (1.95e-1)" "unprognostic (4.10e-3)" "unprognostic (4.54e-4)" "unprognostic (1.98e-1)" "unprognostic (1.75e-5)" "unprognostic (1.84e-1)" "unprognostic (2.30e-1)" "unprognostic (1.38e-2)" "unprognostic (1.86e-2)" 2.8 3.9 2.1 0.2 1.8 0.1 0.4 1.4 2.2 0.0 1.7 0.3 0.0 0.1 0.4 0.2 0.6 0.3 0.5 2.0 4.2 0.2 0.1 0.3 0.0 2.3 5.1 0.3 0.4 0.1 3.7 0.0 2.9 0.3 0.1 1.8 0.1 0.1 0.0 1.2 0.3 0.0 1.5 0.1 0.2 1.5 2.8 0.1 0.1 0.0 0.1 0.3 0.2 1.6 0.0 0.1 0.2 0.8 0.2 0.2 0.0 0.3 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.2 0.4 9.0 0.3 0.1 0.0 0.1 0.8 0.2 1.2 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.4 2.2 0.3 0.0 0.0 0.0 0.2 0.3 0.0 0.1 2.1 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.8 1.4 2.2 2.0 4.2 2.3 5.1 2.9 1.5 2.8 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.9 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 4.9 0.3 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 C3orf20 DKFZP434N1817 ENSG00000131379 "Chromosome 3 open reading frame 20" Q8ND61 3 14675141-14773036 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 15 "testis: 6.6" "Cell type enhanced" "Detected in some" "Astrocytes: 5.9;Early spermatids: 19.3;Excitatory neurons: 8.4;Inhibitory neurons: 6.9;Late spermatids: 34.6;Oligodendrocytes: 7.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Daudi: 4.0;HEL: 8.2;U-698: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA039584 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 36: HEL - Hemostasis" "Cluster 25: Spermatids - Spermatogenesis" "Plasma membrane, Cytosol" "HPA039584: AB_10795152" "unprognostic (1.23e-1)" "unprognostic (2.82e-1)" "unprognostic (5.88e-3)" "unprognostic (2.04e-1)" "unprognostic (3.51e-2)" "unprognostic (5.76e-3)" "unprognostic (1.81e-1)" "unprognostic (7.82e-2)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (9.08e-2)" "unprognostic (4.74e-2)" "unprognostic (3.24e-1)" "unprognostic (1.26e-1)" "unprognostic (1.97e-1)" "unprognostic (1.44e-1)" "unprognostic (1.39e-4)" 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.6 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 8.2 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.2 0.5 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 0.2 0.1 0.1 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 34.6 0.6 0.1 0.0 0.0 0.0 0.0 0.0 2.5 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 C4orf36 MGC26744 ENSG00000163633 "Chromosome 4 open reading frame 36" Q96KX1 4 86876205-86892422 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 10.7" "Group enriched" "Detected in many" 12 "Early spermatids: 129.5;Late spermatids: 349.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.8;CAPAN-2: 2.1;hTCEpi: 1.7;hTERT-HME1: 2.4" HPA057434 Uncertain Uncertain "Focal adhesion sites,Cytosol" NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 31: Spermatids - Spermatogenesis" "Focal adhesion sites" Cytosol "HPA057434: AB_2683438" "unprognostic (2.01e-1)" "unprognostic (2.68e-1)" "unprognostic (7.78e-2)" "unprognostic (4.76e-2)" "unprognostic (7.31e-2)" "unprognostic (5.68e-2)" "unprognostic (5.93e-3)" "unprognostic (2.39e-2)" "unprognostic (5.20e-2)" "unprognostic (2.77e-1)" "unprognostic (2.76e-2)" "unprognostic (2.55e-1)" "prognostic favorable (7.69e-5)" "unprognostic (2.85e-1)" "unprognostic (2.44e-1)" "unprognostic (4.28e-2)" "unprognostic (7.75e-2)" 0.4 0.1 0.1 0.0 0.1 0.0 0.5 0.0 0.4 1.0 0.0 0.1 0.1 0.3 0.0 0.7 0.2 0.0 0.1 0.1 0.2 0.4 0.1 0.4 0.0 0.1 0.1 0.6 0.2 0.1 0.2 0.0 0.1 0.5 0.0 0.0 0.4 0.1 0.0 1.5 0.1 0.2 0.1 0.1 0.1 10.7 0.1 0.0 0.4 0.0 0.1 0.3 0.6 0.3 2.8 0.2 0.1 0.1 0.0 0.1 0.6 1.4 0.4 0.3 0.0 0.1 2.1 0.0 0.2 0.0 0.0 1.2 0.2 1.2 0.3 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.7 0.0 2.4 0.0 0.0 0.1 0.2 0.0 0.0 1.2 0.8 0.1 0.3 0.5 0.0 0.7 0.0 0.0 0.3 1.1 0.3 0.8 0.3 0.2 0.0 0.2 0.5 0.0 0.0 0.2 0.4 0.1 0.1 0.1 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.3 0.2 0.0 0.0 2.6 2.3 5.0 8.9 9.6 4.0 5.4 0.2 0.0 19.2 15.7 5.1 0.0 10.4 0.9 4.0 13.0 0.0 0.1 129.5 0.1 0.4 5.9 3.0 4.8 1.4 0.0 2.9 4.3 11.7 0.2 0.0 0.1 7.9 3.1 3.3 1.7 1.6 9.1 8.2 6.2 5.8 349.7 5.3 3.5 1.8 1.0 1.4 6.4 5.2 1.0 3.6 0.2 11.3 3.4 6.9 3.7 10.8 0.0 5.6 6.7 6.6 6.2 2.3 3.9 6.9 6.7 10.2 9.7 2.1 0.0 7.1 4.6 C7orf31 ENSG00000153790 "Chromosome 7 open reading frame 31" Q8N865 7 25134692-25180356 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 65.6" "Group enriched" "Detected in many" 17 "Early spermatids: 423.9;Late spermatids: 881.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 19.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA020346 Uncertain Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 83: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Mitochondria" Cytosol "HPA020346: AB_1845758" "unprognostic (3.35e-2)" "unprognostic (1.03e-1)" "unprognostic (2.01e-1)" "unprognostic (6.90e-3)" "prognostic unfavorable (1.81e-4)" "unprognostic (1.19e-1)" "unprognostic (3.40e-2)" "unprognostic (1.95e-1)" "unprognostic (2.90e-1)" "unprognostic (1.06e-1)" "unprognostic (3.12e-3)" "unprognostic (8.26e-3)" "unprognostic (1.63e-1)" "unprognostic (4.45e-2)" "unprognostic (9.27e-2)" "unprognostic (1.10e-1)" "unprognostic (1.15e-2)" 3.1 7.8 1.4 3.2 2.1 1.9 2.9 3.2 2.0 3.4 1.7 6.8 4.4 3.8 1.7 2.5 3.5 2.5 2.2 1.4 2.3 2.8 1.3 2.6 3.3 2.3 1.5 5.4 2.1 3.9 2.2 1.3 2.1 2.8 4.6 2.7 3.5 2.5 0.9 2.3 3.9 3.0 1.7 4.0 4.5 65.6 1.9 4.3 4.1 1.1 3.9 3.8 2.8 2.4 3.2 2.1 5.2 5.4 2.0 0.9 2.5 1.3 4.7 3.7 5.5 4.4 3.0 8.1 2.0 2.6 16.5 1.2 5.3 1.5 4.0 3.8 5.1 4.1 0.3 5.8 4.4 7.0 8.5 3.2 4.6 3.0 0.8 2.8 0.7 6.9 5.7 4.7 1.3 0.0 5.5 7.5 2.1 6.4 2.3 8.7 5.5 1.3 2.7 3.8 1.3 4.1 1.2 5.2 5.1 6.7 0.9 9.2 0.9 2.6 6.6 0.1 2.2 19.3 7.0 11.6 0.7 5.7 10.4 0.4 0.4 0.8 0.6 0.2 0.7 1.0 0.3 0.4 0.6 0.6 0.9 0.7 0.0 1.0 0.3 1.9 1.0 0.3 1.4 2.1 3.2 2.0 1.4 2.3 2.3 1.5 2.1 1.7 1.9 2.4 2.6 0.0 5.0 2.6 8.4 1.1 2.4 0.8 2.8 1.1 1.6 1.8 1.6 4.3 0.3 0.0 0.0 3.4 7.0 6.5 3.9 1.9 423.9 0.9 1.9 2.5 4.2 3.0 0.8 3.9 2.9 2.5 4.6 1.2 0.0 3.4 2.2 0.8 2.5 0.0 1.2 3.5 0.0 6.1 3.1 881.6 7.2 3.8 3.6 7.5 6.1 7.7 13.4 0.5 4.3 3.9 6.1 5.3 8.9 1.3 2.2 0.8 3.2 0.8 0.0 3.0 2.8 37.3 15.2 2.5 0.6 2.3 6.6 2.4 7.0 1.3 CA4 "CAIV, Car4, RP17" ENSG00000167434 "Carbonic anhydrase 4" P22748 17 60149942-60170899 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Lyase "Disease variant, FDA approved drug targets, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 263.6" "Group enriched" "Detected in many" 16 "Adipocytes: 704.2;Distal enterocytes: 1289.3;Paneth cells: 2368.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 7.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 7 "neutrophil: 99.5" "Lineage enriched" "Detected in single" 995 "granulocytes: 99.5" "Cell line enhanced" "Detected in single" "OE19: 1.1" "Region enriched" "Detected in all" 5 "cerebellum: 300.3" "Low region specificity" "Detected in all" "HPA011089, HPA017258" Enhanced Uncertain Vesicles,Cytosol NA NA 190000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 37: Intestine - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol Vesicles "HPA011089: AB_1845996, HPA017258: AB_1845997" "unprognostic (2.07e-2)" "unprognostic (7.85e-2)" "unprognostic (1.55e-2)" "unprognostic (7.78e-3)" "unprognostic (8.42e-2)" "unprognostic (1.19e-1)" "unprognostic (3.19e-2)" "unprognostic (5.84e-2)" "unprognostic (7.76e-2)" "unprognostic (9.74e-2)" "unprognostic (1.54e-1)" "unprognostic (1.71e-2)" "unprognostic (2.68e-3)" "unprognostic (8.59e-2)" "unprognostic (1.43e-1)" "unprognostic (2.45e-1)" "unprognostic (4.57e-2)" 83.0 2.3 17.8 3.1 18.8 19.5 80.9 86.8 34.2 12.7 13.9 263.6 3.8 6.0 51.9 1.0 5.0 38.3 55.2 22.8 13.9 47.6 0.7 87.2 0.6 13.4 17.8 6.2 31.8 16.9 15.7 8.6 22.8 8.2 172.6 0.1 10.4 36.9 30.5 3.8 11.2 2.7 12.7 16.0 10.0 1.3 15.1 1.6 74.6 42.3 0.1 6.2 5.6 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.3 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 99.5 0.0 0.0 0.0 0.0 0.1 17.8 18.8 86.8 34.2 22.8 13.9 13.4 17.8 22.8 12.7 15.1 14.9 704.2 0.0 2.4 1.3 1.5 1.5 0.3 0.0 2.2 0.0 2.3 2.5 9.1 0.0 0.6 14.7 0.0 0.0 1.2 1289.3 33.2 11.7 0.5 0.6 13.0 88.3 19.3 0.0 3.8 0.2 0.0 4.4 0.0 0.2 11.4 23.2 1.4 0.0 0.6 0.0 1.4 24.6 0.0 0.0 1.2 0.1 0.6 1.1 0.0 23.4 0.0 0.1 0.0 1.0 0.4 0.1 2368.3 0.0 1.2 0.1 14.9 72.4 0.7 0.0 6.6 5.0 23.4 0.1 0.0 0.1 1.1 0.0 2.4 0.4 41.7 0.3 CACTIN "C19orf29, fSAPc, NY-REN-24" ENSG00000105298 "Cactin, spliceosome C complex subunit" Q8WUQ7 19 3610645-3626815 "Predicted intracellular proteins" "Immunity, Innate immunity, mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042504, HPA042548" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nuclear speckles" Cytosol "HPA042504: AB_10797501, HPA042548: AB_10794760" "unprognostic (1.18e-1)" "unprognostic (7.90e-3)" "unprognostic (1.09e-1)" "prognostic favorable (3.69e-5)" "unprognostic (5.93e-2)" "unprognostic (2.87e-3)" "unprognostic (3.38e-2)" "unprognostic (1.01e-2)" "unprognostic (3.84e-2)" "unprognostic (1.38e-2)" "unprognostic (1.17e-2)" "unprognostic (7.22e-3)" "unprognostic (3.88e-2)" "unprognostic (4.98e-3)" "unprognostic (5.78e-2)" "unprognostic (3.08e-2)" "unprognostic (5.55e-3)" 14.6 14.2 20.6 7.8 19.6 10.0 14.8 19.4 24.0 15.7 16.6 15.4 6.2 16.7 2.6 15.4 16.8 3.0 16.3 20.3 18.8 17.0 19.9 12.3 7.6 21.1 19.6 24.7 17.3 4.2 13.3 4.6 19.1 17.2 3.2 4.6 13.2 4.2 19.4 17.8 15.2 2.9 18.5 18.4 15.8 18.2 19.8 8.7 15.3 6.1 4.4 16.5 14.6 20.1 22.2 12.5 10.3 17.9 7.4 7.2 15.6 15.4 6.3 9.1 10.2 12.5 9.7 18.4 12.9 9.7 10.6 20.4 10.8 12.9 5.5 18.7 14.8 11.4 19.2 15.1 10.3 15.7 15.9 7.1 12.2 8.4 5.8 5.4 13.2 15.6 25.9 19.8 4.9 13.3 28.0 13.5 22.0 13.4 14.8 29.4 13.5 17.5 8.5 11.0 14.2 19.9 17.4 12.1 13.3 5.5 9.8 17.7 17.2 12.3 15.5 27.0 27.4 30.3 21.6 20.7 15.2 24.8 16.8 0.0 0.4 0.0 1.2 1.0 0.4 0.6 0.5 0.5 0.3 0.6 0.6 0.8 0.2 0.3 0.1 1.4 0.5 0.4 20.6 19.6 19.4 24.0 20.3 18.8 21.1 19.6 19.1 18.5 19.8 20.1 7.4 0.0 2.7 5.9 6.3 6.0 4.1 2.8 5.7 5.1 6.9 7.1 3.1 5.7 2.2 1.8 2.1 3.6 7.2 6.9 0.0 5.1 3.3 6.7 5.8 5.3 1.2 7.4 3.9 4.9 5.2 5.1 9.2 7.4 4.5 8.5 3.3 4.8 5.1 0.0 4.1 5.8 2.0 3.9 6.5 4.5 5.9 5.3 1.8 3.7 6.1 6.0 8.2 2.5 5.8 5.2 4.4 5.7 6.0 6.0 3.6 3.1 2.4 6.2 0.0 7.2 6.4 10.8 8.8 7.9 8.0 3.3 5.6 7.6 6.1 3.6 CAMK2B "CAM2, CAMK2, CAMKB, CaMKIIβ" ENSG00000058404 "Calcium/calmodulin dependent protein kinase II beta" Q13554 7 44217150-44334577 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 248.8;skeletal muscle: 132.5" "Cell type enriched" "Detected in many" 7 "Bipolar cells: 857.4" "Cancer enhanced" "Detected in many" "glioma: 6.0;thyroid cancer: 6.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 75.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006849, HPA026307, HPA051783, HPA051785, HPA053973" Enhanced Supported Supported "Plasma membrane,Cell Junctions,Cytosol" NA NA 600000 "Cluster 11: Basophils - Unknown function" "Cluster 47: Non-specific - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 56: Bipolar cells - Visual perception" "Plasma membrane" "Cell Junctions, Cytosol" "CAB006849: , HPA026307: AB_1845941, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328" "unprognostic (1.88e-3)" "unprognostic (4.49e-2)" "unprognostic (3.55e-3)" "unprognostic (1.36e-2)" "unprognostic (5.25e-2)" "unprognostic (2.90e-2)" "unprognostic (8.78e-2)" "unprognostic (1.09e-1)" "unprognostic (1.44e-1)" "unprognostic (2.71e-1)" "unprognostic (1.17e-2)" "unprognostic (1.60e-2)" "unprognostic (5.23e-7)" "unprognostic (7.04e-2)" "unprognostic (2.34e-1)" "unprognostic (3.15e-2)" "unprognostic (3.95e-2)" 0.5 11.3 77.9 0.6 109.0 0.1 1.4 113.0 248.8 0.1 0.0 1.0 1.0 0.2 28.3 1.4 1.1 0.2 65.4 197.6 12.6 1.6 7.7 0.3 1.3 4.4 11.9 0.3 3.8 6.1 51.3 0.1 4.6 3.2 0.4 21.4 1.4 1.6 132.5 1.2 0.9 0.1 3.2 0.3 2.3 2.1 25.9 0.8 20.3 59.2 1.6 0.0 0.3 80.4 0.0 0.8 0.4 0.6 0.0 0.4 0.4 0.3 0.1 0.3 0.0 0.3 0.1 0.2 1.6 0.4 0.1 0.3 0.4 1.4 0.1 2.0 4.5 0.1 0.2 0.2 0.1 0.0 0.9 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.8 0.1 10.1 0.0 0.4 0.2 0.1 4.4 0.2 1.7 0.3 0.0 0.0 75.5 4.0 0.4 0.0 0.0 0.1 3.5 0.3 0.4 0.5 0.7 0.4 0.1 0.9 0.8 0.2 0.2 0.0 0.5 1.0 0.1 0.2 0.1 0.2 0.2 0.2 0.2 0.1 0.1 0.3 0.2 0.2 0.4 0.7 0.3 0.2 0.2 0.2 77.9 109.0 113.0 248.8 197.6 12.6 4.4 11.9 4.6 3.2 25.9 80.4 0.1 0.0 0.0 67.3 0.2 1.1 21.5 0.0 10.8 857.4 3.1 17.5 88.9 2.8 0.0 0.0 45.9 0.1 0.0 0.5 9.8 0.0 0.9 2.3 0.4 1.6 40.7 0.0 111.4 0.0 0.2 2.9 4.1 5.6 4.5 15.4 0.0 4.3 0.2 60.6 90.9 1.5 2.0 0.6 0.4 2.9 1.8 0.5 1.8 5.6 0.0 23.2 0.0 19.6 5.4 0.1 1.2 0.0 0.1 3.3 0.1 1.9 0.0 53.1 0.0 6.9 1.7 0.2 7.8 0.9 0.4 0.3 0.2 0.2 0.3 6.6 CAMTA2 KIAA0909 ENSG00000108509 "Calmodulin binding transcription activator 2" O94983 17 4967992-4987675 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Late spermatids: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027835, HPA051147" Supported "Nucleoplasm,Vesicles,Actin filaments,Mitochondria,Cytosol" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm "Vesicles, Actin filaments, Mitochondria, Cytosol" "HPA027835: , HPA051147: AB_2681362" "unprognostic (2.82e-1)" "unprognostic (3.06e-1)" "unprognostic (1.11e-2)" "unprognostic (1.01e-3)" "unprognostic (1.10e-1)" "unprognostic (3.24e-2)" "unprognostic (2.36e-1)" "unprognostic (4.71e-2)" "unprognostic (2.78e-2)" "unprognostic (7.08e-2)" "prognostic favorable (6.00e-8)" "unprognostic (3.42e-2)" "unprognostic (9.02e-2)" "unprognostic (3.73e-2)" "unprognostic (1.20e-1)" "unprognostic (4.56e-2)" "unprognostic (1.19e-1)" 15.8 15.6 10.7 13.6 15.9 10.3 15.0 5.2 36.7 14.8 0.0 19.6 10.3 17.0 4.4 14.4 14.4 8.7 17.7 24.2 3.4 16.0 12.9 18.4 9.7 10.0 4.4 14.8 17.5 19.2 26.0 7.4 8.5 15.1 10.8 10.7 13.9 11.6 38.0 17.4 19.0 14.2 0.5 21.6 18.6 14.5 7.3 10.4 17.0 27.5 9.5 16.0 13.0 18.4 13.2 23.2 4.2 6.1 27.8 19.0 8.6 12.4 13.8 11.6 10.1 5.9 3.6 15.5 11.9 19.7 9.8 13.1 16.2 19.5 6.6 21.8 20.7 9.8 13.3 6.6 15.9 5.8 40.4 13.4 24.0 10.8 17.1 14.0 19.6 11.8 16.2 13.9 11.0 8.8 10.3 3.7 0.6 15.6 9.5 8.9 4.8 6.1 13.1 13.8 5.8 5.1 7.8 14.1 3.8 7.2 12.6 5.6 25.6 9.1 5.3 9.8 20.6 6.8 8.0 5.6 22.4 11.5 9.2 0.5 1.2 0.9 1.3 1.6 1.0 0.6 0.6 1.2 0.7 0.4 0.8 1.0 3.0 0.6 4.9 1.1 0.5 1.4 10.7 15.9 5.2 36.7 24.2 3.4 10.0 4.4 8.5 0.5 7.3 18.4 15.2 3.2 11.3 11.4 9.2 6.9 3.7 11.6 8.6 14.7 11.9 8.9 8.0 12.8 6.9 11.0 10.4 5.9 9.0 16.1 1.9 7.9 30.1 5.9 12.6 10.0 11.4 7.4 17.9 11.2 9.6 12.3 20.4 11.6 13.3 14.7 16.8 15.3 8.5 35.3 15.7 13.9 20.3 16.7 10.2 54.3 10.2 13.1 3.6 4.7 14.9 6.5 12.3 9.0 9.5 10.6 13.9 9.4 9.0 6.3 20.1 15.4 6.1 11.2 13.1 7.9 14.8 7.2 6.9 8.8 10.4 12.4 11.4 14.4 12.2 4.1 CCDC106 HSU79303 ENSG00000173581 "Coiled-coil domain containing 106" Q9BWC9 19 55641062-55653161 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 69.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive B-cell: 9.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 82.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041925, HPA043219" Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm Cytosol "HPA041925: AB_2677750, HPA043219: AB_2678368" "unprognostic (5.74e-3)" "unprognostic (1.34e-1)" "unprognostic (1.71e-1)" "unprognostic (5.16e-2)" "unprognostic (9.19e-2)" "unprognostic (2.82e-1)" "unprognostic (8.11e-2)" "unprognostic (1.21e-2)" "unprognostic (4.88e-2)" "unprognostic (8.74e-2)" "prognostic favorable (2.23e-6)" "unprognostic (2.28e-1)" "prognostic favorable (7.54e-11)" "unprognostic (5.03e-2)" "unprognostic (7.88e-2)" "unprognostic (3.26e-1)" "unprognostic (8.69e-2)" 12.0 21.7 27.8 5.1 32.7 2.6 11.9 20.4 37.6 11.4 17.7 18.7 4.1 13.4 6.4 8.0 13.3 6.5 21.9 33.0 22.4 29.1 24.3 9.4 10.3 21.8 23.1 12.7 9.8 13.6 27.3 5.1 21.1 15.2 2.7 6.5 11.1 11.2 24.5 9.3 13.7 7.1 18.4 18.2 13.7 20.8 23.5 4.7 16.7 20.2 9.0 12.8 8.3 24.7 8.7 33.6 14.4 25.3 10.1 9.6 2.0 7.4 12.9 25.0 21.0 7.3 13.2 25.6 5.6 13.8 0.7 7.3 24.6 16.0 7.1 1.3 82.2 26.7 23.4 13.3 30.1 1.8 14.3 15.6 1.9 5.9 1.4 17.4 8.0 16.0 20.1 15.7 12.5 2.3 16.3 10.8 6.9 0.8 18.3 25.5 7.3 17.7 25.9 0.8 15.8 29.4 5.9 41.3 14.7 8.5 17.9 17.3 9.0 7.7 7.9 0.7 5.5 9.3 3.5 33.0 20.7 8.4 0.6 0.0 2.3 0.0 0.4 1.5 1.4 7.2 0.4 0.6 2.9 9.6 3.1 1.9 0.0 0.8 0.1 8.9 0.3 1.7 27.8 32.7 20.4 37.6 33.0 22.4 21.8 23.1 21.1 18.4 23.5 24.7 12.0 0.0 1.3 8.8 18.1 2.5 6.0 14.0 12.0 22.3 16.0 17.1 23.8 11.5 6.5 20.2 4.2 13.5 6.8 4.6 41.1 19.6 4.0 3.9 7.2 10.8 4.9 4.2 6.4 7.2 15.0 9.7 11.7 3.3 8.9 10.5 10.0 17.5 17.5 37.0 6.4 8.7 8.2 9.4 6.4 2.7 14.0 7.9 3.6 3.7 11.7 34.1 3.1 4.5 3.6 8.7 8.0 18.8 7.0 6.0 10.6 69.4 3.2 9.7 13.1 9.3 9.0 4.7 30.2 10.3 3.7 8.8 3.9 18.9 6.0 5.7 CCDC13 FLJ25467 ENSG00000244607 "Coiled-coil domain containing 13" Q8IYE1 3 42705756-42773253 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 2.4;choroid plexus: 2.5;fallopian tube: 2.9;retina: 4.3;testis: 5.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 28.0;Distal tubular cells: 17.6;Early spermatids: 18.1;Endometrial ciliated cells: 23.3;Late spermatids: 18.4;Respiratory ciliated cells: 53.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047429 Supported "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Cluster 77: Retina - Visual perception" "Cluster 49: Ciliated cells - Cilium organization" "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA047429: AB_2680043" "unprognostic (3.34e-2)" "unprognostic (3.72e-2)" "unprognostic (2.18e-2)" "unprognostic (1.67e-3)" "unprognostic (2.19e-2)" "unprognostic (5.35e-2)" "unprognostic (4.75e-2)" "unprognostic (8.06e-2)" "unprognostic (4.26e-2)" "unprognostic (1.19e-1)" "unprognostic (1.05e-2)" "unprognostic (2.31e-1)" "unprognostic (1.83e-7)" "unprognostic (6.21e-2)" "unprognostic (2.40e-1)" "unprognostic (5.71e-2)" "unprognostic (2.04e-2)" 0.2 0.1 1.0 0.0 1.9 0.0 0.1 1.1 1.4 0.5 2.5 0.3 0.0 0.2 0.3 0.1 2.9 0.0 0.4 1.1 0.9 0.4 0.8 0.8 0.0 1.9 2.1 0.0 0.2 0.0 0.7 0.0 1.6 0.3 0.1 4.3 0.1 0.0 0.3 0.0 0.2 0.0 1.5 0.1 0.3 5.9 1.4 0.0 0.6 0.0 0.0 0.2 0.2 2.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.9 1.1 1.4 1.1 0.9 1.9 2.1 1.6 1.5 1.4 2.4 0.3 0.0 0.6 7.2 0.4 1.0 0.4 2.8 0.6 28.0 0.8 0.5 1.2 1.5 5.6 3.7 4.2 0.1 0.3 0.9 17.6 0.9 18.1 23.3 2.1 0.6 0.0 0.0 6.0 0.2 0.5 0.8 0.0 1.1 1.3 0.2 0.4 0.4 2.6 0.0 4.0 0.4 0.0 1.6 2.8 18.4 1.5 1.4 1.8 3.7 2.7 1.8 1.0 2.0 4.6 0.2 2.4 0.7 0.0 1.0 0.0 4.6 53.4 5.4 0.0 0.0 1.7 13.3 3.7 0.1 1.1 0.0 0.5 1.0 0.1 0.7 CCDC153 LOC283152 ENSG00000248712 "Coiled-coil domain containing 153" Q494R4 11 119189638-119196769 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 11.1" "Group enriched" "Detected in many" 7 "Endometrial ciliated cells: 92.3;Respiratory ciliated cells: 186.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 4.0;neutrophil: 15.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 15.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.8;EFO-21: 4.2;HEL: 5.0;T-47d: 8.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041497 Uncertain Uncertain Cytosol NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "HPA041497: AB_10794378" "unprognostic (4.66e-2)" "unprognostic (1.86e-2)" "unprognostic (3.88e-2)" "unprognostic (1.45e-2)" "unprognostic (1.53e-1)" "unprognostic (3.22e-2)" "unprognostic (6.87e-2)" "unprognostic (2.23e-3)" "unprognostic (5.19e-2)" "unprognostic (9.43e-3)" "unprognostic (1.36e-1)" "unprognostic (2.36e-1)" "unprognostic (2.92e-3)" "unprognostic (1.15e-1)" "unprognostic (3.80e-1)" "unprognostic (1.52e-3)" "unprognostic (1.98e-3)" 1.1 0.7 1.5 0.5 1.2 2.5 0.7 2.7 1.6 0.9 2.7 0.7 0.3 0.8 0.2 1.0 11.1 1.1 0.3 1.3 1.6 1.3 0.4 1.5 0.3 2.0 1.9 0.2 0.3 2.8 3.3 0.9 1.4 0.4 0.5 1.5 0.5 1.1 0.4 0.7 0.6 0.5 1.7 0.5 1.1 1.8 2.0 0.3 0.8 0.0 0.2 0.4 0.5 1.8 0.6 0.9 0.9 1.0 0.2 0.1 2.8 0.6 1.1 0.4 0.5 1.9 4.8 0.2 4.2 0.2 1.3 0.5 0.3 1.1 0.1 1.1 0.6 5.0 0.4 0.3 0.7 0.6 0.3 0.5 0.7 1.2 0.3 1.4 1.2 0.6 0.7 0.9 0.1 3.4 0.3 0.7 0.3 1.2 1.0 0.7 0.1 0.3 0.4 0.8 1.0 0.2 1.3 0.8 0.7 0.3 8.8 1.4 1.2 0.7 0.5 0.3 0.4 0.4 0.5 0.2 0.3 0.2 0.3 0.5 2.3 4.0 0.3 1.6 0.1 0.3 0.2 0.4 1.7 0.3 0.5 0.4 15.8 0.2 1.6 1.7 0.4 0.8 1.5 1.2 2.7 1.6 1.3 1.6 2.0 1.9 1.4 1.7 2.0 1.8 4.4 0.0 6.1 0.0 0.6 2.8 1.7 14.9 1.8 0.4 2.3 2.2 0.4 1.5 19.8 7.3 0.0 4.3 0.7 5.3 0.0 1.1 3.5 92.3 1.9 3.3 1.8 0.0 0.5 2.0 3.5 2.1 4.6 2.3 0.0 1.5 3.3 1.8 3.6 0.0 0.4 4.2 12.2 4.6 5.5 7.0 0.3 2.7 3.6 1.0 4.5 0.8 1.0 0.0 0.6 1.1 11.3 2.6 3.0 1.0 3.3 4.8 186.9 2.0 6.6 0.7 9.9 5.9 4.0 1.6 2.3 3.3 0.6 0.5 2.9 2.7 CCDC198 "C14orf105, FLJ10650" ENSG00000100557 "Coiled-coil domain containing 198" Q9NVL8 14 57469300-57493867 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 27.5;kidney: 97.3;liver: 36.8;pancreas: 34.0" "Group enriched" "Detected in some" 4 "Collecting duct cells: 57.0;Distal tubular cells: 68.4;Proximal tubular cells: 191.8" "Cancer enriched" "Detected in many" 5 "renal cancer: 25.1" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 8 "A549: 11.5;RPTEC TERT1: 34.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA029202 Uncertain Nucleoplasm,Cytosol NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol Nucleoplasm "HPA029202: AB_10600754" "unprognostic (1.45e-1)" "unprognostic (3.65e-1)" "unprognostic (2.38e-1)" "unprognostic (6.67e-2)" "prognostic unfavorable (5.61e-4)" "unprognostic (1.21e-1)" "unprognostic (5.45e-3)" "unprognostic (1.51e-1)" "prognostic favorable (1.92e-4)" "unprognostic (6.07e-2)" "unprognostic (2.77e-1)" "unprognostic (1.61e-3)" 0.1 0.1 0.5 0.5 0.7 0.6 0.0 1.0 0.6 1.3 0.0 0.2 1.5 0.5 1.9 0.1 27.5 16.8 0.2 0.4 0.4 97.3 36.8 0.1 0.1 0.7 0.5 0.1 34.0 0.0 0.0 0.0 0.8 0.1 0.1 0.1 0.0 1.5 0.2 0.6 0.2 0.0 0.4 0.1 0.4 0.1 0.8 0.0 0.2 0.0 0.0 0.2 0.0 1.6 0.0 11.5 0.0 0.0 0.0 0.6 0.2 0.1 0.1 0.0 0.0 1.1 0.9 0.1 2.9 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.4 0.3 0.2 0.2 0.0 0.2 0.1 0.0 0.2 34.3 0.4 0.1 0.0 0.1 0.1 0.0 0.3 0.2 0.5 0.3 0.4 0.5 0.1 0.0 0.3 0.3 0.3 1.6 0.4 0.0 1.7 0.3 0.2 0.7 0.1 0.9 0.6 1.4 1.0 0.0 1.2 1.2 1.9 1.5 1.0 0.3 0.5 2.2 1.9 0.5 0.7 1.0 0.6 0.4 0.4 0.7 0.5 0.8 0.4 0.8 1.6 0.0 3.2 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 57.0 0.0 0.0 0.1 0.0 68.4 22.2 0.0 19.7 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.1 0.0 0.0 191.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 CCDC83 "CT148, FLJ42119, KP-CoT-23, MGC34732" ENSG00000150676 "Coiled-coil domain containing 83" Q8IWF9 11 85855101-85920021 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 115 "testis: 35.5" "Group enriched" "Detected in some" 46 "Early spermatids: 222.2;Late spermatids: 194.2;Spermatocytes: 160.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "MCF7: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039707, HPA039882" Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Plasma membrane, Cytosol" "HPA039707: AB_10795259, HPA039882: AB_10795410" "unprognostic (1.14e-1)" "unprognostic (4.09e-1)" "unprognostic (1.49e-2)" "unprognostic (4.43e-2)" "unprognostic (7.05e-6)" "unprognostic (3.52e-1)" "unprognostic (2.17e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 222.2 0.1 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 194.2 4.1 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 160.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCKAR ENSG00000163394 "Cholecystokinin A receptor" P32238 4 26481396-26490484 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.9;gallbladder: 29.2;stomach 1: 16.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "stomach cancer: 0.5" "Group enriched" "Detected in some" 5 "hypothalamus: 5.1;midbrain: 6.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "hypothalamus: 7.2" "Region enhanced" "Detected in all" "midbrain: 12.6" HPA073900 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane, Cytosol" Nucleoplasm "HPA073900: " "unprognostic (7.48e-2)" "unprognostic (3.70e-2)" "unprognostic (7.13e-2)" "unprognostic (3.08e-2)" "unprognostic (3.36e-1)" "unprognostic (3.79e-1)" 0.0 0.0 0.5 0.0 0.4 0.0 0.1 0.0 0.4 0.0 0.0 0.3 1.6 0.0 0.0 0.0 0.0 29.2 0.0 0.6 5.1 0.1 0.0 0.0 0.0 0.8 6.9 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 16.5 0.1 1.1 0.3 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.4 0.6 5.1 0.8 6.9 0.6 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CD207 "CLEC4K, Langerin" ENSG00000116031 "CD207 molecule" Q9UJ71 2 70830211-70835816 "CD markers, Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skin 1: 87.7" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 4.0;Langerhans cells: 9.7;Macrophages: 7.6;Melanocytes: 5.4;Suprabasal keratinocytes: 5.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 12 "myeloid DC: 1.1" "Lineage enriched" "Detected in single" 12 "dendritic cells: 1.1" "Cell line enriched" "Detected in some" 4 "AN3-CA: 8.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002222, HPA011216" Enhanced Uncertain Cytosol No NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 11: Alveolar cells - Smell perception" Cytosol "CAB002222: AB_563850, HPA011216: AB_1078453" "unprognostic (1.45e-2)" "unprognostic (8.28e-3)" "unprognostic (9.34e-2)" "unprognostic (1.65e-1)" "unprognostic (1.38e-1)" "unprognostic (2.23e-1)" "unprognostic (3.02e-1)" "unprognostic (1.27e-3)" "unprognostic (1.05e-1)" "unprognostic (4.86e-2)" "unprognostic (3.45e-1)" "unprognostic (1.63e-1)" "unprognostic (7.92e-4)" "unprognostic (2.13e-2)" "unprognostic (1.81e-1)" "unprognostic (1.98e-1)" "unprognostic (2.46e-2)" 0.4 0.1 0.0 0.3 0.0 0.0 3.2 0.0 0.0 1.6 0.1 1.2 3.7 0.8 0.4 17.8 0.9 2.0 0.2 0.0 0.0 0.1 0.7 1.6 0.9 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 2.4 2.7 5.5 1.1 0.8 0.8 87.7 4.9 0.7 0.0 3.7 1.4 0.5 0.0 3.4 0.1 0.3 4.8 1.4 1.7 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.1 1.6 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.6 4.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.2 0.0 7.6 5.4 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.1 0.0 0.0 0.0 CD79B "B29, IGB" ENSG00000007312 "CD79b molecule" P40259 17 63928740-63932336 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins" "Adaptive immunity, Immunity" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 266.7" "Cell type enriched" "Detected in many" 4 "B-cells: 491.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 4 "memory B-cell: 1132.1;naive B-cell: 1505.8" "Lineage enriched" "Detected in all" 5 "B-cells: 1505.8" "Cell line enhanced" "Detected in some" "Daudi: 1060.0;REH: 350.2;U-698: 1475.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA009178, CAB009751, HPA044107" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" "Plasma membrane" "Nucleoplasm, Cytosol" "CAB009751: AB_2275844, HPA009178: AB_1078483, HPA044107: " "unprognostic (3.90e-3)" "unprognostic (1.61e-3)" "unprognostic (5.21e-2)" "unprognostic (3.45e-3)" "unprognostic (4.22e-3)" "prognostic favorable (2.35e-4)" "unprognostic (1.82e-1)" "unprognostic (9.25e-3)" "unprognostic (3.89e-2)" "unprognostic (1.48e-1)" "unprognostic (1.04e-1)" "unprognostic (2.87e-2)" "unprognostic (2.50e-3)" "unprognostic (1.89e-1)" "unprognostic (1.44e-1)" "unprognostic (4.28e-2)" "unprognostic (2.75e-1)" 5.0 1.7 0.9 70.5 0.9 54.6 3.4 0.9 1.4 1.9 1.7 7.7 4.7 1.4 1.6 2.6 1.5 6.8 12.3 0.9 0.9 4.7 3.4 4.9 266.7 1.0 0.9 0.6 0.7 0.7 25.3 3.8 0.9 2.5 7.2 0.0 7.8 0.8 3.4 2.4 66.2 2.6 0.9 147.7 10.7 1.0 1.0 27.1 4.1 5.8 208.4 13.4 2.2 1.0 1.8 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.4 0.0 0.0 1060.0 7.8 0.0 0.4 0.3 0.0 0.0 0.0 0.5 0.0 2.7 0.0 0.4 0.6 0.6 0.5 0.0 0.0 0.1 0.0 0.0 1.2 0.4 1.2 56.9 0.0 0.0 0.6 23.0 0.3 0.0 0.0 350.2 0.9 4.4 0.0 0.0 0.5 0.0 1.7 0.0 0.7 5.8 0.0 16.2 1.7 0.1 3.7 0.3 0.6 51.3 54.4 1475.5 0.0 2.2 0.0 6.2 13.0 1.1 44.9 192.2 51.3 1132.1 57.1 30.1 47.0 1505.8 38.4 23.2 5.8 42.4 304.3 6.7 107.9 112.1 0.9 0.9 0.9 1.4 0.9 0.9 1.0 0.9 0.9 0.9 1.0 1.0 24.9 0.0 1.3 0.0 491.9 4.5 0.4 0.0 1.8 0.0 1.1 4.4 1.4 1.5 0.0 0.0 0.0 0.2 24.2 0.3 0.0 0.1 0.6 0.3 1.0 25.2 1.2 8.6 0.0 0.0 0.4 3.3 0.5 0.3 15.2 0.0 51.4 1.3 5.8 0.0 0.0 0.4 0.0 14.8 5.1 1.4 1.2 13.4 21.4 0.0 14.3 0.0 36.0 0.0 0.0 0.0 0.1 1.9 99.6 0.4 0.0 1.0 0.0 0.0 0.0 4.4 5.4 1.2 0.3 0.7 3.1 0.4 27.0 0.5 0.8 0.2 CD81 "TAPA-1, TAPA1, TSPAN28" ENSG00000110651 "CD81 molecule" P60033 11 2376177-2397397 "CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Host-virus interaction, Immunity" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 1003.1;Endometrial stromal cells: 1050.9;Muller glia cells: 809.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 148.9;naive B-cell: 137.2" "Lineage enriched" "Detected in all" 4 "B-cells: 148.9" "Cell line enhanced" "Detected in many" "ASC diff: 2960.6;fHDF/TERT166: 1752.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002507, HPA007234" Supported Supported "Plasma membrane,Cytosol" NA NA 400000 "Cluster 43: B-cells - Humoral immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" Cytosol "CAB002507: AB_563639, HPA007234: AB_1846333" "unprognostic (2.96e-1)" "unprognostic (3.40e-1)" "prognostic unfavorable (7.56e-4)" "unprognostic (1.84e-2)" "prognostic unfavorable (8.21e-5)" "unprognostic (6.03e-2)" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (2.09e-1)" "unprognostic (1.24e-1)" "prognostic favorable (3.86e-4)" "unprognostic (3.07e-3)" "unprognostic (2.08e-1)" "unprognostic (3.55e-2)" "unprognostic (1.67e-1)" "unprognostic (2.06e-1)" "unprognostic (2.06e-1)" 892.1 299.1 560.6 270.7 598.4 77.8 773.6 614.8 590.2 952.7 498.9 992.0 150.7 1384.0 960.5 364.3 853.1 534.5 937.9 511.1 615.8 636.6 1175.7 768.4 429.0 665.7 640.8 656.8 449.5 258.3 409.1 441.0 651.1 634.0 234.4 75.9 531.1 1602.0 214.3 511.1 423.1 978.5 694.1 631.3 494.3 316.9 655.1 158.9 564.6 227.6 278.6 749.2 763.4 734.4 337.0 342.0 268.5 413.4 2960.6 1668.4 224.8 621.0 1361.6 490.3 492.2 322.8 1.8 285.4 218.3 1752.6 312.5 430.5 167.3 442.2 199.9 135.6 517.8 43.7 117.1 0.3 976.4 188.2 359.8 1222.3 619.9 201.1 302.1 757.9 476.6 204.0 198.7 484.9 696.4 257.2 160.7 239.1 324.4 304.7 274.2 324.7 135.5 183.3 529.1 223.3 288.8 319.2 198.4 514.4 383.8 214.3 171.0 337.8 641.3 249.0 181.6 471.2 216.6 356.9 88.1 529.1 361.3 111.0 435.0 0.9 3.3 22.9 21.1 5.8 34.4 148.9 14.9 33.0 2.6 137.2 9.2 16.9 1.0 14.7 7.3 7.7 12.0 10.7 560.6 598.4 614.8 590.2 511.1 615.8 665.7 640.8 651.1 694.1 655.1 734.4 1003.1 243.6 270.0 95.0 88.2 179.8 391.8 89.7 26.2 82.7 325.6 452.0 277.4 167.3 102.3 207.8 27.1 21.8 267.1 20.0 35.2 105.7 15.9 365.4 1050.9 344.5 71.9 30.7 19.0 55.1 31.7 560.4 21.4 462.7 81.7 204.0 293.4 603.9 251.5 148.0 32.4 48.2 50.8 232.7 179.7 50.2 389.2 277.6 151.2 60.0 23.0 809.2 45.3 145.8 93.6 61.3 14.7 251.3 50.7 147.6 5.0 29.9 85.8 76.1 118.3 356.9 423.6 15.6 19.4 30.6 164.9 20.1 136.8 379.0 41.5 298.1 CDC73 "C1orf28, FIHP, HRPT1, HRPT2, parafibromin" ENSG00000134371 "Cell division cycle 73" Q6P1J9 1 193121983-193254815 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002326, CAB016359, HPA069324" Supported Supported Nucleoplasm,Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 89: Fibroblasts - ECM organization" "Cluster 43: THP-1 - Innate immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm Cytosol "CAB016359: AB_628102, HPA002326: , HPA069324: " "unprognostic (4.41e-2)" "unprognostic (6.22e-2)" "unprognostic (1.90e-2)" "unprognostic (5.30e-2)" "unprognostic (2.88e-3)" "unprognostic (3.53e-2)" "unprognostic (2.48e-3)" "unprognostic (5.74e-2)" "unprognostic (1.25e-1)" "unprognostic (1.40e-1)" "unprognostic (7.23e-3)" "unprognostic (2.17e-1)" "unprognostic (5.44e-3)" "unprognostic (3.47e-1)" "unprognostic (2.49e-1)" "unprognostic (6.73e-3)" "unprognostic (2.98e-3)" 11.3 9.5 5.8 7.3 6.9 8.9 10.7 6.1 7.3 11.1 4.5 10.2 5.6 10.3 8.5 8.4 7.2 5.9 9.6 4.6 8.1 10.4 9.2 7.9 7.5 6.9 7.2 11.5 6.4 12.9 5.6 9.4 7.9 15.1 9.0 10.1 7.7 9.7 12.2 7.0 7.7 10.3 7.9 8.6 7.0 5.9 6.5 10.6 13.1 5.6 7.9 9.7 8.5 8.3 9.3 2.4 16.6 11.5 18.3 18.9 4.9 6.7 16.1 19.5 16.4 6.5 12.3 10.5 5.2 20.4 8.8 10.7 16.8 14.9 24.7 6.1 4.1 7.3 8.1 7.2 16.1 16.0 11.6 13.7 16.0 14.9 17.7 20.6 17.8 11.1 8.1 14.2 28.8 3.5 13.9 9.2 11.9 21.9 2.5 10.6 7.0 15.0 26.6 8.2 3.9 12.3 8.6 26.8 22.3 21.0 18.3 14.0 9.2 19.3 2.2 16.4 12.6 12.2 7.2 7.6 11.9 10.2 30.1 2.2 0.5 0.7 0.8 1.0 1.2 0.9 1.1 0.6 0.6 0.5 1.4 1.2 0.3 1.3 0.8 1.0 0.9 0.4 5.8 6.9 6.1 7.3 4.6 8.1 6.9 7.2 7.9 7.9 6.5 8.3 44.5 35.3 25.4 54.5 44.9 37.2 35.6 38.4 36.5 30.4 24.4 21.8 44.5 25.8 27.2 33.1 35.5 25.0 48.0 18.2 33.2 37.5 19.7 24.6 39.6 38.0 11.4 40.8 71.9 32.2 42.0 39.1 28.1 30.8 41.1 17.6 25.4 17.2 31.6 21.9 76.4 15.8 34.6 27.4 49.1 8.5 33.5 38.3 28.4 54.4 46.0 35.2 41.2 78.4 112.3 35.5 16.9 36.1 50.3 34.9 19.2 36.3 20.6 36.7 26.3 49.0 48.3 55.6 33.0 36.8 34.9 38.0 44.4 30.3 18.6 27.9 CDK13 "CDC2L, CDC2L5, CHED, KIAA1791" ENSG00000065883 "Cyclin dependent kinase 13" Q14004 7 39950121-40099580 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 179.0;Oligodendrocyte precursor cells: 171.9;Oligodendrocytes: 199.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059241 Uncertain Supported "Nuclear speckles,Golgi apparatus,Cytosol" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 34: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "Golgi apparatus, Cytosol" "HPA059241: AB_2683956" "unprognostic (1.99e-1)" "unprognostic (1.22e-2)" "unprognostic (2.67e-1)" "unprognostic (2.72e-1)" "unprognostic (1.83e-1)" "unprognostic (1.02e-1)" "unprognostic (4.18e-3)" "unprognostic (3.42e-2)" "unprognostic (8.09e-2)" "unprognostic (1.13e-2)" "unprognostic (3.77e-2)" "unprognostic (8.13e-2)" "unprognostic (8.20e-2)" "unprognostic (1.21e-1)" "unprognostic (3.33e-2)" "unprognostic (3.53e-1)" "unprognostic (3.53e-2)" 11.4 10.2 8.8 14.6 10.8 28.1 11.1 19.3 9.9 12.8 6.7 11.9 10.5 13.6 14.2 14.7 15.0 12.7 10.4 8.1 10.7 12.7 15.9 12.1 21.7 10.5 8.5 20.1 12.8 17.2 8.0 13.6 8.6 11.2 13.6 19.7 12.9 11.8 11.2 12.0 12.0 12.0 7.2 16.6 12.3 19.0 10.1 19.6 20.6 14.0 20.2 13.4 10.0 14.9 28.4 16.6 28.2 27.0 24.9 24.1 19.3 22.1 23.8 19.8 24.6 17.8 19.1 51.0 12.6 23.4 34.8 33.6 23.4 19.4 29.0 25.3 17.3 22.8 20.0 16.0 23.7 34.8 23.5 14.3 25.5 22.6 30.0 22.6 23.6 23.1 39.0 34.3 20.7 14.7 28.0 24.9 40.8 20.0 19.1 30.5 18.5 20.5 18.5 28.1 20.0 28.8 27.6 59.8 19.9 36.7 24.6 43.0 28.3 27.0 26.0 17.6 30.5 28.3 26.0 41.2 19.8 30.9 35.4 7.8 2.2 4.0 4.1 1.9 2.8 6.4 3.8 3.0 1.3 10.5 3.8 3.9 5.9 4.3 3.1 3.3 3.9 1.3 8.8 10.8 19.3 9.9 8.1 10.7 10.5 8.5 8.6 7.2 10.1 14.9 47.6 44.8 72.0 131.6 49.7 21.4 18.5 15.9 29.0 47.8 36.7 27.7 30.9 25.8 37.1 31.3 70.9 13.7 91.0 23.1 7.9 20.4 13.9 54.3 51.4 30.9 18.7 5.9 179.0 15.4 9.1 31.7 30.1 72.6 17.1 95.5 19.2 23.7 13.2 37.0 166.2 17.6 14.2 23.8 17.4 9.2 26.1 31.6 14.2 145.2 27.9 22.4 53.5 171.9 199.6 28.6 12.9 17.7 50.1 21.8 15.2 12.7 32.8 69.4 6.6 38.5 32.0 36.1 33.4 34.7 26.1 12.2 49.7 56.8 20.1 25.0 CEACAM7 "CEA, CGM2" ENSG00000007306 "CEA cell adhesion molecule 7" Q14002 19 41673303-41706976 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "intestine: 651.8" "Group enriched" "Detected in some" 9 "Distal enterocytes: 1454.0;Paneth cells: 731.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 66.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA069621, HPA073910" Enhanced Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Cluster 37: Intestine - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane" Cytosol "HPA069621: AB_2686162, HPA073910: " "unprognostic (5.24e-2)" "unprognostic (2.72e-1)" "unprognostic (1.64e-2)" "unprognostic (6.03e-2)" "unprognostic (2.07e-2)" "unprognostic (4.30e-2)" "unprognostic (3.61e-2)" "unprognostic (1.74e-1)" "unprognostic (4.66e-2)" "unprognostic (1.86e-1)" "unprognostic (3.14e-1)" 0.6 0.0 0.0 71.4 0.0 0.1 2.9 0.0 0.0 13.3 0.0 595.8 0.5 0.3 0.0 52.6 0.6 39.4 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.4 651.8 0.0 4.0 0.8 0.1 1.4 0.7 5.7 0.0 0.2 2.0 0.1 0.0 0.0 0.0 0.0 12.0 23.4 39.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.2 0.9 0.0 0.0 0.1 0.0 0.1 0.0 2.8 0.0 0.0 0.0 0.0 1454.0 0.0 116.6 0.1 0.0 0.0 0.5 8.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.1 1.0 731.2 0.0 0.0 1.4 0.0 0.0 2.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 38.4 30.3 CEBPE CRP1 ENSG00000092067 "CCAAT enhancer binding protein epsilon" Q15744 14 23117306-23119255 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "bone marrow: 51.8" "Cell type enhanced" "Detected in some" "Hofbauer cells: 6.6;Kupffer cells: 1.4;Macrophages: 2.3;monocytes: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 218 "eosinophil: 750.4" "Lineage enriched" "Detected in many" 250 "granulocytes: 750.4" "Group enriched" "Detected in some" 4 "HL-60: 233.8;NB-4: 122.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002928, CAB005113" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 4: Macrophages - Innate immune response" Nucleoplasm "Plasma membrane, Cytosol" "CAB005113: AB_631240, HPA002928: AB_1078494" "unprognostic (1.33e-2)" "unprognostic (4.76e-2)" "unprognostic (4.19e-2)" "unprognostic (2.04e-1)" "unprognostic (5.01e-2)" "unprognostic (1.66e-3)" "unprognostic (2.84e-1)" "unprognostic (1.49e-2)" "unprognostic (3.33e-2)" "unprognostic (5.69e-2)" "unprognostic (9.03e-2)" "unprognostic (2.22e-1)" "unprognostic (3.80e-3)" "unprognostic (1.42e-1)" "unprognostic (1.12e-2)" "unprognostic (2.57e-2)" "unprognostic (8.19e-2)" 0.1 0.0 0.1 1.6 0.1 51.8 0.0 0.0 0.2 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.5 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.1 3.2 0.3 0.1 3.4 0.8 0.0 0.3 0.5 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 233.8 39.6 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.9 122.5 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.0 26.3 0.0 0.5 3.0 750.4 0.0 0.6 0.1 0.5 1.0 0.4 1.5 0.5 1.8 1.5 3.4 0.0 0.3 1.5 0.0 1.8 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 6.6 0.0 0.0 0.0 0.0 1.4 0.6 0.1 0.0 2.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.6 0.1 0.0 0.0 CEP126 KIAA1377 ENSG00000110318 "Centrosomal protein 126" Q9P2H0 11 101915010-102001062 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 143.7;Horizontal cells: 102.6;Respiratory ciliated cells: 138.5;Spermatocytes: 96.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 6.1;EFO-21: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038381, HPA038399" Uncertain Nucleoplasm,Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Cytosol" "HPA038381: AB_10669780, HPA038399: AB_10670157" "unprognostic (7.61e-2)" "unprognostic (6.75e-2)" "unprognostic (9.07e-2)" "unprognostic (1.02e-2)" "unprognostic (9.31e-2)" "unprognostic (8.87e-2)" "unprognostic (1.55e-4)" "unprognostic (1.52e-2)" "unprognostic (5.77e-2)" "unprognostic (9.55e-2)" "unprognostic (7.72e-3)" "unprognostic (8.87e-2)" "prognostic unfavorable (5.00e-4)" "unprognostic (1.30e-2)" "unprognostic (3.41e-1)" "unprognostic (9.61e-2)" "unprognostic (6.99e-3)" 5.4 4.9 8.2 0.8 9.9 0.9 3.8 9.5 12.3 7.1 16.2 4.2 0.6 4.3 2.6 2.0 9.2 1.9 4.2 9.1 7.1 2.2 0.4 4.4 1.4 9.2 8.9 7.8 2.0 1.4 18.1 0.9 7.4 3.5 1.9 11.1 2.4 3.0 1.0 3.9 2.2 2.1 9.2 1.8 1.9 16.8 8.9 0.8 4.1 1.5 0.8 3.7 5.1 9.0 0.5 1.0 0.6 0.8 6.1 3.3 0.3 0.9 1.1 0.5 0.4 0.3 1.8 0.6 5.7 1.1 2.6 0.5 0.7 1.4 0.4 1.8 0.9 0.1 2.6 0.7 0.7 0.1 0.1 1.0 3.0 0.7 1.5 3.3 1.5 0.8 0.1 0.2 1.3 0.6 0.6 0.1 0.5 0.7 0.9 0.1 0.6 0.0 1.3 0.8 1.7 2.7 0.8 1.2 0.1 1.2 2.2 0.2 1.0 1.7 0.9 0.5 1.4 1.3 0.7 0.1 1.9 0.1 0.5 0.3 0.1 0.3 0.4 0.0 0.3 0.5 0.3 0.4 0.1 0.6 0.4 0.4 0.4 0.9 0.0 1.2 0.1 0.1 8.2 9.9 9.5 12.3 9.1 7.1 9.2 8.9 7.4 9.2 8.9 9.0 6.7 9.6 6.7 0.0 7.2 0.0 5.1 0.0 5.2 29.7 6.4 11.9 6.9 8.6 23.5 18.4 45.9 1.3 20.2 0.5 3.9 2.4 21.7 143.7 45.1 4.0 66.7 2.5 0.0 0.4 0.6 33.4 8.2 3.6 0.0 19.0 3.3 0.0 0.4 102.6 0.0 9.4 0.0 0.3 0.0 12.0 53.7 2.8 0.0 0.0 0.7 25.8 20.6 0.0 0.0 1.1 1.7 51.1 3.5 3.0 0.5 6.0 138.5 53.7 6.6 18.3 11.3 96.3 26.2 1.4 0.0 0.1 6.3 39.3 1.7 2.0 CEP162 "C6orf84, KIAA1009, QN1" ENSG00000135315 "Centrosomal protein 162" Q5TB80 6 84124241-84227643 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 141.3;Oligodendrocytes: 64.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030170, HPA030171, HPA030172, HPA030173" Supported Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Cluster 37: B-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 1: K-562 - Erythropoiesis" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Centriolar satellite, Cytosol" "HPA030170: AB_10611113, HPA030171: AB_10601567, HPA030172: AB_10602414, HPA030173: AB_10602206" "unprognostic (1.75e-1)" "unprognostic (1.46e-2)" "unprognostic (1.64e-1)" "unprognostic (1.26e-2)" "unprognostic (1.06e-1)" "unprognostic (1.63e-3)" "unprognostic (2.95e-4)" "unprognostic (1.03e-1)" "unprognostic (6.73e-2)" "unprognostic (1.21e-3)" "unprognostic (1.57e-3)" "unprognostic (3.98e-2)" "unprognostic (2.87e-3)" "unprognostic (3.27e-2)" "unprognostic (6.32e-2)" "unprognostic (3.58e-1)" "unprognostic (1.44e-3)" 2.0 1.5 1.1 2.3 1.9 2.4 2.6 1.8 1.6 2.4 3.2 1.9 1.2 3.7 2.2 1.8 3.7 2.8 1.6 0.8 1.3 2.5 1.4 2.7 2.2 1.4 1.6 4.1 2.1 4.2 1.2 2.5 1.5 2.4 2.6 2.8 1.9 2.3 1.0 2.3 1.7 2.6 1.3 2.3 2.7 8.6 1.6 3.9 3.5 1.6 2.3 2.1 1.4 3.0 2.5 1.1 7.1 7.8 4.2 6.1 4.6 2.8 2.7 3.9 4.6 3.2 3.4 2.7 2.6 2.2 6.7 3.8 4.2 2.6 6.2 7.0 2.8 5.0 5.1 2.4 2.1 5.5 4.6 2.9 1.9 3.9 1.5 5.0 4.4 3.7 10.2 3.1 2.8 1.3 1.4 3.3 4.8 1.7 1.6 7.6 9.3 1.5 2.9 2.3 4.6 5.7 2.0 1.1 2.1 5.1 2.5 3.7 3.5 3.8 3.4 3.4 3.1 2.3 3.3 1.6 2.4 2.9 4.8 0.0 0.2 0.3 0.4 0.2 0.5 0.5 0.3 0.3 0.1 0.3 0.2 0.4 0.5 0.0 0.2 0.4 0.0 0.2 1.1 1.9 1.8 1.6 0.8 1.3 1.4 1.6 1.5 1.3 1.6 3.0 13.6 32.1 17.6 42.7 9.6 0.0 6.7 0.0 4.6 5.9 6.1 7.1 11.2 4.3 6.8 9.2 12.5 6.5 7.0 7.0 5.9 12.6 141.3 43.2 18.3 11.3 11.4 10.8 35.0 7.1 5.9 13.3 8.6 11.3 18.3 18.0 7.9 4.2 5.5 28.6 29.2 4.7 0.0 7.9 0.0 57.9 11.8 9.9 0.0 36.5 7.6 9.2 6.2 54.3 64.0 6.8 12.7 12.0 3.7 2.5 5.6 6.8 39.4 14.3 13.1 13.8 10.9 58.7 20.0 3.6 0.0 3.8 8.5 13.4 5.0 4.1 CEP170 "FAM68A, KAB, KIAA0470" ENSG00000143702 "Centrosomal protein 170" Q5SW79 1 243124428-243255348 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 52.6;brain: 66.3;testis: 89.8" "Group enriched" "Detected in many" 10 "Early spermatids: 1490.6;Late spermatids: 4804.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 120.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042151, HPA045597, HPA045787" Uncertain Supported Centrosome,Cytosol NA No 21000 "Cluster 14: Monocytes - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 17: WM-115 - Nervous system development" "Cluster 31: Spermatids - Spermatogenesis" Centrosome Cytosol "HPA042151: AB_2677876, HPA045597: AB_2732522, HPA045787: AB_2679453" "unprognostic (2.97e-1)" "unprognostic (2.49e-3)" "unprognostic (8.84e-2)" "unprognostic (1.04e-2)" "unprognostic (1.48e-1)" "unprognostic (7.60e-2)" "unprognostic (6.83e-5)" "unprognostic (8.05e-2)" "unprognostic (9.88e-3)" "unprognostic (7.09e-2)" "unprognostic (3.52e-2)" "unprognostic (6.65e-2)" "prognostic unfavorable (1.30e-9)" "unprognostic (2.21e-2)" "unprognostic (2.17e-1)" "unprognostic (6.49e-3)" "unprognostic (9.62e-3)" 8.0 5.0 9.5 8.5 24.1 52.6 5.9 27.7 15.5 6.2 0.0 5.5 3.1 7.2 3.6 4.8 5.2 8.1 7.5 9.7 17.8 2.7 6.3 8.6 6.5 32.3 19.9 8.9 2.1 2.1 4.3 8.2 29.1 4.0 3.0 10.9 3.7 4.1 10.2 3.7 4.4 6.2 27.3 6.7 3.4 89.8 24.6 10.8 12.4 5.8 6.3 6.5 4.4 66.3 17.9 21.7 28.6 23.2 17.8 30.3 9.4 58.3 19.3 23.3 18.6 13.6 14.4 17.0 33.8 33.8 8.5 8.2 23.1 17.6 23.7 36.8 24.9 18.5 21.5 5.8 12.1 28.7 26.4 25.8 4.8 81.3 36.0 51.2 54.3 8.4 43.3 12.4 21.6 4.0 14.8 13.1 47.2 2.7 53.6 31.7 33.6 5.3 5.2 3.1 47.7 79.1 28.0 1.5 19.4 19.0 6.1 26.8 109.7 50.7 21.8 33.9 51.4 16.9 22.4 29.9 31.3 22.3 120.1 4.3 8.7 8.1 1.8 10.6 2.8 3.4 3.7 1.6 9.2 9.4 4.6 2.7 12.8 3.3 11.9 5.9 3.1 2.5 9.5 24.1 27.7 15.5 9.7 17.8 32.3 19.9 29.1 27.3 24.6 66.3 33.4 19.2 19.8 90.4 46.4 15.2 4.8 11.2 26.2 40.2 8.7 12.1 22.2 8.6 9.6 12.9 6.2 3.8 10.9 0.7 0.0 19.5 1490.6 25.3 40.1 43.4 10.8 16.4 115.9 6.9 7.5 37.3 5.6 12.8 23.4 31.3 22.5 7.3 35.9 45.4 124.6 2.4 4.1 38.9 85.0 4804.7 44.1 70.9 23.2 141.5 36.9 11.9 4.1 147.2 299.7 27.4 1.2 35.3 22.3 2.5 1.0 2.8 24.0 19.3 26.3 41.2 34.4 73.5 29.4 16.9 11.5 1.9 13.6 29.1 1.6 3.1 CEP85 "CCDC21, DKFZP434L0117" ENSG00000130695 "Centrosomal protein 85" Q6P2H3 1 26234200-26278808 "Predicted intracellular proteins" "Chromosome partition" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 132.9;tongue: 65.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 29.0;Oligodendrocytes: 28.8;Spermatocytes: 40.9;Spermatogonia: 34.2;Syncytiotrophoblasts: 41.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 19.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028252 Approved Approved "Nucleoli,Golgi apparatus,Centrosome,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoli, Golgi apparatus" "Centrosome, Cytosol" "HPA028252: AB_1846142" "unprognostic (1.08e-1)" "unprognostic (2.59e-2)" "unprognostic (1.74e-2)" "unprognostic (4.16e-2)" "unprognostic (2.66e-1)" "unprognostic (5.30e-3)" "prognostic unfavorable (4.39e-6)" "unprognostic (3.72e-2)" "unprognostic (5.30e-2)" "unprognostic (8.24e-2)" "unprognostic (9.18e-2)" "unprognostic (1.57e-1)" "unprognostic (1.29e-1)" "unprognostic (7.33e-3)" "unprognostic (5.41e-2)" "unprognostic (1.02e-2)" "unprognostic (2.60e-2)" 2.8 3.5 3.9 5.3 8.3 20.8 3.8 5.6 6.7 4.1 3.7 5.4 3.4 3.2 3.2 8.6 2.7 2.7 25.5 4.3 5.9 6.0 5.8 4.7 6.9 7.1 6.8 3.3 5.0 8.8 6.1 3.2 8.9 2.9 6.0 14.1 5.3 2.4 132.9 9.8 5.2 3.7 3.7 6.3 4.7 31.1 7.1 13.6 7.8 65.9 7.8 3.2 6.2 14.3 29.6 12.5 30.2 22.6 7.3 8.9 52.5 18.8 11.5 31.9 28.5 17.4 28.2 34.3 20.1 9.2 14.6 25.5 41.0 14.4 29.9 23.5 20.9 49.7 31.9 19.4 6.6 46.2 43.8 3.8 13.7 24.9 16.4 12.8 14.5 47.7 57.4 39.9 19.2 9.8 38.7 35.2 23.0 17.4 20.8 39.8 31.3 29.7 10.4 5.5 41.4 16.7 24.5 19.8 15.7 21.5 14.5 26.4 14.3 17.1 26.7 19.3 24.7 30.0 48.4 38.9 9.8 65.2 27.5 5.0 6.4 19.2 3.5 6.1 2.8 2.6 2.6 2.7 4.9 1.8 2.2 3.5 0.6 2.3 7.4 2.1 3.6 3.6 3.9 8.3 5.6 6.7 4.3 5.9 7.1 6.8 8.9 3.7 7.1 14.3 1.0 0.0 2.2 3.6 2.7 6.9 4.0 2.5 6.2 11.2 3.7 2.9 29.0 1.5 3.7 5.5 12.5 3.4 5.1 6.9 7.9 1.7 1.0 3.4 2.3 2.0 1.8 16.8 12.8 1.3 3.9 2.3 3.6 4.9 2.5 9.1 1.4 3.1 4.8 0.0 9.9 3.7 2.0 5.0 3.7 2.9 1.5 4.3 1.8 4.7 4.0 1.8 2.1 3.0 28.8 2.7 3.4 0.4 4.4 2.5 2.3 1.1 2.0 11.1 0.0 2.4 2.3 40.9 34.2 8.6 6.1 41.7 3.4 2.3 4.5 4.5 CEP95 "CCDC45, DKFZp667E1824" ENSG00000258890 "Centrosomal protein 95" Q96GE4 17 64506865-64542461 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052426, HPA052428, HPA061371" Approved Uncertain "Centriolar satellite,Cytosol" NA No "Cluster 16: MAIT-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 46: Photoreceptor cells - Phototransduction" Cytosol "Centriolar satellite" "HPA052426: AB_2681827, HPA052428: AB_2681829, HPA061371: AB_2684495" "unprognostic (1.28e-2)" "unprognostic (9.12e-2)" "unprognostic (3.66e-3)" "unprognostic (4.09e-2)" "unprognostic (3.30e-2)" "prognostic favorable (5.78e-4)" "prognostic unfavorable (2.52e-5)" "unprognostic (6.57e-3)" "unprognostic (7.88e-3)" "unprognostic (1.54e-1)" "unprognostic (1.64e-2)" "unprognostic (3.57e-3)" "prognostic unfavorable (5.76e-5)" "unprognostic (3.48e-1)" "unprognostic (1.84e-2)" "unprognostic (1.34e-1)" "unprognostic (1.79e-3)" 8.4 6.4 8.1 11.7 10.2 42.5 17.5 20.5 10.8 12.8 15.4 11.7 13.5 23.4 15.9 9.4 16.6 13.0 8.5 8.5 8.6 10.4 11.3 11.3 20.1 10.4 10.7 25.6 14.4 10.4 6.3 9.5 10.7 14.6 14.6 40.4 9.6 11.7 9.5 23.1 11.8 12.5 8.9 14.0 13.9 19.0 8.3 18.9 21.3 6.9 16.4 9.7 7.9 16.2 18.5 10.7 26.3 22.8 8.6 15.4 23.7 9.6 10.9 12.8 16.9 14.4 11.3 28.7 6.1 13.3 13.2 25.3 21.2 15.9 24.9 7.3 15.6 27.2 28.2 30.8 21.1 28.9 15.3 18.9 19.8 14.2 30.7 18.5 10.9 29.1 31.5 21.5 12.5 21.4 40.3 23.4 14.8 20.9 14.2 31.6 46.1 21.0 16.5 28.4 14.9 28.0 11.8 22.0 30.2 39.1 20.2 25.0 12.7 27.6 23.9 11.5 13.1 23.6 18.5 31.4 11.6 21.5 19.0 0.6 2.7 2.1 2.9 2.9 7.1 3.5 3.6 4.3 3.0 3.7 5.9 4.0 0.9 2.0 2.8 2.9 3.2 1.8 8.1 10.2 20.5 10.8 8.5 8.6 10.4 10.7 10.7 8.9 8.3 16.2 14.9 41.7 26.3 44.7 29.4 16.2 25.6 14.3 40.5 29.9 17.9 20.2 17.6 14.3 29.4 3.7 45.9 9.4 25.1 18.1 7.9 18.6 58.0 45.9 28.9 13.8 7.7 26.5 47.5 11.8 10.8 23.5 18.8 44.8 29.7 31.9 13.2 8.9 8.5 18.5 56.2 13.8 8.2 10.3 12.8 18.5 20.8 16.6 12.4 23.4 15.2 21.3 15.5 42.7 46.7 14.1 10.4 21.4 21.1 15.4 20.2 6.8 53.1 84.8 13.1 41.3 21.6 38.8 27.5 28.4 20.3 6.6 23.7 23.8 19.7 21.9 CHAF1A "CAF-1, CAF1, CAF1B, CAF1P150, MGC71229, P150" ENSG00000167670 "Chromatin assembly factor 1 subunit A" Q13111 19 4402640-4445018 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, DNA replication" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 31.4" "Cell type enhanced" "Detected in many" "Erythroid cells: 50.3;Spermatocytes: 94.3;Spermatogonia: 103.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 15.7" "Group enriched" "Detected in many" 4 "dendritic cells: 15.7;granulocytes: 4.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB015186 Enhanced Supported Nucleoplasm,Cytosol NA Yes "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Cytosol "CAB015186: AB_628065" "unprognostic (1.91e-1)" "prognostic favorable (8.22e-5)" "unprognostic (2.49e-1)" "unprognostic (4.71e-2)" "unprognostic (2.06e-1)" "unprognostic (1.89e-3)" "unprognostic (5.30e-3)" "unprognostic (8.78e-2)" "unprognostic (2.06e-2)" "unprognostic (2.12e-2)" "unprognostic (2.46e-2)" "unprognostic (1.16e-1)" "unprognostic (8.54e-2)" "prognostic favorable (4.15e-6)" "unprognostic (1.71e-1)" "unprognostic (2.11e-3)" "unprognostic (4.03e-2)" 4.9 4.4 3.5 9.7 3.0 31.4 4.8 5.6 6.6 4.7 1.3 6.9 6.5 3.9 2.0 10.2 4.0 2.7 3.9 3.7 3.0 2.4 4.1 4.0 13.4 3.4 3.1 3.7 3.9 3.3 3.7 6.2 3.0 5.8 6.6 3.4 5.5 3.0 12.2 10.8 6.7 4.1 2.4 6.9 5.1 14.5 3.1 16.3 2.9 4.1 10.5 4.7 5.6 4.1 65.8 44.0 71.8 45.3 7.0 8.5 36.7 61.2 24.8 50.5 56.7 53.5 22.8 100.4 24.7 19.6 28.6 50.3 61.6 41.5 59.8 58.1 67.2 62.9 69.4 42.7 3.5 73.7 48.8 4.8 8.6 41.5 17.7 9.4 24.0 54.9 76.8 88.0 31.3 37.8 119.2 40.7 80.1 33.5 35.6 87.2 56.8 57.2 13.1 76.7 50.6 39.2 41.6 29.1 24.5 45.2 25.7 53.9 17.5 41.3 35.9 71.1 74.9 43.7 71.0 96.3 34.7 92.8 49.9 3.8 2.3 4.7 0.5 2.3 0.4 1.6 0.6 0.1 2.1 1.0 0.5 0.4 1.2 1.2 0.4 15.7 0.9 0.9 3.5 3.0 5.6 6.6 3.7 3.0 3.4 3.1 3.0 2.4 3.1 4.1 2.3 0.0 3.9 2.0 12.5 9.7 4.6 3.5 6.2 12.1 5.1 3.6 5.7 1.5 2.6 5.5 2.1 25.3 17.3 13.9 1.9 8.5 6.7 5.3 4.2 4.6 1.8 50.3 4.1 6.7 37.9 6.1 10.7 6.5 2.5 19.3 3.3 4.8 12.1 1.7 3.6 10.7 0.0 4.8 21.4 6.7 3.1 11.8 1.8 1.9 11.5 5.2 5.2 2.5 2.9 6.8 1.7 3.8 32.5 4.1 4.6 1.8 5.0 8.4 32.9 5.7 5.5 94.3 103.8 18.7 14.9 14.6 7.7 9.4 14.6 5.9 CHTF18 "C16orf41, C321D2.4, CHL12, Ctf18" ENSG00000127586 "Chromosome transmission fidelity factor 18" Q8WVB6 16 788046-800737 "Predicted intracellular proteins" "Cell cycle, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 11.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 23.1;Extravillous trophoblasts: 19.6;Granulosa cells: 22.0;Spermatogonia: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "basophil: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 48.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA040976, HPA056209" Supported Nucleoplasm,Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 71: Testis - DNA repair" "Cluster 28: BEWO - Transcription regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Cytosol "HPA040976: AB_2677232, HPA056209: AB_2683066" "unprognostic (3.83e-2)" "unprognostic (4.97e-2)" "unprognostic (4.25e-2)" "unprognostic (9.35e-2)" "unprognostic (4.59e-2)" "unprognostic (3.02e-3)" "unprognostic (1.80e-3)" "unprognostic (3.02e-2)" "unprognostic (2.61e-1)" "unprognostic (1.19e-1)" "unprognostic (4.00e-2)" "unprognostic (1.44e-2)" "prognostic unfavorable (1.43e-8)" "unprognostic (2.07e-2)" "unprognostic (1.55e-1)" "unprognostic (9.89e-2)" "prognostic favorable (2.78e-4)" 2.7 2.2 0.7 1.1 0.5 6.8 3.2 0.7 1.5 4.3 0.0 3.3 1.9 3.2 0.0 5.1 3.2 0.6 1.8 0.7 0.4 2.6 2.4 2.8 1.4 0.5 0.3 4.8 2.8 0.1 2.5 1.2 0.5 3.4 0.3 0.3 2.7 0.6 2.0 4.0 4.0 0.3 0.1 5.7 3.0 11.7 0.5 1.8 3.1 0.3 0.3 3.1 3.7 0.4 14.4 7.0 5.5 4.5 0.5 0.4 48.3 8.9 2.4 4.4 3.0 12.5 10.8 16.1 8.9 1.5 2.3 15.7 1.2 6.8 0.0 9.2 20.1 7.1 8.6 6.4 0.0 4.4 13.4 0.2 0.8 4.2 2.2 0.6 3.7 16.4 10.9 5.2 1.1 27.7 17.4 16.6 7.2 3.3 8.3 31.1 14.0 21.2 1.5 4.1 7.2 9.2 6.4 14.1 4.8 0.6 10.3 10.8 2.4 6.5 23.5 11.8 12.2 12.3 4.3 9.1 2.0 6.5 11.5 2.5 0.2 0.0 0.7 1.0 0.4 0.1 0.3 0.6 0.4 0.2 0.4 0.1 0.1 0.7 0.6 0.2 0.4 0.2 0.7 0.5 0.7 1.5 0.7 0.4 0.5 0.3 0.5 0.1 0.5 0.4 4.3 3.2 4.2 2.6 3.5 5.4 3.3 2.7 5.7 23.1 4.1 5.5 4.6 0.0 3.0 1.8 2.1 15.2 4.3 7.1 1.9 2.9 1.2 4.2 4.9 2.4 6.6 14.3 2.3 3.9 19.6 3.9 10.2 8.8 4.5 22.0 3.3 2.4 6.4 6.7 1.8 5.3 0.0 2.6 5.8 1.3 1.8 2.9 0.0 2.8 0.3 2.4 2.1 1.5 2.8 1.8 1.0 1.5 5.7 1.4 0.9 1.0 2.5 7.0 0.0 3.2 3.5 13.6 21.2 4.5 2.0 8.6 3.4 5.0 7.4 3.2 CKAP2L "FLJ40629, radmis" ENSG00000169607 "Cytoskeleton associated protein 2 like" Q8IYA6 2 112736349-112764664 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "bone marrow: 13.1;lymphoid tissue: 12.1;testis: 4.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 25.2;Granulosa cells: 12.5;Spermatocytes: 33.0;Spermatogonia: 35.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA039407, HPA040057, HPA070737" Uncertain Supported "Microtubules,Mitotic spindle,Cytosol" Yes Yes "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Microtubules, Mitotic spindle" Cytosol "HPA039407: AB_10794091, HPA040057: AB_10794871, HPA070737: AB_2686303" "unprognostic (2.29e-1)" "unprognostic (1.54e-1)" "unprognostic (4.69e-3)" "unprognostic (1.42e-3)" "unprognostic (1.69e-1)" "unprognostic (5.59e-2)" "unprognostic (5.75e-5)" "prognostic unfavorable (7.63e-4)" "unprognostic (2.49e-3)" "unprognostic (1.91e-1)" "unprognostic (9.57e-6)" "unprognostic (2.42e-1)" "unprognostic (0.00e+0)" "unprognostic (7.37e-2)" "unprognostic (1.24e-1)" "unprognostic (1.30e-1)" "unprognostic (4.49e-2)" 0.4 0.1 0.2 2.6 0.2 13.1 0.4 0.4 0.3 0.4 0.0 1.6 1.5 0.3 0.1 2.3 0.1 0.3 0.0 0.2 0.1 0.1 0.3 0.3 5.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.1 2.2 0.2 0.3 0.0 0.0 1.5 1.1 1.1 0.0 0.9 1.0 4.5 0.2 12.1 0.2 0.0 5.2 0.8 0.6 0.2 47.9 9.6 35.4 16.2 2.0 3.3 7.2 38.5 32.2 37.9 36.1 8.7 13.3 32.0 15.5 15.1 48.3 18.0 20.4 19.6 64.1 44.8 8.9 53.6 12.7 7.7 0.1 25.2 30.9 0.9 1.9 47.4 27.2 10.1 17.5 22.8 14.3 44.9 31.2 6.9 31.0 10.6 15.4 20.0 29.5 22.3 37.0 8.4 6.9 18.7 19.7 12.7 15.2 12.8 13.3 13.2 12.4 11.8 12.9 42.7 33.7 34.5 28.5 9.9 20.1 26.6 18.5 18.1 69.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.2 0.2 0.4 0.3 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.1 3.2 0.6 0.0 1.2 3.3 2.1 2.7 0.6 0.0 0.5 0.8 0.5 1.5 0.4 0.0 0.0 11.1 1.3 1.3 0.0 0.4 2.4 1.1 1.6 1.1 0.0 25.2 0.3 0.4 10.6 2.0 1.5 2.1 0.0 12.5 2.9 0.1 6.6 0.0 0.2 3.1 2.0 1.9 1.4 2.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.0 5.6 1.1 0.1 0.1 0.4 0.0 0.0 0.4 2.8 33.0 35.7 9.5 1.7 1.0 2.5 0.7 3.8 1.1 CLCN5 "ClC-5, CLC5, DENTS, hCIC-K2, hClC-K2, NPHL1, NPHL2, XLRH, XRN" ENSG00000171365 "Chloride voltage-gated channel 5" P51795 X 49922596-50099235 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Antiport, Ion transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "epididymis: 23.7;kidney: 46.2;liver: 16.9" "Cell type enriched" "Detected in many" 4 "Skeletal myocytes: 214.4" "Cancer enhanced" "Detected in all" "renal cancer: 9.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "myeloid DC: 2.6;plasmacytoid DC: 2.8" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in all" 4 "CACO-2: 49.0;RH-30: 66.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000401, HPA003213" Uncertain Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus, Plasma membrane" Cytosol "HPA000401: AB_1078531, HPA003213: AB_2666843" "unprognostic (3.33e-2)" "unprognostic (6.15e-2)" "unprognostic (3.13e-1)" "unprognostic (1.57e-1)" "unprognostic (7.59e-2)" "unprognostic (1.27e-1)" "unprognostic (1.54e-1)" "unprognostic (8.08e-3)" "unprognostic (1.60e-1)" "unprognostic (5.21e-2)" "prognostic favorable (5.20e-4)" "unprognostic (3.59e-2)" "prognostic favorable (2.05e-8)" "unprognostic (7.87e-3)" "unprognostic (1.07e-1)" "unprognostic (1.25e-1)" "unprognostic (3.60e-2)" 2.1 2.5 1.7 1.7 1.9 1.5 1.6 3.8 1.6 1.8 2.5 2.4 4.9 4.0 23.7 2.4 3.0 3.9 1.3 1.5 2.9 46.2 16.9 2.8 1.3 3.2 3.2 7.0 2.1 1.4 2.3 5.8 3.7 1.7 2.8 3.4 2.5 1.0 4.0 4.8 3.8 2.9 2.5 1.8 2.9 2.1 2.7 1.1 2.2 2.8 1.2 1.4 2.0 2.3 2.9 5.4 4.2 5.5 12.8 7.5 7.9 2.8 1.2 1.6 1.9 49.0 3.0 3.5 1.2 2.5 9.7 2.8 9.9 1.7 2.2 1.1 7.5 3.3 2.7 12.8 7.2 4.1 5.7 4.9 1.6 3.7 5.9 1.2 5.8 4.0 4.3 4.7 5.3 3.2 1.6 1.4 5.7 7.4 2.4 1.9 66.0 5.2 6.0 5.5 7.2 5.2 3.3 3.0 5.1 14.1 3.0 2.1 3.8 1.6 3.7 12.7 1.4 3.6 11.9 7.3 2.8 6.6 8.5 0.0 0.9 0.0 0.1 0.9 0.1 0.1 0.2 0.2 2.6 0.1 0.0 0.0 0.2 0.1 0.1 2.8 0.0 0.3 1.7 1.9 3.8 1.6 1.5 2.9 3.2 3.2 3.7 2.5 2.7 2.3 4.3 9.6 8.4 20.5 2.1 7.1 1.8 1.6 5.2 27.4 1.8 1.4 1.9 2.8 2.3 12.9 2.1 6.2 17.7 11.3 11.7 4.1 2.0 8.0 10.0 5.5 0.0 3.4 11.5 3.5 2.6 7.9 8.6 22.8 2.5 0.8 1.4 35.2 11.1 8.4 15.6 6.6 4.1 17.6 19.8 0.6 5.3 10.9 3.6 46.9 10.1 2.7 2.1 20.6 9.6 7.7 7.3 13.2 2.2 4.0 20.4 38.8 4.2 4.3 0.0 214.4 4.8 0.9 2.3 8.1 9.5 5.1 1.9 9.3 7.0 4.8 CLEC4E "CLECSF9, mincle" ENSG00000166523 "C-type lectin domain family 4 member E" Q9ULY5 12 8533305-8540905 "Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 75.7;lymphoid tissue: 52.3" "Cell type enhanced" "Detected in some" "Glandular and luminal cells: 31.9;Kupffer cells: 158.0;Macrophages: 115.2;monocytes: 109.5" "Cancer enhanced" "Detected in many" "testis cancer: 6.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 16 "classical monocyte: 128.8;neutrophil: 448.8" "Group enriched" "Detected in many" 17 "granulocytes: 448.8;monocytes: 128.8" "Group enriched" "Detected in some" 4 "NB-4: 4.3;RPTEC TERT1: 12.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA004935 Uncertain Uncertain Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 41: Macrophages - Immune response" Cytosol "HPA004935: AB_2667299" "unprognostic (3.05e-2)" "unprognostic (2.01e-2)" "unprognostic (8.91e-2)" "unprognostic (3.76e-1)" "unprognostic (1.76e-1)" "unprognostic (9.71e-3)" "unprognostic (1.77e-1)" "unprognostic (1.24e-1)" "unprognostic (9.29e-2)" "unprognostic (1.83e-1)" "unprognostic (1.16e-1)" "unprognostic (2.11e-2)" "unprognostic (7.65e-3)" "unprognostic (1.62e-1)" "unprognostic (1.51e-1)" "unprognostic (8.44e-2)" "unprognostic (2.29e-1)" 13.3 5.4 2.3 37.5 2.1 75.7 4.5 1.8 4.4 5.8 2.2 2.2 0.4 2.3 0.4 3.2 5.5 11.8 2.5 2.3 2.9 3.6 6.6 22.4 7.6 1.3 1.3 1.7 6.2 1.7 1.9 2.1 1.2 2.3 1.0 1.3 1.4 1.2 0.7 0.9 3.1 5.7 0.7 52.3 2.5 1.1 2.0 2.2 10.5 5.0 2.3 9.6 1.7 2.9 0.1 0.4 0.4 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.1 1.5 0.1 0.1 2.0 0.0 0.1 0.1 0.2 0.2 0.1 0.3 0.2 0.2 0.1 0.5 0.1 0.0 1.5 0.0 0.5 0.2 0.2 0.2 0.2 0.0 0.1 0.0 4.3 0.3 0.0 0.0 0.0 0.2 0.1 12.4 0.1 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.4 1.0 0.5 0.1 1.0 0.1 0.2 0.1 0.1 1.3 0.4 0.1 0.2 128.8 0.5 0.1 18.1 0.3 0.1 0.1 0.1 16.9 0.1 0.0 0.1 448.8 0.0 0.7 0.7 0.0 30.3 2.3 2.1 1.8 4.4 2.3 2.9 1.3 1.3 1.2 0.7 2.0 2.9 6.2 0.0 4.7 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 5.7 1.8 1.8 0.0 0.0 0.3 0.0 0.0 9.0 0.3 2.1 4.4 3.5 0.0 0.0 0.0 0.0 0.1 1.4 0.0 31.9 0.0 0.0 7.1 2.1 5.6 0.0 0.0 0.0 0.0 158.0 9.0 2.9 0.9 115.2 0.0 0.0 109.5 0.0 4.1 0.0 0.0 0.4 0.0 0.4 1.3 0.0 0.0 0.2 0.7 0.0 13.1 0.2 0.4 0.2 0.5 0.1 0.0 0.1 1.1 0.0 0.0 0.1 CMAS ENSG00000111726 "Cytidine monophosphate N-acetylneuraminic acid synthetase" Q8NFW8 12 22046218-22065674 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 532.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039905 Supported Uncertain Nucleoli,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 45: Intestine - Brush border" "Cluster 36: HEL - Hemostasis" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Cytosol Nucleoli "HPA039905: AB_10795237" "unprognostic (5.54e-2)" "unprognostic (4.10e-2)" "unprognostic (4.25e-1)" "unprognostic (5.39e-3)" "unprognostic (1.94e-2)" "unprognostic (3.99e-2)" "unprognostic (2.30e-2)" "unprognostic (4.17e-3)" "unprognostic (1.53e-2)" "unprognostic (1.01e-1)" "unprognostic (4.44e-1)" "unprognostic (7.53e-2)" "prognostic unfavorable (7.19e-4)" "unprognostic (2.27e-1)" "unprognostic (1.91e-2)" "unprognostic (3.65e-1)" "unprognostic (2.03e-1)" 19.7 57.0 46.6 23.2 51.1 47.9 32.9 40.3 57.8 29.2 35.8 77.8 66.2 23.5 69.0 71.6 21.8 24.4 42.6 51.2 57.3 28.9 72.2 18.1 24.2 43.8 57.1 25.3 42.5 79.4 30.0 34.0 57.1 36.7 71.9 24.8 32.6 26.7 44.0 29.3 63.6 27.7 41.8 20.1 29.7 69.9 49.0 19.8 23.8 41.1 26.1 24.2 40.3 44.0 63.4 50.2 59.5 29.3 47.0 57.5 88.8 43.2 46.2 45.0 47.2 114.1 72.0 56.5 41.3 37.3 83.9 50.9 35.8 60.1 60.7 75.0 45.4 169.1 38.8 57.2 43.2 45.4 85.5 38.5 56.4 58.1 86.3 61.5 61.3 58.7 108.8 28.1 80.9 83.8 52.0 105.3 147.5 69.4 69.5 36.2 63.6 53.7 56.0 67.8 23.8 42.0 34.2 59.6 51.9 120.2 82.3 62.0 45.5 51.2 42.4 46.2 81.1 19.4 26.0 74.9 83.6 34.6 54.3 22.7 27.3 32.1 20.4 29.7 26.1 19.0 26.9 27.0 31.5 18.2 24.2 24.6 2.8 36.9 27.4 20.2 33.8 25.5 46.6 51.1 40.3 57.8 51.2 57.3 43.8 57.1 57.1 41.8 49.0 44.0 21.5 12.8 17.5 12.4 19.2 29.2 76.8 117.2 14.8 38.3 31.9 21.2 72.7 41.5 102.3 23.9 4.2 175.2 17.8 158.1 76.3 56.6 12.4 17.2 19.6 36.8 41.6 153.9 38.7 83.6 141.3 41.7 21.9 20.0 22.8 28.2 34.2 63.6 66.2 35.3 29.2 118.2 93.6 29.8 22.0 19.0 25.4 32.5 44.4 8.4 45.3 33.4 26.8 16.6 25.5 79.7 156.2 27.8 16.7 112.3 133.6 87.0 82.5 20.4 19.7 30.4 42.3 112.2 97.1 52.3 44.5 532.6 24.6 63.0 90.8 190.6 CNTLN "bA340N12.1, C9orf101, C9orf39, FLJ20276" ENSG00000044459 Centlein Q9NXG0 9 17134982-17503923 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 91.8;Spermatocytes: 84.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 3.9" "Lineage enriched" "Detected in single" 5 "monocytes: 3.9" "Cell line enhanced" "Detected in many" "HEL: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007201, HPA036728, HPA036729" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 36: HEL - Hemostasis" "Cluster 52: Non-specific - Transcription" Centrosome "Nucleoplasm, Cytosol" "HPA007201: AB_2667775, HPA036728: AB_10670847, HPA036729: AB_10670240" "unprognostic (1.97e-2)" "unprognostic (2.81e-3)" "unprognostic (1.81e-1)" "unprognostic (2.48e-1)" "unprognostic (1.55e-1)" "unprognostic (1.60e-1)" "unprognostic (7.71e-2)" "unprognostic (1.68e-1)" "unprognostic (7.71e-3)" "unprognostic (5.07e-3)" "unprognostic (1.06e-1)" "unprognostic (6.65e-2)" "unprognostic (2.47e-1)" "unprognostic (5.38e-2)" "unprognostic (3.35e-2)" "unprognostic (1.37e-1)" "unprognostic (5.80e-2)" 4.4 2.4 2.3 2.1 2.4 7.3 3.5 7.7 2.2 5.0 3.3 4.5 1.2 7.1 2.4 2.7 4.3 4.2 2.3 1.7 2.6 2.4 10.5 2.8 2.7 2.7 3.1 8.8 1.7 4.4 2.2 3.6 3.0 2.7 2.2 2.1 1.6 3.2 1.6 1.9 2.2 4.5 2.6 3.9 1.9 5.2 2.5 2.8 3.1 2.5 1.6 3.5 3.5 2.8 8.3 5.6 12.1 6.8 5.8 13.6 0.4 9.5 6.3 7.0 9.5 0.4 2.7 6.0 1.5 6.6 7.5 0.3 14.1 3.9 10.9 0.3 4.9 35.5 11.7 2.0 6.4 4.9 7.4 8.6 2.0 5.8 5.7 6.5 10.0 2.2 1.3 1.1 11.3 0.6 4.0 7.8 9.4 1.4 10.3 5.8 11.2 3.0 4.1 2.0 7.6 7.9 11.6 0.2 3.0 4.8 2.3 12.3 7.5 9.5 3.7 10.4 8.3 4.7 6.1 0.1 4.4 6.1 4.4 0.2 1.3 0.0 0.0 1.6 0.0 0.1 0.1 0.0 0.7 0.1 0.0 0.0 0.1 0.5 3.9 0.7 0.1 0.2 2.3 2.4 7.7 2.2 1.7 2.6 2.7 3.1 3.0 2.6 2.5 2.8 32.0 6.4 17.6 59.7 1.6 8.8 13.7 6.1 13.1 12.3 3.6 5.8 13.4 7.2 3.4 9.2 0.0 2.5 1.1 2.4 5.9 10.1 16.3 23.4 30.7 24.9 2.4 17.1 20.3 12.0 5.2 29.2 4.1 17.0 7.6 42.4 20.0 38.8 18.4 20.2 37.2 5.9 4.1 40.3 11.6 8.8 45.7 24.0 8.8 91.8 31.0 21.4 1.0 70.4 29.6 4.0 0.8 30.9 1.8 3.8 5.3 8.5 6.7 8.1 13.1 34.2 21.3 84.3 48.9 5.3 5.5 1.0 1.7 31.6 5.5 6.3 CNTRL "CEP1, CEP110" ENSG00000119397 Centriolin Q7Z7A1 9 121074753-121177610 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 28.0;testis: 35.3" "Cell type enhanced" "Detected in many" "Early spermatids: 131.7;Spermatocytes: 385.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 81.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020468, HPA020480, HPA051583" Approved Approved "Centriolar satellite,Centrosome,Cytosol" NA Yes "Cluster 6: Non-specific - Transcription" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 32: U-937 - Innate immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Centrosome, Cytosol" "Centriolar satellite" "HPA020468: AB_2670455, HPA020480: AB_2670457, HPA051583: AB_2681542" "unprognostic (4.33e-3)" "unprognostic (2.89e-3)" "unprognostic (2.09e-2)" "unprognostic (7.97e-2)" "unprognostic (1.17e-2)" "prognostic favorable (9.21e-5)" "unprognostic (1.05e-2)" "unprognostic (3.22e-3)" "unprognostic (3.74e-3)" "unprognostic (2.02e-1)" "unprognostic (1.78e-2)" "unprognostic (5.47e-2)" "unprognostic (3.60e-3)" "unprognostic (9.83e-3)" "unprognostic (2.43e-1)" "unprognostic (3.57e-2)" "unprognostic (1.13e-2)" 5.3 3.7 2.5 13.8 3.6 28.0 5.0 4.0 3.2 4.4 6.9 4.6 4.0 6.7 2.7 4.1 7.8 5.4 2.8 2.1 3.3 2.8 4.1 6.7 23.3 5.4 5.5 7.5 3.9 2.8 3.1 6.3 4.1 4.5 5.6 7.5 3.6 3.8 1.1 4.9 5.2 4.9 3.7 12.6 7.8 35.3 3.4 23.9 4.8 1.8 21.7 6.5 2.8 5.3 12.6 8.3 22.5 16.4 3.3 4.9 4.2 8.4 6.2 6.6 5.6 4.7 13.2 55.7 3.3 6.3 11.8 25.2 7.6 5.2 10.4 34.3 5.5 29.4 15.2 6.1 4.5 81.0 34.1 3.1 3.8 6.9 16.5 2.8 14.6 22.7 19.2 31.0 6.5 7.9 31.2 21.5 8.1 16.0 6.6 30.1 33.4 17.4 3.1 5.7 8.5 12.9 28.4 5.2 6.3 3.9 11.0 36.0 10.3 6.7 11.6 10.8 15.8 22.0 25.6 37.8 5.6 32.2 16.1 16.2 7.0 17.0 7.2 4.3 5.5 11.7 7.5 5.5 3.7 11.9 9.0 6.4 2.7 5.0 6.5 10.6 11.5 2.8 2.5 3.6 4.0 3.2 2.1 3.3 5.4 5.5 4.1 3.7 3.4 5.3 19.8 28.9 32.8 34.9 78.7 3.3 13.8 6.8 9.1 33.5 7.4 12.2 8.9 10.0 29.5 3.7 37.5 2.7 58.2 2.7 3.9 5.1 131.7 61.8 12.3 14.8 8.4 33.2 35.4 6.0 3.0 15.1 14.8 10.9 53.0 20.6 14.6 3.9 27.2 30.3 43.8 8.4 4.1 33.9 16.5 44.3 13.7 50.7 8.8 52.5 55.2 8.2 49.4 37.2 53.1 6.3 4.5 12.0 39.1 4.3 2.2 1.4 114.6 59.6 39.5 33.8 14.5 385.0 114.1 10.9 5.7 0.8 57.0 13.1 6.4 6.2 CNTROB "LIP8, PP1221" ENSG00000170037 "Centrobin, centriole duplication and spindle assembly protein" Q8N137 17 7932101-7949920 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 44.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023319, HPA023320, HPA023321, HPA023325" Approved Supported Centrosome,Cytosol NA NA "Cluster 10: Basophils - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Centrosome Cytosol "HPA023319: AB_1852886, HPA023320: AB_1852888, HPA023321: AB_1852890, HPA023325: AB_1852892" "unprognostic (5.73e-2)" "unprognostic (1.07e-2)" "unprognostic (1.98e-1)" "unprognostic (5.26e-2)" "unprognostic (4.21e-2)" "unprognostic (1.03e-2)" "prognostic unfavorable (9.88e-4)" "unprognostic (1.04e-1)" "unprognostic (1.90e-1)" "unprognostic (1.07e-1)" "unprognostic (3.47e-3)" "unprognostic (1.48e-2)" "unprognostic (8.63e-2)" "unprognostic (4.47e-2)" "unprognostic (1.54e-1)" "unprognostic (4.79e-1)" "unprognostic (2.16e-2)" 18.2 14.6 17.1 13.5 17.7 32.2 17.3 17.9 20.7 26.6 16.2 24.0 10.7 38.0 18.1 20.0 20.1 12.8 15.1 17.8 19.0 18.6 18.1 28.7 15.2 17.8 18.0 20.8 16.8 19.8 18.0 12.0 17.7 19.5 18.9 17.9 16.4 12.5 12.6 26.2 17.2 25.5 16.3 19.0 16.7 65.5 18.7 29.2 19.6 9.8 17.7 18.7 19.5 19.0 51.1 31.0 48.7 25.5 19.1 26.7 15.0 43.9 40.5 59.8 44.0 26.5 18.0 50.2 22.4 38.5 26.9 41.2 36.8 29.9 64.9 50.6 27.4 33.6 58.6 21.5 28.6 31.9 52.8 24.2 21.1 42.0 41.7 28.5 36.6 53.0 24.6 25.9 40.8 15.9 49.5 29.6 10.4 18.5 25.6 51.9 32.6 20.2 26.5 16.1 16.2 29.4 34.3 17.8 14.8 25.2 24.6 20.0 33.2 32.8 27.6 45.2 61.0 38.7 27.1 35.1 28.4 39.6 47.2 6.4 1.8 0.7 1.8 2.5 1.7 1.4 1.4 2.4 1.3 0.9 0.9 1.6 0.2 2.5 1.1 5.3 2.0 2.1 17.1 17.7 17.9 20.7 17.8 19.0 17.8 18.0 17.7 16.3 18.7 19.0 4.2 6.4 19.6 6.5 4.2 7.9 7.5 5.2 4.6 6.6 6.7 6.5 3.4 7.2 6.9 12.9 8.4 4.4 7.4 5.9 1.9 5.8 3.1 5.8 18.0 5.4 3.0 14.1 3.8 6.9 4.7 6.4 6.6 5.4 18.4 10.9 5.7 3.5 6.5 3.3 5.5 7.0 2.0 6.7 9.1 4.8 5.3 9.2 3.6 5.6 1.9 6.4 6.2 4.5 4.3 6.6 3.1 7.9 7.5 5.5 4.4 3.5 5.7 6.2 0.0 5.8 5.4 44.4 8.1 9.0 8.7 2.5 5.7 5.5 8.4 4.5 COL16A1 ENSG00000084636 "Collagen type XVI alpha 1 chain" Q07092 1 31652263-31704319 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 109.0;Oligodendrocyte precursor cells: 62.4;Oligodendrocytes: 122.0;Peritubular cells: 91.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 133.1;ASC TERT1: 102.9;BJ hTERT+: 115.9;fHDF/TERT166: 106.5;HSkMC: 98.7;U-2197: 92.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA027237 Uncertain "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 960000 "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Cytosol "Plasma membrane" "HPA027237: AB_10600699" "unprognostic (2.25e-2)" "unprognostic (9.88e-2)" "unprognostic (5.64e-2)" "unprognostic (8.43e-2)" "prognostic unfavorable (8.08e-4)" "unprognostic (1.00e-1)" "unprognostic (3.99e-2)" "unprognostic (2.04e-1)" "unprognostic (4.48e-3)" "unprognostic (1.66e-3)" "unprognostic (1.44e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (4.00e-9)" "unprognostic (9.62e-2)" "unprognostic (6.13e-2)" "unprognostic (4.60e-2)" "unprognostic (2.15e-2)" 33.6 17.3 19.0 14.4 44.7 0.3 41.0 35.9 32.4 169.7 7.6 78.9 14.8 93.6 23.7 22.4 37.4 39.4 33.6 18.9 29.8 11.5 3.2 31.1 8.5 55.5 43.2 177.9 7.8 3.5 28.6 21.1 48.6 102.8 10.9 8.8 35.5 91.3 8.4 69.3 35.8 56.2 34.0 9.9 42.1 40.9 40.3 5.6 46.8 7.4 4.1 106.9 86.8 57.5 0.1 2.0 0.0 0.1 133.1 102.9 14.6 60.5 115.9 15.1 16.1 0.4 11.0 0.0 1.9 106.5 2.3 48.3 0.0 65.8 3.5 0.0 0.2 0.0 8.1 21.3 45.1 0.0 0.3 98.7 44.6 43.2 22.7 3.8 0.1 0.3 0.0 0.2 2.1 0.0 0.1 0.5 0.1 0.4 0.2 0.2 1.3 0.4 0.0 0.4 1.5 2.7 7.3 1.2 9.6 0.5 1.2 0.0 0.2 52.3 52.5 92.1 1.3 0.1 0.2 0.0 36.1 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 44.7 35.9 32.4 18.9 29.8 55.5 43.2 48.6 34.0 40.3 57.5 4.3 9.6 3.9 109.0 0.1 30.7 14.8 37.5 15.9 2.4 7.9 21.3 8.4 0.0 9.8 18.4 2.1 1.9 0.6 2.0 0.0 4.6 13.6 2.6 11.5 2.8 27.6 0.4 23.9 0.7 3.8 54.3 8.2 2.4 7.0 0.2 5.0 0.0 1.3 0.0 8.2 30.9 8.2 0.6 11.4 26.8 43.8 0.7 14.2 10.3 0.0 31.3 0.0 62.4 122.0 1.2 4.7 91.4 0.3 9.3 16.8 2.1 15.0 2.5 0.0 5.4 25.0 14.9 3.8 1.9 21.2 2.2 2.2 0.5 6.8 15.3 COX10 ENSG00000006695 "Cytochrome c oxidase assembly factor heme A:farnesyltransferase COX10" Q12887 17 14069490-14231736 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Heme biosynthesis" Transferase "Disease variant, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 44.5;tongue: 44.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 88.2;Late spermatids: 81.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032005, HPA032006" Supported Supported Nucleoli,Mitochondria,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 12: NES - Nervous system development" "Cluster 25: Spermatids - Spermatogenesis" Mitochondria "Nucleoli, Cytosol" "HPA032005: AB_10603560, HPA032006: AB_10670554" "unprognostic (6.17e-2)" "unprognostic (3.14e-1)" "unprognostic (1.41e-2)" "unprognostic (4.35e-2)" "unprognostic (1.86e-1)" "unprognostic (2.03e-1)" "unprognostic (1.31e-1)" "unprognostic (7.40e-2)" "unprognostic (6.27e-3)" "unprognostic (1.07e-1)" "unprognostic (9.46e-3)" "unprognostic (6.46e-2)" "prognostic favorable (4.32e-6)" "prognostic favorable (8.73e-4)" "unprognostic (8.82e-2)" "unprognostic (1.02e-2)" "unprognostic (8.71e-2)" 7.1 7.5 3.1 5.4 2.9 10.4 6.0 4.1 4.4 5.8 4.3 12.5 12.5 5.2 4.4 10.9 5.6 4.2 27.9 3.3 3.9 11.6 10.6 4.4 5.8 3.8 3.5 4.5 9.9 9.6 3.3 7.0 3.5 5.6 12.3 5.6 7.2 5.5 44.5 7.4 10.1 7.2 3.0 4.8 9.3 21.1 4.0 5.4 6.2 44.3 7.5 8.5 6.6 3.6 10.1 19.7 7.7 11.9 7.7 5.6 19.5 12.3 8.4 21.9 14.6 16.3 6.6 23.5 9.8 13.0 6.8 20.2 16.6 16.3 17.3 13.1 15.7 14.5 12.4 20.0 14.2 15.5 12.3 9.8 19.5 14.0 17.6 7.9 11.4 15.8 20.4 8.2 9.5 13.1 13.5 10.5 12.8 37.6 9.5 10.3 28.8 18.5 15.2 20.1 5.2 9.8 12.0 18.5 16.5 36.1 9.6 9.2 9.9 8.9 8.0 9.9 15.8 10.1 15.6 11.2 14.9 15.7 11.9 3.8 11.3 4.4 9.8 16.1 10.6 13.2 11.3 10.5 14.9 9.2 11.9 11.5 1.2 10.0 13.9 4.6 20.1 11.0 3.1 2.9 4.1 4.4 3.3 3.9 3.8 3.5 3.5 3.0 4.0 3.6 5.9 0.0 14.7 25.8 9.6 9.7 9.5 9.8 14.2 7.5 8.7 7.4 88.2 5.7 7.3 11.0 10.4 19.7 5.7 13.8 41.1 9.1 41.1 9.6 9.6 7.8 12.6 13.3 33.5 8.7 17.5 8.8 16.3 9.4 5.1 7.5 3.9 9.6 10.8 0.0 43.0 16.4 8.2 4.4 4.7 81.0 2.1 6.7 5.4 22.5 6.3 4.6 8.2 34.7 26.9 8.8 11.4 6.8 12.5 8.7 26.6 17.8 5.8 12.2 0.0 5.2 12.5 22.8 19.2 19.4 10.4 16.1 8.6 6.6 18.9 13.7 CRYGA "CRY-g-A, CRYG1, CRYG5" ENSG00000168582 "Crystallin gamma A" P11844 2 208160740-208163589 "Predicted intracellular proteins" "Eye lens protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Oligodendrocyte precursor cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA043386 Supported Uncertain Vesicles,Cytosol NA NA "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Vesicles, Cytosol" "HPA043386: " "unprognostic (1.49e-1)" 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.2 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.2 0.7 0.6 0.3 0.2 0.3 0.2 0.3 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRYGS CRYG8 ENSG00000213139 "Crystallin gamma S" P22914 3 186538441-186546702 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Eye lens protein" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.5" "Cell type enhanced" "Detected in many" "Astrocytes: 5.2;Excitatory neurons: 5.4;Inhibitory neurons: 6.0;Microglial cells: 5.6;Oligodendrocyte precursor cells: 6.0;Oligodendrocytes: 7.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA035103, HPA063539" Supported Uncertain Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 43: Cardiomyocytes - Nuclear processes" Cytosol "HPA035103: AB_10696367, HPA063539: " "unprognostic (5.52e-4)" "unprognostic (1.29e-3)" "unprognostic (1.44e-2)" "unprognostic (5.45e-2)" "unprognostic (4.90e-2)" "unprognostic (5.85e-2)" "unprognostic (4.79e-2)" "unprognostic (1.73e-2)" "unprognostic (4.76e-2)" "unprognostic (1.12e-1)" "unprognostic (5.84e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (3.72e-9)" "unprognostic (1.10e-1)" "unprognostic (9.53e-2)" "unprognostic (3.67e-1)" "prognostic favorable (2.73e-4)" 1.1 2.0 6.5 1.0 6.9 2.8 1.6 8.0 10.5 1.8 6.9 1.7 1.1 1.6 1.5 1.2 1.5 0.8 2.1 6.5 7.2 2.3 2.1 1.5 2.2 6.5 6.8 1.2 2.1 0.7 1.4 0.9 7.0 1.5 2.0 8.1 1.2 1.4 1.1 1.1 1.9 1.3 6.3 2.8 1.5 2.1 6.8 4.8 1.2 0.6 1.7 1.7 1.6 7.3 0.3 0.7 1.5 1.1 1.5 1.7 0.0 0.2 0.4 0.5 1.0 0.2 0.6 1.5 1.3 1.2 0.6 1.0 0.8 1.1 1.6 1.0 1.8 1.7 0.2 1.1 0.6 1.1 1.3 1.9 1.2 0.3 0.8 1.7 1.5 1.6 0.4 0.8 1.2 0.4 0.8 0.5 0.0 0.5 0.3 1.7 0.2 0.8 0.5 1.0 0.5 0.6 0.2 0.7 0.3 1.0 0.9 0.9 2.2 0.4 0.3 0.5 1.0 1.7 1.1 1.8 0.7 0.5 0.6 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.5 6.9 8.0 10.5 6.5 7.2 6.5 6.8 7.0 6.3 6.8 7.3 1.2 0.0 1.7 5.2 0.7 0.3 0.3 0.7 0.6 1.1 0.9 1.5 3.0 1.5 0.9 0.0 2.1 0.2 0.6 0.5 0.0 0.6 0.2 0.3 0.6 1.0 0.0 3.2 5.4 0.2 0.2 0.9 2.6 0.5 1.3 0.9 2.5 1.3 0.4 1.7 6.0 0.8 2.0 0.3 1.2 1.3 0.3 1.1 0.0 5.6 0.1 0.5 1.0 6.0 7.6 0.2 0.4 0.7 0.1 0.3 0.8 0.2 0.5 3.2 0.0 0.8 0.8 2.4 0.9 0.4 0.1 0.3 0.8 0.9 1.2 0.2 CSNK1A1L MGC33182 ENSG00000180138 "Casein kinase 1 alpha 1 like" Q8N752 13 37103259-37105664 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 3.5" "Group enriched" "Detected in some" 6 "Early spermatids: 30.0;Late spermatids: 23.0;Spermatocytes: 16.1" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 33 "neutrophil: 7.6" "Lineage enriched" "Detected in single" 39 "granulocytes: 7.6" "Not detected" "Not detected" HPA051334 Uncertain Cytosol NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 78: Testis - Spermatogenesis" "Cluster 10: Non-specific - Unknown function" Cytosol "HPA051334: AB_2681446" "unprognostic (1.23e-2)" "unprognostic (1.59e-1)" "unprognostic (3.19e-2)" "unprognostic (3.54e-2)" "unprognostic (2.40e-2)" "unprognostic (5.40e-2)" "unprognostic (8.90e-2)" "unprognostic (3.47e-1)" "unprognostic (1.47e-3)" "unprognostic (4.50e-1)" "unprognostic (2.02e-1)" "unprognostic (2.28e-3)" "unprognostic (3.45e-1)" "unprognostic (2.38e-1)" 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 3.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 7.6 0.1 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.1 1.8 3.5 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 30.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.7 23.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.6 2.2 16.1 1.2 0.0 2.7 0.3 0.0 0.0 0.1 1.7 CTBS CTB ENSG00000117151 Chitobiase Q01459 1 84549611-84574480 "Plasma proteins, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in all" "Region enriched" "Detected in some" 7 "basal ganglia: 7.4" "CAB017043, HPA023594, HPA048810" Approved Uncertain Cytosol "Intracellular and membrane" NA NA 370000000 "Cluster 34: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol "CAB017043: , HPA023594: AB_1847311, HPA048810: " "unprognostic (7.76e-2)" "unprognostic (1.28e-2)" "unprognostic (1.11e-1)" "unprognostic (1.36e-1)" "unprognostic (9.36e-2)" "unprognostic (3.54e-1)" "unprognostic (2.92e-1)" "unprognostic (1.76e-1)" "unprognostic (1.81e-1)" "unprognostic (1.84e-1)" "unprognostic (9.23e-2)" "unprognostic (1.27e-1)" "unprognostic (2.94e-2)" "unprognostic (7.08e-2)" "unprognostic (4.89e-2)" "unprognostic (3.12e-1)" "unprognostic (4.04e-2)" 1.5 1.4 0.4 1.4 0.8 3.3 1.6 1.0 0.6 1.2 2.1 1.2 0.9 1.5 3.1 1.0 1.1 1.2 1.0 0.2 0.6 1.7 3.7 1.4 1.6 1.3 0.9 0.8 1.7 1.6 0.5 1.2 1.5 2.2 1.4 1.4 3.3 0.8 0.8 2.4 1.2 1.1 0.5 2.5 1.4 0.5 0.8 1.0 1.3 0.9 1.0 1.0 0.5 1.3 0.9 0.3 0.2 0.2 2.7 3.2 0.6 0.6 2.2 0.3 0.8 0.1 1.1 1.2 0.2 1.4 0.3 0.4 0.0 0.9 0.9 1.1 0.3 0.8 0.1 0.1 1.6 0.8 0.4 2.4 1.6 0.8 1.2 1.9 0.9 0.5 0.7 2.2 0.6 0.0 0.5 0.9 0.2 0.2 0.3 0.2 0.3 0.8 1.9 0.4 0.1 0.4 0.2 0.9 1.1 0.5 0.5 0.9 1.5 1.1 0.1 1.5 0.7 0.6 0.2 0.3 0.8 1.1 0.8 0.5 0.1 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.7 0.1 0.3 0.1 0.0 0.0 0.4 0.8 1.0 0.6 0.2 0.6 1.3 0.9 1.5 0.5 0.8 1.3 43.6 9.6 23.4 10.4 37.4 30.3 30.2 28.0 34.1 5.9 33.1 15.6 5.8 31.5 25.5 23.9 41.7 26.8 25.4 30.2 43.0 20.2 3.3 24.1 24.4 29.9 23.0 14.1 6.2 19.2 24.2 28.1 25.0 19.4 43.8 9.7 49.6 70.8 48.2 3.3 4.3 18.9 16.2 75.5 27.9 3.7 21.1 58.8 7.2 20.6 56.5 21.8 18.6 5.5 9.0 19.1 25.2 24.5 59.8 36.7 30.0 44.4 38.2 41.9 13.1 20.2 16.6 10.4 12.8 27.3 24.7 25.6 26.8 25.3 18.4 29.9 CTC1 "AAF132, C17orf68, FLJ22170" ENSG00000178971 "CST telomere replication complex component 1" Q2NKJ3 17 8224815-8248056 "Disease related genes, Human disease related genes, Predicted intracellular proteins" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 37.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052436 Supported Nucleoplasm,Cytosol NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 59: Non-specific - Transcription" Nucleoplasm Cytosol "HPA052436: " "unprognostic (6.47e-2)" "unprognostic (1.06e-2)" "unprognostic (6.16e-3)" "unprognostic (2.81e-3)" "unprognostic (1.33e-1)" "unprognostic (2.20e-3)" "unprognostic (3.96e-1)" "unprognostic (2.07e-2)" "unprognostic (3.00e-1)" "unprognostic (5.66e-2)" "prognostic favorable (6.49e-5)" "unprognostic (2.89e-3)" "unprognostic (3.24e-1)" "unprognostic (5.76e-2)" "unprognostic (1.47e-1)" "unprognostic (1.77e-2)" "unprognostic (1.66e-2)" 13.8 11.8 13.4 14.7 14.1 18.5 15.9 19.7 18.8 17.6 13.2 16.9 8.0 13.5 10.7 11.1 17.2 6.9 11.7 13.4 13.4 16.6 18.3 18.5 24.1 13.2 13.3 19.9 18.2 10.4 21.4 6.1 13.3 16.6 10.4 22.2 12.4 9.0 7.0 14.1 25.0 9.3 12.2 37.2 15.8 10.8 13.7 31.2 18.0 5.7 21.4 14.8 13.4 14.6 3.0 6.6 5.9 5.5 18.1 4.3 7.2 3.4 3.8 4.8 3.2 5.0 8.8 10.8 3.4 5.9 3.5 10.0 7.0 5.2 3.0 8.0 6.8 5.3 7.2 6.5 3.0 1.7 16.1 4.4 5.5 6.3 8.6 9.5 8.7 15.4 5.1 3.6 3.4 3.9 18.6 7.3 4.8 9.7 1.6 8.7 2.3 6.9 12.4 7.1 5.2 5.9 6.7 8.6 6.0 10.9 5.3 5.0 11.6 1.5 3.6 3.6 4.0 7.4 4.7 7.1 2.9 6.5 4.5 2.0 0.7 1.2 2.0 0.9 2.0 2.2 2.0 1.9 0.7 2.6 2.8 2.5 2.5 1.3 1.2 2.2 1.8 1.0 13.4 14.1 19.7 18.8 13.4 13.4 13.2 13.3 13.3 12.2 13.7 14.6 6.3 0.0 11.1 8.5 16.7 1.9 3.0 1.0 3.4 7.7 6.2 4.1 3.4 7.2 3.0 5.5 37.5 6.4 12.0 4.6 1.9 3.6 3.7 3.6 2.6 6.4 6.7 1.7 10.2 3.8 3.9 3.8 5.6 5.5 6.3 4.0 5.7 8.1 3.9 1.7 10.3 5.8 2.0 8.2 1.0 6.2 4.4 3.5 0.0 3.7 5.6 2.5 6.2 9.0 6.6 4.4 9.4 2.2 9.6 4.1 4.5 2.2 3.0 17.3 0.0 3.1 4.1 4.7 4.2 3.9 2.0 11.1 10.3 2.1 3.5 3.4 CWC22 "EIF4GL, fSAPb, KIAA1604, NCM" ENSG00000163510 "CWC22 spliceosome associated protein homolog" Q9HCG8 2 179944876-180007297 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036748 Approved Supported "Nuclear speckles,Cytosol" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 50: Fibroblasts - ECM organization" "Nuclear speckles" Cytosol "HPA036748: AB_10669913" "unprognostic (1.90e-1)" "unprognostic (7.10e-2)" "unprognostic (7.30e-2)" "unprognostic (6.14e-2)" "unprognostic (4.96e-2)" "unprognostic (4.33e-2)" "prognostic unfavorable (7.42e-4)" "unprognostic (3.15e-1)" "unprognostic (1.31e-2)" "unprognostic (3.30e-2)" "unprognostic (3.84e-2)" "unprognostic (4.80e-2)" "prognostic unfavorable (7.76e-5)" "unprognostic (1.74e-1)" "unprognostic (3.03e-2)" "unprognostic (1.41e-1)" "unprognostic (9.44e-3)" 12.7 10.2 7.1 13.1 7.8 16.0 15.0 13.5 10.1 14.1 7.1 11.9 10.1 16.9 10.4 12.5 12.0 12.1 10.1 7.6 7.2 13.4 16.8 11.5 18.5 6.4 6.9 19.3 9.2 13.5 8.2 14.5 7.0 12.5 11.8 12.4 10.2 10.9 13.6 11.0 10.4 13.9 7.1 14.7 11.0 9.0 7.0 21.8 16.0 14.5 18.2 14.1 12.1 8.9 19.1 11.2 31.6 21.1 22.7 26.7 24.1 24.5 28.7 29.4 28.7 25.9 23.1 36.7 21.6 17.9 25.6 20.5 30.4 23.1 44.2 33.0 26.2 49.1 15.1 35.4 22.0 69.6 26.2 17.5 27.1 37.4 49.8 19.3 22.3 25.2 54.6 21.9 19.7 18.9 36.5 34.7 48.8 22.5 18.3 32.8 38.9 27.7 20.2 23.5 21.6 28.8 20.3 15.9 28.5 33.8 11.8 42.2 19.0 25.1 21.2 16.8 25.7 19.2 21.5 44.3 22.6 27.2 26.1 49.7 13.3 31.4 16.1 16.7 16.3 17.4 17.3 19.5 13.9 14.5 21.1 16.7 22.0 16.0 13.3 8.6 16.5 11.5 7.1 7.8 13.5 10.1 7.6 7.2 6.4 6.9 7.0 7.1 7.0 8.9 38.0 19.2 33.8 20.5 38.0 19.1 29.2 16.9 22.2 19.5 12.9 19.8 26.6 22.8 27.0 11.0 25.0 18.3 36.5 11.8 9.8 23.4 1.6 24.2 31.9 27.2 15.6 14.9 35.8 19.1 17.5 32.5 19.9 25.1 27.3 24.7 16.8 12.8 13.7 13.5 28.4 16.4 14.2 20.6 12.1 2.4 23.3 24.2 3.6 15.0 31.6 17.3 30.9 35.2 35.1 18.7 17.6 18.4 20.8 16.8 15.7 20.3 34.4 19.1 46.0 40.3 25.1 22.8 21.3 14.1 18.6 24.8 32.5 18.6 15.6 19.5 CXXC5 "HSPC195, RINF, WID" ENSG00000171604 "CXXC finger protein 5" Q7LFL8 5 139647299-139683882 "Predicted intracellular proteins" Transcription "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 317.0;Early spermatids: 714.2;Horizontal cells: 541.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "MAIT T-cell: 30.0;memory B-cell: 85.1;naive B-cell: 96.7;NK-cell: 71.9;plasmacytoid DC: 59.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 210.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036508, HPA058148" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 39: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA036508: AB_10673620, HPA058148: AB_2683621" "unprognostic (3.08e-2)" "unprognostic (9.03e-2)" "prognostic favorable (2.40e-4)" "prognostic unfavorable (4.10e-7)" "unprognostic (2.91e-1)" "unprognostic (2.05e-1)" "unprognostic (1.11e-3)" "unprognostic (2.28e-2)" "unprognostic (2.12e-1)" "unprognostic (2.72e-1)" "unprognostic (2.26e-1)" "unprognostic (2.79e-2)" "unprognostic (2.63e-2)" "unprognostic (8.02e-2)" "unprognostic (1.44e-1)" "unprognostic (7.26e-2)" "unprognostic (1.57e-1)" 26.5 20.6 48.9 17.6 65.6 46.9 21.5 103.6 64.5 29.2 36.4 17.5 10.8 15.1 30.0 25.6 29.8 20.1 30.4 56.2 48.2 70.7 88.1 16.1 30.2 91.5 65.1 5.0 61.2 28.0 43.6 15.9 84.0 15.3 11.6 38.7 53.9 18.3 80.1 24.8 22.5 9.1 66.5 34.5 21.0 51.8 61.4 34.3 22.5 21.5 24.7 14.8 23.9 106.4 36.5 30.1 32.6 12.3 44.5 60.6 12.7 23.3 35.3 9.9 19.5 66.8 36.0 47.4 101.0 62.5 59.7 40.5 6.7 17.9 4.7 5.2 11.5 70.5 25.8 47.0 19.2 16.0 1.8 21.8 4.0 16.7 4.8 95.6 2.7 1.5 67.8 7.6 72.6 94.7 17.2 51.1 39.4 39.2 8.5 30.8 66.5 73.5 75.3 26.0 103.0 106.3 8.3 210.6 18.0 71.2 115.5 74.2 14.6 80.2 15.6 38.8 21.4 27.3 62.4 89.9 121.2 5.3 45.6 1.1 6.6 0.6 9.7 1.4 30.0 85.1 0.9 6.8 5.5 96.7 0.5 2.6 1.8 71.9 0.6 59.0 1.4 10.7 48.9 65.6 103.6 64.5 56.2 48.2 91.5 65.1 84.0 66.5 61.4 106.4 22.9 48.1 18.8 24.5 120.4 26.3 14.8 41.9 8.6 232.0 41.0 67.8 49.3 105.8 32.5 147.1 25.0 2.9 90.2 18.6 317.0 125.1 714.2 47.1 53.9 43.6 18.6 52.2 18.7 144.9 23.9 47.8 24.5 53.7 21.5 41.9 36.0 131.8 38.4 541.8 8.7 50.7 61.1 35.6 92.1 200.3 39.1 32.2 60.5 15.0 40.9 220.5 195.7 16.6 44.3 93.9 17.5 30.5 114.1 34.1 22.6 200.0 38.6 49.1 13.1 150.9 48.5 14.2 13.9 15.7 20.9 37.6 21.1 25.1 27.0 21.4 CYTH4 "CYT4, cytohesin-4, PSCD4" ENSG00000100055 "Cytohesin 4" Q9UIA0 22 37282027-37315341 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 58.3;lymphoid tissue: 67.3" "Cell type enhanced" "Detected in many" "dendritic cells: 117.5;granulocytes: 57.0;Hofbauer cells: 76.8;Kupffer cells: 71.5;Langerhans cells: 87.5;Macrophages: 55.0;NK-cells: 120.5;T-cells: 43.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HL-60: 34.1;HMC-1: 141.1;THP-1: 95.2;U-266/70: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004065, HPA071573" Approved Supported "Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol" Yes NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Plasma membrane" "Cytokinetic bridge, Centriolar satellite, Cytosol" "HPA004065: , HPA071573: AB_2686418" "unprognostic (4.30e-3)" "unprognostic (1.65e-2)" "unprognostic (3.03e-2)" "unprognostic (9.28e-3)" "unprognostic (9.25e-2)" "unprognostic (1.69e-2)" "unprognostic (1.50e-1)" "unprognostic (5.84e-2)" "unprognostic (3.30e-3)" "unprognostic (1.23e-1)" "unprognostic (3.31e-2)" "unprognostic (8.42e-2)" "prognostic unfavorable (2.41e-8)" "unprognostic (3.70e-2)" "unprognostic (1.92e-2)" "unprognostic (5.56e-2)" "unprognostic (2.07e-1)" 21.5 8.8 4.9 67.3 4.5 58.3 5.1 4.4 8.5 5.3 6.0 10.7 8.5 4.4 1.6 6.1 4.8 16.4 5.6 4.7 5.6 4.1 5.7 18.9 57.0 8.8 7.4 3.4 2.5 2.1 2.9 28.0 7.8 3.6 10.0 0.3 7.3 4.3 2.2 2.2 15.2 12.9 6.7 59.2 11.5 2.7 9.7 25.6 3.0 5.1 40.3 23.2 2.5 9.1 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.8 9.3 0.3 0.0 2.5 0.1 0.0 0.6 0.0 5.3 0.0 9.8 0.0 0.0 0.0 34.1 141.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 23.2 0.0 0.0 0.5 13.5 0.0 0.1 1.0 1.3 0.2 19.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 95.2 0.3 0.0 0.1 0.1 0.0 28.4 4.0 4.5 18.5 11.5 0.2 15.8 62.6 87.5 55.4 102.5 39.0 30.3 30.5 44.8 47.5 31.8 30.0 38.3 199.1 45.0 129.4 113.8 30.7 76.2 4.9 4.5 4.4 8.5 4.7 5.6 8.8 7.4 7.8 6.7 9.7 9.1 1.1 3.2 8.4 0.0 37.0 2.4 0.8 0.0 0.6 0.1 0.7 1.5 2.0 0.0 1.8 0.0 0.0 0.5 117.5 0.1 0.0 0.0 0.4 0.1 0.2 2.5 0.0 2.5 0.2 0.2 0.6 1.9 2.0 0.1 57.0 0.0 2.2 1.1 76.8 0.0 0.2 0.2 0.0 71.5 87.5 0.9 0.6 55.0 7.2 24.4 42.7 0.0 120.5 0.5 0.0 0.8 0.0 0.0 25.1 0.3 0.0 0.8 0.0 0.1 0.0 0.9 1.0 0.0 0.2 0.3 2.3 1.0 43.9 0.0 0.2 0.5 DAD1 OST2 ENSG00000129562 "Defender against cell death 1" P61803 14 22564907-22589224 "Cancer-related genes, Metabolic proteins, Predicted membrane proteins, Transporters" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028882 Uncertain Uncertain "Endoplasmic reticulum,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 68: Epididymis - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 55: Plasma cells - Humoral immune response" Cytosol "Endoplasmic reticulum" "HPA028882: AB_10602214" "unprognostic (2.76e-1)" "unprognostic (1.21e-1)" "unprognostic (1.15e-1)" "unprognostic (1.97e-2)" "unprognostic (2.02e-1)" "unprognostic (1.18e-3)" "prognostic unfavorable (7.73e-4)" "unprognostic (9.43e-3)" "unprognostic (3.06e-2)" "unprognostic (6.09e-2)" "unprognostic (1.99e-2)" "unprognostic (9.64e-2)" "unprognostic (6.62e-3)" "unprognostic (1.19e-1)" "unprognostic (3.08e-1)" "unprognostic (1.93e-1)" "unprognostic (1.37e-3)" 204.0 229.3 209.2 159.1 224.4 129.0 224.0 236.2 259.4 229.6 252.2 197.7 165.8 184.3 473.8 187.0 230.5 190.8 202.6 211.4 238.0 296.8 275.7 183.4 169.6 240.2 218.7 174.5 200.2 254.1 201.6 141.8 238.7 145.5 209.9 86.2 286.3 205.5 156.6 137.2 173.8 206.6 237.2 165.3 197.0 150.7 219.2 211.6 272.8 197.5 191.0 200.0 163.4 252.0 373.3 344.7 274.6 375.8 740.2 529.9 238.3 387.0 473.0 340.5 478.1 219.6 520.1 233.7 242.1 453.1 381.4 330.0 291.1 375.7 543.3 319.8 265.1 228.5 180.9 886.0 514.5 321.2 315.8 395.8 498.7 356.0 454.4 383.1 506.2 220.9 176.4 532.1 509.9 459.3 153.6 391.4 169.7 816.1 557.8 211.7 232.4 306.7 503.2 306.1 211.5 263.4 294.9 416.1 445.9 328.7 251.4 323.1 381.1 291.8 232.2 358.2 248.3 391.2 502.6 308.5 263.8 225.5 431.0 532.4 421.9 460.9 528.4 371.9 518.9 527.2 543.8 501.4 401.0 477.1 564.8 497.6 481.5 437.2 332.3 783.9 560.3 941.8 209.2 224.4 236.2 259.4 211.4 238.0 240.2 218.7 238.7 237.2 219.2 252.0 357.9 160.3 161.7 15.0 183.9 198.3 188.3 581.8 149.7 25.1 201.0 274.6 173.8 187.3 315.2 255.6 27.1 260.9 204.6 174.8 215.2 525.4 196.8 270.3 242.9 267.8 135.7 130.2 10.6 415.2 383.1 276.5 145.2 255.6 302.6 150.8 187.7 231.9 350.3 21.9 11.0 242.3 360.1 146.2 224.8 101.5 214.3 166.8 330.8 8.4 217.3 216.8 198.8 18.1 42.5 396.8 160.7 199.0 408.6 172.5 244.8 420.8 393.7 42.6 151.2 141.5 291.0 300.3 128.1 179.6 215.8 289.0 211.7 266.6 183.8 174.4 DCAF12L1 "KIAA1892L, WDR40B" ENSG00000198889 "DDB1 and CUL4 associated factor 12 like 1" Q5VU92 X 126549383-126552814 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 4.9;testis: 6.2" "Group enriched" "Detected in some" 4 "Early spermatids: 20.7;Late spermatids: 44.4;Spermatogonia: 14.4" "Cancer enhanced" "Detected in some" "renal cancer: 1.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "EFO-21: 15.2;U-2 OS: 8.4" "HPA044737, HPA048981, HPA053138" Approved Uncertain Cytosol NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 31: Spermatids - Spermatogenesis" Cytosol "HPA044737: AB_2679067, HPA048981: AB_2680586, HPA053138: AB_2682054" "unprognostic (2.62e-5)" "unprognostic (2.88e-1)" "unprognostic (1.19e-1)" "unprognostic (3.40e-1)" "unprognostic (1.39e-3)" "unprognostic (1.34e-1)" "unprognostic (2.34e-1)" "unprognostic (1.74e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 4.9 0.0 2.5 1.2 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 1.0 0.8 6.2 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 20.7 3.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.3 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 3.8 14.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 DCAF12L2 WDR40C ENSG00000198354 "DDB1 and CUL4 associated factor 12 like 2" Q5VW00 X 126163499-126166289 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.3;epididymis: 21.4" "Cell type enriched" "Detected in some" 7 "Granulosa cells: 11.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HAP1: 2.6;NTERA-2: 2.2;U-2 OS: 3.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA044737, HPA048981, HPA053138" Approved Uncertain Cytosol NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA044737: AB_2679067, HPA048981: AB_2680586, HPA053138: AB_2682054" "unprognostic (1.16e-4)" "unprognostic (8.83e-3)" "unprognostic (2.93e-1)" "unprognostic (2.52e-2)" "unprognostic (2.72e-1)" "unprognostic (3.02e-1)" "unprognostic (3.34e-3)" "unprognostic (1.16e-1)" "unprognostic (8.47e-4)" "unprognostic (1.56e-2)" "unprognostic (4.05e-2)" "unprognostic (3.86e-2)" "unprognostic (2.51e-1)" 0.8 0.9 1.9 0.0 2.0 0.0 0.4 0.1 2.2 1.4 0.0 0.7 0.0 2.4 21.4 0.1 2.3 0.1 0.0 2.5 3.5 0.2 0.0 0.0 0.1 9.3 1.5 1.4 0.0 2.5 1.3 0.0 4.2 1.5 0.0 0.2 0.3 4.3 0.1 0.2 0.2 1.3 1.6 0.0 0.3 5.5 3.1 0.0 0.1 0.9 0.2 1.2 0.5 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.0 0.1 2.2 2.5 3.5 9.3 1.5 4.2 1.6 3.1 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 DCTN2 "DCTN-50, RBP50" ENSG00000175203 "Dynactin subunit 2" Q13561 12 57529633-57547224 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039715, HPA040040" Enhanced Supported Centrosome,Cytosol NA NA 630000 "Cluster 34: Basophils - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 31: Spermatids - Spermatogenesis" Centrosome Cytosol "HPA039715: AB_10795154, HPA040040: AB_10794870" "unprognostic (1.70e-2)" "unprognostic (1.82e-1)" "unprognostic (1.54e-1)" "unprognostic (6.88e-2)" "unprognostic (1.49e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (1.38e-7)" "unprognostic (1.14e-1)" "unprognostic (1.60e-1)" "unprognostic (1.71e-1)" "unprognostic (4.26e-2)" "unprognostic (1.35e-1)" "unprognostic (1.08e-2)" "unprognostic (9.50e-3)" "unprognostic (2.09e-1)" "unprognostic (1.52e-3)" "unprognostic (3.41e-3)" 85.7 99.7 76.3 40.7 80.5 44.6 76.7 88.6 86.1 91.3 62.5 104.6 44.6 98.3 61.8 120.2 71.9 43.6 102.3 81.4 87.9 84.9 50.7 71.7 43.3 91.1 85.1 75.8 116.0 78.2 75.7 52.4 95.5 66.4 73.5 61.3 82.9 65.4 155.2 103.7 75.9 93.3 82.1 64.2 94.9 51.9 82.7 61.4 69.9 102.7 71.4 79.6 89.8 89.9 94.9 109.4 129.1 90.3 194.7 200.0 69.4 104.7 191.7 205.0 149.6 87.2 79.0 95.5 114.1 172.5 83.8 70.8 106.0 136.4 162.0 108.7 119.1 84.8 48.4 69.9 139.3 58.7 60.0 186.3 213.8 131.5 225.1 245.6 201.9 102.0 127.7 126.6 189.5 107.4 89.3 71.8 62.4 56.2 124.0 77.2 101.0 91.4 158.1 92.3 173.2 125.8 98.3 85.2 96.7 104.0 138.5 54.4 153.5 110.6 95.6 69.1 66.7 94.6 91.6 93.8 106.4 73.8 121.2 47.9 48.5 43.7 38.0 54.2 39.3 32.9 37.9 38.0 49.2 30.3 28.1 34.3 22.5 35.1 50.3 37.5 45.5 62.8 76.3 80.5 88.6 86.1 81.4 87.9 91.1 85.1 95.5 82.1 82.7 89.9 82.6 48.1 30.2 20.2 47.5 64.9 87.2 105.1 58.6 84.3 64.7 76.7 70.9 65.8 60.0 35.0 31.3 118.2 53.5 83.4 80.3 162.7 105.5 42.9 58.6 74.0 49.1 53.6 27.9 227.5 122.1 73.6 80.5 52.4 36.2 70.8 69.9 31.7 102.6 72.3 32.6 70.3 83.4 51.8 54.2 265.5 77.9 52.8 76.5 15.0 153.5 141.9 57.7 23.1 28.2 200.4 85.5 73.0 60.9 85.3 121.1 115.8 40.9 67.8 92.1 59.4 107.6 122.7 37.1 93.6 68.5 163.4 52.6 92.3 94.5 89.5 DECR1 "DECR, SDR18C1" ENSG00000104325 "2,4-dienoyl-CoA reductase 1" Q16698 8 90001405-90053633 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 290.1;liver: 272.3" "Cell type enhanced" "Detected in all" "Distal tubular cells: 399.2;Proximal tubular cells: 485.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 81.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023160, HPA023162, HPA023238" Enhanced Supported Mitochondria,Cytosol No No 120000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria Cytosol "HPA023160: AB_1847585, HPA023162: AB_1847586, HPA023238: AB_1847587" "prognostic unfavorable (1.49e-4)" "unprognostic (5.76e-3)" "unprognostic (8.37e-3)" "unprognostic (6.13e-3)" "unprognostic (2.01e-1)" "unprognostic (4.45e-2)" "unprognostic (1.68e-2)" "unprognostic (8.23e-2)" "unprognostic (1.02e-1)" "unprognostic (1.55e-1)" "unprognostic (9.12e-2)" "unprognostic (1.42e-1)" "prognostic favorable (1.79e-7)" "unprognostic (1.40e-1)" "unprognostic (1.73e-2)" "unprognostic (1.16e-1)" "prognostic favorable (6.06e-4)" 60.2 136.8 12.4 9.6 14.4 24.9 54.4 12.5 14.4 29.4 22.2 65.0 20.2 28.0 14.9 52.6 26.1 7.4 290.1 12.7 13.2 103.5 272.3 34.2 15.0 12.2 13.1 35.5 44.4 13.2 32.6 5.9 12.1 28.6 18.8 8.0 42.8 6.5 121.8 43.3 61.0 9.1 12.5 47.1 44.5 52.3 15.4 10.2 33.0 34.4 13.9 31.1 35.8 12.8 13.1 7.9 19.6 16.1 8.0 17.3 5.2 13.2 12.9 5.9 8.2 2.8 13.4 7.7 5.3 15.1 4.1 6.8 7.7 11.1 11.0 12.6 1.2 18.4 13.6 14.5 11.6 8.7 4.4 12.0 7.0 7.6 10.7 10.1 17.4 16.5 21.3 15.5 20.7 16.3 12.5 7.6 1.5 9.1 24.9 7.4 5.8 13.4 23.4 43.9 1.3 10.6 13.0 81.1 7.7 1.1 10.7 7.4 20.1 11.4 6.2 12.9 6.0 10.5 7.5 12.8 8.6 12.0 10.8 3.9 9.1 6.2 7.1 10.2 7.9 7.4 6.9 8.6 8.8 4.6 8.1 7.8 15.2 3.9 9.3 3.9 9.6 5.8 12.4 14.4 12.5 14.4 12.7 13.2 12.2 13.1 12.1 12.5 15.4 12.8 66.1 76.9 59.4 72.5 52.9 41.3 70.6 180.2 35.3 11.4 51.1 57.4 268.3 82.9 96.4 71.7 2.1 50.2 57.6 119.0 399.2 137.8 165.3 68.2 65.5 60.0 104.8 77.4 27.2 92.5 49.0 60.2 61.2 40.6 50.0 81.3 47.8 244.8 115.1 32.0 55.9 105.9 116.0 95.2 82.7 52.6 85.4 85.1 85.4 29.0 107.1 52.5 74.2 66.9 35.0 87.5 111.6 51.6 67.8 30.3 250.3 485.2 69.0 7.6 72.3 54.5 61.7 157.5 24.6 68.6 41.1 41.0 64.4 135.1 139.6 86.8 DEK D6S231E ENSG00000124795 "DEK proto-oncogene" P35659 6 18223860-18264548 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Chromatin regulator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015226, HPA054505, HPA057799" Supported Supported Nucleoplasm,Cytosol NA NA "Cluster 42: Non-specific - Transcription" "Cluster 9: Intestine - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Cytosol "CAB015226: , HPA054505: AB_2682508, HPA057799: AB_2683530" "unprognostic (6.35e-2)" "unprognostic (6.11e-2)" "unprognostic (5.04e-3)" "unprognostic (1.40e-2)" "unprognostic (3.66e-1)" "unprognostic (5.02e-3)" "prognostic unfavorable (9.65e-4)" "unprognostic (1.76e-1)" "unprognostic (1.48e-2)" "unprognostic (1.61e-3)" "unprognostic (6.49e-3)" "unprognostic (1.12e-2)" "prognostic unfavorable (3.45e-4)" "unprognostic (1.59e-1)" "unprognostic (1.68e-1)" "unprognostic (2.31e-1)" "unprognostic (3.78e-1)" 50.8 43.0 17.3 82.4 20.1 158.6 63.1 29.6 25.4 48.1 19.8 74.8 76.9 74.2 29.9 65.4 45.6 49.0 61.0 17.3 18.3 46.0 68.0 53.2 125.5 19.5 20.4 61.4 40.3 43.3 19.3 67.7 20.8 56.2 74.2 46.3 37.3 56.1 116.0 49.8 86.8 63.9 18.2 63.8 58.7 22.1 19.5 116.8 102.3 73.4 112.8 59.3 43.0 26.1 450.1 118.6 330.9 276.6 68.9 118.4 184.2 347.4 210.9 338.9 457.1 190.7 165.5 504.2 390.2 181.8 269.1 251.1 260.7 196.2 591.3 346.5 221.3 305.7 179.9 260.0 70.3 499.2 238.2 58.2 98.1 238.2 198.2 164.7 170.9 188.1 392.9 0.6 236.5 156.2 380.3 222.1 208.6 177.4 131.8 471.7 459.7 299.8 184.2 239.6 196.1 183.8 328.9 290.5 224.6 218.4 277.8 212.7 168.7 382.7 220.0 223.9 474.1 32.4 77.0 540.3 95.0 251.3 380.8 116.2 78.2 41.8 69.6 74.9 83.1 66.3 72.5 78.0 72.9 56.1 55.6 55.7 93.4 70.9 92.9 49.0 75.2 67.8 17.3 20.1 29.6 25.4 17.3 18.3 19.5 20.4 20.8 18.2 19.5 26.1 149.7 121.8 130.8 16.3 126.2 271.2 189.8 128.8 146.3 70.3 143.3 161.3 218.8 161.5 112.0 79.1 81.3 284.2 174.5 156.7 82.2 172.0 17.4 118.8 157.7 156.6 88.5 448.8 10.4 173.1 235.4 159.6 85.1 170.6 111.2 195.1 105.7 125.1 190.9 26.9 18.6 188.1 67.1 185.3 300.7 26.2 189.5 219.1 101.4 31.9 263.3 136.2 212.1 26.2 37.1 136.9 117.3 191.5 44.0 252.9 140.0 129.5 89.0 138.8 210.4 189.1 197.0 87.2 220.7 169.9 233.6 108.6 189.1 138.6 232.5 209.2 DENND1A "FAM31A, FLJ21129, KIAA1608" ENSG00000119522 "DENN domain containing 1A" Q8TEH3 9 123379654-123930152 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Astrocytes: 258.9;Excitatory neurons: 188.2;Inhibitory neurons: 175.8;Late spermatids: 88.5;Microglial cells: 178.0;Oligodendrocyte precursor cells: 165.4;Oligodendrocytes: 145.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 9 "dendritic cells: 12.1;granulocytes: 20.4;monocytes: 21.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020481 Approved Vesicles,Cytosol NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 28: BEWO - Transcription regulation" "Cluster 64: Astrocytes - Nervous system maintenance" "Vesicles, Cytosol" "HPA020481: AB_2092106" "unprognostic (1.35e-1)" "unprognostic (3.96e-2)" "unprognostic (2.00e-1)" "unprognostic (4.25e-2)" "unprognostic (1.62e-2)" "unprognostic (1.47e-1)" "unprognostic (1.34e-1)" "unprognostic (3.19e-3)" "unprognostic (2.14e-2)" "unprognostic (2.14e-2)" "unprognostic (2.48e-3)" "unprognostic (5.63e-2)" "prognostic favorable (4.11e-5)" "unprognostic (1.25e-1)" "unprognostic (1.51e-1)" "unprognostic (9.66e-2)" "unprognostic (4.31e-2)" 8.5 8.3 8.2 10.3 8.3 27.0 7.1 2.7 10.3 7.9 6.8 10.6 11.3 8.3 4.6 7.7 8.7 7.2 7.3 8.1 6.2 11.4 10.8 6.9 9.0 5.6 6.0 7.9 6.2 11.9 10.2 11.3 4.9 7.7 9.6 10.3 6.1 7.6 8.4 6.9 12.6 9.9 4.8 14.2 6.9 9.5 6.4 7.1 10.8 4.8 6.2 7.6 6.5 5.7 29.0 16.7 14.7 28.0 9.8 15.3 68.3 27.4 41.0 22.9 19.6 23.0 12.5 23.1 5.5 22.3 30.1 15.9 12.6 19.9 22.2 9.8 9.7 10.9 39.1 17.1 13.2 13.2 7.0 14.2 17.6 18.9 32.2 8.0 20.6 21.8 30.3 17.2 18.7 16.5 15.8 19.1 29.4 33.1 25.2 24.3 14.4 19.5 11.4 10.1 31.1 25.3 22.1 14.4 16.9 9.6 19.8 32.8 9.7 24.5 9.4 28.9 14.6 26.0 21.7 16.0 20.6 25.9 16.5 20.4 21.1 4.3 1.8 14.6 0.9 1.7 1.3 0.8 12.1 1.8 0.8 1.0 12.8 0.8 12.8 1.9 0.6 5.3 8.2 8.3 2.7 10.3 8.1 6.2 5.6 6.0 4.9 4.8 6.4 5.7 6.4 0.0 1.5 258.9 10.0 5.1 2.6 2.5 1.8 16.1 4.8 4.3 7.7 7.2 1.7 16.5 16.7 10.0 6.8 25.3 5.9 4.3 35.1 5.0 8.2 10.5 12.0 20.2 188.2 5.1 32.2 7.6 20.9 3.9 4.5 8.8 7.5 14.5 18.0 32.0 175.8 7.6 2.0 21.4 8.2 88.5 14.6 18.7 3.6 178.0 18.7 11.6 5.2 165.4 145.2 6.1 9.5 11.3 13.1 5.3 18.3 16.0 2.9 13.1 0.0 6.7 5.9 3.8 1.4 3.8 2.8 8.8 5.3 4.5 7.8 3.9 DGCR8 "C22orf12, DGCRK6, Gy1, pasha" ENSG00000128191 "DGCR8 microprocessor complex subunit" Q8WYQ5 22 20080232-20111877 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 61.3;Rod photoreceptor cells: 60.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "K-562: 78.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA076916, HPA079351" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nuclear bodies, Cytosol" "HPA076916: , HPA079351: " "unprognostic (2.57e-1)" "unprognostic (1.12e-1)" "unprognostic (1.97e-1)" "unprognostic (1.81e-1)" "unprognostic (8.34e-2)" "unprognostic (2.75e-3)" "prognostic unfavorable (1.08e-4)" "unprognostic (2.34e-1)" "unprognostic (5.72e-3)" "unprognostic (2.83e-1)" "unprognostic (1.09e-3)" "unprognostic (2.62e-2)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.02e-2)" "unprognostic (4.20e-1)" "unprognostic (4.68e-2)" "unprognostic (2.26e-2)" 5.2 4.4 5.3 6.1 5.2 7.7 4.8 9.4 5.6 6.8 5.0 7.0 5.0 8.5 3.6 7.1 6.9 4.7 5.2 5.3 4.6 4.7 4.5 5.3 6.3 5.1 5.1 8.4 6.2 6.4 5.2 11.6 5.6 5.5 5.0 6.5 7.2 5.6 14.8 7.5 6.7 6.0 4.7 5.9 6.1 15.2 5.3 9.5 6.0 9.3 5.9 6.8 5.7 6.2 22.7 15.7 20.1 11.9 7.7 12.4 25.5 21.3 12.6 14.1 9.9 17.0 11.3 20.1 11.6 20.0 9.4 21.4 18.4 17.8 12.2 19.7 27.4 21.7 17.4 14.0 20.3 40.7 17.5 10.0 21.6 14.8 10.7 12.9 12.6 12.1 78.7 14.1 16.5 14.6 24.7 12.1 19.4 16.5 11.8 29.0 21.2 6.8 8.5 20.9 22.3 14.3 19.4 11.3 13.0 12.0 10.9 17.2 18.8 20.5 17.1 13.0 21.9 7.8 11.5 19.9 15.3 18.2 20.3 0.0 1.1 0.6 2.0 0.9 1.5 0.7 0.9 2.1 1.3 0.6 0.9 1.2 0.2 1.6 3.6 1.5 1.2 1.5 5.3 5.2 9.4 5.6 5.3 4.6 5.1 5.1 5.6 4.7 5.3 6.2 8.1 6.4 7.9 11.8 6.0 9.6 5.2 6.8 10.2 37.1 9.1 8.0 4.2 11.5 7.3 5.5 39.6 13.6 6.9 9.6 0.0 6.1 61.3 5.5 8.3 10.2 7.3 10.3 12.4 10.2 11.2 7.3 12.8 7.3 3.8 19.2 9.7 14.4 5.3 43.7 12.7 10.3 4.1 8.4 6.5 39.2 18.3 5.0 5.4 6.5 7.2 10.9 11.3 9.5 14.0 10.9 5.8 10.5 9.3 8.6 6.2 3.4 8.1 60.7 6.6 9.7 8.1 25.2 17.5 10.4 9.2 13.5 9.3 15.1 9.7 5.6 DHRSX "DHRS5X, DHRS5Y, DHRSXY, DHRSY, SDR46C1, SDR7C6" ENSG00000169084 "Dehydrogenase/reductase X-linked" Q8N5I4 X 2219506-2502805 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA003035, HPA075955" Approved Uncertain "Mitotic spindle,Cytosol" "Secreted to blood" Yes NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 1: Pancreatic cells - Digestion" Cytosol "Mitotic spindle" "HPA003035: AB_1080631, HPA075955: " "unprognostic (7.77e-2)" "unprognostic (1.06e-1)" "unprognostic (3.95e-2)" "unprognostic (4.65e-3)" "unprognostic (8.87e-2)" "unprognostic (1.78e-1)" "unprognostic (1.29e-1)" "unprognostic (4.59e-3)" "unprognostic (1.08e-1)" "unprognostic (1.21e-1)" "unprognostic (1.08e-2)" "unprognostic (1.17e-1)" "unprognostic (1.10e-1)" "unprognostic (2.66e-1)" "unprognostic (1.57e-1)" "unprognostic (2.11e-1)" "unprognostic (3.69e-2)" 13.1 16.2 7.0 4.8 8.2 5.2 12.2 6.7 7.7 13.3 11.9 12.7 6.5 13.0 8.0 6.0 11.0 8.8 19.9 6.1 6.8 14.7 30.6 10.3 5.6 11.5 10.1 12.6 21.9 11.5 10.6 8.2 8.4 13.2 8.3 2.2 14.7 7.0 12.4 9.0 10.8 6.9 8.5 10.1 16.5 6.4 10.9 6.1 13.3 7.0 3.9 11.2 9.3 8.2 8.1 35.7 23.9 11.0 28.8 18.0 18.5 17.8 29.9 13.3 17.9 26.9 16.8 12.6 22.6 21.5 31.4 3.9 16.4 14.3 9.4 24.1 26.1 12.2 17.9 21.2 33.8 6.6 9.5 22.3 17.7 11.6 11.4 22.7 10.9 13.9 14.0 6.1 21.7 9.2 28.5 9.7 6.9 10.6 9.9 10.4 12.4 3.5 14.5 19.3 24.3 22.9 17.0 20.3 14.2 14.8 8.7 10.8 15.6 14.5 3.6 8.4 10.6 7.1 0.1 33.2 9.7 8.7 6.7 14.9 38.3 34.6 15.1 30.6 16.0 25.0 13.5 12.7 35.1 20.1 12.3 10.6 56.4 17.7 19.5 28.3 18.2 21.0 7.0 8.2 6.7 7.7 6.1 6.8 11.5 10.1 8.4 8.5 10.9 8.2 8.7 19.2 9.3 64.3 19.2 10.6 22.9 58.0 20.5 9.5 19.3 16.9 23.4 25.8 24.4 25.8 10.4 42.9 17.0 32.9 13.7 52.3 0.6 16.1 15.9 14.8 19.2 13.7 41.2 81.2 43.5 26.9 21.4 14.4 17.8 27.1 15.0 50.6 38.4 3.3 42.7 21.4 32.6 20.8 30.7 3.0 24.2 26.3 12.4 61.8 35.9 9.4 14.4 46.3 31.9 71.0 28.8 25.2 29.1 65.3 49.2 43.7 14.8 6.2 19.7 12.0 18.3 12.0 21.2 11.3 6.5 107.3 14.0 14.6 24.1 29.2 DIAPH1 "DFNA1, hDIA1, LFHL1" ENSG00000131504 "Diaphanous related formin 1" O60610 5 141515016-141619055 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Hearing Actin-binding "Cancer-related genes, Deafness, Disease variant, Epilepsy, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 172.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 564.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004916, HPA076913" Approved Uncertain "Plasma membrane,Cytosol" NA NA 2000000 "Cluster 41: Basophils - Cellular respiration" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Plasma membrane, Cytosol" "HPA004916: AB_1847668, HPA076913: " "unprognostic (6.79e-2)" "unprognostic (2.99e-1)" "unprognostic (2.12e-3)" "unprognostic (3.73e-2)" "unprognostic (4.18e-2)" "unprognostic (1.54e-1)" "unprognostic (2.08e-1)" "unprognostic (4.54e-3)" "unprognostic (2.03e-1)" "unprognostic (1.27e-2)" "prognostic unfavorable (7.81e-5)" "unprognostic (2.88e-3)" "prognostic favorable (1.29e-5)" "unprognostic (1.64e-2)" "unprognostic (1.84e-2)" "unprognostic (7.00e-2)" "unprognostic (1.65e-1)" 27.9 20.3 21.0 42.1 22.5 90.2 24.2 18.3 20.9 24.4 40.0 31.0 40.6 18.5 44.3 58.0 25.2 30.0 34.9 21.5 25.7 38.1 91.7 51.3 67.0 18.8 19.9 12.9 37.3 44.6 24.5 25.1 20.1 14.7 31.1 28.4 36.1 19.3 172.0 47.3 36.5 18.7 18.0 36.3 45.1 19.9 27.4 68.5 33.1 55.7 66.4 47.1 30.4 18.6 147.8 92.6 53.2 68.4 40.4 54.5 71.3 59.5 62.2 67.7 70.2 318.1 131.6 156.5 88.1 85.5 103.0 157.9 116.9 191.5 84.8 88.9 66.6 282.6 121.4 103.6 37.7 198.9 564.7 34.4 102.1 94.5 95.5 30.5 87.0 234.8 101.2 106.9 67.7 141.5 217.2 256.8 51.6 75.2 61.6 240.1 87.1 87.6 129.8 158.5 69.4 37.3 146.2 184.6 59.5 47.5 77.5 92.1 52.8 93.9 49.9 52.1 119.9 54.2 94.4 111.7 50.2 153.7 57.8 23.6 12.8 29.8 32.6 14.0 21.2 9.3 20.3 25.3 12.6 9.1 14.8 23.9 13.7 13.7 15.1 10.0 18.7 15.4 21.0 22.5 18.3 20.9 21.5 25.7 18.8 19.9 20.1 18.0 27.4 18.6 33.9 48.1 46.8 11.8 40.0 52.6 60.8 22.4 21.6 17.3 35.1 23.1 18.6 22.8 48.0 44.1 54.2 20.9 96.9 60.5 5.9 62.7 27.9 42.3 18.9 39.0 5.4 52.6 44.1 98.0 31.9 25.9 76.0 83.0 46.9 14.5 16.8 91.6 17.1 6.7 33.6 23.1 12.2 38.4 60.6 9.0 11.8 78.5 19.6 24.4 54.6 12.1 115.4 25.6 9.1 122.9 35.7 10.9 54.1 77.3 35.2 13.9 30.4 69.0 13.1 15.4 26.4 18.3 26.1 38.7 59.7 52.1 92.8 18.3 30.1 91.2 DIMT1 "DIMT1L, HSA9761" ENSG00000086189 "DIMT1 rRNA methyltransferase and ribosome maturation factor" Q9UNQ2 5 62347284-62403943 "Enzymes, Predicted intracellular proteins" "rRNA processing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Prostatic glandular cells: 104.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042944 Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 25: RPMI-8226 - Immune response" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "HPA042944: AB_2678234" "unprognostic (1.58e-1)" "unprognostic (2.27e-1)" "unprognostic (6.02e-3)" "unprognostic (7.16e-2)" "unprognostic (8.95e-3)" "unprognostic (1.73e-2)" "prognostic unfavorable (6.93e-4)" "unprognostic (8.88e-2)" "unprognostic (1.18e-2)" "unprognostic (1.62e-1)" "unprognostic (5.31e-2)" "unprognostic (3.70e-1)" "prognostic unfavorable (8.90e-12)" "unprognostic (8.89e-2)" "unprognostic (2.89e-1)" "unprognostic (1.49e-1)" "unprognostic (5.15e-2)" 16.3 13.6 6.5 13.3 6.5 9.1 19.7 6.7 9.6 17.2 6.4 10.9 8.5 14.6 13.9 17.5 14.5 14.2 17.7 6.6 6.8 10.6 15.4 9.8 15.9 6.7 6.7 15.5 19.3 13.3 10.3 17.3 6.7 15.9 12.0 2.9 15.2 16.2 9.7 8.5 8.8 21.0 6.7 13.3 8.5 8.2 6.6 15.0 13.4 12.8 16.8 26.0 11.4 6.7 33.1 19.9 24.2 44.1 37.7 57.4 35.0 57.3 33.7 57.3 55.8 45.1 36.3 61.4 48.4 61.9 45.4 20.2 38.7 35.8 61.3 46.4 34.0 27.2 15.0 33.8 48.1 32.4 34.7 46.7 31.1 54.1 57.3 28.1 46.1 37.0 49.3 27.9 47.3 43.5 50.1 58.6 36.1 18.9 49.7 28.2 33.3 119.2 45.8 29.9 31.5 19.8 38.5 32.2 35.5 19.6 27.0 29.2 40.3 21.0 29.5 33.7 71.2 27.4 46.7 62.6 27.0 61.6 45.1 7.9 5.3 2.7 6.7 9.1 12.7 10.4 11.2 9.1 9.3 6.1 11.6 9.7 0.1 7.7 6.8 12.1 7.8 6.3 6.5 6.5 6.7 9.6 6.6 6.8 6.7 6.7 6.7 6.7 6.6 6.7 25.3 3.2 9.5 6.5 37.8 50.9 90.3 54.8 69.4 6.2 29.9 20.2 35.3 17.2 36.3 14.7 10.4 45.3 21.9 5.0 21.5 28.6 10.1 23.8 28.3 32.0 4.8 20.4 11.1 22.5 48.1 35.6 13.7 23.2 13.3 13.3 17.5 13.4 33.1 0.0 10.5 12.1 32.6 16.4 22.8 4.4 28.9 18.5 28.4 2.8 19.7 7.4 13.4 8.0 12.9 19.8 7.5 20.3 29.3 104.3 4.0 32.5 24.0 4.7 6.6 51.8 49.8 16.5 20.4 58.7 37.8 35.7 31.1 28.6 18.3 76.6 DISP3 "KIAA1337, PTCHD2" ENSG00000204624 "Dispatched RND transporter family member 3" Q9P2K9 1 11479155-11537551 "Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Differentiation, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "brain: 9.8;pituitary gland: 3.5;retina: 4.6;testis: 6.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "glioma: 2.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.9;NTERA-2: 2.1;SCLC-21H: 2.0;SH-SY5Y: 6.8;SiHa: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054579 Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "HPA054579: AB_2682529" "unprognostic (4.93e-2)" "unprognostic (2.23e-2)" "unprognostic (1.61e-1)" "unprognostic (9.55e-3)" "unprognostic (1.80e-1)" "unprognostic (2.73e-1)" "unprognostic (6.12e-2)" "unprognostic (7.75e-2)" "unprognostic (3.62e-1)" "unprognostic (1.08e-1)" "unprognostic (4.34e-3)" "unprognostic (4.86e-2)" "unprognostic (3.80e-2)" "unprognostic (3.88e-1)" "unprognostic (7.06e-2)" "unprognostic (1.79e-4)" "unprognostic (1.34e-1)" 0.0 0.3 7.1 0.1 9.4 0.0 0.0 4.1 9.8 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 8.6 6.9 0.1 0.0 0.1 0.1 3.3 5.7 0.1 0.5 0.0 3.5 0.0 4.6 0.5 0.0 4.6 0.0 0.0 0.0 0.0 0.2 0.0 3.7 0.3 0.1 6.3 7.8 0.2 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 4.9 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 2.1 0.0 0.0 0.5 0.0 1.3 0.0 0.1 2.0 6.8 1.6 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 9.4 4.1 9.8 8.6 6.9 3.3 5.7 4.6 3.7 7.8 3.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 DKK3 "REIC, RIG" ENSG00000050165 "Dickkopf WNT signaling pathway inhibitor 3" Q9UBP4 11 11956207-12009769 "Plasma proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "heart muscle: 1224.0" "Group enriched" "Detected in many" 7 "Cardiomyocytes: 884.3;Muller glia cells: 1960.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 6.2;memory CD8 T-cell: 3.8" "Lineage enriched" "Detected in single" 62 "T-cells: 6.2" "Cell line enhanced" "Detected in many" "BJ: 418.9;BJ hTERT+: 643.0;fHDF/TERT166: 614.4;hTERT-RPE1: 370.2;TIME: 349.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011868, CAB024949" Approved Supported "Nuclear bodies,Vesicles,Cytosol" "Secreted in other tissues" No No 18000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 5: Muller glia cells - Visual perception" Vesicles "Nuclear bodies, Cytosol" "CAB024949: , HPA011868: AB_1847716" "unprognostic (4.24e-2)" "unprognostic (6.40e-2)" "unprognostic (1.96e-1)" "unprognostic (7.84e-2)" "unprognostic (3.06e-3)" "unprognostic (6.58e-3)" "unprognostic (1.14e-2)" "unprognostic (1.58e-1)" "unprognostic (3.31e-3)" "unprognostic (5.28e-2)" "unprognostic (4.51e-2)" "unprognostic (3.87e-2)" "prognostic unfavorable (6.31e-5)" "unprognostic (7.41e-3)" "unprognostic (1.09e-1)" "unprognostic (2.97e-2)" "unprognostic (1.02e-3)" 31.2 79.1 110.7 10.0 183.6 0.2 26.0 12.6 135.2 89.7 104.8 53.2 14.6 47.0 16.7 29.7 23.0 67.0 1224.0 147.7 80.2 17.0 5.6 123.7 8.5 95.1 54.3 38.1 18.2 34.2 38.2 25.0 46.8 59.4 13.0 204.1 30.9 78.1 7.8 29.7 24.6 43.1 83.9 33.2 31.7 30.9 99.9 4.7 16.4 18.8 5.4 40.9 48.3 121.6 1.5 13.1 18.1 0.1 15.3 29.7 0.6 418.9 643.0 182.4 205.5 9.6 3.2 0.0 44.8 614.4 96.8 64.4 1.5 181.9 69.5 0.1 0.5 0.0 1.7 0.0 113.6 0.0 0.3 45.3 60.0 61.9 151.3 370.2 195.3 0.0 0.2 0.4 256.4 0.0 0.1 0.4 8.6 0.0 0.5 0.1 1.2 0.1 62.5 0.6 0.5 53.2 2.0 0.0 0.2 47.9 0.2 0.5 349.7 107.5 82.8 11.2 110.3 0.1 0.0 0.3 18.1 0.0 103.5 0.0 0.0 0.0 0.5 0.0 6.2 0.0 0.6 3.8 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 110.7 183.6 12.6 135.2 147.7 80.2 95.1 54.3 46.8 83.9 99.9 121.6 5.8 3.2 3.0 94.3 0.1 45.6 59.5 70.3 93.4 31.6 3.2 103.2 884.3 0.0 12.8 0.0 12.5 0.5 0.4 0.0 0.0 0.8 104.3 0.7 8.4 32.9 1.8 0.0 90.4 0.2 0.8 106.1 7.1 0.6 1.3 17.0 66.8 0.4 20.4 13.5 83.7 0.1 0.0 1.3 12.5 88.5 20.5 1.4 64.0 38.4 0.0 1960.4 0.0 27.6 14.7 1.1 0.1 57.6 1.7 32.8 0.0 0.2 2.9 67.5 190.7 12.7 83.4 1.2 3.2 5.8 14.8 0.8 4.1 0.5 0.3 3.0 DLST "DLTS, KGD2, OGDC-E2" ENSG00000119689 "Dihydrolipoamide S-succinyltransferase" P36957 14 74881891-74903743 "Citric acid cycle related proteins, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Tricarboxylic acid cycle" "Acyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003010 Supported Supported Nucleoplasm,Mitochondria,Cytosol NA NA 70000 "Cluster 15: NK-cells - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm "Mitochondria, Cytosol" "HPA003010: AB_1078679" "unprognostic (1.62e-1)" "unprognostic (3.01e-1)" "unprognostic (2.45e-3)" "unprognostic (6.36e-2)" "unprognostic (1.29e-1)" "unprognostic (1.21e-2)" "unprognostic (1.16e-1)" "unprognostic (5.83e-2)" "unprognostic (3.03e-1)" "unprognostic (1.37e-1)" "unprognostic (2.12e-2)" "unprognostic (1.18e-1)" "prognostic favorable (1.13e-12)" "unprognostic (3.29e-2)" "unprognostic (1.08e-1)" "unprognostic (1.66e-1)" "unprognostic (4.55e-3)" 64.5 85.5 33.5 32.3 34.7 75.0 59.6 35.8 34.7 62.1 43.8 63.3 58.7 47.5 43.2 62.9 46.1 36.2 129.0 30.8 35.1 100.4 78.4 48.5 36.9 35.8 34.5 45.8 44.8 78.8 35.4 44.8 34.3 41.3 59.3 37.1 46.5 43.5 144.7 64.3 58.3 52.1 33.6 46.1 57.7 29.3 37.3 42.5 42.9 224.2 45.7 58.0 49.7 32.5 79.1 81.1 63.7 45.4 98.1 110.6 97.5 106.3 107.8 106.8 99.0 80.9 88.1 81.0 44.3 118.1 48.1 87.8 109.0 105.6 112.0 61.5 43.3 68.4 66.3 74.8 101.4 49.5 45.4 114.0 90.5 103.8 126.7 95.5 106.1 36.6 53.4 55.6 110.3 112.0 59.0 69.7 55.0 146.6 79.0 73.8 93.8 46.7 125.8 100.8 75.5 64.1 100.6 129.4 71.3 54.2 121.7 70.5 90.8 63.8 83.2 79.5 74.0 38.7 43.7 73.4 93.9 47.9 68.8 3.0 1.3 2.3 2.1 2.0 1.8 1.6 1.9 1.6 2.1 1.0 1.5 2.2 1.3 3.5 1.8 2.8 2.0 1.5 33.5 34.7 35.8 34.7 30.8 35.1 35.8 34.5 34.3 33.6 37.3 32.5 24.2 6.4 4.8 14.0 22.7 26.4 23.5 19.7 21.6 19.1 25.1 20.4 28.5 21.5 10.1 20.2 31.3 41.0 27.7 41.9 56.7 37.8 7.3 10.9 20.4 19.8 14.8 22.5 21.9 25.7 38.8 25.6 30.5 18.9 21.0 19.4 23.2 43.6 32.1 13.5 24.6 31.8 12.2 20.9 19.0 6.2 18.0 18.8 23.2 13.1 27.1 10.0 20.6 18.6 18.5 44.3 28.0 20.7 20.0 28.2 49.8 73.3 8.7 20.8 26.3 18.3 24.0 12.1 15.3 34.2 28.4 79.5 23.1 19.3 40.5 27.7 DLX1 ENSG00000144355 "Distal-less homeobox 1" P56177 2 172084740-172089677 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 18.8" "Cell type enriched" "Detected in some" 23 "Inhibitory neurons: 30.4" "Cancer enhanced" "Detected in many" "prostate cancer: 11.1" "Region enhanced" "Detected in many" "hypothalamus: 18.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 134.5;U-138 MG: 36.9;WM-115: 42.1" "Group enriched" "Detected in many" 5 "basal ganglia: 28.6;olfactory bulb: 82.6" "Region enriched" "Detected in many" 4 "olfactory bulb: 48.8" "HPA007175, HPA045884" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 65: Brain - Ion transport" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Vesicles, Cytosol" "HPA007175: , HPA045884: AB_10960361" "unprognostic (2.14e-2)" "unprognostic (5.09e-2)" "unprognostic (3.92e-2)" "unprognostic (1.89e-3)" "unprognostic (1.18e-1)" "unprognostic (1.18e-1)" "unprognostic (7.92e-3)" "unprognostic (8.86e-2)" "unprognostic (2.80e-2)" "unprognostic (2.03e-1)" "unprognostic (5.74e-2)" "unprognostic (2.04e-1)" "unprognostic (7.40e-9)" "unprognostic (2.22e-1)" "unprognostic (9.19e-2)" "unprognostic (1.25e-1)" "unprognostic (5.91e-3)" 0.1 1.3 5.9 0.2 4.8 0.0 0.1 0.0 4.4 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 3.5 18.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 0.1 0.0 0.1 0.5 0.2 0.1 0.0 0.0 0.1 0.0 3.5 0.0 1.0 0.1 0.3 0.1 0.2 2.7 2.4 0.6 0.6 134.5 2.0 4.5 0.3 3.2 6.5 7.7 4.1 1.0 0.2 0.0 7.8 7.2 7.5 9.4 7.4 1.2 5.2 0.3 33.3 21.1 14.4 5.7 0.1 7.9 15.9 0.0 2.2 1.9 3.2 5.4 0.0 6.7 12.4 0.0 6.3 8.1 0.1 1.9 0.1 0.0 22.9 0.4 15.8 0.0 0.9 4.5 11.3 0.0 6.1 0.8 17.5 0.4 5.2 9.5 7.1 36.9 0.2 16.4 16.4 0.2 0.0 0.1 15.2 21.4 42.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.9 4.8 0.0 4.4 3.5 18.8 0.0 0.2 0.0 0.0 3.5 2.7 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 30.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DROSHA "Etohi2, HSA242976, RN3, RNASE3L, RNASEN" ENSG00000113360 "Drosha ribonuclease III" Q9NRR4 5 31400494-31532196 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ribosome biogenesis, RNA-mediated gene silencing" "Endonuclease, Hydrolase, Nuclease, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 74.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031150 Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm Cytosol "HPA031150: AB_2673761" "unprognostic (8.37e-3)" "unprognostic (1.81e-1)" "unprognostic (9.56e-2)" "prognostic unfavorable (6.79e-4)" "unprognostic (5.40e-2)" "unprognostic (6.03e-2)" "prognostic unfavorable (1.39e-4)" "unprognostic (3.11e-1)" "unprognostic (4.08e-2)" "unprognostic (9.08e-2)" "unprognostic (1.86e-1)" "unprognostic (5.43e-2)" "unprognostic (1.12e-1)" "unprognostic (1.74e-1)" "unprognostic (2.39e-1)" "unprognostic (6.94e-2)" "unprognostic (2.32e-2)" 12.3 11.3 2.6 15.9 3.8 11.6 11.5 9.4 8.0 13.3 4.2 13.8 13.6 15.9 20.4 11.4 14.5 11.7 13.0 2.0 8.1 12.3 9.7 10.9 16.0 1.1 2.9 20.5 14.4 15.2 4.5 13.8 2.3 13.6 15.6 27.2 12.5 13.2 22.2 13.5 12.2 13.8 0.2 12.5 13.2 11.1 5.2 24.5 15.5 19.6 17.1 12.2 3.9 4.9 38.7 47.3 51.8 70.8 27.0 32.8 74.2 50.0 24.4 45.6 33.9 50.6 49.0 43.3 55.9 36.9 52.7 33.0 63.5 37.8 50.4 40.9 44.6 52.9 157.8 37.0 24.3 59.2 151.6 25.8 26.0 50.7 24.2 34.6 39.5 45.3 68.9 19.7 40.5 38.5 58.3 44.8 49.1 31.2 37.9 52.2 98.9 31.1 25.7 43.2 26.9 35.6 127.1 51.4 30.0 46.0 47.4 34.1 33.9 43.7 50.3 39.0 48.0 35.8 63.5 47.1 30.3 65.9 42.9 0.9 1.2 1.5 2.2 1.3 2.4 1.8 2.4 2.7 2.5 2.0 2.7 2.0 0.3 2.5 2.5 3.0 2.5 1.6 2.6 3.8 9.4 8.0 2.0 8.1 1.1 2.9 2.3 0.2 5.2 4.9 6.2 12.8 14.3 45.4 7.1 3.6 5.0 7.0 10.8 19.4 7.1 6.0 23.4 5.7 12.8 5.5 0.0 8.5 11.4 12.9 3.9 7.8 3.5 12.3 11.6 9.0 11.4 8.0 43.4 8.1 7.6 12.7 8.6 13.6 9.5 20.4 10.0 7.2 7.8 6.7 45.8 8.5 14.2 6.3 3.0 8.2 10.8 6.0 1.8 34.7 8.4 10.2 9.2 74.9 43.9 9.3 10.2 13.2 8.8 6.1 7.3 5.1 16.8 18.8 6.6 10.4 11.6 7.1 10.9 8.8 3.4 4.9 8.3 13.9 11.7 5.9 DSC2 "CDHF2, DSC3" ENSG00000134755 "Desmocollin 2" Q02487 18 31058840-31102522 "Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 164.0;vagina: 97.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 384.0;Paneth cells: 324.8;Squamous epithelial cells: 705.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 48.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "eosinophil: 28.9;neutrophil: 8.1" "Lineage enriched" "Detected in many" 14 "granulocytes: 28.9" "Cell line enhanced" "Detected in many" "BEWO: 37.6;CAPAN-2: 48.3;HaCaT: 71.1;hTCEpi: 76.0;OE19: 60.7;SK-BR-3: 44.4;SuSa: 43.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA011911, HPA012615" Enhanced Supported "Plasma membrane,Cytosol" NA NA 24000000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" "Plasma membrane" Cytosol "HPA011911: AB_1847618, HPA012615: AB_1847619" "unprognostic (3.28e-2)" "unprognostic (3.20e-1)" "unprognostic (2.23e-3)" "unprognostic (2.56e-2)" "unprognostic (1.90e-1)" "unprognostic (3.04e-2)" "unprognostic (1.30e-2)" "prognostic unfavorable (5.80e-4)" "unprognostic (7.66e-2)" "unprognostic (4.07e-2)" "unprognostic (1.22e-3)" "unprognostic (2.10e-1)" "unprognostic (1.43e-3)" "unprognostic (1.60e-1)" "unprognostic (1.75e-1)" "unprognostic (2.49e-1)" "prognostic unfavorable (3.01e-4)" 5.5 1.8 1.3 12.7 1.4 0.7 22.2 1.3 1.6 59.2 1.9 50.5 41.6 1.5 5.9 164.0 6.1 3.7 10.6 1.2 2.0 5.9 7.3 7.9 3.7 2.6 1.5 0.6 10.5 27.0 0.5 21.3 2.2 15.8 44.5 1.0 46.8 1.0 0.3 11.9 42.9 4.0 1.8 3.0 43.2 0.8 1.6 6.6 4.0 3.1 62.2 3.6 97.4 2.3 18.1 1.9 2.9 0.0 0.0 0.0 37.6 0.0 0.0 0.0 0.0 9.8 48.3 0.0 0.7 0.0 0.9 71.1 11.8 4.9 0.0 0.0 6.9 27.1 8.4 16.9 0.3 0.2 0.5 0.4 76.0 0.0 7.3 6.1 0.0 0.0 13.4 0.0 0.0 14.7 0.0 1.1 11.3 60.7 17.4 13.2 0.0 0.2 0.1 0.7 0.0 0.1 0.0 44.4 0.0 43.4 12.2 18.1 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 28.9 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.1 0.0 0.0 0.4 1.3 1.4 1.3 1.6 1.2 2.0 2.6 1.5 2.2 1.8 1.6 2.3 25.1 28.9 5.6 3.3 1.0 83.7 44.5 16.4 67.7 0.8 75.3 65.7 33.8 32.9 11.1 7.3 0.0 100.8 1.0 384.0 0.0 83.5 0.1 19.1 4.0 6.7 69.4 0.4 3.3 33.2 186.6 5.9 47.4 43.8 0.0 2.7 8.2 16.0 24.8 0.0 1.5 83.1 20.3 48.8 29.3 0.2 0.3 35.3 14.2 4.7 25.2 11.2 0.0 2.0 0.2 155.7 324.8 0.7 0.3 140.6 118.2 9.7 3.8 0.7 0.0 1.2 3.0 0.1 1.3 705.6 55.0 83.9 2.0 0.3 114.0 76.1 DSN1 "C20orf172, dJ469A13.2, hKNL-3, KNL3, MIS13" ENSG00000149636 "DSN1 component of MIS12 kinetochore complex" Q9H410 20 36751791-36773818 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 49.8;Spermatocytes: 115.5;Spermatogonia: 75.1;Syncytiotrophoblasts: 47.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002813, HPA030627" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Kinetochore,Cytosol" Yes Yes "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nucleoli fibrillar center, Nuclear bodies, Kinetochore, Cytosol" "HPA002813: AB_1078343, HPA030627: AB_2732460" "unprognostic (3.60e-2)" "prognostic favorable (4.49e-4)" "unprognostic (5.22e-3)" "unprognostic (1.13e-3)" "unprognostic (2.00e-1)" "unprognostic (4.64e-2)" "prognostic unfavorable (4.16e-5)" "unprognostic (3.93e-1)" "unprognostic (9.35e-2)" "unprognostic (5.51e-2)" "unprognostic (2.98e-2)" "unprognostic (7.66e-2)" "prognostic unfavorable (1.54e-5)" "unprognostic (6.92e-2)" "unprognostic (2.53e-1)" "unprognostic (2.58e-2)" "unprognostic (2.84e-1)" 5.9 9.9 4.2 7.5 4.2 14.3 8.6 3.9 4.5 5.0 5.2 9.2 6.8 4.4 9.3 7.9 4.1 4.4 5.1 4.3 4.4 4.8 9.1 6.3 12.8 4.0 3.9 4.3 4.3 5.5 3.5 8.8 4.1 6.5 10.8 10.7 5.9 6.3 4.0 8.0 7.8 6.3 3.9 9.6 7.3 23.3 4.1 16.4 5.1 4.8 14.3 4.4 4.7 4.7 36.7 29.1 35.7 29.5 14.0 18.0 24.7 42.9 35.1 63.9 70.2 52.5 44.4 39.3 27.4 23.0 69.1 45.8 33.3 32.7 60.3 18.2 22.7 78.3 26.2 36.1 3.0 46.2 34.0 7.0 9.4 43.7 13.8 10.4 31.5 42.4 30.9 33.7 41.7 25.3 59.2 34.5 16.8 63.3 55.1 46.1 109.4 28.4 16.2 20.5 37.8 16.9 52.9 53.7 25.8 26.3 55.9 30.5 16.4 60.1 35.0 56.9 46.1 27.3 39.1 46.4 49.8 40.8 42.6 53.4 6.4 14.5 7.4 11.0 8.4 14.6 8.1 10.3 7.1 18.4 10.1 9.0 11.9 11.1 10.1 46.9 12.2 6.7 4.2 4.2 3.9 4.5 4.3 4.4 4.0 3.9 4.1 3.9 4.1 4.7 6.5 6.4 4.4 1.6 10.3 5.0 11.4 7.6 3.4 8.0 8.7 7.6 5.4 2.8 8.6 5.5 29.2 49.8 9.8 9.2 7.9 6.8 10.6 5.5 5.9 8.1 2.4 22.1 6.3 6.4 30.4 8.4 20.9 9.4 3.8 21.8 7.9 6.2 14.7 6.7 4.4 13.6 4.1 6.3 4.6 8.0 8.7 6.7 1.8 5.6 7.4 6.0 7.2 3.0 3.6 5.1 5.4 7.5 22.9 7.1 7.7 3.6 8.2 17.5 0.0 5.3 8.2 115.5 75.1 12.3 7.2 47.5 7.7 6.9 13.6 11.0 DTD1 "bA379J5.3, bA555E18.1, C20orf88, DUEB, HARS2, MGC119131, MGC41905, pqn-68" ENSG00000125821 "D-aminoacyl-tRNA deacylase 1" Q8TEA8 20 18587942-18766644 "Enzymes, Predicted intracellular proteins" "DNA replication" "DNA-binding, Hydrolase, RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040981 Uncertain Uncertain Nucleoli,Cytosol NA NA 350000 "Cluster 41: Basophils - Cellular respiration" "Cluster 72: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" "Nucleoli, Cytosol" "HPA040981: AB_10673268" "unprognostic (3.32e-1)" "unprognostic (1.05e-1)" "unprognostic (1.82e-1)" "unprognostic (5.94e-2)" "unprognostic (1.83e-1)" "unprognostic (2.90e-1)" "unprognostic (1.27e-3)" "unprognostic (9.67e-2)" "unprognostic (1.72e-1)" "unprognostic (1.81e-1)" "unprognostic (6.84e-2)" "unprognostic (1.32e-1)" "unprognostic (9.09e-3)" "unprognostic (2.42e-1)" "unprognostic (8.44e-2)" "unprognostic (2.59e-2)" "unprognostic (8.53e-2)" 23.5 21.1 7.0 3.7 7.0 4.5 21.5 7.2 7.6 18.9 7.1 15.6 2.7 19.7 4.8 26.6 18.6 3.2 17.5 7.1 7.6 25.6 10.8 16.0 4.1 7.3 6.9 17.6 20.4 7.7 33.8 3.4 7.4 13.7 4.2 6.6 21.9 3.1 29.1 27.4 13.7 4.0 7.2 15.3 16.2 19.1 7.3 2.1 19.3 6.7 4.5 17.1 19.4 7.3 10.1 15.7 15.8 16.2 8.8 12.2 9.1 4.3 12.3 10.5 11.3 10.0 11.4 0.1 4.1 13.6 13.9 5.3 13.1 25.0 10.4 6.8 3.2 10.2 4.0 18.7 22.8 9.4 8.2 10.2 22.4 11.8 42.1 8.7 16.5 3.0 7.0 22.5 15.3 24.9 1.7 23.8 11.0 13.5 9.9 0.0 16.6 11.1 16.6 8.2 16.6 13.0 4.4 20.4 23.6 7.1 12.3 9.2 10.2 14.3 3.8 17.7 14.5 5.5 10.2 4.6 8.6 13.9 11.1 1.7 0.7 0.4 1.8 1.0 0.8 1.1 0.6 1.0 1.5 0.7 0.5 0.5 0.9 1.4 1.0 0.2 0.4 0.6 7.0 7.0 7.2 7.6 7.1 7.6 7.3 6.9 7.4 7.2 7.3 7.3 35.5 35.3 24.0 32.0 26.8 23.6 40.9 48.3 22.2 42.4 27.9 33.0 18.8 28.6 23.1 42.3 2.1 26.7 24.7 9.9 43.0 71.9 38.4 16.2 33.1 36.4 23.3 22.1 41.9 87.4 37.8 29.9 13.7 17.8 42.5 24.6 35.7 11.2 47.8 43.7 60.6 23.5 28.5 23.5 35.9 21.8 18.0 27.1 42.7 12.2 42.8 58.2 38.1 53.3 52.2 90.6 19.1 19.5 24.6 50.6 9.3 73.8 22.8 34.9 0.0 30.1 27.5 93.5 124.2 33.2 35.7 12.4 35.5 42.7 26.8 31.9 DTL "CDT2, DCAF2, L2DTL, RAMP" ENSG00000143476 "Denticleless E3 ubiquitin protein ligase homolog" Q9NZJ0 1 212035553-212107400 "Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA replication, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 14.6;intestine: 4.7;lymphoid tissue: 14.2;placenta: 3.9;testis: 13.7" "Cell type enhanced" "Detected in many" "Early spermatids: 25.3;Erythroid cells: 36.2;Extravillous trophoblasts: 16.2;Spermatocytes: 53.2;Spermatogonia: 20.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "T-reg: 2.0" "Lineage enriched" "Detected in single" 8 "T-cells: 2.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028016, HPA032023, HPA032031" Supported Supported Nucleoplasm,Nucleoli,Cytosol Yes Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nucleoli, Cytosol" "HPA028016: AB_10611958, HPA032023: AB_2674114, HPA032031: AB_2674119" "unprognostic (7.61e-2)" "unprognostic (1.01e-3)" "unprognostic (2.14e-2)" "unprognostic (3.05e-2)" "unprognostic (2.19e-1)" "unprognostic (5.31e-2)" "prognostic unfavorable (4.41e-5)" "unprognostic (8.96e-3)" "unprognostic (2.45e-3)" "unprognostic (8.83e-3)" "unprognostic (2.52e-3)" "unprognostic (2.83e-2)" "prognostic unfavorable (1.71e-9)" "unprognostic (5.93e-2)" "unprognostic (2.01e-1)" "unprognostic (1.96e-2)" "unprognostic (2.82e-1)" 0.6 0.2 0.0 4.1 0.0 14.6 1.9 0.0 0.1 0.6 0.0 3.3 2.3 1.1 0.1 1.9 0.4 0.4 0.1 0.0 0.0 0.1 1.2 1.4 5.6 0.0 0.1 0.1 0.1 0.5 0.2 3.9 0.0 0.4 4.7 0.0 0.4 0.1 0.1 2.1 3.0 1.9 0.0 2.5 1.3 13.7 0.1 14.2 0.5 0.0 6.4 1.2 0.7 0.0 34.1 28.1 48.0 23.6 2.9 5.8 23.3 41.3 25.5 38.1 56.1 17.6 29.0 25.2 15.4 16.1 25.0 25.8 62.5 34.9 54.7 31.4 30.9 40.7 33.6 21.5 0.1 54.1 25.3 2.5 1.2 62.2 32.4 6.8 17.7 44.7 49.1 51.1 44.4 13.5 75.3 24.3 56.6 25.2 32.9 57.2 84.0 49.2 11.6 22.9 29.6 46.0 39.2 37.5 17.6 47.7 32.0 24.1 9.7 38.2 28.6 40.5 47.8 18.4 30.5 57.7 19.1 35.5 37.8 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.3 0.5 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 2.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 2.3 2.3 0.4 1.7 0.0 0.0 1.3 1.3 7.0 1.5 0.9 0.0 0.0 12.8 1.4 1.5 0.0 0.4 25.3 0.4 1.3 5.2 0.0 36.2 0.2 0.0 16.2 2.4 3.1 1.0 0.0 11.4 0.7 0.4 4.7 0.0 0.3 3.3 0.0 0.3 0.8 12.4 1.2 2.2 0.0 1.0 0.2 0.0 0.0 0.0 0.1 0.6 0.4 0.0 12.8 0.2 0.6 0.0 0.1 0.0 0.0 0.2 2.7 53.2 20.8 5.6 1.7 1.5 2.6 1.6 5.2 0.7 DUSP28 "DUSP26, VHP" ENSG00000188542 "Dual specificity phosphatase 28" Q4G0W2 2 240560054-240565256 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 39.7;Spermatocytes: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 8.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 8.9" "Cell line enhanced" "Detected in many" "U-266/70: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047456, CAB069448" Uncertain Uncertain "Nuclear speckles,Cytosol" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nuclear speckles" Cytosol "CAB069448: , HPA047456: AB_10961145" "unprognostic (1.88e-2)" "unprognostic (9.29e-2)" "unprognostic (4.86e-2)" "unprognostic (2.32e-1)" "unprognostic (1.65e-1)" "unprognostic (1.07e-2)" "unprognostic (1.09e-2)" "unprognostic (7.56e-3)" "unprognostic (4.13e-3)" "unprognostic (3.71e-2)" "prognostic favorable (1.84e-4)" "unprognostic (9.85e-2)" "unprognostic (1.80e-3)" "unprognostic (6.99e-2)" "unprognostic (2.52e-1)" "unprognostic (2.59e-1)" "unprognostic (2.10e-3)" 1.5 2.4 1.6 1.3 1.7 5.4 1.7 3.0 1.8 2.2 0.5 2.5 1.1 2.1 1.7 3.1 2.6 0.8 3.4 1.3 1.7 3.2 3.2 2.2 1.9 1.7 1.2 2.2 3.0 0.9 3.9 0.6 1.4 3.5 1.0 1.2 2.8 0.8 9.8 2.0 3.6 0.6 1.1 4.7 2.7 6.2 1.5 1.1 3.5 4.0 1.5 2.3 2.2 2.0 1.0 0.8 1.1 1.4 0.7 0.4 1.3 1.0 0.6 0.8 0.5 0.5 2.4 1.7 0.6 0.6 1.3 3.1 0.9 0.3 0.7 2.2 4.0 2.1 2.2 1.3 0.5 1.6 3.7 1.0 0.9 0.6 0.6 1.6 0.4 2.3 1.6 1.9 0.7 1.1 1.7 2.5 0.9 1.4 0.9 2.3 2.4 2.1 0.6 1.6 2.8 1.5 0.9 1.1 1.3 0.7 1.2 2.2 1.0 1.9 1.6 1.3 1.0 8.2 2.1 2.8 1.2 1.0 1.5 8.9 1.1 0.5 1.2 0.7 1.4 1.0 1.2 1.3 0.6 1.8 1.4 1.2 1.9 1.5 0.7 1.9 0.9 0.9 1.6 1.7 3.0 1.8 1.3 1.7 1.7 1.2 1.4 1.1 1.5 2.0 5.7 0.0 4.5 1.3 11.4 3.7 7.7 4.7 6.2 6.7 12.3 10.0 13.8 10.0 3.8 12.9 4.2 7.8 18.4 11.0 15.6 5.1 35.2 11.2 5.5 4.1 8.4 8.8 3.8 5.8 4.8 4.3 14.8 10.2 7.0 6.2 3.3 8.6 11.5 8.4 4.9 9.8 6.1 10.0 6.1 39.7 3.1 13.6 7.2 1.9 10.5 9.9 23.7 2.5 3.6 4.4 10.4 1.5 16.8 8.0 15.7 15.6 11.7 6.8 6.6 4.1 7.2 45.8 18.7 10.7 5.4 7.0 14.9 7.6 11.2 8.7 DUX4 ENSG00000260596 "Double homeobox 4" Q9UBX2 4 190173774-190185942 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.0" "Group enriched" "Detected in some" 26 "Early spermatids: 4.9;Late spermatids: 5.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.5;U-2 OS: 2.2;U-266/70: 4.7;U-266/84: 6.9;U-698: 1.5" "Low region specificity" "Detected in some" HPA058451 Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 16: U-266 - Nucleosome" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Nucleoli" "Golgi apparatus, Cytosol" "HPA058451: AB_2683722" 0.0 0.1 0.3 0.0 0.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 2.2 0.4 0.0 4.7 6.9 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DYNLL2 "Dlc2, DNCL1B, MGC17810, RSPH22" ENSG00000264364 "Dynein light chain LC8-type 2" Q96FJ2 17 58083419-58095542 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 455.4;Late spermatids: 892.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039954 Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 1000000 "Cluster 18: Basophils - Vesicular transport" "Cluster 39: Non-specific - Mitochondria" "Cluster 28: BEWO - Transcription regulation" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA039954: AB_2676771" "unprognostic (7.22e-2)" "unprognostic (7.76e-2)" "unprognostic (3.52e-3)" "unprognostic (3.50e-1)" "unprognostic (1.93e-1)" "unprognostic (3.72e-2)" "unprognostic (6.78e-2)" "unprognostic (2.91e-2)" "unprognostic (1.68e-1)" "unprognostic (1.10e-2)" "prognostic favorable (5.26e-4)" "unprognostic (1.24e-1)" "prognostic favorable (1.12e-12)" "unprognostic (2.87e-2)" "unprognostic (1.28e-1)" "unprognostic (1.31e-1)" "unprognostic (7.02e-2)" 24.5 41.8 76.8 17.7 84.5 17.7 16.9 78.1 77.7 18.2 45.6 26.1 25.0 19.6 22.4 20.3 19.4 13.4 62.8 63.4 80.4 42.1 35.2 17.9 15.5 83.6 90.1 20.4 17.8 47.2 28.7 30.4 83.6 30.3 20.1 41.2 30.8 26.3 113.7 19.1 24.3 18.9 83.4 18.0 21.3 26.2 87.9 22.5 33.0 58.7 18.4 20.7 17.6 72.0 54.1 36.0 72.3 33.1 44.0 24.0 114.6 53.2 21.1 25.2 19.7 80.4 25.4 48.0 58.8 33.1 30.1 28.4 33.8 42.2 43.2 47.8 24.5 52.1 21.9 47.7 34.8 56.2 31.1 24.3 28.2 29.4 23.2 26.4 17.1 39.8 52.7 28.4 24.7 81.5 64.1 23.2 49.9 35.3 36.5 58.3 42.5 19.9 22.0 57.9 49.3 39.4 47.7 19.0 42.0 37.2 56.2 26.1 31.0 49.3 62.2 33.2 39.8 52.6 68.5 57.0 25.5 44.2 35.2 1.0 0.2 0.5 0.6 0.1 0.7 0.4 0.5 0.6 0.1 0.4 0.5 0.8 0.4 0.4 0.9 0.2 0.4 0.2 76.8 84.5 78.1 77.7 63.4 80.4 83.6 90.1 83.6 83.4 87.9 72.0 33.9 12.8 43.8 1.0 28.1 49.1 40.7 13.7 45.5 63.7 55.7 39.8 186.2 44.3 23.8 60.7 39.6 102.1 59.7 56.7 31.3 37.6 455.4 51.5 57.3 32.5 67.2 40.6 1.2 31.2 73.4 30.6 20.9 55.2 22.8 19.1 23.9 104.7 43.0 70.7 2.0 55.7 26.4 28.4 37.4 892.8 29.5 32.8 65.8 1.9 31.9 74.7 19.6 0.5 2.8 38.0 38.6 26.7 19.4 35.3 50.0 78.2 18.4 41.1 26.3 40.1 86.1 46.5 44.8 45.1 46.0 60.1 46.9 29.0 49.7 36.5 DYRK3 "hYAK3-2, RED, REDK" ENSG00000143479 "Dual specificity tyrosine phosphorylation regulated kinase 3" O43781 1 206635536-206684419 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 48.0" "Cell type enhanced" "Detected in many" "Early spermatids: 235.3;Late spermatids: 48.1;Spermatocytes: 108.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 2.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-HME1: 73.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA075041 Supported Nucleoplasm,Cytosol NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 30: Epithelial cell lines - Translation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Cytosol "HPA075041: AB_2686730" "unprognostic (6.51e-2)" "unprognostic (1.24e-2)" "unprognostic (3.36e-2)" "unprognostic (2.03e-1)" "unprognostic (2.81e-2)" "unprognostic (1.23e-1)" "unprognostic (1.20e-4)" "unprognostic (2.69e-1)" "unprognostic (3.91e-1)" "unprognostic (2.71e-1)" "unprognostic (2.79e-3)" "unprognostic (2.52e-1)" "prognostic unfavorable (9.41e-7)" "unprognostic (2.38e-1)" "unprognostic (2.04e-1)" "unprognostic (1.99e-2)" "unprognostic (7.62e-3)" 7.6 2.4 3.7 4.2 3.8 8.8 5.7 1.7 3.7 5.6 5.6 2.3 1.0 5.3 3.1 2.8 5.7 13.5 8.3 5.1 3.8 3.3 4.1 5.5 1.6 3.8 5.1 4.9 3.9 3.0 6.5 1.2 3.4 2.9 1.4 6.4 4.3 3.0 0.8 1.5 1.7 8.1 2.6 1.3 3.1 48.0 3.8 5.9 8.3 1.9 1.8 7.5 2.8 3.5 5.0 6.7 1.6 9.8 16.7 15.9 0.4 15.4 36.7 15.0 19.6 0.4 2.7 7.6 2.2 20.1 25.8 1.5 8.6 14.1 15.8 0.1 4.8 10.5 8.9 1.7 26.9 7.5 6.8 10.9 8.9 25.6 73.6 15.1 11.8 11.6 20.1 1.4 23.2 2.0 16.9 4.4 13.2 0.5 10.8 41.1 4.9 0.1 4.8 0.4 9.3 6.9 13.6 0.6 20.3 2.0 2.0 1.9 8.1 31.1 11.2 14.8 13.2 5.6 2.2 9.1 17.7 8.3 2.9 0.7 0.0 0.2 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.5 0.0 0.0 2.7 0.0 0.0 3.7 3.8 1.7 3.7 5.1 3.8 3.8 5.1 3.4 2.6 3.8 3.5 13.9 3.2 8.2 4.2 1.0 6.5 10.7 9.6 3.4 0.2 4.7 3.3 10.8 1.5 4.2 1.8 10.4 0.0 1.5 0.3 0.0 5.1 235.3 12.6 8.0 8.5 2.4 23.6 3.6 2.2 0.1 12.7 1.1 5.9 0.0 3.4 3.9 1.1 1.0 0.0 1.5 0.4 2.0 1.0 4.6 48.1 4.1 2.9 8.8 1.0 1.0 3.4 0.0 2.5 0.3 1.2 1.2 1.9 2.1 3.8 0.2 1.7 10.5 8.2 6.6 10.2 10.4 108.7 6.4 1.3 3.7 0.4 2.4 3.0 0.6 5.3 EDNRA "ET-A, ETA-R, hET-AR" ENSG00000151617 "Endothelin receptor type A" P25101 4 147480917-147544954 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 113.9" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 117.1;Leydig cells: 43.8;Peritubular cells: 68.1;Sertoli cells: 52.6;Smooth muscle cells: 108.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 9.4;ASC TERT1: 18.2;HHSteC: 9.3;LHCN-M2: 22.7;SH-SY5Y: 16.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013774, CAB018957" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" "Plasma membrane, Cytosol" "CAB018957: AB_2039838, HPA013774: AB_1847994" "unprognostic (3.08e-2)" "unprognostic (6.28e-2)" "unprognostic (1.78e-1)" "unprognostic (3.42e-1)" "unprognostic (1.07e-2)" "unprognostic (1.39e-1)" "unprognostic (3.20e-2)" "unprognostic (7.20e-2)" "unprognostic (2.75e-3)" "unprognostic (1.47e-2)" "unprognostic (1.34e-3)" "unprognostic (2.88e-1)" "prognostic unfavorable (1.50e-7)" "prognostic unfavorable (3.93e-4)" "unprognostic (6.20e-3)" "unprognostic (3.11e-2)" "unprognostic (2.53e-3)" 14.0 5.5 2.1 3.3 2.8 0.0 8.3 2.7 4.2 57.0 2.1 3.2 3.4 44.7 23.3 4.4 18.4 12.7 26.0 2.2 2.2 4.2 3.1 22.7 3.8 2.9 3.1 37.5 1.1 3.4 2.8 12.1 2.9 30.7 3.4 0.3 6.4 113.9 4.0 4.6 2.9 45.1 2.5 8.4 5.4 6.2 2.9 4.9 6.8 5.5 2.6 11.8 24.0 3.0 0.0 1.2 5.2 0.0 9.4 18.2 0.0 2.9 3.8 0.4 0.1 0.2 0.0 0.0 0.0 0.9 0.6 0.0 0.4 0.7 0.2 0.0 1.9 0.0 2.8 0.0 9.3 0.0 0.0 6.9 0.6 0.5 0.0 3.4 0.0 0.0 0.0 1.4 22.7 0.3 0.0 0.1 1.5 0.0 1.1 0.0 0.9 0.1 1.3 1.0 0.0 16.3 0.0 0.0 0.0 3.4 0.0 0.0 0.0 3.6 0.7 0.0 0.0 1.3 0.4 0.0 7.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.8 2.7 4.2 2.2 2.2 2.9 3.1 2.9 2.5 2.9 3.0 7.7 3.2 5.3 1.0 0.0 3.1 0.8 1.7 27.3 0.1 0.8 5.2 24.9 0.0 4.5 0.0 0.0 0.2 0.1 0.0 0.0 0.1 2.9 3.4 117.1 8.0 0.0 0.0 5.3 0.0 0.1 15.9 0.0 2.7 0.0 14.3 0.0 0.0 0.6 0.0 22.5 0.0 0.0 0.0 3.9 3.5 43.8 0.8 3.6 9.4 0.0 0.1 0.0 2.0 1.0 0.2 0.0 68.1 0.0 1.4 0.0 0.5 0.0 0.5 52.6 0.6 108.6 0.7 0.7 7.1 2.7 0.1 0.9 0.3 0.0 0.4 EDNRB "ETB, HSCR, HSCR2" ENSG00000136160 "Endothelin receptor type B" P24530 13 77895481-77975529 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Albinism, Deafness, Disease variant, FDA approved drug targets, Hirschsprung disease, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 127.8" "Cell type enhanced" "Detected in many" "Adipocytes: 120.5;Astrocytes: 126.3;Hepatic stellate cells: 112.5;Melanocytes: 110.3;Muller glia cells: 116.2;Sertoli cells: 216.9;Skeletal myocytes: 81.3;Smooth muscle cells: 102.1" "Cancer enhanced" "Detected in all" "melanoma: 127.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 68.0;ASC diff: 50.5;SK-MEL-30: 66.0;U-266/70: 40.7;WM-115: 131.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017842, HPA027546" Approved Supported "Plasma membrane,Cytosol" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 17: WM-115 - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" "Plasma membrane" Cytosol "CAB017842: , HPA027546: AB_2672327" "unprognostic (7.75e-2)" "unprognostic (6.73e-2)" "unprognostic (1.41e-3)" "unprognostic (2.59e-2)" "unprognostic (8.37e-2)" "unprognostic (2.45e-3)" "unprognostic (4.17e-3)" "unprognostic (5.43e-2)" "unprognostic (1.02e-1)" "unprognostic (1.38e-2)" "unprognostic (3.40e-2)" "unprognostic (3.01e-2)" "prognostic favorable (7.20e-5)" "unprognostic (1.59e-2)" "unprognostic (3.86e-2)" "unprognostic (4.58e-2)" "unprognostic (6.77e-3)" 58.8 41.2 34.7 19.5 50.8 0.9 39.8 44.6 26.1 18.7 6.7 13.0 20.0 13.1 3.7 8.2 14.1 14.9 28.1 27.5 51.6 33.0 50.9 51.2 10.4 76.2 66.0 4.7 11.4 15.3 9.6 127.8 47.9 25.3 13.2 17.9 27.0 6.9 11.3 12.5 21.9 12.9 97.2 16.8 10.6 2.3 64.9 4.0 31.8 18.8 4.7 23.6 15.5 78.7 5.7 0.0 68.0 0.0 50.5 2.0 1.0 0.0 0.1 0.0 0.0 25.9 0.0 0.0 2.6 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.3 0.3 0.0 0.0 3.5 0.0 0.2 13.2 0.0 0.0 0.0 0.1 0.6 0.0 0.2 0.2 1.7 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.7 0.1 0.1 0.5 0.1 0.0 66.0 8.9 0.0 0.3 0.3 0.6 0.1 0.0 0.4 40.7 24.9 0.1 1.2 0.0 131.8 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 34.7 50.8 44.6 26.1 27.5 51.6 76.2 66.0 47.9 97.2 64.9 78.7 120.5 12.8 51.0 126.3 0.2 14.8 1.0 0.0 1.2 5.8 1.2 2.8 10.8 0.0 2.5 0.0 6.2 14.7 0.3 0.1 0.0 0.0 2.9 2.9 20.7 73.3 0.0 0.0 1.3 0.0 13.9 51.1 1.1 35.9 6.3 2.1 112.5 1.1 13.4 0.0 1.6 0.0 0.0 18.7 10.6 2.2 79.9 5.2 110.3 6.5 0.1 116.2 0.0 48.2 0.9 0.1 0.0 2.6 0.1 2.6 0.0 0.1 1.5 4.4 216.9 81.3 102.1 0.4 2.1 0.2 7.2 5.7 1.6 2.5 0.0 1.5 EEF1AKMT4 ENSG00000284753 "EEF1A lysine methyltransferase 4" P0DPD7 3 184249672-184258759 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Breast glandular cells: 9.9;Breast myoepithelial cells: 11.7;Distal tubular cells: 15.6;Ductal cells: 14.7;Exocrine glandular cells: 15.3;Pancreatic endocrine cells: 9.2;Proximal tubular cells: 21.2" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062215 Uncertain Nucleoplasm,Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Cytosol" "HPA062215: AB_2684714" 2.4 3.0 1.0 4.1 1.0 5.0 4.3 3.9 1.6 3.1 1.3 5.6 5.3 1.6 1.4 6.1 1.8 2.2 2.0 0.9 1.7 2.9 14.0 2.0 4.3 1.4 1.2 0.7 12.7 4.8 6.0 1.3 1.9 5.3 0.4 6.6 2.0 2.3 5.3 3.4 3.2 1.2 2.0 3.8 11.4 1.4 4.5 7.2 5.4 5.0 6.2 1.0 50.8 29.9 5.1 17.3 9.9 6.8 41.2 6.4 12.5 10.0 9.4 56.9 7.9 63.7 40.2 7.2 41.8 19.5 31.1 32.2 5.6 23.8 36.9 17.1 18.1 36.8 12.1 43.8 12.8 8.5 39.0 10.8 19.1 3.3 8.2 20.8 33.0 54.7 4.8 84.2 18.6 54.9 11.7 71.0 52.1 32.6 7.0 53.4 11.8 11.2 26.8 9.7 10.8 95.1 24.6 9.2 76.0 21.4 5.8 7.5 11.5 22.4 30.2 33.1 74.5 64.6 7.0 74.9 10.0 0.0 22.9 2.5 8.0 19.1 8.8 8.8 8.4 7.8 19.4 6.5 5.8 9.2 0.5 7.3 13.3 17.5 15.5 10.9 1.0 1.0 3.9 1.6 0.9 1.7 1.4 1.2 1.3 1.2 1.4 1.0 3.8 0.0 2.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 9.9 11.7 0.0 0.0 3.1 7.3 0.0 0.0 1.7 0.0 15.6 14.7 0.0 1.8 3.5 2.1 0.0 0.0 0.0 15.3 0.0 1.5 0.0 2.0 1.3 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.8 0.0 0.0 21.2 1.5 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 1.0 6.7 0.0 0.0 EEF1AKMT4-ECE2 ENSG00000284917 "EEF1AKMT4-ECE2 readthrough" P0DPD8 3 184249695-184293031 "Enzymes, Predicted membrane proteins" "Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062215 Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA062215: AB_2684714" 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EFS "CASS3, EFS1, EFS2, HEFS, SIN" ENSG00000100842 "Embryonal Fyn-associated substrate" O43281 14 23356403-23365752 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 48.9;Squamous epithelial cells: 22.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 73.2;AN3-CA: 39.5;BEWO: 57.7;SH-SY5Y: 66.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA001581, HPA001790" Approved Uncertain Nucleoplasm,Cytosol No NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 35: Glandular cells - Unknown function" Nucleoplasm Cytosol "HPA001581: AB_2666367, HPA001790: " "unprognostic (9.58e-3)" "unprognostic (1.10e-2)" "unprognostic (3.68e-2)" "unprognostic (1.78e-1)" "unprognostic (6.05e-2)" "unprognostic (5.76e-2)" "unprognostic (3.00e-1)" "unprognostic (3.85e-2)" "unprognostic (7.36e-2)" "unprognostic (2.15e-1)" "unprognostic (2.75e-1)" "unprognostic (1.00e-2)" "prognostic unfavorable (4.09e-5)" "unprognostic (3.44e-3)" "unprognostic (1.73e-1)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" 19.3 12.6 39.7 5.5 59.6 0.0 22.7 51.7 45.6 47.3 28.0 24.4 3.1 29.2 9.9 44.1 28.6 8.7 15.0 35.6 39.3 10.0 1.8 12.1 3.6 63.0 57.6 41.9 2.2 22.2 8.4 10.4 54.8 36.8 3.3 10.6 26.2 22.5 3.6 59.0 9.6 12.5 44.8 7.6 11.9 5.4 49.9 3.2 17.5 5.1 4.8 25.3 42.9 76.0 4.7 0.0 73.2 39.5 17.1 20.0 57.7 5.3 11.3 2.0 0.9 0.0 0.0 0.0 0.0 30.3 0.3 27.5 0.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 11.6 18.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 28.1 0.0 0.0 0.0 22.6 0.1 0.0 24.1 7.8 66.5 15.1 2.6 0.0 8.7 17.6 0.0 0.0 7.6 0.0 19.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.7 59.6 51.7 45.6 35.6 39.3 63.0 57.6 54.8 44.8 49.9 76.0 2.0 0.0 6.7 17.0 0.0 11.6 11.6 5.6 9.6 5.0 20.3 16.3 0.7 0.0 4.1 0.0 6.2 9.3 0.2 0.0 1.9 0.1 0.9 0.6 18.9 1.8 0.0 0.0 0.2 0.0 14.7 15.7 0.0 0.7 0.0 4.4 1.8 0.0 1.6 0.0 0.3 0.0 0.0 0.0 3.7 0.8 20.2 0.4 7.2 1.9 0.0 9.0 0.0 22.1 48.9 0.0 0.0 13.9 0.1 7.6 0.0 0.3 1.1 9.3 6.6 12.6 8.9 2.2 0.5 22.7 13.4 18.1 0.5 0.3 0.0 7.0 EIF1AD "haponin, MGC11102" ENSG00000175376 "Eukaryotic translation initiation factor 1A domain containing" Q8N9N8 11 65996545-66002176 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054991, HPA058735" Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 16: U-266 - Nucleosome" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Vesicles" Cytosol "HPA054991: AB_2682664, HPA058735: AB_2683802" "unprognostic (1.11e-1)" "unprognostic (8.83e-2)" "unprognostic (3.03e-1)" "prognostic unfavorable (3.59e-5)" "unprognostic (1.30e-2)" "unprognostic (5.69e-2)" "prognostic unfavorable (8.63e-5)" "unprognostic (1.86e-2)" "unprognostic (1.17e-1)" "unprognostic (8.76e-2)" "unprognostic (1.36e-3)" "unprognostic (2.31e-1)" "unprognostic (1.59e-3)" "unprognostic (7.63e-3)" "unprognostic (1.40e-1)" "unprognostic (1.28e-3)" "unprognostic (3.96e-1)" 15.7 17.7 15.3 19.9 15.8 44.6 16.0 18.7 19.8 13.1 14.4 15.8 15.1 15.9 16.2 21.0 15.3 13.0 17.1 16.4 17.7 15.2 17.3 15.0 23.4 16.1 15.7 20.4 19.2 17.1 16.6 21.1 16.3 13.4 14.7 16.6 16.8 14.9 27.2 23.1 16.9 14.8 14.8 20.0 16.1 19.4 17.3 19.9 13.8 23.3 27.6 17.1 14.5 18.4 51.0 43.9 35.0 35.9 27.6 28.8 32.8 36.4 34.6 44.2 37.7 44.8 47.5 38.2 62.6 41.2 38.0 34.9 42.2 48.8 41.5 35.1 21.7 54.4 52.0 46.4 33.7 50.3 41.8 24.1 41.9 65.3 44.1 31.2 31.0 40.9 81.1 54.4 64.7 68.7 46.6 55.1 25.9 23.3 47.5 50.3 35.9 75.0 25.6 31.8 26.5 31.2 39.3 54.7 41.5 28.1 53.1 31.0 36.5 59.7 39.9 47.8 36.1 66.7 85.5 79.8 42.9 33.8 39.5 52.6 20.5 13.5 17.7 16.6 13.6 19.4 15.0 13.0 21.3 19.0 14.1 13.5 13.1 16.4 21.3 12.7 15.3 13.3 15.3 15.8 18.7 19.8 16.4 17.7 16.1 15.7 16.3 14.8 17.3 18.4 8.2 3.2 5.4 3.3 16.2 37.7 12.2 13.4 12.5 7.2 14.2 9.1 16.2 14.3 7.3 5.5 14.6 16.3 17.7 11.6 15.6 12.7 18.3 9.0 8.3 11.6 2.4 21.0 3.0 13.1 23.0 11.4 7.1 10.5 12.7 31.7 16.4 16.5 24.5 11.8 2.8 11.2 6.1 10.4 29.5 14.3 12.2 14.4 12.4 1.0 17.6 10.5 17.5 5.5 4.5 29.0 15.2 5.7 22.6 13.2 13.8 15.7 10.6 18.5 6.6 9.8 27.0 31.3 23.2 15.7 48.9 25.3 16.2 7.4 10.9 13.2 EIF2A EIF-2A ENSG00000144895 "Eukaryotic translation initiation factor 2A" Q9BY44 3 150546678-150586016 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036256 Approved Uncertain Mitochondria,Cytosol No No 16000 "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" Mitochondria Cytosol "HPA036256: AB_10611961" "unprognostic (1.72e-1)" "unprognostic (2.09e-2)" "unprognostic (2.71e-3)" "unprognostic (3.36e-2)" "unprognostic (3.96e-3)" "unprognostic (7.05e-3)" "prognostic unfavorable (2.36e-5)" "unprognostic (2.11e-1)" "unprognostic (7.92e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (6.57e-6)" "unprognostic (6.30e-2)" "unprognostic (3.08e-2)" "unprognostic (3.78e-1)" "unprognostic (1.13e-1)" "unprognostic (1.48e-1)" "unprognostic (3.39e-1)" 57.0 54.0 14.5 47.8 18.5 86.8 103.4 27.2 25.4 63.9 21.9 57.8 65.5 69.7 46.9 64.7 62.7 55.8 72.3 16.6 18.4 72.2 75.2 47.7 68.4 17.1 15.3 94.9 107.2 62.8 32.8 52.4 18.5 52.8 70.8 52.3 77.2 47.0 87.3 74.0 55.3 68.4 18.1 47.4 59.7 24.3 15.1 68.7 92.1 76.7 83.4 67.5 43.4 22.8 158.0 69.4 76.6 79.9 100.8 234.3 105.0 97.3 158.0 134.1 143.0 202.5 168.9 212.0 142.4 134.3 160.1 125.1 149.9 152.9 193.5 81.3 91.6 129.4 76.1 130.9 101.1 155.0 113.0 151.4 153.6 97.2 221.9 200.7 180.3 112.3 109.8 116.5 105.5 121.3 109.6 70.6 108.4 161.3 98.7 97.5 101.1 238.8 119.9 116.9 93.7 102.1 62.6 88.0 144.5 91.6 130.9 127.3 99.9 76.3 69.3 109.2 186.6 194.9 119.6 195.0 96.4 130.5 39.5 23.6 47.2 10.4 27.9 49.5 46.1 36.2 40.6 35.7 54.2 34.7 51.5 41.6 3.7 46.1 56.9 26.5 37.0 44.4 14.5 18.5 27.2 25.4 16.6 18.4 17.1 15.3 18.5 18.1 15.1 22.8 77.7 35.3 67.1 14.4 91.4 140.1 157.3 109.8 109.3 30.6 86.0 76.5 102.4 58.6 69.2 35.0 27.1 84.1 85.7 43.1 137.0 76.1 21.5 39.6 64.3 67.5 56.8 80.3 30.4 108.3 113.6 63.8 64.7 51.4 75.5 45.0 60.0 30.6 62.4 23.5 33.1 81.7 54.9 96.4 82.8 6.6 61.5 72.7 69.4 19.7 97.4 37.2 73.2 32.6 34.7 64.0 57.7 56.4 112.1 79.6 77.0 138.4 41.7 31.2 78.9 95.4 77.9 40.4 41.9 102.3 122.9 120.3 95.0 55.1 99.0 130.4 ELL "C19orf17, ELL1, Men, PPP1R68" ENSG00000105656 "Elongation factor for RNA polymerase II" P55199 19 18442663-18522116 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 297.2;Late spermatids: 235.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004202, HPA046076" Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "Nuclear bodies, Cytosol" "HPA004202: , HPA046076: AB_2679526" "unprognostic (9.49e-2)" "unprognostic (1.38e-1)" "unprognostic (3.26e-3)" "unprognostic (2.07e-1)" "unprognostic (1.64e-1)" "unprognostic (2.10e-1)" "unprognostic (8.26e-2)" "unprognostic (2.71e-1)" "unprognostic (2.34e-1)" "unprognostic (3.00e-2)" "unprognostic (6.28e-3)" "unprognostic (2.38e-2)" "unprognostic (1.57e-1)" "unprognostic (2.07e-1)" "unprognostic (5.12e-1)" "unprognostic (2.46e-1)" "unprognostic (1.06e-1)" 15.1 7.7 4.0 9.0 6.2 29.8 11.8 8.4 7.0 11.2 5.0 10.6 6.5 11.0 2.0 10.3 10.6 5.7 10.5 3.6 4.2 12.6 14.1 16.6 7.6 4.7 4.2 13.0 10.0 4.1 11.3 10.0 3.8 9.9 2.3 1.2 8.3 3.6 20.1 15.3 12.8 3.6 4.0 17.3 10.1 38.5 6.1 6.8 8.2 9.9 4.3 10.5 11.0 3.9 12.7 5.7 3.2 6.8 3.4 4.2 22.7 10.0 8.8 7.5 7.1 7.1 9.8 15.6 11.8 6.7 5.2 8.6 4.7 11.1 3.8 13.3 10.9 9.4 5.9 6.3 5.2 10.3 11.8 8.6 9.3 9.8 7.7 5.6 5.4 8.5 13.5 21.8 4.0 10.3 12.5 11.9 10.6 7.8 16.8 10.9 4.8 17.4 5.3 8.8 5.7 6.4 7.4 12.3 11.0 4.1 6.4 12.4 9.0 8.6 6.6 11.6 9.3 34.8 23.4 11.7 11.4 17.6 12.5 0.3 5.9 4.5 4.5 4.1 7.3 2.9 2.6 3.9 5.0 2.1 1.7 2.7 18.1 2.3 2.1 8.6 3.1 4.1 4.0 6.2 8.4 7.0 3.6 4.2 4.7 4.2 3.8 4.0 6.1 3.9 12.3 6.4 6.1 9.1 16.3 28.0 26.4 11.9 23.3 4.5 19.7 10.7 5.1 11.5 7.2 3.7 4.2 47.5 29.5 15.2 11.7 8.7 297.2 22.9 16.0 11.4 19.7 10.3 9.1 8.0 17.6 17.2 12.8 37.7 11.4 5.1 7.5 15.5 19.3 1.7 11.2 10.1 6.1 12.8 21.7 235.9 6.5 20.4 7.2 9.4 13.8 5.3 4.1 7.1 8.0 10.8 3.7 3.0 53.6 14.2 11.8 7.0 8.4 3.4 19.7 13.0 16.7 18.2 24.7 19.4 30.4 68.7 19.2 5.9 7.1 19.9 ELMOD1 DKFZp547C176 ENSG00000110675 "ELMO domain containing 1" Q8N336 11 107591091-107666779 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 32.8;pituitary gland: 21.7;retina: 32.6;skin 1: 28.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 33.5;Excitatory neurons: 126.1;Horizontal cells: 37.0;Inhibitory neurons: 103.9;Oligodendrocyte precursor cells: 80.9" "Cancer enriched" "Detected in single" 15 "glioma: 4.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 14.9;RH-30: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038435, HPA066479" Uncertain Nucleoplasm,Cytosol NA NA "Cluster 11: Basophils - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm Cytosol "HPA038435: AB_10795575, HPA066479: " "unprognostic (2.74e-1)" "unprognostic (1.72e-4)" "unprognostic (2.58e-2)" "unprognostic (9.13e-2)" "unprognostic (3.93e-2)" "unprognostic (2.12e-2)" "unprognostic (1.34e-1)" "unprognostic (6.59e-3)" "unprognostic (1.93e-1)" "unprognostic (1.36e-1)" "unprognostic (6.29e-2)" "unprognostic (9.44e-2)" "unprognostic (1.34e-4)" "unprognostic (1.91e-2)" "unprognostic (3.15e-1)" "unprognostic (4.21e-2)" "unprognostic (1.39e-1)" 0.4 2.6 17.2 0.3 27.1 0.1 2.4 13.2 32.8 0.5 0.0 0.5 0.2 0.4 0.1 0.1 2.1 0.1 4.8 24.6 23.5 3.1 0.3 0.4 0.1 15.1 24.8 0.1 0.1 0.9 21.7 0.0 11.8 0.8 0.2 32.6 0.1 0.1 2.6 28.9 0.2 0.3 14.3 0.1 0.1 1.6 18.8 0.4 0.1 1.8 0.0 0.0 0.1 10.7 0.0 0.0 5.6 0.1 0.0 0.1 0.2 0.2 0.0 0.4 1.0 0.0 0.0 0.0 0.0 0.2 4.4 0.5 2.8 0.4 0.5 0.0 2.3 0.1 0.0 0.1 1.5 0.1 0.0 0.5 0.1 0.0 0.0 0.1 14.9 1.9 0.0 0.1 1.1 0.1 0.0 0.1 0.6 0.0 2.2 0.1 33.9 0.0 0.0 0.0 0.3 1.7 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.4 1.6 0.0 0.9 0.2 0.0 0.0 4.5 0.0 2.7 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.1 0.1 0.0 0.0 17.2 27.1 13.2 32.8 24.6 23.5 15.1 24.8 11.8 14.3 18.8 10.7 0.0 0.0 3.9 24.2 0.2 0.0 0.4 0.1 0.0 33.5 0.0 0.1 12.8 0.0 1.3 0.0 16.7 0.1 0.0 0.0 0.0 0.0 11.4 2.2 1.0 1.6 0.0 0.0 126.1 0.0 0.1 0.5 0.0 0.2 0.0 0.1 0.4 1.1 0.1 37.0 103.9 0.0 0.0 0.3 2.2 13.6 0.3 0.4 0.0 7.5 0.0 10.0 0.0 80.9 5.9 0.0 0.0 0.4 0.0 0.3 0.0 4.2 4.8 18.3 0.0 0.7 0.8 5.0 1.5 0.0 3.1 0.0 0.2 0.0 0.0 0.2 ELOA "SIII, TCEB3, TCEB3A" ENSG00000011007 "Elongin A" Q14241 1 23743155-23762059 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 83.9;Ductal cells: 41.3;Syncytiotrophoblasts: 41.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005910 Approved Approved "Nuclear speckles,Cytosol" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 18: U-2197 - ECM organization" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles" Cytosol "HPA005910: AB_1080227" "unprognostic (6.90e-2)" "unprognostic (5.99e-3)" "unprognostic (4.08e-2)" "unprognostic (1.44e-1)" "unprognostic (1.99e-1)" "unprognostic (3.93e-2)" "prognostic unfavorable (1.44e-5)" "unprognostic (1.72e-1)" "unprognostic (8.84e-3)" "unprognostic (6.00e-2)" "unprognostic (4.94e-2)" "unprognostic (2.14e-2)" "unprognostic (2.95e-3)" "unprognostic (2.90e-1)" "unprognostic (4.27e-2)" "unprognostic (4.80e-2)" "unprognostic (4.14e-2)" 25.7 12.7 9.8 18.8 10.8 33.4 16.5 13.0 11.5 15.7 10.4 14.8 12.6 13.3 10.1 23.8 12.9 15.4 15.5 10.1 10.9 14.4 29.6 25.8 17.7 10.9 10.6 16.1 42.4 27.0 11.5 19.2 11.0 14.9 16.5 12.7 17.4 13.3 33.2 20.1 13.9 16.8 9.7 16.2 26.5 18.9 11.1 21.6 21.3 26.4 23.6 24.5 14.6 11.8 52.0 28.3 40.2 34.6 46.2 28.6 25.3 52.4 46.9 76.2 66.1 34.9 44.1 27.0 62.7 53.3 42.8 48.5 83.0 55.2 84.4 77.8 41.1 60.9 42.2 41.1 40.9 64.7 35.3 30.6 43.6 83.3 63.2 28.2 46.4 43.7 91.8 45.3 61.6 39.3 33.5 26.1 46.8 57.7 42.4 49.8 50.9 51.3 35.8 34.8 76.2 42.9 47.7 47.5 58.5 44.3 34.4 23.5 49.5 59.5 52.8 106.9 62.5 46.8 56.4 59.2 52.1 63.2 60.7 28.2 24.6 19.6 16.5 24.9 16.3 23.5 13.8 15.1 22.6 18.5 11.2 14.9 6.5 13.7 24.1 18.4 17.1 17.7 9.8 10.8 13.0 11.5 10.1 10.9 10.9 10.6 11.0 9.7 11.1 11.8 24.1 28.9 83.9 0.0 7.9 0.0 0.0 0.0 0.0 0.0 19.6 16.0 0.0 0.0 18.0 18.4 0.0 28.1 17.5 0.0 5.9 41.3 0.0 15.4 27.4 12.5 0.0 0.0 0.0 32.7 35.7 10.1 0.0 23.3 13.9 21.5 0.0 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 35.2 0.0 0.0 0.0 0.0 37.9 0.0 0.0 4.9 0.0 0.0 19.0 16.8 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 41.3 9.6 32.5 0.0 0.0 EME1 "FLJ31364, MMS4L, SLX2A" ENSG00000154920 "Essential meiotic structure-specific endonuclease 1" Q96AY2 17 50373220-50381483 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 4.4;epididymis: 6.3;testis: 5.7" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 4.6;Extravillous trophoblasts: 4.8;Granulosa cells: 4.5;Spermatocytes: 13.2;Spermatogonia: 9.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 33 "basophil: 18.6" "Lineage enriched" "Detected in single" 33 "granulocytes: 18.6" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016127, HPA052188" Supported Approved "Nuclear bodies,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nuclear bodies, Cytosol" "CAB016127: AB_2278026, HPA052188: " "unprognostic (3.81e-1)" "unprognostic (7.72e-2)" "unprognostic (6.49e-2)" "unprognostic (2.45e-3)" "unprognostic (2.74e-1)" "unprognostic (1.94e-2)" "unprognostic (9.94e-5)" "unprognostic (2.87e-2)" "unprognostic (1.07e-2)" "unprognostic (2.02e-2)" "unprognostic (4.37e-3)" "unprognostic (2.83e-3)" "unprognostic (0.00e+0)" "unprognostic (9.82e-2)" "unprognostic (1.26e-1)" "unprognostic (3.71e-1)" "unprognostic (3.41e-1)" 0.5 0.3 0.2 1.7 0.3 4.4 0.6 0.1 0.4 0.5 0.0 0.9 0.8 0.4 6.3 1.1 0.3 0.3 0.2 0.1 0.1 0.2 0.4 0.4 2.3 0.3 0.2 0.5 0.2 0.1 0.1 1.4 0.3 0.2 1.3 0.4 0.5 0.1 0.2 1.1 0.7 0.6 0.1 0.9 0.5 5.7 0.3 3.3 0.2 0.0 2.6 0.4 0.5 0.4 13.9 20.0 26.2 13.7 1.2 2.6 18.8 14.2 5.4 19.3 17.7 31.7 11.0 11.0 18.3 5.7 12.0 10.7 24.5 11.3 27.3 21.7 19.3 26.3 23.3 14.8 0.1 10.9 8.4 0.5 0.8 22.3 9.2 2.6 4.5 31.2 16.3 25.6 11.6 15.2 25.0 13.9 15.1 14.2 13.6 25.5 50.7 15.4 4.3 5.6 10.1 20.2 8.7 4.8 8.1 20.9 16.8 12.3 3.1 24.8 14.9 16.6 19.7 16.0 17.4 10.5 7.8 12.2 15.6 18.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.2 0.2 0.3 0.1 0.4 0.1 0.1 0.3 0.2 0.3 0.1 0.3 0.4 0.1 0.0 1.1 0.3 0.8 0.1 0.3 0.5 0.6 1.5 0.5 0.3 0.4 0.0 0.7 0.0 0.0 4.6 0.5 0.6 0.0 0.3 0.5 0.8 0.7 0.4 0.0 3.8 0.1 0.0 4.8 0.8 2.0 0.5 0.0 4.5 0.0 0.3 2.2 0.0 0.1 0.9 0.0 0.0 1.4 0.6 0.6 0.8 0.0 0.0 1.0 0.5 1.0 0.0 0.3 0.1 0.0 0.0 2.5 0.1 0.1 0.0 0.9 0.3 0.0 0.6 1.0 13.2 9.1 1.5 0.1 1.1 0.5 0.6 1.3 0.2 EPB42 "MGC116735, MGC116737, PA" ENSG00000166947 "Erythrocyte membrane protein band 4.2" P16452 15 43197227-43221018 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell shape, Erythrocyte maturation" "Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 30 "bone marrow: 98.9" "Cell type enriched" "Detected in many" 33 "Erythroid cells: 480.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 91 "HEL: 85.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040261 Supported Uncertain Nucleoplasm,Cytosol NA NA 1400000 "Cluster 67: Neutrophils - Humoral immune response" "Cluster 36: HEL - Hemostasis" "Cluster 6: Erythroid cells - Oxygen transport" "Nucleoplasm, Cytosol" "HPA040261: AB_10673441" "unprognostic (8.45e-2)" "unprognostic (4.66e-1)" "unprognostic (4.15e-1)" "unprognostic (1.13e-1)" "unprognostic (2.28e-1)" "unprognostic (1.99e-1)" "unprognostic (1.54e-1)" "unprognostic (1.59e-3)" "unprognostic (2.95e-1)" "unprognostic (6.05e-2)" "unprognostic (5.27e-3)" "unprognostic (1.31e-1)" "unprognostic (1.48e-5)" "unprognostic (1.70e-2)" "unprognostic (1.20e-1)" "unprognostic (5.88e-2)" "unprognostic (3.47e-3)" 3.1 0.0 0.0 0.0 0.0 98.9 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.4 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 2.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 85.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 1.9 1.5 0.5 0.0 4.0 0.0 0.0 0.6 1.5 0.5 0.0 6.2 4.5 0.0 1.5 0.0 0.0 14.4 0.0 0.0 1.2 0.0 480.0 0.1 0.0 2.3 0.8 0.0 0.0 4.5 0.0 2.5 1.1 1.1 6.7 0.1 0.9 4.1 2.2 2.8 10.5 2.8 1.1 1.8 0.0 3.6 2.5 14.4 0.0 0.0 0.0 1.7 0.7 0.4 1.5 2.4 0.0 0.6 8.4 6.6 1.0 1.0 13.5 4.6 0.0 2.8 6.7 3.8 0.0 0.8 2.0 ERCC6L "FLJ20105, PICH, RAD26L" ENSG00000186871 "ERCC excision repair 6 like, spindle assembly checkpoint helicase" Q2NKX8 X 72204657-72239027 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 3.2;lymphoid tissue: 3.6" "Cell type enhanced" "Detected in some" "Erythroid cells: 3.4;Granulosa cells: 2.5;Spermatocytes: 2.1;Spermatogonia: 2.4;Squamous epithelial cells: 2.4" "Cancer enhanced" "Detected in many" "testis cancer: 11.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 4 "NK-cell: 1.7" "Lineage enriched" "Detected in single" 4 "NK-cells: 1.7" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA050492 Approved Uncertain Nucleoplasm,Centrosome,Cytosol No Yes "Cluster 15: NK-cells - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Centrosome "Nucleoplasm, Cytosol" "HPA050492: AB_2681145" "prognostic unfavorable (1.80e-4)" "unprognostic (2.93e-1)" "unprognostic (1.95e-2)" "unprognostic (5.76e-3)" "unprognostic (2.43e-1)" "unprognostic (2.36e-1)" "unprognostic (9.23e-6)" "unprognostic (8.63e-3)" "unprognostic (1.57e-2)" "unprognostic (1.99e-2)" "unprognostic (3.68e-5)" "unprognostic (4.61e-2)" "unprognostic (0.00e+0)" "unprognostic (2.97e-3)" "unprognostic (9.56e-2)" "unprognostic (1.17e-1)" "unprognostic (6.41e-2)" 0.1 0.1 0.1 1.3 0.2 3.2 0.4 0.8 0.2 0.4 0.1 0.9 0.7 0.2 0.2 1.1 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.1 2.3 0.1 0.0 0.3 0.1 0.0 0.1 0.5 0.1 0.1 1.1 0.5 0.3 0.0 0.1 0.6 0.6 0.3 0.0 0.5 0.7 0.8 0.2 3.6 0.1 0.0 2.7 0.2 0.4 0.6 19.0 16.3 14.6 9.3 1.0 1.7 8.0 19.8 9.1 17.0 17.7 13.3 11.6 30.5 7.3 7.2 23.0 15.2 27.8 14.8 30.1 17.5 20.2 10.5 5.5 7.9 0.0 20.7 14.2 0.2 0.9 23.7 4.4 2.8 9.6 15.1 14.1 7.3 17.6 14.8 19.8 12.1 26.6 18.3 24.8 16.4 26.2 5.4 4.4 11.5 12.0 8.6 14.7 9.8 3.6 11.8 7.5 4.6 6.0 11.4 18.3 21.8 13.1 5.7 9.4 25.9 8.1 14.1 11.7 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.4 0.1 1.7 0.1 0.1 0.4 0.1 0.1 0.2 0.8 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.6 0.1 0.0 0.0 0.0 0.9 0.3 0.2 0.5 0.0 0.0 0.3 0.6 0.5 1.5 0.2 0.0 0.0 1.1 0.9 0.6 0.0 0.0 0.3 0.9 0.8 0.3 0.0 3.4 0.9 0.0 1.7 0.5 0.0 0.5 0.0 2.5 0.0 0.0 1.0 0.0 0.7 0.4 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 1.7 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.4 2.1 2.4 2.4 0.1 0.4 0.3 0.2 0.9 0.1 ERCC6L2 "C9orf102, FLJ37706, HEBO, RAD26L" ENSG00000182150 "ERCC excision repair 6 like 2" Q5T890 9 95871264-96121154 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 105.8;Excitatory neurons: 90.1;Inhibitory neurons: 88.5;Oligodendrocyte precursor cells: 130.7;Oligodendrocytes: 117.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021259, HPA021260, HPA021271, HPA022422" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 68: Oligodendrocytes - Mixed function" "Nucleoplasm, Cytosol" "HPA021259: AB_1859542, HPA021260: AB_1859544, HPA021271: AB_1859543, HPA022422: " "unprognostic (6.70e-2)" "unprognostic (2.40e-1)" "unprognostic (2.68e-1)" "unprognostic (1.28e-1)" "unprognostic (8.30e-2)" "unprognostic (3.62e-2)" "unprognostic (4.64e-2)" "unprognostic (3.92e-1)" "unprognostic (9.21e-2)" "unprognostic (3.21e-2)" "unprognostic (5.09e-2)" "unprognostic (1.32e-1)" "prognostic favorable (8.70e-5)" "unprognostic (3.63e-1)" "unprognostic (2.32e-1)" "unprognostic (1.07e-1)" "unprognostic (7.39e-2)" 3.2 3.8 3.3 2.6 4.6 5.1 4.1 5.8 4.2 4.4 3.6 4.0 2.6 4.7 3.5 3.2 3.2 3.4 2.9 4.3 3.8 3.8 3.6 3.2 4.4 3.3 3.4 5.0 2.9 5.5 2.1 3.8 4.1 4.3 3.5 5.4 2.8 4.1 3.7 3.0 2.7 4.2 3.0 4.7 4.2 4.5 3.4 6.8 5.5 3.8 3.9 3.4 2.7 6.9 5.4 8.5 8.3 9.0 5.2 4.3 3.7 5.9 7.8 8.1 5.9 8.9 4.4 6.6 2.6 9.5 10.5 8.0 12.0 5.0 8.6 3.9 3.8 8.2 7.5 5.4 4.8 9.4 6.0 5.2 2.9 8.2 6.0 3.4 6.0 7.9 8.2 3.7 4.5 6.4 8.2 4.9 6.0 6.1 5.1 6.3 14.5 2.7 5.3 5.7 7.7 6.0 5.8 4.3 4.1 4.9 5.6 4.0 7.6 8.1 6.7 9.3 6.8 3.0 4.0 3.6 6.5 5.8 7.0 1.2 1.9 2.0 3.7 1.7 4.8 2.6 4.2 3.9 2.0 4.3 5.1 5.1 1.5 2.7 3.0 5.4 3.2 1.1 3.3 4.6 5.8 4.2 4.3 3.8 3.3 3.4 4.1 3.0 3.4 6.9 20.2 16.0 16.2 105.8 13.8 5.0 12.6 7.2 12.5 0.0 6.6 6.2 18.8 8.6 13.5 0.0 0.0 6.3 18.3 7.5 0.0 8.8 7.8 9.0 32.4 12.9 4.9 12.4 90.1 8.2 3.5 19.3 11.7 11.3 15.2 24.9 8.6 6.6 6.3 0.0 88.5 8.4 6.1 11.1 3.8 3.8 26.8 10.8 3.6 62.8 13.7 0.0 12.3 130.7 117.9 8.3 4.5 27.8 13.5 9.7 7.2 4.0 15.5 0.0 19.7 26.1 19.9 17.0 11.1 12.2 4.4 4.8 15.7 45.9 6.4 9.5 ERN2 IRE1b ENSG00000134398 "Endoplasmic reticulum to nucleus signaling 2" Q76MJ5 16 23690310-23713226 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Transcription, Transcription regulation" "Hydrolase, Kinase, Multifunctional enzyme, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "cervix: 19.5;gallbladder: 17.0;intestine: 28.9;salivary gland: 22.9;stomach 1: 51.9" "Cell type enhanced" "Detected in some" "Club cells: 38.4;Distal enterocytes: 80.2;Gastric mucus-secreting cells: 193.7;Intestinal goblet cells: 143.9;Paneth cells: 37.2;Undifferentiated cells: 70.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 17.0;pancreatic cancer: 19.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "OE19: 43.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA076875 Approved Approved "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" "Endoplasmic reticulum, Cytosol" "HPA076875: " "unprognostic (1.06e-1)" "unprognostic (5.20e-2)" "unprognostic (3.45e-1)" "unprognostic (2.98e-2)" "unprognostic (3.83e-2)" "unprognostic (1.13e-2)" "unprognostic (7.67e-4)" "unprognostic (1.31e-1)" "unprognostic (1.16e-1)" "unprognostic (4.93e-2)" "unprognostic (7.34e-2)" "unprognostic (1.19e-1)" "unprognostic (1.14e-9)" "unprognostic (1.48e-1)" "unprognostic (2.14e-1)" "unprognostic (1.06e-1)" "unprognostic (3.13e-3)" 0.1 0.4 0.1 3.0 0.1 0.0 0.1 0.6 0.4 19.5 0.2 28.9 12.9 0.0 0.0 0.9 0.4 17.0 0.0 0.1 0.2 0.1 0.0 0.8 0.0 0.2 0.1 0.0 0.9 0.0 0.2 0.0 0.2 3.5 23.0 0.0 22.9 0.1 0.0 0.2 12.4 0.9 0.0 0.0 51.9 0.1 0.1 0.0 0.0 0.0 0.0 4.6 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 43.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.6 0.4 0.1 0.2 0.2 0.1 0.2 0.0 0.1 0.4 0.0 0.0 1.1 0.0 0.8 0.0 1.5 6.8 0.0 0.0 0.0 0.0 0.5 20.0 38.4 0.0 0.0 0.5 0.0 80.2 0.0 2.3 0.1 0.5 0.2 0.1 10.8 0.0 0.2 1.9 0.0 0.1 193.7 1.6 4.5 0.1 0.0 0.0 0.1 0.0 0.1 143.9 6.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.1 33.1 37.2 0.0 0.5 1.3 6.1 0.1 16.9 0.0 0.0 1.7 1.6 0.0 0.2 0.0 0.0 0.1 0.4 0.0 70.9 11.1 ERVFRD-1 "envFRD, ERVFRDE1, HERV-FRD, HERV-W/FRD, syncytin-2" ENSG00000244476 "Endogenous retrovirus group FRD member 1, envelope" P60508 6 11102489-11111725 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "placenta: 37.0" "Cell type enriched" "Detected in some" 56 "Syncytiotrophoblasts: 575.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SuSa: 38.8" HPA011812 Uncertain "Nucleoplasm,Plasma membrane,Actin filaments,Cytosol" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 28: Placenta - Pregnancy" "Cluster 12: NES - Nervous system development" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Plasma membrane, Actin filaments" "Nucleoplasm, Cytosol" "HPA011812: AB_1857702" "unprognostic (1.99e-1)" "unprognostic (3.29e-4)" "unprognostic (4.75e-2)" "unprognostic (1.80e-1)" "unprognostic (1.34e-1)" "unprognostic (2.19e-3)" "unprognostic (3.35e-1)" "unprognostic (6.44e-2)" "unprognostic (1.24e-1)" "unprognostic (1.99e-1)" "unprognostic (1.30e-2)" "unprognostic (2.78e-3)" "unprognostic (5.80e-4)" "unprognostic (3.40e-2)" "unprognostic (1.82e-1)" "unprognostic (1.95e-2)" "unprognostic (1.37e-2)" 0.3 0.4 0.6 0.1 0.4 0.2 0.4 1.8 0.6 0.4 0.0 0.3 0.5 0.3 1.0 0.3 0.2 0.4 0.1 0.6 0.7 0.5 0.2 0.6 0.0 0.6 0.4 0.0 0.0 7.5 0.0 37.0 0.5 0.3 0.2 0.2 0.2 0.2 0.0 0.5 0.5 0.2 0.1 0.0 0.3 0.1 0.6 0.4 0.0 0.4 0.0 0.5 0.2 0.6 0.0 0.1 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 38.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.4 1.8 0.6 0.6 0.7 0.6 0.4 0.5 0.1 0.6 0.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.3 0.0 0.0 10.1 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.0 0.0 0.0 575.5 0.4 0.5 0.0 0.0 ESYT2 "CHR2SYT, FAM62B, KIAA1228" ENSG00000117868 "Extended synaptotagmin 2" A0FGR8 7 158730995-158830253 "Plasma proteins, Predicted membrane proteins, Transporters" "Endocytosis, Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Microglial cells: 185.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002132, HPA070823" Approved Approved "Plasma membrane,Cytosol" NA NA 24000 "Cluster 48: NK-cells - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 18: U-2197 - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane, Cytosol" "HPA002132: AB_1078807, HPA070823: " "unprognostic (2.30e-1)" "unprognostic (1.06e-2)" "unprognostic (2.72e-2)" "unprognostic (2.84e-2)" "unprognostic (5.72e-2)" "unprognostic (5.43e-2)" "unprognostic (9.01e-2)" "unprognostic (9.94e-2)" "unprognostic (1.72e-1)" "unprognostic (8.71e-3)" "prognostic unfavorable (5.73e-4)" "unprognostic (2.13e-1)" "unprognostic (7.54e-2)" "unprognostic (6.70e-2)" "unprognostic (4.58e-2)" "unprognostic (3.70e-3)" "prognostic unfavorable (2.81e-5)" 53.9 37.0 24.0 25.6 25.0 34.8 33.9 21.8 28.7 30.8 22.7 38.4 22.3 36.1 30.1 45.0 34.4 32.2 35.1 27.7 25.3 27.2 24.5 33.4 27.5 22.1 24.6 48.1 29.2 30.9 20.6 43.3 24.6 25.3 30.3 14.2 32.1 30.5 44.9 31.0 27.6 38.7 21.7 21.4 25.5 15.8 30.7 37.0 39.3 41.8 25.4 35.8 29.3 19.4 92.9 57.8 19.5 19.8 62.2 72.6 55.3 47.5 48.9 36.7 40.6 29.7 106.1 27.5 52.2 86.2 66.6 46.0 27.8 50.2 35.1 31.5 28.3 26.2 44.0 32.2 64.1 95.0 55.8 53.4 51.8 41.8 55.2 73.1 44.8 81.9 56.4 97.8 61.9 71.7 96.0 66.7 29.2 53.9 56.7 82.4 37.0 38.8 58.6 38.4 46.8 30.2 151.6 109.7 66.7 43.4 37.7 96.3 69.3 40.3 18.8 178.7 60.5 68.6 17.3 27.5 102.4 93.8 121.5 1.7 1.4 1.2 6.1 1.8 3.4 1.1 5.1 4.3 2.8 0.6 4.6 5.5 0.9 5.4 1.2 1.8 4.2 2.3 24.0 25.0 21.8 28.7 27.7 25.3 22.1 24.6 24.6 21.7 30.7 19.4 65.7 38.5 32.4 55.5 18.1 46.1 12.9 22.6 19.4 15.0 32.6 21.6 30.8 21.5 33.7 47.8 16.7 31.6 54.0 41.0 3.9 15.3 18.0 60.6 17.8 48.5 21.1 17.7 137.1 20.0 26.1 44.2 15.8 47.0 12.6 36.8 23.2 20.9 20.2 13.5 119.3 31.2 24.4 20.2 83.6 5.3 35.1 27.7 51.6 185.5 21.9 12.1 43.3 67.3 61.4 29.9 14.1 54.5 36.2 23.2 28.0 8.7 61.8 10.8 32.9 42.6 60.4 10.6 10.2 22.0 51.7 40.8 43.4 19.5 26.0 25.8 ETAA1 ETAA16 ENSG00000143971 "ETAA1 activator of ATR kinase" Q9NY74 2 67397322-67412089 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035048, HPA035049" Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 51: Non-specific - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "HPA035048: AB_10670300, HPA035049: AB_2674430" "unprognostic (1.23e-1)" "unprognostic (2.56e-1)" "unprognostic (5.79e-2)" "unprognostic (2.10e-1)" "unprognostic (1.30e-1)" "unprognostic (3.39e-2)" "unprognostic (6.47e-2)" "unprognostic (5.53e-2)" "unprognostic (1.12e-2)" "unprognostic (8.33e-2)" "unprognostic (9.89e-2)" "unprognostic (1.87e-1)" "unprognostic (8.52e-3)" "unprognostic (9.85e-2)" "unprognostic (7.88e-2)" "unprognostic (5.01e-2)" "unprognostic (1.14e-2)" 4.7 11.1 2.7 4.3 3.1 3.9 7.1 4.0 3.3 6.7 3.9 5.0 3.6 6.9 6.2 5.9 6.6 4.3 3.9 2.4 2.7 6.1 5.3 5.4 6.5 2.9 2.8 7.3 8.2 6.1 3.3 4.2 2.9 5.0 4.4 5.7 6.2 3.9 3.5 6.2 5.5 5.1 2.7 5.5 5.2 4.6 2.8 6.3 6.3 3.1 5.0 5.1 6.6 3.5 7.9 5.9 10.2 9.0 7.6 10.4 8.0 8.2 10.8 8.7 8.3 4.8 9.3 14.8 4.4 6.8 12.1 9.5 8.9 10.0 12.3 8.6 6.8 8.1 14.7 7.1 7.2 8.3 7.4 8.3 13.8 6.4 9.7 13.7 13.8 11.8 6.8 6.1 12.0 3.5 12.3 9.0 10.3 12.7 6.3 8.6 16.0 6.8 10.5 5.1 8.5 16.7 8.4 7.6 8.0 9.9 6.6 4.0 9.6 11.6 8.9 5.6 9.8 6.8 6.5 11.6 10.9 8.6 9.0 1.3 1.1 0.9 2.2 1.8 2.4 3.5 2.0 1.3 1.4 3.6 2.7 2.4 0.1 2.0 2.6 2.0 3.2 1.3 2.7 3.1 4.0 3.3 2.4 2.7 2.9 2.8 2.9 2.7 2.8 3.5 7.7 22.4 21.0 10.4 7.6 2.4 7.9 8.3 6.8 5.1 8.8 8.4 10.1 15.7 9.1 12.9 0.0 6.6 9.1 3.5 11.7 17.8 0.6 15.0 15.0 7.8 10.7 13.7 6.3 18.4 6.3 10.9 6.6 11.1 6.3 15.4 10.4 8.9 4.8 5.0 6.6 7.1 2.0 5.1 1.5 1.9 12.2 4.8 1.8 2.8 9.4 6.5 15.5 15.1 13.6 20.4 4.7 13.2 7.0 8.0 5.9 15.0 16.6 4.6 0.0 8.9 7.3 12.7 8.2 7.9 2.6 2.1 7.2 14.1 7.0 6.1 ETS2 ENSG00000157557 "ETS proto-oncogene 2, transcription factor" P15036 21 38805183-38824955 "Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 701.0;Basal squamous epithelial cells: 863.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 33.6;granulocytes: 37.0;monocytes: 32.4" "Cell line enhanced" "Detected in many" "HEL: 309.0;hTCEpi: 269.6;hTERT-HME1: 210.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003176 Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 36: HEL - Hemostasis" "Cluster 41: Macrophages - Immune response" Nucleoplasm "Plasma membrane, Cytosol" "HPA003176: AB_2666824" "unprognostic (2.06e-1)" "unprognostic (5.91e-2)" "unprognostic (9.16e-3)" "unprognostic (5.33e-3)" "unprognostic (1.38e-1)" "unprognostic (1.58e-1)" "unprognostic (1.88e-3)" "unprognostic (7.36e-2)" "unprognostic (8.99e-3)" "unprognostic (3.66e-2)" "unprognostic (1.02e-1)" "unprognostic (1.77e-1)" "unprognostic (1.95e-2)" "unprognostic (2.12e-1)" "unprognostic (1.89e-1)" "unprognostic (8.10e-2)" "unprognostic (7.10e-2)" 109.9 29.7 51.4 95.5 43.3 167.1 87.7 31.6 72.5 89.6 61.4 119.3 131.3 77.5 27.9 90.6 72.5 132.1 68.0 50.9 43.2 66.1 230.7 185.5 38.0 50.0 39.9 65.7 37.5 61.9 56.6 73.6 45.0 80.1 146.5 7.5 50.3 45.7 149.7 248.3 179.7 78.0 47.9 201.0 72.7 7.6 54.0 43.7 62.5 42.8 34.8 210.2 103.6 44.4 120.1 26.2 16.6 5.6 18.8 61.3 49.2 27.4 154.1 36.2 46.5 23.0 35.1 24.7 13.3 25.0 48.5 35.7 28.0 71.2 63.8 24.5 12.0 309.0 152.6 62.2 196.9 18.4 28.2 39.8 269.6 49.6 210.2 22.0 28.3 17.2 31.3 0.2 14.4 20.1 54.1 22.2 56.0 39.3 18.2 189.6 10.2 25.2 50.2 74.4 14.2 18.4 78.4 32.8 6.2 5.7 1.9 36.3 30.8 83.0 13.0 55.3 60.5 0.5 0.3 25.2 20.7 69.4 70.8 21.0 19.5 7.0 3.2 24.9 3.9 0.4 3.0 4.7 33.6 0.4 3.2 3.2 37.0 0.3 32.4 8.1 0.3 8.9 51.4 43.3 31.6 72.5 50.9 43.2 50.0 39.9 45.0 47.9 54.0 44.4 253.0 51.3 156.6 6.2 10.8 427.4 701.0 150.8 863.4 2.1 84.2 69.7 25.6 51.5 141.9 51.5 0.0 58.4 17.5 150.7 11.7 73.7 4.0 241.1 127.4 312.7 91.8 36.4 39.6 108.5 109.3 98.7 161.1 497.9 51.3 0.9 242.0 262.4 62.1 0.0 10.7 266.0 79.3 150.8 291.7 2.0 18.0 253.4 67.6 74.0 41.0 1.5 3.1 4.0 3.1 127.6 175.1 24.8 21.0 184.0 162.2 47.2 107.9 1.6 52.6 81.8 108.8 0.6 3.3 522.6 486.4 177.6 28.8 8.2 243.3 338.7 EVC2 LBN ENSG00000173040 "EvC ciliary complex subunit 2" Q86UK5 4 5542772-5709548 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Ciliopathy, Disease variant, Dwarfism, Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 17.6;Basal squamous epithelial cells: 12.0;Fibroblasts: 8.9;Leydig cells: 11.5;Skeletal myocytes: 14.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 9.7;HHSteC: 13.0;hTERT-HME1: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040910, HPA048122" Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Yes NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 50: Fibroblasts - ECM organization" "Microtubules, Cytokinetic bridge" "Nucleoplasm, Cytosol" "HPA040910: AB_2677195, HPA048122: AB_2680272" "unprognostic (6.56e-2)" "unprognostic (6.74e-2)" "unprognostic (5.10e-2)" "unprognostic (2.25e-1)" "unprognostic (8.23e-3)" "unprognostic (2.80e-1)" "unprognostic (2.05e-2)" "unprognostic (1.22e-2)" "unprognostic (1.71e-1)" "unprognostic (1.28e-1)" "unprognostic (8.57e-2)" "unprognostic (9.37e-2)" "prognostic favorable (1.58e-4)" "unprognostic (2.51e-2)" "unprognostic (3.14e-1)" "unprognostic (5.61e-2)" "unprognostic (6.29e-5)" 4.8 0.7 1.3 1.5 1.4 0.1 3.6 1.2 1.1 6.0 2.3 3.7 0.6 4.7 1.7 2.2 4.7 2.7 3.1 1.3 1.4 2.6 0.7 2.1 1.9 1.6 1.5 7.8 1.7 3.1 1.1 1.3 1.2 3.2 0.6 0.3 2.8 2.0 1.1 3.8 2.0 2.3 1.4 1.0 2.1 1.6 1.5 1.0 3.8 1.9 1.7 4.1 4.4 1.3 0.0 2.7 0.0 6.6 8.4 9.3 0.0 4.1 9.7 3.6 6.0 0.0 0.0 5.2 0.0 3.3 2.0 2.8 0.0 1.7 3.4 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 5.9 4.6 4.6 10.6 0.0 3.9 0.0 0.0 0.2 5.3 0.0 0.0 0.0 3.9 0.0 0.0 8.6 8.2 0.0 0.4 0.0 0.4 0.6 0.0 0.0 0.0 1.6 0.0 0.5 6.7 0.0 0.0 2.4 0.0 4.1 4.7 1.2 2.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 1.4 1.2 1.1 1.3 1.4 1.6 1.5 1.2 1.4 1.5 1.3 0.6 0.0 0.5 17.6 0.8 2.2 4.9 2.3 12.0 0.0 0.9 2.2 1.0 1.5 1.3 0.0 0.0 8.3 1.7 0.0 0.0 1.9 2.2 0.7 5.6 1.2 0.0 0.4 0.3 0.5 0.3 8.9 0.5 1.7 2.5 4.7 1.4 0.1 0.5 0.0 0.3 0.0 0.0 0.3 1.2 0.9 11.5 0.8 0.0 6.5 0.0 1.9 1.0 1.0 0.3 0.6 0.0 7.9 1.7 2.8 0.0 0.9 1.0 0.1 0.0 14.7 3.2 1.8 2.1 4.4 0.9 1.4 2.8 3.4 0.0 1.4 EXOC4 "KIAA1699, MGC27170, SEC8, SEC8L1, Sec8p" ENSG00000131558 "Exocyst complex component 4" Q96A65 7 133253073-134066589 "Plasma proteins, Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 238.6;Excitatory neurons: 334.2;Inhibitory neurons: 306.8;Microglial cells: 341.0;Oligodendrocyte precursor cells: 395.6;Oligodendrocytes: 345.9;Rod photoreceptor cells: 231.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031443, HPA031444" Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA 10000 "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 46: Photoreceptor cells - Phototransduction" "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "HPA031443: AB_10602496, HPA031444: AB_2673886" "unprognostic (1.70e-1)" "unprognostic (1.62e-2)" "unprognostic (2.05e-1)" "unprognostic (5.09e-2)" "unprognostic (1.03e-1)" "unprognostic (4.06e-3)" "unprognostic (8.63e-2)" "unprognostic (2.33e-1)" "unprognostic (4.40e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (6.19e-4)" "unprognostic (9.78e-3)" "prognostic favorable (6.85e-5)" "unprognostic (5.91e-2)" "unprognostic (2.18e-1)" "unprognostic (3.37e-1)" "unprognostic (3.35e-2)" 20.7 21.1 18.7 13.8 20.2 13.8 21.4 19.3 20.3 22.6 24.3 19.7 13.1 21.5 13.6 24.4 27.3 17.8 15.3 20.9 19.4 17.7 17.8 17.7 16.4 18.4 20.3 30.6 27.3 27.3 16.9 19.6 19.9 18.3 21.5 53.1 16.3 20.5 68.4 25.4 13.5 23.9 18.8 21.0 17.3 18.7 19.1 28.1 26.4 38.5 20.3 21.1 18.6 20.8 40.1 32.2 43.3 43.3 49.7 51.6 15.0 28.6 47.2 25.4 33.2 18.8 54.7 29.8 20.1 54.1 36.9 24.7 23.7 38.8 41.8 45.6 28.2 24.0 31.5 19.9 54.7 32.0 25.1 50.4 47.6 36.3 66.5 55.7 43.5 38.6 35.1 28.8 47.7 26.1 58.5 35.2 32.8 47.5 29.8 25.7 38.7 54.2 40.7 35.2 33.9 53.2 43.0 39.1 46.3 48.9 25.8 29.3 47.9 28.1 14.6 30.0 31.5 45.0 29.4 28.1 82.9 36.4 43.8 10.3 12.0 7.2 11.2 12.9 10.0 8.3 11.6 11.9 16.3 8.1 9.4 9.6 4.0 19.6 11.4 7.2 12.9 11.2 18.7 20.2 19.3 20.3 20.9 19.4 18.4 20.3 19.9 18.8 19.1 20.8 22.9 22.4 22.3 238.6 27.3 18.9 16.3 16.6 25.6 39.9 16.8 15.4 30.9 11.5 18.0 14.7 93.8 17.5 26.7 21.5 3.9 15.0 29.6 27.0 21.2 23.0 17.4 18.7 334.2 18.2 16.6 21.2 34.1 21.0 8.2 32.4 23.2 15.9 18.1 50.5 306.8 21.0 26.4 27.3 14.5 27.6 17.4 20.4 14.2 341.0 23.9 20.4 23.7 395.6 345.9 15.4 17.4 18.8 27.7 13.2 16.3 16.9 29.8 231.5 13.1 26.0 15.3 20.5 13.1 28.2 17.0 11.2 26.2 26.4 21.9 20.1 FAAP100 "C17orf70, FLJ22175" ENSG00000185504 "FA core complex associated protein 100" Q0VG06 17 81539885-81553961 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023954, HPA024626, HPA026532" Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 59: Non-specific - Transcription" Nucleoplasm Cytosol "HPA023954: AB_1845601, HPA024626: AB_1845602, HPA026532: AB_1845603" "unprognostic (5.25e-2)" "unprognostic (5.40e-2)" "unprognostic (1.31e-1)" "unprognostic (2.03e-2)" "unprognostic (2.91e-1)" "unprognostic (1.85e-2)" "unprognostic (4.87e-3)" "unprognostic (1.30e-1)" "unprognostic (1.16e-1)" "unprognostic (3.49e-2)" "unprognostic (1.05e-3)" "unprognostic (6.91e-2)" "prognostic unfavorable (1.00e-7)" "unprognostic (1.14e-1)" "unprognostic (1.45e-1)" "unprognostic (9.85e-2)" "unprognostic (4.24e-1)" 14.7 16.8 6.7 13.8 7.0 10.1 15.9 14.7 9.5 18.6 6.8 15.8 12.0 17.3 3.1 16.2 18.8 9.5 16.3 6.7 6.4 21.2 22.7 16.0 15.9 8.1 6.5 19.5 26.6 7.8 22.4 7.2 6.3 20.7 4.9 3.7 14.6 7.8 13.2 16.1 18.8 6.9 5.1 38.1 15.5 13.3 7.3 8.8 24.1 6.0 7.3 17.9 15.5 8.8 11.7 21.3 9.4 26.8 11.0 11.5 14.6 11.2 5.9 14.3 8.9 14.5 14.0 21.0 8.6 15.5 13.8 15.0 4.9 14.5 3.3 6.1 13.9 13.5 23.3 20.0 11.6 15.4 16.0 14.0 10.7 10.4 11.7 17.6 27.0 22.0 20.7 16.5 7.0 23.0 24.4 25.8 11.3 13.6 7.7 22.1 9.4 19.3 10.4 21.1 20.5 17.1 8.5 24.4 10.4 9.7 26.2 20.7 22.8 30.6 18.8 8.3 18.9 18.3 1.5 10.7 8.0 9.9 14.3 0.0 3.0 1.2 2.4 2.8 1.9 3.0 1.6 1.6 2.9 2.0 1.5 1.2 0.4 2.4 1.4 3.2 1.6 2.2 6.7 7.0 14.7 9.5 6.7 6.4 8.1 6.5 6.3 5.1 7.3 8.8 11.4 3.2 7.5 0.0 7.5 0.0 3.5 0.0 4.6 10.3 9.8 10.9 8.9 10.0 2.5 14.7 4.2 6.1 8.5 7.1 3.9 8.2 1.9 4.5 7.3 7.5 7.3 11.8 0.0 6.9 4.8 8.3 15.8 6.8 0.0 14.9 6.8 11.7 8.4 6.7 0.0 6.2 0.0 14.1 0.0 3.0 5.0 7.0 0.0 0.0 8.9 6.2 4.1 0.0 0.0 8.9 4.4 5.3 6.6 5.3 12.7 6.8 1.5 4.9 0.0 7.4 6.4 7.3 7.5 9.5 0.0 3.1 6.2 10.7 7.3 3.6 FAM169A "KIAA0888, SLAP75" ENSG00000198780 "Family with sequence similarity 169 member A" Q9Y6X4 5 74777574-74866966 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.2;retina: 71.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 138.0;Cone photoreceptor cells: 141.8;Excitatory neurons: 103.4;Horizontal cells: 85.8;Inhibitory neurons: 101.3;Muller glia cells: 191.3;Rod photoreceptor cells: 179.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 31.9;Hep G2: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041574 Enhanced Supported "Nuclear membrane,Cytosol" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 77: Retina - Visual perception" "Cluster 28: BEWO - Transcription regulation" "Cluster 5: Muller glia cells - Visual perception" "Nuclear membrane, Cytosol" "HPA041574: AB_10794382" "unprognostic (3.39e-1)" "unprognostic (2.25e-2)" "unprognostic (1.75e-4)" "unprognostic (5.87e-2)" "unprognostic (2.28e-2)" "unprognostic (1.46e-3)" "unprognostic (1.53e-1)" "unprognostic (7.11e-2)" "unprognostic (6.48e-2)" "unprognostic (5.11e-2)" "unprognostic (2.72e-2)" "unprognostic (8.02e-2)" "unprognostic (3.51e-3)" "unprognostic (4.57e-1)" "unprognostic (4.72e-2)" "unprognostic (1.12e-1)" "unprognostic (3.93e-2)" 0.1 2.8 13.2 0.7 14.7 1.1 0.5 4.4 12.9 1.0 0.0 1.3 0.3 2.4 18.0 0.3 2.6 2.1 1.3 9.4 27.2 4.7 2.2 0.3 1.5 14.1 10.6 2.1 1.3 5.1 2.1 0.7 9.6 4.5 2.0 71.4 1.4 4.6 0.1 0.2 0.3 0.3 17.0 1.7 1.4 12.4 17.0 5.1 7.1 0.1 1.6 3.1 0.2 17.1 8.0 7.2 4.8 6.7 0.0 0.0 31.9 1.3 2.5 5.1 5.1 3.0 5.2 0.0 3.4 0.1 13.9 5.4 10.2 15.3 5.5 5.7 11.9 2.2 1.3 23.4 0.2 0.0 0.1 0.1 16.2 1.3 7.2 0.8 0.0 7.3 0.0 0.1 3.0 2.2 7.4 0.1 12.8 1.8 4.1 10.9 3.2 0.5 4.8 12.8 2.8 3.8 12.9 5.5 1.0 21.5 5.6 1.4 0.0 0.3 4.8 0.0 5.5 17.7 18.5 0.0 0.6 0.0 0.6 0.0 0.0 0.0 1.0 0.0 1.4 0.2 0.6 0.9 0.0 0.4 1.2 1.3 0.0 0.3 0.0 0.2 0.3 0.6 13.2 14.7 4.4 12.9 9.4 27.2 14.1 10.6 9.6 17.0 17.0 17.1 0.3 0.0 0.0 32.0 5.7 0.3 6.5 2.8 1.2 138.0 1.2 1.5 1.6 1.5 3.5 49.7 141.8 5.4 14.2 1.6 3.9 1.9 15.5 8.5 1.9 2.6 3.5 1.3 103.4 0.0 0.5 1.5 6.6 10.9 1.3 24.7 0.0 4.1 0.5 85.8 101.3 1.3 2.0 1.9 0.0 29.0 5.0 0.7 1.8 14.0 0.9 191.3 11.3 67.3 58.2 2.9 0.5 4.1 4.8 8.1 2.2 2.8 2.8 179.7 0.0 0.3 1.5 25.2 13.4 1.4 0.1 0.3 7.8 5.7 1.4 4.4 FAM47E-STBD1 ENSG00000272414 "FAM47E-STBD1 readthrough" 4 76251721-76311129 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 41.5;skeletal muscle: 55.9" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 6.4;Alveolar cells type 2: 1.7;Astrocytes: 2.0;Excitatory neurons: 5.1;Inhibitory neurons: 2.8;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 3.4;Respiratory ciliated cells: 3.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.3;OE19: 2.7" HPA053331 Approved Uncertain "Plasma membrane,Cytosol" NA NA "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 21: OE19 - Mitochondria" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane, Cytosol" "HPA053331: AB_2682115" "unprognostic (3.52e-3)" "unprognostic (3.44e-1)" "unprognostic (1.53e-1)" "unprognostic (8.98e-2)" "unprognostic (5.45e-2)" "unprognostic (2.66e-1)" "unprognostic (1.99e-1)" "unprognostic (2.51e-2)" "unprognostic (1.91e-1)" "unprognostic (6.92e-6)" "unprognostic (5.59e-2)" "unprognostic (1.52e-1)" "unprognostic (3.77e-1)" 12.5 1.3 1.5 0.4 1.6 1.0 9.3 1.1 2.5 2.0 1.1 9.0 0.1 2.4 1.3 1.6 2.1 0.6 21.2 1.4 2.0 2.4 41.5 8.3 0.4 1.9 1.5 0.9 2.3 0.5 0.7 0.6 1.7 4.3 0.4 1.8 2.3 0.5 55.9 0.9 12.4 0.7 1.6 0.9 2.9 2.3 1.9 0.1 1.3 0.5 0.1 6.7 2.0 2.0 0.1 0.0 0.1 0.1 0.4 0.1 0.2 0.0 0.2 0.0 0.0 1.3 0.0 0.1 0.2 0.0 0.6 0.1 0.0 0.0 0.3 0.1 0.0 0.3 0.1 0.0 0.0 0.4 0.9 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.1 0.4 0.0 0.1 0.1 2.7 0.4 0.0 0.0 0.4 0.0 0.6 0.7 0.5 0.1 0.1 0.0 0.2 0.0 0.3 0.3 0.1 0.3 0.1 0.2 0.4 0.3 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.0 1.5 1.6 1.1 2.5 1.4 2.0 1.9 1.5 1.7 1.6 1.9 2.0 0.0 6.4 1.7 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM71F1 "FAM137A, NYD-SP18" ENSG00000135248 "Family with sequence similarity 71 member F1" Q96KD3 7 128709061-128731743 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 88 "testis: 93.9" "Group enriched" "Detected in some" 93 "Early spermatids: 1122.8;Late spermatids: 2008.1" "Cancer enriched" "Detected in single" 23 "testis cancer: 4.0" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "NTERA-2: 16.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA020636 Uncertain Cytosol No NA "Cluster 74: Testis - Spermatogenesis" "Cluster 5: NTERA-2 - Transcription" "Cluster 34: Spermatids - Unknown function" Cytosol "HPA020636: AB_1854739" "unprognostic (3.09e-2)" "unprognostic (3.39e-3)" "unprognostic (6.03e-2)" "unprognostic (5.25e-1)" "unprognostic (2.97e-1)" "unprognostic (1.20e-1)" "unprognostic (4.67e-2)" "unprognostic (2.17e-1)" "unprognostic (1.95e-2)" "unprognostic (1.00e-5)" "unprognostic (1.48e-1)" "unprognostic (2.18e-6)" "unprognostic (6.97e-2)" "unprognostic (2.09e-1)" "unprognostic (2.19e-3)" "unprognostic (1.99e-1)" 0.0 0.0 0.8 0.0 0.7 0.0 0.1 0.4 0.9 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.6 0.4 0.0 0.1 0.0 0.6 1.0 0.0 0.1 0.0 0.5 0.0 0.8 0.2 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 93.9 1.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.2 1.4 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.4 0.9 0.7 0.6 0.6 1.0 0.8 0.5 1.0 0.6 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.1 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 1122.8 0.2 0.1 0.6 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.0 0.0 2008.1 12.8 0.7 0.0 0.0 0.0 0.3 0.0 0.5 0.4 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.8 0.1 16.7 6.8 0.0 0.1 1.2 0.0 0.5 0.0 0.0 FAN1 "KIAA1018, MTMR15" ENSG00000198690 "FANCD2 and FANCI associated nuclease 1" Q9Y2M0 15 30890559-30943108 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048198 Supported "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes NA "Cluster 14: Monocytes - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA048198: AB_2680311" "unprognostic (7.18e-3)" "unprognostic (5.63e-2)" "unprognostic (1.96e-1)" "unprognostic (3.30e-2)" "unprognostic (6.99e-2)" "unprognostic (2.86e-1)" "unprognostic (1.97e-1)" "unprognostic (1.19e-1)" "unprognostic (5.94e-2)" "unprognostic (3.53e-2)" "unprognostic (3.53e-2)" "unprognostic (9.67e-2)" "prognostic favorable (1.42e-6)" "unprognostic (3.73e-1)" "unprognostic (1.19e-1)" "unprognostic (8.93e-3)" "unprognostic (1.29e-1)" 6.2 8.5 9.3 0.9 9.5 0.5 6.7 9.4 9.7 10.1 9.3 10.7 0.9 9.2 6.6 6.5 9.0 1.2 8.8 8.9 9.5 9.5 9.6 5.5 0.8 9.7 9.8 11.8 12.7 5.9 11.4 3.0 10.0 11.5 2.0 2.7 9.8 1.4 18.7 10.8 7.3 2.4 9.5 6.8 8.6 8.9 9.9 4.4 10.0 7.3 0.7 9.3 9.7 10.0 5.2 9.9 3.6 1.9 12.4 9.3 0.8 4.4 2.1 4.7 5.0 4.5 1.7 0.6 7.6 3.6 7.4 9.2 4.7 9.4 5.0 4.2 1.4 1.3 5.5 1.9 4.8 1.2 1.9 2.8 7.3 3.0 7.3 7.2 3.4 5.7 4.7 6.1 4.7 0.6 8.6 3.1 2.2 11.5 2.8 7.0 12.0 2.3 6.7 2.3 4.5 4.6 9.2 5.6 3.0 8.8 4.4 3.3 3.3 9.4 3.0 5.0 3.4 7.4 8.7 1.1 4.1 1.9 1.1 0.0 0.1 0.0 1.4 0.3 2.0 1.2 1.2 0.7 0.9 1.5 1.8 1.1 0.0 1.8 4.3 1.1 1.4 0.7 9.3 9.5 9.4 9.7 8.9 9.5 9.7 9.8 10.0 9.5 9.9 10.0 9.1 16.0 8.4 21.2 5.4 4.1 5.8 4.9 9.6 17.0 11.2 9.8 17.0 0.0 10.7 9.2 20.9 6.5 3.5 7.6 9.8 4.5 11.9 10.2 12.9 8.8 7.8 6.9 23.7 2.9 2.2 8.4 8.6 9.0 8.8 15.5 6.8 13.4 3.7 26.9 25.5 11.0 8.2 5.4 2.5 7.1 10.5 3.9 5.4 15.0 3.4 14.9 7.2 13.6 44.2 3.6 6.4 6.8 7.0 6.0 4.2 8.0 13.6 23.5 6.6 9.4 7.6 20.9 16.4 7.2 2.4 4.1 5.3 9.2 10.3 3.7 FANCD2 "FA-D2, FACD, FAD, FANCD" ENSG00000144554 "FA complementation group D2" Q9BXW9 3 10026414-10101932 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Cancer-related genes, Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.8" "Cell type enhanced" "Detected in many" "Erythroid cells: 25.2;Spermatocytes: 62.5;Spermatogonia: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 120.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB016117, HPA063742" Approved Supported "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" No No "Cluster 46: Basophils - DNA binding" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 28: BEWO - Transcription regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nucleoli, Nuclear bodies, Cytosol" "CAB016117: AB_2278211, HPA063742: AB_2685110" "unprognostic (3.25e-2)" "unprognostic (1.09e-1)" "unprognostic (6.21e-2)" "unprognostic (1.12e-2)" "unprognostic (2.92e-1)" "unprognostic (3.36e-2)" "unprognostic (1.08e-5)" "unprognostic (2.96e-2)" "unprognostic (1.59e-3)" "prognostic unfavorable (5.00e-5)" "unprognostic (1.23e-2)" "unprognostic (9.14e-2)" "unprognostic (4.41e-10)" "unprognostic (9.11e-3)" "unprognostic (3.99e-1)" "unprognostic (7.76e-2)" "unprognostic (2.89e-2)" 1.1 0.7 2.7 7.7 2.1 17.8 3.4 1.6 5.3 1.5 1.1 4.0 3.2 2.0 0.7 2.5 2.6 2.0 0.5 3.4 1.6 0.9 1.1 1.9 12.2 3.9 1.4 3.6 0.8 0.8 0.5 4.7 3.0 1.9 6.4 3.1 4.9 1.0 4.8 4.5 4.0 2.0 2.4 6.4 3.5 11.8 2.3 9.8 1.9 0.4 13.0 2.3 1.3 5.1 24.1 25.4 46.5 13.2 2.4 3.5 120.7 22.0 9.8 31.3 25.4 18.8 23.0 46.7 9.8 7.0 25.1 20.2 48.8 16.7 31.0 22.6 33.0 63.6 39.6 17.9 0.4 48.1 37.9 1.2 2.6 34.1 18.4 4.2 18.4 39.3 39.6 51.6 23.1 27.2 40.6 17.9 56.1 18.1 17.6 43.4 37.7 32.5 10.3 26.7 13.0 25.3 26.4 20.1 8.3 33.5 31.0 29.4 10.6 24.6 28.4 15.1 31.5 21.7 46.4 77.2 14.1 47.7 43.2 2.7 0.6 1.9 0.6 0.5 0.6 2.4 0.9 0.5 0.4 3.2 1.1 0.9 1.5 1.0 1.4 1.8 1.5 0.5 2.7 2.1 1.6 5.3 3.4 1.6 3.9 1.4 3.0 2.4 2.3 5.1 0.7 0.0 0.5 0.7 12.5 4.6 3.5 2.9 2.8 3.1 4.5 2.7 2.0 1.5 1.9 1.8 10.4 12.7 5.6 3.1 0.0 1.9 5.9 2.6 1.5 2.1 1.2 25.2 3.0 3.5 15.2 2.6 2.0 3.4 1.3 11.8 3.3 1.5 5.7 0.0 2.6 3.2 6.1 3.8 7.0 8.0 2.1 3.7 3.6 1.9 4.9 0.6 1.0 1.5 2.4 1.8 3.6 1.5 8.1 2.2 0.5 0.7 2.0 5.6 19.7 2.6 2.1 62.5 30.2 4.1 2.7 7.0 5.2 1.6 7.6 3.1 FBXL22 "Fbl22, FLJ39626" ENSG00000197361 "F-box and leucine rich repeat protein 22" Q6P050 15 63597353-63602428 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 60.4;intestine: 60.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "MCF7: 4.9;SCLC-21H: 5.3;U-937: 3.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA047624, HPA054627" Uncertain Uncertain Nucleoli,Cytosol NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoli, Cytosol" "HPA047624: AB_2680107, HPA054627: AB_2682548" "unprognostic (2.17e-1)" "unprognostic (3.19e-2)" "unprognostic (2.99e-3)" "unprognostic (5.28e-2)" "unprognostic (3.03e-2)" "unprognostic (1.29e-2)" "unprognostic (1.15e-1)" "unprognostic (6.51e-2)" "unprognostic (2.53e-1)" "unprognostic (1.65e-1)" "unprognostic (2.82e-2)" "unprognostic (1.34e-1)" "unprognostic (1.07e-3)" "unprognostic (1.90e-2)" "unprognostic (1.99e-1)" "unprognostic (1.01e-2)" "unprognostic (1.02e-2)" 3.6 0.9 1.9 2.8 1.7 0.3 1.8 2.7 2.0 15.7 0.2 60.1 2.9 60.4 3.6 7.0 21.2 8.8 17.2 1.6 1.3 1.0 0.5 1.1 0.9 0.8 1.1 4.5 0.7 0.6 0.7 0.9 0.9 16.9 4.8 0.6 3.2 29.4 4.9 1.4 7.3 28.9 0.5 0.6 11.1 3.0 1.8 0.4 1.5 1.8 0.2 26.3 10.1 1.0 0.7 1.2 0.2 0.8 0.5 0.5 0.1 0.2 0.0 0.3 0.0 0.8 0.9 0.3 0.7 0.2 0.4 0.8 0.6 0.4 0.0 0.8 0.6 0.3 1.1 2.2 0.1 0.4 0.1 0.2 0.2 0.1 0.5 0.1 0.2 2.2 0.0 1.1 0.0 4.9 0.7 0.7 1.7 0.8 0.4 0.7 0.0 2.4 0.3 0.3 5.3 0.2 0.6 1.0 0.3 0.0 1.9 0.6 0.8 0.3 1.0 0.5 0.2 0.7 1.5 0.8 0.5 3.7 0.8 0.2 0.0 0.0 0.5 0.0 0.5 0.6 0.6 0.6 0.0 0.4 1.0 0.4 0.1 0.7 0.0 1.6 0.0 0.2 1.9 1.7 2.7 2.0 1.6 1.3 0.8 1.1 0.9 0.5 1.8 1.0 1.4 0.0 0.0 1.0 3.4 0.1 1.8 0.4 0.6 10.1 4.7 8.6 7.7 2.8 0.7 7.3 4.2 0.7 2.7 2.3 9.8 1.2 0.9 3.2 5.8 1.3 4.9 2.5 1.5 1.1 1.2 3.4 7.7 5.8 0.0 0.9 3.9 4.0 0.7 0.0 1.8 6.1 0.0 1.6 0.4 0.5 0.3 1.7 0.0 0.0 0.7 10.6 2.1 1.5 0.5 0.8 3.0 11.3 9.1 1.7 1.9 4.0 0.1 3.8 0.0 6.2 8.1 3.8 3.2 4.4 0.9 0.5 4.4 2.7 4.0 0.8 FDXACB1 "hCG_2033039, LOC91893" ENSG00000255561 "Ferredoxin-fold anticodon binding domain containing 1" Q9BRP7 11 111874056-111881243 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 37.1;Late spermatids: 14.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039012, HPA061375" Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoplasm, Cytosol" "HPA039012: AB_10670916, HPA061375: " "unprognostic (2.91e-2)" "unprognostic (3.32e-3)" "unprognostic (1.32e-2)" "unprognostic (6.81e-7)" "unprognostic (1.32e-1)" "unprognostic (9.64e-2)" "unprognostic (2.05e-1)" "unprognostic (7.11e-3)" "unprognostic (3.95e-2)" "unprognostic (7.42e-2)" "unprognostic (3.67e-1)" "unprognostic (1.04e-1)" "unprognostic (1.09e-2)" "unprognostic (6.57e-2)" "unprognostic (4.42e-1)" "unprognostic (4.61e-2)" "unprognostic (1.79e-2)" 1.1 1.9 0.9 1.9 1.0 2.0 2.1 0.8 1.2 1.7 0.7 1.4 1.6 1.4 2.4 1.1 1.5 1.0 0.9 1.0 1.2 1.5 1.6 1.7 3.1 1.0 1.0 1.5 1.5 1.6 0.9 1.2 0.9 1.2 1.7 0.7 0.8 0.9 0.7 2.7 1.5 1.1 1.0 2.4 1.0 3.1 1.2 1.7 1.3 0.8 3.2 1.6 0.8 1.1 1.4 1.9 2.1 5.3 2.0 1.8 1.2 1.1 1.2 1.2 1.2 2.4 3.1 5.5 2.7 1.0 1.5 4.3 2.6 2.5 2.7 6.9 1.1 6.1 1.1 1.8 1.2 6.4 5.3 1.5 1.5 1.7 2.2 1.0 2.2 6.5 4.4 6.4 2.3 1.8 6.0 6.2 1.4 6.0 2.7 3.6 1.6 6.5 2.8 2.5 1.0 1.6 1.5 3.2 1.4 1.2 4.5 3.9 1.7 2.5 2.7 3.0 2.6 3.6 5.5 14.1 1.6 9.1 3.7 0.3 2.3 1.5 5.0 3.7 6.5 4.6 4.4 4.4 3.8 3.8 6.5 7.5 0.7 4.8 3.0 3.6 2.5 3.7 0.9 1.0 0.8 1.2 1.0 1.2 1.0 1.0 0.9 1.0 1.2 1.1 2.2 6.4 0.6 0.7 3.1 0.8 1.3 4.2 1.2 3.0 1.6 1.4 1.6 0.0 3.0 0.0 0.0 3.4 1.3 1.2 5.9 2.5 37.1 1.5 1.2 1.8 2.4 0.8 1.0 3.3 1.9 1.3 1.1 0.9 1.3 2.2 2.2 1.8 4.0 1.7 1.3 1.4 4.1 1.3 1.2 14.2 3.1 2.0 0.0 1.9 2.2 3.2 4.1 1.0 1.2 2.1 0.5 0.4 1.6 1.9 0.9 2.3 1.6 2.5 6.6 1.1 1.2 7.5 9.1 1.0 1.3 2.2 2.6 3.8 1.6 0.8 FOXC1 "ARA, FKHL7, FREAC3, IGDA, IHG1, IRID1" ENSG00000054598 "Forkhead box C1" Q12948 6 1609915-1613897 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Angiogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Deafness, Disease variant, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "salivary gland: 154.4" "Cell type enhanced" "Detected in many" "Adipocytes: 93.7;Breast myoepithelial cells: 59.4;Endothelial cells: 64.7;Hepatic stellate cells: 65.7;Urothelial cells: 64.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 92.4;HEK 293: 91.8;RPTEC TERT1: 35.9" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 18.0" HPA040670 Supported Nucleoplasm,Cytosol NA NA "Cluster 24: Salivary gland - Salivary secretion" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm Cytosol "HPA040670: AB_10673412" "unprognostic (2.65e-2)" "unprognostic (1.15e-2)" "prognostic unfavorable (3.53e-4)" "unprognostic (3.22e-2)" "unprognostic (3.22e-2)" "unprognostic (1.24e-1)" "unprognostic (3.30e-2)" "unprognostic (1.54e-2)" "unprognostic (4.04e-3)" "unprognostic (1.58e-1)" "unprognostic (2.33e-3)" "unprognostic (9.55e-2)" "unprognostic (1.11e-2)" "unprognostic (6.48e-2)" "unprognostic (2.04e-1)" "unprognostic (3.83e-3)" "unprognostic (3.74e-1)" 12.3 6.0 7.7 1.2 8.3 0.6 9.0 7.1 9.3 6.3 11.0 1.7 0.9 3.7 1.7 4.8 5.0 7.5 14.0 6.0 6.5 19.9 1.2 3.3 1.7 9.0 7.4 4.7 3.6 1.6 9.5 4.1 8.7 8.6 0.9 0.3 154.4 6.4 2.4 11.1 1.6 2.3 7.1 0.4 1.7 2.0 9.2 8.3 5.6 2.9 2.2 9.4 5.6 7.1 18.0 2.0 0.6 92.4 4.2 4.6 2.9 8.9 10.3 5.4 4.3 6.7 3.7 0.0 10.0 5.2 3.9 19.9 8.8 6.5 4.5 5.7 91.8 3.7 5.3 3.3 2.8 1.4 6.0 15.6 8.7 7.3 8.3 2.8 7.9 0.6 2.7 0.1 2.3 3.8 0.0 2.0 0.3 8.9 7.6 0.0 3.7 0.5 35.9 13.3 3.4 8.0 10.9 0.1 6.4 4.5 2.6 1.5 2.0 11.5 7.1 5.9 9.6 0.4 0.8 0.0 3.2 4.5 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.7 8.3 7.1 9.3 6.0 6.5 9.0 7.4 8.7 7.1 9.2 7.1 93.7 0.0 0.6 0.0 0.4 17.7 31.9 26.3 13.6 0.0 42.2 59.4 7.1 0.0 23.6 11.0 0.0 5.3 1.9 0.9 1.9 3.9 0.6 8.6 1.1 64.7 0.0 0.0 0.0 17.1 0.6 21.2 1.5 3.8 0.0 0.7 65.7 0.4 1.3 0.0 0.0 1.5 8.2 1.3 5.5 1.4 16.1 2.7 1.8 23.4 0.0 0.3 0.0 0.5 0.1 16.2 0.1 28.2 0.1 9.5 0.0 7.4 34.9 0.0 0.0 19.2 40.4 0.7 3.1 11.2 6.5 0.8 1.1 4.4 0.6 64.9 FOXM1 "FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident" ENSG00000111206 "Forkhead box M1" Q08050 12 2857680-2877174 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 25.0;lymphoid tissue: 32.2;testis: 21.4" "Cell type enhanced" "Detected in many" "Early spermatids: 22.4;Erythroid cells: 18.7;Extravillous trophoblasts: 18.2;Late spermatids: 25.5;Plasma cells: 19.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" CAB017832 Uncertain Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA Yes "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Nucleoli, Nucleoli rim" Cytosol "CAB017832: " "unprognostic (3.18e-2)" "unprognostic (1.69e-1)" "unprognostic (1.22e-2)" "unprognostic (1.09e-2)" "unprognostic (4.30e-2)" "unprognostic (3.75e-2)" "prognostic unfavorable (1.95e-6)" "prognostic unfavorable (2.92e-4)" "unprognostic (1.01e-2)" "unprognostic (3.25e-2)" "prognostic unfavorable (3.03e-5)" "unprognostic (6.09e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.80e-2)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (1.94e-1)" 1.9 1.1 0.4 9.4 0.5 25.0 1.8 0.8 0.8 1.7 0.2 10.5 9.7 1.7 0.2 11.1 0.8 1.5 0.5 0.8 0.3 0.7 1.2 1.8 11.3 0.4 0.9 0.3 0.4 0.4 0.1 6.1 0.6 0.7 12.5 1.1 1.9 0.8 0.6 6.4 8.8 7.5 0.1 3.1 5.2 21.4 1.0 32.2 0.9 0.3 15.2 3.0 3.2 0.6 133.0 129.5 101.3 92.2 14.2 19.0 129.2 84.0 80.4 165.2 147.2 166.9 114.8 84.5 17.7 119.8 188.5 100.2 153.1 76.1 160.0 159.8 80.3 94.7 121.6 71.6 2.0 79.2 75.0 9.9 8.3 154.4 106.1 39.1 117.8 96.8 55.6 184.9 130.5 122.6 108.3 36.8 225.6 136.1 95.4 77.3 149.8 44.1 38.1 82.7 56.3 89.1 106.7 90.4 46.6 189.4 87.1 87.8 48.0 134.3 200.5 160.4 300.4 24.7 44.3 122.1 63.1 74.3 147.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.5 0.8 0.8 0.8 0.3 0.4 0.9 0.6 0.1 1.0 0.6 0.1 0.0 1.3 0.7 2.4 2.9 1.3 1.0 1.2 2.0 1.7 1.3 0.5 1.5 0.8 1.8 4.2 7.1 0.8 6.6 1.9 0.2 22.4 1.2 2.1 2.5 0.0 18.7 1.1 0.0 18.2 3.2 10.2 2.4 0.0 15.4 3.6 0.8 9.1 5.0 0.6 7.5 2.0 4.2 1.2 25.5 0.9 2.4 0.0 0.0 1.1 0.6 1.0 0.5 1.0 0.3 0.3 0.7 19.9 1.0 1.4 0.4 0.2 4.0 0.0 1.2 3.0 15.0 9.9 10.2 1.4 1.9 3.3 0.9 12.9 1.9 FUT2 "SE, Se2, SEC2, sej" ENSG00000176920 "Fucosyltransferase 2" Q10981 19 48695971-48705951 "Blood group antigen proteins, Enzymes, Metabolic proteins, Predicted membrane proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 44.5;salivary gland: 66.2;stomach 1: 28.9" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 56.4;Club cells: 69.4;Distal enterocytes: 110.0;Gastric mucus-secreting cells: 83.6;Ionocytes: 57.0;Paneth cells: 75.5;Proximal enterocytes: 182.4;Undifferentiated cells: 62.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 4 "cerebellum: 5.5" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "CAPAN-2: 63.6;OE19: 76.1" "Region enhanced" "Detected in some" "cerebellum: 2.3" "Low region specificity" "Detected in all" HPA014402 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Plasma membrane, Cytosol" "HPA014402: AB_1849194" "unprognostic (2.95e-2)" "unprognostic (6.07e-2)" "unprognostic (2.80e-3)" "unprognostic (4.63e-3)" "unprognostic (2.63e-1)" "prognostic favorable (5.83e-4)" "unprognostic (6.30e-3)" "unprognostic (6.55e-3)" "unprognostic (1.58e-1)" "unprognostic (8.44e-2)" "unprognostic (7.89e-2)" "unprognostic (5.11e-1)" "unprognostic (4.04e-2)" "unprognostic (6.52e-3)" "unprognostic (1.73e-1)" "unprognostic (3.12e-1)" "unprognostic (2.87e-1)" 0.2 0.6 0.8 6.2 0.9 0.3 1.7 5.5 1.2 16.0 0.0 23.5 44.5 1.1 0.1 26.0 2.6 13.5 0.5 0.9 0.0 1.0 0.3 0.9 0.5 0.2 0.1 1.1 5.2 0.1 2.0 0.1 0.3 1.4 19.8 0.9 66.2 2.9 0.7 4.8 21.9 0.8 0.0 0.6 28.9 0.8 0.4 0.6 0.7 0.0 6.6 6.3 9.7 0.6 2.0 1.5 0.3 0.9 0.0 0.0 0.2 0.2 0.0 0.0 0.0 7.2 63.6 0.7 0.5 0.0 0.3 10.6 0.0 0.0 0.0 0.5 0.5 0.6 0.6 0.3 0.0 0.1 0.6 0.0 0.1 0.0 0.0 1.0 0.0 1.2 0.1 0.8 0.1 0.5 0.7 1.5 0.4 76.1 0.3 0.5 0.2 3.0 0.0 0.6 3.4 0.5 0.3 0.6 0.1 0.4 9.5 0.1 0.3 0.4 0.4 0.5 0.2 0.7 0.5 0.1 0.3 0.4 0.2 1.1 0.1 0.1 0.4 0.1 0.2 0.3 0.5 0.2 0.1 0.3 0.4 0.1 0.5 0.2 0.1 0.4 0.6 0.2 0.8 0.9 5.5 1.2 0.9 0.0 0.2 0.1 0.3 0.0 0.4 0.6 0.5 0.0 0.6 0.7 0.6 0.9 2.3 56.4 5.7 2.5 6.1 3.0 0.8 32.9 69.4 20.2 2.1 0.1 0.4 110.0 1.9 4.7 0.5 8.4 2.7 0.7 11.4 0.0 2.3 46.5 0.0 0.5 83.6 23.9 0.0 0.1 0.0 0.1 0.1 0.0 1.4 42.1 57.0 0.3 0.3 0.2 0.0 0.3 1.8 0.0 0.3 0.5 2.1 0.5 1.2 31.8 75.5 0.0 0.2 2.9 182.4 0.1 37.8 4.2 0.0 1.2 2.4 0.3 0.2 9.9 1.4 0.1 0.8 0.3 62.9 19.4 FXYD4 CHIF ENSG00000150201 "FXYD domain containing ion transport regulator 4" P59646 10 43371636-43376335 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 43 "kidney: 297.7" "Cell type enriched" "Detected in some" 107 "Collecting duct cells: 5039.3" "Group enriched" "Detected in many" 5 "renal cancer: 10.7;urothelial cancer: 20.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 29 "SuSa: 10.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA058421 Enhanced Uncertain Cytosol NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 12: NES - Nervous system development" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol "HPA058421: AB_2683714" "unprognostic (2.92e-3)" "unprognostic (5.25e-1)" "unprognostic (9.46e-2)" "unprognostic (2.60e-2)" "unprognostic (2.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.32e-1)" "unprognostic (2.00e-1)" "unprognostic (5.17e-2)" "unprognostic (2.19e-1)" "unprognostic (6.12e-2)" "unprognostic (7.88e-2)" "unprognostic (1.26e-1)" "unprognostic (3.20e-1)" "unprognostic (2.09e-2)" 0.1 0.0 1.5 0.0 2.6 0.0 0.0 1.5 2.7 0.0 1.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.3 1.4 2.0 297.7 0.0 1.1 0.0 1.6 2.2 0.0 0.0 0.0 0.1 0.0 1.7 0.1 0.0 0.0 5.6 2.7 1.3 0.0 0.0 0.0 1.4 0.0 6.9 0.8 2.2 0.0 0.0 0.4 0.0 1.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.6 1.5 2.7 1.4 2.0 1.6 2.2 1.7 1.4 2.2 2.7 0.0 6.4 1.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.1 5039.3 0.0 0.5 0.0 0.5 46.9 0.0 2.6 6.4 2.6 0.0 0.0 0.0 0.0 0.2 0.1 0.4 9.2 15.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 11.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.2 0.1 0.1 8.0 0.0 0.0 0.0 0.0 0.1 1.4 0.1 0.0 0.0 0.4 0.3 0.1 1.0 1.4 GABARAPL2 "ATG8, ATG8C, GATE-16, GATE16, GEF2" ENSG00000034713 "GABA type A receptor associated protein like 2" P60520 16 75566375-75577881 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036726 Uncertain Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA036726: AB_10672476" "unprognostic (3.29e-2)" "unprognostic (3.16e-2)" "unprognostic (1.30e-2)" "unprognostic (7.00e-2)" "unprognostic (4.44e-2)" "prognostic unfavorable (7.63e-4)" "unprognostic (2.58e-1)" "unprognostic (6.85e-2)" "unprognostic (2.13e-1)" "unprognostic (4.95e-2)" "unprognostic (9.86e-3)" "unprognostic (1.33e-2)" "prognostic favorable (5.95e-8)" "unprognostic (3.11e-3)" "unprognostic (3.84e-3)" "unprognostic (1.37e-2)" "unprognostic (3.85e-1)" 129.2 166.9 269.1 68.0 278.1 101.6 122.3 297.7 310.8 105.9 237.2 118.5 67.1 101.3 158.1 91.9 106.0 84.1 279.9 259.7 294.9 153.8 113.6 111.3 94.7 280.8 278.4 108.7 81.4 209.5 169.0 113.8 289.2 113.7 81.4 201.4 100.8 102.2 262.9 135.0 90.1 98.6 306.0 112.0 99.7 78.3 282.4 102.1 124.5 186.7 98.9 95.3 104.8 320.2 103.4 85.9 142.7 67.7 217.1 189.9 72.6 118.2 169.9 158.0 176.4 79.8 129.1 148.1 143.0 135.3 95.2 86.6 107.6 110.6 193.9 64.8 208.7 86.9 72.2 119.1 118.2 84.1 151.3 132.0 153.5 133.3 98.6 143.0 130.5 130.5 130.3 58.4 160.2 145.7 125.4 161.0 85.8 114.5 95.8 139.4 69.0 179.6 166.2 66.4 167.7 175.5 184.7 43.7 177.4 113.3 140.1 130.4 119.5 67.9 104.7 100.0 64.5 166.2 172.8 310.6 163.6 80.6 102.6 345.1 148.8 370.8 128.4 140.3 163.0 215.0 135.2 146.8 176.8 199.0 121.4 114.6 502.5 115.3 157.0 274.1 208.1 241.5 269.1 278.1 297.7 310.8 259.7 294.9 280.8 278.4 289.2 306.0 282.4 320.2 341.0 86.6 136.2 30.7 163.9 274.9 278.8 311.4 141.7 247.9 196.5 236.2 361.4 145.8 212.5 174.7 45.9 251.3 188.5 201.5 686.7 183.9 48.2 209.6 112.8 270.1 277.8 457.6 37.0 175.4 120.6 203.5 80.5 162.4 110.1 85.9 239.8 128.5 223.9 307.9 39.6 156.4 297.0 169.6 428.8 59.7 243.5 197.2 257.9 21.5 404.6 491.0 145.2 27.6 63.6 223.6 237.0 261.1 137.5 306.1 195.7 552.4 263.0 208.1 157.8 182.1 187.9 288.1 219.9 136.6 273.9 390.1 159.3 182.5 121.2 328.6 GAGE10 ENSG00000215274 "G antigen 10" A6NGK3 X 49303669-49319844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.0;testis: 1.6" "Cell type enhanced" "Detected in some" "Granulosa cells: 2.1;Leydig cells: 1.2;Microglial cells: 1.0;Peritubular cells: 1.2;Spermatocytes: 3.2;Spermatogonia: 5.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.5;WM-115: 1.0" HPA043232 Supported Uncertain "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" "unprognostic (2.81e-2)" "unprognostic (2.26e-1)" "unprognostic (3.97e-1)" 0.0 0.0 1.0 0.0 1.4 0.0 0.2 0.9 2.0 0.1 0.8 0.1 0.0 0.1 0.5 0.0 0.4 0.0 0.1 1.0 0.8 0.0 0.0 0.0 0.2 0.9 1.1 0.9 0.0 0.0 0.8 0.0 1.0 0.1 0.1 0.6 0.0 0.3 0.1 0.0 0.0 0.3 0.9 0.1 0.0 1.6 0.8 0.0 0.2 0.0 0.1 0.1 0.0 1.0 0.0 0.0 0.2 2.5 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.4 0.9 2.0 1.0 0.8 0.9 1.1 1.0 0.9 0.8 1.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 3.2 5.2 0.0 0.1 0.0 0.0 0.6 0.0 0.1 GAGE12E ENSG00000216649 "G antigen 12E" A1L429 X 49551333-49558649 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 1.8" "Cell type enriched" "Detected in some" 4 "Spermatogonia: 11.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.4;U-266/84: 2.1" HPA043232 Supported Uncertain "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 16: U-266 - Nucleosome" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 2.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GFRA3 GFRa-3 ENSG00000146013 "GDNF family receptor alpha 3" O60609 5 138252380-138274621 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 13.0" "Cell type enhanced" "Detected in some" "Early spermatids: 8.7;Enteroendocrine cells: 53.1;granulocytes: 26.7;Late spermatids: 20.9;Spermatogonia: 8.4" "Cancer enhanced" "Detected in many" "endometrial cancer: 11.9" "Region enriched" "Detected in single" 8 "cerebellum: 2.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SH-SY5Y: 32.0" "Not detected" "Not detected" HPA020731 Approved Uncertain "Plasma membrane,Cytosol" NA NA 150000 "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "Plasma membrane" Cytosol "HPA020731: AB_1849635" "unprognostic (1.22e-1)" "unprognostic (6.35e-2)" "unprognostic (1.64e-1)" "unprognostic (1.28e-1)" "unprognostic (2.57e-1)" "unprognostic (4.47e-2)" "unprognostic (1.47e-3)" "unprognostic (2.77e-3)" "unprognostic (1.27e-1)" "unprognostic (7.65e-3)" "unprognostic (1.44e-1)" "unprognostic (1.33e-2)" "unprognostic (1.90e-5)" "unprognostic (2.19e-2)" "unprognostic (3.35e-1)" "unprognostic (1.79e-1)" "unprognostic (6.23e-2)" 1.8 1.6 0.0 2.1 0.2 0.0 1.6 2.5 0.3 7.4 0.0 13.0 2.7 0.5 2.5 2.3 1.2 1.9 5.7 0.1 0.2 0.5 0.5 2.0 0.1 0.1 0.1 1.3 3.7 0.0 2.0 0.0 0.2 4.1 3.8 0.0 3.2 5.9 0.2 3.1 3.3 2.0 0.1 0.0 6.3 4.2 0.1 0.5 0.8 0.4 0.1 5.1 7.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.1 0.1 0.0 0.0 2.0 1.2 0.5 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 32.0 0.5 0.0 0.3 0.2 0.1 1.1 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.3 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 1.8 0.0 0.7 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 8.7 0.0 0.0 0.0 53.1 0.0 0.2 0.2 0.2 0.5 0.0 0.0 26.7 0.3 0.0 0.0 0.1 0.0 0.1 0.2 6.1 0.0 0.2 20.9 0.0 0.2 1.8 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 3.8 8.4 0.1 0.0 0.3 0.0 0.1 0.0 0.1 GJC1 "CX45, GJA7" ENSG00000182963 "Gap junction protein gamma 1" P36383 17 44798448-44830816 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 40.0" "Group enriched" "Detected in many" 4 "Sertoli cells: 157.8;Smooth muscle cells: 101.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.0" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071788 Uncertain "Nucleoli,Cell Junctions,Cytosol" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 48: Smooth muscle cells - ECM organization" Nucleoli "Cell Junctions, Cytosol" "HPA071788: " "unprognostic (1.84e-2)" "unprognostic (2.04e-1)" "unprognostic (2.13e-2)" "unprognostic (1.35e-1)" "unprognostic (1.75e-1)" "unprognostic (2.22e-1)" "unprognostic (7.02e-2)" "unprognostic (4.01e-1)" "unprognostic (1.60e-2)" "unprognostic (1.11e-1)" "unprognostic (3.02e-1)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.55e-8)" "unprognostic (5.18e-2)" "unprognostic (2.20e-1)" "unprognostic (8.52e-2)" "prognostic unfavorable (7.83e-4)" 9.5 0.7 3.1 3.6 2.8 0.8 5.2 10.1 3.8 9.2 5.5 28.6 1.6 24.7 2.9 2.7 5.3 5.4 11.8 2.3 1.4 2.2 0.7 7.2 2.7 2.1 2.9 2.2 1.4 3.4 0.6 40.0 2.6 8.9 2.9 1.0 1.1 18.6 4.6 2.0 5.3 32.7 1.3 0.7 7.6 8.8 4.0 1.6 6.7 5.9 2.0 11.4 6.1 3.0 44.5 21.9 62.0 18.9 8.3 10.6 20.5 50.3 36.6 50.0 52.6 12.4 24.7 0.5 2.3 46.4 69.9 10.1 29.2 13.7 70.8 0.5 19.8 0.4 12.1 1.6 3.8 0.3 1.7 8.8 1.6 37.0 11.8 20.4 17.1 9.6 1.8 0.5 31.4 0.4 6.7 4.3 29.5 0.1 16.2 39.5 73.8 0.3 11.4 16.8 10.2 21.5 4.6 0.5 16.2 41.3 10.9 8.0 12.3 43.8 39.3 22.2 38.9 0.4 11.3 32.5 15.9 0.3 40.7 2.0 0.2 0.2 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.2 0.2 0.2 1.0 0.5 0.1 0.2 0.1 0.1 3.1 2.8 10.1 3.8 2.3 1.4 2.1 2.9 2.6 1.3 4.0 3.0 11.7 0.0 0.0 0.7 0.2 2.0 1.7 0.5 0.0 3.4 0.6 1.4 25.1 0.0 0.2 1.8 2.1 0.5 0.4 0.1 0.0 1.5 1.5 1.4 14.9 19.5 0.0 0.0 8.1 0.0 2.6 6.3 0.0 3.0 0.0 9.4 4.2 0.3 1.5 13.5 1.4 0.0 0.0 0.3 4.2 0.3 1.5 1.2 3.6 1.0 0.6 0.2 0.0 0.0 0.3 0.6 0.0 2.2 0.0 1.4 0.0 0.3 0.2 0.9 157.8 4.8 101.1 15.6 28.4 0.6 3.0 0.5 0.8 7.8 0.1 1.3 GLYATL1 "FLJ34646, MGC15397" ENSG00000166840 "Glycine-N-acyltransferase like 1" Q969I3 11 58905398-59043527 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 576.3" "Group enriched" "Detected in some" 4 "Hepatocytes: 234.3;Proximal tubular cells: 797.1" "Group enriched" "Detected in some" 8 "liver cancer: 14.1;prostate cancer: 13.3;renal cancer: 10.1" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 2.0;Daudi: 4.9;RPTEC TERT1: 1.5;U-2197: 1.2" HPA039501 Supported Uncertain "Golgi apparatus,Cytosol" NA NA "Cluster 85: Liver - Metabolism" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" Cytosol "HPA039501: AB_2676545" "unprognostic (9.46e-3)" "unprognostic (5.33e-2)" "unprognostic (3.90e-5)" "unprognostic (3.93e-3)" "unprognostic (3.54e-3)" "unprognostic (2.17e-1)" "prognostic favorable (3.69e-4)" "unprognostic (3.62e-1)" "unprognostic (2.51e-1)" "unprognostic (1.05e-1)" "unprognostic (2.08e-1)" "unprognostic (2.92e-1)" "prognostic favorable (3.03e-5)" "unprognostic (1.50e-1)" "unprognostic (1.01e-1)" "unprognostic (1.86e-2)" "unprognostic (4.55e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 1.3 0.3 0.4 0.1 0.4 0.3 1.6 0.1 0.7 0.1 1.3 0.9 0.0 0.1 0.3 141.4 576.3 0.0 0.1 0.9 0.2 0.0 1.7 2.6 0.0 0.0 1.1 11.1 0.3 0.2 1.9 0.0 0.0 0.6 0.2 0.0 0.3 0.1 2.7 0.1 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.2 0.1 0.5 0.4 2.0 0.0 4.9 0.0 0.3 0.4 0.0 0.0 0.0 0.8 0.0 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.5 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 1.2 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.1 0.3 0.9 0.2 1.1 0.3 0.3 0.3 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.3 12.8 0.0 14.7 0.0 0.0 0.0 0.1 107.6 0.1 0.0 2.5 0.1 0.5 0.0 8.0 0.7 0.6 0.0 0.1 0.0 0.1 0.0 0.1 5.0 234.3 0.0 0.0 0.8 0.1 0.0 8.1 0.0 0.0 0.0 3.1 1.8 0.0 0.0 0.0 0.0 0.5 0.2 0.3 0.0 0.0 0.0 1.3 0.0 797.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 1.9 0.1 0.9 0.2 GLYATL1B GLYATL1P3 ENSG00000255151 "Glycine-N-acyltransferase like 1B" A0A0U1RQE8 11 59086307-59094786 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 7 "breast: 7.3;lymphoid tissue: 2.8" "Cell type enriched" "Detected in single" 57 "Proximal tubular cells: 5.8" "Cancer enhanced" "Detected in single" "prostate cancer: 0.7" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.5" "Lineage enriched" "Detected in single" 15 "B-cells: 1.5" "Cell line enhanced" "Detected in some" "Daudi: 1.8;T-47d: 1.2;U-266/70: 1.8" HPA039501 Uncertain Uncertain "Golgi apparatus,Cytosol" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" Cytosol "HPA039501: AB_2676545" "unprognostic (1.39e-1)" "unprognostic (3.46e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (5.20e-2)" "unprognostic (2.62e-1)" "unprognostic (2.11e-1)" "unprognostic (3.21e-4)" "unprognostic (3.45e-1)" 0.0 0.0 0.0 0.8 0.0 0.0 7.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.9 0.0 1.8 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GM2A SAP-3 ENSG00000196743 "GM2 ganglioside activator" P17900 5 151212150-151270440 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Disease variant, Gangliosidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 224.7;Hofbauer cells: 100.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "B-cells: 30.9;dendritic cells: 39.6;monocytes: 40.4" "Cell line enhanced" "Detected in all" "BEWO: 207.1;HBEC3-KT: 291.8;hTCEpi: 287.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008063 Enhanced Approved Vesicles,Cytosol "Intracellular and membrane" NA NA 19000000 "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 38: Extravillous trophoblasts - Unknown function" "Vesicles, Cytosol" "HPA008063: AB_1849842" "unprognostic (4.33e-2)" "unprognostic (8.97e-3)" "unprognostic (2.27e-1)" "unprognostic (3.01e-1)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "prognostic unfavorable (1.77e-5)" "unprognostic (1.22e-1)" "unprognostic (1.72e-2)" "unprognostic (1.31e-2)" "unprognostic (1.50e-2)" "unprognostic (5.33e-3)" "unprognostic (9.81e-2)" "unprognostic (4.24e-2)" "unprognostic (4.42e-2)" "unprognostic (3.02e-2)" "unprognostic (1.65e-1)" 17.4 20.5 29.3 30.0 39.7 20.6 28.0 38.9 31.1 30.8 17.9 19.7 15.8 15.1 30.8 56.2 15.4 23.4 26.2 27.1 34.3 11.4 24.8 39.0 61.4 42.6 37.9 21.3 14.9 28.3 6.6 57.9 44.3 21.1 26.3 11.7 17.0 17.9 7.2 81.8 16.3 20.0 39.0 36.0 15.8 11.6 36.2 72.3 13.0 10.5 77.9 40.3 49.5 46.7 22.3 14.8 15.1 71.7 98.0 48.2 207.1 35.0 75.1 19.0 25.6 30.3 26.1 71.9 35.1 26.9 51.1 60.0 16.7 291.8 27.2 41.4 10.5 11.7 16.8 37.9 23.7 19.1 117.1 65.4 287.0 24.4 16.4 26.0 27.6 85.1 11.4 30.7 30.1 9.6 38.4 18.0 10.2 11.4 32.3 17.7 7.1 46.3 18.4 43.3 3.9 13.4 29.1 133.0 58.3 52.0 30.7 22.5 24.6 46.0 17.6 38.3 10.6 75.2 96.8 187.0 53.1 30.1 19.4 7.6 40.4 2.4 3.7 13.6 2.7 30.9 4.3 3.9 39.6 29.8 6.1 4.8 8.7 4.4 3.4 28.0 5.4 18.6 29.3 39.7 38.9 31.1 27.1 34.3 42.6 37.9 44.3 39.0 36.2 46.7 5.8 16.0 23.0 5.5 25.0 14.9 18.5 63.2 26.7 5.8 5.4 15.5 30.9 0.0 29.7 18.4 2.1 53.6 8.3 4.4 1.9 7.2 0.5 5.7 6.8 7.3 3.6 5.0 2.2 8.1 224.7 10.2 10.7 7.7 69.6 16.3 8.6 24.2 100.8 6.7 2.7 5.4 10.2 55.7 32.5 1.6 8.1 67.8 8.8 2.8 52.5 8.0 7.2 3.5 9.5 6.0 4.7 13.9 28.8 6.7 6.2 5.4 19.9 3.7 0.0 7.9 6.9 1.8 4.2 45.6 23.9 52.5 5.6 6.4 6.7 36.5 GOLPH3L GPP34R ENSG00000143457 "Golgi phosphoprotein 3 like" Q9H4A5 1 150646230-150697154 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 6 "U-698: 313.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072016 Supported "Golgi apparatus,Cytosol" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus" Cytosol "HPA072016: " "unprognostic (1.21e-1)" "unprognostic (2.61e-1)" "unprognostic (3.76e-3)" "unprognostic (3.24e-1)" "unprognostic (3.24e-2)" "unprognostic (1.82e-1)" "unprognostic (3.18e-2)" "unprognostic (4.72e-2)" "unprognostic (5.00e-2)" "unprognostic (2.64e-1)" "unprognostic (9.88e-3)" "unprognostic (2.71e-1)" "unprognostic (3.36e-2)" "unprognostic (1.67e-1)" "unprognostic (2.48e-1)" "unprognostic (1.38e-1)" "unprognostic (1.93e-2)" 10.9 14.3 8.8 11.8 9.3 6.0 20.8 9.3 11.4 21.8 13.5 31.1 17.9 14.7 33.3 30.3 25.3 14.1 10.3 8.7 11.4 18.6 9.6 13.6 12.6 9.3 13.3 21.4 22.8 19.0 11.0 13.0 11.7 15.8 36.4 12.8 23.3 17.6 14.7 18.9 20.1 15.2 9.0 11.0 22.7 14.4 10.9 15.8 25.7 13.5 18.5 21.5 13.5 8.5 25.2 23.0 12.2 7.6 31.8 22.5 21.8 22.6 33.0 23.7 32.9 10.3 45.1 29.3 31.5 14.7 16.1 21.6 20.8 18.5 28.6 21.1 21.5 33.8 13.2 15.2 26.7 27.8 28.2 16.1 31.8 24.2 54.4 26.1 37.5 21.1 27.6 19.6 14.1 25.4 24.2 13.1 25.7 46.1 21.6 16.8 14.5 36.5 30.6 17.5 19.3 18.8 11.6 33.2 18.0 31.4 25.6 32.5 29.3 7.3 13.3 10.2 18.5 23.8 22.9 313.5 22.3 28.3 10.9 7.5 1.6 2.8 9.5 1.6 13.0 10.5 9.9 9.7 8.7 9.8 12.7 9.4 1.4 18.0 3.6 12.6 11.6 5.4 8.8 9.3 9.3 11.4 8.7 11.4 9.3 13.3 11.7 9.0 10.9 8.5 11.7 9.6 10.3 12.1 9.8 12.9 11.3 16.7 9.6 9.0 26.3 14.4 10.4 24.3 22.6 12.9 6.2 22.1 9.7 50.0 25.4 21.6 22.2 27.5 10.3 14.1 21.0 10.9 12.7 36.6 17.9 12.9 17.9 15.6 11.4 48.6 16.1 10.9 12.4 0.0 13.6 46.6 14.2 9.1 7.4 12.7 16.4 7.5 16.0 24.4 13.1 14.9 6.2 11.6 13.5 21.2 34.6 19.9 15.0 27.7 31.6 26.9 51.2 13.3 0.0 10.0 9.5 14.6 4.3 15.7 17.8 30.8 10.4 22.0 36.0 39.6 GPR142 PGR2 ENSG00000257008 "G protein-coupled receptor 142" Q7Z601 17 74367407-74372622 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 4 "pancreatic cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031392 Uncertain Uncertain "Plasma membrane,Cell Junctions,Cytosol" NA NA "Cluster 43: Cardiomyocytes - Nuclear processes" "Plasma membrane, Cytosol" "Cell Junctions" "HPA031392: AB_10601935" "unprognostic (6.81e-2)" "unprognostic (1.75e-1)" "unprognostic (1.98e-1)" "unprognostic (1.34e-1)" "unprognostic (1.36e-1)" "unprognostic (6.54e-5)" "unprognostic (4.16e-2)" "unprognostic (4.85e-7)" "unprognostic (3.95e-2)" "unprognostic (7.72e-4)" "unprognostic (1.93e-1)" "unprognostic (1.68e-3)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR63 "PSP24(beta), PSP24B" ENSG00000112218 "G protein-coupled receptor 63" Q9BZJ6 6 96794125-96837477 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in many" "Early spermatids: 31.4;Excitatory neurons: 46.2;Granulosa cells: 31.2;Inhibitory neurons: 20.3;Late spermatids: 35.2;Spermatocytes: 24.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 8.8;HHSteC: 13.5;Karpas-707: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039103 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 65: Brain - Ion transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Plasma membrane, Cytosol" "HPA039103: AB_10672841" "unprognostic (8.22e-2)" "unprognostic (2.77e-1)" "unprognostic (1.71e-2)" "unprognostic (1.02e-2)" "unprognostic (1.83e-1)" "unprognostic (1.33e-1)" "unprognostic (2.65e-2)" "unprognostic (1.15e-1)" "unprognostic (3.39e-1)" "unprognostic (2.53e-2)" "unprognostic (7.29e-3)" "unprognostic (3.00e-1)" "unprognostic (2.03e-3)" "unprognostic (1.67e-1)" "unprognostic (1.34e-1)" "unprognostic (2.34e-1)" "unprognostic (2.30e-2)" 0.5 0.9 1.4 0.7 3.5 0.1 0.4 0.7 2.7 1.5 2.7 1.2 1.5 0.5 0.3 0.5 0.7 0.7 0.5 1.5 0.1 0.3 0.0 0.3 0.1 1.6 0.6 1.0 1.4 1.0 0.9 0.7 2.0 0.9 1.8 0.2 0.4 0.5 0.2 0.4 1.1 0.6 0.0 0.3 1.1 2.4 0.9 0.6 0.6 0.1 0.2 0.8 1.4 1.8 0.0 0.1 1.6 0.4 2.3 0.8 0.4 1.0 0.0 0.0 0.2 0.2 1.2 0.1 0.0 0.1 1.3 1.2 5.4 2.5 0.0 8.8 4.1 5.2 0.4 0.0 13.5 3.3 0.6 2.5 0.4 0.0 3.7 0.3 0.0 7.6 3.8 20.8 0.5 0.4 2.5 0.0 5.4 0.0 0.7 0.0 1.9 4.3 0.3 0.2 2.4 1.5 0.3 3.3 0.6 1.7 1.3 0.7 0.0 1.4 2.1 0.2 2.0 1.6 0.9 0.1 0.8 2.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.4 0.2 0.0 0.1 0.0 0.0 1.4 3.5 0.7 2.7 1.5 0.1 1.6 0.6 2.0 0.0 0.9 1.8 0.6 0.0 0.0 2.3 0.2 1.9 0.7 0.3 4.0 1.5 0.6 0.9 0.7 2.8 0.1 1.8 0.0 0.2 0.3 0.1 0.0 0.4 31.4 0.1 0.5 0.7 3.0 0.4 46.2 0.9 0.7 2.5 1.1 0.1 0.0 31.2 1.1 0.0 0.2 0.0 20.3 0.5 0.0 0.0 8.9 35.2 3.4 0.4 1.8 9.4 0.1 0.2 0.0 11.6 4.8 0.4 0.1 4.9 1.0 1.1 0.1 0.2 0.0 0.2 0.0 0.4 2.2 24.6 10.5 1.9 0.3 0.1 0.4 2.1 0.5 0.3 GPRC5C RAIG-3 ENSG00000170412 "G protein-coupled receptor class C group 5 member C" Q9NQ84 17 74424851-74451653 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 192.7;stomach 1: 230.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 211.3;Gastric mucus-secreting cells: 143.2;Hepatocytes: 183.6;Paneth cells: 153.8;Sertoli cells: 144.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 7.9" "Group enriched" "Detected in many" 9 "dendritic cells: 7.9;monocytes: 3.7" "Cell line enhanced" "Detected in many" "Hep G2: 82.4;HMC-1: 146.7;PC-3: 80.8;RPTEC TERT1: 172.1;RT4: 89.9;T-47d: 108.0" "Region enriched" "Detected in all" 9 "cerebellum: 42.5" "Low region specificity" "Detected in all" HPA029776 Enhanced Uncertain "Nucleoplasm,Centriolar satellite,Cytosol" NA Yes 15000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 3: HMC-1 - Innate immune response" "Cluster 15: Hepatocytes - Hemostasis" "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA029776: AB_10602324" "unprognostic (1.48e-1)" "unprognostic (3.35e-1)" "unprognostic (6.01e-2)" "unprognostic (2.37e-3)" "unprognostic (1.80e-2)" "unprognostic (1.09e-2)" "unprognostic (4.40e-2)" "unprognostic (1.57e-1)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" "unprognostic (9.61e-3)" "unprognostic (1.05e-1)" "prognostic favorable (1.58e-5)" "unprognostic (7.58e-2)" "unprognostic (3.70e-2)" "unprognostic (2.75e-2)" "unprognostic (1.54e-3)" 16.1 19.3 17.4 3.1 18.4 0.4 20.1 48.9 18.1 42.0 28.0 38.7 25.0 17.1 10.2 12.2 30.0 21.3 33.7 14.8 16.9 135.7 192.7 23.0 2.1 18.1 18.7 38.2 136.1 28.2 14.8 11.9 18.6 45.6 14.6 1.5 37.4 24.3 110.1 43.9 30.3 4.0 16.6 22.3 230.3 4.0 17.0 4.4 74.8 33.9 3.0 30.8 20.9 15.7 17.3 61.6 3.8 5.5 0.0 0.0 0.2 0.3 0.0 0.0 0.0 66.4 73.0 0.0 45.0 0.3 18.5 52.9 7.7 1.0 0.1 0.2 10.7 0.0 4.0 82.4 15.8 0.0 146.7 1.3 26.7 0.0 0.0 69.2 0.0 0.1 4.8 1.2 0.0 18.0 0.7 17.2 9.2 79.5 80.8 0.2 0.1 2.8 172.1 89.9 27.5 2.5 3.7 5.9 0.1 33.1 108.0 4.6 0.0 0.0 5.5 0.1 0.1 0.1 0.4 0.2 6.5 2.5 0.4 0.0 1.1 0.1 0.0 2.5 0.0 0.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 3.7 7.9 0.0 0.3 17.4 18.4 48.9 18.1 14.8 16.9 18.1 18.7 18.6 16.6 17.0 15.7 11.2 3.2 57.7 13.4 1.4 13.6 39.2 79.6 26.7 0.8 27.3 19.4 211.3 67.2 76.2 136.1 0.0 0.8 11.8 74.9 29.4 65.5 0.1 62.5 6.6 20.9 45.5 5.3 0.1 68.1 20.3 11.3 143.2 74.9 10.2 0.1 48.2 183.6 12.3 5.0 0.5 50.8 69.2 16.3 4.6 1.7 18.0 6.3 3.6 2.8 4.1 15.9 0.0 5.0 0.2 41.2 153.8 22.2 1.2 44.6 61.0 73.5 45.4 1.5 144.7 4.7 64.0 0.5 5.0 14.8 11.2 25.3 2.4 1.5 48.5 63.1 GRAMD1C DKFZp434C0328 ENSG00000178075 "GRAM domain containing 1C" Q8IYS0 3 113828182-113947174 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 181.8;Early spermatids: 97.1;Late spermatids: 80.5;Oligodendrocyte precursor cells: 82.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "memory B-cell: 2.7;naive B-cell: 2.9;neutrophil: 2.1" "Group enriched" "Detected in many" 13 "B-cells: 2.9;granulocytes: 2.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 13.5;HUVEC TERT2: 10.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA012316 Approved Uncertain "Plasma membrane,Cytosol" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 64: Astrocytes - Nervous system maintenance" "Plasma membrane, Cytosol" "HPA012316: AB_1849949" "unprognostic (2.73e-3)" "unprognostic (6.16e-3)" "unprognostic (3.27e-1)" "unprognostic (1.93e-1)" "unprognostic (5.50e-2)" "unprognostic (9.81e-3)" "unprognostic (1.43e-3)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (1.39e-1)" "unprognostic (1.85e-1)" "unprognostic (5.49e-2)" "prognostic favorable (4.22e-15)" "unprognostic (8.48e-2)" "unprognostic (9.96e-2)" "unprognostic (3.61e-2)" "unprognostic (2.09e-2)" 1.4 1.9 13.0 1.7 12.0 0.1 8.8 11.9 15.3 3.1 9.0 5.0 7.6 2.2 2.0 5.5 10.7 2.6 0.7 11.6 12.1 24.0 27.7 4.9 2.0 13.9 15.4 0.8 12.7 10.6 8.1 6.1 11.8 2.6 3.9 14.3 12.0 2.1 0.8 12.1 16.7 0.7 12.3 1.3 9.0 16.8 14.5 1.1 3.9 3.2 3.9 2.0 3.7 10.0 1.6 0.0 4.0 3.0 0.7 1.8 5.2 3.5 3.1 0.7 2.1 0.0 13.5 0.4 1.0 2.0 1.4 1.3 0.7 1.5 1.8 1.9 0.6 0.3 0.1 0.0 1.4 0.2 0.0 3.0 1.0 0.6 0.1 7.1 10.2 4.5 0.0 0.1 1.1 0.4 1.6 0.2 0.3 1.4 0.5 0.0 0.8 2.4 4.2 1.9 0.8 1.1 1.0 5.2 3.4 1.6 3.6 0.0 2.2 1.5 2.8 0.0 0.3 2.2 1.3 1.9 2.2 0.1 1.8 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.1 0.2 0.0 2.9 0.1 0.1 2.1 0.1 0.0 0.0 0.0 0.0 13.0 12.0 11.9 15.3 11.6 12.1 13.9 15.4 11.8 12.3 14.5 10.0 4.5 12.8 10.5 181.8 15.6 1.0 6.9 3.0 5.2 0.2 9.9 7.0 0.9 15.7 7.1 14.7 37.5 17.5 0.3 10.1 31.3 4.4 97.1 33.3 8.5 4.7 4.9 2.7 29.7 2.7 3.7 1.5 6.6 51.9 0.0 1.4 5.7 17.0 1.5 11.8 4.3 5.5 4.1 0.3 0.8 80.5 2.8 0.9 1.8 9.4 0.1 13.4 0.0 82.4 1.7 2.3 9.3 1.5 6.3 2.8 34.3 14.0 27.9 19.7 0.0 1.2 1.7 28.2 6.7 6.8 4.7 42.4 1.9 5.0 5.3 7.0 GRM7 "GLUR7, GPRC1G, mGlu7, MGLUR7, PPP1R87" ENSG00000196277 "Glutamate metabotropic receptor 7" Q14831 3 6770001-7741533 "G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Cardiomyopathy, Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.1;parathyroid gland: 4.4" "Group enriched" "Detected in some" 14 "Excitatory neurons: 773.1;Inhibitory neurons: 597.7;Oligodendrocyte precursor cells: 1189.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "SH-SY5Y: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015964 Uncertain Cytosol NA NA "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Cytosol "HPA015964: " "unprognostic (2.04e-2)" "unprognostic (7.03e-3)" "unprognostic (1.43e-1)" "unprognostic (9.37e-2)" "unprognostic (8.48e-3)" "unprognostic (2.58e-1)" "unprognostic (7.30e-2)" "unprognostic (3.50e-2)" "unprognostic (2.20e-1)" "unprognostic (1.78e-1)" "unprognostic (1.46e-2)" "unprognostic (2.54e-1)" "unprognostic (6.84e-6)" "unprognostic (1.45e-1)" "unprognostic (2.82e-2)" "unprognostic (5.43e-2)" "unprognostic (2.59e-2)" 0.2 2.0 2.8 0.0 2.9 0.0 0.1 0.1 3.8 0.9 0.0 0.1 0.2 0.9 0.0 0.0 0.2 0.0 0.0 3.9 5.1 0.0 0.1 0.1 0.0 2.0 3.0 0.1 0.0 4.4 0.0 0.1 1.7 0.3 0.1 1.1 0.7 0.3 0.0 0.0 0.0 2.3 3.7 0.1 0.0 1.1 5.0 0.3 0.1 0.0 0.0 0.2 0.1 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.9 0.1 3.8 3.9 5.1 2.0 3.0 1.7 3.7 5.0 1.7 0.1 0.0 0.0 29.4 0.0 0.1 1.2 0.1 0.0 24.1 0.1 0.5 1.1 4.3 0.7 0.0 8.4 0.0 0.1 0.0 1.9 0.0 32.7 0.1 2.7 0.2 0.0 0.0 773.1 0.0 0.1 1.6 0.0 0.1 1.3 0.1 0.0 0.0 0.1 1.7 597.7 0.0 0.0 0.0 1.2 41.7 0.3 0.4 0.0 13.1 0.1 1.3 0.0 1189.3 56.9 0.0 0.0 0.0 0.0 0.7 0.0 0.1 8.0 3.5 6.6 0.7 0.4 2.7 0.8 0.0 0.0 0.0 0.1 0.5 0.0 0.7 GSTM5 ENSG00000134201 "Glutathione S-transferase mu 5" P46439 1 109711780-109775428 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "breast: 929.9" "Group enriched" "Detected in many" 4 "Fibroblasts: 59.0;Leydig cells: 143.5;Muller glia cells: 213.3;Peritubular cells: 127.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "plasmacytoid DC: 3.9" "Lineage enriched" "Detected in single" 4 "dendritic cells: 3.9" "Group enriched" "Detected in some" 5 "fHDF/TERT166: 21.6;HHSteC: 10.3;HSkMC: 10.9" "HPA055972, HPA055973" Approved Uncertain "Cytokinetic bridge,Cytosol" Yes NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 5: Breast - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 5: Muller glia cells - Visual perception" Cytosol "Cytokinetic bridge" "HPA055972: AB_2682992, HPA055973: AB_2682993" "unprognostic (1.46e-2)" "unprognostic (8.64e-3)" "unprognostic (5.58e-2)" "unprognostic (1.42e-1)" "unprognostic (5.34e-3)" "unprognostic (8.09e-2)" "unprognostic (9.64e-4)" "unprognostic (1.31e-2)" "unprognostic (1.44e-1)" "unprognostic (9.16e-2)" "unprognostic (3.31e-1)" "unprognostic (1.92e-2)" "unprognostic (1.42e-2)" "unprognostic (3.74e-2)" "unprognostic (4.39e-2)" "unprognostic (3.03e-3)" "unprognostic (1.40e-1)" 21.7 6.4 60.3 4.6 65.3 0.5 929.9 60.4 71.1 72.5 62.9 13.9 2.3 35.1 32.9 11.6 62.0 25.8 17.0 61.4 54.5 5.5 3.9 18.0 5.0 57.2 55.4 213.9 4.7 0.2 9.4 0.8 56.7 27.9 7.8 12.4 7.9 32.6 3.9 12.2 10.3 26.5 60.1 7.7 13.2 11.4 53.5 6.4 9.1 14.0 6.5 27.9 47.6 58.6 0.0 0.0 0.0 0.0 1.7 1.6 0.4 1.3 0.0 0.3 0.2 0.0 0.0 0.1 0.0 21.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.8 0.0 0.0 10.3 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.7 0.1 0.0 0.1 0.0 0.6 0.0 3.9 0.9 0.7 60.3 65.3 60.4 71.1 61.4 54.5 57.2 55.4 56.7 60.1 53.5 58.6 2.5 0.0 0.5 32.3 0.0 6.6 0.9 0.2 0.0 2.0 0.5 0.8 0.9 1.5 0.0 0.0 2.1 0.0 0.3 0.0 0.0 0.0 9.0 0.3 12.3 2.2 0.0 2.1 0.1 0.0 0.1 59.0 1.1 0.3 0.0 0.6 5.7 0.0 0.3 0.0 0.5 0.1 0.0 0.6 9.3 15.1 143.5 0.6 10.6 1.9 0.0 213.3 0.0 2.0 0.3 0.0 0.0 127.2 0.1 0.1 0.1 0.0 0.0 6.8 26.3 2.3 9.4 2.0 1.8 1.0 6.5 0.0 2.8 2.4 0.1 0.6 GTF2A1 TFIIA ENSG00000165417 "General transcription factor IIA subunit 1" P52655 14 81175452-81221377 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 7.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000869 Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 23: Testis - Cell cycle regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA000869: AB_1080253" "unprognostic (1.93e-1)" "unprognostic (1.31e-1)" "unprognostic (7.98e-3)" "unprognostic (1.40e-1)" "unprognostic (1.50e-2)" "unprognostic (1.20e-1)" "unprognostic (6.04e-3)" "unprognostic (1.65e-1)" "unprognostic (1.14e-1)" "unprognostic (1.85e-1)" "unprognostic (7.49e-2)" "unprognostic (2.76e-1)" "unprognostic (3.87e-2)" "unprognostic (4.04e-2)" "unprognostic (2.44e-1)" "unprognostic (2.11e-1)" "unprognostic (5.88e-2)" 10.4 10.1 3.0 12.9 4.3 7.4 13.0 12.3 11.1 11.0 0.1 10.1 9.6 12.0 14.7 13.2 8.7 9.9 10.2 4.6 4.3 11.4 14.5 9.0 16.2 2.3 2.8 13.0 9.8 14.5 5.7 13.2 2.7 10.8 11.0 13.5 8.3 9.0 10.7 11.3 9.1 10.4 2.4 12.6 10.6 19.6 3.3 21.1 23.2 15.5 14.7 10.7 7.4 5.3 20.5 20.0 41.0 27.8 22.8 19.0 15.7 25.9 24.7 21.6 19.4 30.0 20.1 33.9 20.5 20.1 15.9 15.5 28.7 18.2 38.0 31.1 9.0 31.4 21.5 17.9 22.5 21.6 30.6 17.9 13.6 29.8 38.4 22.5 22.4 27.1 19.5 44.0 27.9 34.0 54.9 12.5 22.9 15.5 19.8 30.0 36.6 20.8 14.4 41.2 40.2 23.7 59.8 22.8 25.6 19.6 34.6 17.8 29.4 21.9 17.0 30.7 25.9 35.9 42.2 34.5 17.5 24.6 35.8 7.3 0.7 1.3 1.3 0.5 1.0 0.7 1.2 0.7 0.4 0.6 1.0 1.2 1.2 1.0 2.6 1.9 0.7 0.5 3.0 4.3 12.3 11.1 4.6 4.3 2.3 2.8 2.7 2.4 3.3 5.3 27.0 19.2 13.6 25.5 22.3 18.0 8.6 11.9 10.8 24.9 18.4 19.7 26.5 5.7 14.0 23.9 35.5 15.1 21.4 21.2 1.9 12.0 59.4 14.5 26.5 20.7 18.6 32.0 32.9 13.0 14.4 20.0 17.9 18.9 30.4 37.2 16.8 25.9 17.0 40.4 33.4 17.5 10.2 25.2 22.1 8.0 12.8 25.0 10.6 29.0 30.9 22.0 18.6 26.7 26.4 12.4 15.8 13.5 56.2 16.6 13.0 15.0 11.4 15.8 26.3 22.0 23.7 28.6 26.5 23.9 24.4 26.0 21.7 16.2 11.6 12.0 GTF2IRD1 "BEN, Cream1, GTF3, MusTRD1, RBAP2, WBSCR11, WBSCR12" ENSG00000006704 "GTF2I repeat domain containing 1" Q9UHL9 7 74453790-74602605 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 68.1" "Cell type enhanced" "Detected in many" "Astrocytes: 48.3;Inhibitory neurons: 42.1;Rod photoreceptor cells: 41.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044254 Approved Supported Nucleoplasm,Cytosol Yes No "Cluster 13: Striated muscle - Muscle contraction" "Cluster 30: Epithelial cell lines - Translation" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm Cytosol "HPA044254: AB_10964747" "unprognostic (8.92e-2)" "unprognostic (6.94e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (9.71e-5)" "unprognostic (2.24e-1)" "unprognostic (3.35e-2)" "unprognostic (2.71e-3)" "unprognostic (3.77e-2)" "unprognostic (1.84e-2)" "unprognostic (6.26e-2)" "unprognostic (4.89e-3)" "unprognostic (3.31e-1)" "unprognostic (2.53e-1)" "unprognostic (8.61e-2)" "unprognostic (1.08e-1)" "unprognostic (3.06e-2)" "unprognostic (2.25e-3)" 6.0 12.6 7.0 3.4 7.0 0.5 6.9 7.2 8.1 16.8 14.0 15.1 7.7 11.3 8.6 26.7 8.8 5.7 11.6 6.0 8.4 18.6 4.6 11.7 1.0 9.2 8.9 10.5 10.0 18.9 27.6 5.8 9.0 13.3 5.6 36.7 17.3 8.2 68.1 22.4 6.7 8.4 6.7 2.0 13.9 5.0 10.1 3.4 17.4 29.7 5.4 15.0 19.8 10.2 21.2 12.9 28.1 30.8 22.2 10.8 0.2 8.8 23.7 17.1 17.7 21.7 30.1 5.4 6.5 18.1 41.7 11.6 22.6 10.2 12.6 0.2 13.0 1.1 43.1 26.1 71.2 0.2 0.7 14.7 42.1 12.0 48.9 39.7 8.9 10.4 15.5 0.1 19.2 26.1 2.7 18.9 22.6 25.7 12.8 28.1 16.4 20.0 32.7 14.6 23.1 30.5 21.7 39.0 19.9 14.2 23.4 21.2 4.6 17.5 16.9 11.4 20.5 1.1 3.4 8.9 6.7 0.3 14.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 7.0 7.0 7.2 8.1 6.0 8.4 9.2 8.9 9.0 6.7 10.1 10.2 0.9 9.6 8.2 48.3 0.1 7.9 9.9 10.5 9.6 30.8 5.6 4.1 10.4 12.8 6.8 9.2 33.3 1.4 1.5 4.5 11.7 7.6 1.6 11.5 8.0 4.1 4.2 0.8 24.6 9.2 1.8 5.6 6.1 17.0 2.5 8.0 2.9 3.1 2.6 21.9 42.1 3.6 8.2 1.2 5.7 0.3 4.1 2.5 7.2 14.0 0.7 5.9 1.0 25.6 24.9 11.6 3.2 5.7 0.0 17.8 3.6 17.4 12.7 41.1 0.0 19.0 5.7 0.1 3.7 18.2 6.7 2.9 1.1 2.4 7.4 15.8 GUK1 ENSG00000143774 "Guanylate kinase 1" Q16774 1 228139962-228148984 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028118, HPA048587, HPA068324" Approved Uncertain Nucleoplasm,Cytosol NA NA 240000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 16: Pancreatic endocrine cells - Mixed function" Nucleoplasm Cytosol "HPA028118: AB_2756308, HPA048587: AB_2680453, HPA068324: " "unprognostic (9.15e-2)" "unprognostic (2.63e-2)" "unprognostic (3.60e-3)" "unprognostic (7.91e-2)" "unprognostic (8.54e-3)" "unprognostic (1.24e-1)" "unprognostic (3.55e-3)" "unprognostic (2.05e-1)" "unprognostic (3.47e-1)" "unprognostic (7.32e-2)" "unprognostic (3.38e-2)" "unprognostic (5.28e-2)" "prognostic unfavorable (8.85e-5)" "unprognostic (2.91e-1)" "unprognostic (5.41e-1)" "unprognostic (2.39e-2)" "unprognostic (6.12e-2)" 226.7 198.9 291.7 93.9 277.9 251.9 213.3 255.3 465.2 187.1 274.1 196.5 113.8 169.2 48.6 333.8 161.8 116.3 240.0 302.8 257.9 230.6 318.1 222.8 124.5 263.1 263.0 146.9 208.9 72.0 165.7 78.9 261.8 161.3 31.5 110.8 191.0 71.6 149.0 285.7 155.0 53.6 266.3 179.4 202.0 107.3 281.3 97.1 151.3 61.8 39.2 188.6 202.4 289.4 356.1 122.4 53.0 164.5 155.6 186.6 264.3 230.8 116.5 130.8 102.8 70.6 239.1 133.4 266.5 151.4 110.0 230.3 45.7 252.0 14.0 203.7 357.1 79.3 292.9 156.3 282.8 90.5 133.0 260.0 150.6 91.9 73.3 94.2 179.2 279.9 219.5 205.1 109.5 295.2 411.4 194.3 166.8 172.6 522.9 155.3 99.9 354.9 125.2 164.1 173.7 311.3 148.7 250.2 309.7 13.5 185.2 191.7 318.5 237.7 157.4 353.4 387.5 186.8 221.9 151.6 300.3 146.2 246.0 379.0 323.8 663.9 420.6 363.0 406.5 265.0 346.8 454.1 279.7 230.8 256.5 323.4 420.1 339.5 390.9 567.3 394.6 571.4 291.7 277.9 255.3 465.2 302.8 257.9 263.1 263.0 261.8 266.3 281.3 289.4 503.7 60.9 87.2 35.3 199.9 660.0 271.5 643.5 215.7 195.5 425.9 448.7 130.8 195.9 312.2 237.3 717.2 241.6 351.2 655.8 694.6 510.9 134.0 212.5 272.0 451.4 269.6 866.9 50.2 685.5 417.9 276.9 189.1 304.2 182.6 162.5 365.5 353.4 407.5 109.4 33.5 426.5 384.5 291.7 557.0 609.3 233.6 265.6 519.4 22.5 355.5 411.0 398.6 16.1 58.6 975.0 718.8 243.8 365.6 571.5 857.7 801.1 231.6 570.9 249.8 158.2 378.6 89.8 100.3 448.6 719.7 262.4 326.7 226.3 331.5 612.2 H6PD "GDH, H6PDH" ENSG00000049239 "Hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase" O95479 1 9234774-9271337 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Hydrolase, Multifunctional enzyme, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 94.5" "Cell type enhanced" "Detected in many" "Hepatocytes: 164.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 68.9;ASC TERT1: 78.9;HSkMC: 77.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004824, HPA005440" Approved Uncertain Cytosol "Intracellular and membrane" NA NA 140000000 "Cluster 7: Monocytes - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 2: Hepatocytes - Metabolism" Cytosol "HPA004824: AB_1079037, HPA005440: AB_1079036" "unprognostic (4.83e-3)" "unprognostic (3.91e-2)" "unprognostic (1.18e-1)" "unprognostic (3.49e-1)" "unprognostic (5.53e-3)" "unprognostic (2.86e-2)" "unprognostic (8.35e-2)" "unprognostic (5.18e-2)" "unprognostic (9.73e-2)" "unprognostic (1.26e-3)" "unprognostic (2.16e-2)" "unprognostic (7.35e-3)" "unprognostic (8.20e-2)" "unprognostic (3.61e-1)" "unprognostic (1.30e-1)" "unprognostic (8.65e-2)" "unprognostic (1.95e-1)" 29.0 30.5 7.5 12.6 11.6 9.7 23.0 8.2 9.0 22.6 18.8 15.1 11.2 25.7 14.4 13.5 28.3 12.6 18.9 6.4 7.8 11.5 94.5 20.3 12.4 14.4 10.8 44.9 18.9 10.6 12.7 14.1 11.4 19.5 9.1 4.2 56.2 13.1 48.3 35.7 16.8 16.6 9.6 14.5 18.7 8.1 11.4 13.1 14.7 21.0 11.4 16.7 16.5 10.9 9.9 8.0 6.8 25.5 68.9 78.9 6.4 9.8 24.0 7.1 10.9 1.5 20.1 10.9 11.2 15.3 9.1 10.3 1.8 4.8 10.3 32.8 2.2 0.0 2.8 6.7 38.6 3.5 4.1 77.7 9.1 17.2 11.1 15.6 32.9 5.9 2.9 18.2 14.0 5.7 3.9 8.2 3.7 7.5 4.6 1.2 0.9 9.3 9.1 4.0 2.3 12.0 12.9 10.0 12.0 4.7 7.5 17.4 32.9 24.3 3.9 6.2 2.8 24.1 7.6 2.5 40.8 15.6 15.7 1.6 2.3 0.3 1.6 2.4 1.3 1.3 1.2 1.5 1.0 1.6 1.2 1.1 1.5 1.2 2.3 1.4 1.1 1.5 7.5 11.6 8.2 9.0 6.4 7.8 14.4 10.8 11.4 9.6 11.4 10.9 24.1 25.6 29.5 17.9 10.1 14.3 13.2 16.9 18.8 19.6 10.3 8.3 17.5 58.6 18.8 20.2 27.1 11.2 9.1 16.6 0.0 22.9 0.8 11.2 36.0 19.8 7.8 9.0 8.4 21.3 8.5 33.6 5.6 15.5 3.8 29.9 19.6 164.0 12.1 16.8 9.1 15.1 8.2 25.4 11.4 2.9 48.1 14.2 12.4 13.1 51.6 10.4 19.6 16.6 18.6 20.0 17.0 36.9 4.5 17.2 23.1 7.4 19.1 10.9 0.0 50.5 11.7 4.6 5.5 10.5 12.8 5.9 11.6 26.1 23.6 14.2 HAO2 "GIG16, HAOX2" ENSG00000116882 "Hydroxyacid oxidase 2" Q9NYQ3 1 119368779-119394130 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "kidney: 303.7;liver: 425.6" "Group enriched" "Detected in some" 7 "Hepatocytes: 256.8;Proximal tubular cells: 450.1" "Group enriched" "Detected in some" 26 "liver cancer: 25.6;renal cancer: 11.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA050355 Uncertain Vesicles,Cytosol NA NA "Cluster 81: Kidney & Liver - Metabolism" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol Vesicles "HPA050355: " "unprognostic (1.13e-1)" "unprognostic (1.68e-2)" "unprognostic (2.07e-1)" "unprognostic (1.00e-1)" "unprognostic (6.22e-2)" "unprognostic (5.33e-3)" "unprognostic (2.80e-2)" "unprognostic (3.27e-1)" "unprognostic (3.15e-1)" "unprognostic (3.17e-1)" "unprognostic (1.41e-1)" "unprognostic (1.73e-1)" "prognostic favorable (4.92e-4)" "unprognostic (9.66e-2)" "unprognostic (1.79e-1)" "unprognostic (2.89e-2)" "unprognostic (5.14e-4)" 0.0 0.6 0.2 0.1 0.6 0.0 0.6 0.1 0.6 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 303.7 425.6 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.1 0.4 0.2 0.1 0.3 23.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.1 0.6 0.2 0.0 0.2 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.7 0.0 11.0 0.0 0.0 0.0 0.0 49.0 0.0 0.0 0.0 0.0 0.6 0.0 13.5 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 4.2 256.8 0.1 0.0 0.1 0.0 0.0 6.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 450.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 HAUS6 "dgt6, FAM29A, FLJ20060, KIAA1574" ENSG00000147874 "HAUS augmin like complex subunit 6" Q7Z4H7 9 19053141-19102904 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 124.9;Spermatocytes: 68.9;Spermatogonia: 56.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 215.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020960, HPA020965" Approved Approved "Nuclear speckles,Centriolar satellite,Cytosol" No No "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 36: HEL - Hemostasis" "Cluster 29: Early spermatids - Spermatogenesis" "Centriolar satellite, Cytosol" "Nuclear speckles" "HPA020960: AB_1848393, HPA020965: AB_1848394" "unprognostic (1.58e-1)" "unprognostic (9.85e-2)" "unprognostic (6.04e-3)" "unprognostic (6.51e-3)" "unprognostic (1.04e-1)" "unprognostic (1.99e-1)" "prognostic unfavorable (3.84e-4)" "unprognostic (1.21e-1)" "unprognostic (2.15e-1)" "unprognostic (1.27e-1)" "unprognostic (3.69e-2)" "unprognostic (1.48e-2)" "prognostic unfavorable (3.13e-5)" "unprognostic (2.52e-1)" "unprognostic (1.68e-1)" "unprognostic (3.13e-2)" "unprognostic (2.03e-1)" 5.3 6.5 5.2 7.9 7.3 17.0 9.2 8.9 7.4 5.4 4.2 5.8 4.0 7.1 6.2 5.2 4.7 5.1 5.2 5.1 6.2 4.1 6.9 4.7 11.4 6.4 6.2 8.2 3.9 6.1 3.0 6.9 6.6 5.6 6.2 9.1 4.5 5.6 4.4 8.1 5.2 7.2 6.1 6.9 4.3 24.0 6.1 15.1 5.3 7.2 10.7 6.2 4.2 9.3 34.7 23.7 46.4 36.3 17.4 20.9 25.1 36.5 25.5 32.7 49.9 12.2 15.4 40.5 13.1 21.1 25.0 14.2 43.3 21.3 50.4 36.8 20.9 215.8 42.1 27.8 11.6 29.0 46.7 13.0 21.5 30.9 66.9 16.9 24.0 40.4 29.8 25.7 37.8 11.3 56.6 49.1 49.9 19.4 23.2 43.3 31.8 16.4 18.0 19.8 27.1 37.3 16.4 15.0 23.6 29.5 11.6 36.1 24.1 29.3 17.7 25.5 42.2 10.2 24.0 39.7 27.3 24.0 13.0 9.8 1.5 1.6 2.8 1.5 3.9 2.3 2.8 3.6 1.5 2.3 3.3 2.9 2.3 5.0 1.4 1.8 3.7 1.7 5.2 7.3 8.9 7.4 5.1 6.2 6.4 6.2 6.6 6.1 6.1 9.3 15.9 19.2 12.5 7.8 14.3 9.7 12.6 8.7 9.1 11.8 9.4 9.3 8.4 5.7 7.2 9.2 10.4 10.5 21.9 5.6 0.0 9.8 124.9 11.8 14.4 11.6 2.4 34.1 10.3 6.1 15.3 9.5 5.6 15.3 11.4 23.8 3.9 6.8 8.2 11.8 10.2 4.6 2.0 5.8 7.7 28.2 11.8 14.5 8.8 10.3 8.2 13.5 12.3 7.1 16.8 9.0 3.4 8.2 17.3 14.6 4.5 3.2 3.6 9.7 6.6 16.2 10.1 68.9 56.0 9.1 8.1 4.9 18.2 11.0 9.4 9.4 HERPUD1 "HERP, KIAA0025, Mif1, SUP" ENSG00000051108 "Homocysteine inducible ER protein with ubiquitin like domain 1" Q15011 16 56932142-56944864 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Unfolded protein response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 2680.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 497.6;U-266/70: 533.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037041, CAB037104, HPA040754, HPA041219" Approved Uncertain "Plasma membrane,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Plasma membrane, Cytosol" "CAB037041: AB_1840910, CAB037104: AB_1840912, HPA040754: AB_10794068, HPA041219: AB_10794268" "unprognostic (1.92e-1)" "unprognostic (3.47e-1)" "unprognostic (8.64e-2)" "unprognostic (3.93e-3)" "unprognostic (3.39e-1)" "unprognostic (5.00e-3)" "unprognostic (1.17e-1)" "unprognostic (9.69e-3)" "unprognostic (3.33e-1)" "unprognostic (2.56e-1)" "unprognostic (2.84e-1)" "unprognostic (3.50e-1)" "prognostic favorable (1.41e-9)" "unprognostic (1.06e-1)" "unprognostic (3.93e-2)" "unprognostic (2.19e-2)" "unprognostic (2.27e-3)" 75.3 108.4 68.4 102.0 70.6 113.6 128.9 73.7 92.6 127.1 99.0 149.5 98.2 65.7 220.2 53.2 86.5 77.8 92.0 67.9 77.9 193.1 193.0 92.0 114.1 77.3 72.8 188.8 377.0 206.9 78.8 97.1 75.2 213.0 141.8 39.7 170.0 102.0 102.9 58.7 84.9 77.8 78.4 114.8 144.1 25.0 74.6 58.0 213.6 120.9 246.6 94.5 45.0 82.8 28.6 30.9 29.8 61.8 66.9 86.9 105.2 65.9 104.6 83.5 64.9 43.1 63.5 115.0 82.7 64.6 84.6 47.9 51.0 23.3 82.4 67.1 30.8 9.9 48.3 156.3 364.6 21.1 49.5 106.0 219.2 38.0 119.6 100.4 64.4 125.9 15.9 159.6 236.3 24.1 39.8 42.7 19.1 164.8 68.9 27.0 74.9 497.6 179.8 31.8 32.7 37.5 57.5 278.8 308.2 41.9 31.3 77.4 40.0 34.8 34.4 30.8 26.8 533.9 191.0 182.6 49.3 28.7 46.4 224.0 291.2 139.5 113.2 238.1 124.0 383.2 120.1 149.7 230.6 340.4 77.2 117.8 215.9 179.6 175.0 915.5 263.8 417.7 68.4 70.6 73.7 92.6 67.9 77.9 77.3 72.8 75.2 78.4 74.6 82.8 316.4 70.5 105.9 16.6 964.5 364.0 561.8 316.3 203.7 134.6 191.3 185.2 221.5 91.5 193.4 71.7 281.5 131.9 577.3 369.1 170.2 192.7 73.3 162.5 121.3 199.8 434.4 40.8 29.9 197.7 182.4 223.8 251.8 260.5 151.8 108.8 134.2 164.0 194.7 47.1 32.2 569.7 290.9 241.6 395.9 251.6 104.1 507.7 948.0 88.1 197.0 94.3 81.4 21.1 30.7 144.8 336.5 95.5 2680.7 447.4 156.1 209.0 95.6 117.1 98.6 178.8 215.6 54.7 10.6 146.6 255.3 693.8 342.6 137.4 311.4 456.8 HEXA ENSG00000213614 "Hexosaminidase subunit alpha" P06865 15 72340924-72376420 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease variant, Gangliosidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 234.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018082, HPA054583" Supported Supported Vesicles,Cytosol "Intracellular and membrane" NA NA 20000000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 4: Macrophages - Innate immune response" Vesicles Cytosol "HPA018082: , HPA054583: AB_2682531" "unprognostic (1.51e-2)" "unprognostic (1.73e-2)" "unprognostic (3.41e-1)" "prognostic favorable (5.63e-8)" "unprognostic (6.58e-2)" "unprognostic (1.32e-2)" "unprognostic (1.34e-2)" "unprognostic (2.82e-2)" "unprognostic (3.75e-1)" "unprognostic (1.09e-1)" "unprognostic (1.59e-2)" "unprognostic (9.98e-2)" "unprognostic (3.98e-1)" "unprognostic (7.05e-3)" "unprognostic (3.02e-2)" "unprognostic (4.73e-2)" "unprognostic (8.69e-2)" 49.8 56.1 18.3 37.6 21.1 110.0 58.5 20.4 21.6 73.8 28.5 55.1 49.8 42.6 164.6 24.8 47.8 76.7 54.3 19.9 20.1 90.1 79.4 84.2 54.2 23.0 21.3 39.3 30.6 54.0 26.3 102.0 24.6 45.3 67.0 32.1 45.0 53.3 22.1 21.8 41.2 59.5 21.7 54.7 45.1 35.6 27.0 38.1 76.5 33.2 42.4 71.6 19.7 29.9 39.8 66.4 27.8 53.8 223.6 253.1 39.7 54.8 274.1 115.3 182.8 34.6 282.7 32.9 50.9 110.0 59.9 77.1 74.5 34.6 72.5 26.5 30.0 41.4 60.4 60.9 172.9 99.9 113.1 216.7 101.3 50.4 89.3 210.3 107.4 48.4 65.1 197.6 156.0 33.9 21.7 50.0 16.0 128.9 0.3 22.3 60.6 75.3 129.1 61.6 23.8 26.4 136.5 126.6 307.3 56.1 23.4 123.9 54.1 171.9 70.7 160.1 59.3 104.7 151.8 33.4 62.1 130.4 85.3 24.2 84.6 60.1 43.8 35.7 38.7 41.1 28.8 38.9 98.0 38.0 22.5 33.2 8.1 51.3 13.3 37.3 28.2 63.0 18.3 21.1 20.4 21.6 19.9 20.1 23.0 21.3 24.6 21.7 27.0 29.9 68.9 64.1 62.4 19.9 46.3 22.2 33.3 94.3 19.4 42.4 28.6 30.4 26.9 30.0 68.0 66.2 106.3 150.2 54.2 36.6 60.7 88.3 20.6 27.2 30.2 50.8 47.2 19.1 22.7 38.0 68.0 78.7 42.8 40.6 29.9 49.9 43.5 42.9 234.3 26.9 24.7 46.3 81.4 92.8 75.0 13.7 74.3 118.1 94.3 24.4 60.3 38.4 82.4 20.6 26.7 39.1 74.6 44.8 37.7 33.0 68.5 66.7 37.5 56.9 46.0 24.5 31.7 24.3 32.3 13.5 15.6 157.6 36.7 45.2 50.6 27.5 HHIPL2 "FLJ13840, KIAA1822L" ENSG00000143512 "HHIP like 2" Q6UWX4 1 222522258-222548104 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 4.8;thyroid gland: 2.0" "Group enriched" "Detected in some" 9 "Early spermatids: 16.7;Late spermatids: 25.5;Spermatocytes: 13.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 18.7;Hep G2: 5.7;RH-30: 21.3;SuSa: 7.8;U-87 MG: 10.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059673 Enhanced Uncertain Mitochondria,Cytosol "Secreted in other tissues" No NA "Cluster 1: Thyroid gland - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 66: Spermatocytes - Spermatogenesis" Mitochondria Cytosol "HPA059673: AB_2684100" "unprognostic (1.35e-2)" "unprognostic (4.62e-3)" "unprognostic (2.91e-1)" "unprognostic (9.21e-2)" "unprognostic (3.58e-1)" "unprognostic (5.27e-2)" "unprognostic (6.74e-3)" "prognostic unfavorable (4.64e-4)" "unprognostic (8.07e-2)" "unprognostic (3.64e-1)" "unprognostic (2.29e-2)" "unprognostic (2.14e-2)" "unprognostic (0.00e+0)" "unprognostic (6.52e-2)" "unprognostic (4.21e-4)" "unprognostic (2.30e-3)" "unprognostic (8.38e-2)" 0.2 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.1 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 4.2 0.1 0.1 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 18.7 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.9 5.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.1 0.3 0.0 21.3 0.0 0.2 0.0 0.3 0.1 0.1 0.1 0.0 7.8 0.0 0.0 0.0 1.0 0.3 0.0 0.2 0.0 0.1 0.0 10.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.1 0.1 0.0 1.8 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 25.5 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.2 13.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 HORMAD2 "CT46.2, MGC26710" ENSG00000176635 "HORMA domain containing 2" Q8N7B1 22 30080464-30177075 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 22.8" "Group enriched" "Detected in some" 7 "Early spermatids: 52.8;Spermatocytes: 133.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA003074, HPA043880" Enhanced Supported Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "Centrosome, Cytosol" "HPA003074: AB_1850916, HPA043880: " "unprognostic (1.43e-1)" "unprognostic (6.77e-3)" "unprognostic (2.33e-1)" "unprognostic (1.36e-2)" "unprognostic (8.19e-3)" "unprognostic (1.96e-1)" "unprognostic (2.50e-2)" "unprognostic (2.12e-1)" 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 2.9 0.0 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 22.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.3 0.2 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.0 0.0 3.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.8 0.1 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 3.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 9.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.6 0.2 0.0 133.0 12.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 HOXB1 "HOX2, HOX2I" ENSG00000120094 "Homeobox B1" P14653 17 48528526-48531011 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Early spermatids: 2.2" "Cancer enriched" "Detected in single" 15 "testis cancer: 3.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA044576 Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm Cytosol "HPA044576: AB_10794501" "unprognostic (1.80e-2)" "unprognostic (9.50e-3)" "unprognostic (8.22e-2)" "unprognostic (1.22e-1)" "unprognostic (6.26e-2)" "unprognostic (2.40e-2)" "unprognostic (1.03e-1)" "unprognostic (1.96e-1)" "unprognostic (6.74e-2)" "unprognostic (1.45e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.2 HOXB5 "HOX2, HOX2A" ENSG00000120075 "Homeobox B5" P09067 17 48591257-48593779 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.1;kidney: 32.5" "Cell type enhanced" "Detected in some" "Collecting duct cells: 53.3;Distal tubular cells: 25.4;Endometrial ciliated cells: 48.8;Glandular and luminal cells: 46.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 28.1" "Region enhanced" "Detected in many" "medulla oblongata: 39.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 28.8;HeLa: 8.7;RPTEC TERT1: 21.7" "Region enriched" "Detected in single" 230 "pons and medulla: 22.9" "Group enriched" "Detected in some" 9 "medulla oblongata: 19.3;spinal cord: 14.3" "HPA043851, HPA074454" Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 44: Endometrium - Transcription" Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA043851: AB_2732509, HPA074454: AB_2686690" "unprognostic (6.50e-2)" "unprognostic (1.63e-1)" "unprognostic (4.22e-2)" "prognostic favorable (6.28e-4)" "unprognostic (6.48e-3)" "unprognostic (7.12e-2)" "unprognostic (8.14e-2)" "prognostic unfavorable (4.61e-4)" "unprognostic (2.47e-1)" "unprognostic (1.47e-3)" "unprognostic (5.10e-2)" "unprognostic (9.64e-2)" "unprognostic (7.61e-3)" "unprognostic (8.08e-3)" "unprognostic (1.35e-1)" "unprognostic (2.86e-2)" "prognostic favorable (8.59e-5)" 4.8 3.9 0.1 2.5 0.0 0.1 1.8 0.0 0.1 6.2 0.0 16.6 1.7 2.3 18.4 0.2 7.4 0.2 0.1 0.1 0.0 32.5 0.6 5.9 0.1 39.1 0.3 0.2 0.7 1.0 0.0 1.2 10.9 1.1 4.9 0.0 0.0 6.9 0.4 0.8 12.2 1.9 24.8 2.6 4.9 0.8 0.0 0.0 0.5 0.2 0.0 2.8 1.5 9.0 2.6 6.5 0.0 3.2 3.2 3.5 0.0 0.0 0.0 0.0 0.0 0.1 3.5 0.0 6.5 3.7 0.7 0.0 0.3 0.0 0.0 0.0 28.8 1.3 8.7 0.0 5.5 0.0 1.4 1.8 0.0 3.9 0.0 1.1 2.0 0.2 2.1 0.0 4.4 0.0 0.0 0.0 0.0 3.6 2.3 0.0 1.2 0.0 21.7 2.2 0.0 0.0 0.2 0.0 3.3 0.1 0.6 0.0 6.5 0.9 2.6 0.7 0.4 0.0 0.0 0.0 0.2 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 39.1 0.3 10.9 24.8 0.0 9.0 4.9 0.0 1.1 0.0 0.0 0.9 0.2 0.0 1.2 0.0 0.3 0.3 0.4 0.0 0.0 53.3 0.0 0.0 0.1 13.5 25.4 0.0 0.9 48.8 4.1 6.6 4.2 2.7 0.0 0.0 0.0 3.8 1.1 46.0 0.0 0.0 8.2 0.0 0.7 0.0 0.0 11.4 0.0 4.2 0.8 0.5 0.0 0.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.4 0.0 0.1 7.0 0.5 0.0 0.0 0.0 0.2 4.9 8.6 11.0 0.3 0.3 0.0 0.6 0.0 11.3 0.1 HOXB7 "HOX2, HOX2C" ENSG00000260027 "Homeobox B7" P09629 17 48607232-48633572 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "epididymis: 135.1" "Cell type enhanced" "Detected in many" "Collecting duct cells: 86.5;Distal enterocytes: 131.3;Distal tubular cells: 148.7;Endometrial ciliated cells: 82.9;Glandular and luminal cells: 73.1;Intestinal goblet cells: 77.6;Paneth cells: 67.8;Proximal enterocytes: 140.3;Undifferentiated cells: 63.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 8 "medulla oblongata: 5.6;spinal cord: 13.3;white matter: 7.5" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 81.9;OE19: 74.7;RPTEC TERT1: 66.5;SK-MEL-30: 84.3" "Region enriched" "Detected in single" 58 "pons and medulla: 5.7" "Region enriched" "Detected in some" 7 "spinal cord: 22.2" HPA049940 Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Nuclear bodies" Cytosol "HPA049940: AB_2616461" "unprognostic (6.76e-2)" "unprognostic (6.76e-2)" "unprognostic (1.03e-1)" "unprognostic (1.44e-1)" "unprognostic (1.39e-3)" "unprognostic (1.42e-2)" "unprognostic (1.69e-2)" "unprognostic (8.05e-3)" "unprognostic (9.16e-2)" "unprognostic (9.91e-2)" "unprognostic (7.01e-3)" "unprognostic (7.81e-3)" "unprognostic (1.17e-2)" "unprognostic (1.56e-2)" "unprognostic (1.06e-1)" "unprognostic (2.41e-1)" "prognostic favorable (2.39e-4)" 13.2 11.0 0.1 3.9 0.1 0.2 12.4 0.0 0.3 21.8 0.1 16.9 1.1 5.2 135.1 0.4 8.7 0.7 0.3 0.1 0.1 30.4 0.4 2.2 2.7 5.6 0.1 0.5 0.8 5.5 0.1 5.8 1.1 2.4 15.9 0.0 0.2 16.9 1.7 3.3 18.1 6.7 13.3 3.0 5.9 1.9 0.3 0.2 0.4 0.2 0.9 7.7 5.5 7.5 48.1 20.6 0.0 0.5 14.2 21.1 0.0 0.0 0.0 0.2 0.8 31.9 0.9 0.9 81.9 19.9 23.9 6.9 0.1 0.0 0.0 22.3 15.1 7.4 15.4 0.0 11.7 0.0 14.8 13.8 6.3 14.2 0.0 3.5 43.8 14.7 8.0 0.3 46.0 12.5 1.0 0.4 0.0 74.7 0.1 0.0 39.2 5.5 66.5 15.8 0.0 0.1 16.0 0.0 84.3 1.1 3.8 4.7 38.1 0.0 24.8 20.5 36.9 2.6 6.3 0.1 0.4 0.0 58.6 0.0 0.0 0.0 1.5 0.0 0.8 0.7 0.2 0.8 0.0 1.4 0.0 0.5 0.0 1.0 0.0 0.7 2.1 0.2 0.1 0.1 0.0 0.3 0.1 0.1 5.6 0.1 1.1 13.3 0.3 7.5 55.4 0.0 0.0 0.0 2.0 5.5 0.9 0.0 0.6 0.0 0.9 1.0 0.3 0.0 0.0 86.5 0.0 6.8 1.6 131.3 148.7 0.1 0.3 82.9 6.3 20.3 36.5 1.3 0.0 1.3 19.3 6.4 0.0 73.1 5.1 0.0 1.4 0.2 11.5 0.0 0.0 77.6 0.0 10.6 5.4 0.2 0.6 2.8 24.9 0.0 1.7 0.0 2.1 0.0 0.0 0.3 67.8 0.0 5.1 0.6 140.3 31.6 0.0 0.0 0.0 3.5 8.9 1.7 20.9 0.2 2.0 1.8 2.6 0.1 63.1 3.5 HOXC6 "HOX3, HOX3C" ENSG00000197757 "Homeobox C6" P09630 12 53990624-54030823 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 27.1;ovary: 26.2" "Cell type enhanced" "Detected in many" "Distal tubular cells: 17.6;Fibroblasts: 14.0;Granulosa cells: 13.2;Leydig cells: 22.4;Peritubular cells: 15.1;Skeletal myocytes: 13.5;Spermatocytes: 34.0" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 15 "medulla oblongata: 4.1;pons: 4.3;spinal cord: 3.1;white matter: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 94.4;fHDF/TERT166: 47.9;HDLM-2: 80.6" "Region enriched" "Detected in single" 14 "pons and medulla: 1.4" "Region enriched" "Detected in single" 32 "spinal cord: 9.7" HPA054981 Supported Nucleoplasm,Cytosol No No "Cluster 89: Fibroblasts - ECM organization" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 33: Fibroblasts - ECM organization" Nucleoplasm Cytosol "HPA054981: AB_2682662" "unprognostic (3.54e-2)" "unprognostic (9.20e-2)" "unprognostic (1.68e-6)" "unprognostic (3.92e-2)" "unprognostic (1.10e-3)" "unprognostic (5.01e-4)" "unprognostic (5.52e-3)" "unprognostic (3.32e-3)" "unprognostic (2.81e-1)" "unprognostic (6.26e-2)" "unprognostic (8.82e-2)" "unprognostic (3.70e-3)" "prognostic unfavorable (3.55e-6)" "unprognostic (8.63e-2)" "unprognostic (5.76e-2)" "unprognostic (1.40e-2)" "unprognostic (4.71e-2)" 18.9 14.8 0.0 1.1 0.0 0.0 13.4 0.0 0.1 1.1 0.0 1.0 0.3 5.3 19.3 2.9 27.1 0.1 0.6 0.0 0.1 17.8 0.0 0.7 4.3 4.1 0.2 26.2 0.4 0.3 0.0 5.7 4.3 1.3 0.2 0.5 0.2 0.5 17.3 13.3 11.4 8.8 3.1 0.2 0.7 3.5 0.1 0.1 1.0 0.0 0.0 1.3 1.5 1.5 6.6 4.5 0.0 94.4 34.1 32.0 1.0 4.9 4.7 7.9 7.1 4.1 7.4 3.0 6.3 47.9 2.3 10.7 3.8 0.5 6.7 80.6 27.3 5.2 14.6 0.0 3.8 0.5 12.0 30.7 5.0 15.7 5.6 0.0 0.3 0.3 3.5 0.0 27.4 1.5 0.0 3.3 0.0 0.8 4.1 0.0 3.6 0.0 24.1 0.2 0.0 11.8 7.3 7.0 21.7 8.2 16.6 1.3 0.0 9.7 21.1 10.7 7.0 0.7 0.9 0.2 3.7 0.8 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.1 0.2 4.3 3.1 0.1 1.5 3.9 0.0 0.0 0.0 0.3 6.2 0.0 0.0 9.1 0.0 3.2 5.8 0.6 0.0 0.0 3.7 0.0 0.4 0.2 0.0 17.6 0.0 1.6 0.0 0.6 1.1 0.0 0.0 0.0 0.0 3.0 14.0 0.0 0.0 0.0 13.2 0.0 0.0 0.9 0.0 0.0 2.3 0.0 0.0 1.8 1.0 22.4 0.4 12.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 15.1 0.1 0.0 0.8 9.6 0.0 2.1 6.6 13.5 11.8 34.0 2.7 5.1 4.0 0.3 0.4 7.4 0.2 0.0 ICAM2 CD102 ENSG00000108622 "Intercellular adhesion molecule 2" P13598 17 64002594-64020634 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 168.1" "Cell type enhanced" "Detected in many" "Adipocytes: 341.8;Endothelial cells: 180.8;Hepatic stellate cells: 128.5;NK-cells: 106.1;Plasma cells: 114.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 6 "HUVEC TERT2: 1260.8;TIME: 319.0" "Low region specificity" "Detected in all" HPA071155 Approved "Plasma membrane,Cytosol" NA NA 730000000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 16: Immune cells - Immune response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Plasma membrane" Cytosol "HPA071155: " "unprognostic (9.43e-3)" "unprognostic (3.31e-2)" "unprognostic (5.15e-2)" "unprognostic (1.15e-1)" "unprognostic (8.97e-2)" "unprognostic (1.64e-3)" "unprognostic (1.34e-1)" "unprognostic (3.74e-1)" "unprognostic (8.28e-2)" "unprognostic (2.15e-1)" "unprognostic (4.18e-2)" "unprognostic (1.55e-2)" "unprognostic (9.07e-2)" "unprognostic (1.48e-1)" "unprognostic (3.93e-2)" "unprognostic (6.04e-2)" "unprognostic (2.29e-1)" 97.4 11.3 39.6 30.4 39.6 20.7 78.7 40.3 48.3 20.3 34.6 26.3 14.1 24.4 6.7 12.1 22.2 18.8 99.7 38.2 40.5 44.3 14.6 84.5 60.5 42.1 40.9 12.7 15.4 9.0 12.4 79.3 42.9 16.1 18.2 1.2 16.0 8.6 37.9 16.3 34.2 29.5 41.4 168.1 18.8 3.5 44.6 31.5 33.6 55.9 41.8 33.0 21.4 40.6 0.0 0.0 0.0 0.0 11.3 10.8 3.2 1.1 0.7 0.3 1.1 2.7 52.2 92.9 16.6 0.0 0.3 0.4 1.2 0.0 1.7 22.3 0.0 82.9 4.4 10.0 1.8 14.2 0.3 0.4 0.0 0.8 0.2 0.0 1260.8 78.8 67.7 50.5 0.3 0.0 101.8 11.8 0.1 0.7 0.0 60.3 0.2 128.7 6.7 12.8 0.0 0.8 0.0 0.2 0.0 0.1 0.0 10.3 319.0 0.2 0.8 6.2 0.0 47.6 18.7 83.4 0.1 17.7 0.0 444.8 191.8 62.1 282.8 464.6 326.0 265.6 371.2 270.7 203.6 328.9 400.3 253.3 23.1 188.5 525.8 67.2 450.8 502.0 39.6 39.6 40.3 48.3 38.2 40.5 42.1 40.9 42.9 41.4 44.6 40.6 341.8 0.0 8.4 0.0 47.8 7.4 4.0 5.2 0.6 0.1 6.1 11.3 0.5 1.5 4.5 7.3 0.0 0.5 41.7 1.7 0.0 1.2 0.6 1.2 2.4 180.8 1.2 28.2 0.1 1.4 0.3 13.8 1.1 0.8 12.0 0.7 128.5 1.9 20.0 0.0 0.0 2.2 2.0 55.6 13.4 1.3 0.3 56.9 28.4 21.5 25.7 0.4 106.1 0.5 0.2 6.8 4.7 1.9 114.4 3.8 0.6 0.5 4.1 0.5 6.6 7.4 11.6 0.2 0.3 0.7 5.4 1.0 60.1 6.5 4.2 2.8 IFI30 "GILT, IFI-30, IP-30, IP30, MGC32056" ENSG00000216490 "IFI30 lysosomal thiol reductase" P13284 19 18173162-18178117 "Predicted intracellular proteins, Predicted membrane proteins" Immunity Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 572.7;lymphoid tissue: 708.3" "Cell type enhanced" "Detected in many" "Hofbauer cells: 155.9;Kupffer cells: 205.4;Langerhans cells: 139.3;Macrophages: 426.2;monocytes: 144.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 9509.8;eosinophil: 3890.4;intermediate monocyte: 14243.6;myeloid DC: 5699.9;non-classical monocyte: 9865.9" "Group enriched" "Detected in all" 8 "dendritic cells: 5699.9;granulocytes: 3890.4;monocytes: 14243.6" "Cell line enhanced" "Detected in many" "Daudi: 655.7;RPMI-8226: 717.7;SK-BR-3: 457.4;U-266/84: 794.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA026650 Enhanced Supported Vesicles,Cytosol "Intracellular and membrane" NA NA 110000 "Cluster 7: Monocytes - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 16: U-266 - Nucleosome" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Vesicles, Cytosol" "HPA026650: AB_10602237" "unprognostic (4.66e-2)" "unprognostic (1.25e-4)" "unprognostic (2.35e-3)" "unprognostic (7.40e-2)" "unprognostic (1.76e-2)" "unprognostic (3.11e-2)" "unprognostic (8.10e-3)" "unprognostic (2.40e-1)" "unprognostic (4.01e-2)" "unprognostic (9.19e-3)" "unprognostic (3.04e-1)" "unprognostic (1.19e-1)" "unprognostic (7.29e-11)" "unprognostic (3.50e-1)" "unprognostic (1.62e-2)" "unprognostic (3.39e-2)" "unprognostic (9.59e-3)" 132.4 121.0 18.4 708.3 20.8 283.8 58.6 20.3 104.5 40.8 48.7 129.0 197.3 22.2 26.9 38.7 57.3 109.6 31.2 18.0 23.3 80.3 148.2 572.7 370.7 32.0 24.9 14.8 61.3 75.0 27.9 128.8 40.5 31.6 148.0 2.6 66.3 22.0 12.6 55.0 153.6 165.0 26.8 385.3 112.2 16.0 69.4 91.9 54.2 9.0 221.0 215.7 19.6 49.8 115.5 59.2 0.4 37.9 11.2 19.9 102.6 11.8 17.2 34.6 91.8 132.3 193.1 655.7 96.6 39.7 175.2 85.1 69.9 30.1 3.7 182.5 55.2 8.1 98.1 188.9 111.8 20.1 46.9 70.4 60.4 59.8 19.7 4.4 2.0 23.8 96.8 394.8 16.6 217.3 9.9 2.5 21.2 380.6 68.7 65.8 4.5 717.7 101.1 3.7 5.3 8.0 200.5 457.4 11.3 7.4 31.6 8.8 4.2 55.2 34.2 120.7 12.0 14.6 794.7 368.5 154.1 133.5 8.5 106.9 9509.8 3890.4 40.8 14243.6 38.8 952.6 28.5 31.1 5699.9 708.1 19.7 24.3 2102.8 70.2 9865.9 173.2 41.5 11082.7 18.4 20.8 20.3 104.5 18.0 23.3 32.0 24.9 40.5 26.8 69.4 49.8 6.4 9.6 38.8 0.0 54.2 3.6 2.5 2.1 2.2 0.4 8.6 13.2 1.1 4.3 18.3 12.9 0.0 5.6 4.0 8.3 1.9 1.8 0.3 2.5 1.7 8.4 0.0 4.6 0.1 1.1 14.8 8.1 6.6 4.1 13.9 0.2 3.6 1.3 155.9 0.0 0.1 14.9 2.0 205.4 139.3 0.2 0.3 426.2 5.4 1.0 144.1 0.7 5.2 0.0 0.1 1.2 3.4 0.0 47.7 4.6 5.9 5.4 8.9 0.7 0.0 2.6 1.8 0.2 0.7 3.7 3.3 12.0 9.6 1.5 9.6 1.2 IFITM1 "9-27, CD225, DSPA2a, IFI17" ENSG00000185885 "Interferon induced transmembrane protein 1" P13164 11 310041-315272 "CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Antiviral defense, Immunity, Innate immunity, Osteogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 673.8;Endothelial cells: 364.4;Leydig cells: 300.8;Sertoli cells: 276.1;T-cells: 595.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 1494.7;gdT-cell: 2906.3;MAIT T-cell: 2003.4;memory CD4 T-cell: 3120.6;memory CD8 T-cell: 3000.3;naive CD4 T-cell: 2939.3;naive CD8 T-cell: 2996.4;neutrophil: 2741.6;NK-cell: 4679.9;T-reg: 1944.8" "Group enriched" "Detected in all" 7 "granulocytes: 2741.6;NK-cells: 4679.9;T-cells: 3120.6" "Cell line enhanced" "Detected in many" "BJ hTERT+: 1038.8;BJ hTERT+ SV40 Large T+: 2266.3;BJ hTERT+ SV40 Large T+ RasG12V: 4016.8;HMC-1: 1138.9" "HPA004810, CAB017615" Enhanced Uncertain "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 58: T-cells - T-cell receptor" "Golgi apparatus" "Plasma membrane, Cytosol" "CAB017615: AB_2264496, HPA004810: AB_1851419" "unprognostic (1.03e-3)" "unprognostic (6.79e-2)" "unprognostic (1.03e-1)" "unprognostic (2.98e-1)" "unprognostic (2.57e-1)" "unprognostic (9.06e-2)" "unprognostic (7.58e-2)" "unprognostic (3.03e-1)" "unprognostic (6.21e-2)" "unprognostic (5.53e-2)" "unprognostic (6.64e-3)" "unprognostic (1.48e-2)" "prognostic unfavorable (5.77e-9)" "unprognostic (7.29e-2)" "unprognostic (6.29e-2)" "unprognostic (3.15e-2)" "unprognostic (3.82e-2)" 477.7 102.3 291.8 282.0 303.4 367.1 401.7 293.8 402.1 563.3 321.5 249.0 128.4 314.6 1152.4 147.4 537.4 247.9 368.4 292.6 305.4 317.5 191.4 246.5 417.2 324.8 295.6 607.5 78.8 154.0 145.1 278.5 322.5 190.6 172.0 14.9 199.8 324.3 134.2 164.6 252.4 367.4 308.6 679.7 141.6 56.3 317.5 296.5 263.4 259.3 295.9 307.4 364.7 304.3 125.7 5.5 1011.4 74.5 79.1 279.8 7.4 250.1 1038.8 2266.3 4016.8 3.7 782.2 3.0 157.9 257.1 23.5 269.0 36.5 26.2 52.0 255.3 51.8 125.9 77.5 11.8 668.2 182.8 1138.9 496.3 0.2 26.6 2.6 27.0 4.2 41.1 450.0 880.7 1.7 23.9 85.1 318.2 264.5 0.5 33.5 27.1 3.1 24.5 654.9 0.0 1.0 2.2 122.7 11.9 196.9 138.5 42.1 17.0 8.8 3.8 4.7 1.5 1.1 61.6 44.8 6.8 3.4 253.8 3.1 544.4 62.1 1494.7 2906.3 312.7 2003.4 364.9 3120.6 3000.3 114.2 323.6 2939.3 2996.4 2741.6 4679.9 539.0 33.7 1944.8 4673.8 291.8 303.4 293.8 402.1 292.6 305.4 324.8 295.6 322.5 308.6 317.5 304.3 240.7 35.3 119.4 2.6 88.2 27.9 17.1 70.2 673.8 0.0 13.0 12.6 8.4 2.8 115.3 33.1 0.0 3.3 258.6 13.7 5.9 1.7 1.4 14.6 96.5 364.4 1.2 27.8 0.0 1.4 30.7 236.0 33.6 20.8 18.9 5.6 164.6 24.6 11.8 0.0 0.0 17.3 10.2 10.1 26.8 3.8 300.8 45.4 78.2 42.2 2.1 0.0 126.7 0.0 0.2 0.7 15.0 124.5 141.2 2.3 15.0 1.0 26.0 0.0 276.1 16.4 213.4 0.6 1.5 50.4 14.3 4.0 595.8 2.1 29.2 5.7 IFITM5 "BRIL, DSPA1, fragilis4, Hrmp1" ENSG00000206013 "Interferon induced transmembrane protein 5" A6NNB3 11 298200-299526 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Mineral balance" "Developmental protein" "Disease variant, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 4.9;pancreas: 7.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 8 "cerebral cortex: 4.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA039258 Supported "Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 48: Smooth muscle cells - ECM organization" "Plasma membrane" "Vesicles, Cytosol" "HPA039258: AB_10673608" "unprognostic (9.84e-2)" "unprognostic (2.15e-1)" "unprognostic (1.38e-1)" "unprognostic (5.80e-2)" "unprognostic (7.46e-2)" "unprognostic (4.20e-2)" "unprognostic (4.42e-2)" "unprognostic (8.31e-2)" "unprognostic (7.99e-3)" "unprognostic (1.94e-3)" "unprognostic (1.01e-1)" "unprognostic (1.47e-1)" "unprognostic (4.90e-2)" 0.1 0.0 0.0 0.1 0.0 0.7 0.2 0.0 4.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.2 0.4 0.1 0.1 0.1 0.0 7.3 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.1 0.1 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFT122 "FAP80, SPG, WDR10, WDR10p, WDR140" ENSG00000163913 "Intraflagellar transport 122" Q9HBG6 3 129440036-129520507 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "Ciliopathy, Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 72.8" "Cell type enhanced" "Detected in many" "Early spermatids: 81.7;Late spermatids: 70.3;Spermatocytes: 120.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041815 Uncertain Uncertain Cytosol NA NA "Cluster 10: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 66: Spermatocytes - Spermatogenesis" Cytosol "HPA041815: AB_10804118" "unprognostic (7.16e-2)" "unprognostic (3.71e-3)" "unprognostic (3.67e-1)" "unprognostic (7.61e-3)" "unprognostic (5.29e-2)" "unprognostic (5.33e-3)" "unprognostic (4.68e-2)" "unprognostic (1.82e-1)" "unprognostic (7.90e-2)" "unprognostic (3.30e-1)" "unprognostic (1.67e-2)" "unprognostic (3.50e-2)" "unprognostic (1.09e-2)" "unprognostic (7.67e-2)" "unprognostic (5.33e-1)" "unprognostic (9.91e-2)" "unprognostic (4.20e-3)" 9.6 7.4 5.7 5.2 7.6 10.1 12.4 6.5 9.2 13.1 15.3 7.6 4.7 12.6 12.7 7.2 24.7 6.7 12.0 6.8 6.8 11.7 9.2 8.8 6.7 4.5 6.2 25.4 13.3 13.9 14.4 10.8 3.0 7.4 6.9 11.2 7.9 8.5 3.9 13.8 5.3 8.9 3.7 4.5 9.0 72.8 7.0 8.9 13.1 2.9 5.7 6.6 8.4 6.3 16.5 24.6 21.0 13.5 29.7 21.0 10.5 8.5 12.9 14.8 14.1 11.9 10.7 10.6 10.0 11.3 14.5 10.4 8.2 7.7 13.3 5.8 8.8 8.2 21.8 10.3 8.1 22.2 7.2 24.7 5.7 11.4 8.8 12.9 20.3 21.8 8.4 22.1 12.1 18.2 18.2 11.6 14.1 12.3 7.0 16.3 8.0 7.7 15.7 3.0 25.9 10.6 24.8 8.2 7.5 7.9 22.6 17.9 9.0 10.1 8.7 13.6 10.2 15.0 11.4 9.3 9.2 11.3 8.1 4.5 3.1 3.7 0.9 2.2 1.6 1.9 1.6 2.3 3.2 2.1 1.8 2.2 1.4 1.5 0.9 0.8 3.0 2.1 5.7 7.6 6.5 9.2 6.8 6.8 4.5 6.2 3.0 3.7 7.0 6.3 7.5 9.6 8.2 28.1 4.3 2.7 5.8 4.5 2.8 9.7 18.0 13.3 6.4 15.7 5.6 25.8 37.5 6.7 4.5 6.2 7.9 5.2 81.7 43.4 11.0 9.7 3.0 7.4 35.1 8.9 5.2 9.8 19.9 10.2 5.1 8.7 20.7 6.0 9.3 5.0 23.1 10.2 4.1 7.2 2.2 70.3 18.6 4.1 3.6 15.0 3.8 11.8 3.1 12.1 15.9 3.4 4.2 13.9 3.4 3.6 6.2 8.2 37.3 21.4 0.0 12.8 7.7 120.4 38.0 5.4 2.8 2.6 4.1 10.6 8.7 3.4 IL21R CD360 ENSG00000103522 "Interleukin 21 receptor" Q9HBE5 16 27402174-27452042 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins" Receptor "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 7.6;lymphoid tissue: 24.7" "Cell type enhanced" "Detected in some" "B-cells: 15.5;dendritic cells: 21.8;Langerhans cells: 11.4;NK-cells: 23.7;Plasma cells: 13.4;T-cells: 25.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 25.9;HDLM-2: 110.8;Karpas-707: 49.3;RH-30: 37.2;RPMI-8226: 63.0;U-266/70: 24.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA042296 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 3: T-cells - Adaptive immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "Plasma membrane, Cytosol" "HPA042296: AB_10806236" "unprognostic (2.91e-2)" "unprognostic (2.65e-3)" "unprognostic (6.64e-4)" "unprognostic (1.58e-3)" "unprognostic (2.14e-1)" "prognostic favorable (7.29e-4)" "unprognostic (8.33e-2)" "unprognostic (2.06e-1)" "unprognostic (8.50e-6)" "unprognostic (2.26e-2)" "unprognostic (1.13e-2)" "unprognostic (8.71e-2)" "unprognostic (2.34e-10)" "unprognostic (8.79e-2)" "unprognostic (4.42e-2)" "unprognostic (1.50e-1)" "unprognostic (9.58e-2)" 0.5 0.4 1.4 11.9 1.0 7.6 0.2 1.1 2.6 0.2 0.9 0.8 0.6 0.3 0.2 0.3 0.2 1.1 0.7 0.9 2.3 0.9 0.4 2.9 24.7 2.1 2.3 0.2 0.3 0.0 0.5 0.8 3.3 0.4 0.9 1.1 0.6 0.1 0.3 0.8 2.1 0.7 1.2 5.5 1.5 1.1 1.2 14.4 0.6 0.0 18.8 2.2 0.2 1.6 0.1 0.2 0.3 0.2 0.0 1.3 0.8 0.8 0.1 0.1 2.2 0.2 0.2 25.9 0.2 2.1 1.4 0.1 0.0 0.1 0.1 110.8 0.1 5.4 0.2 0.7 3.4 0.2 1.5 3.8 0.0 6.8 0.1 0.7 0.0 0.6 0.3 49.3 3.8 0.2 0.1 0.5 0.9 0.1 0.0 0.4 37.2 63.0 0.0 0.1 0.2 0.2 0.1 0.1 2.7 0.2 0.1 1.3 2.8 1.9 0.7 0.6 0.2 24.7 9.4 5.9 5.2 1.4 0.2 0.5 0.4 0.1 13.4 8.3 4.9 1.8 8.6 14.2 2.3 14.2 9.2 9.3 0.9 9.5 27.0 1.1 10.8 7.3 1.4 1.0 1.1 2.6 0.9 2.3 2.1 2.3 3.3 1.2 1.2 1.6 0.2 0.0 1.3 0.0 15.5 0.4 0.1 0.0 0.0 2.0 0.2 0.1 1.9 0.0 0.0 0.0 4.2 0.1 21.8 0.1 0.0 0.0 6.5 0.1 0.2 0.9 0.0 0.0 0.4 0.0 0.1 0.3 1.5 0.2 0.0 0.0 1.1 0.2 8.2 0.0 0.5 0.0 0.0 5.0 11.4 5.7 0.0 3.6 1.8 2.8 1.8 0.2 23.7 0.5 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.2 0.0 0.5 0.0 0.8 0.8 0.2 0.0 0.0 0.9 0.1 25.1 0.1 0.1 0.1 INTS12 "INT12, PHF22, SBBI22" ENSG00000138785 "Integrator complex subunit 12" Q96CB8 4 105682627-105895986 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035772, HPA041814" Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Cytosol" "Nuclear bodies, Plasma membrane" "HPA035772: AB_10671109, HPA041814: AB_2677687" "unprognostic (5.30e-2)" "unprognostic (4.54e-2)" "unprognostic (1.84e-3)" "unprognostic (1.78e-1)" "unprognostic (3.68e-2)" "unprognostic (2.58e-3)" "prognostic unfavorable (2.67e-4)" "unprognostic (3.95e-2)" "unprognostic (1.13e-1)" "unprognostic (1.53e-3)" "unprognostic (3.00e-2)" "unprognostic (3.48e-2)" "unprognostic (5.93e-3)" "unprognostic (3.62e-1)" "unprognostic (1.37e-1)" "unprognostic (2.16e-2)" "unprognostic (2.06e-1)" 15.2 11.1 12.8 10.9 13.3 30.4 20.2 14.9 18.0 14.1 12.0 14.7 18.1 14.6 17.8 13.5 13.2 12.7 18.9 12.4 14.9 18.7 22.6 16.4 14.0 12.3 14.0 11.6 12.6 17.2 10.3 11.9 12.5 18.1 15.6 17.2 14.4 13.4 26.5 14.0 15.5 17.1 12.7 12.6 15.0 13.9 14.3 19.9 19.9 26.0 17.0 15.6 11.2 13.7 24.4 12.8 28.5 29.8 27.5 32.6 20.8 28.2 29.1 34.7 35.9 18.1 26.9 34.9 15.4 31.9 26.9 13.8 31.7 40.7 42.8 36.9 19.0 26.3 19.6 25.7 44.3 46.7 23.0 31.0 51.7 34.5 51.4 22.5 32.3 29.1 39.8 26.7 37.8 25.6 55.3 28.9 12.4 35.3 19.5 28.0 31.0 26.8 32.5 16.3 30.7 24.6 19.8 32.6 31.0 22.4 26.4 27.2 21.3 22.7 23.3 24.8 30.5 40.8 40.9 52.2 25.3 31.5 46.0 64.0 23.7 38.5 25.7 26.6 28.9 33.0 29.4 29.4 27.7 32.1 30.6 28.3 17.9 42.9 28.3 42.6 34.8 21.9 12.8 13.3 14.9 18.0 12.4 14.9 12.3 14.0 12.5 12.7 14.3 13.7 19.0 12.8 11.8 14.0 15.1 11.0 11.8 25.8 15.4 10.5 12.1 11.7 18.7 11.5 12.9 3.7 10.4 16.1 13.6 8.3 43.0 25.2 35.8 8.1 11.2 16.8 6.0 15.6 13.8 20.3 18.6 10.8 8.6 8.7 24.7 9.9 11.7 9.3 17.8 10.1 15.7 5.2 30.5 9.0 9.5 28.4 12.2 9.8 7.2 9.4 15.5 14.0 21.6 27.2 19.1 20.5 6.8 8.2 18.9 14.2 16.5 17.1 6.2 9.3 0.0 12.9 20.1 13.4 16.2 14.1 10.4 18.3 13.0 14.9 10.2 11.0 INTU "CPLANE4, KIAA1284, PDZD6, PDZK6" ENSG00000164066 "Inturned planar cell polarity protein" Q9ULD6 4 127623271-127726737 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 13.2" "Cell type enhanced" "Detected in many" "Astrocytes: 133.5;Cone photoreceptor cells: 137.6;Endometrial ciliated cells: 81.4;Oligodendrocytes: 78.0;Respiratory ciliated cells: 84.0;Rod photoreceptor cells: 181.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036714, HPA036715, HPA061467" Approved Uncertain Cytosol NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 58: Brain - Synaptic function" "Cluster 12: NES - Nervous system development" "Cluster 9: Photoreceptor cells - Phototransduction" Cytosol "HPA036714: AB_10670238, HPA036715: AB_2675267, HPA061467: " "unprognostic (1.09e-1)" "unprognostic (2.89e-1)" "unprognostic (4.11e-2)" "unprognostic (1.38e-2)" "unprognostic (1.48e-1)" "unprognostic (1.40e-1)" "unprognostic (2.88e-3)" "unprognostic (4.30e-2)" "unprognostic (2.91e-1)" "unprognostic (1.43e-1)" "unprognostic (3.90e-2)" "unprognostic (1.53e-1)" "unprognostic (1.22e-1)" "unprognostic (9.49e-2)" "unprognostic (3.28e-1)" "unprognostic (2.36e-1)" "unprognostic (5.33e-2)" 1.5 1.6 6.0 1.2 5.9 2.6 2.9 4.0 7.0 1.4 4.9 1.2 2.1 2.6 5.1 1.3 2.4 1.5 0.9 4.6 3.2 1.9 0.7 1.6 1.1 1.0 3.1 3.3 1.2 1.1 2.8 1.0 1.3 1.8 1.6 13.2 1.8 1.2 1.1 3.8 1.0 1.3 0.3 1.3 2.1 2.3 6.3 0.6 2.7 2.5 0.7 1.2 1.6 5.9 2.5 1.7 8.7 3.1 1.1 2.7 0.7 1.4 0.7 1.0 1.9 1.2 2.2 1.8 2.1 1.2 2.8 1.5 7.0 1.3 2.9 0.8 2.1 2.6 3.3 3.0 1.1 2.3 1.2 1.2 1.5 2.9 0.7 2.6 2.7 0.9 3.4 2.0 1.4 1.2 0.8 1.2 4.0 0.9 1.6 0.8 2.0 0.5 1.8 1.8 4.1 2.9 2.9 1.6 1.0 4.3 1.8 1.3 2.1 2.5 1.9 2.2 2.0 1.2 1.9 0.6 2.1 1.0 1.5 1.1 0.2 0.1 0.2 0.1 0.2 0.2 0.2 0.1 0.1 0.3 0.2 0.2 1.4 0.3 0.2 0.4 0.1 0.0 6.0 5.9 4.0 7.0 4.6 3.2 1.0 3.1 1.3 0.3 6.3 5.9 8.9 22.4 15.4 133.5 0.6 6.0 10.4 7.2 12.0 56.3 13.7 24.8 15.6 10.0 18.8 3.7 137.6 8.3 0.4 2.7 7.9 7.6 10.2 81.4 30.5 8.2 11.5 3.8 36.0 5.1 6.2 18.7 10.2 15.8 5.1 22.9 6.4 2.5 3.0 37.0 36.6 5.9 10.2 1.6 9.6 11.9 14.0 3.0 7.2 23.4 0.5 16.5 0.0 19.6 78.0 3.4 1.5 11.7 0.0 6.9 1.1 11.2 84.0 181.8 0.0 17.8 10.9 8.7 20.4 7.9 6.1 1.9 1.7 12.9 7.0 6.4 IRF4 "LSIRF, MUM1" ENSG00000137265 "Interferon regulatory factor 4" Q15306 6 391752-411443 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 29.2;cervix: 19.0;lymphoid tissue: 26.1" "Cell type enhanced" "Detected in some" "B-cells: 57.2;dendritic cells: 66.8;Langerhans cells: 109.7;Melanocytes: 44.4;monocytes: 56.1;Plasma cells: 235.6" "Cancer enriched" "Detected in many" 9 "melanoma: 27.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory B-cell: 10.4;myeloid DC: 10.6;naive B-cell: 10.8;plasmacytoid DC: 12.1;T-reg: 5.8" "Group enriched" "Detected in many" 5 "B-cells: 10.8;dendritic cells: 12.1;T-cells: 5.8" "Cell line enhanced" "Detected in some" "HDLM-2: 221.4;Karpas-707: 197.8;RPMI-8226: 200.0;U-266/70: 177.2;U-266/84: 141.3;WM-115: 109.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA002038, HPA002698, CAB013508" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 2: Immune cells - Immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm Cytosol "CAB013508: , HPA002038: AB_1079148, HPA002698: AB_1851893" "prognostic favorable (6.44e-4)" "unprognostic (1.88e-3)" "unprognostic (1.00e-3)" "unprognostic (1.72e-4)" "unprognostic (2.74e-1)" "prognostic favorable (1.64e-6)" "unprognostic (4.72e-2)" "unprognostic (1.05e-1)" "unprognostic (1.89e-2)" "unprognostic (5.74e-4)" "unprognostic (8.51e-2)" "unprognostic (1.12e-1)" "unprognostic (9.18e-7)" "unprognostic (2.38e-1)" "unprognostic (6.24e-2)" "unprognostic (2.90e-1)" "unprognostic (3.65e-2)" 3.1 0.4 0.1 15.9 0.1 29.2 3.2 0.1 0.2 19.0 0.2 6.9 7.6 1.5 0.3 0.9 0.7 2.5 1.0 0.1 0.1 0.4 2.4 2.2 23.2 0.3 0.1 0.6 0.1 0.0 0.3 0.1 0.2 0.5 6.8 0.0 4.5 0.4 0.2 6.8 10.2 0.7 0.2 17.4 7.2 1.1 0.1 7.0 1.1 0.1 26.1 6.3 2.4 0.2 0.4 0.0 0.0 0.0 22.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 221.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 197.8 0.0 0.0 0.1 0.1 1.2 0.0 0.0 26.1 0.0 200.0 0.0 0.0 0.4 0.0 0.0 0.2 32.0 0.6 0.1 0.3 0.0 0.0 0.1 0.0 0.3 177.2 141.3 58.4 0.2 0.0 109.0 0.1 1.8 0.0 0.6 1.5 0.0 10.4 1.0 1.0 10.6 10.8 1.7 0.7 0.0 0.3 1.5 12.1 5.8 1.5 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.2 0.2 0.1 0.2 0.8 0.0 5.3 0.0 57.2 8.3 0.1 0.0 0.0 0.0 0.6 1.5 1.2 1.5 0.0 0.0 0.0 0.0 66.8 0.2 0.0 0.1 0.0 0.3 0.9 0.6 0.0 0.0 0.1 0.7 0.0 1.8 1.5 0.4 0.0 0.0 1.1 0.5 0.3 0.0 0.1 0.1 0.0 0.6 109.7 0.2 3.4 21.7 44.4 0.0 56.1 0.0 0.0 0.0 0.3 0.1 0.1 0.0 235.6 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.9 0.0 1.0 0.4 4.3 0.1 29.8 0.0 0.1 0.1 ITGAV "CD51, MSK8, VNRA, VTNR" ENSG00000138448 "Integrin subunit alpha V" P06756 2 186590056-186680901 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "basophil: 6.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 6.2" "Cell line enhanced" "Detected in many" "RT4: 369.7;SuSa: 297.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002499, HPA004856" Supported Approved "Focal adhesion sites,Cytosol" NA NA 2000000 "Cluster 34: Basophils - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 15: RT4 - Unknown function" "Cluster 44: Endometrium - Transcription" "Focal adhesion sites, Cytosol" "CAB002499: AB_563594, HPA004856: AB_1846316" "unprognostic (4.03e-2)" "unprognostic (5.17e-3)" "unprognostic (1.22e-2)" "unprognostic (5.22e-2)" "unprognostic (1.33e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (2.08e-4)" "unprognostic (1.48e-2)" "unprognostic (6.95e-2)" "unprognostic (2.89e-1)" "prognostic unfavorable (5.07e-4)" "unprognostic (5.84e-2)" "unprognostic (2.67e-2)" "prognostic unfavorable (1.05e-6)" "unprognostic (2.61e-1)" "unprognostic (9.11e-2)" "unprognostic (8.07e-2)" 39.9 38.7 20.1 36.5 30.8 6.4 27.7 39.7 23.5 39.7 40.3 20.1 15.9 36.8 10.5 24.5 26.3 47.3 80.0 18.2 32.7 52.1 18.0 25.7 15.8 42.5 33.0 64.7 25.7 82.7 11.9 47.4 46.4 29.8 21.6 80.4 32.1 28.1 16.3 41.4 16.3 56.7 45.3 21.4 34.2 14.7 30.2 18.0 62.6 30.5 21.6 43.1 16.0 54.6 49.1 57.5 37.4 119.9 134.1 90.0 141.7 93.8 75.5 32.5 32.5 50.7 164.0 0.4 179.7 106.3 113.4 60.2 19.3 88.5 46.7 9.7 17.2 11.7 69.1 69.6 52.8 8.3 7.0 65.8 41.3 72.7 61.1 194.1 78.7 5.9 11.6 23.9 87.4 19.4 5.0 6.8 28.3 29.1 28.5 0.1 76.2 6.8 83.5 369.7 7.7 23.0 108.6 33.2 40.1 297.0 26.2 22.4 240.5 199.4 61.9 41.4 80.3 5.9 10.4 5.5 80.3 3.3 100.6 6.2 0.6 0.9 0.4 1.1 0.3 0.1 0.2 0.4 0.4 0.0 0.2 0.2 0.2 0.2 0.6 0.2 0.6 0.2 20.1 30.8 39.7 23.5 18.2 32.7 42.5 33.0 46.4 45.3 30.2 54.6 39.8 28.9 22.9 134.8 4.9 128.4 64.0 127.7 42.7 118.4 50.4 23.4 145.5 80.1 35.3 77.3 77.2 55.1 9.4 32.4 1.9 78.7 0.6 61.7 61.1 47.2 7.3 2.1 36.3 101.8 26.9 65.4 57.6 100.2 49.5 21.2 27.8 18.2 27.6 15.2 35.9 19.9 14.2 44.3 56.7 3.1 19.3 29.3 46.2 75.9 17.4 70.9 2.1 184.5 156.1 165.9 23.8 25.9 9.2 103.4 11.2 32.4 27.0 60.2 32.9 29.0 63.3 1.7 2.4 27.7 103.7 39.7 10.9 18.1 15.5 77.7 KANK4 "ANKRD38, KIAA0172" ENSG00000132854 "KN motif and ankyrin repeat domains 4" Q5T7N3 1 62236165-62319434 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.6;pancreas: 15.2" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 31.8;Exocrine glandular cells: 8.0;Extravillous trophoblasts: 19.0;Oligodendrocytes: 34.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 31.8;Hep G2: 13.4;SCLC-21H: 6.2;SuSa: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA014030 Uncertain Uncertain Microtubules,Cytosol NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 28: BEWO - Transcription regulation" "Cluster 47: Cytotrophoblasts - Unknown function" Cytosol Microtubules "HPA014030: AB_2128155" "unprognostic (1.66e-2)" "unprognostic (1.90e-3)" "unprognostic (2.65e-2)" "unprognostic (1.11e-3)" "unprognostic (2.27e-2)" "unprognostic (1.48e-2)" "unprognostic (6.31e-2)" "unprognostic (1.66e-2)" "unprognostic (3.58e-2)" "unprognostic (1.54e-1)" "unprognostic (3.85e-3)" "unprognostic (1.30e-1)" "unprognostic (4.08e-3)" "unprognostic (9.06e-2)" "unprognostic (1.97e-1)" "unprognostic (3.31e-2)" "unprognostic (7.74e-6)" 10.7 0.5 1.0 0.5 5.8 0.0 2.6 10.1 3.2 0.3 0.1 1.0 0.3 0.2 0.7 0.2 0.3 0.5 0.3 0.8 4.6 1.4 3.0 2.5 0.0 19.2 13.8 0.3 15.2 5.6 0.1 10.8 22.6 1.5 1.0 1.0 8.4 0.6 0.2 0.5 0.3 0.2 5.3 0.8 2.0 0.9 7.6 0.8 0.3 0.8 0.0 0.2 0.5 8.9 0.0 0.0 1.1 0.0 0.0 0.0 31.8 0.1 0.0 0.1 0.0 4.8 0.0 0.0 0.1 1.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 2.4 13.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.2 0.0 1.0 0.6 0.0 27.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 5.8 10.1 3.2 0.8 4.6 19.2 13.8 22.6 5.3 7.6 8.9 0.1 0.0 0.0 1.3 0.0 0.0 2.4 0.4 0.6 0.3 0.5 7.0 0.9 0.0 0.0 0.0 0.0 31.8 0.0 0.5 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.0 2.3 8.0 19.0 0.9 0.0 0.1 0.0 0.1 0.4 1.5 2.3 0.0 2.3 1.4 0.0 0.0 0.0 0.3 0.0 0.4 1.8 1.0 0.0 0.1 0.0 0.5 34.3 0.4 0.2 3.8 0.0 0.0 0.0 0.8 0.0 0.5 0.0 1.2 4.2 0.0 1.0 0.2 0.0 5.5 0.1 0.0 1.0 0.1 KAT6A "MOZ, MYST3, RUNXBP2, ZC2HC6A, ZNF220" ENSG00000083168 "Lysine acetyltransferase 6A" Q92794 8 41929479-42051994 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase" "Cancer-related genes, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017023, HPA063266, HPA065052" Supported Supported "Nucleoli,Nuclear speckles,Cytosol" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Nuclear speckles" "Nucleoli, Cytosol" "CAB017023: , HPA063266: AB_2684973, HPA065052: AB_2685414" "unprognostic (3.51e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-1)" "unprognostic (3.23e-2)" "unprognostic (2.28e-1)" "unprognostic (9.27e-3)" "unprognostic (3.61e-1)" "unprognostic (2.29e-1)" "unprognostic (2.95e-1)" "unprognostic (2.45e-2)" "unprognostic (1.50e-1)" "unprognostic (4.45e-2)" "unprognostic (4.20e-3)" "unprognostic (1.18e-1)" "unprognostic (2.24e-1)" "unprognostic (8.58e-2)" "unprognostic (2.95e-2)" 14.4 7.1 8.6 15.4 12.7 38.2 12.3 20.1 10.5 13.7 9.7 10.2 9.6 15.6 8.6 13.4 12.0 11.2 9.1 9.1 12.8 9.1 10.0 16.7 16.8 12.7 12.4 21.5 11.7 18.0 6.7 14.9 12.9 11.0 10.6 18.1 9.6 9.7 13.1 16.6 12.1 13.5 8.2 15.7 11.3 11.4 10.1 27.0 14.2 16.0 17.2 12.0 10.7 16.7 19.6 23.2 34.8 21.8 17.8 20.3 9.8 15.4 20.6 17.9 14.2 16.3 11.5 33.4 13.4 19.0 19.5 17.3 27.3 18.6 23.2 16.1 14.4 60.4 14.2 10.3 14.8 27.3 23.6 17.1 19.1 20.4 24.8 14.5 18.8 29.7 36.6 24.2 16.0 10.4 59.9 9.4 12.8 20.4 8.1 37.7 39.1 9.9 11.0 27.1 17.6 16.7 15.8 12.4 13.8 15.8 26.3 12.9 25.5 21.6 15.3 21.1 15.5 16.8 22.1 33.8 12.6 14.1 17.3 2.5 0.8 1.8 1.6 0.9 1.6 1.4 1.6 2.1 0.6 1.6 1.9 1.8 5.1 1.9 0.9 1.1 1.9 1.2 8.6 12.7 20.1 10.5 9.1 12.8 12.7 12.4 12.9 8.2 10.1 16.7 87.5 35.3 34.9 64.0 54.0 50.3 24.2 15.5 18.2 54.8 31.7 25.5 23.7 18.6 25.3 12.9 54.2 14.4 61.5 23.2 3.9 14.2 2.6 30.3 47.5 56.7 24.7 31.2 62.8 11.8 17.0 32.4 21.4 44.8 35.4 31.9 43.5 25.3 17.0 58.9 76.6 24.9 10.2 44.2 34.5 4.8 28.3 43.7 23.2 120.9 30.3 27.9 61.8 93.5 129.2 15.7 20.2 23.0 38.7 30.7 22.9 10.6 22.8 44.9 19.7 49.3 34.6 37.8 37.0 23.0 61.2 21.1 61.4 19.7 19.3 27.2 KATNAL1 MGC2599 ENSG00000102781 "Katanin catalytic subunit A1 like 1" Q9BW62 13 30202630-30307551 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 144.3;Excitatory neurons: 80.6;Oligodendrocytes: 78.5;Spermatocytes: 59.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 63.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046205 Uncertain Nucleoplasm,Cytosol NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Cytosol" "HPA046205: AB_10965325" "unprognostic (3.34e-1)" "unprognostic (6.44e-3)" "unprognostic (2.08e-2)" "unprognostic (6.91e-2)" "unprognostic (2.53e-1)" "unprognostic (1.52e-1)" "unprognostic (1.57e-2)" "unprognostic (2.84e-2)" "unprognostic (3.43e-1)" "unprognostic (4.68e-3)" "unprognostic (4.54e-2)" "unprognostic (2.17e-2)" "unprognostic (1.84e-3)" "unprognostic (7.41e-2)" "unprognostic (6.42e-2)" "unprognostic (5.12e-2)" "unprognostic (1.83e-3)" 8.7 3.8 7.0 5.0 8.8 6.5 4.7 7.5 8.9 9.7 0.0 8.7 1.4 9.3 2.7 5.8 4.8 3.8 17.9 8.0 8.1 4.0 3.9 4.9 6.5 7.2 6.4 4.2 1.9 2.2 2.9 3.0 7.0 4.5 4.1 7.9 2.2 5.9 5.1 2.6 2.8 15.0 7.5 3.3 2.8 20.8 8.4 9.2 3.0 6.6 7.1 5.0 5.2 11.8 11.7 9.6 16.5 8.8 12.3 26.0 0.4 47.5 15.2 24.9 19.4 1.9 11.6 18.8 5.5 63.7 31.3 3.2 11.8 12.2 37.5 16.3 4.4 13.4 11.2 4.4 6.5 6.7 8.7 10.1 6.0 28.0 6.8 23.3 26.4 10.2 7.3 8.1 30.8 2.4 15.2 6.1 7.1 0.2 6.1 16.8 19.4 1.9 8.8 0.8 6.8 14.3 12.6 2.6 9.0 13.6 4.1 4.1 24.2 21.8 32.7 12.1 19.3 4.2 8.2 25.8 8.7 6.5 32.1 1.5 0.7 2.9 4.4 0.4 2.1 1.9 3.4 4.4 1.9 4.5 0.8 1.8 0.2 7.7 0.9 5.5 5.8 1.2 7.0 8.8 7.5 8.9 8.0 8.1 7.2 6.4 7.0 7.5 8.4 11.8 12.9 9.6 1.8 30.3 7.2 5.9 3.9 4.7 6.2 10.2 4.0 5.6 41.4 2.8 2.3 5.5 27.1 0.4 6.6 0.3 3.9 6.5 144.3 10.3 26.5 9.3 10.2 16.4 80.6 1.5 0.8 12.3 1.5 3.6 10.1 10.3 7.9 10.6 2.9 21.9 34.5 1.0 0.0 2.8 8.9 50.7 9.0 5.9 17.8 21.5 21.9 9.6 13.4 29.1 78.5 5.7 0.0 5.3 6.4 1.9 0.3 8.4 14.7 18.7 6.6 11.9 13.7 59.0 24.6 5.2 5.7 0.3 9.8 19.2 0.7 1.7 KCNA10 Kv1.8 ENSG00000143105 "Potassium voltage-gated channel subfamily A member 10" Q16322 1 110517217-110519175 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015061, CAB022564" Uncertain Nucleoplasm,Cytosol No NA "Nucleoplasm, Cytosol" "CAB022564: , HPA015061: AB_1855573" "unprognostic (2.96e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNE5 KCNE1L ENSG00000176076 "Potassium voltage-gated channel subfamily E regulatory subunit 5" Q9UJ90 X 109623700-109625172 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Alport syndrome, Deafness, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.8;skeletal muscle: 4.0;tongue: 4.9" "Cell type enhanced" "Detected in some" "Astrocytes: 4.6;Erythroid cells: 3.8;monocytes: 9.4;Muller glia cells: 5.3;Peritubular cells: 3.8" "Group enriched" "Detected in some" 8 "glioma: 7.9;testis cancer: 2.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "myeloid DC: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HMC-1: 1.5;hTEC/SVTERT24-B: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042316 Uncertain Cytosol NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 3: HMC-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "HPA042316: AB_10795397" "unprognostic (5.33e-2)" "unprognostic (2.28e-2)" "unprognostic (1.62e-1)" "unprognostic (1.15e-1)" "unprognostic (1.59e-2)" "unprognostic (1.01e-1)" "unprognostic (2.14e-3)" "unprognostic (3.27e-2)" "unprognostic (9.46e-2)" "unprognostic (1.05e-1)" "unprognostic (4.62e-3)" "unprognostic (7.83e-2)" "unprognostic (5.64e-6)" "unprognostic (5.10e-2)" "unprognostic (9.06e-2)" "unprognostic (1.36e-1)" "unprognostic (5.37e-3)" 1.1 0.8 3.2 0.1 5.4 1.6 0.5 9.4 2.7 0.2 0.7 0.1 0.0 0.0 0.1 0.1 0.0 0.4 0.7 2.7 6.6 0.7 0.2 0.4 0.0 6.3 9.8 0.5 0.1 0.0 0.3 0.2 6.9 0.3 0.0 0.2 0.2 0.3 4.0 0.1 0.1 0.1 4.0 0.9 0.1 0.3 7.8 2.3 0.1 4.9 0.0 0.3 0.2 4.6 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.1 0.2 0.2 0.0 0.1 0.1 0.0 0.1 0.3 0.3 0.0 0.8 0.3 0.0 0.1 1.0 1.1 0.7 0.0 0.0 1.5 0.2 0.5 2.0 0.5 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.5 0.0 0.4 0.5 0.0 0.9 0.4 0.7 0.3 0.3 0.9 0.2 0.2 0.1 0.4 0.4 0.1 0.0 0.3 0.0 0.3 0.8 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 3.2 5.4 9.4 2.7 2.7 6.6 6.3 9.8 6.9 4.0 7.8 4.6 0.1 0.0 1.1 4.6 0.1 0.0 0.0 0.0 1.2 0.0 0.3 1.1 0.6 0.0 0.0 0.0 0.0 0.4 2.2 0.0 0.0 0.3 0.0 0.5 0.1 0.2 0.0 3.8 0.1 0.4 1.2 1.4 0.0 0.5 1.3 0.7 1.1 0.0 0.6 0.0 0.1 0.0 0.0 2.0 0.0 0.0 1.2 2.1 0.0 1.0 9.4 5.3 0.0 0.0 0.0 0.3 0.0 3.8 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.2 0.4 0.0 0.0 0.1 0.0 0.8 0.2 0.1 0.0 0.1 KCNJ12 "hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v" ENSG00000184185 "Potassium inwardly rectifying channel subfamily J member 12" Q14500 17 21376357-21419870 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 25.5;skeletal muscle: 69.1;tongue: 25.7" "Cell type enriched" "Detected in many" 6 "Horizontal cells: 89.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 25.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.3;HeLa: 3.9;PC-3: 4.3;SCLC-21H: 4.8;SiHa: 2.5;SuSa: 5.2;U-2197: 4.2" HPA027021 Approved Uncertain "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 62: Horizontal cells - Visual perception" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA027021: AB_10602912" "unprognostic (3.81e-3)" "unprognostic (2.69e-2)" "unprognostic (8.60e-2)" "prognostic unfavorable (7.84e-5)" "unprognostic (2.29e-1)" "unprognostic (1.73e-2)" "unprognostic (3.80e-2)" "unprognostic (1.54e-2)" "unprognostic (4.39e-2)" "unprognostic (4.91e-2)" "unprognostic (8.12e-2)" "unprognostic (1.16e-1)" "unprognostic (4.22e-2)" "unprognostic (2.23e-1)" "unprognostic (1.51e-1)" "unprognostic (5.90e-2)" "unprognostic (9.70e-3)" 1.3 1.1 2.9 0.6 2.2 0.4 0.8 25.5 3.3 1.2 0.0 0.9 0.1 0.5 0.6 1.4 2.1 0.4 6.4 1.5 2.9 1.3 0.1 1.9 0.1 4.0 6.0 0.4 0.2 5.5 0.8 0.4 3.1 0.6 0.3 1.3 0.7 0.6 69.1 3.6 0.4 0.6 1.1 1.2 1.1 0.8 10.8 0.1 1.1 25.7 1.0 0.7 0.5 1.4 0.0 0.7 0.3 1.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 2.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 1.0 0.0 4.3 0.0 0.6 1.1 0.0 0.0 4.8 0.2 2.5 0.0 1.1 5.2 0.0 0.0 2.0 0.0 0.3 4.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 2.2 25.5 3.3 1.5 2.9 4.0 6.0 3.1 1.1 10.8 1.4 1.4 0.0 0.0 0.7 0.0 1.5 0.0 2.3 0.0 2.9 0.0 0.3 14.3 0.0 1.2 1.8 0.0 0.0 0.1 1.1 1.9 0.0 0.5 0.4 0.5 3.4 1.2 0.0 2.8 0.0 0.0 3.4 0.5 1.8 0.0 0.0 6.8 0.1 0.2 89.2 5.7 1.4 4.1 0.0 1.2 0.5 7.5 0.1 0.0 2.8 0.0 10.2 0.0 0.0 0.2 0.0 0.5 4.1 0.0 0.2 0.0 0.8 0.1 1.5 0.0 3.0 0.7 0.6 2.5 0.0 2.3 0.1 0.5 0.0 1.8 0.2 KCNJ18 "KIR2.6, TTPP2" ENSG00000260458 "Potassium inwardly rectifying channel subfamily J member 18" B7U540 17 21692523-21704612 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 7.6" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "cervical cancer: 0.8;head and neck cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA027021 Uncertain Uncertain "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 61: Skin - Cornification" "Cluster 43: Cardiomyocytes - Nuclear processes" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA027021: AB_10602912" "unprognostic (2.41e-1)" "unprognostic (3.90e-5)" "unprognostic (2.56e-1)" "unprognostic (1.95e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNN4 "hIKCa1, hKCa4, hSK4, IK, KCa3.1" ENSG00000104783 "Potassium calcium-activated channel subfamily N member 4" O15554 19 43766533-43781257 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Immunity, Ion transport, Transport" "Calmodulin-binding, Ion channel" "Disease variant, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 130.8" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 231.1;Syncytiotrophoblasts: 763.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 85.7;WM-115: 258.6" "Region enhanced" "Detected in single" "olfactory bulb: 1.9" "Not detected" "Not detected" "HPA013367, HPA053841, HPA059622" Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 17: WM-115 - Nervous system development" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Plasma membrane, Cytosol" "HPA013367: , HPA053841: AB_2682278, HPA059622: AB_2684085" "unprognostic (1.23e-2)" "unprognostic (3.22e-2)" "unprognostic (4.29e-1)" "unprognostic (3.74e-3)" "prognostic unfavorable (2.68e-4)" "unprognostic (1.98e-2)" "unprognostic (7.33e-2)" "unprognostic (1.42e-2)" "unprognostic (2.48e-3)" "unprognostic (4.12e-2)" "prognostic unfavorable (4.56e-4)" "unprognostic (9.96e-3)" "prognostic unfavorable (1.05e-14)" "unprognostic (3.70e-2)" "unprognostic (2.17e-2)" "unprognostic (7.50e-2)" "prognostic favorable (1.75e-4)" 3.6 0.7 1.7 11.8 1.9 18.3 12.4 1.3 1.8 11.8 1.4 18.5 6.4 1.6 1.8 6.5 5.8 3.5 1.1 1.5 1.6 1.4 0.8 7.3 12.5 1.6 1.6 0.6 1.0 0.0 0.7 14.3 1.7 28.6 6.2 0.2 130.8 7.5 0.4 29.1 26.0 0.7 1.9 20.5 35.1 2.7 2.0 5.0 2.1 0.2 9.2 18.2 6.5 2.3 22.4 35.2 0.1 0.2 0.0 2.2 55.0 0.8 1.7 0.7 0.1 0.5 85.7 6.7 9.8 0.9 9.1 13.6 0.0 28.8 1.7 40.9 0.0 29.8 48.6 0.5 0.0 0.3 0.3 0.0 2.9 1.3 6.6 52.7 0.0 0.3 2.6 2.3 0.3 18.7 4.8 17.9 0.2 43.1 42.4 16.8 0.7 21.0 13.0 55.3 0.2 0.1 62.2 70.1 32.6 1.7 0.3 15.1 1.5 12.6 75.9 0.4 45.3 0.1 1.4 2.6 45.9 5.1 258.6 5.8 21.1 0.0 0.5 35.3 0.7 37.3 10.4 5.0 30.7 21.6 6.6 6.3 1.1 0.0 20.1 0.9 15.2 11.2 1.7 1.9 1.3 1.8 1.5 1.6 1.6 1.6 1.7 1.9 2.0 2.3 1.6 0.0 1.9 1.3 24.7 2.8 45.7 79.5 3.4 0.2 69.7 56.6 0.4 7.2 18.4 1.8 4.2 231.1 4.1 22.0 0.0 5.9 1.2 1.7 0.2 4.0 0.0 32.4 1.5 3.9 14.1 2.3 57.1 4.2 0.0 0.0 0.4 0.0 43.7 0.0 1.1 8.9 2.0 7.2 78.2 0.3 0.0 23.3 21.4 1.0 2.5 0.1 1.0 0.5 0.8 63.8 22.3 0.0 22.4 63.5 1.0 0.1 2.2 0.5 0.0 0.3 1.4 0.4 1.4 2.1 2.3 763.3 9.5 0.0 51.1 65.6 KDM1A "AOF2, BHC110, KDM1, KIAA0601, LSD1" ENSG00000004487 "Lysine demethylase 1A" O60341 1 23019443-23083689 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, Oxidoreductase, Repressor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 131.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005884, HPA053660" Supported Supported Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 7700 "Cluster 37: B-cells - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 14: REH - Unknown function" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm Cytosol "CAB005884: AB_443964, HPA053660: AB_2682220" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "prognostic favorable (6.31e-4)" "unprognostic (1.50e-1)" "unprognostic (6.83e-2)" "unprognostic (3.95e-2)" "prognostic unfavorable (4.47e-12)" "unprognostic (1.80e-2)" "unprognostic (1.99e-2)" "unprognostic (9.41e-2)" "unprognostic (3.34e-3)" "unprognostic (2.13e-1)" "unprognostic (2.61e-1)" "unprognostic (1.41e-1)" "unprognostic (3.73e-2)" "unprognostic (7.74e-2)" "unprognostic (1.39e-1)" 25.7 30.8 24.7 23.5 25.8 48.1 30.6 26.5 27.0 33.1 20.4 31.6 26.4 36.0 46.9 35.0 34.2 25.3 26.1 25.3 28.2 24.7 22.3 24.5 34.7 19.8 22.0 41.4 36.2 51.2 41.5 31.5 21.0 32.2 33.8 30.9 36.6 29.4 47.3 38.2 29.2 30.1 21.2 25.2 29.3 86.9 27.4 55.8 28.5 34.0 37.2 34.6 31.5 21.8 128.1 64.7 180.8 160.7 47.0 59.5 128.4 53.1 66.4 106.0 93.7 61.2 120.5 94.5 74.1 87.6 53.7 139.5 169.5 101.0 133.3 86.3 102.7 133.0 105.7 150.6 59.6 103.7 56.0 55.6 71.4 112.8 78.9 93.0 134.1 171.7 148.0 43.4 76.3 75.9 227.3 79.2 118.3 70.8 93.0 214.7 119.1 64.1 89.0 81.0 225.0 169.9 239.4 62.4 80.2 126.1 62.7 76.2 109.5 47.0 78.4 88.1 73.6 55.6 47.1 109.3 49.2 120.4 68.3 2.0 2.5 4.3 4.1 4.3 3.4 7.4 3.5 3.8 3.1 2.1 4.5 4.9 0.2 3.0 5.5 6.8 4.4 1.4 24.7 25.8 26.5 27.0 25.3 28.2 19.8 22.0 21.0 21.2 27.4 21.8 18.7 19.2 29.1 33.6 15.9 18.6 27.1 19.9 33.0 27.5 20.4 22.1 24.4 11.5 19.0 23.9 27.1 31.6 18.1 15.7 17.6 35.4 43.5 45.9 49.3 20.4 22.8 29.7 51.1 24.7 57.2 24.8 23.4 44.4 12.0 49.5 16.8 17.2 15.0 15.2 51.2 24.9 22.4 15.1 19.7 20.3 21.5 20.2 12.4 30.0 28.1 19.3 12.3 50.3 30.4 28.1 13.5 23.0 28.9 26.3 17.2 15.7 29.5 19.8 0.0 22.2 25.0 131.8 67.1 36.1 12.8 16.6 15.4 34.3 27.6 20.5 KDM4A "JHDM3A, JMJD2, JMJD2A, KIAA0677, TDRD14A" ENSG00000066135 "Lysine demethylase 4A" O75164 1 43650149-43705518 "Enzymes, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007610 Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 56: Intestine - Transmembrane transport" "Cluster 43: THP-1 - Innate immune response" "Cluster 59: Non-specific - Transcription" "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA007610: AB_1852006" "unprognostic (7.01e-2)" "unprognostic (1.50e-1)" "unprognostic (3.22e-2)" "unprognostic (6.18e-2)" "unprognostic (3.54e-2)" "unprognostic (5.40e-3)" "prognostic unfavorable (1.39e-5)" "unprognostic (4.88e-3)" "unprognostic (1.13e-1)" "unprognostic (5.47e-1)" "unprognostic (2.70e-1)" "unprognostic (7.95e-2)" "unprognostic (2.81e-1)" "unprognostic (2.32e-3)" "unprognostic (2.02e-1)" "unprognostic (1.92e-1)" "unprognostic (1.28e-1)" 10.6 20.6 10.7 12.2 11.3 12.1 12.8 12.7 12.4 15.1 11.8 18.0 28.0 14.2 13.0 14.4 18.0 11.8 10.0 10.7 9.3 12.7 14.8 14.7 15.6 10.7 10.4 19.7 12.7 19.1 10.9 11.2 10.9 13.7 18.5 19.6 13.3 11.4 11.1 21.8 22.6 14.9 10.0 13.9 14.4 5.7 10.7 21.6 17.3 15.7 18.0 13.7 11.8 11.2 25.1 22.6 36.6 63.6 34.5 32.6 25.3 23.4 26.4 34.7 34.6 26.0 21.7 32.5 23.5 23.4 26.3 25.3 45.1 27.6 35.4 23.2 37.8 46.5 33.7 21.2 32.7 33.4 35.9 35.4 43.2 33.7 42.3 26.6 37.0 27.9 23.5 45.1 25.5 19.6 26.4 28.2 59.9 21.5 23.0 35.0 42.2 23.9 24.3 48.8 32.1 29.1 50.5 34.2 63.3 52.8 20.0 111.5 28.1 20.6 32.8 18.7 31.9 20.7 26.7 29.2 21.3 27.8 39.3 10.2 4.9 9.0 4.4 3.7 4.9 4.3 4.3 3.6 4.1 3.1 2.9 2.6 3.0 4.1 5.2 3.6 4.9 3.5 10.7 11.3 12.7 12.4 10.7 9.3 10.7 10.4 10.9 10.0 10.7 11.2 5.3 9.6 22.3 12.7 14.0 9.2 5.3 8.3 25.6 20.1 8.9 7.5 7.4 8.6 8.2 1.8 37.5 8.5 10.4 19.3 5.9 8.6 9.7 11.2 9.8 9.2 12.0 16.4 21.3 6.7 6.1 9.8 23.4 6.9 13.3 12.0 7.9 13.1 8.9 32.0 17.8 16.6 10.2 9.7 5.5 6.1 12.5 7.9 1.8 5.6 11.6 10.9 13.4 17.6 23.8 10.7 13.5 14.7 14.3 5.4 17.3 6.9 25.4 23.5 6.6 11.1 7.7 0.6 2.9 21.0 4.7 8.1 9.5 13.6 15.4 6.0 KDM4B "JMJD2B, KIAA0876, TDRD14B" ENSG00000127663 "Lysine demethylase 4B" O94953 19 4969113-5153598 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 98.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 5.1;dendritic cells: 1.7;granulocytes: 4.7" "Cell line enhanced" "Detected in all" "T-47d: 61.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071568 Supported Nucleoplasm,Cytosol NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 72: Non-specific - Transcription" "Cluster 6: T47d - Mammary gland" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA071568: " "prognostic favorable (7.39e-4)" "unprognostic (1.99e-1)" "prognostic unfavorable (2.74e-4)" "prognostic favorable (4.25e-7)" "unprognostic (5.95e-2)" "unprognostic (7.96e-3)" "unprognostic (2.72e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.13e-4)" "unprognostic (3.89e-2)" "unprognostic (8.24e-3)" "unprognostic (5.14e-3)" "unprognostic (8.66e-2)" "unprognostic (1.98e-1)" "unprognostic (3.82e-1)" "unprognostic (4.14e-2)" "unprognostic (5.44e-2)" 12.4 19.4 7.8 8.9 9.4 13.5 16.8 15.8 10.0 23.4 5.1 14.7 6.6 18.4 6.7 17.0 20.2 4.7 16.0 9.3 5.3 10.4 21.2 12.5 11.7 9.2 7.3 17.8 13.7 6.6 18.4 9.5 7.5 25.6 2.9 14.7 14.1 7.4 32.2 21.7 13.8 4.9 4.7 22.1 12.6 16.1 8.8 8.8 29.4 8.3 7.2 13.4 18.2 11.9 16.1 5.5 12.8 15.4 7.3 7.2 25.7 7.9 5.8 6.8 8.5 9.6 4.4 22.4 8.2 9.1 5.5 8.9 7.8 9.3 4.2 10.1 19.9 7.5 9.9 8.0 13.6 7.6 16.7 11.2 9.9 5.6 4.7 12.3 9.3 12.4 18.7 13.3 6.2 8.3 8.8 11.5 11.3 5.8 13.6 14.7 9.7 19.0 6.8 10.5 23.7 18.1 10.3 11.2 12.5 12.3 61.5 19.7 13.5 10.1 5.7 12.5 8.0 36.5 16.4 17.1 20.0 15.1 6.0 1.5 0.6 1.9 0.3 0.2 0.2 4.2 0.2 0.2 0.3 5.1 0.4 0.5 4.7 0.8 0.3 1.7 0.4 0.3 7.8 9.4 15.8 10.0 9.3 5.3 9.2 7.3 7.5 4.7 8.8 11.9 15.3 6.4 10.4 18.9 73.2 7.4 14.1 10.8 7.4 72.5 36.1 22.2 15.3 10.0 9.4 7.3 98.0 25.7 25.5 15.3 7.9 10.5 17.0 25.4 18.7 16.4 8.4 9.4 33.6 7.6 26.2 14.6 26.5 30.2 8.2 34.3 15.4 30.9 9.0 74.0 30.6 16.7 16.2 14.2 7.8 12.1 18.3 15.8 10.6 27.2 17.0 23.5 19.6 29.7 28.7 18.0 14.1 23.3 23.9 19.3 7.4 6.6 11.7 69.2 6.6 23.1 13.7 25.2 9.1 14.1 15.3 24.1 13.9 29.7 9.5 12.9 KDM5B "CT31, JARID1B, PLU-1, PPP1R98, RBBP2H1A" ENSG00000117139 "Lysine demethylase 5B" Q9UGL1 1 202724495-202808487 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 62.3" "Cell type enhanced" "Detected in all" "Late spermatids: 243.6;Spermatocytes: 390.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027179, HPA053723, CAB068193" Enhanced Supported Nucleoplasm,Cytosol NA Yes "Cluster 10: Basophils - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Cytosol "CAB068193: AB_2665696, HPA027179: AB_1851987, HPA053723: AB_2682241" "unprognostic (1.19e-1)" "unprognostic (1.74e-2)" "unprognostic (1.03e-1)" "unprognostic (4.67e-2)" "unprognostic (1.92e-2)" "unprognostic (2.31e-1)" "unprognostic (3.49e-3)" "unprognostic (3.02e-2)" "unprognostic (3.23e-2)" "unprognostic (6.12e-2)" "unprognostic (1.61e-2)" "unprognostic (4.79e-2)" "unprognostic (8.25e-3)" "unprognostic (2.56e-2)" "unprognostic (1.61e-1)" "unprognostic (5.56e-2)" "unprognostic (4.13e-1)" 9.1 7.7 1.5 2.6 2.2 14.1 9.9 5.8 4.8 14.7 7.9 10.6 2.1 12.6 3.3 21.0 9.9 2.9 6.0 4.6 1.5 6.2 4.6 10.8 2.2 0.8 0.4 12.8 8.3 2.6 6.9 4.7 0.2 10.6 2.2 17.8 12.5 2.4 4.7 24.3 8.6 3.1 1.0 7.4 8.7 62.3 1.2 4.1 8.4 0.8 2.1 10.9 15.7 2.3 9.9 2.4 14.0 9.8 7.2 6.6 23.7 6.2 9.4 6.2 6.4 2.2 8.8 0.1 5.7 7.9 2.3 11.8 9.0 8.3 5.4 0.5 12.8 7.7 2.4 1.9 5.5 17.7 8.9 9.4 12.1 7.0 7.2 10.1 11.7 7.3 20.9 0.3 4.9 6.3 5.8 16.4 21.9 4.3 28.0 18.7 0.1 0.4 6.5 10.7 10.7 23.4 14.7 7.9 8.7 15.7 16.6 10.5 12.8 8.2 5.8 1.4 5.2 2.3 1.1 8.2 6.0 5.5 4.1 44.6 6.4 19.6 7.7 4.8 4.6 10.9 8.9 4.3 4.2 17.4 9.6 6.0 34.4 12.9 10.4 6.6 7.2 3.9 1.5 2.2 5.8 4.8 4.6 1.5 0.8 0.4 0.2 1.0 1.2 2.3 24.5 89.8 38.5 46.7 22.2 64.4 34.8 53.0 84.2 35.5 57.1 50.0 9.5 11.5 53.6 16.5 62.6 41.8 12.4 23.7 5.9 47.6 191.6 65.2 71.8 31.9 43.6 50.2 75.8 22.3 34.3 42.7 47.9 69.5 27.1 28.6 17.2 10.9 7.7 15.2 53.5 38.1 44.7 15.1 21.9 243.6 36.4 15.5 26.6 40.3 11.3 69.8 10.3 39.7 42.5 45.4 21.8 32.7 25.8 43.1 15.2 8.2 61.9 138.6 32.9 22.8 40.2 390.9 71.0 95.9 116.2 82.4 21.2 61.5 30.2 55.6 KEL "CD238, ECE3" ENSG00000197993 "Kell metallo-endopeptidase (Kell blood group)" P23276 7 142941114-142962363 "Blood group antigen proteins, Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen, Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "bone marrow: 56.3;testis: 32.3" "Cell type enhanced" "Detected in some" "Erythroid cells: 79.7;Oligodendrocytes: 30.1;Squamous epithelial cells: 16.8" "Cancer enhanced" "Detected in some" "testis cancer: 2.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "HEL: 31.7;K-562: 26.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA064442 Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 6: Erythroid cells - Oxygen transport" "Golgi apparatus, Plasma membrane" "Nucleoplasm, Cytosol" "HPA064442: " "unprognostic (5.78e-3)" "unprognostic (1.08e-5)" "unprognostic (5.29e-3)" "unprognostic (4.85e-3)" "unprognostic (9.68e-2)" "unprognostic (1.96e-2)" "unprognostic (1.03e-1)" "unprognostic (1.54e-2)" "unprognostic (5.18e-2)" "unprognostic (1.08e-2)" "unprognostic (3.71e-2)" "unprognostic (3.57e-2)" "unprognostic (2.29e-3)" "unprognostic (9.24e-2)" "unprognostic (7.05e-2)" "unprognostic (3.32e-2)" "unprognostic (3.25e-3)" 0.2 0.0 1.8 0.8 2.7 56.3 0.3 1.7 2.2 0.9 1.4 0.1 0.0 0.2 0.0 0.8 0.5 0.0 0.3 2.0 1.5 0.6 0.3 0.5 10.6 2.5 2.2 0.2 0.2 0.0 0.2 0.4 2.4 0.3 0.0 0.1 0.6 0.1 0.2 0.1 0.9 0.0 1.9 4.9 0.2 32.3 2.4 1.3 0.3 0.0 6.7 0.1 0.4 2.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 31.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.1 0.5 0.1 0.6 0.0 0.0 0.1 0.0 0.2 0.0 1.4 0.0 0.2 0.0 0.0 0.3 0.4 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.7 1.7 2.2 2.0 1.5 2.5 2.2 2.4 1.9 2.4 2.8 0.2 0.0 0.0 0.3 0.0 0.0 1.3 0.2 4.0 0.0 0.3 0.1 0.4 0.0 1.4 3.7 0.0 0.1 0.1 0.0 1.9 0.3 2.4 0.2 0.1 0.1 0.0 79.7 3.0 0.0 0.2 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.0 0.0 0.8 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 3.1 0.0 1.4 0.2 16.8 0.0 0.1 0.0 0.0 0.0 0.9 KIAA0513 ENSG00000135709 KIAA0513 O60268 16 85027751-85094230 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.3" "Cell type enhanced" "Detected in many" "Early spermatids: 50.2;Excitatory neurons: 53.5;Inhibitory neurons: 53.3;Late spermatids: 199.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 25.8;monocytes: 23.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012866, HPA014431" Enhanced Uncertain Nucleoplasm,Cytosol NA NA 67000 "Cluster 18: Basophils - Vesicular transport" "Cluster 6: Brain - Smell perception" "Cluster 1: K-562 - Erythropoiesis" "Cluster 51: Myeloid cells - Hemostasis" "Nucleoplasm, Cytosol" "HPA012866: AB_1852321, HPA014431: AB_1852322" "unprognostic (1.98e-2)" "unprognostic (2.47e-2)" "unprognostic (2.35e-1)" "unprognostic (1.69e-2)" "unprognostic (1.49e-2)" "unprognostic (9.37e-3)" "unprognostic (2.90e-2)" "unprognostic (8.56e-2)" "unprognostic (1.38e-1)" "unprognostic (4.85e-2)" "prognostic favorable (1.72e-5)" "unprognostic (7.52e-2)" "unprognostic (1.94e-3)" "unprognostic (7.88e-2)" "unprognostic (4.00e-1)" "unprognostic (2.33e-2)" "unprognostic (2.34e-1)" 5.4 11.3 23.5 9.9 35.8 17.1 2.5 35.8 63.3 7.7 0.0 11.0 4.6 5.2 2.7 7.7 3.3 4.7 4.6 41.2 3.3 3.6 2.5 7.5 5.9 12.1 2.6 2.7 15.2 4.1 32.6 3.9 2.6 9.2 6.1 9.2 6.9 4.8 10.2 10.6 6.8 5.6 0.8 8.2 10.8 5.8 2.8 2.8 2.4 3.7 6.6 14.9 6.4 27.4 6.7 7.1 4.7 6.8 8.6 6.4 1.2 6.6 10.4 9.2 5.3 3.2 3.1 2.2 2.8 8.0 5.6 5.8 4.4 10.5 5.7 4.9 3.6 4.3 1.9 1.7 4.1 0.5 5.9 11.9 5.5 10.6 1.4 3.9 5.0 4.6 19.1 5.4 8.3 10.5 0.8 1.8 4.6 7.8 5.6 0.8 6.0 1.4 8.7 4.8 13.7 2.1 7.7 12.7 3.1 4.7 10.3 1.3 10.0 5.7 4.3 8.7 2.3 8.4 1.6 4.8 7.5 3.3 6.2 24.6 11.1 17.9 1.4 13.4 0.4 0.0 0.9 0.9 4.1 0.1 0.8 0.9 25.8 1.3 23.9 5.9 0.3 5.3 23.5 35.8 35.8 63.3 41.2 3.3 12.1 2.6 2.6 0.8 2.8 27.4 0.9 6.4 5.8 7.5 2.6 4.0 7.8 12.4 2.2 17.9 2.7 1.1 8.3 2.8 15.3 1.8 6.2 0.6 8.0 16.0 0.0 2.8 50.2 2.8 7.5 3.3 11.4 0.4 53.5 4.7 0.8 6.9 10.7 4.9 2.5 1.7 3.3 2.9 6.9 48.8 53.3 8.6 10.2 21.5 4.6 199.5 16.1 30.9 3.6 11.2 24.5 3.1 3.1 8.5 7.0 9.1 7.2 26.7 16.5 15.0 4.8 1.8 23.9 5.4 0.0 5.4 3.4 4.1 4.1 1.2 4.4 3.4 4.6 4.8 5.2 29.8 KIAA0753 "MNR, OFIP" ENSG00000198920 KIAA0753 Q2KHM9 17 6578147-6640711 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Ciliopathy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 90.9;Excitatory neurons: 46.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA023057, HPA023494" Enhanced Approved Centrosome,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" "Centrosome, Cytosol" "HPA023057: AB_1852338, HPA023494: AB_1852339" "unprognostic (3.72e-2)" "unprognostic (5.91e-2)" "unprognostic (1.60e-2)" "unprognostic (2.93e-2)" "unprognostic (5.17e-2)" "unprognostic (1.47e-1)" "unprognostic (4.19e-3)" "unprognostic (1.47e-1)" "unprognostic (3.01e-3)" "unprognostic (1.82e-1)" "unprognostic (6.10e-3)" "unprognostic (1.47e-2)" "unprognostic (9.57e-2)" "unprognostic (1.37e-1)" "unprognostic (2.70e-1)" "unprognostic (1.55e-1)" "unprognostic (1.77e-3)" 4.9 5.7 6.8 4.6 6.8 3.5 7.3 3.8 7.3 8.4 10.5 7.1 3.5 8.5 11.0 7.1 10.1 5.2 4.1 7.2 6.6 8.7 3.7 5.3 5.0 4.3 4.9 10.1 5.6 14.0 8.8 5.3 3.6 7.7 6.9 10.8 5.7 8.3 2.1 5.7 5.4 8.4 3.4 7.6 6.5 16.6 6.0 8.5 9.0 2.7 5.1 6.4 6.4 5.5 19.9 16.1 19.4 13.2 7.2 11.9 7.7 10.5 10.0 15.1 14.0 11.1 4.8 7.9 7.1 10.4 9.9 18.4 17.8 10.1 23.9 8.1 15.1 4.3 14.8 8.7 12.0 6.9 9.3 7.1 12.9 13.7 13.0 15.5 11.8 9.1 9.9 1.0 12.3 5.9 7.7 6.2 11.8 9.7 8.1 11.1 6.8 2.5 13.9 12.9 7.3 12.7 13.2 3.9 8.9 12.5 6.5 4.5 11.1 13.1 6.7 7.6 16.8 1.8 2.6 2.8 9.8 4.5 10.6 0.0 0.7 0.6 0.5 0.7 0.6 0.8 0.5 0.5 0.4 0.4 0.3 0.3 1.9 0.4 0.4 0.6 0.4 0.2 6.8 6.8 3.8 7.3 7.2 6.6 4.3 4.9 3.6 3.4 6.0 5.5 5.4 6.4 12.3 25.8 3.4 3.2 2.9 2.6 4.6 3.8 5.9 5.2 3.6 7.2 8.3 0.0 16.7 2.4 2.9 5.2 0.0 4.1 90.9 13.2 9.5 5.7 7.2 3.0 46.6 3.8 1.1 6.3 9.7 5.8 1.3 12.9 3.9 2.1 2.5 10.1 29.2 3.9 4.1 3.1 0.6 15.4 4.4 3.2 0.0 25.3 2.8 2.1 2.1 27.2 14.7 3.9 4.9 3.4 5.6 3.6 2.2 2.9 29.3 12.1 0.0 5.9 5.4 15.1 7.8 5.0 2.4 1.2 3.1 9.3 4.4 2.7 KLF4 "EZF, GKLF" ENSG00000136826 "Kruppel like factor 4" O43474 9 107484852-107490482 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 254.7" "Cell type enhanced" "Detected in many" "Adipocytes: 1054.7;Basal squamous epithelial cells: 832.1;Distal enterocytes: 789.2;Intestinal goblet cells: 710.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 1.0;non-classical monocyte: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 39.2;hTCEpi: 84.4;hTERT-HME1: 54.5;OE19: 47.2;U-2197: 111.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002926 Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 18: U-2197 - ECM organization" "Cluster 41: Macrophages - Immune response" Nucleoplasm Cytosol "HPA002926: AB_1852541" "unprognostic (2.06e-1)" "unprognostic (1.42e-2)" "unprognostic (1.14e-2)" "unprognostic (2.45e-1)" "unprognostic (1.55e-1)" "unprognostic (6.58e-3)" "unprognostic (3.44e-2)" "unprognostic (6.49e-2)" "unprognostic (3.45e-1)" "unprognostic (1.29e-2)" "unprognostic (1.18e-2)" "unprognostic (1.08e-1)" "prognostic favorable (3.93e-5)" "unprognostic (2.55e-1)" "unprognostic (1.67e-1)" "unprognostic (8.13e-2)" "unprognostic (8.32e-2)" 73.5 23.9 5.1 21.0 4.7 50.5 63.7 4.0 7.8 53.2 4.6 87.3 28.4 16.0 5.6 102.1 43.0 44.3 31.0 3.7 5.1 6.2 12.4 44.8 5.6 5.0 4.7 29.0 7.0 5.7 4.9 32.4 5.0 16.7 96.0 0.8 27.5 7.6 14.2 254.7 40.5 40.6 4.1 24.1 58.0 17.8 6.0 17.0 25.2 23.2 14.5 43.9 58.9 4.0 13.3 3.9 0.6 0.1 16.6 39.2 5.2 4.4 27.6 6.7 8.1 1.0 18.0 0.0 0.6 6.9 23.7 8.7 6.1 3.9 3.0 0.0 2.2 0.0 7.5 0.3 21.6 0.0 0.0 5.0 84.4 14.0 54.5 1.5 0.6 0.2 0.6 0.0 4.1 7.3 0.0 1.4 4.1 47.2 25.2 0.3 1.6 0.2 2.3 3.7 0.4 0.2 4.0 11.8 15.2 12.7 1.3 5.4 3.5 3.6 0.1 111.5 2.1 0.2 0.1 0.0 3.4 2.6 6.8 0.0 0.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 1.0 0.2 0.0 0.1 5.1 4.7 4.0 7.8 3.7 5.1 5.0 4.7 5.0 4.1 6.0 4.0 1054.7 12.8 41.1 0.3 32.2 436.0 284.3 143.0 832.1 0.5 206.7 205.0 70.3 35.8 71.5 1.8 8.4 49.1 15.0 789.2 1.9 24.4 263.1 154.1 216.0 336.6 123.8 4.8 0.0 38.7 75.5 463.2 537.2 297.4 54.7 4.7 216.0 4.6 89.9 0.0 0.2 710.9 83.4 232.9 282.0 163.0 143.8 401.0 206.3 16.9 36.8 2.0 0.0 0.0 0.0 49.3 540.9 60.5 38.3 187.3 198.0 2.1 46.4 2.0 39.5 463.7 130.0 21.6 15.9 639.9 674.0 107.9 26.8 63.5 332.6 236.8 KLF6 "BCD1, COPEB, CPBP, GBF, PAC1, ST12, Zf9" ENSG00000067082 "Kruppel like factor 6" Q99612 10 3775996-3785281 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 436.6" "Cell type enhanced" "Detected in all" "Squamous epithelial cells: 2075.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013529, HPA069585" Supported Supported Nucleoplasm,Nucleoli,Vesicles,Cytosol No No "Cluster 1: Neutrophils - Mixed function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nucleoli, Vesicles, Cytosol" "CAB013529: AB_2533431, HPA069585: AB_2686157" "unprognostic (1.23e-1)" "unprognostic (1.53e-2)" "unprognostic (1.47e-3)" "unprognostic (4.53e-2)" "unprognostic (1.47e-1)" "unprognostic (7.55e-2)" "unprognostic (2.00e-1)" "unprognostic (1.08e-3)" "unprognostic (1.61e-1)" "unprognostic (2.83e-2)" "unprognostic (1.36e-2)" "unprognostic (2.35e-2)" "prognostic favorable (2.28e-4)" "unprognostic (8.07e-3)" "unprognostic (4.85e-2)" "unprognostic (6.87e-2)" "unprognostic (1.37e-2)" 211.3 46.9 19.0 122.1 18.0 436.6 129.7 19.2 22.4 95.4 21.9 92.1 55.4 98.1 17.7 165.5 77.2 181.9 49.7 18.0 19.2 64.1 141.8 117.0 65.4 29.4 20.1 47.3 118.3 31.8 12.0 98.2 25.2 32.8 99.6 18.4 73.8 33.7 84.9 197.1 106.0 208.2 22.7 64.3 73.2 14.6 23.0 56.8 193.9 41.3 45.0 136.3 92.7 25.0 55.0 14.7 27.2 9.0 155.1 154.3 17.1 91.7 46.5 95.9 64.8 38.0 71.4 15.6 20.8 100.0 74.5 32.7 17.0 84.9 79.5 76.6 10.2 2.2 17.5 35.8 66.4 10.3 51.5 51.4 158.2 68.6 129.3 34.2 99.3 10.1 17.5 117.9 123.6 4.0 19.4 15.9 10.2 29.2 26.0 12.6 28.2 55.5 94.1 53.4 12.0 11.5 22.5 64.0 142.8 73.5 32.0 8.6 130.9 128.7 17.8 76.9 43.0 22.6 78.1 28.6 34.7 13.7 40.8 318.8 85.2 234.1 129.8 74.2 115.9 81.1 147.4 131.5 67.6 70.9 44.9 69.0 391.6 72.5 104.6 152.8 120.6 148.7 19.0 18.0 19.2 22.4 18.0 19.2 29.4 20.1 25.2 22.7 23.0 25.0 511.0 1246.8 489.4 14.0 716.9 585.5 1298.4 625.8 1227.0 39.6 985.9 630.0 63.6 544.7 451.9 138.0 33.3 163.1 518.3 1507.0 21.5 808.6 58.0 1065.6 618.9 469.9 397.3 77.9 18.5 553.0 473.8 545.5 1120.3 1905.9 626.7 195.9 248.4 309.9 583.6 37.0 10.0 746.7 429.3 968.7 885.1 53.2 130.5 992.1 483.8 58.1 609.8 42.9 150.4 7.5 4.3 857.9 949.9 133.9 1172.5 600.2 1009.9 97.4 342.0 90.1 138.1 194.8 441.8 9.0 19.4 2075.6 628.2 195.9 920.5 67.1 542.0 572.5 KLF7 UKLF ENSG00000118263 "Kruppel like factor 7" O75840 2 207074137-207167267 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 95.2;Oligodendrocytes: 160.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003423, HPA030490" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 41: Macrophages - Immune response" Nucleoplasm Cytosol "HPA003423: , HPA030490: AB_10601922" "unprognostic (5.93e-2)" "unprognostic (2.49e-3)" "unprognostic (2.98e-1)" "unprognostic (3.99e-3)" "unprognostic (2.56e-1)" "unprognostic (2.85e-3)" "unprognostic (5.44e-2)" "unprognostic (1.24e-2)" "unprognostic (6.75e-2)" "unprognostic (8.78e-2)" "unprognostic (3.67e-2)" "unprognostic (1.47e-1)" "prognostic favorable (4.26e-4)" "unprognostic (3.27e-3)" "unprognostic (1.23e-1)" "unprognostic (1.73e-1)" "unprognostic (3.47e-2)" 19.9 8.2 8.2 13.8 15.0 40.3 15.0 19.3 9.1 8.9 0.0 11.4 4.6 16.9 5.9 9.7 10.0 11.8 10.1 8.3 13.4 7.9 7.1 15.2 7.7 20.2 17.0 14.2 5.1 3.0 4.9 5.8 20.9 8.2 5.3 4.7 7.4 7.4 4.9 6.8 10.3 20.9 12.1 10.3 9.1 6.8 17.4 14.3 8.8 7.4 7.3 9.8 9.8 20.3 8.8 6.1 16.3 1.1 5.6 14.4 3.4 10.0 8.0 15.3 6.7 0.1 7.1 0.1 6.3 20.6 26.5 21.5 13.9 46.2 8.2 6.0 0.8 0.2 18.5 3.5 9.7 4.6 6.7 19.3 15.3 10.7 35.0 22.0 18.1 4.6 0.0 8.2 11.8 0.2 5.6 1.7 9.7 0.9 3.0 2.4 4.3 6.4 3.7 6.8 25.0 30.5 8.6 12.0 7.8 13.0 2.0 6.9 35.9 30.3 14.5 12.9 12.0 6.2 4.5 0.0 26.7 3.8 6.1 28.9 9.4 12.3 1.6 12.1 0.6 5.7 8.4 1.6 5.3 7.7 14.3 9.9 40.8 22.9 22.7 2.4 7.7 6.1 8.2 15.0 19.3 9.1 8.3 13.4 20.2 17.0 20.9 12.1 17.4 20.3 95.2 41.7 6.7 74.4 15.8 21.9 23.1 35.0 6.2 9.0 9.9 11.4 17.6 14.3 15.1 9.2 12.5 0.5 6.9 0.4 1.9 22.7 10.2 13.9 33.7 65.8 6.0 2.5 46.4 51.5 0.8 22.0 11.7 17.3 12.0 3.6 79.9 14.7 15.6 11.8 31.1 2.6 34.6 50.0 22.9 5.2 13.7 37.6 3.6 61.8 28.3 7.1 8.2 68.9 160.5 79.9 1.4 10.1 4.3 9.2 14.1 4.3 9.8 8.7 46.0 38.6 42.0 0.8 14.8 8.1 15.3 1.1 7.6 7.9 4.3 9.3 KLF9 BTEB1 ENSG00000119138 "Kruppel like factor 9" Q13886 9 70384597-70414624 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 264.3;Skeletal myocytes: 223.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 60.4;ASC TERT1: 83.0;HHSteC: 107.4;HSkMC: 71.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029308 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 37: B-cells - Transcription" "Cluster 52: Non-specific - Ribosome" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "Plasma membrane, Cytosol" "HPA029308: AB_10601923" "unprognostic (2.12e-2)" "unprognostic (2.56e-1)" "unprognostic (3.12e-1)" "unprognostic (2.69e-2)" "unprognostic (5.86e-2)" "unprognostic (1.37e-1)" "unprognostic (3.64e-3)" "unprognostic (4.34e-1)" "unprognostic (5.55e-1)" "unprognostic (9.47e-2)" "unprognostic (7.86e-2)" "unprognostic (3.44e-1)" "prognostic favorable (6.59e-6)" "unprognostic (1.43e-3)" "unprognostic (1.75e-1)" "unprognostic (3.17e-2)" "unprognostic (1.02e-2)" 82.0 36.5 12.5 22.8 22.1 18.2 67.6 29.8 22.5 29.9 14.9 66.5 15.3 56.5 16.7 41.1 73.0 42.6 54.7 15.7 14.4 54.9 91.3 71.6 14.4 21.3 21.1 63.4 52.9 51.1 25.5 10.2 17.3 36.5 26.2 19.2 35.4 24.4 123.3 40.8 33.2 58.9 15.6 22.9 48.9 7.7 21.7 12.1 57.1 94.7 14.3 43.4 37.2 19.1 0.4 0.6 0.0 7.8 60.4 83.0 0.8 4.1 27.1 1.4 3.0 0.1 3.6 0.1 3.0 7.5 2.0 0.1 11.9 18.4 2.8 0.0 9.3 4.2 13.1 2.4 107.4 2.1 10.9 71.6 18.4 1.1 25.9 37.1 23.9 1.8 8.4 16.4 10.2 1.3 0.3 6.2 0.7 1.2 3.9 0.0 3.7 10.9 5.0 0.0 1.0 5.2 37.3 21.5 45.2 2.5 7.1 6.7 32.8 7.1 5.1 8.2 2.2 11.8 13.5 0.6 6.4 6.6 35.9 0.7 0.1 0.1 0.4 0.1 0.6 0.9 0.5 0.4 0.3 0.6 0.7 0.4 0.0 0.1 0.2 0.4 0.6 0.1 12.5 22.1 29.8 22.5 15.7 14.4 21.3 21.1 17.3 15.6 21.7 19.1 264.3 41.7 25.5 25.8 36.5 48.2 62.7 13.0 97.3 45.3 48.3 34.7 74.1 64.3 22.3 14.7 20.9 0.2 51.0 36.7 31.3 10.5 22.3 40.6 171.6 124.3 13.8 14.5 32.1 13.1 0.5 180.8 55.5 59.6 7.6 2.0 109.9 158.8 3.7 80.8 13.7 32.3 14.2 70.1 44.6 18.1 90.7 81.3 39.2 29.0 9.7 126.1 19.6 3.0 11.1 12.8 26.1 85.0 30.2 74.0 54.5 39.7 17.4 10.1 78.9 223.8 203.5 2.1 3.2 72.7 34.2 0.0 54.9 16.3 31.9 33.3 KLRB1 "CD161, CLEC5B, hNKR-P1A, NKR, NKR-P1, NKR-P1A" ENSG00000111796 "Killer cell lectin like receptor B1" Q12918 12 9594551-9607916 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 47.4;lymphoid tissue: 36.4" "Group enriched" "Detected in many" 9 "dendritic cells: 642.3;NK-cells: 1855.8;T-cells: 790.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in all" "MAIT T-cell: 2177.1" "Group enriched" "Detected in all" 140 "NK-cells: 756.7;T-cells: 2177.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA039113 Approved Uncertain Nucleoplasm,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm Cytosol "HPA039113: AB_10674979" "prognostic favorable (3.51e-5)" "unprognostic (1.23e-3)" "unprognostic (7.03e-3)" "prognostic favorable (1.42e-5)" "unprognostic (1.69e-1)" "prognostic favorable (6.99e-5)" "unprognostic (1.54e-3)" "unprognostic (7.15e-3)" "unprognostic (4.12e-1)" "unprognostic (8.23e-3)" "unprognostic (3.57e-2)" "unprognostic (1.65e-1)" "unprognostic (1.17e-2)" "unprognostic (2.45e-1)" "unprognostic (1.34e-1)" "prognostic favorable (5.61e-4)" "unprognostic (1.17e-2)" 3.1 1.7 0.7 17.8 0.8 47.4 5.1 0.3 0.8 4.2 0.2 7.7 10.7 1.6 1.4 3.2 1.5 10.7 0.7 0.6 0.7 1.4 11.3 6.7 20.1 0.6 0.6 1.0 0.4 0.2 0.3 1.4 0.6 2.1 8.1 0.1 0.8 1.0 0.7 0.8 20.1 1.6 0.6 28.9 10.1 0.6 0.6 5.7 1.3 0.9 36.4 10.6 1.3 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.5 0.0 0.2 0.2 0.2 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.1 0.3 0.0 0.4 0.2 9.5 2.2 1.1 519.7 2.1 2177.1 1.6 307.4 346.1 1.9 1.5 17.1 98.0 10.5 756.7 3.6 3.9 77.9 285.3 0.7 0.8 0.3 0.8 0.6 0.7 0.6 0.6 0.6 0.6 0.6 0.8 6.1 0.0 8.9 0.0 19.0 9.7 0.9 0.0 1.2 0.0 5.2 2.5 1.0 4.3 1.3 0.0 0.0 0.4 642.3 1.7 0.0 0.6 0.0 1.9 1.5 6.2 0.0 118.1 0.4 0.0 0.1 7.9 12.2 2.4 0.0 0.0 45.3 10.1 0.9 0.0 0.6 1.0 0.0 36.2 15.8 0.0 0.0 13.2 24.9 0.0 28.1 0.0 1855.8 2.5 0.1 0.0 3.3 0.0 23.0 1.1 0.9 2.0 0.0 0.0 0.0 1.6 4.1 0.0 0.1 1.2 8.8 1.0 790.5 0.0 2.0 1.3 KMT2A "ALL-1, CXXC7, HRX, HTRX1, MLL, MLL1A, TRX1" ENSG00000118058 "Lysine methyltransferase 2A" Q03164 11 118436490-118526832 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Apoptosis, Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017794, CAB024270, HPA044910" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "CAB017794: , CAB024270: , HPA044910: AB_2679141" "unprognostic (6.80e-2)" "unprognostic (8.93e-2)" "unprognostic (1.83e-1)" "unprognostic (4.56e-1)" "unprognostic (4.96e-2)" "unprognostic (1.72e-3)" "unprognostic (4.52e-3)" "unprognostic (6.07e-2)" "unprognostic (1.61e-1)" "unprognostic (8.46e-2)" "unprognostic (3.21e-1)" "unprognostic (1.16e-1)" "unprognostic (5.91e-3)" "unprognostic (7.90e-2)" "unprognostic (3.73e-1)" "unprognostic (1.67e-1)" "unprognostic (1.02e-1)" 9.9 6.7 8.0 8.5 8.6 19.5 9.9 21.2 9.3 10.3 1.6 10.8 5.4 10.7 8.2 6.8 10.3 6.4 6.5 7.4 9.6 6.7 6.0 10.5 12.4 6.3 6.3 21.2 11.1 9.8 10.2 5.6 6.6 9.2 6.4 23.9 9.4 8.4 7.4 10.4 9.8 7.6 3.2 9.7 8.2 5.3 7.0 14.1 9.9 8.4 11.3 10.7 9.3 11.9 17.9 8.6 20.1 14.5 11.1 16.1 6.2 8.7 11.8 9.0 9.6 17.3 11.4 23.1 15.9 10.8 14.6 16.0 22.9 7.2 17.9 26.0 10.0 45.7 8.9 9.3 6.1 28.5 7.8 7.2 7.4 20.3 24.0 8.9 12.8 13.3 32.8 18.8 9.2 12.7 18.2 12.7 13.6 6.6 13.7 13.8 21.9 6.9 9.8 13.8 18.0 11.8 22.0 6.7 3.9 9.8 11.9 9.1 20.4 14.1 12.7 9.4 14.7 5.1 4.4 15.6 4.7 17.6 8.3 2.1 0.6 1.9 1.6 0.6 1.6 2.5 1.8 1.5 0.3 1.8 1.8 1.2 0.5 2.0 0.7 1.4 1.7 0.4 8.0 8.6 21.2 9.3 7.4 9.6 6.3 6.3 6.6 3.2 7.0 11.9 87.1 70.5 65.8 93.4 83.4 86.9 67.6 29.4 64.9 158.1 76.8 73.9 44.5 40.0 32.2 38.6 152.2 13.9 81.0 26.2 3.9 33.0 10.1 62.1 101.4 74.4 66.4 67.3 146.0 25.6 10.2 65.6 44.4 85.2 29.0 57.5 60.0 27.3 16.8 195.2 170.1 29.6 20.3 37.0 63.7 5.8 66.8 44.8 42.7 62.8 49.9 98.9 78.2 106.6 131.9 28.2 20.1 78.6 83.3 88.3 22.7 10.5 52.7 152.4 65.7 113.4 84.6 25.5 30.7 46.3 80.6 6.0 102.8 55.8 30.6 64.8 KMT5A "PR-Set7, SET07, SET8, SETD8" ENSG00000183955 "Lysine methyltransferase 5A" Q9NQR1 12 123383773-123409353 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 62.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064495 Supported Nucleoplasm,Cytosol NA Yes "Cluster 49: Eosinophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 1: K-562 - Erythropoiesis" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "HPA064495: AB_2685273" "unprognostic (5.62e-2)" "unprognostic (4.45e-2)" "unprognostic (3.90e-1)" "unprognostic (3.04e-1)" "unprognostic (2.20e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (6.21e-7)" "unprognostic (3.88e-3)" "unprognostic (1.06e-2)" "unprognostic (1.64e-2)" "unprognostic (6.13e-2)" "unprognostic (3.44e-1)" "unprognostic (4.75e-3)" "unprognostic (4.27e-2)" "unprognostic (1.30e-1)" "unprognostic (4.39e-2)" "unprognostic (1.06e-1)" 13.7 10.1 22.6 15.3 22.1 39.2 13.1 20.8 23.2 22.2 18.7 17.7 12.8 21.3 12.9 40.7 21.7 13.6 17.0 22.2 20.6 13.7 14.0 15.5 15.4 22.4 22.7 12.0 19.7 11.4 10.7 16.5 22.9 30.2 14.4 11.7 24.0 19.7 24.4 28.1 15.6 16.7 21.4 16.8 16.9 7.9 23.3 17.9 25.7 15.3 16.6 16.6 25.7 23.9 37.3 24.3 27.8 43.5 18.1 30.9 40.1 57.4 26.3 32.0 26.9 28.8 21.9 84.9 33.1 37.5 11.7 35.8 41.6 21.7 33.3 39.3 45.0 68.8 26.4 15.2 26.5 54.8 18.8 15.1 27.1 34.7 32.8 30.2 26.2 36.4 136.8 38.1 27.5 29.9 58.1 84.9 13.8 34.6 29.0 70.4 22.1 24.1 22.8 43.4 37.9 30.9 51.3 28.3 28.6 23.6 39.6 75.3 32.4 35.2 26.0 42.3 42.3 23.0 25.9 75.9 24.6 29.6 29.9 2.3 1.2 4.3 1.3 2.1 2.7 1.7 1.6 2.1 1.0 1.1 0.9 1.1 1.8 2.3 2.1 2.0 1.5 0.3 22.6 22.1 20.8 23.2 22.2 20.6 22.4 22.7 22.9 21.4 23.3 23.9 34.5 12.8 14.5 0.0 12.7 0.0 17.6 0.0 20.5 20.8 32.0 27.3 0.0 7.2 6.8 27.6 6.2 15.1 22.4 10.4 7.9 9.2 10.1 46.8 43.8 20.7 4.9 62.1 0.0 9.4 16.6 14.7 15.8 41.1 2.5 21.3 30.4 19.5 17.7 3.3 0.0 22.2 0.0 16.8 0.0 3.2 16.1 19.6 0.0 0.0 3.4 28.7 7.2 0.0 0.0 13.6 9.6 42.9 15.9 24.1 14.3 13.1 11.7 17.9 6.6 23.2 19.7 9.7 10.2 38.8 0.0 14.2 14.5 18.4 12.7 22.5 LAMP5 "BAD-LAMP, C20orf103, dJ1119D9.3, UNC-46" ENSG00000125869 "Lysosomal associated membrane protein family member 5" Q9UJQ1 20 9514358-9530524 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 96.6;retina: 29.6" "Cell type enhanced" "Detected in many" "dendritic cells: 78.4;Granulosa cells: 22.2;Horizontal cells: 60.6;Inhibitory neurons: 38.9;Theca cells: 23.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 15 "plasmacytoid DC: 141.3" "Lineage enriched" "Detected in many" 31 "dendritic cells: 141.3" "Cell line enhanced" "Detected in some" "Karpas-707: 469.4;SH-SY5Y: 86.4;THP-1: 169.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004802, HPA070765" Enhanced Uncertain "Mitotic spindle,Centriolar satellite,Cytosol" Yes NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 2: Karpas-707 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "Mitotic spindle, Centriolar satellite" "HPA004802: AB_10603682, HPA070765: AB_2686309" "unprognostic (2.78e-2)" "unprognostic (3.90e-3)" "unprognostic (5.73e-4)" "unprognostic (5.47e-2)" "unprognostic (7.89e-2)" "unprognostic (2.67e-1)" "unprognostic (3.80e-3)" "unprognostic (1.45e-1)" "unprognostic (1.54e-2)" "unprognostic (1.91e-1)" "unprognostic (1.94e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (6.46e-6)" "unprognostic (5.12e-3)" "unprognostic (3.74e-2)" "unprognostic (1.08e-2)" "unprognostic (4.49e-3)" 0.5 4.3 41.7 1.5 96.6 2.3 0.9 11.0 51.8 8.8 3.7 2.2 1.2 4.8 6.3 0.4 10.6 3.1 0.4 39.1 14.3 0.8 0.2 0.9 5.7 47.7 10.1 21.9 1.2 0.7 6.3 0.1 43.7 2.3 1.2 29.6 1.1 3.8 0.1 0.7 1.3 3.9 29.1 1.8 1.4 0.9 35.3 1.4 0.9 0.2 5.2 0.7 1.2 13.6 0.1 0.2 1.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 469.4 0.0 0.0 0.0 0.0 2.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.3 86.4 0.0 0.0 0.1 0.4 0.0 169.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 21.1 0.3 4.2 1.7 0.0 0.0 0.3 0.2 4.5 0.0 0.1 9.5 0.5 0.0 0.0 0.4 0.0 0.0 141.3 0.0 2.4 41.7 96.6 11.0 51.8 39.1 14.3 47.7 10.1 43.7 29.1 35.3 13.6 0.5 0.0 1.1 6.2 3.4 0.1 0.0 0.0 0.0 12.3 0.3 4.3 0.3 0.0 0.0 0.0 8.4 0.0 78.4 0.0 0.0 0.8 5.4 0.2 0.7 0.8 0.0 0.0 10.0 0.0 0.0 8.4 0.0 0.7 0.0 22.2 0.0 0.0 1.3 60.6 38.9 0.0 0.0 0.6 0.8 7.5 0.6 3.5 3.6 4.7 5.4 3.9 0.0 13.0 1.5 0.4 0.0 0.0 5.5 0.5 0.0 0.0 0.0 5.7 0.0 0.3 13.9 0.6 1.1 0.0 0.0 0.0 0.9 23.2 0.1 0.0 LCA5L "C21orf13, MGC33295" ENSG00000157578 "Lebercilin LCA5 like" O95447 21 39405728-39445805 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 110.5" "Group enriched" "Detected in many" 11 "Early spermatids: 1312.6;Late spermatids: 472.4;Spermatocytes: 465.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 3.7;T-47d: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA019790, HPA032010" Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Cluster 77: Retina - Visual perception" "Cluster 6: T47d - Mammary gland" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Cytosol "HPA019790: AB_1845690, HPA032010: AB_2674110" "unprognostic (1.02e-1)" "unprognostic (3.81e-1)" "unprognostic (2.43e-1)" "unprognostic (2.54e-3)" "unprognostic (4.69e-2)" "unprognostic (1.68e-1)" "unprognostic (3.15e-2)" "unprognostic (6.34e-2)" "unprognostic (1.27e-2)" "unprognostic (1.85e-2)" "unprognostic (5.50e-2)" "unprognostic (2.37e-1)" "unprognostic (7.53e-3)" "unprognostic (1.40e-1)" "unprognostic (1.04e-2)" "unprognostic (9.68e-3)" "unprognostic (1.95e-1)" 0.4 1.7 0.6 0.4 0.7 0.3 1.7 1.4 1.1 1.8 3.4 0.6 0.4 1.2 7.6 0.4 7.2 0.8 0.5 0.6 0.8 2.4 0.7 1.5 0.3 2.0 2.5 0.9 1.3 2.2 2.0 0.3 1.6 0.8 0.5 10.8 0.9 0.9 2.1 0.9 0.4 0.6 2.0 0.4 0.8 110.5 0.9 0.3 4.3 1.5 0.2 0.5 0.5 1.1 0.9 1.0 0.6 1.7 0.8 0.7 0.1 0.2 0.4 0.5 0.0 0.5 1.0 0.7 0.7 0.9 0.2 0.2 0.1 0.5 0.3 0.3 0.8 0.4 0.8 0.1 0.7 1.1 0.0 0.6 2.3 1.6 1.7 1.1 0.3 1.0 1.7 0.6 0.6 3.7 0.3 0.4 3.2 0.6 1.0 0.2 0.2 0.7 1.7 0.3 1.1 0.5 2.0 0.8 1.4 0.3 3.9 0.1 0.1 0.3 0.2 0.9 0.2 1.8 1.1 0.1 1.4 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 1.4 1.1 0.6 0.8 2.0 2.5 1.6 2.0 0.9 1.1 1.1 3.2 0.5 5.5 0.3 0.5 0.9 2.7 1.2 2.0 4.5 5.0 2.6 1.5 16.8 7.3 6.2 1.1 0.1 0.4 19.6 3.5 1312.6 34.9 2.4 1.6 4.2 0.0 3.8 2.2 0.2 2.2 0.5 2.8 0.0 1.8 1.4 1.6 0.5 1.7 2.6 1.4 0.0 0.6 0.7 472.4 6.5 1.3 1.8 1.0 0.6 3.2 0.0 0.5 2.1 1.6 0.5 7.9 0.0 0.6 0.2 12.0 68.0 17.4 19.7 3.6 1.7 465.8 26.7 0.3 0.6 0.3 0.3 3.2 0.9 0.7 LGALS9B ENSG00000170298 "Galectin 9B" Q3B8N2 17 20449395-20467539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 15.4;intestine: 11.1;stomach 1: 30.9" "Cell type enhanced" "Detected in some" "Distal enterocytes: 17.7;Gastric mucus-secreting cells: 109.1;Intestinal goblet cells: 32.6;NK-cells: 28.8;Paneth cells: 42.3" "Cancer enhanced" "Detected in some" "stomach cancer: 1.3" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 17 "NK-cell: 12.7" "Lineage enriched" "Detected in single" 17 "NK-cells: 12.7" "Group enriched" "Detected in some" 7 "CAPAN-2: 8.5;U-937: 2.8" "HPA046876, HPA047218" Approved Uncertain Cytosol NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 27: Mucus-secreting cells - Mucin production" Cytosol "HPA046876: AB_2679852, HPA047218: AB_2679988" "unprognostic (4.69e-2)" "unprognostic (1.11e-2)" "unprognostic (2.67e-2)" "unprognostic (4.05e-1)" "unprognostic (8.62e-2)" "unprognostic (1.94e-1)" "unprognostic (3.93e-3)" "unprognostic (2.72e-1)" "unprognostic (2.26e-2)" "unprognostic (6.85e-2)" "unprognostic (1.32e-2)" "unprognostic (3.20e-1)" "unprognostic (3.79e-2)" "unprognostic (1.38e-2)" "unprognostic (1.92e-1)" "unprognostic (5.27e-2)" "unprognostic (1.05e-1)" 0.0 0.0 0.0 0.5 0.0 1.8 0.0 0.0 0.0 1.6 0.0 8.2 3.3 0.0 0.0 15.4 0.0 7.4 0.0 0.1 0.0 0.0 0.1 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 11.1 0.0 2.2 0.0 0.0 0.6 3.4 0.3 0.0 0.6 30.9 0.1 0.0 0.0 0.0 0.0 1.7 0.0 4.3 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.2 0.1 0.0 0.3 0.2 0.1 0.3 0.1 12.7 0.3 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 2.3 0.3 1.1 0.6 0.0 0.0 0.0 0.1 1.5 2.2 0.0 0.0 0.0 9.9 17.7 0.0 0.2 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 109.1 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 32.6 2.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.1 0.0 28.8 0.0 0.0 0.6 42.3 0.0 1.2 0.2 7.7 0.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.0 2.1 0.0 6.6 0.3 LILRB3 "CD85a, HL9, ILT5, LIR-3, LIR3, PIR-B, PIRB" ENSG00000204577 "Leukocyte immunoglobulin like receptor B3" O75022 19 54216278-54223506 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 27.0;lymphoid tissue: 49.9" "Group enriched" "Detected in many" 5 "Hofbauer cells: 63.4;Kupffer cells: 88.6;Macrophages: 88.8;monocytes: 71.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "neutrophil: 44.8" "Group enriched" "Detected in many" 4 "granulocytes: 44.8;monocytes: 15.4" "Not detected" "Not detected" HPA026985 Approved "Plasma membrane,Cytosol" NA NA 16000000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 64: Macrophages - Immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Plasma membrane" Cytosol "HPA026985: " "unprognostic (7.51e-2)" "unprognostic (3.52e-2)" "unprognostic (9.59e-2)" "unprognostic (4.53e-1)" "unprognostic (1.83e-3)" "unprognostic (5.28e-3)" "unprognostic (2.91e-2)" "unprognostic (2.55e-1)" "unprognostic (5.58e-2)" "unprognostic (2.35e-1)" "unprognostic (1.43e-1)" "unprognostic (1.63e-1)" "unprognostic (1.92e-8)" "unprognostic (2.18e-1)" "unprognostic (2.19e-3)" "unprognostic (1.84e-1)" "unprognostic (1.75e-1)" 9.9 3.4 0.4 8.3 0.4 14.6 2.9 0.4 2.1 1.2 0.9 2.7 0.3 1.2 0.3 1.3 5.4 0.1 3.4 0.4 0.4 2.3 4.1 27.0 0.3 1.2 0.8 1.0 1.9 0.0 1.3 1.2 1.3 1.7 0.0 0.2 2.4 0.0 1.1 0.8 2.6 0.1 0.6 49.9 2.3 0.5 1.8 0.6 1.6 0.0 0.2 3.2 1.6 1.4 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 15.4 0.6 0.1 14.3 0.2 0.1 0.3 0.0 7.2 0.1 0.0 0.1 44.8 0.0 5.6 0.5 0.0 11.6 0.4 0.4 0.4 2.1 0.4 0.4 1.2 0.8 1.3 0.6 1.8 1.4 1.5 9.6 13.0 0.3 2.2 2.4 1.2 6.5 0.0 0.7 1.6 2.2 0.4 4.3 8.3 1.8 0.0 1.5 2.1 0.6 0.0 0.3 1.3 0.8 1.9 3.0 0.0 0.8 0.2 0.6 6.7 2.9 0.0 2.2 7.6 0.5 1.8 3.2 63.4 0.0 0.1 1.9 0.0 88.6 8.4 4.1 0.3 88.8 1.8 1.9 71.2 0.9 3.1 0.0 0.1 0.2 1.3 0.7 2.1 1.6 0.4 0.4 5.2 2.9 6.6 4.3 1.3 0.8 1.5 0.1 3.0 1.2 3.8 2.6 2.0 0.4 LIMS4 LIMS3L ENSG00000256671 "LIM zinc finger domain containing 4" P0CW20 2 110446640-110473075 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Exocrine glandular cells: 1.5;Glandular and luminal cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.0;hTEC/SVTERT24-B: 1.8;HUVEC TERT2: 1.0;U-138 MG: 1.9" HPA058455 Uncertain Uncertain "Focal adhesion sites,Cytosol" NA NA "Cluster 10: BJ & FHDF - ECM organization" "Cluster 44: Endometrium - Transcription" Cytosol "Focal adhesion sites" "HPA058455: AB_2683723" "unprognostic (2.12e-1)" 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.3 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 LMOD2 ENSG00000170807 "Leiomodin 2" Q6P5Q4 7 123655866-123664290 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 39 "heart muscle: 778.4;skeletal muscle: 933.7;tongue: 793.6" "Cell type enriched" "Detected in some" 26 "Cardiomyocytes: 1432.4" "Group enriched" "Detected in some" 20 "head and neck cancer: 3.5;prostate cancer: 1.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HSkMC: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA046370, HPA051039" Enhanced Uncertain "Plasma membrane,Actin filaments,Cytosol" NA NA "Cluster 38: Heart - Muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" "Plasma membrane" "Actin filaments, Cytosol" "HPA046370: , HPA051039: AB_2681321" "unprognostic (2.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.43e-1)" "unprognostic (2.38e-3)" "unprognostic (1.18e-1)" "unprognostic (5.50e-1)" "unprognostic (5.69e-2)" "unprognostic (6.98e-2)" "unprognostic (2.13e-2)" "unprognostic (1.43e-3)" "unprognostic (3.37e-2)" "unprognostic (1.51e-1)" "unprognostic (1.82e-3)" 0.2 0.1 0.0 0.0 0.0 0.6 0.5 0.1 0.5 0.0 0.2 0.1 0.0 0.0 0.0 21.2 0.0 0.1 778.4 0.2 0.0 0.0 0.2 0.3 0.3 0.0 0.1 0.1 0.2 0.0 0.1 0.8 0.0 10.2 0.0 0.1 10.0 0.0 933.7 0.4 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.2 793.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1432.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.4 0.5 0.4 9.4 0.0 0.0 0.1 0.0 0.1 27.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.9 7.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 LYPLA2 APT-2 ENSG00000011009 "Lysophospholipase 2" O95372 1 23791145-23795539 "Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063151 Uncertain Nucleoplasm,Cytosol NA NA 110000 "Cluster 5: Granulocytes - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 5: NTERA-2 - Transcription" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol Nucleoplasm "HPA063151: " "unprognostic (8.84e-2)" "unprognostic (6.87e-2)" "unprognostic (2.65e-1)" "unprognostic (7.81e-3)" "unprognostic (2.12e-2)" "unprognostic (2.22e-2)" "prognostic unfavorable (5.84e-5)" "unprognostic (3.06e-1)" "unprognostic (1.80e-1)" "unprognostic (5.18e-2)" "unprognostic (2.52e-1)" "unprognostic (2.40e-1)" "prognostic favorable (4.99e-4)" "unprognostic (6.10e-2)" "unprognostic (1.47e-1)" "unprognostic (1.71e-3)" "unprognostic (1.24e-1)" 32.6 41.1 31.3 33.3 33.2 55.2 33.4 31.1 43.9 33.1 82.4 48.9 49.6 28.2 13.7 76.2 43.2 32.3 40.9 40.4 31.3 79.5 82.2 40.8 43.5 31.1 32.3 28.4 43.7 77.2 35.0 37.1 30.2 45.2 29.4 15.7 51.2 24.7 43.4 51.3 51.3 20.1 30.6 61.1 47.7 23.4 33.0 42.8 39.0 25.2 33.2 46.3 40.3 28.2 80.3 54.2 61.0 70.6 30.4 37.0 83.7 50.8 49.4 50.0 42.6 75.2 130.1 45.8 67.7 49.4 34.9 78.2 45.7 141.2 19.8 88.4 67.9 58.1 87.1 127.5 49.8 54.0 72.5 48.1 85.3 74.9 27.5 61.9 118.8 52.6 84.2 45.4 55.0 89.4 67.3 90.0 120.3 72.6 76.6 78.9 35.0 79.1 122.6 64.6 87.2 149.4 57.7 87.0 88.5 43.5 71.7 58.6 98.6 46.5 61.2 56.7 43.2 116.4 104.1 62.6 74.3 125.1 58.5 82.7 95.3 125.0 105.8 96.0 87.1 62.9 89.1 93.9 77.9 67.9 75.6 80.0 113.2 83.5 80.2 58.8 88.7 113.6 31.3 33.2 31.1 43.9 40.4 31.3 31.1 32.3 30.2 30.6 33.0 28.2 21.3 9.6 27.3 6.2 27.7 38.9 31.0 80.0 23.3 34.1 36.9 35.4 16.1 35.8 36.5 36.8 18.8 118.7 29.9 105.0 68.4 105.8 15.5 44.9 13.7 33.8 44.3 26.9 5.1 112.8 108.8 19.1 40.8 27.5 36.8 23.1 21.0 35.0 69.3 23.5 5.7 53.5 52.9 17.2 23.3 13.4 10.5 27.6 19.6 4.7 62.1 30.2 46.4 7.5 5.2 130.2 71.9 6.4 20.8 33.3 77.1 92.2 57.6 26.0 26.3 8.6 23.3 8.0 19.1 33.1 41.5 115.9 36.2 64.0 56.6 42.4 MAOA ENSG00000189221 "Monoamine oxidase A" P21397 X 43654907-43746824 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Catecholamine metabolism, Neurotransmitter degradation" Oxidoreductase "Disease variant, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 230.3" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 819.8;Proximal tubular cells: 569.9;Undifferentiated cells: 285.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 162.1;HHSteC: 302.9;HSkMC: 76.1;hTCEpi: 87.2;RT4: 131.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009437, HPA054807, HPA059299" Enhanced Supported Mitochondria,Cytosol No No "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 30: Epithelial cell lines - Translation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria Cytosol "CAB009437: AB_2137260, HPA054807: AB_2682607, HPA059299: AB_2683970" "unprognostic (9.54e-3)" "unprognostic (1.63e-1)" "unprognostic (7.99e-2)" "unprognostic (3.07e-1)" "unprognostic (6.75e-2)" "unprognostic (3.32e-1)" "unprognostic (9.51e-2)" "unprognostic (6.89e-3)" "unprognostic (2.21e-1)" "unprognostic (4.29e-2)" "unprognostic (3.94e-1)" "unprognostic (3.54e-1)" "unprognostic (1.45e-3)" "unprognostic (1.16e-2)" "unprognostic (1.47e-1)" "unprognostic (4.04e-2)" "unprognostic (2.98e-3)" 143.9 27.7 24.7 8.6 27.6 0.4 71.6 26.5 26.6 26.6 13.9 116.4 163.4 24.0 14.1 46.7 39.1 16.9 49.6 22.3 31.7 76.9 119.1 63.5 2.4 26.9 32.5 40.7 39.1 31.4 4.0 30.2 56.4 46.3 117.9 28.2 77.3 35.0 33.5 37.4 230.3 24.0 21.3 6.3 55.9 3.7 41.4 9.9 118.4 34.3 5.3 65.0 38.8 19.0 0.0 3.7 0.6 9.9 162.1 0.0 0.6 0.2 0.0 0.0 0.0 0.4 0.4 0.0 0.2 0.0 4.6 17.2 6.1 22.3 0.1 0.0 2.5 6.9 0.5 18.6 302.9 0.0 16.9 76.1 87.2 0.2 45.2 0.1 20.0 0.0 0.3 0.4 5.7 2.9 0.1 0.8 1.6 20.7 5.0 0.0 0.3 0.5 22.3 131.8 3.1 7.8 0.0 0.0 0.3 0.4 0.5 0.0 8.7 0.0 8.2 0.7 0.0 0.3 0.0 0.0 9.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.7 27.6 26.5 26.6 22.3 31.7 26.9 32.5 56.4 21.3 41.4 19.0 35.2 70.5 146.9 23.2 4.6 11.0 177.7 32.3 116.7 5.0 13.6 10.2 101.3 94.4 49.3 60.7 22.9 11.5 0.2 248.0 121.3 36.7 25.2 50.4 42.5 43.6 38.0 4.8 4.0 13.4 21.3 24.3 40.2 175.1 5.7 7.3 53.6 193.7 6.6 3.3 5.0 137.5 67.1 12.2 2.1 33.9 5.6 6.7 10.6 21.5 17.1 25.4 0.0 7.5 1.3 49.5 140.5 0.0 2.6 64.6 819.8 569.9 32.8 27.4 6.6 4.4 30.5 1.3 0.8 120.6 14.3 207.0 3.7 3.5 285.1 129.0 MAP3K19 "FLJ23074, RCK, YSK4" ENSG00000176601 "Mitogen-activated protein kinase kinase kinase 19" Q56UN5 2 134964485-135047468 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 5.0;choroid plexus: 9.3;fallopian tube: 18.3;testis: 5.4" "Group enriched" "Detected in some" 8 "Early spermatids: 59.7;Endometrial ciliated cells: 73.7;Late spermatids: 148.4;Respiratory ciliated cells: 121.0" "Cancer enhanced" "Detected in some" "endometrial cancer: 0.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011388 Uncertain Cytosol NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 25: Spermatids - Spermatogenesis" Cytosol "HPA011388: AB_1848822" "unprognostic (7.12e-3)" "unprognostic (6.55e-3)" "unprognostic (6.96e-2)" "unprognostic (3.90e-3)" "unprognostic (3.63e-1)" "unprognostic (2.21e-1)" "unprognostic (1.96e-1)" "unprognostic (9.38e-2)" "unprognostic (1.09e-1)" "unprognostic (4.33e-1)" "unprognostic (2.02e-2)" "unprognostic (1.32e-1)" "unprognostic (4.04e-6)" "unprognostic (1.50e-1)" "unprognostic (4.13e-2)" "unprognostic (1.54e-1)" "unprognostic (2.83e-4)" 0.0 0.1 1.1 0.0 1.2 0.0 0.0 0.8 0.8 0.5 9.3 0.0 0.0 0.6 0.0 0.0 18.3 0.0 0.1 1.1 1.9 0.0 0.0 1.5 0.1 5.0 3.6 0.0 0.0 0.0 0.3 0.0 3.0 0.1 0.0 0.5 0.1 0.0 0.0 0.1 0.1 0.0 3.8 0.0 0.0 5.4 1.9 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.2 0.8 0.8 1.1 1.9 5.0 3.6 3.0 3.8 1.9 3.1 0.1 0.0 1.1 2.3 0.1 0.0 0.1 2.6 0.0 0.3 0.0 0.0 0.4 0.0 11.4 0.0 10.4 0.0 0.0 0.0 0.0 0.0 59.7 73.7 0.4 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 2.0 0.0 0.0 148.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 1.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 121.0 0.2 0.0 0.0 0.8 7.5 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 MAP4 ENSG00000047849 "Microtubule associated protein 4" P27816 3 47850690-48089272 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 743.9" "Cell type enhanced" "Detected in all" "Bipolar cells: 392.2;Cardiomyocytes: 921.5;Cone photoreceptor cells: 625.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038149, HPA038150" Enhanced Approved "Plasma membrane,Microtubules,Cytosol" NA NA 880000 "Cluster 27: Non-specific - Gene expression" "Cluster 80: Striated muscle - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 54: Cardiomyocytes - Muscle contraction" "Microtubules, Cytosol" "Plasma membrane" "HPA038149: AB_10672471, HPA038150: AB_10672505" "unprognostic (2.51e-1)" "unprognostic (4.48e-1)" "unprognostic (2.72e-1)" "unprognostic (1.95e-2)" "unprognostic (3.36e-1)" "unprognostic (4.57e-1)" "prognostic unfavorable (1.82e-4)" "unprognostic (6.82e-2)" "unprognostic (1.46e-2)" "unprognostic (5.02e-2)" "unprognostic (2.23e-2)" "unprognostic (1.30e-2)" "unprognostic (2.25e-2)" "unprognostic (8.89e-2)" "unprognostic (6.45e-2)" "unprognostic (1.88e-1)" "unprognostic (1.21e-3)" 127.4 55.7 475.5 50.4 483.4 16.1 98.0 433.2 406.8 118.0 215.5 193.2 35.1 111.7 69.7 90.7 94.7 52.9 380.9 351.2 408.7 88.3 66.0 105.0 35.0 567.9 490.6 90.0 71.4 31.4 56.1 64.8 509.2 92.7 47.6 149.0 71.4 88.1 743.9 120.6 80.6 94.5 526.1 64.0 93.9 80.0 552.3 42.1 61.1 491.0 37.8 135.5 115.2 533.2 121.9 95.7 117.1 89.3 168.6 298.5 49.5 222.6 241.2 184.1 204.9 81.3 74.4 102.3 50.7 337.9 172.8 79.2 151.4 201.6 204.7 148.7 63.8 69.3 102.8 106.0 228.6 48.6 53.9 251.4 246.4 224.0 271.6 167.1 245.1 70.6 91.2 115.3 146.9 69.1 69.5 58.9 70.9 59.9 195.0 36.6 110.1 128.1 118.2 100.1 46.4 72.3 171.0 68.3 118.6 163.0 50.1 44.8 334.5 172.7 132.3 182.9 144.4 80.4 66.9 47.8 222.2 58.6 167.3 10.5 6.6 3.7 15.6 10.6 7.5 12.3 10.2 12.7 7.1 11.5 4.9 7.6 2.6 13.4 27.3 10.8 13.0 9.7 475.5 483.4 433.2 406.8 351.2 408.7 567.9 490.6 509.2 526.1 552.3 533.2 147.9 70.5 48.2 124.4 45.1 74.8 55.4 53.1 42.7 392.2 34.7 36.2 921.5 48.6 53.4 80.9 625.5 33.8 54.6 43.7 27.4 97.8 116.2 78.2 143.2 110.4 28.8 21.6 63.7 65.3 81.0 105.5 39.8 93.4 27.8 81.6 50.0 57.3 38.0 47.1 71.2 31.7 34.6 28.3 50.5 38.8 77.0 40.0 78.2 95.5 72.0 82.8 47.4 77.9 167.2 92.0 28.0 103.0 47.2 89.0 37.1 39.2 43.6 97.5 72.3 149.0 119.0 65.6 64.3 58.7 69.6 22.4 60.5 137.4 39.5 44.7 MAP7D3 FLJ12649 ENSG00000129680 "MAP7 domain containing 3" Q8IWC1 X 136213220-136256482 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 264.2;Late spermatids: 288.5;Spermatogonia: 106.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035598, HPA058101" Approved Uncertain Centrosome,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 89: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Centrosome Cytosol "HPA035598: AB_10671108, HPA058101: AB_2683604" "unprognostic (2.89e-1)" "unprognostic (1.23e-1)" "unprognostic (9.56e-2)" "prognostic unfavorable (9.00e-5)" "unprognostic (8.83e-3)" "unprognostic (3.77e-3)" "unprognostic (4.16e-5)" "unprognostic (5.35e-2)" "unprognostic (6.57e-2)" "unprognostic (1.02e-1)" "unprognostic (1.12e-1)" "unprognostic (4.20e-2)" "unprognostic (9.91e-2)" "prognostic unfavorable (7.91e-4)" "unprognostic (2.04e-1)" "unprognostic (1.01e-2)" "prognostic unfavorable (5.38e-5)" 18.1 4.5 1.4 5.8 1.5 5.0 11.4 1.2 1.8 7.4 2.9 8.3 2.2 9.7 6.1 6.1 13.2 6.0 8.7 1.2 1.7 3.7 4.1 5.9 6.6 1.8 1.6 16.8 2.1 5.8 4.7 7.1 2.0 3.7 3.3 1.5 3.0 4.1 11.5 4.5 5.6 8.8 1.5 6.3 5.0 15.8 1.8 5.3 8.2 9.1 5.0 7.7 6.4 1.9 33.6 11.8 8.7 15.0 19.3 20.1 12.1 31.6 17.4 25.3 34.6 11.7 16.5 17.3 50.0 27.9 26.8 15.7 25.6 16.9 33.5 15.9 25.6 10.3 18.0 0.0 21.0 25.2 10.2 41.1 9.5 26.0 32.0 14.2 20.0 28.1 9.0 26.1 18.8 20.9 30.4 10.2 12.4 8.1 0.3 29.5 23.5 8.4 0.8 5.1 6.1 13.0 18.4 6.7 11.4 14.5 0.1 11.5 60.3 26.9 15.5 34.6 40.6 17.8 22.7 19.3 18.5 42.3 13.0 6.6 3.5 1.1 5.2 4.2 6.5 7.5 4.9 5.8 4.4 6.4 5.2 4.1 0.7 6.6 7.9 4.6 3.8 2.9 1.4 1.5 1.2 1.8 1.2 1.7 1.8 1.6 2.0 1.5 1.8 1.9 36.6 16.0 6.7 4.2 18.5 7.1 7.2 15.4 14.8 0.7 5.1 9.1 41.5 11.5 8.7 18.4 0.0 10.3 13.8 3.7 1.9 8.6 264.2 13.7 47.3 24.9 5.4 12.6 1.9 14.7 103.4 46.5 2.0 5.1 35.5 15.2 50.7 30.4 15.4 20.2 1.0 2.8 8.2 17.3 7.8 288.5 63.3 15.0 7.2 5.6 23.4 12.2 22.6 1.5 3.6 13.0 14.1 47.8 10.0 13.5 0.7 54.6 6.5 2.9 39.5 29.8 61.5 53.2 106.9 5.3 4.8 13.4 18.6 15.9 3.3 2.4 MBD3L2 ENSG00000230522 "Methyl-CpG binding domain protein 3 like 2" Q8NHZ7 19 7049321-7051735 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051259 Uncertain Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 43: Cardiomyocytes - Nuclear processes" "Nucleoplasm, Nucleoli" Cytosol "HPA051259: AB_2681411" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBD3L2B ENSG00000196589 "Methyl-CpG binding domain protein 3 like 2B" A0A1B0GVZ6 19 7018969-7021432 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051259 Uncertain Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA051259: AB_2681411" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBD3L4 ENSG00000205718 "Methyl-CpG binding domain protein 3 like 4" A6NDZ8 19 7037748-7040179 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051259 Uncertain Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA051259: AB_2681411" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBD3L5 ENSG00000237247 "Methyl-CpG binding domain protein 3 like 5" A6NJ08 19 7030578-7033011 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051259 Uncertain Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 43: Cardiomyocytes - Nuclear processes" "Nucleoplasm, Nucleoli" Cytosol "HPA051259: AB_2681411" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MCM8 "C20orf154, dJ967N21.5, MGC119522, MGC119523, MGC12866, MGC4816, REC" ENSG00000125885 "Minichromosome maintenance 8 homologous recombination repair factor" Q9UJA3 20 5950652-5998977 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, DNA replication" "DNA-binding, Helicase, Hydrolase" "Disease variant, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 71.8;Spermatogonia: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "HPA045141, HPA066433" Supported Nucleoplasm,Cytosol NA NA "Cluster 35: T-regs - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm Cytosol "HPA045141: AB_2679230, HPA066433: " "unprognostic (6.55e-2)" "unprognostic (2.46e-2)" "unprognostic (4.43e-1)" "unprognostic (2.22e-3)" "unprognostic (1.90e-1)" "unprognostic (5.78e-2)" "prognostic unfavorable (9.30e-8)" "unprognostic (5.21e-2)" "unprognostic (5.14e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (7.50e-4)" "unprognostic (6.74e-2)" "unprognostic (1.11e-2)" "unprognostic (5.53e-2)" "unprognostic (2.76e-1)" "unprognostic (2.66e-2)" "unprognostic (3.47e-1)" 2.9 2.9 3.0 4.6 4.1 10.2 2.8 6.8 4.4 4.0 4.2 3.9 3.6 3.1 2.1 3.7 3.2 1.7 3.3 3.1 3.4 2.4 1.8 2.4 7.5 2.9 3.1 2.6 3.1 2.0 1.6 3.3 3.1 3.6 3.2 5.3 2.9 1.8 6.9 4.7 3.7 2.1 2.6 3.6 3.3 13.4 3.1 9.0 2.4 4.6 6.5 3.4 3.6 5.8 48.6 33.0 27.7 30.3 4.6 6.6 27.4 38.1 12.3 26.6 32.0 35.4 27.6 48.3 11.3 10.2 51.5 50.9 46.1 25.7 47.9 13.4 21.5 49.3 16.8 27.9 0.9 56.6 7.4 2.5 3.8 47.2 17.6 5.3 12.3 28.7 56.7 45.8 27.1 12.3 27.6 30.0 40.3 25.3 21.6 34.8 50.9 18.6 5.0 15.3 21.6 23.2 40.0 36.3 22.5 28.6 27.1 16.4 9.6 51.5 43.2 28.2 56.8 20.1 53.8 82.2 9.6 33.5 43.4 1.0 0.1 0.4 0.4 0.1 0.7 0.3 0.2 0.4 0.0 0.3 0.2 0.4 0.4 0.4 0.2 0.4 0.5 0.1 3.0 4.1 6.8 4.4 3.1 3.4 2.9 3.1 3.1 2.6 3.1 5.8 3.3 0.0 4.4 1.6 6.0 2.3 3.0 1.9 4.6 7.3 2.1 2.8 10.3 7.2 2.4 12.9 16.7 7.2 4.2 5.8 0.0 1.9 8.5 4.9 3.5 4.2 4.2 14.9 3.7 2.8 6.3 5.0 3.1 5.4 1.3 24.4 2.9 1.9 4.5 6.7 2.9 4.0 6.1 2.8 4.6 3.2 3.7 3.7 1.8 2.8 0.3 3.7 8.2 3.5 6.6 3.6 3.9 3.0 9.2 3.3 4.7 2.4 4.0 11.5 6.6 5.7 4.8 71.8 37.1 5.0 2.6 4.0 6.0 3.0 6.3 2.2 MDM1 ENSG00000111554 "Mdm1 nuclear protein" Q8TC05 12 68272443-68332381 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Respiratory ciliated cells: 44.0;Spermatocytes: 56.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040411, HPA041594" Uncertain Supported "Centriolar satellite,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "Centriolar satellite" Cytosol "HPA040411: AB_10805711, HPA041594: AB_10793968" "unprognostic (7.41e-2)" "prognostic favorable (6.01e-4)" "unprognostic (8.58e-2)" "unprognostic (2.62e-3)" "unprognostic (1.21e-1)" "unprognostic (3.50e-3)" "unprognostic (4.24e-3)" "unprognostic (3.89e-2)" "unprognostic (2.80e-3)" "unprognostic (2.92e-1)" "unprognostic (2.56e-3)" "unprognostic (3.13e-2)" "unprognostic (4.29e-3)" "unprognostic (1.29e-1)" "unprognostic (2.84e-1)" "unprognostic (4.63e-2)" "unprognostic (5.23e-3)" 5.3 5.7 6.3 9.5 7.2 16.5 9.1 6.8 7.2 9.0 13.2 25.7 4.8 13.9 11.2 4.3 18.2 5.9 4.7 5.7 7.5 8.1 4.6 6.4 13.0 8.5 9.1 9.6 5.3 7.1 9.4 5.6 8.2 9.3 9.8 29.2 6.4 13.9 3.0 3.7 7.1 13.0 9.2 9.4 6.6 20.6 7.3 15.2 10.0 3.3 13.0 10.9 6.4 8.5 8.4 6.9 13.0 12.7 6.3 8.5 10.0 11.0 6.1 17.2 15.7 8.3 3.8 19.3 7.1 5.0 8.4 8.6 9.0 5.9 19.4 25.4 8.6 42.5 9.1 5.7 9.8 23.8 16.1 3.9 7.6 11.6 11.2 9.3 9.9 21.9 8.2 21.1 10.0 6.1 33.7 16.7 6.9 8.3 8.4 32.8 11.7 5.7 8.2 7.3 11.8 6.3 10.6 6.3 11.1 10.3 15.1 16.9 5.2 13.7 6.0 8.7 10.3 10.9 34.0 13.3 7.2 15.3 8.9 9.9 5.1 15.0 5.0 12.0 8.1 7.5 6.5 5.2 4.4 6.9 7.6 6.2 3.3 7.2 19.4 2.5 6.7 5.7 6.3 7.2 6.8 7.2 5.7 7.5 8.5 9.1 8.2 9.2 7.3 8.5 8.3 3.2 4.6 14.0 12.9 4.8 3.9 5.3 5.2 16.0 8.0 9.0 10.8 2.8 6.8 7.3 0.0 4.7 13.2 2.8 9.8 4.8 26.0 35.4 16.0 6.6 2.4 25.2 12.5 3.5 4.2 5.7 5.6 5.3 7.0 12.0 6.1 4.9 6.3 8.4 11.7 2.8 10.2 4.7 5.1 13.5 9.0 14.5 16.0 8.4 7.3 25.7 18.6 9.5 18.7 3.0 4.7 13.5 9.3 1.8 1.8 10.4 44.0 34.6 6.6 7.4 8.2 56.3 22.3 6.3 4.1 0.3 13.9 8.6 4.9 1.7 MDN1 "KIAA0301, Rea1" ENSG00000112159 "Midasin AAA ATPase 1" Q9NU22 6 89642498-89819794 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 82.5;Inhibitory neurons: 79.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "K-562: 24.7;NTERA-2: 22.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029666, HPA029667, HPA029668, HPA029669" Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 18: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoli, Cytosol" "Nucleoplasm, Intermediate filaments" "HPA029666: AB_10600888, HPA029667: AB_10696207, HPA029668: AB_10669868, HPA029669: AB_10670429" "unprognostic (2.00e-1)" "unprognostic (4.46e-2)" "unprognostic (7.62e-2)" "unprognostic (2.26e-2)" "unprognostic (6.14e-3)" "unprognostic (3.46e-1)" "unprognostic (6.68e-2)" "unprognostic (1.40e-1)" "unprognostic (3.51e-1)" "unprognostic (1.75e-1)" "unprognostic (1.77e-2)" "unprognostic (9.07e-2)" "unprognostic (2.54e-3)" "unprognostic (6.28e-3)" "unprognostic (9.22e-2)" "unprognostic (2.02e-1)" "unprognostic (6.09e-2)" 4.2 4.6 3.4 1.9 3.6 4.2 4.3 4.4 3.3 4.5 1.7 4.4 1.2 5.6 2.1 4.9 5.0 1.2 4.9 3.1 3.3 4.4 9.1 3.9 2.6 3.3 3.1 7.6 5.9 3.0 4.6 1.2 3.7 3.6 1.8 3.0 3.9 1.5 8.3 7.1 5.0 1.7 2.2 4.5 4.6 6.5 3.3 2.8 6.0 3.4 2.5 4.2 4.3 5.7 4.2 4.1 4.1 3.8 6.6 6.3 4.1 2.8 2.1 3.1 3.8 9.4 1.5 12.5 3.1 2.9 3.3 3.6 10.7 3.8 5.5 4.9 7.1 13.5 5.6 6.1 2.5 17.7 3.2 3.9 3.1 8.3 7.6 1.9 5.6 5.6 24.7 2.9 3.1 5.0 2.8 6.6 22.7 3.4 3.5 5.5 7.8 3.1 2.7 5.8 7.5 3.3 3.9 2.3 2.5 5.4 1.6 7.7 7.2 2.1 3.8 2.8 6.5 3.3 3.9 5.9 2.8 9.8 3.7 3.2 0.3 0.6 0.7 0.2 0.6 1.0 1.0 0.8 0.2 1.3 1.3 1.0 0.0 1.1 0.3 3.0 0.4 0.1 3.4 3.6 4.4 3.3 3.1 3.3 3.3 3.1 3.7 2.2 3.3 5.7 13.2 28.9 19.1 55.2 19.2 29.3 8.2 6.0 30.7 24.4 14.0 11.0 39.2 11.5 16.9 14.7 25.0 5.5 25.2 6.6 0.0 6.3 7.5 20.1 21.9 15.0 7.7 58.5 82.5 8.1 7.2 13.3 19.4 25.2 6.3 26.4 6.4 48.5 6.6 18.5 79.5 7.7 6.1 6.3 9.5 4.3 7.2 8.6 12.4 33.7 6.6 8.0 9.2 35.7 74.8 6.9 3.7 8.6 26.0 18.1 4.7 2.5 12.9 18.7 0.0 33.1 12.7 37.5 50.1 26.1 30.1 3.4 19.4 17.4 10.3 8.5 METTL25 "C12orf26, FLJ22789" ENSG00000127720 "Methyltransferase like 25" Q8N6Q8 12 82358528-82479239 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 23.5" "Group enriched" "Detected in many" 4 "Astrocytes: 68.2;Excitatory neurons: 63.2;Inhibitory neurons: 58.4;Microglial cells: 45.9;Oligodendrocyte precursor cells: 89.0;Oligodendrocytes: 98.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039534, HPA041207" Enhanced Uncertain "Plasma membrane,Mitochondria,Cytosol" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 6: Brain - Smell perception" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Plasma membrane, Mitochondria, Cytosol" "HPA039534: AB_10794749, HPA041207: AB_10794406" "unprognostic (1.60e-2)" "unprognostic (3.36e-3)" "unprognostic (2.06e-2)" "unprognostic (4.15e-2)" "unprognostic (1.56e-1)" "unprognostic (3.15e-1)" "unprognostic (5.73e-3)" "unprognostic (1.21e-2)" "unprognostic (5.20e-2)" "unprognostic (6.66e-2)" "unprognostic (7.00e-3)" "unprognostic (2.15e-2)" "unprognostic (2.59e-3)" "unprognostic (1.48e-1)" "unprognostic (1.11e-2)" "unprognostic (4.05e-2)" "unprognostic (1.44e-2)" 3.1 3.1 2.5 3.0 3.2 3.1 5.7 2.7 23.5 3.9 3.3 4.1 4.1 3.7 4.5 3.5 3.6 2.8 4.7 3.2 4.4 4.5 2.5 3.5 4.8 14.0 1.9 5.4 2.6 4.1 2.6 3.5 10.5 3.2 4.7 6.0 4.2 2.9 4.5 3.6 3.1 3.4 1.0 3.7 2.8 5.9 6.8 4.3 4.7 3.7 4.0 3.6 3.1 14.0 1.2 2.8 3.8 0.9 4.0 4.6 3.6 5.6 3.3 2.9 2.2 3.1 3.0 7.3 1.2 4.3 0.7 1.2 7.5 1.0 1.9 6.3 5.6 3.7 1.4 3.4 2.3 6.4 4.1 3.5 3.4 1.0 0.0 5.8 6.2 2.6 2.3 3.1 3.1 4.1 2.7 5.5 5.6 3.2 1.0 1.7 2.2 3.9 9.2 3.9 2.7 2.1 2.2 3.5 3.7 3.0 2.9 6.0 2.5 1.4 1.4 2.3 3.3 3.9 2.4 2.9 2.2 3.9 3.0 19.0 6.5 3.9 4.3 6.0 6.1 5.3 4.6 3.7 4.9 7.2 6.0 4.9 12.2 10.0 5.5 11.1 4.3 3.6 2.5 3.2 2.7 23.5 3.2 4.4 14.0 1.9 10.5 1.0 6.8 14.0 7.9 9.6 9.6 68.2 7.6 4.6 7.3 12.4 4.6 7.0 8.1 8.5 12.7 8.6 8.4 3.7 6.2 11.8 11.5 5.5 7.9 5.5 4.9 5.6 6.6 7.0 7.3 1.7 63.2 3.2 5.4 7.4 8.2 5.9 3.8 7.1 10.8 4.5 5.6 3.3 58.4 4.1 12.2 3.8 5.2 1.7 4.7 6.4 5.4 45.9 14.7 4.2 4.1 89.0 98.9 4.3 5.6 10.5 11.6 3.4 6.3 8.4 12.7 11.5 0.0 12.3 7.2 12.9 9.5 10.6 6.1 7.8 6.4 8.7 6.0 4.4 MGST2 MGST-II ENSG00000085871 "Microsomal glutathione S-transferase 2" Q99735 4 139665768-139740745 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Leukotriene biosynthesis, Lipid metabolism" "Lyase, Oxidoreductase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 393.2" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 441.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 194.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 276.3;OE19: 558.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA010690, HPA010707" Enhanced Uncertain "Endoplasmic reticulum,Cytosol" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 22: Epithelial cell types - Mixed function" Cytosol "Endoplasmic reticulum" "HPA010690: , HPA010707: AB_1853922" "unprognostic (9.35e-2)" "unprognostic (6.13e-2)" "unprognostic (4.33e-2)" "prognostic favorable (5.26e-5)" "unprognostic (1.58e-1)" "unprognostic (8.26e-2)" "unprognostic (1.02e-2)" "unprognostic (1.18e-1)" "unprognostic (4.38e-2)" "unprognostic (2.77e-2)" "unprognostic (8.78e-2)" "unprognostic (6.41e-2)" "prognostic favorable (3.22e-9)" "unprognostic (4.10e-1)" "unprognostic (9.91e-2)" "unprognostic (1.77e-2)" "unprognostic (1.01e-2)" 61.8 92.7 43.5 30.4 42.9 42.6 66.6 45.1 60.6 63.6 54.8 112.5 132.5 39.2 82.1 177.6 70.8 87.6 118.3 42.6 45.7 99.2 393.2 49.0 36.0 46.6 44.6 26.3 66.2 102.0 44.6 75.6 46.5 74.9 121.2 7.8 90.6 50.0 104.2 97.1 143.5 57.4 46.6 60.5 72.5 50.6 45.3 35.1 45.8 118.4 64.6 86.7 78.4 48.9 40.8 58.5 28.7 0.3 4.8 15.4 17.7 7.2 66.1 3.2 10.7 62.3 276.3 0.1 158.2 17.5 13.6 74.8 52.7 81.2 4.9 22.3 47.7 174.9 57.3 251.5 13.3 152.7 130.0 53.0 197.2 2.1 12.5 63.9 166.3 0.3 75.9 25.7 23.3 33.9 0.2 24.7 6.5 558.9 59.4 12.7 33.4 54.0 153.0 87.4 71.9 21.6 53.2 83.2 64.8 2.0 52.9 202.2 104.9 5.6 27.3 7.8 6.4 29.7 22.5 9.7 3.8 254.8 12.6 43.8 103.8 30.4 4.1 64.8 2.9 1.3 7.6 3.5 147.0 2.4 2.3 2.6 17.7 26.4 22.2 194.6 37.7 39.4 43.5 42.9 45.1 60.6 42.6 45.7 46.6 44.6 46.5 46.6 45.3 48.9 327.9 25.6 36.6 5.5 7.7 61.1 295.9 316.7 75.7 7.8 99.1 57.3 100.5 205.9 185.5 95.6 25.0 85.3 71.0 168.3 90.1 121.0 6.3 132.5 27.1 238.4 121.8 60.2 19.4 138.6 62.8 31.8 90.2 172.9 43.2 56.9 203.1 419.3 378.1 6.7 24.2 215.1 170.9 107.8 77.8 12.8 44.4 85.3 39.2 49.6 83.6 14.1 27.8 11.6 4.7 121.8 213.1 33.4 7.1 94.6 441.1 277.2 126.6 3.5 13.1 44.6 49.6 4.6 15.1 264.0 124.9 67.2 15.2 43.6 258.2 344.9 MICAL2 KIAA0750 ENSG00000133816 "Microtubule associated monooxygenase, calponin and LIM domain containing 2" O94851 11 12094008-12359144 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Actin-binding, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 61.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 193.5;Inhibitory neurons: 108.8;Late spermatids: 192.7;Peritubular cells: 112.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 8.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-138 MG: 109.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030437, HPA039895, HPA040438" Approved Uncertain "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 58: Brain - Synaptic function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus, Cytosol" "Nucleoplasm, Plasma membrane" "HPA030437: AB_10601873, HPA039895: AB_2676731, HPA040438: AB_10672896" "unprognostic (2.68e-2)" "unprognostic (1.77e-2)" "unprognostic (5.77e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (6.88e-4)" "unprognostic (2.20e-2)" "unprognostic (3.60e-2)" "unprognostic (9.32e-2)" "unprognostic (2.86e-1)" "unprognostic (1.36e-1)" "unprognostic (1.15e-2)" "unprognostic (6.47e-2)" "prognostic unfavorable (3.63e-5)" "unprognostic (4.61e-2)" "unprognostic (1.97e-1)" "unprognostic (1.21e-1)" "unprognostic (1.67e-1)" 4.7 3.8 13.9 12.2 13.6 11.6 2.5 61.6 38.1 6.9 42.6 18.8 9.8 12.3 7.2 18.6 7.4 10.0 42.2 37.8 0.0 2.3 2.9 17.5 3.3 0.0 0.0 3.9 4.1 1.0 0.2 7.3 0.0 2.9 16.3 4.0 0.8 9.6 16.8 14.0 10.8 30.8 0.0 3.3 6.7 32.5 0.0 1.9 6.1 4.1 2.5 12.4 0.3 19.9 29.1 9.7 0.4 2.7 2.3 6.8 14.2 32.1 53.7 16.2 28.3 24.3 23.3 0.2 8.4 25.3 47.7 25.0 4.0 65.1 41.6 35.9 4.8 27.5 4.1 0.9 12.8 5.3 2.7 12.7 11.1 76.0 54.6 25.3 46.9 1.6 43.5 0.8 22.9 1.2 0.3 1.6 1.2 13.6 9.8 0.3 15.2 14.2 2.1 35.5 14.3 0.8 8.6 38.6 2.9 9.9 4.5 2.3 42.6 109.6 35.0 17.4 39.6 0.9 2.6 1.5 64.3 5.2 1.4 0.1 4.2 0.5 1.3 0.7 1.5 0.1 0.8 0.4 3.4 0.2 0.0 0.4 8.9 2.2 0.4 0.9 0.7 1.5 13.9 13.6 61.6 38.1 37.8 0.0 0.0 0.0 0.0 0.0 0.0 19.9 3.2 41.7 37.1 7.2 1.2 10.1 11.8 4.5 4.0 5.7 4.2 5.3 32.2 7.2 8.5 3.7 0.0 2.6 11.2 66.5 0.0 10.2 74.4 7.8 8.9 9.2 22.6 35.6 193.5 14.3 12.6 9.0 12.2 11.4 1.3 1.4 12.8 19.6 3.4 0.0 108.8 10.6 6.1 10.1 5.6 192.7 21.1 11.1 5.4 4.7 21.6 0.5 8.2 6.6 17.5 42.5 24.0 112.8 2.1 8.9 18.3 0.9 5.5 1.6 13.1 1.9 29.4 1.2 1.3 1.7 9.5 2.3 10.8 0.7 14.5 11.9 MIS18BP1 "C14orf106, FLJ11186, KIAA1903, KNL2, M18BP1" ENSG00000129534 "MIS18 binding protein 1" Q6P0N0 14 45203190-45253540 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 40.7" "Cell type enhanced" "Detected in many" "Granulosa cells: 145.1;monocytes: 150.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA006504 Approved Approved Nucleoli,Cytosol NA Yes "Cluster 14: Monocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 32: U-937 - Innate immune response" "Cluster 41: Macrophages - Immune response" Nucleoli Cytosol "HPA006504: AB_1078317" "unprognostic (2.12e-1)" "unprognostic (1.06e-1)" "unprognostic (2.58e-2)" "unprognostic (1.44e-2)" "unprognostic (1.51e-1)" "unprognostic (1.05e-2)" "prognostic unfavorable (3.83e-4)" "unprognostic (4.18e-1)" "unprognostic (1.36e-2)" "unprognostic (3.33e-1)" "unprognostic (3.32e-2)" "unprognostic (2.32e-3)" "unprognostic (3.31e-2)" "unprognostic (5.49e-2)" "unprognostic (2.30e-1)" "unprognostic (2.97e-1)" "unprognostic (2.21e-1)" 8.6 3.7 1.5 14.1 1.4 40.7 10.7 0.9 1.6 7.3 1.1 8.0 8.4 10.2 5.3 7.1 6.7 7.7 3.8 1.4 1.7 3.7 4.1 9.5 23.2 2.1 1.9 12.2 4.6 2.3 1.3 10.6 2.4 6.3 10.1 1.2 6.7 5.8 1.3 8.6 9.6 9.6 1.9 15.2 8.5 13.5 1.5 24.4 6.8 3.8 21.7 7.8 3.9 2.8 54.1 20.0 40.7 18.0 12.1 17.2 30.0 36.4 19.2 29.7 36.5 10.7 50.7 73.6 15.5 18.5 12.8 37.0 23.9 18.5 55.3 39.5 15.3 44.5 23.2 13.8 8.1 103.7 39.7 12.5 7.4 17.6 16.5 19.4 36.7 14.1 19.7 17.2 29.1 19.9 44.1 45.9 30.8 26.5 24.9 51.5 16.4 28.5 15.3 22.3 28.4 12.3 16.2 24.6 13.1 24.1 29.5 58.1 20.4 15.7 47.4 19.5 16.6 15.3 21.5 34.5 8.8 42.6 22.8 64.5 28.8 35.8 7.9 28.5 8.5 28.5 7.5 6.8 21.5 25.5 5.0 5.1 17.8 10.8 53.8 31.0 10.9 9.1 1.5 1.4 0.9 1.6 1.4 1.7 2.1 1.9 2.4 1.9 1.5 2.8 54.6 25.6 27.8 6.8 87.7 20.1 11.6 17.7 19.4 8.4 24.3 27.3 13.3 7.2 26.1 9.2 16.7 40.9 91.6 17.1 5.9 14.0 3.5 29.2 47.6 43.5 27.6 72.6 34.5 11.1 42.5 32.5 35.7 28.0 43.6 145.1 30.4 7.3 35.4 0.0 7.6 25.8 18.3 89.8 30.9 6.8 55.3 115.7 5.4 74.0 150.1 5.1 55.6 9.5 11.1 13.5 47.7 60.5 73.5 25.0 12.1 5.0 20.9 7.6 0.0 13.9 23.3 80.0 105.4 32.5 26.3 19.4 54.5 77.9 29.9 24.6 MLLT10 AF10 ENSG00000078403 "MLLT10 histone lysine methyltransferase DOT1L cofactor" P55197 10 21524646-21743630 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 93.0" "Cell type enhanced" "Detected in all" "Excitatory neurons: 201.3;Spermatocytes: 233.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005736, HPA005747, HPA072790" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Cytosol "HPA005736: , HPA005747: AB_1079393, HPA072790: " "unprognostic (6.58e-2)" "unprognostic (1.57e-1)" "unprognostic (7.32e-2)" "unprognostic (1.47e-2)" "unprognostic (1.31e-2)" "prognostic favorable (8.75e-4)" "unprognostic (1.03e-3)" "unprognostic (9.56e-3)" "unprognostic (9.29e-2)" "unprognostic (1.78e-1)" "unprognostic (2.69e-2)" "unprognostic (7.85e-2)" "unprognostic (6.57e-2)" "unprognostic (1.26e-1)" "unprognostic (1.50e-1)" "unprognostic (1.07e-1)" "unprognostic (1.67e-1)" 15.6 13.0 11.9 12.0 13.6 30.5 14.4 21.5 16.0 18.2 16.6 20.8 9.1 18.7 16.0 16.1 17.4 11.4 17.1 11.5 15.2 15.1 15.6 14.6 15.3 14.6 11.9 24.7 13.5 18.6 12.6 16.4 14.1 13.0 12.7 20.6 13.7 11.8 15.6 25.4 13.2 16.8 11.9 12.8 12.3 93.0 13.7 23.2 21.8 14.2 14.5 19.1 16.5 18.6 32.1 29.6 38.3 22.2 23.3 25.0 44.1 19.6 10.6 21.7 21.6 29.5 31.3 34.9 10.8 20.7 21.1 24.1 43.3 25.1 22.2 25.0 21.9 59.2 24.5 44.5 29.6 1.6 33.4 21.3 28.6 17.7 19.2 21.8 30.1 34.3 65.4 26.5 19.3 28.1 44.1 28.5 17.3 17.5 9.2 36.6 23.5 31.7 23.2 12.6 13.8 39.6 24.7 29.0 45.8 30.7 13.3 37.1 29.8 14.7 24.6 26.7 18.9 23.5 32.2 43.4 15.4 21.5 9.9 10.3 6.5 13.5 5.0 4.1 4.6 5.3 6.1 6.1 5.1 4.3 6.6 6.0 4.8 4.6 4.7 7.5 5.5 2.5 11.9 13.6 21.5 16.0 11.5 15.2 14.6 11.9 14.1 11.9 13.7 18.6 33.3 28.9 40.4 155.7 25.1 37.7 17.4 22.4 44.3 38.4 19.9 20.7 31.5 18.6 19.6 18.4 43.8 34.0 24.9 13.3 13.7 14.6 66.1 16.1 26.6 28.7 3.5 30.9 201.3 12.8 58.6 26.6 21.9 21.3 25.2 28.6 26.0 22.7 28.9 30.3 169.6 16.3 26.4 36.1 23.0 109.0 39.4 28.6 48.0 107.7 29.7 17.8 21.6 148.3 160.0 13.2 14.6 48.2 23.5 22.7 18.8 23.1 18.7 53.7 39.5 31.4 35.7 233.8 57.4 48.5 43.9 50.2 29.5 24.2 18.0 13.5 MLLT3 "AF-9, AF9, YEATS3" ENSG00000171843 "MLLT3 super elongation complex subunit" P42568 9 20341669-20622499 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Astrocytes: 144.6;Excitatory neurons: 284.0;Inhibitory neurons: 288.4;Intestinal goblet cells: 112.3;Microglial cells: 114.3;Oligodendrocyte precursor cells: 254.3;Oligodendrocytes: 216.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "NK-cells: 5.1;T-cells: 16.3" "Cell line enriched" "Detected in many" 5 "HEL: 316.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001824 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 36: HEL - Hemostasis" "Cluster 27: Mucus-secreting cells - Mucin production" Nucleoplasm Cytosol "HPA001824: AB_1079394" "unprognostic (3.31e-1)" "unprognostic (2.22e-1)" "unprognostic (1.23e-3)" "unprognostic (1.27e-2)" "unprognostic (1.99e-1)" "unprognostic (7.57e-2)" "unprognostic (3.83e-2)" "unprognostic (1.01e-3)" "unprognostic (2.12e-1)" "unprognostic (3.92e-3)" "unprognostic (1.05e-1)" "unprognostic (2.03e-2)" "prognostic favorable (1.84e-4)" "unprognostic (1.85e-1)" "unprognostic (4.81e-2)" "unprognostic (1.40e-2)" "unprognostic (1.68e-1)" 6.7 15.4 11.6 10.0 16.0 37.3 12.7 9.7 16.4 11.7 2.6 28.8 8.1 12.6 10.6 8.8 12.8 13.9 8.9 17.4 10.9 12.3 2.4 12.6 11.3 6.4 7.8 11.9 4.8 10.1 9.8 11.9 6.6 12.7 37.8 8.2 25.3 12.8 11.1 7.0 15.7 12.3 6.4 6.9 20.1 4.2 9.1 24.3 27.2 11.1 8.3 10.6 6.3 12.0 8.7 24.4 8.4 9.6 19.8 11.7 5.4 22.3 37.8 9.6 11.5 22.8 8.2 36.1 11.9 10.6 3.2 4.4 8.5 38.0 9.2 68.0 23.6 316.4 68.3 12.3 13.8 4.9 20.1 9.4 15.4 3.8 25.3 34.7 9.8 13.8 0.4 42.5 21.7 6.8 24.9 18.6 5.1 50.8 6.8 0.0 15.4 8.8 50.0 13.4 27.2 11.0 18.1 10.2 10.1 8.4 9.3 11.9 6.5 0.0 5.6 6.0 8.3 18.4 18.7 13.1 0.4 10.6 4.8 2.3 0.4 0.6 4.5 0.3 4.3 0.6 8.6 6.5 0.9 1.4 16.3 10.3 0.1 5.1 0.4 0.6 10.8 3.6 11.6 16.0 9.7 16.4 17.4 10.9 6.4 7.8 6.6 6.4 9.1 12.0 20.0 28.9 30.0 144.6 8.0 8.3 15.9 18.7 21.1 7.8 21.2 12.3 13.5 18.6 32.5 22.0 33.3 0.9 17.3 23.5 13.7 29.2 3.0 10.3 17.5 13.7 33.0 28.4 284.0 8.2 6.1 18.0 23.0 19.5 12.0 8.7 11.4 2.2 2.4 5.0 288.4 112.3 16.2 1.9 6.5 7.4 13.7 7.1 23.2 114.3 2.7 31.9 17.5 254.3 216.6 27.3 23.6 9.4 18.2 14.5 13.8 9.0 11.7 2.2 0.0 25.2 21.6 1.0 10.5 14.2 8.4 1.6 33.3 9.8 27.0 15.7 MLNR GPR38 ENSG00000102539 "Motilin receptor" O43193 13 49220338-49222377 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.3;thyroid gland: 1.7" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 7 "testis cancer: 2.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.3;THP-1: 4.0" "Not detected" "Not detected" HPA070324 Approved "Plasma membrane,Cytosol" NA NA "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 43: THP-1 - Innate immune response" "Plasma membrane, Cytosol" "HPA070324: " "unprognostic (9.75e-2)" "unprognostic (2.13e-2)" "unprognostic (2.90e-1)" "unprognostic (1.13e-1)" "unprognostic (6.03e-2)" "unprognostic (7.80e-2)" "unprognostic (1.54e-2)" "unprognostic (7.79e-2)" "unprognostic (1.88e-2)" "unprognostic (3.74e-1)" "unprognostic (2.61e-4)" "unprognostic (3.53e-2)" "unprognostic (1.04e-1)" "unprognostic (1.38e-1)" 0.0 0.0 0.1 0.0 0.3 1.3 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.1 0.4 0.1 1.7 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.3 0.3 0.4 0.3 0.2 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 MMP11 STMY3 ENSG00000099953 "Matrix metallopeptidase 11" P24347 22 23768226-23784316 "Cancer-related genes, Enzymes, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "cervix: 64.8;endometrium 1: 142.8;placenta: 39.6" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 84.9;Extravillous trophoblasts: 37.6;Granulosa cells: 61.9;Smooth muscle cells: 35.8" "Cancer enhanced" "Detected in all" "pancreatic cancer: 119.1" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 5 "plasmacytoid DC: 4.4" "Lineage enriched" "Detected in single" 5 "dendritic cells: 4.4" "Cell line enhanced" "Detected in many" "AN3-CA: 38.4;hTERT-RPE1: 19.7;REH: 16.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002593, HPA055204, HPA068864" Approved Approved "Golgi apparatus,Cytosol" "Secreted to extracellular matrix" NA NA 640000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 36: Stromal cells - Cell proliferation" "Golgi apparatus" Cytosol "CAB002593: , HPA055204: , HPA068864: AB_2686051" "unprognostic (1.06e-1)" "unprognostic (3.08e-1)" "unprognostic (1.83e-1)" "unprognostic (1.84e-3)" "unprognostic (2.77e-2)" "unprognostic (6.73e-2)" "unprognostic (2.14e-2)" "unprognostic (5.15e-1)" "unprognostic (2.73e-2)" "unprognostic (2.20e-1)" "unprognostic (1.89e-3)" "unprognostic (7.04e-2)" "prognostic unfavorable (2.62e-4)" "unprognostic (8.05e-2)" "unprognostic (6.78e-2)" "unprognostic (1.10e-1)" "unprognostic (1.68e-2)" 3.3 1.6 0.4 1.4 0.3 0.5 2.2 0.3 1.2 64.8 0.3 3.9 6.8 142.8 0.1 1.0 5.7 6.8 7.2 0.3 0.4 2.5 0.6 1.4 3.9 0.4 0.4 12.5 1.3 3.3 0.5 39.6 0.4 1.9 3.5 0.0 5.3 1.5 0.9 3.8 6.0 9.4 0.4 1.4 2.6 6.7 0.4 3.1 1.3 0.9 1.7 2.9 3.6 0.4 0.3 0.0 4.8 38.4 5.7 8.3 0.1 0.6 10.4 1.3 0.8 0.4 1.3 1.3 5.1 2.8 1.8 0.2 2.2 0.0 0.4 0.0 0.8 0.0 0.0 2.2 4.2 0.0 0.0 5.4 0.9 1.1 0.1 19.7 6.0 0.4 0.6 0.0 1.4 0.3 0.1 0.1 1.4 1.2 0.2 16.6 0.0 0.4 0.7 0.0 6.0 10.3 3.9 0.6 0.0 5.9 3.6 0.0 2.7 0.6 0.0 1.6 0.1 0.1 0.2 5.0 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 4.4 0.0 0.1 0.4 0.3 0.3 1.2 0.3 0.4 0.4 0.4 0.4 0.4 0.4 0.4 1.2 0.0 2.5 0.3 3.4 1.0 0.8 0.8 0.6 0.4 1.9 0.5 6.1 1.5 0.1 0.0 0.0 0.7 1.8 0.4 1.9 8.6 10.3 4.4 84.9 0.9 1.8 0.0 0.2 0.7 37.6 8.4 1.5 4.1 1.3 61.9 1.1 0.0 0.8 0.0 0.4 1.3 2.0 0.0 1.1 10.5 0.6 1.0 1.8 1.0 0.0 0.3 0.0 0.0 0.2 1.4 0.2 0.4 0.2 0.5 0.1 2.2 0.8 0.5 0.0 2.7 35.8 3.1 5.5 0.5 0.6 18.6 2.0 5.7 1.0 0.3 MOB3A "MOB-LAK, MOB1C, MOBKL2A, moblak" ENSG00000172081 "MOB kinase activator 3A" Q96BX8 19 2071036-2096673 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Kupffer cells: 74.4;Langerhans cells: 91.3;monocytes: 81.1;NK-cells: 77.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057744 Uncertain "Intermediate filaments,Cytosol" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 16: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 41: Macrophages - Immune response" "Intermediate filaments, Cytosol" "HPA057744: " "unprognostic (2.05e-2)" "unprognostic (3.58e-2)" "unprognostic (1.39e-1)" "prognostic favorable (1.33e-6)" "unprognostic (3.40e-2)" "unprognostic (3.53e-3)" "unprognostic (3.12e-3)" "unprognostic (1.17e-2)" "unprognostic (2.48e-2)" "unprognostic (2.16e-2)" "unprognostic (7.74e-3)" "unprognostic (3.83e-1)" "prognostic unfavorable (1.93e-4)" "unprognostic (5.90e-2)" "unprognostic (3.27e-1)" "unprognostic (1.27e-1)" "unprognostic (1.18e-1)" 24.8 15.3 19.8 49.7 19.3 53.7 20.9 19.5 45.6 25.4 21.9 36.0 12.9 32.3 9.4 22.4 27.4 17.5 14.8 19.7 19.4 15.8 9.7 25.1 73.3 26.8 21.3 20.4 13.6 8.7 12.2 15.8 22.8 25.9 15.0 6.7 17.1 20.1 14.0 21.1 31.7 28.6 20.2 60.4 20.4 8.8 24.8 34.9 16.0 14.4 65.7 27.1 22.9 21.2 45.6 18.4 21.5 20.6 49.7 54.7 16.7 28.1 17.7 18.7 14.9 7.4 16.1 116.4 10.1 48.8 15.2 18.9 12.0 62.2 15.0 41.2 6.2 25.3 12.3 10.1 49.2 40.0 125.7 32.4 40.4 51.5 21.7 21.6 35.5 22.1 13.4 113.4 27.6 18.1 20.9 40.6 6.6 5.5 13.1 12.6 6.4 91.2 23.5 11.3 13.7 18.3 14.3 14.9 15.9 15.9 16.0 64.3 60.8 22.6 12.4 42.5 16.9 22.1 86.8 90.4 61.0 26.7 27.7 80.8 87.0 100.7 62.3 83.8 52.9 43.6 45.8 51.9 58.7 39.1 34.1 44.1 274.5 54.2 96.3 33.4 60.3 85.6 19.8 19.3 19.5 45.6 19.7 19.4 26.8 21.3 22.8 20.2 24.8 21.2 8.6 3.2 4.5 8.8 50.6 15.0 10.9 11.7 8.6 3.7 9.4 7.4 3.7 4.3 9.7 11.0 20.9 11.1 50.8 18.9 3.9 10.8 1.6 6.1 12.7 11.7 14.9 11.8 6.5 9.5 53.5 12.0 8.2 9.6 27.9 8.1 18.5 4.7 33.3 1.7 5.8 12.2 14.2 74.4 91.3 4.8 18.3 50.1 16.0 6.5 81.1 6.9 77.2 4.0 6.0 10.1 12.6 17.0 38.0 11.9 16.0 9.0 10.1 6.6 6.6 10.5 11.2 9.4 6.6 7.2 15.9 27.5 37.3 7.7 9.5 10.8 MOB3B "C9orf35, FLJ13204, MOB1D, MOBKL2B" ENSG00000120162 "MOB kinase activator 3B" Q86TA1 9 27325209-27529814 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.4" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 431.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 2.5;myeloid DC: 2.7;naive B-cell: 2.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 16.0;HAP1: 16.7;K-562: 49.9;SK-BR-3: 19.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057744 Uncertain "Intermediate filaments,Cytosol" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 45: Intestine - Brush border" "Cluster 1: K-562 - Erythropoiesis" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Intermediate filaments, Cytosol" "HPA057744: " "unprognostic (6.96e-3)" "unprognostic (9.60e-2)" "unprognostic (5.10e-3)" "unprognostic (1.41e-1)" "unprognostic (1.38e-1)" "unprognostic (1.02e-1)" "unprognostic (1.87e-1)" "unprognostic (7.05e-2)" "unprognostic (2.42e-1)" "unprognostic (7.57e-3)" "unprognostic (1.28e-1)" "unprognostic (9.45e-2)" "prognostic favorable (2.33e-10)" "unprognostic (1.55e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (1.02e-4)" "unprognostic (7.99e-2)" 5.7 1.7 10.0 3.9 23.8 0.7 6.2 19.3 14.4 7.1 11.7 12.1 17.5 9.6 5.1 3.6 7.9 4.9 1.4 8.5 13.5 7.4 1.4 6.7 4.0 23.7 19.4 26.0 3.6 0.5 1.1 4.6 22.8 2.2 13.1 7.4 3.4 2.9 5.9 6.3 15.6 6.3 19.2 8.1 5.6 3.2 19.2 3.6 5.4 5.3 5.6 3.6 4.7 30.4 3.4 2.5 7.6 0.0 1.9 0.1 16.0 0.0 0.1 0.1 0.1 1.9 0.0 0.1 3.2 0.0 0.0 10.9 16.7 13.2 0.0 7.7 2.6 4.9 9.8 0.1 0.0 0.0 1.0 3.4 13.7 0.0 2.5 0.0 0.0 0.0 49.9 0.1 0.0 0.0 0.0 0.0 9.8 6.3 0.9 3.3 0.7 0.1 4.6 6.4 0.1 2.4 2.7 19.8 4.7 9.9 1.3 0.0 0.1 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 3.1 0.5 0.0 0.5 0.0 0.0 0.8 0.0 2.5 0.0 0.0 2.7 2.9 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.3 10.0 23.8 19.3 14.4 8.5 13.5 23.7 19.4 22.8 19.2 19.2 30.4 6.9 3.2 4.1 13.7 22.1 22.7 7.7 7.6 40.9 2.1 6.7 12.6 1.5 27.1 4.3 11.0 0.0 22.1 0.4 83.3 9.8 16.4 1.0 6.5 20.1 8.7 2.4 1.7 81.7 21.0 56.0 20.8 21.4 9.2 1.3 1.9 4.6 3.1 5.4 1.7 88.9 26.9 12.2 13.2 30.6 3.1 15.8 20.4 16.0 76.8 10.8 65.3 2.1 79.4 431.9 10.6 26.1 16.1 1.2 6.5 50.3 10.5 2.7 1.3 0.0 4.5 19.2 2.2 5.0 8.4 9.5 11.8 1.6 7.7 36.8 6.9 MOB3C "MOB1E, MOBKL2C" ENSG00000142961 "MOB kinase activator 3C" Q70IA8 1 46607715-46616884 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057744 Uncertain "Intermediate filaments,Cytosol" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 59: Non-specific - Translation" "Cluster 36: HEL - Hemostasis" "Cluster 51: Myeloid cells - Hemostasis" "Intermediate filaments, Cytosol" "HPA057744: " "unprognostic (1.76e-3)" "prognostic favorable (3.16e-5)" "unprognostic (1.32e-2)" "unprognostic (1.45e-2)" "unprognostic (3.36e-2)" "unprognostic (7.22e-2)" "unprognostic (6.26e-3)" "unprognostic (1.56e-1)" "unprognostic (1.76e-1)" "unprognostic (9.97e-2)" "unprognostic (3.85e-2)" "unprognostic (1.20e-1)" "unprognostic (4.81e-2)" "unprognostic (1.00e-1)" "unprognostic (2.92e-2)" "unprognostic (2.35e-2)" "unprognostic (4.61e-3)" 21.2 11.3 11.9 9.4 12.9 5.8 14.2 16.4 11.8 13.3 10.7 15.4 10.3 9.9 10.8 17.5 13.2 11.1 16.6 10.6 15.9 14.3 10.2 16.9 10.1 13.8 12.7 15.6 38.2 11.2 14.1 13.8 13.6 16.6 10.4 1.8 14.2 13.2 24.6 7.8 13.7 11.1 12.7 19.3 14.6 5.7 12.6 9.2 13.1 49.4 10.5 20.8 14.8 11.5 10.6 4.5 2.0 6.1 19.7 15.2 0.9 5.8 14.7 10.3 10.0 1.6 7.3 0.9 6.2 9.9 14.9 14.7 2.2 7.5 5.4 15.7 0.3 24.6 6.1 1.5 10.2 2.1 8.9 12.5 11.3 9.8 2.7 13.7 6.8 2.5 3.8 6.0 4.3 4.4 1.0 3.3 0.7 6.5 12.7 2.8 6.7 4.6 5.7 18.7 0.8 2.5 9.0 6.3 7.4 2.4 3.8 8.2 5.1 5.1 3.6 8.7 5.2 5.6 1.3 0.7 7.7 3.6 4.3 3.0 11.5 22.9 15.8 12.7 27.6 9.3 15.4 15.9 7.9 11.2 13.4 13.6 8.1 22.9 8.4 9.8 11.1 16.8 11.9 12.9 16.4 11.8 10.6 15.9 13.8 12.7 13.6 12.7 12.6 11.5 12.0 6.4 6.9 3.6 4.9 11.1 10.2 5.6 12.5 2.9 6.3 4.8 4.9 5.7 4.6 7.3 0.0 1.9 5.1 7.0 5.9 3.2 7.7 2.0 4.3 7.7 8.4 7.8 0.5 6.3 0.9 9.1 3.1 2.3 5.7 7.7 8.2 3.3 13.1 5.0 0.8 8.9 2.0 8.4 14.9 0.9 6.2 23.9 3.6 5.6 5.9 1.8 4.1 3.5 1.3 3.9 2.7 6.8 5.4 14.5 6.8 4.0 5.4 0.8 6.6 13.7 8.1 0.2 0.4 8.0 6.5 1.4 8.1 6.9 5.7 18.5 MPHOSPH8 "HSMPP8, mpp8" ENSG00000196199 "M-phase phosphoprotein 8" Q99549 13 19633659-19673441 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039701, HPA040035" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Plasma membrane, Cytosol" "HPA039701: AB_10805484, HPA040035: AB_10794207" "unprognostic (4.22e-1)" "unprognostic (5.58e-2)" "unprognostic (2.66e-1)" "unprognostic (4.01e-3)" "unprognostic (3.05e-2)" "unprognostic (1.86e-1)" "unprognostic (2.81e-3)" "unprognostic (4.90e-2)" "unprognostic (4.55e-2)" "unprognostic (1.59e-1)" "unprognostic (3.52e-3)" "unprognostic (3.40e-2)" "unprognostic (6.49e-2)" "unprognostic (3.86e-2)" "unprognostic (4.93e-2)" "unprognostic (2.10e-1)" "unprognostic (1.02e-1)" 29.0 32.5 32.4 30.0 31.9 27.9 28.7 36.5 48.7 38.6 31.1 39.7 22.5 36.1 31.6 23.3 34.0 23.4 36.1 31.6 40.2 22.9 21.1 28.7 39.2 31.8 35.7 51.4 28.2 26.3 31.6 25.4 31.5 31.2 24.4 36.9 32.3 31.2 23.4 33.6 33.3 26.6 26.8 39.9 28.3 21.5 33.6 23.2 32.9 18.5 26.4 32.3 31.7 36.5 26.0 16.4 23.9 39.0 30.3 38.2 42.2 38.2 27.5 23.6 20.1 25.1 44.5 40.8 29.7 23.1 36.6 42.2 44.4 26.7 30.2 51.1 22.7 65.7 27.8 30.8 27.0 47.8 51.4 22.8 33.8 18.6 26.1 35.8 31.6 32.5 32.5 25.5 22.2 25.1 36.8 39.9 23.4 48.0 18.1 29.3 55.2 32.6 40.7 19.8 32.7 20.0 35.7 32.3 35.3 39.8 19.7 39.1 37.3 18.1 16.4 34.8 19.6 17.2 19.2 40.1 13.8 43.4 28.7 133.6 23.4 42.5 31.5 18.2 28.1 64.3 35.6 31.1 11.4 54.1 42.5 34.8 69.2 30.4 27.8 35.8 30.9 9.9 32.4 31.9 36.5 48.7 31.6 40.2 31.8 35.7 31.5 26.8 33.6 36.5 117.3 93.0 110.6 42.1 129.7 69.0 102.1 99.0 97.3 201.0 74.8 95.0 94.4 110.1 92.2 103.0 83.4 151.1 132.0 95.1 49.0 57.6 84.3 82.3 129.2 109.0 58.8 78.9 94.7 54.6 83.7 118.8 62.7 118.8 144.2 101.0 133.2 81.3 72.9 210.3 89.4 113.2 67.1 74.5 55.5 37.9 179.3 71.4 67.6 51.5 99.8 114.9 166.9 56.3 78.7 48.2 99.7 157.2 118.5 80.8 100.5 61.6 66.6 219.0 177.5 111.5 118.5 211.0 203.7 57.9 74.0 58.7 142.7 105.3 86.8 65.3 MPHOSPH9 MPP9 ENSG00000051825 "M-phase phosphoprotein 9" Q99550 12 123152320-123244014 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 114.7;Excitatory neurons: 87.7;Inhibitory neurons: 84.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037485 Approved Uncertain "Nucleoplasm,Golgi apparatus,Plasma membrane,Centrosome,Cytosol" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 24: NB-4 - Immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "Plasma membrane, Cytosol" "Nucleoplasm, Golgi apparatus, Centrosome" "HPA037485: AB_10672792" "unprognostic (2.98e-2)" "unprognostic (5.00e-1)" "unprognostic (4.36e-3)" "unprognostic (1.45e-2)" "unprognostic (1.62e-1)" "unprognostic (2.81e-1)" "unprognostic (5.81e-3)" "unprognostic (1.64e-1)" "unprognostic (1.58e-2)" "unprognostic (1.88e-1)" "unprognostic (8.34e-2)" "unprognostic (1.08e-2)" "unprognostic (6.53e-3)" "unprognostic (1.31e-2)" "unprognostic (2.75e-1)" "unprognostic (5.14e-3)" "unprognostic (1.17e-1)" 4.6 5.4 13.7 8.0 15.2 26.2 5.0 21.6 19.8 4.7 18.9 6.1 6.8 5.3 11.1 3.1 5.3 3.6 5.6 14.3 13.2 6.2 9.6 3.9 12.1 13.8 13.7 4.5 4.0 8.9 4.4 5.2 13.9 4.6 6.8 21.3 5.5 4.4 6.8 5.0 5.2 5.2 13.4 8.1 5.1 12.4 14.4 32.8 5.2 7.8 10.3 4.2 1.9 16.0 15.0 15.9 23.9 28.0 10.7 10.1 9.1 15.7 7.8 18.7 15.2 15.1 7.2 29.6 10.6 10.1 15.7 10.2 30.3 11.1 26.0 17.6 20.7 30.5 17.9 15.0 6.6 27.0 24.6 10.5 4.7 18.2 16.1 15.6 19.5 40.1 21.4 12.7 17.3 12.9 32.6 44.6 17.1 9.4 17.2 27.6 24.9 19.1 14.7 14.8 31.4 15.0 23.7 9.3 15.4 22.4 17.5 21.2 11.1 15.3 21.5 17.5 22.1 19.0 33.8 24.4 12.2 26.4 32.4 11.5 3.7 5.4 10.1 3.7 7.2 6.5 8.4 9.5 3.7 6.0 11.6 12.0 0.8 10.1 3.3 5.3 7.8 2.8 13.7 15.2 21.6 19.8 14.3 13.2 13.8 13.7 13.9 13.4 14.4 16.0 7.3 9.6 9.5 50.3 15.6 4.5 4.5 5.7 8.6 43.5 5.8 5.2 16.3 10.0 7.2 7.3 114.7 12.2 25.3 2.8 5.9 4.8 57.9 21.2 12.4 8.5 14.3 33.6 87.7 1.8 7.1 10.6 5.1 6.5 2.5 23.6 7.9 31.1 8.6 53.8 84.7 5.6 6.1 15.3 7.4 73.3 7.2 10.4 3.6 24.4 17.0 14.7 32.0 46.3 48.1 1.8 1.6 11.3 21.4 3.0 4.3 11.0 14.9 65.9 0.0 11.6 7.2 31.7 20.4 8.4 2.3 1.6 26.8 17.2 9.8 2.7 MPIG6B "C6orf25, G6b, G6b-B, NG31" ENSG00000204420 "Megakaryocyte and platelet inhibitory receptor G6b" O95866 6 31718594-31726714 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Heparin-binding, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 4.8;skin 1: 8.3" "Cell type enriched" "Detected in single" 14 "granulocytes: 10.1" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "NK-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 14 "HEL: 6.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA054404, HPA073017" Approved "Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 330000 "Cluster 15: NK-cells - Transcription" "Cluster 31: Skin - Epidermis development" "Cluster 36: HEL - Hemostasis" "Cluster 60: Granulocytes - Receptor signaling" "Golgi apparatus" "Nucleoplasm, Endoplasmic reticulum, Plasma membrane, Cytosol" "HPA054404: , HPA073017: AB_2686566" "unprognostic (1.45e-1)" "unprognostic (1.25e-1)" "unprognostic (2.93e-1)" "unprognostic (1.77e-2)" "unprognostic (1.23e-1)" "unprognostic (6.53e-2)" "unprognostic (3.53e-2)" "unprognostic (2.71e-2)" "unprognostic (1.19e-1)" "unprognostic (1.43e-2)" "unprognostic (2.70e-1)" "unprognostic (1.71e-2)" "unprognostic (1.82e-2)" "unprognostic (1.02e-1)" "unprognostic (1.34e-1)" "unprognostic (2.55e-2)" "unprognostic (1.71e-2)" 0.5 0.0 0.0 0.1 0.0 1.1 0.4 0.1 0.2 1.0 0.1 0.3 0.1 0.4 0.0 1.6 0.5 0.2 0.8 0.1 0.1 0.1 0.3 3.5 0.0 0.1 0.2 0.2 0.1 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.6 0.0 0.2 8.3 0.4 0.0 0.0 4.8 0.3 2.3 0.1 0.0 0.5 0.0 0.0 0.5 1.3 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.8 0.0 2.2 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 MROH2A HEATR7B1 ENSG00000185038 "Maestro heat like repeat family member 2A" A6NES4 2 233775679-233833423 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 1.7;thyroid gland: 1.6" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 3.4;Early spermatids: 1.3;Hepatocytes: 1.0;Late spermatids: 1.7;Spermatocytes: 1.5" "Cancer enhanced" "Detected in some" "urothelial cancer: 2.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "RT4: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA052107 Uncertain Uncertain Cytosol NA NA "Cluster 1: Thyroid gland - Transcription" "Cluster 15: RT4 - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" Cytosol "HPA052107: AB_2681729" "unprognostic (7.00e-2)" "unprognostic (3.37e-3)" "unprognostic (4.77e-1)" "unprognostic (1.65e-2)" "unprognostic (4.03e-1)" "unprognostic (1.71e-1)" "unprognostic (1.87e-1)" "unprognostic (4.41e-2)" "unprognostic (2.69e-1)" "unprognostic (1.67e-1)" "unprognostic (4.32e-2)" "unprognostic (5.05e-2)" "unprognostic (4.06e-9)" "unprognostic (5.65e-2)" "unprognostic (3.90e-2)" "unprognostic (1.18e-1)" "unprognostic (1.41e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.7 0.1 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.4 3.4 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.6 0.1 0.0 0.0 0.0 0.0 0.3 MRPL50 "FLJ20493, MRP-L50" ENSG00000136897 "Mitochondrial ribosomal protein L50" Q8N5N7 9 101387633-101398618 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 203.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022925 Approved Supported Mitochondria,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Mitochondria Cytosol "HPA022925: AB_1854117" "unprognostic (6.17e-2)" "unprognostic (6.03e-2)" "unprognostic (4.65e-2)" "unprognostic (2.03e-2)" "unprognostic (2.04e-1)" "unprognostic (1.27e-2)" "unprognostic (5.75e-3)" "unprognostic (1.59e-1)" "unprognostic (1.55e-1)" "unprognostic (6.99e-2)" "unprognostic (1.19e-2)" "unprognostic (3.46e-2)" "prognostic favorable (1.21e-10)" "unprognostic (7.06e-2)" "unprognostic (2.39e-1)" "unprognostic (1.01e-1)" "unprognostic (1.06e-1)" 9.6 16.0 10.6 8.3 11.6 4.0 11.8 15.8 13.5 7.8 9.7 8.1 8.6 7.8 12.7 7.1 8.0 7.2 14.5 11.1 11.2 13.3 14.0 7.1 11.0 10.0 11.1 11.9 11.9 13.1 8.9 8.2 10.3 9.8 8.6 19.0 8.4 8.0 10.9 5.7 8.3 7.2 10.8 9.4 10.1 6.5 10.8 8.6 9.1 14.9 11.6 10.3 5.7 11.5 12.6 14.9 23.3 13.6 16.0 17.0 16.5 16.0 15.2 17.3 14.6 20.4 12.3 30.6 10.1 12.5 21.3 28.4 23.0 19.2 18.6 18.6 13.7 15.0 16.4 59.0 17.2 27.5 13.9 14.0 21.9 14.0 25.5 13.0 15.9 15.9 32.1 16.1 17.8 20.7 17.0 20.3 25.6 73.9 20.2 17.1 33.1 19.2 25.8 13.7 22.4 16.6 17.0 16.9 18.5 15.9 11.9 17.0 13.2 11.8 17.6 20.7 15.4 12.0 38.0 12.8 15.0 16.0 16.9 9.8 12.5 9.9 13.9 15.2 16.8 20.6 19.3 16.0 16.3 19.5 22.4 20.3 2.2 14.7 15.9 13.0 23.1 16.8 10.6 11.6 15.8 13.5 11.1 11.2 10.0 11.1 10.3 10.8 10.8 11.5 33.0 16.0 20.8 11.4 46.4 90.5 133.6 203.4 51.2 19.1 31.0 31.9 76.0 35.8 86.9 57.0 12.5 74.8 29.3 15.3 152.6 66.8 10.4 31.4 33.6 41.0 19.8 30.1 12.5 69.4 73.8 46.9 23.4 25.7 44.5 24.0 32.2 43.9 51.9 5.0 15.1 28.0 162.8 25.9 50.6 7.4 34.2 28.3 30.2 5.6 32.1 21.9 27.8 8.0 17.2 66.8 32.7 40.6 39.4 112.8 26.4 186.5 67.4 18.2 46.0 37.6 52.4 44.7 39.3 41.6 99.3 76.5 43.2 63.1 34.3 130.4 MSS51 "FLJ39565, ZMYND17" ENSG00000166343 "MSS51 mitochondrial translational activator" Q4VC12 10 73423579-73433561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 261.3" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 5.3;Excitatory neurons: 11.9;Inhibitory neurons: 9.7;Oligodendrocyte precursor cells: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038564 Uncertain Vesicles,Cytosol NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 37: Myocytes - Muscle contraction" Vesicles Cytosol "HPA038564: AB_10674687" "unprognostic (2.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.40e-3)" "unprognostic (2.06e-1)" "unprognostic (3.21e-2)" "unprognostic (1.62e-3)" "unprognostic (3.05e-3)" "unprognostic (7.88e-3)" "unprognostic (1.98e-2)" "unprognostic (3.78e-2)" "unprognostic (1.50e-4)" "unprognostic (1.22e-1)" "unprognostic (1.78e-7)" "unprognostic (1.51e-1)" "unprognostic (2.60e-1)" "unprognostic (2.67e-1)" "unprognostic (1.55e-2)" 1.9 1.5 1.5 1.5 1.8 1.6 1.7 4.3 2.0 3.2 1.6 2.3 1.2 2.1 1.7 1.4 2.2 1.2 10.9 1.5 0.6 1.7 1.6 2.2 1.8 0.2 0.3 3.0 1.9 56.2 2.3 0.6 0.2 2.5 1.3 2.5 1.7 0.8 261.3 3.7 2.7 1.1 0.0 3.9 1.8 1.4 0.7 1.5 1.5 5.9 1.5 2.2 2.2 1.3 0.9 0.6 1.5 2.7 2.1 2.8 1.2 0.7 0.5 0.3 0.6 0.3 0.7 2.1 0.2 0.7 0.1 1.1 1.0 0.2 0.8 1.1 0.9 1.7 1.3 0.5 0.7 1.1 1.7 2.4 0.7 0.6 1.7 2.1 0.2 0.8 0.6 1.0 1.2 0.2 0.9 1.6 0.4 0.5 0.7 0.5 4.1 0.1 0.8 0.9 0.3 0.8 0.5 1.0 0.9 1.4 0.9 0.9 1.3 1.2 0.7 0.4 1.7 0.6 2.1 1.1 0.5 1.9 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.8 4.3 2.0 1.5 0.6 0.2 0.3 0.2 0.0 0.7 1.3 0.9 0.0 3.6 4.6 1.0 0.5 0.1 0.6 0.0 1.4 0.4 0.5 5.3 0.0 0.2 0.0 0.0 0.3 0.4 0.4 0.0 0.4 0.3 0.4 0.7 1.2 0.0 1.3 11.9 0.4 0.2 0.8 1.1 0.8 5.1 1.8 1.4 0.2 0.2 0.0 9.7 0.4 0.0 0.8 0.6 0.3 3.1 0.5 0.0 4.7 1.1 0.5 1.0 6.0 3.4 0.2 3.9 1.5 0.4 0.5 0.6 0.2 0.3 1.2 0.0 4.0 0.6 0.7 0.3 0.0 0.0 0.1 1.1 1.4 0.6 0.2 MT-ND3 "MTND3, NAD3, ND3" ENSG00000198840 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3" P03897 MT 10059-10404 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease variant, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 184151.1" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 37883.1;Proximal enterocytes: 23257.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 23280.2;HeLa: 21694.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063296 Enhanced Uncertain Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 39: Non-specific - Mitochondria" "Cluster 20: HeLa - Mitochondria" "Cluster 54: Cardiomyocytes - Muscle contraction" Cytosol "HPA063296: AB_2684978" "unprognostic (1.71e-2)" "unprognostic (1.05e-1)" "unprognostic (8.10e-2)" "unprognostic (3.07e-1)" "unprognostic (2.48e-1)" "unprognostic (1.36e-1)" "prognostic favorable (4.63e-5)" "unprognostic (2.45e-2)" "unprognostic (7.13e-2)" "unprognostic (8.85e-2)" "unprognostic (1.76e-3)" "unprognostic (1.74e-1)" "unprognostic (7.63e-2)" "unprognostic (2.51e-2)" "unprognostic (1.19e-1)" "unprognostic (2.07e-1)" "unprognostic (5.65e-3)" 31356.6 42036.1 79316.1 3483.1 80070.8 4077.5 25368.6 75454.6 124729.8 8985.8 81148.8 26406.1 11478.9 8410.1 8217.8 12712.6 10495.3 3610.0 184151.1 75602.8 85299.8 84244.0 72988.4 9018.3 3610.8 89729.0 83678.9 9439.2 26008.9 14199.5 13387.4 6281.1 85648.8 23996.0 10095.2 6318.4 14787.5 8355.4 70313.2 16879.7 21792.1 4960.7 71704.7 11407.9 36122.2 10815.9 84470.1 3654.8 14626.9 73367.5 3934.1 18841.5 10373.7 74059.9 3324.0 5255.7 3450.6 3399.1 23280.2 4613.0 2871.7 2717.2 1592.1 1441.9 1616.6 7973.2 5004.1 3408.8 4095.7 3519.2 2600.2 6710.1 1504.4 5941.5 2461.9 4945.3 7153.7 3371.4 21694.2 13369.3 3629.0 5018.8 4874.1 8076.0 10704.2 2416.7 2704.4 8547.3 2285.4 3853.4 2711.1 3864.5 2747.1 10748.2 2646.2 6609.3 1779.4 9407.1 4824.1 2262.5 3389.7 3164.0 8729.4 8962.3 1417.0 3058.9 1310.8 2587.7 5763.8 8928.3 6011.6 7960.5 3898.6 2207.0 3378.3 3876.8 2982.9 1492.1 2128.5 7735.7 1794.0 2976.6 1284.1 2263.7 612.4 386.5 336.6 346.8 441.9 672.5 393.0 417.4 321.5 686.4 568.4 769.3 968.2 447.0 335.5 312.1 262.5 353.1 79316.1 80070.8 75454.6 124729.8 75602.8 85299.8 89729.0 83678.9 85648.8 71704.7 84470.1 74059.9 4254.0 701.9 879.1 0.0 6320.6 1987.5 2507.9 1722.8 5384.4 0.0 3350.4 5821.1 37883.1 9781.1 1560.8 5041.1 0.0 0.0 5039.9 14324.8 1164.1 1320.8 1023.5 11751.2 6030.4 3302.6 2852.4 14390.0 0.0 2870.2 0.0 3063.4 6039.9 17552.8 1453.7 17373.9 10407.8 20920.6 0.0 0.0 0.0 11328.3 870.8 16584.4 1757.6 5643.0 9133.7 4877.6 1858.7 0.0 4964.0 0.0 2775.5 0.0 0.0 2194.1 9034.9 4865.3 6343.6 1554.6 23257.1 8457.2 2113.9 0.0 7001.2 6561.9 3856.1 5442.6 3706.2 3801.0 1888.8 0.0 4844.1 3423.5 10381.8 2314.6 MTERF3 "CGI-12, FLJ10939, MTERFD1" ENSG00000156469 "Mitochondrial transcription termination factor 3" Q96E29 8 96239398-96261610 "Predicted intracellular proteins" "Ribosome biogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007355 Supported Mitochondria,Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 47: Cytotrophoblasts - Unknown function" Mitochondria Cytosol "HPA007355: " "unprognostic (4.08e-2)" "unprognostic (1.46e-1)" "unprognostic (4.68e-2)" "unprognostic (2.31e-2)" "unprognostic (3.86e-2)" "unprognostic (6.66e-2)" "unprognostic (2.75e-3)" "unprognostic (3.11e-3)" "unprognostic (6.43e-2)" "unprognostic (2.00e-1)" "unprognostic (3.84e-2)" "unprognostic (8.56e-2)" "prognostic unfavorable (5.88e-5)" "unprognostic (8.67e-3)" "unprognostic (8.81e-2)" "unprognostic (2.27e-1)" "unprognostic (1.74e-3)" 15.0 16.3 16.3 15.3 16.9 11.5 17.9 18.6 21.8 14.0 20.9 14.7 12.6 13.5 22.9 11.6 12.7 12.4 27.8 16.1 17.3 18.3 23.1 12.1 18.2 16.4 16.3 12.1 15.5 22.3 12.6 16.7 17.2 13.5 14.4 16.0 12.9 17.2 30.2 17.0 11.5 16.6 15.9 16.0 12.7 11.8 16.6 16.7 11.9 38.2 19.4 16.4 12.0 17.8 41.1 25.9 38.1 30.3 26.4 27.4 17.5 30.8 25.0 43.9 44.2 18.8 29.6 36.5 63.3 18.2 22.5 22.8 39.7 24.1 53.2 35.6 29.3 52.5 20.6 22.8 37.1 17.9 20.7 27.5 35.4 35.6 33.5 22.9 36.5 39.0 45.1 18.7 44.7 26.9 76.6 52.8 19.8 71.6 39.8 45.9 31.2 28.8 32.7 21.8 25.9 20.4 23.0 6.6 33.8 24.5 34.3 25.0 16.3 30.9 20.8 36.0 27.7 21.3 28.9 43.2 33.4 47.3 41.3 39.5 13.4 6.1 15.6 15.9 22.6 20.4 17.7 17.8 20.2 17.7 19.8 20.2 2.2 23.8 15.8 24.3 18.6 10.1 16.3 16.9 18.6 21.8 16.1 17.3 16.4 16.3 17.2 15.9 16.6 17.8 10.4 3.2 6.9 7.8 10.8 0.0 21.2 0.0 10.8 0.0 6.6 8.5 31.2 5.7 5.6 5.5 0.0 30.4 10.8 0.9 13.7 12.5 5.6 6.2 10.1 8.1 0.0 12.4 12.9 9.8 21.0 12.7 4.1 5.4 6.3 11.2 6.1 8.0 16.2 0.0 12.6 3.6 0.0 5.2 0.0 4.1 13.7 7.1 0.0 4.7 16.0 0.0 15.5 7.5 14.2 7.7 3.3 13.9 7.0 22.9 3.3 11.1 5.1 0.0 13.1 10.3 9.9 28.2 21.2 9.1 0.0 17.4 8.8 9.5 5.3 11.7 MTTP "ABL, MTP" ENSG00000138823 "Microsomal triglyceride transfer protein" P55157 4 99564081-99623997 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "intestine: 275.2;liver: 266.6" "Group enriched" "Detected in many" 9 "Hepatocytes: 244.2;Proximal enterocytes: 605.4" "Cancer enriched" "Detected in many" 13 "liver cancer: 28.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 10.8;Hep G2: 12.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA051170, HPA054862" Uncertain Approved "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA 640000 "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 45: Enterocytes - Digestion" "Endoplasmic reticulum, Cytosol" "HPA051170: , HPA054862: AB_2682628" "unprognostic (1.66e-2)" "unprognostic (1.14e-1)" "unprognostic (5.64e-2)" "unprognostic (5.33e-2)" "unprognostic (3.49e-3)" "unprognostic (7.38e-2)" "unprognostic (1.05e-1)" "unprognostic (2.74e-2)" "unprognostic (1.08e-1)" "unprognostic (3.66e-2)" "unprognostic (1.00e-2)" "unprognostic (1.62e-1)" "unprognostic (1.27e-3)" "unprognostic (2.02e-2)" "unprognostic (3.64e-1)" "unprognostic (1.53e-2)" "unprognostic (1.31e-1)" 0.3 0.1 0.9 0.2 0.9 0.0 0.2 0.8 0.9 0.1 0.3 1.3 243.2 0.1 1.0 0.1 0.6 1.3 0.9 0.8 1.5 12.9 266.6 0.3 0.3 1.1 1.6 2.0 0.0 0.0 0.5 0.0 1.3 0.5 0.3 5.6 0.1 0.2 0.4 0.1 275.2 0.5 1.2 0.0 0.8 9.6 1.2 0.2 0.1 0.3 0.1 0.9 0.0 1.9 0.0 0.2 10.8 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.2 0.1 12.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.6 0.5 0.1 0.2 0.1 0.1 1.0 0.0 0.0 0.7 0.8 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.9 0.8 0.9 0.8 1.5 1.1 1.6 1.3 1.2 1.2 1.9 0.1 0.0 0.0 4.6 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.4 2.8 4.3 0.1 1.8 0.0 0.2 0.2 0.2 0.0 0.0 44.2 1.0 0.1 0.1 0.0 2.7 1.6 0.0 0.0 0.8 1.5 0.2 0.0 30.1 3.6 244.2 0.1 0.0 0.7 16.7 2.0 3.5 0.0 12.0 0.9 0.2 0.0 0.0 0.6 0.0 0.0 0.0 2.0 0.2 12.5 0.4 0.1 0.0 605.4 23.5 1.0 0.0 6.6 0.5 0.5 32.1 5.7 0.0 0.0 0.0 0.4 12.0 21.0 0.0 MXD1 "bHLHc58, MAD, MAD1" ENSG00000059728 "MAX dimerization protein 1" Q05195 2 69897688-69942945 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 173.4;esophagus: 130.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 507.0;Langerhans cells: 224.8;Paneth cells: 369.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 496.3" "Lineage enriched" "Detected in all" 49 "granulocytes: 496.3" "Cell line enhanced" "Detected in many" "hTERT-HME1: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001599 Enhanced Uncertain Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 30: Epithelial cell lines - Translation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Mitochondria" Cytosol "HPA001599: AB_1079434" "unprognostic (1.59e-1)" "unprognostic (5.11e-2)" "unprognostic (1.63e-2)" "prognostic unfavorable (8.14e-6)" "unprognostic (1.49e-1)" "unprognostic (1.76e-1)" "unprognostic (4.36e-2)" "unprognostic (8.73e-3)" "unprognostic (3.39e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (8.50e-4)" "unprognostic (8.72e-2)" "unprognostic (3.24e-2)" "unprognostic (1.59e-1)" "unprognostic (1.61e-1)" "unprognostic (1.56e-3)" "unprognostic (1.77e-2)" 13.5 3.6 6.2 40.4 6.9 173.4 7.0 10.0 15.8 35.2 6.4 30.3 28.8 5.4 1.9 130.0 8.1 9.4 8.3 6.5 7.8 6.8 11.3 36.5 3.9 7.1 6.3 6.1 4.6 6.8 6.7 10.9 8.1 5.5 28.9 15.6 17.4 2.0 6.0 12.8 43.7 9.1 5.4 32.8 16.9 6.3 10.7 13.9 7.5 6.5 15.1 17.4 50.6 10.5 5.0 2.1 3.0 2.2 6.5 3.2 11.2 5.5 3.1 2.6 1.9 6.8 3.8 2.8 2.8 2.1 2.5 17.3 5.8 10.7 2.7 1.6 6.9 5.9 6.6 7.0 21.9 7.3 5.7 3.7 17.8 5.9 27.0 3.2 3.4 2.8 10.4 10.9 1.6 4.0 3.4 14.1 0.8 7.3 3.5 1.6 3.1 7.1 3.4 5.8 9.8 4.1 7.3 9.3 3.9 3.4 1.4 4.1 13.2 3.7 1.0 4.1 5.2 7.5 13.7 1.1 3.8 12.5 1.4 124.0 10.2 105.7 2.3 6.4 2.5 1.1 1.6 1.7 5.2 1.3 1.8 1.9 496.3 2.8 5.5 1.6 1.5 4.5 6.2 6.9 10.0 15.8 6.5 7.8 7.1 6.3 8.1 5.4 10.7 10.5 18.0 38.5 23.7 16.0 25.4 25.7 31.6 61.8 21.6 29.8 51.6 29.3 6.9 10.0 44.7 1.8 54.2 10.1 46.2 507.0 7.9 12.9 17.0 34.3 17.5 12.0 97.5 17.7 23.6 16.5 8.0 17.9 110.1 81.6 27.3 3.0 5.7 6.8 28.6 10.1 20.2 155.5 71.2 56.5 224.8 17.8 4.7 190.8 16.0 11.2 40.7 62.1 18.6 20.1 21.7 70.1 369.6 2.6 33.1 43.3 178.8 6.9 24.2 21.7 0.0 14.7 18.3 19.9 2.7 88.2 56.4 105.9 30.3 5.2 65.9 126.7 MYCBP2 "FLJ10106, KIAA0916, PAM, PHR1" ENSG00000005810 "MYC binding protein 2" O75592 13 77044657-77327094 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Biological rhythms, Ubl conjugation pathway" "Guanine-nucleotide releasing factor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 425.4;Inhibitory neurons: 471.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 110.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058807 Supported Nucleoplasm,Vesicles,Cytosol "Intracellular and membrane" NA NA "Cluster 37: B-cells - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Vesicles, Cytosol" "HPA058807: AB_2732627" "unprognostic (1.79e-1)" "unprognostic (1.25e-1)" "unprognostic (1.60e-1)" "unprognostic (1.06e-1)" "unprognostic (1.75e-1)" "unprognostic (2.03e-2)" "unprognostic (8.36e-2)" "unprognostic (1.21e-1)" "unprognostic (1.09e-1)" "unprognostic (1.80e-1)" "unprognostic (1.48e-1)" "unprognostic (6.42e-2)" "prognostic favorable (5.01e-5)" "unprognostic (2.63e-1)" "unprognostic (9.84e-2)" "unprognostic (4.04e-2)" "unprognostic (1.00e-1)" 69.9 22.2 42.3 19.0 46.2 32.8 49.3 37.3 52.4 43.4 18.8 29.4 9.0 27.2 29.8 45.9 29.2 12.5 32.9 48.6 35.9 22.6 24.5 28.3 40.0 34.6 29.6 43.1 30.9 14.9 32.3 10.9 36.9 28.0 12.5 28.9 29.1 13.3 26.5 79.7 34.8 11.9 30.1 56.4 24.9 26.3 33.9 34.6 27.2 18.1 37.8 30.4 41.5 38.7 21.6 10.8 12.9 14.1 62.9 27.9 7.5 13.4 19.8 11.5 14.7 9.7 11.0 61.4 8.3 26.6 11.2 19.5 22.4 24.7 15.5 24.5 22.2 52.2 22.2 20.1 21.4 110.8 17.7 31.5 20.2 10.6 20.8 11.4 26.5 22.3 11.3 18.8 20.7 13.1 30.5 74.3 6.8 28.7 13.6 34.2 13.1 15.0 19.6 21.1 20.2 9.4 16.2 23.1 12.8 13.0 8.6 83.8 35.0 10.9 9.1 7.3 13.0 20.3 15.0 42.7 22.1 89.2 11.3 1.4 2.0 2.0 3.2 2.1 2.8 4.9 3.6 2.8 1.9 4.3 4.1 3.2 1.8 2.8 1.6 2.7 4.5 1.4 42.3 46.2 37.3 52.4 48.6 35.9 34.6 29.6 36.9 30.1 33.9 38.7 92.2 38.5 52.2 158.7 170.3 82.3 39.9 32.6 63.7 229.3 36.8 38.4 69.7 25.8 30.9 35.0 104.3 46.1 109.2 14.2 1.9 26.1 56.0 50.9 61.1 83.8 32.6 46.9 425.4 33.1 31.5 80.6 38.2 66.6 48.2 34.0 44.6 52.4 41.8 218.7 471.3 19.7 26.4 106.9 48.2 23.4 65.9 100.4 32.0 282.9 116.7 121.5 120.5 338.8 212.5 30.2 15.8 96.3 121.9 53.7 15.2 13.2 19.5 94.8 105.2 76.7 76.0 81.5 71.6 129.1 150.7 43.9 121.5 67.4 28.1 42.4 NAA60 "FLJ14154, NAT15" ENSG00000122390 "N-alpha-acetyltransferase 60, NatF catalytic subunit" Q9H7X0 16 3443649-3486953 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Chromosome partition" "Acyltransferase, Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040916 Approved Uncertain "Actin filaments,Cytosol" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 45: Enterocytes - Digestion" "Actin filaments, Cytosol" "HPA040916: AB_10794428" "unprognostic (8.59e-2)" "unprognostic (2.16e-3)" "unprognostic (3.39e-1)" "prognostic favorable (3.14e-4)" "unprognostic (1.81e-1)" "unprognostic (5.90e-2)" "unprognostic (2.88e-2)" "unprognostic (1.53e-2)" "unprognostic (5.23e-2)" "unprognostic (5.12e-2)" "prognostic favorable (4.30e-4)" "unprognostic (9.54e-2)" "unprognostic (1.64e-1)" "unprognostic (1.60e-2)" "unprognostic (8.96e-2)" "unprognostic (3.59e-1)" "unprognostic (6.74e-3)" 25.5 45.4 31.5 16.9 30.0 20.1 25.1 37.5 35.9 28.4 22.7 40.4 40.5 31.6 18.7 31.0 28.2 20.3 48.9 31.9 27.5 52.4 67.5 32.0 20.2 30.8 30.5 26.8 47.9 49.1 41.6 19.5 29.3 35.2 22.6 16.3 26.0 23.9 42.9 24.2 39.3 19.1 28.8 42.9 58.9 32.7 31.2 19.5 32.0 21.2 16.7 28.4 23.2 30.3 16.8 61.9 40.1 44.1 26.5 19.4 39.1 26.9 25.0 29.3 26.6 43.9 30.5 31.7 30.0 29.6 21.0 37.4 40.1 31.2 29.4 49.7 27.8 35.4 25.7 53.0 32.9 53.1 45.6 24.4 27.9 20.4 38.9 29.2 45.1 29.4 44.8 41.4 19.4 73.6 33.4 36.3 50.1 35.8 18.1 42.3 30.8 47.5 27.7 29.7 21.6 42.5 45.8 48.3 24.6 38.5 40.2 34.7 30.8 36.0 27.7 12.8 26.7 35.2 33.6 30.5 12.1 29.0 29.2 33.3 18.6 53.8 17.7 20.6 19.2 11.6 15.8 17.7 18.1 11.0 12.3 16.4 20.0 18.4 23.6 11.6 20.1 19.5 31.5 30.0 37.5 35.9 31.9 27.5 30.8 30.5 29.3 28.8 31.2 30.3 26.3 9.6 16.0 24.8 17.7 0.1 13.4 0.1 17.6 21.2 24.5 16.4 15.5 38.6 5.6 12.9 6.2 28.3 22.7 66.7 43.0 30.1 55.7 33.3 25.7 21.0 27.0 18.7 22.2 41.7 40.0 18.0 37.2 30.9 30.4 18.4 26.7 53.5 32.1 11.8 26.5 43.1 0.0 34.8 0.3 54.4 11.5 23.6 0.0 25.3 27.0 29.3 26.8 22.1 34.8 37.0 54.3 15.8 15.4 20.2 84.2 49.0 3.7 15.3 26.3 16.8 17.7 19.6 24.5 16.5 0.3 33.0 22.9 21.1 35.3 23.5 NAALADL1 ENSG00000168060 "N-acetylated alpha-linked acidic dipeptidase like 1" Q9UQQ1 11 65044818-65058553 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "intestine: 99.3" "Cell type enriched" "Detected in many" 11 "Proximal enterocytes: 588.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 182.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.8;fHDF/TERT166: 7.8;HHSteC: 20.2;HSkMC: 13.5;SCLC-21H: 10.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA047123 Enhanced Uncertain Cytosol NA NA "Cluster 46: Basophils - DNA binding" "Cluster 9: Intestine - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 45: Enterocytes - Digestion" Cytosol "HPA047123: AB_2679942" "unprognostic (2.98e-2)" "unprognostic (2.06e-1)" "unprognostic (1.58e-1)" "unprognostic (8.76e-2)" "unprognostic (1.70e-1)" "unprognostic (1.28e-3)" "unprognostic (1.36e-1)" "unprognostic (1.40e-1)" "unprognostic (1.89e-2)" "unprognostic (1.38e-1)" "unprognostic (3.03e-1)" "unprognostic (2.18e-1)" "unprognostic (1.75e-4)" "unprognostic (2.10e-3)" "unprognostic (3.22e-2)" "unprognostic (1.45e-1)" "unprognostic (4.80e-2)" 13.9 3.2 4.4 6.6 4.1 21.1 12.1 4.7 6.0 23.5 7.0 18.4 19.8 18.8 4.6 7.3 15.2 9.4 10.5 3.9 4.1 7.4 2.6 10.9 10.9 4.7 4.3 16.6 2.3 2.0 6.0 2.3 4.6 13.8 7.1 1.9 4.9 11.5 2.7 5.4 99.3 10.5 4.6 15.3 8.2 8.7 4.4 3.4 5.7 4.1 6.9 12.7 14.5 4.0 0.0 0.0 0.1 0.2 0.5 5.8 1.0 2.3 0.0 2.8 1.3 0.0 0.0 0.1 0.0 7.8 0.0 0.0 0.0 0.2 0.1 0.9 0.4 0.0 0.2 3.5 20.2 0.0 0.0 13.5 0.0 2.7 0.0 0.1 3.6 0.1 0.0 0.3 0.0 0.2 0.2 0.7 0.0 0.1 0.1 0.1 0.0 1.0 0.2 0.0 10.5 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.8 0.0 0.1 0.1 182.0 21.2 35.9 29.6 14.6 15.8 25.7 23.8 14.8 16.3 29.8 27.0 15.0 3.7 80.2 8.8 0.7 45.2 24.6 4.4 4.1 4.7 6.0 3.9 4.1 4.7 4.3 4.6 4.6 4.4 4.0 19.1 0.0 0.0 0.0 8.0 3.6 3.4 5.6 6.2 2.0 0.8 9.1 1.8 1.5 0.4 0.0 0.0 0.2 9.8 31.3 3.9 0.1 0.8 0.4 5.8 11.1 1.2 2.5 0.3 0.8 0.3 11.4 1.1 0.2 19.7 4.3 16.8 0.4 2.8 10.1 0.4 21.0 2.0 5.6 5.7 2.6 11.8 5.2 16.0 1.0 17.3 12.2 41.2 1.0 0.1 0.2 50.0 18.0 1.1 0.5 588.6 0.5 0.5 0.9 0.0 8.3 11.1 1.6 3.5 1.3 3.3 0.4 11.1 3.9 11.8 0.4 NAPA ENSG00000105402 "NSF attachment protein alpha" P54920 19 47487637-47515091 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010100, HPA046149, HPA050196" Approved Uncertain Cytosol NA NA 2200000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 39: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" Cytosol "CAB010100: AB_628263, HPA046149: AB_2679557, HPA050196: AB_2681048" "unprognostic (9.83e-2)" "unprognostic (9.43e-3)" "unprognostic (1.12e-2)" "unprognostic (1.76e-3)" "unprognostic (9.72e-2)" "unprognostic (3.08e-2)" "unprognostic (2.15e-1)" "unprognostic (1.29e-1)" "unprognostic (1.08e-1)" "unprognostic (5.61e-2)" "unprognostic (2.42e-3)" "unprognostic (1.09e-3)" "prognostic favorable (4.26e-9)" "unprognostic (4.04e-2)" "unprognostic (4.17e-2)" "unprognostic (8.55e-2)" "unprognostic (2.90e-2)" 83.0 147.5 104.8 56.8 112.1 115.2 83.6 112.4 146.1 87.2 89.8 79.5 61.9 102.0 54.5 122.7 86.0 63.7 112.9 125.1 102.5 98.6 153.2 79.8 57.0 120.9 99.8 66.4 92.0 101.1 96.5 56.9 119.3 105.1 50.8 83.7 124.3 94.6 180.2 131.9 62.4 72.6 97.3 66.4 83.6 79.3 111.2 85.2 74.6 116.8 53.1 76.7 85.7 112.8 73.1 99.3 48.1 85.3 100.4 80.9 36.7 78.1 98.7 189.3 229.1 76.1 44.3 55.8 41.5 110.4 119.1 56.3 77.7 98.1 72.8 89.2 84.6 70.1 88.5 93.6 256.9 80.6 124.5 122.0 70.2 77.0 47.6 38.1 92.1 74.9 67.0 150.0 123.7 66.2 115.7 284.6 40.5 110.7 75.7 79.8 42.2 82.6 149.6 133.5 174.9 67.6 101.0 126.4 76.6 43.8 98.9 136.9 91.0 97.4 51.3 83.9 93.6 94.5 143.7 76.9 176.3 89.5 102.5 196.4 165.0 313.1 96.1 189.8 81.3 68.7 82.9 94.3 132.3 70.3 84.8 85.3 187.9 111.1 201.1 209.9 112.2 209.4 104.8 112.1 112.4 146.1 125.1 102.5 120.9 99.8 119.3 97.3 111.2 112.8 59.1 12.8 41.5 19.9 48.6 63.3 91.1 73.5 92.2 55.1 69.5 63.5 3.8 72.9 44.5 51.5 27.1 106.4 73.3 89.1 178.1 110.9 44.2 40.8 37.5 49.3 83.6 89.9 30.5 99.8 69.0 48.0 94.8 70.0 64.7 23.8 39.7 89.6 131.1 35.3 21.7 62.6 99.7 58.4 69.1 37.4 42.9 87.7 97.8 14.0 79.1 76.7 66.9 11.1 21.8 100.2 69.8 46.3 92.9 50.5 80.3 99.0 20.1 47.3 92.1 44.3 63.0 119.0 73.7 97.4 68.6 228.9 58.0 61.7 50.7 75.5 NAPB "SNAP-BETA, SNAPB" ENSG00000125814 "NSF attachment protein beta" Q9H115 20 23374519-23421519 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "brain: 126.9;retina: 154.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 203.4;Cone photoreceptor cells: 66.7;Excitatory neurons: 68.8;Horizontal cells: 67.3;Late spermatids: 75.6;Rod photoreceptor cells: 84.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SCLC-21H: 31.8;U-937: 32.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037225, CAB037227, HPA046149, HPA050196" Supported Uncertain Cytosol NA NA "Cluster 46: Basophils - DNA binding" "Cluster 58: Brain - Synaptic function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 56: Bipolar cells - Visual perception" Cytosol "CAB037225: AB_477555, CAB037227: AB_477554, HPA046149: AB_2679557, HPA050196: AB_2681048" "unprognostic (3.89e-1)" "unprognostic (2.71e-1)" "unprognostic (5.95e-2)" "unprognostic (1.05e-1)" "unprognostic (2.54e-2)" "unprognostic (3.92e-2)" "unprognostic (1.32e-3)" "unprognostic (1.25e-1)" "unprognostic (4.71e-2)" "unprognostic (6.37e-2)" "unprognostic (4.46e-3)" "unprognostic (7.52e-3)" "prognostic unfavorable (1.14e-4)" "unprognostic (1.42e-1)" "unprognostic (2.31e-1)" "unprognostic (1.12e-1)" "unprognostic (4.60e-2)" 6.7 24.3 89.3 5.2 98.3 10.6 6.5 53.4 126.9 10.7 8.1 10.0 5.0 7.4 8.8 7.3 9.4 4.8 7.1 102.4 92.6 8.3 7.3 8.3 5.8 90.7 42.4 13.3 6.6 7.8 18.5 8.7 90.5 8.0 6.7 154.1 6.9 5.9 6.4 7.7 8.0 6.0 38.0 8.7 7.1 8.9 48.3 6.1 9.0 3.1 4.4 8.2 9.5 84.1 5.8 3.7 6.0 6.2 6.6 6.1 8.5 7.4 4.0 5.9 5.1 4.4 5.1 8.6 8.6 4.4 4.3 7.3 7.8 5.0 7.1 2.8 5.8 9.4 5.4 10.5 7.8 7.0 5.4 6.1 6.5 4.2 5.2 5.4 4.4 8.6 8.0 11.0 9.4 4.0 7.2 6.4 2.6 4.7 6.7 4.8 4.9 6.5 7.7 6.2 31.8 10.1 4.3 4.1 7.1 8.7 4.2 4.4 5.2 5.6 4.1 6.2 5.4 8.0 6.7 3.8 2.9 32.9 5.7 2.5 0.5 0.0 1.9 0.5 0.6 0.6 0.8 0.9 0.8 1.2 0.7 1.2 0.6 0.6 0.9 0.6 1.0 0.9 89.3 98.3 53.4 126.9 102.4 92.6 90.7 42.4 90.5 38.0 48.3 84.1 4.1 12.8 6.5 30.0 6.6 8.7 5.6 4.1 6.2 203.4 4.2 2.9 6.0 7.2 6.8 14.7 66.7 7.0 5.9 3.6 0.0 3.3 39.9 4.4 5.8 7.5 10.2 2.5 68.8 1.4 5.4 7.4 3.1 3.8 11.4 14.3 9.7 5.5 5.2 67.3 63.8 2.7 14.2 7.2 10.2 75.6 9.0 4.0 10.6 24.4 7.9 20.5 15.5 38.2 37.2 2.9 1.8 9.1 4.7 6.4 9.2 3.6 6.1 84.8 6.6 5.4 5.5 13.4 11.2 3.9 8.4 6.2 6.5 9.3 4.2 4.6 NARS2 "DFNB94, FLJ23441, SLM5" ENSG00000137513 "Asparaginyl-tRNA synthetase 2, mitochondrial" Q96I59 11 78435968-78574874 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Deafness, Disease variant, Leigh syndrome, Non-syndromic deafness, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026793 Supported Approved Nucleoplasm,Mitochondria,Cytosol No No "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Mitochondria" Cytosol "HPA026793: AB_1848833" "unprognostic (1.80e-1)" "unprognostic (1.95e-1)" "unprognostic (5.73e-3)" "unprognostic (1.79e-3)" "unprognostic (1.40e-2)" "unprognostic (2.05e-1)" "unprognostic (1.28e-1)" "unprognostic (5.62e-2)" "unprognostic (4.62e-3)" "prognostic favorable (1.39e-5)" "unprognostic (1.96e-1)" "unprognostic (1.56e-1)" "prognostic favorable (1.22e-6)" "unprognostic (8.57e-2)" "unprognostic (1.45e-1)" "unprognostic (2.93e-1)" "unprognostic (1.60e-1)" 7.3 11.9 10.7 6.8 12.3 6.2 11.1 12.4 13.3 9.6 19.8 11.3 10.3 9.1 11.2 8.1 9.9 7.0 11.7 10.4 11.7 19.0 23.5 7.6 9.6 11.7 13.9 11.4 10.6 11.4 7.6 8.0 13.1 10.8 10.9 13.4 10.7 7.3 23.5 7.2 9.7 7.4 11.3 7.4 9.9 7.5 11.4 11.7 11.5 19.6 9.7 8.7 8.1 12.3 16.7 22.8 23.5 15.4 16.1 13.5 19.5 13.5 13.1 20.6 16.9 39.4 17.4 40.9 34.1 8.7 19.8 21.5 39.9 26.3 28.3 27.0 21.3 28.9 17.3 33.7 13.3 31.3 10.1 9.4 16.8 18.1 32.0 18.3 17.9 33.7 44.5 11.0 23.1 19.4 32.7 50.3 25.6 67.3 27.3 33.6 38.2 55.5 27.2 23.0 27.8 17.5 20.1 25.4 35.5 25.1 24.1 12.3 10.9 27.7 32.8 32.0 23.1 18.1 33.1 91.1 5.4 27.7 19.2 9.5 9.3 4.4 11.1 10.4 13.8 17.6 12.8 12.5 16.6 15.0 18.5 16.7 2.0 20.3 12.8 12.7 10.5 10.3 10.7 12.3 12.4 13.3 10.4 11.7 11.7 13.9 13.1 11.3 11.4 12.3 5.8 19.2 26.4 27.7 14.5 13.5 14.2 12.0 12.5 5.2 9.4 6.5 8.8 5.7 10.3 5.5 2.1 20.0 4.4 4.0 29.4 9.5 13.1 10.1 7.4 6.6 12.0 9.2 34.7 7.3 23.6 9.0 10.2 9.0 8.2 14.0 2.5 19.8 12.4 0.0 45.1 8.3 22.4 6.3 11.6 5.4 7.8 6.3 17.8 45.0 2.9 6.3 4.1 42.7 47.7 7.5 9.9 4.9 14.6 17.5 7.0 28.9 10.2 9.0 6.6 7.5 8.8 8.6 19.5 12.0 13.8 15.3 7.8 9.0 14.6 10.7 NCKAP1L HEM1 ENSG00000123338 "NCK associated protein 1 like" P55160 12 54497752-54548243 "Plasma proteins, Predicted membrane proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 44.9" "Cell type enhanced" "Detected in many" "B-cells: 66.2;dendritic cells: 92.3;Hofbauer cells: 115.5;Kupffer cells: 175.1;Macrophages: 108.1;monocytes: 153.2;NK-cells: 113.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HL-60: 112.4;HMC-1: 112.4;NB-4: 82.6;REH: 59.1;THP-1: 121.3;U-937: 70.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039490, HPA040772" Approved Uncertain "Plasma membrane,Cytosol" NA NA 33000 "Cluster 51: Monocytes - Innate immune response" "Cluster 16: Immune cells - Immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" Cytosol "Plasma membrane" "HPA039490: AB_2676540, HPA040772: AB_2677129" "unprognostic (4.54e-2)" "unprognostic (5.20e-3)" "unprognostic (1.61e-2)" "unprognostic (1.22e-3)" "unprognostic (9.29e-2)" "unprognostic (1.01e-2)" "unprognostic (3.69e-1)" "unprognostic (2.95e-2)" "unprognostic (6.53e-3)" "unprognostic (4.80e-1)" "unprognostic (1.76e-1)" "unprognostic (2.08e-1)" "unprognostic (1.54e-3)" "unprognostic (2.57e-1)" "unprognostic (2.76e-2)" "unprognostic (3.63e-2)" "unprognostic (4.74e-2)" 9.7 4.6 3.3 34.8 4.0 28.4 4.7 3.6 3.7 4.0 4.0 19.7 5.8 2.5 1.3 6.1 3.4 7.3 2.6 2.9 3.7 2.3 7.1 20.2 42.5 6.9 4.8 1.8 1.6 4.0 1.5 11.0 6.5 4.7 9.7 0.4 3.5 5.2 1.2 2.3 18.1 10.3 5.4 44.9 6.7 1.2 6.8 37.4 2.2 2.0 43.4 27.9 2.8 8.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 47.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 40.4 0.3 47.9 0.0 0.0 0.0 112.4 112.4 0.0 0.0 0.0 0.0 0.0 0.7 40.1 7.7 43.7 0.0 0.0 47.9 82.6 0.1 0.0 0.0 59.1 0.2 47.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 121.3 0.0 0.2 0.0 0.1 0.1 2.4 2.9 38.4 0.2 70.4 0.0 31.7 68.6 55.0 31.7 103.9 26.2 30.2 28.3 32.7 72.0 28.8 17.9 26.4 16.9 36.1 121.3 40.8 45.1 65.1 3.3 4.0 3.6 3.7 2.9 3.7 6.9 4.8 6.5 5.4 6.8 8.4 1.0 0.0 11.6 0.3 66.2 1.3 0.3 0.0 0.0 1.3 0.6 2.2 1.5 4.3 1.8 0.0 0.0 0.7 92.3 0.2 0.0 0.1 0.9 0.2 0.3 3.6 0.0 22.1 0.8 0.4 1.0 2.7 2.0 0.3 56.3 0.1 7.5 1.4 115.5 0.0 0.5 0.0 0.0 175.1 28.5 2.3 1.2 108.1 5.4 42.2 153.2 0.4 113.3 0.5 0.0 0.0 0.1 0.0 40.0 0.1 0.0 0.3 0.7 0.9 0.0 0.8 1.3 0.9 1.6 0.1 0.6 1.4 59.7 0.2 0.0 0.2 NDRG4 "KIAA1180, SMAP-8" ENSG00000103034 "NDRG family member 4" Q9ULP0 16 58462846-58513628 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 380.7;heart muscle: 352.7" "Group enriched" "Detected in many" 4 "Cardiomyocytes: 433.0;Horizontal cells: 516.5" "Cancer enriched" "Detected in many" 6 "glioma: 23.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 32.5;GAMG: 28.6;hTERT-RPE1: 26.8;HUVEC TERT2: 21.0;SCLC-21H: 49.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015313, HPA017587" Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 62: Horizontal cells - Visual perception" "Nucleoplasm, Cytosol" "HPA015313: AB_1854343, HPA017587: AB_1854344" "unprognostic (1.52e-1)" "unprognostic (1.30e-1)" "unprognostic (9.03e-3)" "unprognostic (1.59e-2)" "unprognostic (3.97e-1)" "unprognostic (1.03e-1)" "unprognostic (1.82e-3)" "unprognostic (1.56e-1)" "unprognostic (6.07e-2)" "unprognostic (1.02e-1)" "unprognostic (4.84e-3)" "unprognostic (5.98e-2)" "unprognostic (2.27e-2)" "unprognostic (1.22e-2)" "unprognostic (8.51e-2)" "unprognostic (4.45e-2)" "unprognostic (7.17e-2)" 16.4 128.8 122.7 2.9 136.0 0.1 11.4 239.4 248.6 25.3 0.0 6.5 3.7 25.5 6.8 20.8 8.0 3.6 352.7 195.0 170.4 1.6 1.0 17.7 4.1 379.4 113.0 1.8 2.7 12.0 71.6 2.0 380.7 3.1 3.2 115.5 5.3 30.2 8.7 21.5 3.9 13.3 41.6 21.9 4.1 48.1 190.9 4.5 2.7 3.6 4.0 3.7 57.5 91.7 0.2 16.9 15.8 3.1 0.4 2.9 1.3 5.2 8.2 2.5 1.7 6.5 4.3 0.4 32.5 4.0 28.6 1.5 1.2 0.9 2.2 0.0 3.3 0.7 3.3 4.7 4.4 0.3 0.3 3.6 0.3 1.6 0.0 26.8 21.0 0.1 0.3 0.2 2.4 4.3 1.7 0.2 1.4 0.6 12.4 0.4 4.4 0.4 0.7 10.6 49.2 18.4 0.5 1.4 0.1 2.0 0.6 0.2 7.7 2.1 6.0 0.6 0.8 0.9 0.5 5.7 11.4 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 122.7 136.0 239.4 248.6 195.0 170.4 379.4 113.0 380.7 41.6 190.9 91.7 8.9 0.0 1.9 53.5 0.2 2.0 6.8 0.6 1.2 52.3 0.7 1.5 433.0 0.0 0.3 0.0 4.2 0.0 0.1 0.6 0.0 4.0 5.9 4.0 5.6 17.0 1.8 0.0 95.7 0.2 0.1 10.1 1.5 11.5 0.0 13.6 29.3 0.3 0.0 516.5 94.3 0.1 2.0 1.0 1.2 10.8 4.4 0.3 7.2 22.5 0.0 82.6 0.0 29.7 14.1 3.7 0.0 2.6 0.0 4.9 0.0 0.2 0.2 33.4 6.6 3.5 6.7 4.8 6.5 14.5 5.8 0.0 0.3 0.3 0.0 8.8 NDUFA12 "B17.2, DAP13" ENSG00000184752 "NADH:ubiquinone oxidoreductase subunit A12" Q9UI09 12 94897055-95003748 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 558.6;tongue: 563.1" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 2159.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039903 Supported Supported Mitochondria,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 54: Cardiomyocytes - Muscle contraction" Mitochondria Cytosol "HPA039903: AB_10795516" "unprognostic (2.76e-1)" "unprognostic (5.32e-3)" "unprognostic (1.17e-1)" "unprognostic (2.56e-2)" "unprognostic (2.85e-1)" "unprognostic (4.03e-2)" "unprognostic (3.05e-2)" "unprognostic (6.68e-2)" "unprognostic (1.67e-1)" "unprognostic (2.47e-2)" "unprognostic (1.89e-1)" "unprognostic (1.64e-1)" "unprognostic (3.13e-3)" "unprognostic (2.32e-1)" "unprognostic (1.65e-1)" "unprognostic (6.13e-2)" "unprognostic (3.27e-2)" 100.2 94.1 158.6 73.9 162.8 93.2 77.1 168.9 228.1 67.8 159.8 148.6 109.3 66.8 87.1 89.8 77.8 52.9 361.8 161.3 172.6 133.8 143.7 70.3 92.5 166.4 162.1 64.7 59.6 159.5 73.5 79.5 164.1 74.7 143.9 106.8 75.3 77.8 558.6 74.2 101.5 98.4 162.6 97.6 87.7 58.9 165.1 108.9 89.6 563.1 122.0 81.0 73.0 161.1 255.3 281.1 223.6 160.8 183.3 171.8 165.8 118.8 178.5 258.5 234.6 347.6 125.8 293.7 68.8 187.6 141.1 188.2 236.1 278.4 296.7 254.8 282.9 241.2 218.6 358.8 186.3 344.0 285.3 183.0 352.4 215.7 266.9 270.4 222.2 246.0 235.2 130.4 260.8 381.1 238.6 533.6 167.0 313.7 484.0 179.9 189.4 335.2 262.5 393.9 213.2 128.5 201.3 287.3 164.6 193.9 287.2 226.9 243.5 134.1 134.0 195.0 204.2 207.5 349.9 443.7 80.6 293.6 211.2 643.9 420.5 228.2 354.8 512.5 336.4 482.8 479.5 429.9 576.2 415.5 631.9 455.9 62.0 464.6 506.6 355.5 570.8 814.8 158.6 162.8 168.9 228.1 161.3 172.6 166.4 162.1 164.1 162.6 165.1 161.1 213.5 73.7 68.4 26.8 81.3 108.6 163.9 364.5 71.2 67.4 87.9 171.7 2159.0 135.8 168.3 108.5 64.6 254.0 127.9 172.0 620.3 162.0 240.0 110.3 98.9 206.0 85.3 86.5 19.6 163.9 254.5 172.6 67.2 100.7 58.3 103.5 109.2 149.1 192.3 37.0 29.0 171.8 244.1 103.6 161.9 122.1 97.6 111.1 160.1 13.1 203.5 141.6 199.8 20.6 22.3 234.6 228.8 133.5 98.8 123.8 229.9 338.3 134.7 130.5 105.2 120.8 291.2 156.3 109.8 127.9 127.7 209.6 120.2 181.9 219.2 182.0 NDUFAF1 "CGI-65, CIA30" ENSG00000137806 "NADH:ubiquinone oxidoreductase complex assembly factor 1" Q9Y375 15 41387218-41409403 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Chaperone "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 85.3;Spermatocytes: 84.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039933, HPA040064" Supported Approved Mitochondria,Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 43: THP-1 - Innate immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Mitochondria, Cytosol" "HPA039933: AB_10795265, HPA040064: AB_10795687" "unprognostic (2.02e-1)" "unprognostic (1.02e-1)" "unprognostic (1.72e-1)" "unprognostic (2.10e-3)" "unprognostic (2.38e-1)" "unprognostic (1.20e-1)" "prognostic favorable (2.88e-5)" "unprognostic (3.01e-1)" "unprognostic (2.34e-1)" "unprognostic (8.92e-2)" "unprognostic (1.34e-1)" "unprognostic (1.46e-1)" "prognostic favorable (3.34e-6)" "unprognostic (1.68e-1)" "unprognostic (3.23e-1)" "unprognostic (3.17e-2)" "unprognostic (2.05e-1)" 16.0 33.4 20.0 9.5 20.7 4.2 12.4 21.6 29.6 9.7 22.8 12.7 12.6 10.5 15.5 13.8 9.8 7.7 42.7 20.7 21.4 29.0 38.7 9.3 11.5 21.1 21.0 9.7 11.8 18.3 11.5 8.0 21.3 10.1 10.4 12.4 12.2 13.2 63.5 9.7 10.9 10.8 21.5 11.9 14.1 21.1 20.8 10.9 10.5 60.9 13.1 12.8 9.9 22.9 15.9 13.3 16.4 13.3 30.0 28.3 14.9 26.1 25.1 23.6 21.3 22.5 8.1 16.7 38.2 24.9 17.5 25.0 20.1 15.9 19.3 32.9 23.9 22.4 25.0 13.8 27.1 24.7 17.0 30.0 18.5 20.8 18.0 19.9 19.0 31.9 38.2 17.2 30.6 17.5 19.9 28.6 12.6 27.5 17.9 15.0 17.4 40.6 41.9 27.8 17.5 13.8 13.2 31.8 12.6 16.9 25.1 50.2 15.4 18.0 10.1 30.5 24.2 15.8 34.7 28.0 24.0 43.5 19.3 35.0 12.8 16.2 7.8 15.0 9.1 13.8 9.6 9.5 11.8 11.8 10.6 8.6 9.4 13.4 13.3 18.2 16.8 8.5 20.0 20.7 21.6 29.6 20.7 21.4 21.1 21.0 21.3 21.5 20.8 22.9 7.7 12.8 10.1 6.5 14.6 4.7 15.8 43.8 9.6 15.7 12.3 11.9 58.7 15.7 27.3 22.0 12.5 36.3 19.8 8.5 64.6 30.5 59.5 14.2 14.2 11.1 6.7 13.5 8.8 31.3 34.6 12.5 12.2 13.1 7.0 16.3 8.6 28.2 28.8 6.7 9.1 8.5 30.5 12.8 7.0 15.0 16.4 16.2 10.6 3.7 23.4 20.7 16.5 4.0 10.3 20.9 3.7 16.1 15.0 11.8 23.3 85.3 30.6 19.2 26.3 15.3 17.3 84.7 21.6 11.3 7.7 50.3 12.3 32.6 11.9 16.3 NDUFV1 CI-51K ENSG00000167792 "NADH:ubiquinone oxidoreductase core subunit V1" P49821 11 67605653-67612554 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease variant, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 526.2" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 482.4;Proximal tubular cells: 499.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045211, HPA075051" Enhanced Supported Mitochondria,Cytosol No No 37000 "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria Cytosol "HPA045211: AB_10962830, HPA075051: AB_2686732" "unprognostic (4.57e-2)" "unprognostic (2.17e-2)" "unprognostic (2.84e-1)" "unprognostic (7.07e-2)" "unprognostic (1.54e-1)" "unprognostic (4.54e-3)" "unprognostic (1.19e-1)" "unprognostic (3.31e-2)" "unprognostic (2.19e-1)" "unprognostic (4.95e-2)" "unprognostic (4.02e-2)" "unprognostic (3.03e-2)" "prognostic favorable (7.49e-10)" "unprognostic (1.12e-2)" "unprognostic (1.80e-1)" "unprognostic (2.12e-1)" "unprognostic (1.16e-1)" 95.0 126.5 87.6 52.5 93.7 72.5 90.9 105.6 107.1 93.9 104.8 142.3 124.5 85.2 33.8 114.0 84.6 47.1 400.2 91.6 97.0 188.4 187.0 77.1 66.7 103.3 91.5 101.9 117.2 169.8 84.5 46.7 110.4 77.4 73.7 81.6 90.2 73.2 526.2 117.7 96.6 51.1 86.9 98.8 132.0 76.0 104.9 51.6 107.6 440.5 62.8 88.1 88.6 99.9 132.9 133.6 68.8 141.3 85.6 83.4 130.6 84.1 76.4 122.2 82.6 256.8 155.3 241.9 167.3 69.2 99.7 176.8 146.1 126.4 38.4 125.2 114.9 100.0 189.1 127.9 119.0 136.9 106.9 126.7 119.0 100.4 88.0 76.9 109.3 173.9 180.9 192.6 75.8 190.2 163.1 268.0 68.5 295.3 168.8 184.5 135.8 399.1 99.3 95.3 109.9 104.6 104.3 347.4 275.3 46.0 177.4 138.0 90.7 118.9 88.8 172.3 87.5 187.7 116.8 122.6 138.0 144.6 117.7 39.0 72.8 38.1 65.1 83.4 71.6 59.8 55.0 63.2 110.7 60.1 50.2 63.7 13.1 104.0 51.2 73.0 78.1 77.0 87.6 93.7 105.6 107.1 91.6 97.0 103.3 91.5 110.4 86.9 104.9 99.9 54.6 60.9 75.0 33.3 76.2 80.3 95.9 187.6 77.4 68.7 82.1 94.4 482.4 61.5 120.7 86.5 50.1 203.5 72.8 235.7 397.2 114.9 74.0 43.1 47.5 56.7 98.5 85.0 32.9 112.1 158.8 82.4 137.1 55.2 61.4 99.6 56.4 136.2 136.5 63.9 36.5 155.9 152.5 68.8 81.4 222.7 65.6 68.4 113.8 13.1 81.0 89.3 60.8 19.1 34.6 70.1 122.8 59.0 146.6 55.0 199.4 499.2 80.3 78.5 46.0 90.8 136.9 100.7 83.3 127.0 80.6 189.1 79.3 145.9 274.8 111.7 NDUFV2 CI-24k ENSG00000178127 "NADH:ubiquinone oxidoreductase core subunit V2" P19404 18 9102630-9134345 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 606.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003404, HPA077896" Supported Approved Nucleoplasm,Mitochondria,Cytosol No No 7600 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Mitochondria "Nucleoplasm, Cytosol" "HPA003404: AB_1079466, HPA077896: AB_2686866" "unprognostic (1.18e-1)" "unprognostic (3.89e-2)" "unprognostic (2.89e-1)" "unprognostic (8.22e-2)" "unprognostic (1.32e-2)" "unprognostic (6.72e-3)" "unprognostic (1.36e-2)" "unprognostic (1.18e-1)" "unprognostic (6.72e-3)" "unprognostic (1.32e-3)" "unprognostic (2.39e-1)" "unprognostic (6.84e-2)" "unprognostic (1.70e-1)" "unprognostic (5.51e-2)" "unprognostic (1.31e-1)" "unprognostic (6.56e-2)" "unprognostic (1.95e-3)" 97.4 171.6 94.3 69.2 97.4 149.8 101.7 106.8 139.7 63.9 106.0 124.2 102.3 69.7 91.1 142.6 64.0 68.7 419.3 96.7 106.0 180.7 404.2 88.6 105.0 105.9 104.4 52.4 111.6 136.7 72.1 73.7 105.9 88.5 119.8 129.9 97.4 72.4 606.9 94.7 100.5 80.6 103.7 86.4 133.8 79.6 102.7 90.2 72.7 538.3 105.1 122.1 76.5 104.6 136.5 139.8 159.1 148.4 116.6 164.0 133.4 165.4 266.5 217.7 205.5 265.1 109.4 209.4 149.5 158.6 200.3 66.9 157.5 175.5 208.8 104.6 136.6 133.0 135.3 364.8 133.6 373.8 159.2 139.2 144.3 134.9 146.2 156.8 239.3 184.3 216.5 644.0 204.6 171.6 263.5 328.9 131.4 750.5 172.3 124.5 118.2 794.2 354.3 218.7 167.0 122.3 164.6 188.0 220.3 113.6 174.2 282.8 145.8 273.4 194.3 198.8 223.0 180.4 292.3 237.1 195.4 166.0 181.0 250.8 161.8 194.2 118.1 196.1 148.3 237.6 176.9 140.5 237.9 201.1 153.5 142.7 76.0 124.2 187.9 315.1 231.9 231.8 94.3 97.4 106.8 139.7 96.7 106.0 105.9 104.4 105.9 103.7 102.7 104.6 107.3 80.1 145.8 17.6 143.1 148.0 319.0 629.4 159.4 101.2 165.0 167.3 69.9 178.7 339.5 150.8 87.6 344.1 146.6 211.0 876.5 415.2 271.5 160.3 108.2 117.3 106.5 165.4 32.9 531.4 323.3 122.0 144.3 183.9 120.3 109.7 96.4 351.5 313.5 94.2 37.3 201.7 480.1 115.7 267.1 186.2 122.1 170.2 231.3 17.8 293.2 167.1 96.8 32.2 46.5 530.3 201.2 102.0 244.9 554.3 349.9 810.6 293.4 184.2 105.2 124.0 196.3 217.4 175.0 226.5 147.6 289.4 165.7 266.7 227.3 469.0 NEXMIF "KIAA2022, KIDLIA, MRX98, XPN" ENSG00000050030 "Neurite extension and migration factor" Q5QGS0 X 74732856-74925472 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.7" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 3.6;Breast glandular cells: 1.4;Club cells: 2.5;Hofbauer cells: 1.3;Respiratory ciliated cells: 2.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HAP1: 3.7;Karpas-707: 5.9;SiHa: 5.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000407 Uncertain Supported "Nucleoplasm,Midbody,Mitotic spindle,Cytosol" Yes NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Midbody, Mitotic spindle, Cytosol" "HPA000407: AB_2665984" "unprognostic (1.04e-3)" "unprognostic (6.07e-5)" "unprognostic (1.81e-2)" "unprognostic (2.07e-5)" "unprognostic (2.15e-1)" "unprognostic (2.18e-2)" "unprognostic (3.37e-1)" "unprognostic (1.74e-3)" "unprognostic (3.71e-1)" "unprognostic (1.79e-2)" "unprognostic (1.64e-3)" "unprognostic (8.25e-2)" "unprognostic (7.58e-3)" "unprognostic (1.37e-2)" "unprognostic (3.80e-2)" "unprognostic (2.79e-4)" "unprognostic (6.94e-4)" 0.1 0.9 3.0 0.1 3.1 0.0 0.3 1.0 2.5 0.4 0.0 0.8 0.1 0.5 0.2 0.3 0.3 0.1 0.0 2.6 6.7 0.7 0.0 0.1 0.1 0.3 0.7 0.4 1.5 1.8 1.7 0.1 0.5 0.9 0.3 1.0 0.4 0.6 0.0 0.3 0.4 0.7 0.2 0.1 0.6 0.2 4.8 0.0 0.4 0.1 0.1 0.2 0.2 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 5.9 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 5.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 3.1 1.0 2.5 2.6 6.7 0.3 0.7 0.5 0.2 4.8 0.7 0.3 0.0 3.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.4 0.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.9 0.1 0.4 0.0 0.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 2.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 NFKBID "IkappaBNS, IkBNS, TA-NFKBH" ENSG00000167604 "NFKB inhibitor delta" Q8NI38 19 35887653-35902303 "Predicted intracellular proteins, Transcription factors" "Inflammatory response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.9" "Cell type enhanced" "Detected in many" "B-cells: 152.7;granulocytes: 90.3;Langerhans cells: 418.5;Macrophages: 89.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054778 Uncertain "Nuclear bodies,Plasma membrane,Cytosol" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 3: HMC-1 - Innate immune response" "Cluster 41: Macrophages - Immune response" Cytosol "Nuclear bodies, Plasma membrane" "HPA054778: " "prognostic favorable (6.01e-4)" "unprognostic (9.60e-2)" "unprognostic (1.00e-1)" "unprognostic (3.28e-2)" "unprognostic (1.51e-2)" "prognostic favorable (5.43e-4)" "unprognostic (4.21e-2)" "unprognostic (7.68e-2)" "unprognostic (3.83e-1)" "unprognostic (4.10e-2)" "unprognostic (1.47e-3)" "unprognostic (5.64e-2)" "unprognostic (6.83e-2)" "unprognostic (1.04e-1)" "unprognostic (5.21e-2)" "unprognostic (2.71e-2)" "prognostic favorable (8.34e-6)" 4.0 1.8 0.7 4.4 0.6 15.9 2.5 2.7 1.6 1.9 2.1 2.3 1.1 1.8 0.0 2.1 3.0 2.4 1.5 0.8 1.4 2.5 1.5 5.6 4.8 1.4 0.9 3.3 2.1 0.9 4.2 0.8 1.2 2.2 0.8 0.7 1.6 0.5 0.4 2.2 4.0 0.5 1.0 5.4 2.0 0.4 1.3 5.2 3.9 0.2 3.1 2.2 2.0 1.7 3.3 3.0 0.6 2.0 0.3 0.5 1.4 2.0 2.4 2.1 1.5 0.7 2.6 4.0 1.5 2.1 1.9 1.7 2.1 1.6 0.9 2.3 0.4 2.4 4.9 0.7 0.5 2.1 7.0 0.7 1.0 3.9 0.9 0.5 0.8 1.8 0.5 2.4 0.4 2.6 1.7 2.5 0.8 0.6 0.6 0.9 0.4 0.8 1.8 1.4 1.0 0.8 2.7 2.1 0.2 0.5 0.9 2.1 0.8 3.3 3.0 1.5 1.4 1.7 0.6 4.6 1.8 4.9 0.5 0.0 0.9 1.7 1.4 0.6 1.1 3.3 0.6 1.1 0.9 5.5 1.0 0.6 3.2 1.5 1.1 1.2 1.5 0.5 0.7 0.6 2.7 1.6 0.8 1.4 1.4 0.9 1.2 1.0 1.3 1.7 11.7 0.0 11.3 2.9 152.7 29.7 14.3 12.9 34.7 8.0 10.9 7.5 1.1 5.7 5.6 1.8 20.9 1.3 58.9 5.7 0.0 2.5 0.1 27.8 6.8 21.5 3.0 1.7 4.9 1.0 2.8 11.3 2.0 80.8 90.3 3.8 9.3 0.3 39.2 0.0 3.4 5.7 2.0 31.0 418.5 0.4 1.2 89.4 19.6 2.8 40.0 1.0 13.4 1.5 0.5 2.8 2.1 1.9 38.1 13.8 9.2 1.7 3.9 9.2 0.0 3.3 6.7 0.4 1.0 20.7 33.4 1.0 45.3 2.4 6.2 10.0 NKX1-1 "HSPX153, SAX2" ENSG00000235608 "NK1 homeobox 1" Q15270 4 1402932-1406442 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA029367 Uncertain Uncertain "Nucleoli fibrillar center,Cytosol" NA NA "Cluster 31: Spermatids - Spermatogenesis" Cytosol "Nucleoli fibrillar center" "HPA029367: AB_2673011" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NKX2-3 "CSX3, NKX2.3, NKX2C, NKX4-3" ENSG00000119919 "NK2 homeobox 3" Q8TAU0 10 99532942-99536524 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "intestine: 38.9;lymphoid tissue: 31.4;salivary gland: 15.7" "Group enriched" "Detected in some" 4 "Endothelial cells: 2.2;Hepatic stellate cells: 4.2" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.7;REH: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA047561 Uncertain Uncertain Nucleoli,Cytosol NA NA "Cluster 14: B-cells - Humoral immune response" "Cluster 14: REH - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoli, Cytosol" "HPA047561: AB_2680088" "unprognostic (5.70e-2)" "unprognostic (2.95e-1)" "unprognostic (2.70e-4)" "unprognostic (6.34e-3)" "unprognostic (3.92e-2)" "unprognostic (7.40e-2)" "unprognostic (1.20e-1)" "unprognostic (4.91e-2)" "unprognostic (1.12e-1)" "unprognostic (1.19e-1)" "unprognostic (1.53e-2)" "unprognostic (3.14e-1)" "unprognostic (3.50e-2)" "unprognostic (1.83e-1)" 1.4 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 38.9 11.5 0.0 0.0 0.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 4.9 0.0 15.7 0.0 0.0 0.0 22.4 3.6 0.0 31.4 2.5 0.1 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 2.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 NKX2-6 "CSX2, NKX4-2" ENSG00000180053 "NK2 homeobox 6" A6NCS4 8 23701740-23706756 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "salivary gland: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "hTEC/SVTERT24-B: 5.6;JURKAT: 2.1;LHCN-M2: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA025288 Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA025288: " "unprognostic (1.86e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 2.1 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NLRP14 "CLR11.2, GC-LRR, Nalp-iota, NALP14, NOD5, PAN8" ENSG00000158077 "NLR family pyrin domain containing 14" Q86W24 11 7020479-7071526 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Astrocytes: 2.3;Bipolar cells: 2.2;Cone photoreceptor cells: 2.1;Distal tubular cells: 1.9;Early spermatids: 2.2;Excitatory neurons: 2.2;Rod photoreceptor cells: 3.2;Spermatocytes: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA039477 Approved Uncertain Cytosol NA NA "Cluster 46: Photoreceptor cells - Phototransduction" Cytosol "HPA039477: AB_10794748" "unprognostic (6.46e-3)" "unprognostic (5.76e-3)" "unprognostic (1.44e-4)" "unprognostic (7.20e-4)" "unprognostic (5.57e-2)" "unprognostic (8.02e-3)" "unprognostic (6.57e-2)" "unprognostic (2.65e-1)" "unprognostic (2.68e-1)" "unprognostic (1.44e-1)" "unprognostic (2.68e-1)" "unprognostic (2.65e-2)" "unprognostic (3.17e-3)" "unprognostic (6.69e-2)" "unprognostic (3.22e-1)" "unprognostic (3.85e-2)" "unprognostic (1.25e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.5 0.1 0.1 0.2 0.2 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.2 0.1 0.2 0.0 0.4 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.9 0.1 2.2 0.3 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.5 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.2 0.0 0.0 0.0 2.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPHP4 "KIAA0673, POC10, SLSN4" ENSG00000131697 "Nephrocystin 4" O75161 1 5862811-5992473 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ciliopathy, Disease variant, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 24.2;Cone photoreceptor cells: 33.3;Excitatory neurons: 47.1;Inhibitory neurons: 30.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebral cortex: 2.7;hippocampal formation: 3.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063852, HPA065526" Approved Approved "Nucleoplasm,Nuclear bodies,Vesicles,Cytosol" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Cytosol" "Nuclear bodies, Vesicles" "HPA063852: , HPA065526: AB_2685505" "unprognostic (1.82e-1)" "unprognostic (1.57e-2)" "unprognostic (1.76e-1)" "unprognostic (7.30e-2)" "unprognostic (5.83e-2)" "unprognostic (2.53e-2)" "unprognostic (1.08e-2)" "unprognostic (1.95e-1)" "unprognostic (2.52e-1)" "unprognostic (1.23e-2)" "unprognostic (7.49e-3)" "unprognostic (9.00e-2)" "unprognostic (1.75e-2)" "unprognostic (2.96e-2)" "unprognostic (1.34e-1)" "unprognostic (2.54e-1)" "unprognostic (1.37e-1)" 2.7 2.2 1.0 2.3 0.8 3.7 2.7 0.0 2.7 2.9 2.5 2.2 2.1 2.8 2.3 2.0 7.9 2.1 1.9 3.1 0.0 2.2 1.3 3.0 2.3 0.0 0.0 2.9 2.4 2.7 7.8 1.6 0.0 2.2 1.2 2.4 2.2 2.3 2.2 4.9 2.1 2.2 0.0 2.2 2.0 5.3 0.0 2.5 6.7 1.9 1.1 2.1 2.5 0.0 7.8 4.8 5.4 4.3 4.7 6.8 4.1 3.9 3.9 5.3 4.2 4.1 6.5 4.0 9.6 4.6 3.6 7.4 2.7 6.6 2.7 5.1 7.3 3.4 8.1 4.1 3.7 6.5 5.1 5.6 3.2 6.3 3.9 3.4 3.8 9.4 6.2 4.1 2.4 5.9 8.3 7.1 1.0 4.0 5.5 7.1 3.4 6.5 2.6 1.0 17.0 5.5 6.1 4.5 6.5 2.3 6.0 7.2 3.7 7.6 3.2 13.0 4.8 5.0 7.0 4.2 3.4 8.3 2.0 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 1.0 0.8 0.0 2.7 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 1.1 24.2 1.3 4.0 1.2 1.8 3.4 7.3 3.0 3.6 3.1 4.3 3.9 3.7 33.3 0.6 2.2 2.1 1.9 1.6 2.0 10.2 3.3 2.9 3.6 3.2 47.1 1.8 0.5 3.5 4.1 3.0 0.0 4.0 1.8 1.5 2.0 5.0 30.8 2.2 2.0 3.5 3.7 1.4 4.1 2.4 10.6 14.0 1.8 6.3 2.1 10.6 17.3 2.1 2.2 2.2 2.6 1.8 1.1 1.9 10.9 18.2 6.6 1.6 2.7 11.6 6.5 1.9 5.3 1.1 1.7 4.0 1.7 1.1 NPPB ENSG00000120937 "Natriuretic peptide B" P16860 1 11857464-11858945 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Hormone, Vasoactive, Vasodilator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 767 "heart muscle: 5154.6" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 351.7;Ductal cells: 266.6;Pancreatic endocrine cells: 86.2" "Cancer enhanced" "Detected in some" "testis cancer: 2.2" "Group enriched" "Detected in some" 4 "basal ganglia: 3.4;cerebral cortex: 1.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 135.5;CACO-2: 362.2;SuSa: 67.7" "Region enhanced" "Detected in single" "pons and medulla: 1.4" HPA077324 Approved Vesicles,Cytosol "Secreted to blood" NA NA 9680 "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 39: CACO-2 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" Vesicles Cytosol "HPA077324: " "unprognostic (3.87e-1)" "unprognostic (1.29e-2)" "unprognostic (2.49e-1)" "unprognostic (4.23e-1)" "unprognostic (3.28e-2)" 1.0 0.3 0.3 0.1 3.4 0.0 0.7 0.4 1.8 0.3 0.1 0.3 0.0 0.3 0.3 0.2 0.0 0.6 5154.6 0.3 0.3 0.3 0.5 6.7 0.9 0.3 0.4 0.8 4.0 0.1 0.5 0.8 0.3 0.5 0.0 0.1 1.2 0.0 0.8 0.5 0.4 0.0 0.6 0.1 0.7 0.8 0.5 0.1 0.5 0.0 0.0 0.2 0.3 0.5 0.0 0.1 0.0 0.0 0.0 0.0 135.5 0.3 0.0 2.1 1.1 362.2 0.0 0.0 0.1 0.1 0.3 3.8 0.1 0.0 2.5 0.0 0.0 0.0 0.0 1.0 0.2 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.2 0.1 0.4 0.2 0.0 67.7 0.0 0.0 0.0 0.0 32.0 0.2 0.2 0.0 0.1 0.0 0.1 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.4 0.4 1.8 0.3 0.3 0.3 0.4 0.3 0.6 0.5 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 351.7 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 266.6 0.1 0.8 0.1 4.9 0.0 0.0 0.2 8.3 2.2 11.7 0.0 1.4 0.0 0.2 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 2.0 0.2 0.0 0.0 0.0 86.2 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 17.6 5.8 0.1 0.0 0.0 3.4 0.0 0.0 0.0 0.1 NR2F6 "EAR-2, EAR2, ERBAL2" ENSG00000160113 "Nuclear receptor subfamily 2 group F member 6" P10588 19 17231883-17245919 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 104.0" "Cell type enhanced" "Detected in all" "Distal enterocytes: 206.0;Hepatocytes: 148.4;Horizontal cells: 151.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BEWO: 187.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB079917 Supported "Nuclear speckles,Cytosol" NA Yes "Cluster 15: NK-cells - Transcription" "Cluster 85: Liver - Metabolism" "Cluster 28: BEWO - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nuclear speckles" Cytosol "CAB079917: AB_2635238" "unprognostic (1.48e-1)" "unprognostic (1.30e-1)" "unprognostic (2.17e-1)" "prognostic unfavorable (4.36e-4)" "unprognostic (1.08e-1)" "unprognostic (1.12e-1)" "unprognostic (3.07e-1)" "unprognostic (3.67e-1)" "unprognostic (7.20e-2)" "unprognostic (1.02e-2)" "unprognostic (2.39e-1)" "unprognostic (6.62e-2)" "unprognostic (9.68e-2)" "unprognostic (1.31e-1)" "unprognostic (2.29e-2)" "unprognostic (7.28e-3)" "unprognostic (1.37e-3)" 17.0 21.8 19.3 5.0 16.9 1.2 17.7 15.8 22.8 18.8 23.8 39.4 31.2 19.8 14.3 47.4 19.1 2.9 39.0 16.8 20.2 32.8 104.0 17.5 1.7 23.9 21.4 12.1 44.6 10.4 22.0 13.1 18.6 25.3 9.3 6.6 28.0 9.8 27.9 23.9 25.4 4.5 17.5 9.9 38.6 14.3 20.4 1.8 21.6 9.9 2.7 25.5 22.2 15.6 65.0 38.1 20.3 37.2 7.9 8.8 187.2 35.7 12.9 15.2 13.1 26.1 55.5 15.2 108.8 16.0 8.9 31.9 15.6 20.5 6.7 20.4 90.0 13.9 24.4 47.3 17.3 6.7 18.8 11.6 23.2 7.0 11.3 15.9 9.5 6.8 33.3 3.7 6.7 34.7 5.9 24.7 55.8 48.1 58.5 11.6 12.7 13.2 21.2 41.3 16.3 46.7 19.9 68.7 43.1 19.6 38.2 21.1 15.8 10.7 26.1 20.6 28.8 21.0 7.9 10.9 13.1 9.9 13.4 0.0 0.6 1.1 1.7 0.0 1.4 0.3 2.3 1.5 1.1 2.3 3.8 1.3 0.1 4.6 0.1 0.5 2.4 0.8 19.3 16.9 15.8 22.8 16.8 20.2 23.9 21.4 18.6 17.5 20.4 15.6 21.2 9.6 22.9 6.8 4.7 10.6 14.1 12.8 11.4 71.9 65.9 54.7 36.4 34.3 20.8 25.8 77.2 65.4 3.7 206.0 29.4 23.2 13.3 51.7 32.5 20.8 46.0 4.4 7.2 47.8 65.3 17.6 47.4 60.0 1.3 26.1 15.0 148.4 16.3 151.4 7.6 80.2 24.4 4.7 4.6 6.0 17.7 5.2 10.6 8.4 2.4 45.7 1.0 6.6 5.8 50.4 78.5 18.8 1.2 23.2 72.3 30.2 25.9 54.3 6.6 17.3 24.5 1.6 9.0 24.3 10.5 79.8 4.2 44.3 75.3 18.2 NR5A1 "AD4BP, ELP, FTZ1, FTZF1, hSF-1, SF-1, SF1" ENSG00000136931 "Nuclear receptor subfamily 5 group A member 1" Q13285 9 124481236-124507420 "Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Disease variant, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 188.3;lymphoid tissue: 142.8" "Group enriched" "Detected in some" 8 "Granulosa cells: 47.9;Theca cells: 180.1" "Group enriched" "Detected in some" 5 "head and neck cancer: 1.7;ovarian cancer: 2.4;testis cancer: 2.6" "Region enriched" "Detected in some" 9 "thalamus: 18.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 82.9;Hep G2: 59.2;K-562: 20.6" "Region enriched" "Detected in single" 52 "hypothalamus: 5.2" "Region enriched" "Detected in single" 8 "hypothalamus: 1.2" HPA079181 Supported Nucleoplasm,Cytosol NA NA "Cluster 64: Macrophages - Immune response" "Cluster 36: HEL - Hemostasis" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA079181: " "unprognostic (1.66e-1)" "unprognostic (3.08e-1)" "unprognostic (6.13e-5)" "unprognostic (2.32e-7)" "unprognostic (3.95e-1)" "unprognostic (1.16e-1)" "unprognostic (1.13e-1)" "unprognostic (1.61e-1)" "unprognostic (1.60e-2)" "unprognostic (9.74e-2)" "unprognostic (4.14e-2)" "unprognostic (4.75e-3)" "unprognostic (1.14e-1)" "unprognostic (1.49e-2)" 0.1 188.3 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 2.0 0.0 0.1 0.0 0.1 0.0 0.0 35.8 0.0 0.0 21.1 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 142.8 0.1 14.1 18.3 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 82.9 0.0 59.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.6 0.1 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.2 2.0 0.0 0.0 0.3 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.9 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 47.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 11.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 1.4 0.3 0.2 0.0 0.0 0.0 0.0 180.1 0.0 0.0 NRF1 "ALPHA-PAL, EWG" ENSG00000106459 "Nuclear respiratory factor 1" Q16656 7 129611720-129757082 "Metabolic proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Astrocytes: 127.0;Excitatory neurons: 115.4;Inhibitory neurons: 109.4;Microglial cells: 75.9;Oligodendrocyte precursor cells: 143.2;Oligodendrocytes: 122.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029329 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm Cytosol "HPA029329: AB_10601240" "unprognostic (2.80e-2)" "unprognostic (2.20e-3)" "unprognostic (4.51e-1)" "unprognostic (4.04e-2)" "unprognostic (2.01e-1)" "unprognostic (4.20e-3)" "prognostic unfavorable (6.02e-4)" "unprognostic (1.09e-1)" "unprognostic (2.13e-2)" "unprognostic (3.69e-2)" "unprognostic (1.18e-3)" "unprognostic (2.99e-3)" "unprognostic (1.83e-2)" "unprognostic (2.06e-1)" "unprognostic (6.52e-2)" "unprognostic (4.20e-1)" "unprognostic (2.06e-3)" 8.3 5.6 9.2 7.9 9.9 16.7 7.9 13.3 11.1 10.8 11.5 8.8 6.4 9.9 6.4 7.2 12.8 5.5 9.4 9.3 10.7 9.0 6.1 8.0 12.3 11.1 10.6 16.6 7.3 8.5 7.7 7.0 10.1 8.0 6.8 12.7 7.5 6.2 15.6 9.3 8.3 7.7 9.1 10.3 6.7 5.6 10.2 18.0 9.7 8.8 11.1 8.7 8.0 13.0 15.9 12.8 18.1 15.9 10.7 8.5 14.4 10.9 11.2 16.3 12.6 15.6 10.4 18.3 7.8 12.3 10.2 11.9 19.7 11.0 16.5 17.5 14.1 15.1 11.0 10.3 7.8 18.7 14.5 7.3 10.2 16.1 15.5 9.4 12.1 17.4 18.6 13.7 10.1 14.5 36.9 17.6 16.9 14.5 11.3 23.2 14.6 16.2 9.2 11.5 15.6 17.1 16.4 16.8 11.0 14.7 10.5 17.4 9.4 9.2 12.6 10.8 20.3 14.7 15.7 32.0 9.7 17.0 18.1 5.6 4.2 10.6 8.2 5.2 9.8 5.5 6.3 7.7 5.5 5.9 6.8 6.0 8.8 5.0 5.8 3.6 7.2 5.8 9.2 9.9 13.3 11.1 9.3 10.7 11.1 10.6 10.1 9.1 10.2 13.0 6.8 3.2 6.5 127.0 15.8 6.6 3.2 3.4 4.6 10.8 5.4 5.1 6.2 2.8 4.8 3.7 10.4 2.8 11.3 5.5 0.0 2.3 0.4 8.9 6.4 7.1 6.7 3.0 115.4 3.6 4.1 6.0 7.1 5.7 5.1 6.9 7.1 4.1 3.1 10.1 109.4 5.3 4.1 7.7 9.5 1.9 5.3 5.4 5.4 75.9 4.0 6.4 12.3 143.2 122.3 3.0 10.2 4.5 14.2 6.8 3.7 2.3 13.1 11.2 6.6 10.0 6.4 9.0 6.6 6.2 7.7 3.4 13.8 2.3 4.2 5.4 NRL "D14S46E, NRL-MAF, RP27" ENSG00000129535 "Neural retina leucine zipper" P54845 14 24078662-24115010 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" "Activator, Developmental protein, DNA-binding" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 75 "retina: 317.3" "Cell type enriched" "Detected in many" 5 "Rod photoreceptor cells: 3720.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SuSa: 4.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB026066, HPA064599" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 79: Retina - Phototransduction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 46: Photoreceptor cells - Phototransduction" Nucleoplasm Cytosol "CAB026066: , HPA064599: AB_2685295" "unprognostic (2.71e-2)" "unprognostic (8.17e-4)" "unprognostic (4.60e-2)" "unprognostic (1.80e-1)" "unprognostic (7.23e-2)" "unprognostic (1.99e-2)" "unprognostic (5.29e-2)" "unprognostic (1.88e-5)" "unprognostic (3.59e-2)" "unprognostic (7.84e-3)" "unprognostic (1.75e-3)" "unprognostic (3.49e-2)" "unprognostic (2.38e-5)" "unprognostic (2.56e-2)" "unprognostic (1.10e-1)" "unprognostic (1.73e-1)" "unprognostic (1.35e-3)" 0.8 2.5 1.7 0.5 1.5 0.5 1.0 2.3 2.2 1.1 0.6 0.9 1.1 1.1 0.7 1.1 1.0 0.9 2.2 1.5 1.5 3.1 3.6 1.0 1.0 2.3 1.8 1.2 1.7 1.9 2.4 0.3 1.7 1.5 0.3 317.3 1.0 0.7 2.5 0.7 1.3 0.3 1.7 2.1 1.2 4.2 1.6 1.2 2.7 1.4 0.7 1.1 0.8 1.7 0.3 1.2 1.6 1.6 0.3 0.2 0.4 0.3 0.3 0.5 0.3 0.7 0.5 1.2 0.4 0.5 1.0 0.5 0.6 0.3 0.2 0.6 0.5 0.7 0.6 2.2 0.6 1.4 1.6 0.4 0.5 0.2 0.7 0.7 0.5 2.2 0.7 1.2 0.3 0.9 1.2 0.6 1.8 1.8 0.9 1.2 1.5 0.0 0.4 1.3 1.7 1.2 0.8 0.7 0.8 4.8 0.9 1.5 0.4 1.1 0.5 0.1 0.7 3.6 1.9 1.5 0.3 0.9 1.1 0.2 0.3 1.3 0.2 0.4 0.1 1.0 0.2 0.4 0.3 0.7 0.8 0.6 0.1 0.5 0.3 0.4 0.2 0.3 1.7 1.5 2.3 2.2 1.5 1.5 2.3 1.8 1.7 1.7 1.6 1.7 1.4 0.0 0.5 5.5 6.2 0.8 1.6 0.1 1.2 434.4 2.0 1.9 2.1 0.0 0.7 7.3 431.6 1.4 3.2 1.5 13.7 0.6 2.7 1.3 0.7 24.1 1.8 3.2 1.8 1.1 0.9 0.7 2.6 1.0 0.0 0.7 0.7 3.3 2.0 250.7 2.6 1.7 0.0 1.3 0.4 4.2 1.2 1.4 1.8 0.0 1.1 636.4 5.2 2.0 4.4 0.3 5.3 1.9 1.7 2.0 5.6 6.7 0.1 3720.7 0.0 1.2 0.7 9.7 4.3 2.2 0.4 2.5 2.6 2.3 1.0 2.1 NUDCD2 "DKFZp686E10109, NudCL2" ENSG00000170584 "NudC domain containing 2" Q8WVJ2 5 163446526-163460102 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037384, HPA037385" Uncertain Supported "Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes NA 18000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" Microtubules "Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA037384: AB_2675447, HPA037385: AB_10673630" "unprognostic (3.96e-1)" "unprognostic (3.69e-2)" "prognostic favorable (2.80e-4)" "unprognostic (1.46e-1)" "unprognostic (9.12e-2)" "unprognostic (3.75e-3)" "unprognostic (1.84e-1)" "unprognostic (4.74e-1)" "unprognostic (3.47e-2)" "unprognostic (7.63e-3)" "unprognostic (1.81e-1)" "unprognostic (2.45e-1)" "unprognostic (3.91e-2)" "unprognostic (1.34e-2)" "unprognostic (6.86e-2)" "unprognostic (3.40e-2)" "unprognostic (7.85e-2)" 13.9 11.8 11.1 13.2 13.2 11.7 11.2 13.2 14.0 8.1 10.2 11.2 14.5 10.2 6.4 12.8 9.7 5.7 8.3 11.0 11.4 11.7 15.3 8.7 15.1 12.8 12.6 8.9 15.4 6.8 9.3 10.3 13.7 8.9 6.1 7.3 14.0 3.6 20.9 10.7 13.3 6.3 12.8 12.8 11.8 10.4 12.5 8.1 9.4 5.0 9.8 9.2 10.3 17.7 62.3 32.3 23.5 37.1 14.1 10.4 31.3 24.6 7.0 8.7 13.9 28.6 46.3 35.5 57.5 4.0 39.8 30.6 12.6 13.9 10.7 70.6 36.6 32.4 42.0 26.4 15.3 37.3 35.3 3.8 7.7 8.4 12.1 12.3 9.8 39.1 35.1 42.6 8.9 25.2 55.1 80.9 25.8 18.4 35.2 45.7 39.2 63.0 8.0 14.3 59.6 33.6 38.7 24.7 66.3 13.8 47.2 37.8 21.9 29.4 43.8 32.6 56.7 35.0 63.8 61.5 34.2 63.2 31.4 49.9 48.3 32.5 60.2 59.8 76.5 91.7 84.0 71.8 68.0 68.0 88.7 79.0 6.2 83.8 51.5 81.1 83.5 69.1 11.1 13.2 13.2 14.0 11.0 11.4 12.8 12.6 13.7 12.8 12.5 17.7 58.0 28.9 23.8 9.1 47.5 59.4 54.9 92.6 42.7 30.7 70.4 88.6 43.1 35.8 53.1 38.6 22.9 118.7 43.8 25.4 148.7 63.6 95.1 57.6 44.1 47.4 43.8 78.4 18.8 64.0 55.8 48.6 32.1 38.3 31.6 35.7 36.0 55.1 69.8 10.1 14.0 45.3 87.5 41.8 42.7 24.5 51.6 35.7 49.8 11.2 46.4 51.4 52.5 11.1 36.0 59.9 33.6 51.1 55.5 95.2 31.5 112.5 65.1 38.2 39.5 51.3 46.5 87.6 44.2 56.0 67.6 56.8 48.3 64.8 68.6 59.3 NUF2 "CDCA1, CT106, NUF2R" ENSG00000143228 "NUF2 component of NDC80 kinetochore complex" Q9BZD4 1 163266576-163355764 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 28.4;lymphoid tissue: 26.0;testis: 53.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 60.8;Spermatocytes: 208.2;Spermatogonia: 40.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in many" "T-reg: 4.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA059692, HPA076604" Supported Nucleoplasm,Kinetochore,Cytosol Yes Yes "Cluster 35: T-regs - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Kinetochore, Cytosol" "HPA059692: AB_2684103, HPA076604: " "unprognostic (9.41e-2)" "unprognostic (2.61e-1)" "unprognostic (2.56e-1)" "unprognostic (5.32e-3)" "unprognostic (6.20e-2)" "unprognostic (3.77e-2)" "prognostic unfavorable (1.04e-5)" "prognostic unfavorable (9.16e-4)" "prognostic unfavorable (4.83e-4)" "unprognostic (8.45e-2)" "prognostic unfavorable (9.75e-4)" "unprognostic (3.70e-2)" "unprognostic (0.00e+0)" "unprognostic (9.79e-2)" "unprognostic (7.88e-2)" "unprognostic (2.69e-1)" "unprognostic (5.96e-2)" 0.8 0.6 0.5 6.9 0.8 28.4 1.2 0.5 0.8 1.0 0.4 4.2 4.3 1.1 0.3 5.8 0.4 1.0 0.3 0.6 0.6 0.3 0.7 0.9 18.2 0.9 0.8 0.4 0.2 0.6 0.2 4.7 0.9 0.4 5.3 1.5 0.9 0.3 0.1 4.1 4.3 2.3 0.7 3.6 2.6 53.5 0.8 26.0 0.5 0.2 16.7 1.8 1.8 1.0 90.8 30.8 80.5 33.9 2.5 8.1 43.6 55.9 39.3 88.9 77.3 23.7 77.7 77.4 45.5 22.6 37.0 51.6 49.6 21.0 111.5 81.4 35.6 30.3 34.8 34.4 0.3 53.0 60.2 1.0 2.0 45.0 31.6 16.8 41.1 74.5 58.1 103.9 85.0 17.6 97.3 70.6 43.9 66.1 47.0 65.0 70.3 68.4 25.3 12.4 59.9 68.9 29.9 32.2 30.6 49.7 49.3 109.5 29.4 65.9 73.8 50.1 115.1 73.9 111.5 148.9 22.0 42.9 74.7 1.4 0.1 1.3 1.2 0.0 0.5 0.6 1.8 1.2 0.2 0.7 1.2 1.0 0.4 1.8 0.1 0.3 4.3 0.4 0.5 0.8 0.5 0.8 0.6 0.6 0.9 0.8 0.9 0.7 0.8 1.0 0.5 0.0 0.5 1.3 5.3 5.9 1.9 4.2 1.2 1.2 1.3 2.7 0.9 0.0 3.3 0.0 0.0 21.7 3.6 2.6 0.0 0.8 17.7 2.5 2.5 1.8 0.0 60.8 1.1 0.2 29.7 3.4 5.6 3.0 4.5 18.3 3.3 0.4 14.0 0.0 1.4 3.3 0.0 5.2 3.6 21.4 2.5 3.1 0.0 1.0 0.9 2.0 6.2 0.5 3.6 0.2 0.1 2.2 17.8 0.8 0.9 0.2 0.7 2.3 6.6 0.9 4.2 208.2 40.3 10.6 2.4 4.0 5.0 1.7 9.0 3.8 NUP188 KIAA0169 ENSG00000095319 "Nucleoporin 188" Q5SRE5 9 128947699-129007096 "Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Cataract, Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 45.9;Spermatocytes: 52.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061750, HPA063942" Approved Uncertain Nucleoplasm,Nucleoli,Cytosol No No "Cluster 44: Non-specific - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm "Nucleoli, Cytosol" "HPA061750: AB_2684602, HPA063942: AB_2685156" "unprognostic (4.64e-1)" "unprognostic (6.91e-3)" "unprognostic (2.36e-1)" "prognostic favorable (5.20e-5)" "unprognostic (9.50e-2)" "unprognostic (4.41e-2)" "unprognostic (1.85e-3)" "unprognostic (1.91e-1)" "unprognostic (1.47e-1)" "unprognostic (1.63e-1)" "unprognostic (7.78e-2)" "unprognostic (4.53e-2)" "unprognostic (1.01e-1)" "unprognostic (4.68e-2)" "unprognostic (2.87e-1)" "unprognostic (2.81e-3)" "unprognostic (3.53e-3)" 13.1 15.5 9.5 16.2 10.9 21.4 11.9 13.1 10.0 15.6 10.0 14.8 7.5 13.1 8.0 23.7 11.9 9.4 13.6 9.0 9.7 10.4 9.9 16.7 18.0 11.4 11.1 11.4 12.0 13.1 14.9 11.8 11.8 13.5 11.5 13.7 13.9 9.8 15.7 21.4 13.4 13.9 9.3 16.8 13.6 56.6 10.9 27.3 12.6 10.3 20.4 16.1 15.6 11.7 33.6 62.6 50.8 69.7 37.7 37.2 45.4 45.9 35.9 82.1 54.4 76.3 26.2 58.2 16.7 50.7 52.9 96.6 115.2 56.8 61.0 47.1 55.5 51.9 113.3 60.8 23.9 89.6 50.2 26.0 26.3 86.5 43.8 24.1 47.8 74.1 116.0 40.3 58.8 84.6 77.3 36.5 68.2 63.8 59.4 69.9 109.8 59.2 25.5 37.3 71.2 34.3 118.8 44.7 17.1 37.2 49.3 32.7 39.0 67.7 48.2 69.2 83.5 34.1 67.9 76.9 39.5 56.3 51.2 8.2 4.8 1.7 7.5 8.9 9.7 4.9 6.4 7.4 6.8 4.3 6.4 7.0 0.6 5.4 5.2 2.9 8.3 6.8 9.5 10.9 13.1 10.0 9.0 9.7 11.4 11.1 11.8 9.3 10.9 11.7 9.6 0.0 12.6 15.7 10.4 6.5 6.6 6.4 5.7 16.2 7.6 7.6 3.5 10.0 5.9 5.5 45.9 8.0 8.6 6.0 1.9 6.1 14.5 7.9 13.2 9.4 9.1 8.6 11.3 6.5 6.5 9.5 9.7 12.2 6.3 24.0 11.0 5.0 8.4 20.2 13.1 7.2 6.1 4.7 6.1 5.7 9.6 8.1 1.8 12.2 5.3 6.8 9.2 12.5 13.0 9.0 2.3 11.7 8.3 10.1 3.3 2.5 6.3 24.4 26.3 18.2 7.1 52.9 37.8 13.6 11.2 8.6 9.4 12.5 7.4 8.2 NUP43 "bA350J20.1, FLJ13287" ENSG00000120253 "Nucleoporin 43" Q8NFH3 6 149724315-149749665 "Metabolic proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 78.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027126, HPA027291, HPA028500" Enhanced Approved "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 16: Immune cells - Immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nuclear speckles" Cytosol "HPA027126: AB_10599301, HPA027291: AB_10601851, HPA028500: AB_10602287" "prognostic unfavorable (2.08e-4)" "unprognostic (3.02e-1)" "unprognostic (3.86e-2)" "unprognostic (1.45e-3)" "unprognostic (2.29e-1)" "unprognostic (8.19e-3)" "prognostic unfavorable (7.13e-7)" "unprognostic (5.14e-2)" "unprognostic (2.45e-1)" "unprognostic (2.35e-1)" "unprognostic (1.11e-1)" "unprognostic (1.06e-2)" "unprognostic (2.74e-2)" "unprognostic (6.25e-3)" "unprognostic (2.02e-1)" "unprognostic (2.72e-2)" "unprognostic (3.60e-2)" 8.4 8.6 6.2 11.4 7.5 6.2 13.6 7.2 6.9 9.7 6.5 9.4 8.7 9.8 7.5 9.5 8.2 6.4 10.8 5.6 6.6 9.9 9.6 8.0 15.9 6.6 6.6 9.1 12.2 8.9 5.6 11.4 6.9 10.3 9.7 9.8 8.8 9.2 14.2 13.5 10.9 9.4 6.6 13.6 9.8 7.9 6.5 12.8 11.1 11.6 17.0 9.0 9.1 8.3 21.1 34.9 31.1 49.6 20.0 23.7 48.9 36.3 20.3 34.0 43.0 49.5 19.5 61.4 36.6 20.2 32.1 33.5 54.6 31.6 58.3 27.8 38.2 70.9 35.5 49.6 13.4 73.2 44.1 15.3 16.4 49.9 33.1 13.0 27.5 34.6 71.4 33.6 29.6 20.7 52.2 30.4 28.3 24.1 21.0 50.2 43.2 20.6 23.2 28.9 12.9 21.2 43.4 27.1 14.2 25.6 28.7 30.9 21.3 28.3 30.2 41.2 53.9 20.5 43.3 63.9 25.2 49.3 40.5 2.9 4.9 3.4 3.5 5.4 3.8 4.3 4.2 3.5 2.6 6.2 4.3 5.5 1.9 3.7 4.8 5.0 4.9 2.2 6.2 7.5 7.2 6.9 5.6 6.6 6.6 6.6 6.9 6.6 6.5 8.3 5.8 3.2 7.8 9.1 11.5 7.9 5.5 4.7 2.8 11.9 4.5 5.0 14.3 11.5 5.2 3.7 6.2 10.9 11.3 4.7 3.9 9.0 33.3 4.3 8.7 5.7 10.2 7.6 4.8 7.8 12.2 6.4 6.1 6.0 0.0 12.8 8.2 4.4 7.8 6.7 5.1 6.9 2.0 11.9 6.9 78.9 10.2 6.5 8.8 9.4 15.1 10.5 9.2 11.1 17.4 6.6 2.3 10.5 8.7 6.2 3.9 5.4 4.2 9.5 13.1 6.9 22.1 7.1 9.2 5.5 8.5 6.6 7.6 7.4 8.4 6.7 OPRK1 "KOR, OPRK" ENSG00000082556 "Opioid receptor kappa 1" P41145 8 53225724-53251637 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 14.5" "Group enriched" "Detected in some" 5 "Endometrial ciliated cells: 4.5;Excitatory neurons: 6.7;Extravillous trophoblasts: 8.0;Glandular and luminal cells: 9.8;Inhibitory neurons: 10.1;Leydig cells: 4.7" "Cancer enhanced" "Detected in some" "prostate cancer: 1.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-937: 21.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067549 Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 65: Brain - Ion transport" "Cluster 32: U-937 - Innate immune response" "Cluster 44: Endometrium - Transcription" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA067549: AB_2732770" "unprognostic (1.01e-1)" "unprognostic (1.17e-2)" "unprognostic (8.70e-3)" "unprognostic (3.73e-2)" "unprognostic (6.74e-2)" "unprognostic (2.22e-3)" "unprognostic (8.09e-2)" "unprognostic (9.71e-2)" "unprognostic (4.28e-3)" "unprognostic (3.29e-1)" "unprognostic (3.35e-2)" "unprognostic (9.54e-4)" "unprognostic (1.61e-1)" 0.1 0.1 7.3 0.0 14.5 0.0 0.0 1.3 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.9 5.4 0.0 0.0 0.1 0.0 5.8 1.7 0.0 0.0 0.0 0.0 0.2 5.1 1.6 0.0 0.6 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.7 6.9 0.1 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 21.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 14.5 1.3 8.3 3.9 5.4 5.8 1.7 5.1 0.3 6.9 2.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.6 1.3 0.0 0.0 0.0 0.2 4.5 0.6 0.1 0.0 0.0 6.7 0.0 8.0 0.1 0.0 9.8 0.0 0.0 0.0 0.0 0.2 0.0 10.1 0.0 0.0 0.0 0.0 0.3 4.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 1.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 OR6B2 OR6B2P ENSG00000182083 "Olfactory receptor family 6 subfamily B member 2" Q6IFH4 2 240028965-240030456 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047529 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA047529: AB_2680077" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6B3 "OR6B3P, OR6B3Q" ENSG00000178586 "Olfactory receptor family 6 subfamily B member 3" Q8NGW1 2 240045077-240047027 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 13 "retina: 20.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047529 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 77: Retina - Visual perception" "Plasma membrane" Cytosol "HPA047529: AB_2680077" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OXSM "CEM1, FASN2D, FLJ20604, KS" ENSG00000151093 "3-oxoacyl-ACP synthase, mitochondrial" Q9NWU1 3 25782917-25794534 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 59.5;Spermatocytes: 48.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021293, HPA021300, HPA021337" Enhanced Approved Mitochondria,Cytosol No No "Cluster 24: B-cells - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Mitochondria, Cytosol" "HPA021293: AB_1848772, HPA021300: AB_1848774, HPA021337: AB_1848776" "unprognostic (2.20e-2)" "unprognostic (3.28e-1)" "prognostic favorable (1.35e-4)" "prognostic favorable (5.51e-4)" "unprognostic (1.01e-1)" "unprognostic (8.17e-2)" "unprognostic (2.15e-3)" "unprognostic (1.41e-1)" "unprognostic (1.76e-1)" "unprognostic (2.83e-2)" "unprognostic (3.06e-2)" "unprognostic (1.20e-1)" "prognostic favorable (4.18e-9)" "unprognostic (1.79e-2)" "unprognostic (2.42e-1)" "unprognostic (3.10e-1)" "unprognostic (1.73e-2)" 6.1 11.0 3.1 5.5 3.4 4.0 9.3 3.5 4.6 4.9 5.3 11.1 9.4 4.6 13.9 8.5 6.8 3.9 12.9 3.3 3.6 13.7 22.0 4.9 7.9 3.3 3.3 4.9 10.5 10.0 5.8 5.9 3.4 5.9 12.3 10.2 10.1 5.9 14.6 7.7 7.8 5.2 3.5 7.9 8.2 11.7 3.5 7.1 8.6 15.6 8.8 5.5 5.3 3.4 11.0 18.1 3.8 10.5 10.7 11.6 10.9 8.6 12.4 15.8 11.2 13.8 12.9 20.4 11.5 8.0 9.2 11.3 15.7 16.6 14.9 12.3 16.0 22.5 15.2 16.9 13.1 18.4 13.7 11.0 20.4 12.7 13.3 10.3 13.8 18.9 23.5 16.0 13.7 16.6 13.6 14.4 0.7 8.8 20.6 17.8 9.9 33.7 23.3 6.8 5.4 9.7 13.8 23.6 18.3 6.0 25.5 16.9 8.5 10.0 11.9 13.1 12.7 15.1 18.8 6.6 13.9 16.0 10.4 2.1 5.1 3.7 8.6 6.0 10.1 7.9 8.8 10.8 8.4 8.9 10.2 10.7 0.8 11.4 6.8 8.8 6.0 6.3 3.1 3.4 3.5 4.6 3.3 3.6 3.3 3.3 3.4 3.5 3.5 3.4 5.9 0.0 9.4 3.9 9.3 3.1 5.9 23.0 4.0 6.5 8.7 13.2 13.3 10.0 12.0 11.0 4.2 19.5 7.1 5.4 11.7 13.5 59.5 7.8 7.2 4.9 2.4 2.1 4.5 6.8 16.9 5.9 4.6 6.4 10.1 13.0 7.5 17.4 8.5 5.0 5.1 9.8 14.2 3.8 3.2 15.1 7.2 6.8 5.4 1.0 5.2 9.1 6.2 3.5 3.8 7.5 8.9 4.1 7.8 6.5 10.6 18.4 9.2 7.4 0.0 5.3 5.8 48.0 12.6 7.2 4.4 14.1 5.9 19.2 8.8 3.6 P2RY2 P2U ENSG00000175591 "Purinergic receptor P2Y2" P41231 11 73218281-73242427 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 29.7;skeletal muscle: 50.2;tongue: 31.3" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 16.5;Distal enterocytes: 18.0;Pancreatic endocrine cells: 18.9;Proximal enterocytes: 14.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 57.6" "Group enriched" "Detected in many" 12 "granulocytes: 57.6;monocytes: 20.2" "Cell line enhanced" "Detected in many" "HaCaT: 32.8;HL-60: 30.8;MCF7: 25.1;NB-4: 26.1;PC-3: 24.5;SK-BR-3: 29.6;THP-1: 76.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB022642 Uncertain Uncertain Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 59: Non-specific - Translation" "Cluster 43: THP-1 - Innate immune response" "Cluster 47: Cytotrophoblasts - Unknown function" Cytosol "CAB022642: " "unprognostic (1.24e-1)" "unprognostic (1.13e-1)" "unprognostic (6.36e-2)" "unprognostic (7.97e-3)" "unprognostic (6.50e-4)" "unprognostic (2.04e-2)" "unprognostic (4.66e-3)" "unprognostic (8.93e-2)" "unprognostic (2.87e-1)" "unprognostic (4.17e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (9.69e-2)" "unprognostic (4.92e-4)" "unprognostic (1.34e-1)" "unprognostic (2.82e-1)" "unprognostic (1.05e-1)" "unprognostic (8.57e-3)" 0.8 3.8 1.4 1.8 1.6 15.8 1.7 1.3 1.0 6.9 1.1 3.3 2.7 0.5 0.3 29.7 1.4 0.7 10.0 1.3 1.8 2.7 3.9 3.5 0.1 2.1 1.9 0.4 0.7 4.8 1.6 2.0 1.6 2.1 2.8 1.2 6.2 1.2 50.2 6.0 5.9 0.5 1.3 3.9 1.1 1.2 2.6 0.2 8.8 31.3 2.8 2.2 19.0 1.4 7.2 6.7 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 17.2 5.4 0.0 10.4 0.4 0.0 32.8 0.9 15.2 0.0 0.0 0.6 2.3 0.6 3.2 0.1 30.8 0.0 0.0 6.8 2.3 0.5 0.0 1.4 0.0 1.4 0.0 0.0 25.1 0.1 26.1 0.4 6.8 24.5 0.0 0.0 1.1 2.4 17.9 0.0 0.0 0.5 29.6 0.0 0.2 12.9 76.5 10.2 0.0 0.3 0.0 0.0 1.0 0.4 0.0 0.0 5.6 0.0 0.5 6.6 57.6 0.0 20.2 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.3 0.0 13.5 0.0 0.0 2.5 1.4 1.6 1.3 1.0 1.3 1.8 2.1 1.9 1.6 1.3 2.6 1.4 0.7 3.2 0.5 0.0 0.2 3.7 8.6 13.2 1.2 0.7 2.8 0.5 6.1 5.7 10.3 0.0 0.0 16.5 0.0 18.0 1.9 5.8 6.0 1.4 0.1 1.5 0.0 0.8 0.0 6.3 1.3 0.7 0.5 0.8 0.0 1.2 0.0 5.2 2.6 0.0 0.0 5.1 0.0 3.7 0.7 8.8 0.0 4.5 0.0 0.0 2.8 6.0 0.0 0.0 0.1 18.9 10.9 0.0 0.2 5.3 14.2 0.3 2.8 0.4 0.0 0.8 1.4 0.1 0.1 12.6 7.2 10.9 0.1 0.1 3.0 11.7 P4HTM "EGLN4, FLJ20262, HIFPH4, P4H-TM, PH-4, PH4, PHD4" ENSG00000178467 "Prolyl 4-hydroxylase, transmembrane" Q9NXG6 3 48989889-49007153 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 155.3;Respiratory ciliated cells: 169.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007199 Supported Uncertain Vesicles,Cytosol NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 25: RPMI-8226 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" "Vesicles, Cytosol" "HPA007199: AB_1855272" "unprognostic (1.95e-2)" "unprognostic (3.12e-2)" "unprognostic (9.47e-2)" "prognostic favorable (8.18e-4)" "unprognostic (7.78e-2)" "unprognostic (1.05e-1)" "unprognostic (6.47e-2)" "unprognostic (2.02e-2)" "unprognostic (1.89e-2)" "unprognostic (3.78e-2)" "unprognostic (2.51e-3)" "unprognostic (1.54e-2)" "prognostic favorable (3.28e-5)" "unprognostic (1.10e-2)" "unprognostic (3.51e-1)" "unprognostic (2.60e-2)" "unprognostic (9.65e-3)" 13.3 37.1 50.6 4.9 53.3 5.9 12.4 44.3 67.9 18.4 89.7 14.7 12.1 17.6 18.7 8.2 39.8 11.2 26.2 53.5 57.3 29.8 11.9 15.7 6.5 52.2 49.6 20.0 38.5 39.4 75.9 11.0 51.5 18.5 7.4 16.4 19.6 16.8 15.2 10.1 13.0 7.4 45.8 10.7 25.1 23.6 53.3 5.5 26.5 11.3 3.8 12.8 13.1 49.6 8.6 27.9 4.8 0.1 15.5 17.6 0.4 16.8 24.6 13.2 14.8 6.3 55.6 8.1 15.8 21.6 10.5 4.8 12.5 6.6 4.1 30.4 19.5 0.0 42.1 0.0 38.6 8.3 0.2 11.0 6.3 13.4 1.1 51.4 15.0 0.1 0.0 37.9 6.5 48.1 1.2 1.0 6.8 52.6 31.2 0.0 0.0 53.5 24.4 15.9 20.9 0.2 17.7 25.0 0.1 1.1 20.1 13.1 9.9 8.0 6.1 19.9 14.5 50.0 28.6 0.1 54.9 0.7 7.1 8.0 9.0 5.9 6.7 3.5 9.6 8.4 12.3 11.7 9.4 15.9 13.0 8.3 0.8 5.9 4.5 1.6 17.0 6.0 50.6 53.3 44.3 67.9 53.5 57.3 52.2 49.6 51.5 45.8 53.3 49.6 15.1 22.4 17.3 36.2 16.1 9.2 34.6 41.1 12.5 72.9 28.7 23.0 12.0 41.5 44.0 46.0 87.6 31.4 13.4 27.4 19.6 38.3 138.4 106.4 23.7 12.6 80.9 12.4 55.7 39.1 9.9 28.1 48.9 31.2 22.9 31.6 15.4 8.5 16.8 117.8 48.6 40.4 65.1 6.3 12.8 155.3 30.4 13.0 12.4 20.6 11.3 58.4 14.4 17.1 32.3 23.6 51.8 25.9 28.9 24.4 56.2 30.4 169.4 72.5 19.7 32.9 24.7 32.5 7.0 12.9 10.4 26.1 25.0 23.9 40.9 31.2 PARM1 "Cipar1, DKFZP564O0823, WSC4" ENSG00000169116 "Prostate androgen-regulated mucin-like protein 1" Q6UWI2 4 74933095-75050115 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 181.9;Distal enterocytes: 398.3;Intestinal goblet cells: 109.7;Paneth cells: 132.1" "Cancer enhanced" "Detected in all" "thyroid cancer: 56.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 15 "memory B-cell: 8.1;myeloid DC: 4.0;naive B-cell: 5.6" "Group enriched" "Detected in many" 15 "B-cells: 8.1;dendritic cells: 4.0" "Cell line enhanced" "Detected in many" "ASC diff: 44.6;Karpas-707: 44.9;U-266/70: 49.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038236 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 46: Fibroblasts - ECM organization" "Cluster 2: Karpas-707 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Vesicles, Cytosol" "HPA038236: AB_10675789" "unprognostic (2.57e-2)" "unprognostic (5.20e-2)" "unprognostic (1.26e-3)" "unprognostic (8.61e-2)" "unprognostic (1.44e-1)" "unprognostic (8.49e-3)" "unprognostic (3.08e-1)" "unprognostic (2.42e-2)" "unprognostic (2.73e-1)" "unprognostic (9.74e-2)" "unprognostic (9.44e-2)" "unprognostic (3.51e-2)" "unprognostic (5.21e-2)" "unprognostic (1.96e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (2.23e-1)" 45.1 51.8 4.1 27.7 5.4 0.4 29.3 0.0 19.3 43.3 2.1 91.3 7.0 34.7 14.0 13.5 23.3 28.6 103.6 10.4 26.0 55.9 1.3 33.7 18.2 1.3 3.9 19.6 34.1 73.1 41.0 40.7 21.2 83.8 113.4 6.0 39.4 64.5 21.0 11.1 15.7 48.2 0.0 15.3 13.4 12.0 4.1 17.3 123.7 18.1 20.9 44.9 25.0 0.0 1.1 1.9 1.7 0.0 44.6 0.3 0.2 0.0 0.2 0.0 0.0 3.9 0.3 0.0 0.2 0.0 0.1 0.1 15.1 0.0 0.0 0.2 3.3 0.0 0.0 0.0 7.4 0.0 1.3 1.0 0.0 0.0 0.0 0.1 0.0 3.8 0.0 44.9 0.8 0.5 5.2 0.2 4.3 0.0 2.7 0.0 4.1 11.8 0.2 9.5 2.8 0.1 0.1 0.3 0.0 1.8 0.0 0.0 0.0 2.7 2.9 0.3 4.2 49.8 5.1 12.9 4.7 0.0 0.7 0.0 0.1 0.0 0.0 0.3 0.0 8.1 0.0 0.0 4.0 5.6 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.5 4.1 5.4 0.0 19.3 10.4 26.0 1.3 3.9 21.2 0.0 4.1 0.0 44.8 16.0 84.1 2.9 11.6 3.2 27.2 6.5 4.0 7.0 4.0 3.4 181.9 31.5 10.4 0.0 0.0 0.3 0.1 398.3 3.9 0.5 10.1 3.0 73.5 6.4 19.9 2.7 51.3 49.2 0.7 13.2 2.0 2.8 1.3 61.9 2.9 0.0 1.5 0.0 77.8 109.7 14.2 0.3 34.7 28.6 36.7 4.9 8.8 1.0 0.7 0.1 0.0 6.0 3.6 23.5 132.1 74.4 42.9 32.6 2.5 27.7 7.2 1.7 46.0 5.4 61.5 1.6 3.2 0.3 1.8 0.8 1.9 14.9 81.6 9.1 PATJ "Cipp, INADL" ENSG00000132849 "PATJ crumbs cell polarity complex component" Q8NI35 1 61742477-62178675 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 75.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 86.6;Alveolar cells type 2: 60.6;Club cells: 39.0;Collecting duct cells: 57.0;Endometrial ciliated cells: 55.7;Glandular and luminal cells: 98.3;Pancreatic endocrine cells: 47.9" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 75.0" "Immune cell enhanced" "Detected in many" "eosinophil: 7.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 36.3;RPTEC TERT1: 30.3;RT4: 33.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 72.3" "HPA066352, HPA066960, HPA069079" Approved Supported "Cell Junctions,Centriolar satellite,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 54: Non-specific - Microtubule organization" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 44: Endometrium - Transcription" "Cell Junctions" "Centriolar satellite, Cytosol" "HPA066352: AB_2685663, HPA066960: AB_2685755, HPA069079: AB_2686079" "unprognostic (1.81e-1)" "unprognostic (5.70e-3)" "unprognostic (1.75e-2)" "unprognostic (2.32e-1)" "unprognostic (1.34e-1)" "unprognostic (1.35e-1)" "unprognostic (7.96e-2)" "unprognostic (7.60e-2)" "unprognostic (1.88e-1)" "unprognostic (9.90e-2)" "unprognostic (3.39e-3)" "unprognostic (2.99e-2)" "prognostic favorable (1.47e-5)" "unprognostic (3.05e-3)" "unprognostic (6.72e-3)" "unprognostic (2.21e-2)" "unprognostic (2.43e-1)" 3.4 7.2 6.8 3.6 5.4 3.5 18.1 75.0 5.3 8.4 25.3 12.2 8.9 5.8 26.5 19.3 8.3 7.1 45.2 3.8 9.2 27.5 12.4 10.0 2.9 12.8 9.0 6.8 12.4 20.0 10.9 3.5 14.2 12.3 11.1 15.8 20.0 7.9 45.4 22.4 9.3 3.5 11.5 3.1 10.2 5.1 9.1 4.0 13.1 16.1 6.2 7.9 13.2 9.5 36.3 7.0 2.3 3.2 1.3 3.3 29.5 2.1 2.8 2.2 3.0 12.5 13.2 0.2 9.1 4.4 18.7 21.1 5.1 18.9 3.8 3.5 8.8 0.2 10.4 11.3 2.9 0.1 0.2 1.2 19.7 3.7 8.0 5.3 1.2 0.0 0.0 0.0 1.9 12.6 0.1 0.1 12.0 16.4 1.9 0.1 2.8 5.2 30.3 33.4 6.1 2.0 8.8 29.4 7.7 23.7 23.7 0.3 0.3 1.8 4.3 0.2 4.2 1.4 2.7 4.8 1.7 0.0 0.5 0.4 0.0 7.2 1.2 0.1 2.3 1.2 2.0 1.7 0.0 1.1 2.6 1.7 0.6 2.6 0.1 0.2 1.9 0.6 6.8 5.4 75.0 5.3 3.8 9.2 12.8 9.0 14.2 11.5 9.1 9.5 6.4 86.6 60.6 0.0 4.5 0.0 0.0 0.0 0.0 0.0 35.0 29.8 0.0 0.0 39.0 57.0 0.0 4.3 3.8 0.0 5.9 37.6 0.0 55.7 8.6 1.6 0.0 0.0 0.0 26.4 0.7 5.5 0.0 98.3 1.3 14.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.9 0.0 0.0 2.7 0.0 0.0 35.7 27.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 26.4 10.3 1.7 0.0 0.0 PAX5 BSAP ENSG00000196092 "Paired box 5" Q02548 9 36833269-37034268 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "lymphoid tissue: 39.7" "Cell type enriched" "Detected in some" 29 "B-cells: 91.3" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "midbrain: 6.5" "Group enriched" "Detected in some" 43 "memory B-cell: 39.0;naive B-cell: 26.0" "Lineage enriched" "Detected in single" 52 "B-cells: 39.0" "Group enriched" "Detected in some" 9 "Daudi: 66.6;REH: 194.1;U-698: 87.1" "Region enriched" "Detected in single" 11 "midbrain: 3.9" "Low region specificity" "Detected in all" "CAB026269, CAB026869, HPA056394, HPA068498" Enhanced Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" NA NA "Cluster 37: B-cells - Transcription" "Cluster 16: Immune cells - Immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 57: B-cells - Immune response" Nucleoplasm "Nucleoli fibrillar center, Vesicles, Cytosol" "CAB026269: , CAB026869: , HPA056394: AB_2683116, HPA068498: AB_2685997" "unprognostic (4.69e-4)" "unprognostic (3.83e-1)" "unprognostic (9.13e-2)" "unprognostic (1.42e-1)" "unprognostic (2.65e-2)" "unprognostic (1.15e-1)" "unprognostic (2.09e-2)" "unprognostic (2.95e-2)" "unprognostic (2.48e-1)" "unprognostic (2.00e-2)" "unprognostic (1.03e-1)" "unprognostic (2.46e-2)" "unprognostic (1.11e-3)" "unprognostic (3.15e-1)" "unprognostic (8.96e-2)" "unprognostic (6.03e-2)" "unprognostic (1.01e-1)" 0.3 0.1 0.4 14.9 0.3 9.4 0.1 0.5 0.5 0.0 0.2 0.8 0.5 0.2 0.1 0.2 0.0 0.8 0.2 0.3 0.6 0.1 0.2 0.3 39.7 1.1 6.5 0.0 0.0 0.0 0.2 0.1 4.1 0.3 0.8 0.5 1.0 0.0 3.1 0.0 6.6 0.0 0.8 18.7 1.6 0.6 1.9 2.8 0.2 0.0 36.2 1.1 0.0 0.3 0.1 0.3 5.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 66.6 0.1 0.0 0.1 0.2 0.1 0.0 0.0 3.5 0.1 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.5 0.1 0.3 1.9 0.3 0.4 194.1 0.4 0.3 0.0 0.0 13.2 2.9 0.1 0.7 0.0 0.0 0.0 7.5 0.2 0.0 0.2 0.1 0.0 0.2 0.1 87.1 0.0 1.5 0.1 0.7 0.0 0.1 0.0 0.1 0.1 39.0 0.0 0.0 0.1 26.0 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.7 0.4 0.3 0.5 0.5 0.3 0.6 1.1 6.5 4.1 0.8 1.9 0.3 0.0 0.0 0.0 0.7 91.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.4 0.6 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.4 0.0 0.0 0.5 0.1 0.0 0.3 0.0 3.1 0.0 0.9 0.0 0.0 0.2 0.5 0.0 0.0 0.3 0.0 0.1 0.0 2.7 0.4 0.0 0.1 0.0 0.1 0.0 0.8 0.1 0.6 0.2 0.2 0.0 0.0 2.0 0.0 0.0 0.3 PCDH8 "ARCADLIN, PAPC" ENSG00000136099 "Protocadherin 8" O95206 13 52842889-52848641 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "brain: 28.4" "Cell type enhanced" "Detected in some" "Bipolar cells: 18.2;Excitatory neurons: 24.8;Inhibitory neurons: 18.6;Muller glia cells: 25.8" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Region enhanced" "Detected in many" "hippocampal formation: 28.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "AF22: 23.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010509 Uncertain Uncertain "Golgi apparatus,Cytosol" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 12: NES - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" Cytosol "HPA010509: AB_10601384" "unprognostic (3.50e-3)" "unprognostic (6.48e-2)" "unprognostic (1.40e-1)" "unprognostic (9.11e-4)" "unprognostic (2.12e-2)" "unprognostic (1.97e-2)" "unprognostic (7.01e-2)" "unprognostic (1.13e-1)" "unprognostic (1.17e-1)" "unprognostic (3.59e-1)" "unprognostic (1.21e-2)" "unprognostic (1.07e-1)" "unprognostic (1.32e-1)" 0.0 0.0 5.8 0.0 12.1 0.0 0.0 0.0 19.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 4.5 0.0 0.0 0.0 0.0 1.1 1.2 0.0 0.0 0.0 1.4 0.0 1.3 1.0 0.0 0.6 0.1 0.0 0.1 0.1 0.0 0.0 5.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 12.1 0.0 19.7 28.4 4.5 1.1 1.2 1.3 5.0 0.0 0.0 0.1 0.0 0.0 5.9 0.0 0.1 2.1 0.0 0.0 18.2 0.4 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.6 0.0 0.1 0.0 0.0 24.8 0.0 0.0 0.3 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 18.6 0.1 0.0 0.0 0.0 1.1 0.0 0.1 0.0 3.7 0.0 25.8 0.0 2.5 2.2 0.0 0.1 0.4 0.0 0.6 0.0 0.0 0.0 1.6 0.0 0.4 0.1 2.7 2.8 0.0 0.0 0.0 0.0 0.0 0.1 1.1 PCDHB4 PCDH-BETA4 ENSG00000081818 "Protocadherin beta 4" Q9Y5E5 5 141121818-141125623 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 9.7;Endometrial stromal cells: 8.2;Fibroblasts: 9.5;Horizontal cells: 8.4;Peritubular cells: 6.4;Skeletal myocytes: 8.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "SCLC-21H: 8.7;SH-SY5Y: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014466 Approved Uncertain "Plasma membrane,Intermediate filaments,Cytosol" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 21: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane, Cytosol" "Intermediate filaments" "HPA014466: AB_1855058" "unprognostic (2.60e-1)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (2.22e-1)" "unprognostic (8.60e-3)" "unprognostic (4.03e-1)" "unprognostic (6.44e-2)" "unprognostic (2.44e-1)" "unprognostic (8.66e-2)" "unprognostic (1.52e-1)" "unprognostic (6.70e-3)" "unprognostic (1.44e-1)" "unprognostic (2.82e-3)" "unprognostic (1.11e-3)" "unprognostic (2.17e-1)" "unprognostic (3.32e-4)" "unprognostic (5.18e-3)" 3.2 2.1 2.7 0.7 3.0 0.0 3.4 3.3 3.7 3.6 0.3 2.0 0.6 5.4 3.8 1.5 4.0 2.4 2.3 3.2 4.2 1.5 0.3 2.1 0.4 5.0 3.7 4.2 8.5 1.4 2.7 0.1 5.7 2.4 0.9 1.6 2.1 1.9 1.6 1.3 0.9 3.3 5.0 0.7 1.3 0.5 2.7 0.4 1.5 2.1 0.2 2.1 2.1 6.7 0.0 0.0 0.3 1.4 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.7 5.8 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.7 3.0 3.3 3.7 3.2 4.2 5.0 3.7 5.7 5.0 2.7 6.7 9.7 0.0 0.5 0.0 0.0 1.1 0.4 0.2 0.6 4.9 2.6 3.8 1.2 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.4 8.2 4.3 0.0 0.0 0.0 1.7 0.0 9.5 0.0 0.3 0.0 0.1 3.6 0.0 0.1 8.4 0.0 0.0 2.0 0.0 1.1 0.0 1.5 0.1 1.8 0.0 0.0 2.0 0.0 0.0 0.0 0.6 0.0 6.4 0.0 0.7 0.0 0.0 2.5 0.6 0.0 8.7 4.0 1.4 0.5 0.0 2.0 0.0 0.0 0.5 0.0 0.4 PCDHGA1 PCDH-GAMMA-A1 ENSG00000204956 "Protocadherin gamma subfamily A, 1" Q9Y5H4 5 141330571-141512981 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.2" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Bipolar cells: 2.4;Cardiomyocytes: 1.8;Horizontal cells: 3.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "LHCN-M2: 4.5;T-47d: 7.3;WM-115: 3.3" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA036547" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 6: T47d - Mammary gland" "Cluster 37: Myocytes - Muscle contraction" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA036547: AB_10669798" "unprognostic (9.50e-4)" "unprognostic (2.39e-2)" "unprognostic (9.88e-2)" "unprognostic (4.42e-3)" "unprognostic (3.39e-1)" "unprognostic (3.97e-2)" "unprognostic (2.42e-1)" "unprognostic (5.61e-3)" "unprognostic (1.70e-2)" "unprognostic (6.89e-2)" "unprognostic (2.86e-1)" "unprognostic (1.03e-1)" "unprognostic (1.07e-3)" "unprognostic (4.76e-2)" "unprognostic (1.38e-1)" "unprognostic (2.73e-2)" "unprognostic (1.45e-3)" 0.3 0.2 1.1 0.2 2.3 0.2 0.2 3.2 2.0 0.5 0.0 0.5 0.2 0.6 0.9 0.2 0.4 0.1 1.2 2.2 0.9 0.2 0.1 0.3 0.1 1.5 1.4 0.6 0.5 0.5 0.9 0.5 0.9 0.3 0.2 1.0 0.2 0.2 0.7 0.3 0.1 0.4 1.7 0.2 0.1 0.7 1.4 0.1 0.2 0.4 0.1 0.4 0.3 1.3 0.0 0.2 0.3 1.1 0.7 1.3 0.1 1.1 0.7 0.3 0.6 0.3 0.1 0.2 1.8 0.7 0.5 0.1 0.1 0.2 0.7 0.1 0.1 0.1 0.2 0.1 0.2 0.0 0.1 1.1 0.3 0.0 0.4 2.1 0.0 0.1 0.1 0.5 4.5 0.0 0.1 0.5 0.1 0.0 0.2 2.0 1.6 0.2 0.2 0.2 1.0 1.3 0.1 0.6 1.1 0.3 7.3 0.2 0.5 2.0 0.3 1.0 0.2 0.1 0.6 0.1 2.4 0.1 3.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.1 2.3 3.2 2.0 2.2 0.9 1.5 1.4 0.9 1.7 1.4 1.3 0.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 3.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.7 0.3 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 PCDHGA10 PCDH-GAMMA-A10 ENSG00000253846 "Protocadherin gamma subfamily A, 10" Q9Y5H3 5 141412987-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 27.7;Cone photoreceptor cells: 16.7;Horizontal cells: 23.5;Skeletal myocytes: 14.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 14.6;HSkMC: 16.1;T-47d: 19.7;U-2197: 11.6" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA077276" Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 6: T47d - Mammary gland" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077276: " "unprognostic (2.92e-1)" "unprognostic (2.17e-4)" "unprognostic (1.63e-1)" "unprognostic (3.33e-2)" "unprognostic (1.12e-1)" "unprognostic (3.05e-2)" "unprognostic (9.99e-2)" "unprognostic (1.06e-2)" "unprognostic (2.01e-1)" "unprognostic (2.02e-1)" "unprognostic (4.39e-2)" "unprognostic (2.03e-2)" "unprognostic (2.64e-3)" "unprognostic (2.32e-3)" "unprognostic (1.34e-1)" "unprognostic (2.06e-1)" "unprognostic (8.83e-3)" 1.6 1.6 3.5 0.4 3.2 0.1 1.1 4.1 2.4 1.3 0.8 1.0 0.8 1.3 0.7 1.7 1.3 1.4 1.0 2.7 3.8 0.5 1.5 1.3 0.4 3.3 3.1 1.3 0.6 2.1 0.8 3.6 3.4 1.4 0.9 2.5 1.8 1.8 1.1 2.0 1.0 1.1 4.2 0.9 2.0 0.5 3.9 0.4 2.1 0.3 0.5 0.8 1.3 3.8 0.0 0.0 14.6 7.5 6.3 2.7 6.9 2.6 0.1 3.6 5.6 0.3 0.9 0.8 9.6 3.7 0.2 0.4 3.5 2.4 2.8 0.9 0.1 0.0 0.3 0.0 2.5 1.5 0.3 16.1 0.4 2.4 1.0 0.4 1.4 0.3 0.0 0.1 9.0 0.1 0.1 0.4 1.4 0.0 0.1 0.2 1.2 0.0 2.4 0.1 2.0 0.7 0.4 0.1 0.4 3.5 19.7 1.9 3.3 6.7 0.4 11.6 0.1 0.2 1.2 0.1 3.4 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.5 3.2 4.1 2.4 2.7 3.8 3.3 3.1 3.4 4.2 3.9 3.8 5.8 0.0 2.0 0.0 0.9 0.1 2.3 0.6 1.2 27.7 2.2 2.2 3.4 1.5 1.6 1.8 16.7 2.1 1.3 0.7 0.0 1.0 0.0 1.3 7.7 4.8 1.2 0.4 0.0 1.4 1.3 4.8 1.5 2.0 1.3 1.0 4.6 1.7 1.0 23.5 0.0 1.6 0.0 0.0 0.0 0.2 3.4 0.7 1.8 0.0 0.0 5.7 0.0 0.0 0.0 3.1 0.4 2.2 0.5 2.8 0.4 0.5 0.0 6.7 6.6 14.9 3.7 0.4 0.7 1.2 0.4 0.4 0.5 3.0 1.3 1.5 PCDHGA11 PCDH-GAMMA-A11 ENSG00000253873 "Protocadherin gamma subfamily A, 11" Q9Y5H2 5 141421047-141512975 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;Bipolar cells: 2.5;Hepatic stellate cells: 1.1;Horizontal cells: 1.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 24.3;ASC TERT1: 25.9;GAMG: 47.4;hTERT-RPE1: 69.8;WM-115: 43.9" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.13e-2)" "unprognostic (1.78e-3)" "unprognostic (9.13e-2)" "unprognostic (1.15e-2)" "unprognostic (1.68e-2)" "unprognostic (2.62e-1)" "unprognostic (2.70e-2)" "unprognostic (1.16e-3)" "unprognostic (1.09e-1)" "unprognostic (1.95e-2)" "unprognostic (2.97e-1)" "unprognostic (2.22e-1)" "unprognostic (3.03e-2)" "unprognostic (3.74e-2)" "unprognostic (3.54e-1)" "unprognostic (4.34e-3)" "unprognostic (1.89e-1)" 0.8 0.7 1.4 0.7 1.8 0.0 0.6 5.1 1.3 0.8 0.7 1.0 0.2 0.7 0.3 0.7 0.9 0.5 1.6 2.1 2.3 0.5 0.4 0.6 0.4 1.8 1.2 1.1 0.5 0.3 0.6 2.2 2.1 0.5 0.3 3.1 0.7 0.7 1.1 1.7 0.4 0.8 2.4 0.3 0.4 0.8 1.9 0.3 0.8 0.5 0.3 0.6 0.8 2.9 0.0 0.0 0.7 2.4 24.3 25.9 0.9 5.5 10.6 4.2 6.6 0.1 0.2 0.6 9.1 5.6 47.4 3.7 0.1 0.6 6.6 0.2 2.4 0.1 0.1 0.0 4.0 0.4 0.0 19.0 0.3 7.4 0.1 69.8 6.5 1.2 0.0 0.1 0.1 0.0 0.0 0.3 2.9 0.0 0.1 17.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 21.3 9.9 0.5 3.2 7.9 0.8 0.1 0.6 0.1 0.0 0.4 0.0 0.1 0.0 43.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 1.8 5.1 1.3 2.1 2.3 1.8 1.2 2.1 2.4 1.9 2.9 0.5 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.7 0.1 0.5 0.8 0.0 0.0 0.0 0.2 0.3 0.5 0.0 0.1 0.0 0.2 1.1 0.0 0.4 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.4 0.0 0.3 0.0 0.1 0.0 0.6 0.0 0.6 0.3 0.1 0.1 0.7 0.0 0.1 0.0 0.2 0.1 0.1 PCDHGA12 "CDH21, FIB3, KIAA0588, PCDH-GAMMA-A12" ENSG00000253159 "Protocadherin gamma subfamily A, 12" O60330 5 141430507-141512975 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.0" "Cell type enhanced" "Detected in some" "Adipocytes: 2.2;Bipolar cells: 3.8;Cardiomyocytes: 1.6;Endometrial stromal cells: 2.3;Endothelial cells: 2.2;Fibroblasts: 3.2;Skeletal myocytes: 2.0" "Group enriched" "Detected in many" 5 "glioma: 1.7;melanoma: 5.8" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "memory B-cell: 1.2" "Lineage enriched" "Detected in single" 4 "B-cells: 1.2" "Cell line enhanced" "Detected in some" "BJ: 9.3;BJ hTERT+: 15.4;fHDF/TERT166: 23.3;HHSteC: 7.2;HSkMC: 16.5;TIME: 7.5" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA 21000 "Cluster 37: B-cells - Transcription" "Cluster 57: Non-specific - Angiogenesis" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.17e-3)" "unprognostic (2.71e-2)" "unprognostic (1.04e-2)" "unprognostic (2.67e-1)" "unprognostic (2.74e-1)" "unprognostic (5.06e-2)" "unprognostic (1.99e-1)" "unprognostic (9.01e-3)" "unprognostic (1.19e-1)" "unprognostic (4.65e-4)" "unprognostic (2.98e-1)" "unprognostic (3.02e-1)" "unprognostic (1.28e-4)" "unprognostic (8.30e-3)" "unprognostic (1.57e-1)" "unprognostic (2.42e-1)" "unprognostic (6.85e-3)" 3.0 4.3 5.3 0.8 6.8 0.0 1.5 5.5 3.7 2.0 0.8 1.3 0.2 2.6 0.4 1.0 1.9 3.9 4.2 5.1 8.4 1.0 0.7 3.1 0.4 10.0 4.2 1.9 1.1 0.3 1.4 2.2 4.5 1.0 0.3 1.4 0.9 1.5 1.3 1.7 0.8 1.7 5.5 1.2 1.0 0.3 5.2 0.9 1.6 1.1 0.4 1.2 2.0 4.6 0.0 0.0 0.1 1.9 0.8 1.4 0.1 9.3 15.4 0.0 0.0 0.0 0.0 0.5 0.0 23.3 0.1 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.2 0.0 0.0 16.5 0.0 4.5 0.0 0.0 5.4 0.0 0.0 0.0 3.2 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 2.6 7.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.3 6.8 5.5 3.7 5.1 8.4 10.0 4.2 4.5 5.5 5.2 4.6 2.2 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 3.8 0.2 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.3 2.2 0.0 0.0 0.0 0.2 0.0 3.2 1.1 0.1 0.0 0.1 0.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.3 0.0 0.0 0.0 0.7 0.0 2.0 1.0 0.0 0.0 0.4 0.0 0.0 0.1 0.7 0.0 0.0 PCDHGA2 PCDH-GAMMA-A2 ENSG00000081853 "Protocadherin gamma subfamily A, 2" Q9Y5H1 5 141338760-141512975 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 1.2;Bipolar cells: 3.2;Cardiomyocytes: 1.8;Fibroblasts: 1.5;Leydig cells: 1.2;Peritubular cells: 2.6;Skeletal myocytes: 1.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 6.4;BJ: 3.9;fHDF/TERT166: 4.4;HSkMC: 3.4;hTERT-RPE1: 3.9" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA038625" Approved Approved "Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol" NA NA "Cluster 21: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Vesicles, Plasma membrane" "Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA038625: AB_2732480" "unprognostic (2.43e-3)" "unprognostic (2.10e-2)" "unprognostic (1.32e-2)" "unprognostic (4.54e-1)" "unprognostic (2.92e-1)" "unprognostic (1.14e-1)" "unprognostic (3.01e-1)" "unprognostic (2.82e-1)" "unprognostic (1.56e-1)" "unprognostic (1.18e-1)" "unprognostic (9.01e-2)" "unprognostic (4.32e-2)" "unprognostic (8.45e-3)" "unprognostic (9.68e-3)" "unprognostic (1.04e-2)" "unprognostic (1.18e-2)" "unprognostic (2.23e-4)" 2.2 1.6 1.8 0.7 1.4 0.0 1.9 2.7 2.5 3.0 0.7 1.5 0.1 2.9 1.9 0.8 3.1 1.4 4.9 2.9 1.5 1.1 0.7 2.0 0.2 3.8 3.2 6.3 1.8 3.8 2.6 0.7 2.6 1.9 0.3 2.3 1.2 2.2 1.0 1.0 0.6 2.1 3.5 0.6 0.9 2.3 2.6 0.8 1.6 1.1 0.2 1.4 1.7 2.2 0.0 0.7 0.3 0.2 2.8 6.4 0.0 3.9 1.3 0.3 0.5 0.0 0.0 0.1 0.4 4.4 0.5 0.1 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 3.4 0.1 0.0 0.2 3.9 1.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.1 0.5 0.0 0.2 0.5 0.0 2.3 0.1 0.3 0.4 0.0 2.3 0.6 0.3 0.2 0.0 0.0 0.3 0.0 1.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.4 2.7 2.5 2.9 1.5 3.8 3.2 2.6 3.5 2.6 2.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 3.2 0.3 0.9 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 1.1 0.9 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.1 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 2.6 0.0 0.0 0.0 0.4 0.0 0.4 0.0 1.5 0.5 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGA3 PCDH-GAMMA-A3 ENSG00000254245 "Protocadherin gamma subfamily A, 3" Q9Y5H0 5 141343829-141512975 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Bipolar cells: 2.4;Cardiomyocytes: 1.6;Endometrial stromal cells: 1.9;Fibroblasts: 1.3;Horizontal cells: 3.3;Skeletal myocytes: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 7.1;BJ: 2.3;EFO-21: 5.7" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 12: NES - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (6.47e-2)" "unprognostic (4.79e-2)" "unprognostic (1.48e-2)" "unprognostic (1.64e-1)" "unprognostic (4.53e-2)" "unprognostic (1.03e-1)" "unprognostic (2.35e-1)" "unprognostic (1.85e-1)" "unprognostic (7.44e-2)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (3.17e-2)" "unprognostic (2.43e-1)" "unprognostic (2.32e-3)" "unprognostic (7.12e-3)" "unprognostic (3.31e-2)" "unprognostic (2.52e-4)" 1.2 1.2 2.6 0.2 1.7 0.0 0.9 2.2 2.6 1.6 0.1 0.7 0.0 1.4 0.9 0.2 1.2 0.9 3.7 2.5 1.8 0.5 0.6 0.9 0.0 3.8 2.9 2.5 0.9 0.6 1.2 1.7 2.2 0.7 0.2 1.8 0.7 0.8 0.8 0.5 0.2 0.9 3.4 0.2 0.4 1.5 2.9 0.2 0.8 0.9 0.1 0.8 0.9 2.5 0.0 0.0 7.1 0.0 0.0 0.9 0.0 2.3 0.2 0.0 0.0 0.0 0.0 0.0 5.7 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.3 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.7 2.2 2.6 2.5 1.8 3.8 2.9 2.2 3.4 2.9 2.5 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.1 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.9 0.9 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 1.6 0.9 0.1 0.5 0.0 0.0 0.1 0.0 0.4 0.0 0.0 PCDHGA4 PCDH-GAMMA-A4 ENSG00000262576 "Protocadherin gamma subfamily A, 4" Q9Y5G9 5 141355021-141512975 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.0;Skeletal myocytes: 1.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 7.4;BJ: 4.3;HSkMC: 4.3;HUVEC TERT2: 4.3;U-87 MG: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.27e-2)" "unprognostic (4.55e-3)" "unprognostic (2.00e-2)" "unprognostic (6.54e-4)" "unprognostic (1.87e-2)" "unprognostic (1.06e-2)" "unprognostic (1.02e-1)" "unprognostic (1.20e-2)" "unprognostic (5.62e-2)" "unprognostic (3.76e-1)" "unprognostic (6.31e-2)" "unprognostic (1.74e-1)" "unprognostic (2.94e-2)" "unprognostic (1.30e-2)" "unprognostic (2.30e-2)" "unprognostic (1.65e-1)" "unprognostic (2.31e-4)" 1.7 1.3 1.6 0.4 1.8 0.0 0.9 3.7 1.7 1.3 0.0 0.9 0.2 1.6 0.8 0.4 0.9 0.8 1.5 2.9 1.5 0.4 0.3 1.0 0.1 2.1 2.4 1.6 2.1 2.3 1.0 0.8 1.7 1.1 0.3 1.5 0.8 1.1 0.7 0.5 0.3 1.5 2.0 0.3 0.4 0.7 2.1 0.2 0.7 1.0 0.1 0.7 0.8 2.5 0.0 0.1 0.8 0.4 3.3 7.4 0.0 4.3 3.4 0.2 0.8 0.0 0.1 0.7 1.4 3.7 1.3 0.0 0.1 0.1 0.4 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.3 4.3 0.1 0.0 0.0 2.6 4.3 0.0 0.1 0.2 1.8 0.6 0.2 0.2 0.1 0.0 0.2 0.3 1.2 0.1 0.2 0.0 0.6 1.3 0.2 0.2 0.9 0.3 1.6 0.0 2.8 1.8 0.5 2.4 0.3 0.1 0.2 0.1 6.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.8 3.7 1.7 2.9 1.5 2.1 2.4 1.7 2.0 2.1 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 PCDHGA5 "CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5" ENSG00000253485 "Protocadherin gamma subfamily A, 5" Q9Y5G8 5 141364232-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 4.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 11.5;Endometrial stromal cells: 9.2;Horizontal cells: 10.1;Sertoli cells: 6.6;Skeletal myocytes: 5.7" "Cancer enhanced" "Detected in single" "prostate cancer: 1.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "ASC diff: 15.8;ASC TERT1: 6.2" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.61e-2)" "unprognostic (1.04e-2)" "unprognostic (5.28e-2)" "unprognostic (4.83e-1)" "unprognostic (6.60e-3)" "unprognostic (5.71e-2)" "unprognostic (8.46e-2)" "unprognostic (6.53e-3)" "unprognostic (4.07e-1)" "unprognostic (9.40e-2)" "unprognostic (1.38e-1)" "unprognostic (1.05e-1)" "unprognostic (1.12e-1)" "unprognostic (5.90e-2)" "unprognostic (3.93e-2)" "unprognostic (1.55e-2)" "unprognostic (8.38e-4)" 1.0 0.6 1.0 0.3 1.6 0.1 1.2 4.9 1.1 2.5 0.0 1.1 0.1 2.0 0.6 0.8 1.4 1.1 1.9 1.2 1.2 0.3 0.2 1.1 0.2 2.2 2.1 2.0 0.6 0.6 0.9 0.6 1.0 1.4 0.3 1.2 0.8 0.9 0.6 0.7 0.4 1.0 1.2 0.2 0.5 0.3 1.2 0.3 0.5 0.7 0.1 1.0 1.3 2.0 0.0 0.4 0.2 0.1 15.8 6.2 0.0 0.7 0.1 0.1 0.3 0.0 0.0 0.8 0.3 0.3 0.8 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.2 0.1 0.1 0.1 0.0 1.5 0.2 0.0 0.0 0.4 0.5 0.0 0.1 0.5 0.6 0.3 0.5 0.6 0.1 0.0 0.3 0.8 0.6 0.1 0.0 0.0 0.2 0.2 0.0 0.2 0.3 0.2 1.4 0.0 0.9 0.5 0.1 0.9 0.6 0.1 0.9 0.1 0.3 0.1 0.7 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 1.0 1.6 4.9 1.1 1.2 1.2 2.2 2.1 1.0 1.2 1.2 2.0 1.8 0.0 1.1 0.0 0.2 0.1 0.8 0.1 0.6 11.5 0.3 0.4 2.6 0.0 0.7 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.1 0.4 9.2 1.9 0.0 0.0 0.0 0.2 0.0 4.0 0.0 0.2 1.3 0.6 1.4 0.3 0.1 10.1 0.0 0.0 0.0 0.3 0.0 0.0 3.7 0.4 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.5 0.0 0.1 0.1 1.3 6.6 5.7 1.7 0.0 0.3 0.3 0.0 0.0 0.6 0.9 0.0 0.4 PCDHGA6 PCDH-GAMMA-A6 ENSG00000253731 "Protocadherin gamma subfamily A, 6" Q9Y5G7 5 141373891-141512975 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 10.6;Cardiomyocytes: 5.0;Endometrial stromal cells: 4.6;Hepatic stellate cells: 3.6;Skeletal myocytes: 5.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 9.6;T-47d: 5.6;WM-115: 12.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 21: Non-specific - Transcription" "Cluster 17: WM-115 - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (4.49e-2)" "unprognostic (8.91e-3)" "unprognostic (5.45e-2)" "unprognostic (1.43e-1)" "unprognostic (1.15e-1)" "unprognostic (1.49e-2)" "unprognostic (1.16e-1)" "unprognostic (1.18e-1)" "unprognostic (1.25e-1)" "unprognostic (2.07e-2)" "unprognostic (3.86e-3)" "unprognostic (2.02e-2)" "unprognostic (5.26e-2)" "unprognostic (7.44e-2)" "unprognostic (5.21e-2)" "unprognostic (1.11e-1)" "unprognostic (4.19e-3)" 1.4 1.1 1.6 0.7 1.8 0.1 1.3 7.2 1.6 2.7 0.0 2.0 0.2 3.2 1.4 0.8 2.0 1.1 2.7 1.7 1.8 0.8 0.5 1.5 0.4 1.8 1.7 3.5 1.2 1.1 1.8 2.3 0.9 1.2 0.4 2.0 1.5 1.6 0.9 1.5 0.8 2.0 0.8 0.9 0.7 0.8 2.0 0.5 1.2 1.0 0.4 1.6 1.5 1.9 0.0 0.3 2.7 0.4 1.3 4.7 0.1 2.1 0.7 1.1 1.1 0.0 0.1 2.0 2.6 3.3 1.0 0.4 0.1 0.4 0.7 0.0 0.2 0.0 0.3 0.2 0.7 0.1 0.1 4.9 0.3 0.2 0.1 1.0 1.6 0.1 0.2 1.1 0.3 0.4 0.7 1.7 0.3 0.0 0.1 1.4 0.4 0.0 0.3 0.1 9.6 0.7 0.1 0.3 0.6 0.6 5.6 0.1 4.8 0.7 0.3 0.7 0.7 0.4 1.7 0.4 0.8 0.7 12.2 0.4 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.0 1.6 1.8 7.2 1.6 1.7 1.8 1.8 1.7 0.9 0.8 2.0 1.9 2.8 0.0 2.2 0.0 0.4 0.0 0.8 0.0 0.0 10.6 0.3 1.0 5.0 1.5 0.6 0.0 0.0 0.1 0.3 0.0 0.0 0.4 0.5 0.4 4.6 1.8 0.0 0.4 0.0 1.5 0.1 2.2 0.0 0.4 0.0 0.6 3.6 0.7 0.1 1.7 0.0 0.2 0.0 0.3 0.0 0.3 1.2 0.5 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.6 0.1 2.2 1.6 0.4 0.0 0.3 0.7 0.9 0.0 5.2 1.9 0.3 0.3 0.5 0.0 0.3 0.2 0.5 0.2 0.2 PCDHGA7 PCDH-GAMMA-A7 ENSG00000253537 "Protocadherin gamma subfamily A, 7" Q9Y5G6 5 141382739-141512975 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 5.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 4.3;Cardiomyocytes: 1.6;Endometrial stromal cells: 2.2;Skeletal myocytes: 2.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 11.3;BJ hTERT+: 20.8;hTERT-RPE1: 10.9;SH-SY5Y: 18.6;T-47d: 8.1" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 21: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.00e-2)" "unprognostic (4.73e-3)" "unprognostic (1.42e-1)" "unprognostic (7.49e-2)" "unprognostic (2.10e-1)" "unprognostic (6.85e-2)" "unprognostic (2.61e-1)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (5.78e-2)" "unprognostic (3.72e-2)" "unprognostic (1.66e-1)" "unprognostic (3.56e-1)" "unprognostic (4.21e-3)" "unprognostic (6.30e-2)" "unprognostic (4.99e-2)" "unprognostic (1.42e-3)" 0.5 0.4 1.0 0.2 0.9 0.0 0.6 5.9 1.0 1.2 0.0 1.1 0.1 1.3 1.1 0.5 1.0 0.4 1.5 1.1 0.6 0.6 0.4 0.7 0.1 1.5 1.2 1.5 0.7 2.2 0.8 1.3 0.9 0.9 0.3 1.6 0.8 0.8 0.7 1.0 0.4 0.8 1.0 0.4 0.3 0.5 1.3 0.2 1.9 0.5 0.1 0.9 0.7 1.5 0.0 1.6 2.3 0.0 6.6 11.3 0.0 3.3 20.8 4.2 6.1 0.0 0.0 0.5 5.2 0.7 0.2 0.2 0.0 0.1 3.4 0.0 0.3 0.0 0.4 0.2 1.1 0.0 0.0 5.0 0.1 0.0 0.7 10.9 1.7 0.0 0.0 0.1 0.1 0.1 0.6 0.3 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.4 18.6 0.0 0.1 0.1 3.7 8.1 0.0 6.7 0.1 0.1 3.1 0.1 0.1 1.9 0.0 0.5 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.9 5.9 1.0 1.1 0.6 1.5 1.2 0.9 1.0 1.3 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.3 0.3 0.3 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.2 2.2 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.6 0.0 2.8 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.3 PCDHGA8 "KIAA0327, PCDH-GAMMA-A8" ENSG00000253767 "Protocadherin gamma subfamily A, 8" Q9Y5G5 5 141390157-141512975 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "brain: 3.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 11.4;Cardiomyocytes: 3.5;Horizontal cells: 3.3;Skeletal myocytes: 5.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 50: Fibroblasts - ECM organization" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.28e-2)" "unprognostic (2.27e-2)" "unprognostic (4.86e-2)" "unprognostic (3.38e-2)" "unprognostic (2.80e-1)" "unprognostic (4.10e-2)" "unprognostic (7.68e-2)" "unprognostic (2.30e-2)" "unprognostic (1.83e-2)" "unprognostic (2.23e-1)" "unprognostic (1.24e-1)" "unprognostic (1.35e-2)" "unprognostic (1.49e-3)" "unprognostic (7.59e-2)" "unprognostic (3.92e-2)" "unprognostic (3.38e-1)" "unprognostic (1.99e-3)" 0.1 0.1 0.6 0.1 0.6 0.4 0.1 3.9 0.8 0.2 0.2 0.1 0.0 0.2 0.2 0.1 0.1 0.1 0.5 0.8 0.5 0.0 0.1 0.1 0.1 1.1 0.7 0.3 0.1 0.0 0.2 0.2 0.7 0.1 0.1 0.5 0.1 0.0 0.3 0.3 0.1 0.1 0.3 0.1 0.1 0.1 0.9 0.1 0.4 0.1 0.1 0.1 0.1 1.2 0.0 0.0 0.3 0.1 0.2 0.6 0.1 0.6 0.4 0.4 0.1 0.0 0.1 0.3 0.2 0.4 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.6 0.2 0.4 0.6 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.6 0.6 3.9 0.8 0.8 0.5 1.1 0.7 0.7 0.3 0.9 1.2 1.2 0.0 0.6 0.0 0.1 0.0 0.9 0.0 0.0 11.4 0.3 0.3 3.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.6 0.1 2.1 1.2 0.0 0.0 0.0 0.6 0.0 1.1 0.0 0.2 0.0 0.3 0.4 0.7 0.1 3.3 0.0 0.0 0.0 0.3 0.0 0.0 2.1 0.2 0.0 0.0 0.0 1.3 1.0 0.0 0.0 0.1 0.1 1.5 0.0 0.7 0.0 0.2 0.0 1.7 0.0 5.2 0.9 0.7 1.1 0.0 0.0 0.0 0.1 0.5 0.0 0.5 PCDHGA9 PCDH-GAMMA-A9 ENSG00000261934 "Protocadherin gamma subfamily A, 9" Q9Y5G4 5 141402932-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 6.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 4.5;Cardiomyocytes: 1.3;Endometrial stromal cells: 1.5;Horizontal cells: 3.3;Skeletal myocytes: 2.3" "Cancer enhanced" "Detected in some" "glioma: 3.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 3.6;HSkMC: 4.0;hTERT-RPE1: 16.9;TIME: 4.6;U-87 MG: 5.1" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 21: Non-specific - Transcription" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 50: Fibroblasts - ECM organization" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.98e-2)" "unprognostic (7.47e-3)" "unprognostic (9.86e-3)" "unprognostic (2.22e-1)" "unprognostic (4.68e-2)" "unprognostic (4.96e-2)" "unprognostic (1.61e-1)" "unprognostic (2.15e-1)" "unprognostic (2.39e-1)" "unprognostic (1.87e-3)" "unprognostic (2.26e-1)" "unprognostic (1.79e-1)" "unprognostic (4.48e-3)" "unprognostic (1.94e-2)" "unprognostic (8.83e-2)" "unprognostic (2.71e-1)" "unprognostic (1.83e-2)" 1.8 1.6 3.3 0.7 3.5 0.1 1.3 6.6 3.2 2.0 0.4 1.2 0.5 2.5 1.1 1.4 1.9 2.0 1.1 3.7 2.6 0.8 0.4 1.5 0.5 3.6 3.4 2.8 0.8 1.1 0.9 1.0 3.8 1.5 0.7 4.4 1.1 2.2 0.8 1.7 0.6 1.8 3.7 1.1 0.8 0.4 3.6 0.5 1.4 1.2 0.7 1.2 1.4 5.7 0.0 0.1 0.6 1.6 0.1 0.2 0.2 0.7 0.0 0.6 0.6 0.2 0.4 1.3 3.6 2.0 0.3 0.1 0.1 0.2 0.7 0.0 0.3 0.0 0.1 0.0 1.1 0.0 0.2 4.0 0.1 0.4 0.3 16.9 1.0 0.0 0.1 0.2 0.3 0.3 0.1 0.5 0.2 0.0 0.0 0.1 0.4 0.0 0.1 0.2 0.4 1.1 0.4 0.1 0.5 0.4 0.9 0.4 4.6 0.3 0.3 0.1 2.5 0.2 0.0 0.0 5.1 0.1 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 3.5 6.6 3.2 3.7 2.6 3.6 3.4 3.8 3.7 3.6 5.7 0.6 0.0 0.0 0.0 0.1 0.3 0.2 0.3 0.6 4.5 0.2 0.3 1.3 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 1.5 0.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.1 0.4 0.2 0.1 3.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 2.3 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.1 PCDHGB3 PCDH-GAMMA-B3 ENSG00000262209 "Protocadherin gamma subfamily B, 3" Q9Y5G1 5 141370242-141512975 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.8" "Cell type enhanced" "Detected in single" "Cardiomyocytes: 1.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 10.4;ASC TERT1: 8.4;fHDF/TERT166: 3.5;TIME: 5.5" "HPA008755, HPA010580, HPA035822, HPA035823" Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 21: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 43: Cardiomyocytes - Nuclear processes" "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA035822: , HPA035823: AB_2674802" "unprognostic (6.93e-3)" "unprognostic (9.10e-4)" "unprognostic (1.35e-1)" "unprognostic (7.05e-2)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" "unprognostic (7.83e-2)" "unprognostic (1.92e-1)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (3.51e-2)" "unprognostic (5.81e-2)" "unprognostic (3.11e-1)" "unprognostic (3.62e-2)" "unprognostic (3.89e-2)" "unprognostic (2.80e-3)" 0.7 0.3 0.4 0.2 0.8 0.0 0.5 3.8 0.8 0.8 0.0 0.8 0.0 1.0 0.6 0.3 0.7 0.4 1.2 0.9 0.5 0.3 0.2 0.5 0.2 1.3 1.4 1.2 0.7 1.1 0.7 0.4 0.6 0.4 0.3 0.8 0.8 0.4 0.5 0.6 0.3 0.7 0.6 0.4 0.4 0.4 0.8 0.3 0.6 0.5 0.2 0.6 0.6 1.4 0.0 0.6 0.4 0.3 10.4 8.4 0.2 1.2 2.0 0.7 0.8 0.0 0.0 1.8 0.3 3.5 0.6 0.5 0.0 0.2 0.5 0.0 0.2 0.0 0.2 0.1 0.4 0.1 0.0 2.1 0.4 0.2 0.1 0.2 1.0 0.0 0.2 0.8 0.2 0.4 0.6 0.9 0.1 0.0 0.1 1.5 0.6 0.0 0.2 0.1 2.4 0.5 0.0 0.0 0.2 0.3 0.6 0.0 5.5 0.5 0.1 0.5 0.6 0.2 1.8 0.2 0.4 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 3.8 0.8 0.9 0.5 1.3 1.4 0.6 0.6 0.8 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGB4 "CDH20, FIB2, PCDH-GAMMA-B4" ENSG00000253953 "Protocadherin gamma subfamily B, 4" Q9UN71 5 141387698-141512975 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Bipolar cells: 1.1;Horizontal cells: 1.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 43.3;SuSa: 15.5;TIME: 22.7" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 56: Bipolar cells - Visual perception" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.33e-1)" "unprognostic (1.83e-3)" "unprognostic (2.91e-1)" "unprognostic (1.18e-1)" "unprognostic (1.23e-2)" "unprognostic (9.25e-3)" "unprognostic (2.20e-1)" "unprognostic (1.25e-2)" "unprognostic (1.99e-1)" "unprognostic (1.74e-1)" "unprognostic (1.29e-1)" "unprognostic (3.78e-2)" "unprognostic (2.31e-2)" "unprognostic (2.70e-2)" "unprognostic (2.62e-1)" "unprognostic (1.13e-1)" "unprognostic (3.27e-2)" 1.3 1.1 1.3 0.4 1.5 0.0 0.9 4.4 1.4 1.5 1.8 1.1 0.2 1.6 1.5 0.7 1.3 0.5 1.5 2.0 3.2 1.4 1.6 1.1 0.1 2.0 2.0 2.4 1.0 1.9 1.2 3.0 1.5 1.2 0.4 1.4 1.6 1.4 1.0 1.7 0.5 1.0 1.4 0.4 0.4 0.5 2.5 0.7 1.7 0.8 0.2 1.0 1.1 1.5 0.0 1.1 11.1 0.1 6.9 8.5 1.3 10.8 43.3 4.4 3.0 0.0 0.0 0.4 8.3 0.3 0.2 3.3 0.0 0.0 4.6 0.0 0.0 0.0 0.2 2.4 2.8 0.0 0.0 8.4 0.1 4.1 0.0 0.1 6.7 0.0 0.4 0.1 0.0 0.0 1.1 0.2 2.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.4 0.0 15.5 5.6 4.2 22.7 6.0 1.8 0.3 0.0 0.0 0.4 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 1.5 4.4 1.4 2.0 3.2 2.0 2.0 1.5 1.4 2.5 1.5 0.2 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.6 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 PCDHGB5 PCDH-GAMMA-B5 ENSG00000276547 "Protocadherin gamma subfamily B, 5" Q9Y5G0 5 141397987-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 20.3" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 1.2;Bipolar cells: 1.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 66.3;ASC TERT1: 49.6;BJ hTERT+ SV40 Large T+: 29.2;BJ hTERT+ SV40 Large T+ RasG12V: 32.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (2.71e-3)" "unprognostic (1.95e-2)" "unprognostic (1.09e-1)" "unprognostic (4.14e-2)" "unprognostic (2.35e-1)" "unprognostic (1.20e-1)" "unprognostic (3.64e-2)" "unprognostic (2.34e-2)" "unprognostic (1.54e-1)" "unprognostic (1.23e-1)" "unprognostic (1.90e-1)" "unprognostic (2.29e-1)" "unprognostic (1.69e-4)" "unprognostic (9.63e-3)" "unprognostic (3.21e-1)" "unprognostic (1.12e-1)" "unprognostic (8.25e-4)" 2.8 2.7 3.6 1.1 3.6 0.0 1.8 5.8 3.1 2.0 3.3 1.7 0.7 3.1 2.0 1.9 2.8 1.6 2.9 3.9 6.4 2.2 2.1 2.7 0.4 5.1 4.7 5.7 3.8 20.3 1.7 4.8 5.4 3.0 0.9 3.1 4.7 3.9 2.1 3.8 0.8 2.8 5.3 1.3 1.5 1.9 4.9 1.3 4.5 1.9 0.8 1.9 2.1 6.1 0.0 2.4 0.3 0.0 66.3 49.6 1.3 18.3 0.0 29.2 32.5 2.9 10.0 10.6 23.4 20.5 0.0 13.9 0.0 7.6 16.4 0.0 3.1 0.0 0.0 0.1 6.9 0.0 6.5 17.6 1.5 1.7 9.4 12.6 9.0 0.0 0.2 0.0 1.0 8.1 0.0 1.5 0.4 0.0 0.0 0.0 0.0 0.0 1.6 5.5 0.0 0.1 0.0 0.1 0.0 2.0 19.1 0.1 9.2 0.0 2.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 3.6 5.8 3.1 3.9 6.4 5.1 4.7 5.4 5.3 4.9 6.1 0.5 0.0 0.0 0.0 0.2 0.0 0.3 0.0 1.2 1.5 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.6 0.6 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.8 0.5 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.0 0.1 PCDHGB6 PCDH-GAMMA-B6 ENSG00000253305 "Protocadherin gamma subfamily B, 6" Q9Y5F9 5 141408021-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Bipolar cells: 6.9;Cone photoreceptor cells: 6.2;Horizontal cells: 10.1;Skeletal myocytes: 5.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 16.0;EFO-21: 5.4;HSkMC: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 21: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.11e-1)" "unprognostic (4.18e-2)" "unprognostic (2.63e-1)" "unprognostic (7.81e-2)" "unprognostic (1.04e-1)" "unprognostic (1.90e-1)" "unprognostic (1.18e-1)" "unprognostic (1.85e-2)" "unprognostic (3.51e-1)" "unprognostic (1.11e-1)" "unprognostic (4.77e-2)" "unprognostic (9.89e-2)" "unprognostic (1.43e-1)" "unprognostic (2.17e-2)" "unprognostic (3.27e-1)" "unprognostic (1.21e-2)" "unprognostic (7.71e-4)" 3.1 3.1 3.0 0.9 3.6 0.4 2.2 5.0 2.4 2.9 2.9 2.4 0.5 3.2 2.0 1.2 2.9 1.7 2.4 2.5 3.5 1.1 1.3 2.0 0.7 3.6 3.5 6.0 1.2 2.8 1.8 3.1 3.2 1.4 0.7 2.8 2.2 2.4 2.9 2.1 1.0 1.9 3.3 1.5 1.1 0.6 3.7 0.6 2.6 1.5 0.6 1.8 2.3 3.9 0.0 0.1 16.0 0.1 0.5 0.6 0.8 1.4 0.0 0.4 0.9 0.2 0.2 1.4 5.4 0.9 0.2 0.3 0.0 0.3 1.0 0.0 0.3 0.0 0.2 0.1 1.3 0.1 0.1 3.6 1.8 0.8 0.1 0.1 0.5 0.3 0.1 0.2 0.1 0.3 0.1 1.1 0.6 0.0 0.0 0.2 0.0 0.1 2.5 0.2 0.2 0.3 0.0 0.1 0.1 0.4 1.2 0.3 2.6 0.1 0.2 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.7 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 3.0 3.6 5.0 2.4 2.5 3.5 3.6 3.5 3.2 3.3 3.7 3.9 3.6 3.2 0.5 0.0 1.0 0.0 1.5 0.0 0.0 6.9 0.6 0.4 3.9 0.0 1.3 0.0 6.2 0.2 0.6 0.4 0.0 0.7 0.0 0.6 3.8 2.6 0.0 0.0 0.0 1.2 0.1 3.3 1.1 0.5 0.0 0.4 1.4 0.7 0.3 10.1 0.0 0.4 0.0 0.0 0.0 0.2 1.8 0.2 0.0 0.0 0.1 2.7 0.0 0.0 0.0 2.0 0.1 1.2 1.5 0.8 0.1 0.3 0.7 2.5 0.0 5.2 3.2 0.2 0.5 0.3 0.1 0.1 0.7 0.8 0.4 0.8 PCDHGB7 "ME6, PCDH-GAMMA-B7" ENSG00000254122 "Protocadherin gamma subfamily B, 7" Q9Y5F8 5 141417645-141512975 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Bipolar cells: 7.9;Fibroblasts: 3.4;Horizontal cells: 3.3;Skeletal myocytes: 5.9" "Cancer enhanced" "Detected in many" "glioma: 7.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "AN3-CA: 86.7;HSkMC: 26.7;hTERT-RPE1: 72.4" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 21: Non-specific - Transcription" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 50: Fibroblasts - ECM organization" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.22e-2)" "unprognostic (2.55e-2)" "unprognostic (7.39e-3)" "unprognostic (2.95e-1)" "unprognostic (1.49e-1)" "unprognostic (3.34e-1)" "unprognostic (1.98e-1)" "unprognostic (1.25e-1)" "unprognostic (8.40e-2)" "unprognostic (4.43e-2)" "unprognostic (2.61e-2)" "unprognostic (1.88e-2)" "unprognostic (3.05e-1)" "unprognostic (2.22e-2)" "unprognostic (1.44e-1)" "unprognostic (1.91e-1)" "unprognostic (5.68e-2)" 5.2 4.6 4.6 1.8 4.7 0.1 4.2 10.8 3.5 4.9 5.0 5.0 0.9 5.7 2.2 3.0 4.4 4.4 4.3 4.5 7.0 2.4 1.5 5.8 1.2 6.0 6.0 8.1 1.7 4.3 2.2 5.5 5.3 3.8 1.7 5.8 3.7 5.5 3.0 3.3 2.1 5.1 7.7 2.7 2.4 1.9 5.0 1.5 4.0 4.1 0.9 3.3 3.8 7.3 0.0 0.0 2.9 86.7 1.9 0.3 0.9 5.7 0.7 2.1 4.3 0.1 5.3 0.7 4.6 11.7 0.8 1.4 0.2 1.0 2.0 0.1 0.6 0.0 0.2 0.0 6.4 0.5 0.1 26.7 0.7 1.7 0.9 72.4 4.6 0.2 0.0 0.0 0.3 0.0 0.0 0.1 1.0 0.0 0.6 10.1 1.9 0.0 0.2 0.0 9.3 12.8 0.2 0.0 0.0 1.0 1.0 0.9 11.5 10.3 0.2 0.9 0.1 0.1 0.2 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.6 4.7 10.8 3.5 4.5 7.0 6.0 6.0 5.3 7.7 5.0 7.3 2.2 3.2 1.3 0.0 0.3 0.4 0.8 0.0 0.0 7.9 0.3 0.5 1.4 0.0 0.1 0.0 2.1 0.1 0.0 0.0 0.0 0.2 0.1 0.4 2.1 2.2 0.0 0.0 0.0 0.5 0.1 3.4 0.0 0.3 1.3 0.5 0.4 0.0 0.1 3.3 0.0 0.0 0.0 0.0 0.4 0.0 1.2 0.2 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.1 0.0 1.9 0.1 0.4 0.0 0.3 0.0 0.7 0.0 5.9 2.2 0.0 0.1 0.5 0.4 0.0 0.0 1.2 0.1 0.2 PCDHGC4 PCDH-GAMMA-C4 ENSG00000242419 "Protocadherin gamma subfamily C, 4" Q9Y5F7 5 141484997-141512979 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 31.4" "Cell type enhanced" "Detected in some" "Bipolar cells: 1.1;Horizontal cells: 3.3" "Cancer enriched" "Detected in single" 10 "glioma: 4.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 9.1;SCLC-21H: 7.3;SH-SY5Y: 14.2;SuSa: 10.0" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 70: Brain - Nervous system development" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (6.05e-2)" "unprognostic (1.26e-3)" "unprognostic (4.78e-2)" "unprognostic (1.41e-1)" "unprognostic (3.44e-1)" "unprognostic (7.84e-2)" "unprognostic (9.48e-2)" "unprognostic (3.27e-1)" "unprognostic (4.55e-1)" "unprognostic (1.17e-1)" "unprognostic (8.72e-3)" "unprognostic (4.73e-3)" "unprognostic (2.20e-4)" "unprognostic (8.78e-2)" "unprognostic (3.06e-2)" "unprognostic (1.47e-1)" "unprognostic (2.75e-2)" 0.2 1.1 17.3 0.1 12.2 0.0 0.2 19.3 14.6 0.3 0.1 0.6 0.0 0.4 0.2 0.2 0.3 0.2 2.2 12.7 13.9 0.1 0.1 0.4 0.1 12.9 21.9 0.3 0.3 0.0 1.1 0.1 10.3 0.2 0.1 6.6 0.3 0.1 0.7 0.5 0.1 0.2 22.4 0.1 0.2 0.9 14.3 0.0 0.1 0.3 0.2 0.2 0.3 31.4 0.0 0.0 0.9 0.2 0.2 0.7 0.4 0.1 0.1 0.1 0.2 0.0 0.0 0.2 0.8 0.9 0.1 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.8 0.0 1.3 0.0 0.0 9.1 0.5 0.0 0.0 0.1 7.3 14.2 0.1 0.0 0.1 10.0 0.1 0.3 0.1 0.8 0.1 0.2 0.6 0.2 0.0 0.2 0.6 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 12.2 19.3 14.6 12.7 13.9 12.9 21.9 10.3 22.4 14.3 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 PCDHGC5 PCDH-GAMMA-C5 ENSG00000240764 "Protocadherin gamma subfamily C, 5" Q9Y5F6 5 141489081-141512975 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 28.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "glioma: 3.1;head and neck cancer: 0.8" "Region enhanced" "Detected in many" "hippocampal formation: 28.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 4.6;SuSa: 7.4;U-138 MG: 14.4;U-251 MG: 6.5;U-87 MG: 8.9" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA076140" Supported Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076140: " "unprognostic (2.86e-3)" "unprognostic (7.63e-4)" "unprognostic (2.00e-1)" "unprognostic (3.52e-3)" "unprognostic (5.42e-2)" "unprognostic (1.14e-1)" "unprognostic (5.65e-2)" "unprognostic (2.38e-2)" "unprognostic (2.14e-1)" "unprognostic (3.16e-2)" "unprognostic (3.90e-1)" "unprognostic (1.66e-2)" "unprognostic (1.01e-9)" "unprognostic (6.87e-3)" "unprognostic (3.89e-2)" "unprognostic (3.13e-1)" "unprognostic (3.77e-3)" 0.3 0.5 5.6 0.1 8.6 0.0 0.3 0.0 11.7 0.8 0.0 1.3 0.0 1.2 0.2 0.3 0.7 0.2 5.3 28.4 0.0 0.2 0.1 0.7 0.0 0.0 0.0 0.7 0.4 0.0 1.2 0.1 0.0 0.5 0.0 1.2 0.4 0.5 1.2 0.5 0.2 0.7 0.0 0.1 0.3 0.6 0.3 0.1 0.2 0.2 0.0 0.5 0.6 0.0 0.0 0.0 0.3 0.3 0.3 1.5 0.1 0.8 0.5 0.4 0.5 0.0 0.0 0.4 1.4 2.2 0.1 0.1 0.0 0.4 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 3.2 0.0 4.6 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.8 0.8 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 7.4 0.1 0.2 0.1 14.4 0.2 0.2 6.5 0.0 0.0 0.0 8.9 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 8.6 0.0 11.7 28.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCNT "KEN, KIAA0402, PCN, PCNT2, PCNTB, SCKL4" ENSG00000160299 Pericentrin O95613 21 46324141-46445769 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Calmodulin-binding Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 239.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 6 "dendritic cells: 4.6;granulocytes: 6.0;T-cells: 8.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016820, HPA019887, HPA032101" Uncertain Supported "Centriolar satellite,Centrosome,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 36: HEL - Hemostasis" "Cluster 37: Myocytes - Muscle contraction" Centrosome "Centriolar satellite, Cytosol" "HPA016820: AB_1855079, HPA019887: AB_1855080, HPA032101: AB_2674151" "unprognostic (9.07e-2)" "unprognostic (1.01e-1)" "unprognostic (1.65e-2)" "unprognostic (1.30e-2)" "unprognostic (5.35e-2)" "unprognostic (3.40e-3)" "unprognostic (1.27e-2)" "unprognostic (2.59e-1)" "unprognostic (9.29e-2)" "unprognostic (1.35e-2)" "unprognostic (1.59e-3)" "unprognostic (3.86e-2)" "unprognostic (1.95e-2)" "unprognostic (5.83e-2)" "unprognostic (2.90e-1)" "unprognostic (3.36e-1)" "unprognostic (5.86e-2)" 9.7 11.1 7.6 5.9 10.5 17.7 8.9 4.2 11.9 8.6 5.3 10.7 4.1 8.2 4.3 11.7 8.5 3.6 28.3 6.0 5.4 7.7 10.9 8.2 8.2 9.0 3.9 9.6 7.8 4.3 20.3 3.5 9.5 8.2 4.3 4.6 9.7 4.2 239.2 12.3 10.1 4.4 2.6 11.5 9.5 25.6 4.7 12.5 8.4 52.0 5.5 9.6 9.2 7.4 15.4 11.6 18.0 11.1 8.9 8.8 11.3 11.6 8.0 11.3 10.0 14.2 9.7 15.2 7.3 13.4 15.3 10.8 14.6 9.9 7.8 44.9 20.4 40.2 24.1 11.3 3.1 20.6 16.1 4.8 7.5 15.2 7.6 5.5 8.8 15.8 20.9 22.4 15.8 25.4 20.6 21.3 18.0 13.9 8.0 25.3 7.2 13.5 8.7 16.3 22.1 9.8 25.4 15.7 8.0 4.4 14.8 16.0 12.1 20.4 10.2 11.7 18.9 19.3 17.2 16.4 12.6 19.9 11.1 6.0 0.6 1.2 1.5 0.5 4.6 0.3 0.7 4.8 2.0 0.1 0.5 8.8 0.4 0.4 1.0 4.6 0.8 2.0 7.6 10.5 4.2 11.9 6.0 5.4 9.0 3.9 9.5 2.6 4.7 7.4 10.5 28.9 32.0 19.9 8.6 8.3 5.7 7.0 13.6 15.0 8.9 8.6 35.7 10.0 15.3 0.0 6.2 6.4 36.7 14.0 0.0 7.1 20.4 17.0 19.9 10.1 15.6 36.2 38.1 7.6 7.4 13.1 25.0 17.8 16.4 25.4 7.1 9.0 23.3 23.5 39.0 11.2 4.1 6.9 5.5 25.6 12.8 12.7 0.0 17.8 14.7 6.8 25.7 10.6 21.9 5.7 5.7 12.0 31.4 4.2 5.7 4.1 13.0 11.1 26.3 61.3 14.2 40.5 39.8 25.0 7.1 6.4 18.8 15.1 10.4 5.1 PDCD1LG2 "B7-DC, bA574F11.2, Btdc, CD273, PD-L2, PDL2" ENSG00000197646 "Programmed cell death 1 ligand 2" Q9BQ51 9 5510531-5571282 "Cancer-related genes, CD markers, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.1" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 17.9;Langerhans cells: 13.1;Microglial cells: 12.2;monocytes: 26.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 71.4;BJ hTERT+: 111.6;HDLM-2: 88.1;TIME: 49.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA013411 Approved Uncertain Cytosol "Secreted - unknown location" NA NA 31000000 "Cluster 46: Basophils - DNA binding" "Cluster 16: Immune cells - Immune response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 3: Monocytes - Immune response regulation" Cytosol "HPA013411: AB_1855102" "unprognostic (3.93e-2)" "unprognostic (1.90e-1)" "unprognostic (3.51e-3)" "unprognostic (6.68e-3)" "unprognostic (7.66e-2)" "unprognostic (6.77e-2)" "unprognostic (5.72e-2)" "unprognostic (2.91e-1)" "unprognostic (1.68e-1)" "unprognostic (4.37e-3)" "unprognostic (5.79e-2)" "unprognostic (5.29e-2)" "prognostic unfavorable (1.15e-4)" "unprognostic (5.00e-2)" "unprognostic (4.66e-2)" "unprognostic (2.01e-1)" "unprognostic (7.51e-3)" 4.4 0.8 0.4 6.9 0.6 0.3 4.3 0.5 0.5 2.5 0.3 1.7 0.7 2.2 1.2 2.0 2.4 3.4 2.7 0.4 0.8 1.2 4.2 7.1 10.4 1.1 0.6 1.6 0.6 0.4 0.2 4.8 1.1 1.0 2.1 0.0 1.3 1.4 1.5 1.4 1.5 3.1 0.9 15.1 1.4 0.6 0.7 5.0 1.0 2.2 6.2 4.2 2.2 1.3 6.0 0.0 0.0 0.0 4.7 5.4 0.1 71.4 111.6 33.7 40.4 0.0 0.3 0.0 0.2 29.2 4.8 0.5 0.1 9.7 33.3 88.1 0.0 0.0 0.0 0.0 26.5 0.0 0.0 5.0 0.1 15.8 18.5 9.7 22.4 0.0 0.0 8.5 41.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.0 0.7 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.2 0.0 0.1 49.7 24.0 1.4 11.8 20.1 1.2 0.1 0.1 13.6 0.0 3.0 1.5 0.3 0.0 0.5 1.4 0.6 0.2 0.7 0.3 0.3 0.1 0.0 0.3 0.7 0.0 0.1 0.0 1.1 0.3 0.4 0.6 0.5 0.5 0.4 0.8 1.1 0.6 1.1 0.9 0.7 1.3 6.1 6.4 0.5 1.6 0.4 1.0 0.1 0.7 1.8 0.0 0.2 1.5 0.1 0.0 0.7 0.0 0.0 0.6 0.4 0.0 0.0 0.1 0.0 0.0 0.4 2.2 0.0 0.0 1.6 0.2 17.9 6.7 0.5 0.0 3.8 0.2 6.8 0.0 2.9 0.0 1.4 0.0 0.0 5.3 13.1 0.0 5.9 2.5 1.8 12.2 26.4 0.0 0.0 1.0 2.4 3.7 0.0 2.2 1.5 0.1 0.0 0.0 0.0 0.0 0.0 2.2 3.1 0.0 0.0 0.3 1.0 0.8 1.1 0.1 0.0 0.1 PEAK3 "C19orf35, FLJ45778" ENSG00000188305 "PEAK family member 3" Q6ZS72 19 2274631-2282175 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 2.3;lymphoid tissue: 4.1" "Cell type enhanced" "Detected in some" "dendritic cells: 1.5;Hofbauer cells: 1.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 41.0" "Lineage enriched" "Detected in many" 7 "granulocytes: 41.0" "Cell line enriched" "Detected in some" 9 "HMC-1: 12.2" "Group enriched" "Detected in some" 5 "basal ganglia: 6.7;cerebellum: 3.1" HPA057806 Uncertain Uncertain Cytosol NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" Cytosol "HPA057806: AB_2683534" "unprognostic (9.42e-2)" "unprognostic (3.26e-2)" "unprognostic (7.27e-2)" "unprognostic (6.23e-2)" "unprognostic (2.65e-2)" "unprognostic (8.40e-3)" "unprognostic (3.67e-1)" "unprognostic (3.08e-1)" "unprognostic (1.81e-1)" "unprognostic (2.08e-1)" "unprognostic (6.89e-2)" "unprognostic (1.43e-1)" "unprognostic (2.19e-2)" "unprognostic (2.01e-1)" "unprognostic (3.57e-2)" "unprognostic (3.20e-2)" "unprognostic (1.90e-1)" 0.5 0.4 0.5 1.3 0.9 2.3 0.3 0.5 1.6 0.2 0.1 0.4 0.2 0.2 0.0 0.2 0.5 0.2 0.7 0.4 0.5 0.3 0.2 1.1 0.4 1.4 1.0 0.1 0.2 0.0 0.2 0.1 1.0 0.3 0.2 0.0 0.2 0.0 0.3 0.3 0.8 0.1 0.9 4.1 0.3 0.1 0.8 0.1 0.2 0.0 0.3 0.3 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.4 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 10.5 4.4 11.7 1.6 5.7 0.2 0.2 0.1 0.2 1.8 0.4 0.1 0.3 41.0 4.5 1.9 0.2 0.0 1.1 0.5 0.9 0.5 1.6 0.4 0.5 1.4 1.0 1.0 0.9 0.8 0.6 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 PEMT "PEMPT, PEMT2" ENSG00000133027 "Phosphatidylethanolamine N-methyltransferase" Q9UBM1 17 17505563-17591708 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 166.2;liver: 267.4" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 122.9;Hepatocytes: 220.1;Peritubular cells: 346.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042375, HPA073930" Approved Supported "Endoplasmic reticulum,Vesicles,Mitochondria,Cytosol" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 36: Stromal cells - Cell proliferation" "Endoplasmic reticulum, Mitochondria" "Vesicles, Cytosol" "HPA042375: AB_10796905, HPA073930: " "unprognostic (1.39e-2)" "unprognostic (3.43e-1)" "unprognostic (2.43e-2)" "prognostic favorable (6.77e-6)" "unprognostic (2.85e-1)" "unprognostic (7.14e-2)" "unprognostic (1.31e-1)" "unprognostic (1.28e-1)" "unprognostic (3.89e-1)" "unprognostic (3.41e-2)" "unprognostic (5.47e-3)" "unprognostic (2.67e-1)" "unprognostic (8.63e-3)" "unprognostic (2.08e-1)" "unprognostic (2.10e-1)" "unprognostic (6.66e-2)" "unprognostic (7.60e-2)" 71.6 33.9 13.2 5.2 13.6 9.2 92.7 16.3 20.0 47.4 12.7 13.6 15.0 36.9 166.2 26.8 26.5 5.4 24.5 13.0 15.2 30.2 267.4 25.8 5.2 14.9 15.3 27.9 32.2 13.3 24.7 7.3 16.8 30.8 3.4 2.8 27.1 24.0 29.5 34.3 13.7 6.8 15.1 12.8 19.5 40.8 14.2 5.6 33.5 10.7 4.5 21.1 24.2 17.2 34.3 64.7 16.5 43.4 34.6 23.8 25.1 21.6 19.0 28.5 22.4 38.2 22.6 29.8 38.1 21.9 21.6 39.9 24.6 12.8 7.2 22.2 86.9 14.8 33.2 55.4 38.4 13.5 21.4 24.9 26.7 19.2 29.1 9.7 15.7 41.3 14.6 12.3 12.9 66.0 23.9 24.2 23.2 65.5 52.4 22.2 26.7 27.5 24.1 12.5 16.7 39.5 15.3 10.1 39.2 31.5 15.6 5.1 13.9 28.1 28.2 47.4 18.9 17.0 12.1 5.5 25.9 18.5 23.6 1.9 41.1 2.1 16.9 39.0 24.8 23.5 22.2 21.5 30.5 28.3 17.2 19.4 3.1 29.3 28.0 27.7 22.4 21.3 13.2 13.6 16.3 20.0 13.0 15.2 14.9 15.3 16.8 15.1 14.2 17.2 38.1 16.0 17.5 4.9 12.4 18.2 21.0 27.9 39.3 4.5 33.0 45.1 15.5 11.5 24.9 27.6 0.0 19.5 5.9 9.3 17.6 33.3 2.9 21.8 122.9 18.5 68.8 17.1 5.4 38.5 21.6 30.4 8.2 23.8 12.7 52.4 10.4 220.1 23.5 5.0 6.8 30.9 24.4 13.7 12.2 14.9 94.8 11.2 21.4 3.7 5.7 34.7 2.1 9.5 4.0 25.7 10.8 346.8 15.3 35.1 21.7 32.3 14.2 6.1 6.6 20.0 23.6 21.0 24.9 39.5 18.2 14.6 12.5 49.3 24.1 23.8 PGM5 PGMRP ENSG00000154330 "Phosphoglucomutase 5" Q15124 9 68328308-68531061 "Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Cell adhesion, Glucose metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 269.4" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 107.2;Endothelial cells: 36.6;Hepatic stellate cells: 39.3;Microglial cells: 124.6;Sertoli cells: 52.6;Smooth muscle cells: 35.9" "Cancer enhanced" "Detected in many" "prostate cancer: 16.2" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 48 "neutrophil: 4.8" "Lineage enriched" "Detected in single" 48 "granulocytes: 4.8" "Group enriched" "Detected in some" 5 "hTERT-RPE1: 28.7;PC-3: 56.5;RH-30: 38.8;SK-BR-3: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034397, HPA046329, HPA067102" Enhanced Uncertain Cytosol NA NA 450000 "Cluster 1: Neutrophils - Mixed function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Cytosol "CAB034397: AB_1118633, HPA046329: AB_2679625, HPA067102: AB_2732758" "unprognostic (3.43e-1)" "unprognostic (2.17e-2)" "unprognostic (3.98e-3)" "unprognostic (5.75e-2)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (3.15e-4)" "unprognostic (1.22e-3)" "unprognostic (2.79e-1)" "unprognostic (5.28e-3)" "unprognostic (4.78e-2)" "unprognostic (2.28e-2)" "prognostic favorable (1.83e-5)" "unprognostic (3.04e-2)" "unprognostic (2.91e-1)" "unprognostic (2.48e-1)" "unprognostic (4.73e-2)" 28.9 61.0 3.7 12.6 4.1 0.0 21.0 5.8 3.8 51.7 3.3 269.4 15.4 154.0 40.8 98.6 96.5 19.6 126.1 3.1 4.1 11.5 5.1 14.6 5.8 4.6 4.0 19.8 2.7 5.0 4.3 5.8 4.3 159.0 34.2 8.0 6.7 214.0 37.5 11.1 72.0 132.5 4.7 10.8 65.2 3.0 4.6 2.9 13.1 30.5 2.9 216.7 40.6 4.6 0.2 0.2 0.0 0.0 0.7 0.0 0.3 8.2 6.3 3.8 1.7 0.0 0.0 0.2 0.0 0.0 0.1 0.1 9.2 0.0 9.4 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.1 0.8 0.0 0.0 0.0 28.7 0.0 0.0 0.0 0.1 0.0 4.1 0.1 0.7 0.0 0.0 56.5 0.0 38.8 1.8 1.5 0.0 0.0 0.2 0.1 47.8 2.8 1.2 0.0 0.0 0.1 0.0 5.7 0.3 0.3 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 3.7 4.1 5.8 3.8 3.1 4.1 4.6 4.0 4.3 4.7 4.6 4.6 21.6 0.0 1.7 0.7 0.2 2.3 5.6 0.0 0.6 25.3 0.2 1.5 107.2 2.8 1.8 12.9 4.2 0.0 0.1 0.1 1.9 0.1 1.8 3.7 2.8 36.6 0.0 4.0 1.4 0.0 0.2 12.4 0.0 1.1 0.0 18.7 39.3 0.1 0.1 0.0 1.7 2.7 0.0 4.0 2.8 0.5 8.1 2.1 3.6 124.6 1.0 8.3 0.0 1.0 2.3 0.1 0.1 4.9 0.0 2.1 0.8 1.2 0.8 1.9 52.6 1.7 35.9 0.1 0.2 0.4 2.4 0.0 0.6 30.0 1.6 1.5 PHF20 "C20orf104, dJ1121G12.1, TDRD20A" ENSG00000025293 "PHD finger protein 20" Q9BVI0 20 35771974-35950370 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 452.5;Late spermatids: 661.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029619, HPA029620, HPA029621" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 36: HEL - Hemostasis" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "Nuclear membrane, Cytosol" "HPA029619: AB_10600090, HPA029620: AB_10601110, HPA029621: AB_10602201" "unprognostic (1.21e-3)" "unprognostic (7.30e-2)" "unprognostic (3.20e-2)" "unprognostic (2.35e-3)" "unprognostic (1.36e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (2.76e-1)" "unprognostic (2.17e-1)" "unprognostic (2.64e-2)" "unprognostic (4.59e-2)" "unprognostic (1.09e-1)" "unprognostic (1.92e-2)" "unprognostic (1.17e-1)" "unprognostic (1.07e-1)" "unprognostic (7.23e-2)" "unprognostic (1.01e-2)" 12.9 8.2 10.4 12.0 11.5 11.8 12.5 15.4 13.0 10.8 9.4 10.9 6.0 11.8 7.3 11.9 9.2 10.8 11.5 11.2 10.4 7.8 8.2 10.0 14.2 11.6 11.1 13.2 6.8 12.1 5.4 11.7 11.1 10.3 8.4 14.4 9.5 10.8 32.3 8.1 7.8 11.6 9.5 14.7 8.2 11.8 11.8 14.7 10.2 17.6 13.9 10.5 8.5 14.7 18.1 14.2 24.4 36.0 17.3 19.7 22.5 20.2 19.1 19.8 17.2 41.4 13.1 30.1 17.9 27.1 24.4 10.7 22.6 28.2 24.1 13.7 9.6 55.8 26.3 15.6 17.3 27.2 20.8 15.6 38.8 21.0 32.2 23.5 22.1 21.0 23.3 18.8 23.1 10.8 27.6 15.9 12.0 11.9 17.5 20.0 35.9 17.9 15.9 12.4 21.9 17.9 36.0 41.0 18.4 21.8 32.6 20.0 31.1 43.7 9.9 23.0 21.0 17.2 22.0 21.5 32.2 19.5 22.9 17.3 11.2 33.1 12.4 11.5 13.6 15.0 12.5 14.6 10.6 11.1 14.0 14.7 25.9 16.0 16.9 9.9 7.2 9.0 10.4 11.5 15.4 13.0 11.2 10.4 11.6 11.1 11.1 9.5 11.8 14.7 51.2 38.5 41.8 28.4 131.1 34.8 76.6 52.5 31.3 77.4 49.8 53.5 62.2 31.5 43.5 38.6 98.0 106.7 191.0 16.3 37.2 29.8 452.5 39.8 41.6 46.3 36.0 37.6 49.7 19.9 52.5 53.6 23.0 34.7 142.4 41.2 47.2 18.2 54.5 114.4 49.5 27.9 30.5 62.7 84.3 661.6 35.8 87.1 39.2 62.8 62.6 50.0 105.0 34.2 55.2 24.1 26.5 53.4 76.9 60.0 14.0 24.8 50.2 80.7 19.7 65.5 50.6 60.4 47.0 29.8 28.3 22.3 127.8 30.1 28.8 55.4 PIGB ENSG00000069943 "Phosphatidylinositol glycan anchor biosynthesis class B" Q92521 15 55318960-55355648 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039929 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 32: U-937 - Innate immune response" "Cluster 57: B-cells - Immune response" "Plasma membrane, Cytosol" "HPA039929: AB_10673539" "unprognostic (1.91e-2)" "unprognostic (7.45e-2)" "unprognostic (3.00e-1)" "unprognostic (2.03e-2)" "unprognostic (2.96e-2)" "unprognostic (4.65e-2)" "unprognostic (2.04e-1)" "unprognostic (3.37e-3)" "unprognostic (7.52e-2)" "unprognostic (3.52e-2)" "unprognostic (2.56e-2)" "unprognostic (4.27e-2)" "unprognostic (2.13e-1)" "unprognostic (1.30e-1)" "unprognostic (2.86e-1)" "unprognostic (5.93e-2)" "unprognostic (4.24e-2)" 6.4 4.8 2.3 5.8 2.6 9.1 9.0 2.8 2.6 5.5 3.1 7.0 7.5 6.4 11.0 5.7 7.8 6.3 2.8 2.5 3.3 10.3 9.4 6.3 8.2 2.8 2.7 4.7 5.7 10.6 3.9 4.8 2.6 7.7 7.8 7.9 4.3 6.8 1.5 6.1 5.8 5.6 2.7 6.1 7.6 6.5 2.7 6.3 13.3 1.8 8.6 7.5 3.7 3.1 10.5 12.2 5.8 4.1 6.6 13.2 7.8 9.0 19.9 10.4 17.8 5.1 10.3 10.9 10.4 12.9 15.6 18.3 3.3 9.5 8.6 10.4 6.4 10.9 13.6 6.7 11.9 30.8 8.7 12.5 11.4 7.9 10.7 13.8 13.6 9.2 12.2 6.9 15.0 9.1 3.4 12.8 3.1 7.9 4.8 4.9 5.6 24.1 18.4 12.4 2.5 6.2 8.1 12.2 17.3 5.4 11.7 22.2 9.5 13.6 4.3 3.7 18.6 8.1 15.9 8.6 12.4 34.5 10.2 13.6 7.7 3.3 6.2 9.7 7.0 6.0 6.1 6.9 7.0 3.9 4.8 5.5 14.5 5.3 11.4 5.4 6.5 5.5 2.3 2.6 2.8 2.6 2.5 3.3 2.8 2.7 2.6 2.7 2.7 3.1 3.5 9.6 9.5 17.6 27.5 4.6 9.5 14.9 4.6 3.3 5.6 4.2 3.4 1.5 14.9 0.0 12.5 12.4 11.2 4.8 1.9 7.4 26.8 4.3 3.2 4.7 6.6 8.2 18.3 10.9 12.0 6.0 6.1 6.4 8.2 4.6 6.8 4.4 8.6 1.7 17.7 4.1 4.1 7.5 6.7 5.1 1.5 8.8 3.6 12.2 8.4 2.7 11.3 17.1 14.6 6.9 4.0 1.5 3.8 3.4 6.4 9.7 7.9 9.4 6.6 4.8 4.2 5.9 3.8 5.7 4.0 6.6 12.5 4.2 4.0 7.4 PIH1D2 ENSG00000150773 "PIH1 domain containing 2" Q8WWB5 11 112063218-112074274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 66.5" "Cell type enhanced" "Detected in many" "Early spermatids: 425.9;Endometrial ciliated cells: 68.8;Late spermatids: 157.5;Respiratory ciliated cells: 115.3;Spermatocytes: 215.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "T-47d: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039496 Uncertain Nucleoplasm,Cytosol NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Cytosol "HPA039496: AB_10959385" "unprognostic (8.74e-2)" "unprognostic (6.64e-3)" "unprognostic (1.29e-1)" "unprognostic (3.01e-3)" "unprognostic (4.72e-2)" "unprognostic (1.35e-2)" "unprognostic (3.74e-2)" "unprognostic (1.17e-1)" "unprognostic (2.43e-3)" "unprognostic (5.82e-2)" "unprognostic (9.05e-3)" "unprognostic (1.03e-1)" "unprognostic (2.81e-3)" "unprognostic (1.59e-1)" "unprognostic (6.08e-2)" "unprognostic (3.38e-2)" "unprognostic (1.12e-1)" 0.8 1.0 1.8 0.5 1.8 0.4 1.9 1.6 1.8 1.8 9.6 0.9 0.5 1.7 4.8 1.2 14.8 1.6 1.3 1.9 2.0 3.9 0.7 2.9 0.4 4.0 4.6 1.2 1.1 4.1 3.3 0.7 3.4 0.9 0.8 12.4 1.3 1.4 1.0 1.2 0.4 0.6 3.5 0.3 1.0 66.5 2.1 0.6 5.3 0.4 0.4 0.8 0.8 2.5 1.9 1.1 3.1 1.6 0.7 0.8 2.3 0.7 2.2 1.8 2.3 3.0 6.4 0.9 2.4 1.8 2.5 2.6 0.6 1.8 1.9 0.9 2.1 1.3 1.4 1.6 1.3 1.8 0.3 1.2 2.3 4.7 2.6 1.6 0.9 1.3 2.0 0.6 1.3 0.7 0.7 2.5 1.0 1.0 1.6 1.1 2.0 2.6 5.6 0.9 3.6 1.0 2.9 0.5 1.0 0.7 8.0 0.5 0.1 1.6 1.4 0.8 0.6 0.4 0.3 1.3 1.9 0.1 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 1.8 1.6 1.8 1.9 2.0 4.0 4.6 3.4 3.5 2.1 2.5 1.4 6.4 0.5 10.1 0.0 0.6 1.6 7.8 1.8 2.6 1.9 2.2 3.1 5.7 9.9 3.7 2.1 0.9 0.0 0.5 15.6 3.8 425.9 68.8 2.8 1.3 3.0 0.0 5.1 2.3 0.7 1.5 0.0 2.6 1.3 1.5 1.1 0.2 0.7 1.7 5.8 0.5 10.2 0.3 0.4 157.5 2.8 0.8 3.6 1.9 0.6 5.6 0.0 4.0 3.9 1.6 0.4 1.5 0.0 0.6 0.2 10.4 115.3 16.9 0.0 0.7 3.3 215.5 8.4 0.4 1.0 0.3 0.6 1.6 0.4 0.9 PIRT ENSG00000233670 "Phosphoinositide interacting regulator of transient receptor potential channels" P0C851 17 10822470-10838087 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 24.0" "Cell type enhanced" "Detected in single" "Astrocytes: 2.6" "Cancer enriched" "Detected in single" 40 "glioma: 5.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA042337 Uncertain "Plasma membrane,Cytosol" NA NA "Cluster 70: Brain - Nervous system development" "Cluster 64: Astrocytes - Nervous system maintenance" Cytosol "Plasma membrane" "HPA042337: AB_10794795" "unprognostic (2.95e-1)" "unprognostic (2.19e-2)" "unprognostic (7.57e-2)" "unprognostic (6.58e-3)" "unprognostic (9.42e-2)" "unprognostic (2.05e-1)" "unprognostic (2.85e-3)" 0.0 2.5 7.5 1.1 8.7 0.0 0.0 11.5 6.8 0.0 1.7 4.0 1.0 0.0 0.0 0.1 0.2 0.1 0.0 5.4 11.6 0.0 0.0 0.0 0.0 22.4 16.5 0.0 0.0 0.0 0.0 0.0 14.0 0.1 2.6 0.2 0.0 0.0 0.0 0.3 1.9 0.8 11.8 0.0 1.4 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.5 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 8.7 11.5 6.8 5.4 11.6 22.4 16.5 14.0 11.8 24.0 10.8 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PKD2 "Pc-2, PC2, PKD4, TRPP2" ENSG00000118762 "Polycystin 2, transient receptor potential cation channel" Q13563 4 88007635-88077777 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Potassium transport, Transport, Wnt signaling pathway" "Calcium channel, Ion channel, Potassium channel, Voltage-gated channel" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 129.1;Inhibitory neurons: 148.6;Microglial cells: 95.5;Oligodendrocyte precursor cells: 178.9;Oligodendrocytes: 219.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ: 137.2;BJ hTERT+: 207.1;fHDF/TERT166: 166.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004544, HPA015794, HPA055297" Approved Supported "Endoplasmic reticulum,Cytosol" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Endoplasmic reticulum" Cytosol "CAB004544: AB_672377, HPA015794: AB_1855437, HPA055297: " "unprognostic (2.01e-1)" "unprognostic (3.57e-2)" "unprognostic (1.22e-1)" "unprognostic (6.83e-2)" "unprognostic (9.71e-2)" "unprognostic (1.97e-1)" "unprognostic (3.17e-2)" "unprognostic (1.88e-1)" "unprognostic (8.64e-2)" "unprognostic (1.08e-1)" "unprognostic (6.59e-2)" "unprognostic (1.09e-1)" "unprognostic (1.17e-3)" "unprognostic (3.54e-3)" "unprognostic (1.07e-1)" "unprognostic (1.12e-2)" "unprognostic (2.51e-1)" 30.7 24.2 9.6 13.9 12.2 10.7 18.6 10.0 12.0 40.0 7.3 32.5 10.7 61.1 14.7 12.7 39.3 26.9 19.7 9.0 8.9 48.6 15.0 22.2 11.5 10.4 11.2 47.7 14.8 27.9 9.0 24.5 10.0 23.3 13.2 14.0 9.7 39.2 5.8 10.3 14.8 53.7 9.1 10.9 20.0 10.3 11.9 7.6 16.4 11.7 8.7 20.6 18.4 14.6 7.4 40.8 44.9 23.2 101.8 67.6 13.3 137.2 207.1 62.9 62.2 2.0 12.8 4.0 29.3 166.4 24.0 9.1 8.1 20.4 54.5 21.2 7.1 6.6 21.8 4.3 56.5 16.2 12.9 56.4 9.1 49.4 26.4 85.6 28.8 7.6 0.9 10.9 55.5 14.4 11.4 7.7 23.4 5.3 6.7 21.5 26.8 6.0 55.6 17.2 9.0 20.1 25.5 1.2 32.5 45.0 9.7 12.1 44.7 59.1 12.9 16.8 18.8 8.7 2.9 4.4 35.2 2.5 55.3 1.4 0.1 0.2 0.2 0.2 0.4 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.2 0.3 0.1 0.4 0.1 0.1 9.6 12.2 10.0 12.0 9.0 8.9 10.4 11.2 10.0 9.1 11.9 14.6 14.8 3.2 6.3 59.4 3.5 7.4 5.3 7.4 23.3 16.7 7.4 11.3 7.1 18.6 7.2 69.9 10.4 10.4 2.7 0.6 0.0 14.0 0.3 10.3 41.7 19.2 6.7 13.5 129.1 3.8 3.4 42.0 2.0 11.1 1.3 12.7 21.4 10.6 12.2 26.9 148.6 3.4 4.1 5.0 6.8 1.1 23.0 9.8 23.2 95.5 9.5 17.3 4.1 178.9 219.4 2.2 4.6 50.8 3.1 6.5 3.9 17.0 12.3 1.9 26.3 53.0 31.5 0.8 3.8 13.3 6.7 2.7 6.1 11.5 2.8 3.4 PLAC1 "CT92, OOSP2B, OOSP2L" ENSG00000170965 "Placenta enriched 1" Q9HBJ0 X 134565838-134764322 "Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 29 "placenta: 27.9" "Cell type enhanced" "Detected in some" "Fibroblasts: 24.5;Leydig cells: 5.6;Peritubular cells: 7.9;Spermatocytes: 6.5;Spermatogonia: 11.0;Syncytiotrophoblasts: 10.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 20.1;hTCEpi: 15.6;hTERT-HME1: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000163, HPA063425" Enhanced Approved Vesicles,Cytosol "Secreted in female reproductive system" NA NA "Cluster 28: Placenta - Pregnancy" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 33: Fibroblasts - ECM organization" Vesicles Cytosol "HPA000163: , HPA063425: AB_2685012" "unprognostic (2.93e-1)" "unprognostic (2.50e-3)" "unprognostic (2.89e-4)" "unprognostic (1.35e-7)" "unprognostic (3.83e-3)" "unprognostic (2.07e-2)" "unprognostic (1.63e-2)" "unprognostic (1.26e-1)" "unprognostic (2.01e-1)" "unprognostic (4.28e-2)" "unprognostic (1.48e-2)" "unprognostic (2.87e-2)" "unprognostic (3.33e-16)" "unprognostic (7.64e-3)" "unprognostic (4.03e-2)" "unprognostic (1.61e-1)" "unprognostic (1.91e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 27.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.9 0.0 1.2 0.0 0.2 1.2 0.3 0.4 1.1 0.0 2.0 0.3 0.1 1.8 0.3 0.5 20.1 0.0 0.1 0.3 2.3 0.0 0.0 0.9 15.6 0.1 6.3 0.1 2.4 0.2 0.1 1.7 0.1 1.0 0.0 0.3 0.0 1.3 2.6 0.0 0.3 3.7 0.0 0.0 3.0 0.0 0.0 3.7 0.7 2.2 0.1 0.0 0.0 0.5 0.8 0.2 0.0 0.4 0.1 0.3 0.2 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 1.3 0.0 2.8 24.5 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.9 0.0 0.0 0.0 0.0 0.7 5.6 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.5 0.1 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 11.0 0.0 0.0 10.7 0.0 2.1 0.0 0.0 PLD3 HU-K4 ENSG00000105223 "Phospholipase D family member 3" Q8IV08 19 40348456-40380439 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response" "Exonuclease, Hydrolase, Nuclease" "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 711.9" "Cell type enhanced" "Detected in all" "Hofbauer cells: 688.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "basophil: 1727.4" "Lineage enriched" "Detected in all" 7 "granulocytes: 1727.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012800, CAB020812" Approved Approved "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA 450000 "Cluster 10: Basophils - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 3: HMC-1 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" "Endoplasmic reticulum, Cytosol" Nucleoplasm "CAB020812: , HPA012800: AB_1855330" "unprognostic (1.11e-1)" "unprognostic (1.06e-1)" "unprognostic (1.64e-3)" "unprognostic (2.56e-3)" "unprognostic (2.06e-3)" "unprognostic (2.68e-1)" "unprognostic (4.52e-2)" "unprognostic (3.89e-2)" "unprognostic (1.09e-1)" "unprognostic (4.60e-2)" "prognostic favorable (6.44e-4)" "unprognostic (4.34e-2)" "prognostic favorable (2.21e-4)" "unprognostic (3.49e-2)" "unprognostic (2.10e-1)" "unprognostic (1.38e-2)" "unprognostic (6.42e-2)" 169.3 200.0 143.3 78.4 159.7 48.3 138.4 46.0 229.7 139.4 54.0 131.4 71.7 155.7 84.7 84.9 133.5 96.7 206.1 202.5 294.4 130.2 121.3 181.5 98.1 132.4 128.5 199.0 151.0 105.9 711.9 123.4 137.9 133.4 49.2 51.4 138.7 106.2 105.1 120.5 105.3 79.1 63.8 197.0 126.5 77.7 197.7 44.3 120.8 82.3 41.4 126.2 126.0 129.6 85.6 257.8 163.7 259.1 444.2 210.2 124.5 206.5 208.6 146.4 166.6 49.4 93.8 36.9 211.0 180.9 47.8 39.3 39.9 81.2 63.5 138.4 145.3 39.9 82.1 63.2 302.7 16.8 435.1 402.5 167.0 112.1 76.6 244.2 125.0 59.3 142.5 144.5 106.7 111.5 29.5 79.6 107.4 138.7 52.8 37.0 124.5 154.2 75.2 63.2 116.7 193.9 99.0 60.6 113.8 169.5 83.6 283.2 222.3 122.8 58.5 105.6 47.0 148.9 173.3 38.8 197.7 66.2 77.9 1727.4 256.7 378.7 75.0 129.5 62.0 34.4 59.5 67.7 235.0 28.1 60.8 61.3 25.7 102.3 64.2 34.7 64.5 208.6 143.3 159.7 46.0 229.7 202.5 294.4 132.4 128.5 137.9 63.8 197.7 129.6 66.7 32.1 69.6 59.4 27.0 35.4 93.6 263.1 39.9 101.5 45.9 61.2 22.0 45.8 90.4 57.0 33.3 158.2 27.2 42.5 21.5 52.5 8.7 32.0 49.8 53.9 72.8 18.7 99.1 58.3 107.2 158.8 38.2 31.5 60.3 134.7 88.2 43.1 688.4 121.1 113.4 41.3 126.1 280.9 59.1 15.7 151.6 261.3 92.5 50.6 54.2 94.1 35.0 53.3 70.2 54.3 42.6 143.7 85.8 57.9 78.8 37.1 35.2 47.6 19.7 73.1 59.7 24.2 67.9 32.4 33.4 195.9 28.8 114.1 41.6 68.2 PLEK2 ENSG00000100558 "Pleckstrin 2" Q9NYT0 14 67386984-67412167 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 51.1" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 149.0;Pancreatic endocrine cells: 179.8;Suprabasal keratinocytes: 90.6;Theca cells: 107.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 2.0;naive CD4 T-cell: 3.1" "Lineage enriched" "Detected in single" 7 "T-cells: 3.1" "Cell line enhanced" "Detected in many" "A-431: 91.0;CAPAN-2: 94.4;HBEC3-KT: 177.4;PC-3: 64.1;TIME: 69.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA001208 Enhanced Uncertain Vesicles,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 16: Pancreatic endocrine cells - Mixed function" Vesicles Cytosol "HPA001208: AB_1079631" "unprognostic (4.41e-3)" "unprognostic (3.77e-1)" "unprognostic (1.15e-1)" "unprognostic (6.23e-2)" "unprognostic (6.88e-2)" "unprognostic (3.17e-3)" "unprognostic (1.18e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (1.97e-1)" "unprognostic (9.21e-3)" "prognostic unfavorable (8.26e-5)" "unprognostic (1.06e-1)" "unprognostic (3.09e-3)" "unprognostic (2.90e-1)" "unprognostic (1.29e-1)" "unprognostic (8.98e-2)" "unprognostic (4.59e-2)" 0.8 51.1 0.3 5.5 0.3 12.7 3.9 0.8 0.6 3.9 0.1 25.1 29.6 1.5 32.4 16.4 1.7 3.9 0.3 0.4 0.2 9.7 29.7 1.6 0.2 0.3 0.2 0.6 7.9 7.0 1.3 1.5 0.3 7.7 28.7 0.1 6.8 4.2 0.3 26.5 32.6 1.3 0.2 0.6 20.6 3.1 0.4 22.9 23.5 0.2 5.5 12.1 7.9 0.4 91.0 13.4 0.0 0.1 0.0 1.0 8.4 17.9 2.7 4.2 5.2 48.8 94.4 0.0 17.3 2.5 0.2 42.4 0.1 177.4 9.6 0.1 0.7 0.0 19.4 0.4 3.8 0.0 0.0 1.9 12.3 4.6 55.4 0.0 14.8 0.0 0.4 0.4 3.0 28.9 0.0 0.2 0.3 57.4 64.1 0.0 0.1 14.0 30.0 2.4 0.7 0.2 17.0 7.9 5.2 0.9 11.6 0.9 69.3 0.0 54.1 0.3 0.4 0.3 0.2 0.3 10.7 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.3 0.4 0.0 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.3 0.8 0.6 0.4 0.2 0.3 0.2 0.3 0.2 0.4 0.4 0.1 0.0 1.1 1.0 0.6 149.0 29.0 69.9 37.0 0.0 4.9 6.0 0.5 10.0 11.8 5.5 0.0 1.0 0.0 25.0 3.9 42.1 0.1 2.3 0.2 2.0 8.4 16.0 0.8 46.3 5.5 4.2 37.2 2.2 0.0 24.0 0.0 11.5 6.8 0.0 0.6 68.5 26.4 1.3 57.1 0.3 0.3 7.4 21.4 0.0 5.2 0.0 0.0 0.5 0.3 179.8 23.9 0.0 0.0 15.8 47.9 3.2 4.5 0.0 0.0 0.0 4.6 0.4 2.3 21.2 90.6 1.5 1.3 107.7 54.8 25.5 PLEKHA2 TAPP2 ENSG00000169499 "Pleckstrin homology domain containing A2" 8 38901235-38973912 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 78.7" "Cell type enhanced" "Detected in many" "B-cells: 94.1;dendritic cells: 132.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 164.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004706 Approved Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 37: B-cells - Transcription" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Nuclear bodies, Cytosol" "HPA004706: AB_1079633" "unprognostic (2.78e-1)" "unprognostic (8.80e-3)" "unprognostic (4.15e-3)" "unprognostic (3.03e-1)" "unprognostic (8.61e-2)" "unprognostic (9.07e-3)" "unprognostic (6.16e-3)" "unprognostic (1.45e-1)" "unprognostic (1.76e-1)" "unprognostic (1.08e-1)" "unprognostic (1.39e-2)" "unprognostic (6.59e-2)" "prognostic unfavorable (1.95e-6)" "unprognostic (2.39e-2)" "unprognostic (1.00e-1)" "unprognostic (4.55e-2)" "unprognostic (9.60e-3)" 17.5 15.7 13.6 35.3 11.1 39.7 10.6 6.1 18.3 16.9 13.1 16.9 10.1 15.0 10.6 14.0 15.8 17.7 42.8 25.3 10.2 17.1 9.4 20.1 78.7 10.7 6.9 19.1 6.6 21.2 8.7 17.8 11.8 10.2 12.4 5.4 7.4 18.8 4.5 8.4 16.0 18.9 10.1 43.0 12.6 5.9 10.1 17.9 19.3 8.0 66.1 17.3 10.3 16.3 30.0 6.5 4.1 10.0 10.2 20.1 4.6 35.7 27.2 25.9 21.5 3.7 19.4 164.7 41.3 31.9 22.9 17.9 10.8 21.6 38.4 42.8 1.0 84.7 54.4 4.0 36.9 28.0 32.9 46.3 14.7 13.2 23.6 60.1 4.4 26.3 8.7 45.0 24.1 3.7 56.0 12.8 3.9 23.2 10.2 14.1 22.4 34.6 31.3 24.9 0.5 6.5 41.9 7.4 27.9 6.1 16.9 13.0 6.5 18.5 14.5 3.2 28.5 14.7 14.8 76.3 29.3 28.7 4.2 6.9 1.5 8.1 1.9 2.0 2.0 10.0 2.2 2.3 1.8 12.7 1.4 2.6 3.3 3.9 2.2 5.4 1.9 1.0 13.6 11.1 6.1 18.3 25.3 10.2 10.7 6.9 11.8 10.1 10.1 16.3 8.8 3.2 17.9 15.0 94.1 8.8 15.7 17.1 6.8 1.8 7.2 5.2 40.7 12.8 17.3 40.5 0.0 7.7 132.0 9.0 1.9 7.4 1.0 17.8 28.7 10.9 13.1 12.2 21.2 5.5 17.7 22.2 9.2 25.4 36.8 21.3 19.6 10.2 48.8 58.9 7.7 11.8 6.1 79.6 55.3 2.5 22.7 49.7 16.0 35.6 48.4 12.1 64.9 52.3 4.7 24.5 4.7 25.2 56.4 9.9 15.9 16.3 23.5 1.4 13.1 35.8 24.8 0.7 7.9 5.1 6.7 4.5 53.9 4.4 12.8 35.7 PLOD2 LH2 ENSG00000152952 "Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2" O00469 3 146069440-146163653 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Disease variant, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 130.9;Basal respiratory cells: 115.1;Distal enterocytes: 143.7;Extravillous trophoblasts: 130.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBF TERT88: 636.0;hTERT-RPE1: 723.8;U-87 MG: 566.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025898, HPA069126" Approved Uncertain Nucleoli,Cytosol "Intracellular and membrane" NA NA 21000 "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Nucleoli, Cytosol" "CAB025898: , HPA069126: " "unprognostic (8.68e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (2.23e-1)" "unprognostic (2.15e-1)" "unprognostic (1.34e-2)" "unprognostic (1.29e-3)" "prognostic unfavorable (7.64e-10)" "prognostic unfavorable (1.42e-4)" "unprognostic (2.97e-2)" "unprognostic (3.36e-2)" "unprognostic (6.27e-3)" "unprognostic (2.24e-1)" "prognostic unfavorable (4.99e-11)" "prognostic unfavorable (2.83e-4)" "unprognostic (6.07e-2)" "unprognostic (4.06e-2)" "unprognostic (4.41e-3)" 63.1 20.1 13.4 35.6 14.5 1.1 18.6 15.1 17.2 10.2 19.4 36.2 42.2 23.5 13.4 18.2 11.4 41.5 22.1 13.3 15.1 26.1 57.3 12.9 3.8 23.1 18.1 20.5 18.7 16.5 7.9 80.6 16.3 13.2 29.9 56.6 9.5 16.2 3.0 3.9 35.0 46.8 17.8 5.4 20.1 8.5 20.6 10.5 90.0 3.9 5.5 25.7 10.0 17.6 134.5 94.3 29.0 9.5 102.5 109.6 73.2 465.5 141.6 247.7 463.0 7.2 13.4 0.0 88.8 79.5 113.1 27.8 34.0 400.5 636.0 0.6 53.5 33.3 84.3 66.9 262.5 0.1 0.6 192.9 56.5 215.2 104.1 723.8 347.7 0.1 45.1 1.8 441.6 48.8 0.3 0.6 18.5 0.3 40.0 0.2 19.2 0.6 105.0 6.5 14.5 0.5 370.3 39.4 39.9 135.1 107.5 4.2 440.4 304.2 92.2 97.8 280.7 138.9 20.9 0.5 566.5 0.4 55.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 13.4 14.5 15.1 17.2 13.3 15.1 23.1 18.1 16.3 17.8 20.6 17.6 29.1 16.0 11.4 130.9 0.4 7.0 6.4 115.1 30.1 17.1 23.7 10.2 14.3 44.3 47.0 27.6 35.5 9.2 0.3 143.7 9.8 64.5 0.5 35.4 13.8 24.3 19.8 4.6 22.8 53.1 130.6 68.1 19.9 38.7 0.0 42.7 21.0 65.2 5.1 0.0 46.4 19.5 22.4 1.0 2.5 1.2 13.1 3.0 14.2 21.5 0.7 53.8 0.0 64.3 6.0 82.4 48.8 4.9 1.3 8.9 50.5 8.2 33.0 24.7 19.7 36.9 47.2 11.0 18.0 27.5 5.5 18.7 1.0 24.5 25.1 5.6 PNPLA7 "C9orf111, FLJ31318, FLJ43070, FLJ44279, NTE-R1, NTEL1, RP11-48C7.2" ENSG00000130653 "Patatin like phospholipase domain containing 7" Q6ZV29 9 137459952-137550402 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 56.2;Excitatory neurons: 23.6;Inhibitory neurons: 21.5;Oligodendrocytes: 21.0" "Cancer enhanced" "Detected in many" "prostate cancer: 9.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive B-cell: 1.0;T-reg: 1.2" "Group enriched" "Detected in many" 4 "B-cells: 1.0;T-cells: 1.2" "Cell line enriched" "Detected in some" 22 "HMC-1: 83.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009130 Uncertain Uncertain "Centriolar satellite,Cytosol" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 50: Non-specific - Ribosome" "Cluster 3: HMC-1 - Innate immune response" "Cluster 64: Astrocytes - Nervous system maintenance" Cytosol "Centriolar satellite" "HPA009130: AB_2268411" "unprognostic (1.49e-1)" "unprognostic (1.40e-2)" "unprognostic (3.61e-3)" "unprognostic (2.38e-2)" "unprognostic (3.68e-2)" "unprognostic (6.69e-3)" "unprognostic (2.72e-3)" "unprognostic (5.14e-4)" "unprognostic (3.24e-1)" "unprognostic (1.40e-2)" "prognostic favorable (2.24e-5)" "unprognostic (1.09e-1)" "unprognostic (2.23e-3)" "unprognostic (2.42e-1)" "unprognostic (6.80e-2)" "unprognostic (8.81e-2)" "unprognostic (3.45e-3)" 9.6 7.0 5.2 2.2 5.3 2.1 11.3 1.9 8.6 17.6 1.2 10.8 2.2 12.3 1.0 2.7 13.0 3.7 6.9 6.6 2.6 6.3 14.0 4.7 4.4 4.6 2.6 21.5 17.9 2.0 8.9 0.6 3.6 22.5 1.4 1.3 15.9 2.7 17.3 14.3 8.4 1.6 2.2 7.0 16.3 2.6 4.2 1.4 17.3 3.4 1.4 10.5 7.6 5.9 0.1 1.0 0.2 0.3 0.8 0.5 0.4 0.8 0.8 0.2 0.2 0.1 0.5 0.6 0.8 0.4 0.4 0.3 0.1 0.0 0.0 1.6 0.9 0.8 1.0 0.3 0.5 0.4 83.7 1.2 0.1 0.3 0.0 1.4 0.1 0.1 0.1 2.3 0.1 1.6 0.2 1.6 0.0 1.2 0.9 2.0 1.3 2.8 0.1 0.3 1.6 0.4 0.1 0.6 0.3 0.2 3.7 1.2 0.6 0.0 0.1 0.4 0.1 0.8 0.2 0.2 1.2 0.8 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.1 0.1 0.2 1.0 0.3 0.2 0.0 0.0 0.0 0.1 1.2 0.2 5.2 5.3 1.9 8.6 6.6 2.6 4.6 2.6 3.6 2.2 4.2 5.9 3.0 9.6 5.9 56.2 4.8 1.5 1.1 0.9 2.2 2.5 6.5 8.3 3.9 4.3 2.6 1.8 6.2 0.2 2.1 6.6 0.0 0.7 0.5 1.7 4.8 1.2 17.3 0.8 23.6 0.0 0.3 3.6 12.2 3.8 7.0 1.2 2.5 10.2 2.6 5.0 21.5 9.2 0.0 4.5 1.0 0.6 4.4 1.2 0.0 9.4 1.3 2.5 1.0 11.6 21.0 0.6 7.1 1.9 1.6 2.5 3.8 1.0 1.6 9.6 0.0 2.3 2.1 3.1 4.0 0.9 3.3 0.0 2.3 0.6 2.0 0.7 POLA2 FLJ21662 ENSG00000014138 "DNA polymerase alpha 2, accessory subunit" Q14181 11 65261920-65305589 "Metabolic proteins, Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 23.2;Spermatocytes: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA037570 Supported Supported Nucleoplasm,Cytosol NA Yes "Cluster 44: Non-specific - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Cytosol "HPA037570: AB_10672280" "unprognostic (2.28e-1)" "prognostic favorable (4.61e-4)" "unprognostic (1.67e-2)" "unprognostic (7.44e-2)" "unprognostic (5.20e-2)" "unprognostic (3.18e-2)" "prognostic unfavorable (2.11e-6)" "unprognostic (1.14e-1)" "unprognostic (2.87e-2)" "unprognostic (1.15e-2)" "unprognostic (4.05e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (4.09e-8)" "unprognostic (1.60e-3)" "unprognostic (8.26e-2)" "unprognostic (8.16e-2)" "unprognostic (6.25e-3)" 3.3 2.6 1.9 5.3 2.9 6.9 3.5 4.8 3.3 4.5 1.7 5.3 3.6 5.0 3.3 4.5 3.8 1.8 2.9 1.9 1.5 3.5 3.7 3.5 10.0 4.5 2.8 5.1 3.3 3.2 1.9 2.1 3.7 3.0 4.9 3.6 4.2 3.1 3.1 5.1 4.2 4.1 3.1 5.7 3.8 5.2 2.6 15.9 3.3 3.4 13.2 3.2 3.2 7.0 32.6 21.9 47.3 20.4 3.7 3.6 19.5 25.6 15.9 64.4 43.3 6.9 24.0 48.1 20.4 11.0 35.5 18.9 38.8 25.1 61.1 21.3 14.7 32.4 39.4 10.4 0.9 33.5 25.6 3.7 2.9 47.4 8.5 10.3 14.6 20.2 30.2 25.3 44.4 34.9 62.6 13.2 38.6 16.1 16.2 33.4 29.9 40.7 14.1 21.8 32.5 18.1 14.9 15.9 7.9 29.7 28.6 14.1 3.9 25.4 18.7 19.8 16.0 12.0 14.7 45.0 14.9 18.8 33.7 10.0 5.2 2.3 3.8 3.2 4.5 3.9 4.2 4.2 7.4 3.9 3.5 3.1 1.4 3.8 1.7 5.9 4.6 5.3 1.9 2.9 4.8 3.3 1.9 1.5 4.5 2.8 3.7 3.1 2.6 7.0 2.6 0.0 3.4 1.0 5.1 1.7 4.2 5.7 2.2 2.2 3.0 2.3 2.9 7.2 3.7 5.5 2.1 15.6 4.3 3.0 3.9 5.3 2.7 1.8 2.9 3.7 3.0 23.2 4.3 3.4 19.0 7.7 5.6 2.5 0.0 11.0 5.3 2.1 9.7 3.3 3.6 3.5 2.0 2.8 3.7 4.0 7.5 5.3 0.0 12.2 8.0 2.2 5.2 1.5 8.7 4.9 2.2 7.5 10.4 3.4 1.7 2.0 3.2 5.4 6.6 19.6 5.0 23.7 17.7 4.3 1.4 7.3 5.5 4.0 6.3 3.7 POLQ POLH ENSG00000051341 "DNA polymerase theta" O75417 3 121431427-121546641 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 6.0;lymphoid tissue: 4.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 16.4;Excitatory neurons: 9.5;Granulosa cells: 12.6;Inhibitory neurons: 7.8;Plasma cells: 12.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebellum: 1.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 2.5" HPA053359 Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA Yes "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Golgi apparatus, Cytosol" "HPA053359: " "unprognostic (1.59e-1)" "unprognostic (4.18e-2)" "unprognostic (2.66e-2)" "prognostic unfavorable (5.46e-5)" "unprognostic (2.70e-1)" "unprognostic (6.23e-3)" "unprognostic (3.09e-5)" "unprognostic (8.55e-3)" "unprognostic (1.09e-4)" "unprognostic (2.86e-1)" "unprognostic (5.59e-5)" "unprognostic (2.06e-3)" "unprognostic (0.00e+0)" "prognostic favorable (1.04e-4)" "unprognostic (1.76e-1)" "unprognostic (6.01e-2)" "unprognostic (5.76e-2)" 0.1 0.2 0.0 1.6 0.1 6.0 0.4 1.0 0.2 0.2 0.0 1.2 1.2 0.2 0.0 2.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.2 2.8 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.1 2.0 0.0 0.3 0.0 0.0 1.4 0.9 0.4 0.0 0.8 0.5 2.2 0.0 4.5 0.0 0.0 2.3 0.3 0.5 0.0 18.2 12.1 10.2 7.2 0.9 1.2 9.2 8.5 3.2 9.7 12.9 9.8 6.6 21.5 3.7 4.6 11.7 14.0 12.2 5.4 16.4 6.3 6.7 13.8 8.0 6.1 0.1 15.1 12.1 0.2 0.4 8.9 5.4 1.7 4.9 7.9 9.3 15.9 10.3 7.1 13.7 8.8 9.7 5.5 5.9 11.4 12.2 7.6 3.1 10.3 5.5 5.0 9.8 5.2 3.4 8.8 4.8 14.8 3.8 8.6 11.2 3.4 11.1 8.0 6.9 21.8 4.1 11.0 6.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 1.6 0.7 0.9 0.5 0.6 0.0 0.9 0.6 0.6 1.6 0.0 2.0 0.0 0.0 3.1 0.6 1.6 0.0 0.1 0.4 0.9 1.0 0.5 0.0 16.4 9.5 0.0 3.3 1.2 4.6 1.0 0.0 12.6 0.0 0.2 2.3 0.0 7.8 1.6 2.0 1.3 1.2 0.7 0.3 1.7 0.0 1.0 0.6 0.4 0.0 1.5 1.3 0.2 1.2 0.0 12.2 0.5 0.2 0.1 2.4 0.2 0.0 0.1 1.0 6.8 3.4 4.9 0.1 0.3 1.8 0.9 3.2 0.8 POLR2C RPB3 ENSG00000102978 "RNA polymerase II subunit C" P19387 16 57462660-57472009 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040919, HPA041826" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 6: Non-specific - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm Cytosol "HPA040919: AB_10795483, HPA041826: AB_10793935" "unprognostic (2.10e-2)" "unprognostic (4.42e-2)" "unprognostic (7.52e-3)" "unprognostic (1.82e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (1.48e-4)" "unprognostic (2.90e-1)" "unprognostic (9.54e-2)" "unprognostic (1.95e-1)" "unprognostic (2.48e-2)" "unprognostic (2.60e-2)" "unprognostic (6.63e-2)" "prognostic favorable (3.03e-6)" "unprognostic (2.29e-1)" "unprognostic (2.31e-2)" "unprognostic (1.20e-1)" "unprognostic (5.43e-3)" 35.1 41.6 49.9 30.4 51.2 43.9 39.6 52.3 60.3 36.8 49.4 36.0 33.1 39.2 67.1 31.2 47.0 31.3 52.1 51.0 52.0 59.8 62.3 47.7 38.7 50.5 51.0 54.3 45.1 55.1 46.9 39.5 51.8 40.4 40.0 59.3 39.0 45.9 74.2 34.5 31.8 40.6 52.4 30.8 36.4 25.4 50.4 47.7 40.8 61.4 44.9 39.1 31.2 54.5 59.3 94.0 81.2 72.7 72.7 62.9 67.6 75.4 84.9 126.0 82.3 121.7 74.7 65.8 86.4 89.3 75.6 60.5 111.9 83.5 134.2 30.2 77.0 51.1 53.5 142.0 81.8 95.0 94.4 57.8 66.4 96.7 88.7 66.6 74.8 90.0 90.2 37.3 81.6 78.6 106.9 98.6 118.4 72.1 138.0 151.4 94.4 120.5 99.7 56.7 102.5 117.4 122.9 69.8 81.4 74.0 51.6 85.2 54.4 76.3 76.3 56.8 89.0 82.2 76.2 135.0 75.3 79.5 102.5 79.8 38.3 70.3 44.6 37.8 49.2 52.4 50.6 42.8 38.1 48.4 60.4 57.4 96.9 64.6 49.5 31.2 54.9 60.5 49.9 51.2 52.3 60.3 51.0 52.0 50.5 51.0 51.8 52.4 50.4 54.5 49.5 25.6 43.0 11.1 49.2 31.0 46.0 51.3 30.1 81.6 39.4 52.5 11.0 41.5 31.9 27.6 56.3 78.8 49.8 38.2 92.0 62.9 5.6 25.0 25.4 39.0 38.2 35.6 13.3 65.8 80.8 40.5 15.8 22.3 61.0 46.1 23.2 25.1 41.2 52.2 13.9 34.5 48.8 22.9 30.3 8.4 51.6 22.7 40.9 8.4 49.1 102.7 58.7 8.0 9.6 59.5 44.6 51.9 40.0 43.9 63.8 120.4 29.4 93.9 46.0 30.0 49.1 50.4 66.4 30.0 30.0 92.9 52.9 49.0 38.4 43.5 POLR3G "C31, RPC32, RPC7" ENSG00000113356 "RNA polymerase III subunit G" O15318 5 90471748-90514557 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 24.8;Inhibitory neurons: 21.2;Oligodendrocytes: 70.8;Spermatogonia: 26.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 84.5" "CAB010109, HPA052658, HPA074330" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "Nuclear bodies, Cytosol" "CAB010109: AB_2165718, HPA052658: AB_2681904, HPA074330: " "unprognostic (4.31e-1)" "unprognostic (5.35e-2)" "unprognostic (2.62e-2)" "unprognostic (3.55e-3)" "unprognostic (1.18e-1)" "unprognostic (3.42e-2)" "unprognostic (4.19e-6)" "unprognostic (2.17e-3)" "unprognostic (1.91e-1)" "unprognostic (1.93e-2)" "unprognostic (3.52e-2)" "unprognostic (9.71e-2)" "unprognostic (1.21e-14)" "unprognostic (3.86e-2)" "unprognostic (3.19e-2)" "unprognostic (1.53e-2)" "unprognostic (8.17e-5)" 1.8 0.6 3.5 2.4 4.5 3.0 2.0 6.3 5.9 1.3 0.7 1.6 1.8 1.5 4.7 4.3 1.2 1.3 1.8 3.6 6.0 0.9 2.2 1.6 4.7 5.7 4.4 1.9 2.4 2.0 0.9 1.8 6.8 1.7 1.5 3.3 2.3 0.5 3.0 4.3 1.4 0.8 1.9 1.8 1.2 4.5 4.2 0.8 3.2 0.8 1.9 2.0 1.7 6.3 24.1 13.0 18.8 5.3 5.9 8.2 7.7 11.9 4.3 19.8 16.8 9.0 18.8 63.7 4.2 5.3 20.0 11.6 20.8 23.2 69.2 29.6 19.6 26.2 8.1 15.1 9.5 19.4 6.2 6.7 8.1 32.7 25.8 4.6 27.2 26.5 35.8 6.4 8.3 13.2 19.1 14.1 78.1 4.0 63.2 16.5 7.4 40.2 5.9 3.2 22.0 6.4 3.7 9.6 35.1 7.7 5.4 6.2 29.1 10.3 21.2 13.2 48.3 13.5 36.7 50.0 22.1 23.7 84.5 3.3 0.2 0.2 1.5 0.4 0.7 1.7 0.5 0.9 0.4 0.9 1.1 1.2 0.7 2.9 1.5 1.0 0.2 0.3 3.5 4.5 6.3 5.9 3.6 6.0 5.7 4.4 6.8 1.9 4.2 6.3 3.2 6.4 2.2 11.8 2.8 3.6 1.6 1.5 1.8 3.0 2.8 3.7 5.2 0.0 0.7 1.8 8.4 0.8 0.7 0.9 3.9 2.4 4.5 1.6 2.3 2.0 6.7 8.8 24.8 4.4 5.4 3.8 0.5 1.2 7.0 1.6 4.6 2.6 1.7 3.3 21.2 1.4 0.0 0.3 0.3 1.0 0.3 1.2 1.8 5.6 0.0 1.1 1.0 14.6 70.8 4.1 3.0 1.2 5.4 6.1 0.4 1.5 3.0 0.8 0.0 1.1 1.8 7.2 26.6 6.3 8.5 0.8 1.7 6.5 2.0 0.8 PPARGC1B "PERC, PGC1B" ENSG00000155846 "PPARG coactivator 1 beta" Q86YN6 5 149730298-149855022 "Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 12.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 111.8;Cone photoreceptor cells: 135.5;Rod photoreceptor cells: 72.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 9.7" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 3.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050543 Supported Nucleoplasm,Cytosol NA Yes "Cluster 14: Monocytes - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 15: RT4 - Unknown function" "Cluster 56: Bipolar cells - Visual perception" Nucleoplasm Cytosol "HPA050543: AB_2681165" "unprognostic (2.86e-1)" "unprognostic (1.07e-2)" "unprognostic (5.09e-3)" "unprognostic (1.13e-3)" "unprognostic (2.63e-1)" "unprognostic (2.00e-3)" "unprognostic (4.51e-3)" "unprognostic (6.55e-2)" "unprognostic (9.14e-3)" "unprognostic (2.65e-2)" "unprognostic (1.83e-1)" "unprognostic (1.21e-1)" "unprognostic (9.01e-6)" "unprognostic (8.45e-2)" "unprognostic (5.09e-2)" "unprognostic (1.51e-1)" "unprognostic (2.77e-3)" 2.2 0.9 2.1 2.4 2.2 2.0 1.4 9.7 3.1 1.4 0.0 7.0 7.0 2.1 1.1 4.1 2.2 1.2 6.3 1.6 0.4 0.8 1.6 3.6 1.4 1.9 0.2 1.3 1.0 4.4 0.6 1.5 2.0 1.8 6.0 12.4 1.4 3.3 6.2 3.3 6.4 2.8 0.4 2.1 3.8 0.8 0.3 0.9 0.4 2.5 1.8 3.7 2.6 0.5 0.5 1.9 0.7 4.5 1.8 0.6 7.3 0.3 0.0 0.5 0.7 8.5 1.8 9.2 1.3 0.0 2.1 5.5 6.9 3.5 0.6 0.5 5.9 8.6 3.6 1.8 0.5 12.0 3.2 0.9 4.6 1.8 3.0 0.2 1.0 4.0 6.0 2.9 0.4 2.3 4.4 5.4 2.9 2.6 4.8 8.3 5.0 5.1 1.4 11.2 2.4 0.5 1.2 9.8 1.5 1.3 2.5 3.9 1.3 1.0 1.6 3.6 1.8 3.6 2.8 5.3 2.2 7.4 0.9 0.5 0.9 0.1 0.1 1.7 0.3 0.8 0.1 0.1 1.1 0.3 0.2 0.2 0.6 0.3 3.1 0.1 0.1 0.3 2.1 2.2 9.7 3.1 1.6 0.4 1.9 0.2 2.0 0.4 0.3 0.5 6.1 0.0 1.1 1.6 3.0 5.1 3.9 17.9 12.0 111.8 2.5 3.2 22.3 1.5 7.4 1.8 135.5 1.8 0.7 15.4 1.9 0.5 0.3 1.7 4.1 5.4 5.4 5.7 29.2 0.8 1.6 2.7 18.8 2.5 1.3 2.1 4.2 3.5 7.6 8.4 26.2 10.3 0.0 12.5 4.7 0.2 1.5 12.1 3.6 12.2 6.1 4.0 2.1 12.1 0.9 0.5 6.7 0.4 5.5 5.1 19.6 3.0 2.9 72.0 6.6 3.0 8.9 0.2 3.2 23.1 10.7 4.9 2.0 2.1 24.9 6.1 PPIG "CARS-Cyp, SCAF10, SRCyp" ENSG00000138398 "Peptidylprolyl isomerase G" Q13427 2 169584342-169641406 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021788, HPA057469" Supported Supported "Nuclear speckles,Cytosol" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 1: K-562 - Erythropoiesis" "Cluster 10: Non-specific - Unknown function" "Nuclear speckles" Cytosol "HPA021788: AB_1847408, HPA057469: AB_2683445" "unprognostic (2.70e-1)" "unprognostic (2.17e-1)" "unprognostic (2.40e-1)" "unprognostic (2.04e-3)" "unprognostic (4.17e-2)" "unprognostic (3.49e-2)" "unprognostic (1.55e-3)" "unprognostic (3.66e-2)" "unprognostic (2.15e-3)" "unprognostic (3.15e-3)" "unprognostic (2.47e-2)" "unprognostic (2.28e-1)" "prognostic unfavorable (4.56e-4)" "unprognostic (5.23e-2)" "unprognostic (3.29e-1)" "unprognostic (3.41e-2)" "unprognostic (3.39e-2)" 26.0 23.2 23.1 28.4 22.1 54.2 27.5 28.8 58.6 27.6 22.9 26.3 26.6 28.8 31.5 27.5 23.6 22.0 25.6 21.5 29.9 29.2 47.1 24.7 36.9 24.6 25.6 26.5 21.2 32.6 25.8 28.0 24.3 27.9 26.0 29.3 26.5 22.9 27.6 25.4 29.7 21.7 22.9 32.3 27.4 20.1 23.7 36.1 29.9 26.2 35.4 26.3 26.5 25.9 56.4 25.5 70.8 35.9 35.4 42.5 63.7 58.9 42.3 45.0 45.9 66.3 58.9 94.8 52.5 44.1 55.5 50.5 56.6 48.4 65.6 68.0 45.7 129.9 36.7 88.3 34.4 136.8 58.9 36.6 54.0 58.5 64.6 40.6 50.4 53.5 142.7 76.2 49.5 43.5 101.0 81.9 100.8 45.3 25.1 90.7 71.7 90.5 53.9 81.2 60.5 41.2 63.4 47.2 68.9 52.9 44.2 78.7 52.7 53.9 43.7 38.4 52.6 41.1 65.3 126.8 38.5 68.1 54.1 31.9 22.5 36.7 22.8 25.1 26.7 32.9 30.9 29.2 18.2 38.4 33.4 27.6 40.4 21.1 31.4 30.0 26.8 17.0 23.1 22.1 28.8 58.6 21.5 29.9 24.6 25.6 24.3 22.9 23.7 25.9 159.7 221.2 175.1 53.5 188.8 151.4 191.4 185.9 101.3 204.6 120.8 156.1 148.4 107.2 169.5 93.8 54.2 170.0 160.1 91.6 80.3 103.1 11.0 104.6 142.3 141.1 104.8 163.5 82.4 103.3 177.0 142.4 66.8 126.3 179.1 115.8 121.7 181.2 151.7 220.4 81.8 135.8 116.0 130.3 126.5 15.6 142.0 129.6 110.3 46.9 152.4 137.6 133.9 53.8 69.7 93.9 118.0 146.7 130.1 161.8 121.1 113.8 132.2 109.1 164.3 150.2 193.9 276.4 183.8 108.3 172.8 205.5 166.7 147.1 149.9 167.7 PPP2R2B "B55beta, PR52B, PR55-BETA, SCA12" ENSG00000156475 "Protein phosphatase 2 regulatory subunit Bbeta" Q00005 5 146580742-147084784 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" Apoptosis "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 77.1;retina: 43.0" "Cell type enhanced" "Detected in many" "Astrocytes: 1539.0;Excitatory neurons: 846.0;Inhibitory neurons: 788.8;Late spermatids: 876.4;Oligodendrocyte precursor cells: 1035.4;Oligodendrocytes: 4480.1" "Cancer enriched" "Detected in some" 8 "glioma: 7.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 5.2;MAIT T-cell: 4.1;memory CD4 T-cell: 2.4;memory CD8 T-cell: 6.2;naive CD8 T-cell: 3.8;NK-cell: 2.9;T-reg: 3.4" "Group enriched" "Detected in many" 9 "NK-cells: 2.9;T-cells: 6.2" "Cell line enhanced" "Detected in some" "HaCaT: 7.2;HDLM-2: 24.2;RT4: 12.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038118, HPA042122, HPA042770" Approved Uncertain Cytosol NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 58: Brain - Synaptic function" "Cluster 44: HDLM-2 - Immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Cytosol "HPA038118: AB_10697238, HPA042122: AB_2677859, HPA042770: AB_2678155" "unprognostic (4.54e-5)" "unprognostic (1.74e-1)" "unprognostic (1.21e-1)" "unprognostic (2.80e-4)" "unprognostic (2.48e-1)" "unprognostic (1.44e-1)" "unprognostic (2.76e-1)" "unprognostic (1.84e-2)" "unprognostic (2.68e-1)" "unprognostic (3.20e-2)" "unprognostic (9.73e-4)" "unprognostic (4.51e-2)" "unprognostic (1.49e-8)" "unprognostic (2.02e-1)" "unprognostic (3.67e-1)" "unprognostic (5.48e-5)" "unprognostic (1.14e-4)" 1.3 7.8 53.9 0.9 71.4 1.9 0.8 44.7 77.1 1.2 6.0 6.5 1.0 0.4 0.5 1.3 3.6 1.8 2.5 57.8 53.9 3.7 0.7 0.8 1.7 50.7 56.3 0.4 1.9 2.8 14.8 0.7 50.4 1.9 1.9 43.0 1.0 1.0 0.3 3.4 2.2 1.3 50.7 1.8 1.1 18.9 71.6 0.8 3.1 0.3 0.8 7.5 2.0 73.9 0.2 0.0 1.3 2.0 0.2 0.0 0.4 0.7 0.3 0.7 0.2 2.3 1.9 0.2 0.2 0.1 0.0 7.2 0.5 0.4 1.8 24.2 0.4 0.4 4.8 0.6 0.4 0.1 0.4 0.2 1.2 0.0 0.4 0.8 0.3 0.7 0.7 0.5 0.9 0.3 0.2 0.1 2.3 0.0 0.9 1.6 0.2 0.0 1.9 12.5 1.3 0.2 0.3 0.0 0.3 1.4 0.7 0.0 0.4 0.1 0.3 1.7 0.6 0.1 0.4 0.2 0.9 1.9 2.0 0.5 0.0 0.0 5.2 0.0 4.1 0.1 2.4 6.2 0.0 0.0 0.6 3.8 0.1 2.9 0.1 0.0 3.4 1.4 53.9 71.4 44.7 77.1 57.8 53.9 50.7 56.3 50.4 50.7 71.6 73.9 0.5 3.2 1.8 1539.0 0.3 2.0 1.1 2.3 4.6 90.5 0.5 3.6 1.6 10.0 0.9 9.2 150.1 18.9 30.2 0.0 21.5 1.7 295.3 1.0 0.1 2.0 13.1 1.3 846.0 0.0 0.3 1.1 1.1 0.4 0.0 0.0 0.0 0.0 0.9 47.1 788.8 0.0 0.0 1.2 4.7 876.4 3.4 1.4 5.4 58.1 0.3 45.0 57.7 1035.4 4480.1 0.6 0.0 2.2 3.3 1.0 0.0 5.5 0.1 275.4 0.0 0.7 11.0 4.8 2.2 1.6 1.4 5.3 31.0 0.1 0.0 0.9 PPP2R5C "B56G, B56gamma, PR61G" ENSG00000078304 "Protein phosphatase 2 regulatory subunit B'gamma" Q13362 14 101761798-101927989 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "dendritic cells: 525.3;T-cells: 323.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027553 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA027553: AB_10602081" "unprognostic (3.28e-1)" "unprognostic (1.66e-1)" "unprognostic (2.19e-1)" "unprognostic (3.24e-2)" "unprognostic (1.36e-1)" "unprognostic (1.10e-1)" "unprognostic (2.78e-1)" "unprognostic (1.23e-1)" "unprognostic (1.99e-1)" "unprognostic (1.31e-3)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" "unprognostic (2.33e-3)" "unprognostic (1.17e-1)" "unprognostic (3.09e-1)" "unprognostic (4.49e-1)" "unprognostic (1.72e-1)" 54.7 58.4 72.7 77.6 75.1 129.2 62.0 67.3 81.2 59.2 55.1 70.7 52.4 53.8 63.5 73.8 49.2 57.7 112.6 89.3 72.5 58.6 89.3 66.8 136.9 73.1 71.1 61.2 59.6 64.1 43.2 45.6 72.4 50.5 74.4 56.2 69.2 55.8 79.2 67.3 57.3 60.8 74.2 72.0 53.8 66.5 71.9 114.4 66.5 73.0 124.6 67.3 44.1 72.8 100.6 67.4 111.8 108.6 99.5 138.8 107.9 92.7 121.5 113.5 107.9 68.2 169.8 272.1 86.9 120.8 79.7 102.7 103.6 98.2 146.6 123.2 48.3 79.0 74.8 66.7 73.3 122.7 162.4 91.9 124.4 78.2 72.1 100.7 103.3 145.3 167.5 111.7 109.7 153.2 124.1 135.1 65.0 200.7 111.2 103.7 125.8 67.8 109.3 112.1 87.2 163.3 125.6 82.2 161.1 78.0 150.2 92.9 103.0 71.1 67.3 276.4 93.0 154.8 249.3 449.4 106.6 89.5 81.0 97.5 72.7 72.6 217.2 94.3 140.0 74.8 139.8 172.3 65.4 68.8 98.4 153.5 133.7 68.2 104.6 95.8 156.2 91.3 72.7 75.1 67.3 81.2 89.3 72.5 73.1 71.1 72.4 74.2 71.9 72.8 51.0 83.3 93.9 61.4 94.4 58.6 45.7 35.0 26.2 30.8 51.7 35.8 133.9 47.1 52.4 36.8 58.4 49.8 525.3 69.3 46.9 38.3 79.6 104.2 39.2 45.9 47.4 45.3 124.6 46.9 46.6 43.4 33.6 54.9 69.6 38.7 59.3 78.5 73.2 26.9 92.2 78.9 38.7 122.9 84.5 69.5 52.5 78.4 85.4 84.3 128.2 49.9 280.2 71.4 89.8 50.6 69.7 45.5 193.9 48.9 51.0 62.8 76.5 43.3 39.5 34.3 54.1 47.1 27.5 36.2 70.3 52.4 323.4 42.7 62.6 71.6 PRKACG PKACg ENSG00000165059 "Protein kinase cAMP-activated catalytic subunit gamma" P22612 9 69012504-69014113 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 152 "testis: 24.6" "Group enriched" "Detected in some" 27 "Early spermatids: 71.0;Late spermatids: 88.4;Spermatocytes: 41.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB004530, HPA071185" Supported Uncertain "Cytokinetic bridge,Cytosol" Yes NA "Cluster 74: Testis - Spermatogenesis" "Cluster 66: Spermatocytes - Spermatogenesis" Cytosol "Cytokinetic bridge" "CAB004530: AB_628137, HPA071185: AB_2686356" "unprognostic (2.74e-1)" "unprognostic (3.61e-2)" "unprognostic (7.22e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 88.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.3 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PROSER2 "C10orf47, MGC35403" ENSG00000148426 "Proline and serine rich 2" Q86WR7 10 11823339-11872277 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 41.0" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 28.4;Glandular and luminal cells: 28.4;Hepatocytes: 31.2;Prostatic glandular cells: 34.6;Urothelial cells: 69.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 86.5;CAPAN-2: 99.5;HBEC3-KT: 64.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 14.4" HPA041337 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA 220000 "Cluster 85: Liver - Metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "Plasma membrane, Cytosol" "HPA041337: AB_10794663" "unprognostic (2.36e-3)" "unprognostic (1.39e-1)" "unprognostic (3.55e-2)" "unprognostic (1.19e-1)" "unprognostic (4.60e-2)" "unprognostic (7.60e-3)" "unprognostic (4.80e-2)" "unprognostic (1.84e-1)" "unprognostic (1.20e-1)" "unprognostic (2.82e-1)" "unprognostic (1.25e-3)" "unprognostic (1.61e-1)" "unprognostic (1.26e-2)" "unprognostic (4.04e-2)" "unprognostic (3.01e-1)" "unprognostic (5.06e-2)" "unprognostic (8.69e-2)" 4.5 1.6 1.9 1.0 2.0 10.4 4.1 1.4 1.6 3.6 4.8 3.1 1.2 3.4 0.5 9.9 3.8 1.7 1.8 1.7 1.8 14.0 41.0 9.8 0.3 1.9 2.3 2.4 7.5 0.5 1.9 7.2 2.0 9.1 1.8 0.1 6.9 2.2 2.0 5.1 1.7 1.0 1.7 7.3 6.6 6.1 3.1 1.9 6.7 0.4 2.8 4.0 6.0 1.3 86.5 12.1 0.7 0.3 2.5 3.1 4.9 3.8 1.8 3.0 1.5 28.1 99.5 0.0 15.1 0.3 1.3 22.1 8.4 64.2 1.5 0.1 20.3 9.8 4.8 18.4 14.2 0.0 5.9 3.6 13.6 17.8 19.9 0.3 9.2 1.6 15.0 0.1 4.3 11.7 0.0 3.2 5.3 11.3 6.9 13.9 11.3 0.0 6.6 4.2 0.1 1.1 6.5 24.9 11.1 4.1 13.1 5.3 6.8 0.1 19.7 33.2 0.4 0.0 0.2 0.1 0.1 3.4 4.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 1.9 2.0 1.4 1.6 1.7 1.8 1.9 2.3 2.0 1.7 3.1 1.3 3.0 9.6 5.9 1.3 0.0 5.7 28.4 8.2 8.6 0.0 5.5 5.2 1.1 18.6 6.5 5.5 0.0 5.5 0.2 3.2 5.9 11.6 3.0 18.6 2.8 3.7 1.8 2.5 0.7 3.8 18.3 3.6 6.1 28.4 0.0 1.9 1.1 31.2 0.8 0.0 0.7 1.3 2.0 0.3 0.7 3.0 1.8 3.7 3.6 6.5 0.1 0.1 0.0 0.5 0.4 20.0 1.5 4.5 0.0 34.6 0.2 0.8 6.8 0.1 0.0 0.6 1.3 3.7 5.6 4.6 4.7 0.7 0.5 0.7 2.6 69.4 PRR23B FLJ46116 ENSG00000184814 "Proline rich 23B" Q6ZRT6 3 139019031-139020926 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "testis: 1.3" "Group enriched" "Detected in some" 8 "Spermatocytes: 6.4;Spermatogonia: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047473 Uncertain Uncertain "Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes NA "Cluster 83: Testis - Spermatogenesis" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Microtubules" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA047473: AB_2680062" "unprognostic (7.57e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 PTPRS ENSG00000105426 "Protein tyrosine phosphatase receptor type S" Q13332 19 5158495-5340803 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Heparin-binding, Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 76.8;Inhibitory neurons: 104.2;Melanocytes: 80.0;Oligodendrocytes: 90.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 89 "plasmacytoid DC: 12.5" "Lineage enriched" "Detected in single" 89 "dendritic cells: 12.5" "Cell line enhanced" "Detected in many" "AN3-CA: 121.8;HaCaT: 124.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054747 Approved "Plasma membrane,Cytosol" "Secreted - unknown location" NA NA 150000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane, Cytosol" "HPA054747: AB_2682591" "unprognostic (8.14e-2)" "unprognostic (4.59e-3)" "unprognostic (2.57e-2)" "unprognostic (9.20e-2)" "unprognostic (2.15e-1)" "unprognostic (6.96e-3)" "unprognostic (6.85e-2)" "unprognostic (2.36e-1)" "unprognostic (3.12e-3)" "unprognostic (1.86e-1)" "prognostic favorable (1.07e-4)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (2.80e-1)" "unprognostic (1.45e-1)" "unprognostic (4.05e-1)" "unprognostic (3.46e-2)" 54.7 21.2 34.4 5.0 25.5 1.5 36.2 3.2 30.9 40.2 0.0 25.2 2.6 30.5 2.2 16.5 41.1 13.7 37.0 34.3 10.0 11.2 6.0 26.9 5.5 16.4 16.4 35.8 32.4 9.7 29.1 2.3 17.6 30.5 1.6 5.7 18.6 14.6 14.4 20.6 13.6 8.6 1.6 9.0 23.2 9.9 27.3 4.2 29.4 7.4 4.4 32.0 31.8 34.9 11.3 64.0 56.2 121.8 25.3 20.5 7.4 19.4 22.5 22.8 18.5 0.7 6.2 0.2 44.5 32.2 18.0 124.6 15.1 0.2 10.0 1.5 24.3 0.0 27.2 40.5 11.7 0.0 14.1 21.8 5.4 4.8 0.9 29.4 0.6 7.9 18.5 0.2 9.1 48.0 5.2 12.3 31.7 0.4 27.0 0.0 12.4 0.0 4.7 22.5 43.1 58.9 18.3 3.4 34.6 10.7 22.0 4.8 2.8 20.2 34.3 46.9 23.6 6.2 0.1 36.9 10.5 0.0 44.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 34.4 25.5 3.2 30.9 34.3 10.0 16.4 16.4 17.6 1.6 27.3 34.9 1.1 6.4 1.1 53.8 3.2 60.9 42.4 16.1 22.2 49.6 3.3 5.5 14.1 27.1 4.9 12.9 2.1 0.7 56.4 0.1 9.8 1.4 3.4 5.4 11.4 9.7 3.0 0.0 76.8 0.9 32.2 51.2 5.1 5.3 0.0 4.0 25.4 20.2 1.7 11.8 104.2 0.0 10.2 0.3 20.0 5.4 46.6 3.4 80.0 15.9 0.8 46.6 0.0 71.9 90.2 0.5 0.0 36.1 6.3 35.0 0.0 2.9 1.7 10.1 13.1 46.4 22.6 7.4 14.8 16.8 36.7 1.0 2.0 2.7 0.4 30.0 PWWP3A "EXPAND1, MUM-1, MUM1" ENSG00000160953 "PWWP domain containing 3A, DNA repair factor" Q2TAK8 19 1354711-1378431 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 20.7;Cardiomyocytes: 31.4;Cytotrophoblasts: 18.8;Extravillous trophoblasts: 24.5;Fibroblasts: 14.5;Hofbauer cells: 16.9;Smooth muscle cells: 13.0;Syncytiotrophoblasts: 14.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048063, HPA054491" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Cytosol" "HPA048063: AB_2680243, HPA054491: " "unprognostic (2.50e-2)" "unprognostic (4.67e-1)" "unprognostic (1.72e-1)" "prognostic favorable (4.82e-4)" "unprognostic (1.14e-1)" "unprognostic (4.21e-3)" "unprognostic (4.84e-2)" "unprognostic (2.77e-2)" "unprognostic (1.21e-1)" "unprognostic (2.24e-2)" "prognostic favorable (2.25e-6)" "unprognostic (1.60e-1)" "unprognostic (6.05e-3)" "unprognostic (5.34e-2)" "unprognostic (1.57e-1)" "unprognostic (1.79e-1)" "unprognostic (7.29e-3)" 16.3 13.8 28.2 5.2 26.2 3.1 16.2 21.4 27.3 20.5 14.9 17.7 4.9 23.1 5.8 10.0 22.6 5.4 13.0 24.9 28.4 14.0 22.6 12.1 5.1 31.5 29.6 29.4 11.8 6.3 30.4 6.6 27.7 15.8 4.8 8.0 13.2 9.1 13.1 13.1 14.6 10.1 23.7 16.6 13.3 36.4 30.8 4.9 15.5 5.9 4.4 16.3 13.8 26.4 7.9 12.3 11.4 15.8 7.7 10.2 18.5 11.1 6.9 8.8 7.7 8.2 5.5 14.9 5.3 13.4 3.1 9.1 9.4 7.2 7.5 17.2 10.3 6.9 12.9 12.4 9.1 5.8 20.5 7.8 5.0 5.2 2.9 12.6 9.3 9.7 14.4 7.5 8.9 9.6 10.1 8.7 16.4 6.7 5.9 18.4 11.6 6.6 6.9 12.3 9.9 24.6 8.7 14.8 8.7 10.0 7.7 16.8 11.4 12.2 16.2 9.5 13.0 15.8 11.5 5.2 14.8 10.6 17.2 9.6 0.8 4.8 2.9 1.8 2.5 2.8 1.7 2.1 1.4 2.5 2.3 2.4 1.4 3.1 1.6 2.6 0.8 0.9 28.2 26.2 21.4 27.3 24.9 28.4 31.5 29.6 27.7 23.7 30.8 26.4 20.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.0 0.0 18.8 6.2 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 24.5 14.5 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 0.0 14.2 0.8 0.0 0.0 0.0 RAB25 CATX-8 ENSG00000132698 "RAB25, member RAS oncogene family" P57735 1 156061160-156070504 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 423.3;skin 1: 210.0" "Cell type enhanced" "Detected in many" "Paneth cells: 249.6;Squamous epithelial cells: 300.6;Undifferentiated cells: 244.6;Urothelial cells: 232.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "BEWO: 120.9;CAPAN-2: 119.9;MCF7: 171.5;OE19: 392.3;RT4: 153.4;SK-BR-3: 243.3;T-47d: 227.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA010872, CAB033645" Enhanced Uncertain "Cell Junctions,Cytosol" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 21: OE19 - Mitochondria" "Cluster 61: Squamous epithelial cells - Keratinization" "Cell Junctions, Cytosol" "CAB033645: AB_1128883, HPA010872: AB_1079729" "unprognostic (2.43e-1)" "unprognostic (4.57e-1)" "unprognostic (2.24e-1)" "unprognostic (1.71e-1)" "unprognostic (2.64e-1)" "unprognostic (1.97e-1)" "unprognostic (4.27e-2)" "unprognostic (4.63e-2)" "unprognostic (2.82e-1)" "unprognostic (2.03e-2)" "unprognostic (1.22e-2)" "unprognostic (1.39e-1)" "prognostic favorable (1.38e-6)" "unprognostic (2.31e-2)" "unprognostic (3.24e-2)" "unprognostic (3.14e-2)" "unprognostic (4.94e-2)" 0.6 0.1 0.1 10.2 0.1 0.1 52.0 0.3 0.3 76.2 0.0 86.2 72.9 7.3 37.5 423.3 47.5 26.4 0.1 0.0 0.0 41.6 1.7 39.2 0.4 0.1 0.1 0.4 57.1 68.9 27.5 12.4 0.1 36.3 78.1 0.0 105.3 28.4 0.9 210.0 65.6 3.7 0.2 0.2 80.9 0.3 0.1 10.1 50.6 0.0 44.0 69.9 148.2 0.3 93.3 0.0 0.0 0.0 0.0 0.0 120.9 0.0 0.0 0.0 0.0 90.4 119.9 0.0 0.1 0.0 0.0 109.5 0.0 51.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 105.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 171.5 0.0 0.4 4.8 392.3 0.0 0.1 0.0 0.3 0.0 153.4 13.3 0.0 0.0 243.3 0.3 21.1 227.9 0.4 0.0 0.2 0.2 0.0 0.2 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.0 0.2 0.0 0.0 1.2 1.1 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.1 0.3 0.3 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.3 1.2 28.9 41.0 0.0 1.5 55.1 102.9 113.9 74.0 0.0 121.4 137.7 0.1 94.4 98.7 86.5 0.0 102.1 2.3 197.8 166.3 170.4 0.0 58.6 6.4 2.6 85.4 0.0 0.1 150.3 30.0 2.3 96.4 66.2 5.7 0.0 0.0 0.4 7.3 0.0 0.1 208.5 89.5 0.0 5.8 0.0 0.3 2.1 21.4 0.0 3.6 0.0 0.0 0.0 0.1 197.3 249.6 0.0 0.3 114.0 195.9 35.5 66.3 0.0 0.0 0.0 6.8 0.2 1.1 300.6 154.7 80.3 2.7 0.0 244.6 232.3 RAB9A RAB9 ENSG00000123595 "RAB9A, member RAS oncogene family" P51151 X 13689128-13710504 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 345.3;Syncytiotrophoblasts: 370.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003094, CAB016411" Supported Uncertain Nucleoplasm,Cytosol NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 25: RPMI-8226 - Immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Cytosol "CAB016411: AB_630176, HPA003094: AB_1079736" "unprognostic (3.40e-2)" "unprognostic (1.36e-2)" "unprognostic (3.56e-3)" "unprognostic (3.08e-2)" "unprognostic (1.62e-1)" "unprognostic (2.56e-2)" "unprognostic (1.79e-2)" "unprognostic (1.45e-1)" "unprognostic (8.77e-2)" "unprognostic (8.23e-2)" "unprognostic (1.27e-2)" "unprognostic (4.88e-2)" "prognostic favorable (3.35e-5)" "unprognostic (3.93e-2)" "unprognostic (3.19e-1)" "unprognostic (1.46e-1)" "unprognostic (2.68e-2)" 28.9 51.7 24.2 18.4 27.2 56.0 32.8 28.3 28.2 31.4 21.8 28.4 14.9 29.4 21.3 29.7 21.5 22.8 20.7 23.4 26.0 30.3 24.9 24.9 25.1 28.0 25.3 28.2 33.2 38.1 15.5 28.7 28.7 20.2 25.0 21.7 37.0 18.9 19.7 37.0 19.1 22.1 28.5 22.0 21.4 7.6 25.0 16.5 21.1 16.5 31.7 27.4 27.9 32.1 34.8 18.1 22.9 54.5 75.1 59.7 20.4 19.0 66.4 28.5 41.2 19.6 37.7 31.3 45.7 29.9 68.1 34.8 34.4 40.4 27.8 69.6 53.4 9.9 36.6 22.9 45.0 17.7 25.8 64.6 69.5 35.8 38.2 45.7 26.8 17.3 19.5 44.8 30.9 23.9 16.8 28.8 24.7 24.0 34.1 22.7 24.2 94.7 78.8 31.7 18.8 13.2 40.3 56.3 69.3 56.8 31.4 18.5 21.1 21.5 11.2 76.9 11.6 35.4 66.4 12.8 21.5 15.1 21.5 34.1 37.7 17.5 38.1 25.3 29.9 20.0 20.7 31.9 26.5 14.2 15.3 26.3 22.5 31.0 24.1 29.1 18.0 22.0 24.2 27.2 28.3 28.2 23.4 26.0 28.0 25.3 28.7 28.5 25.0 32.1 25.4 48.1 27.3 19.9 35.0 64.7 69.0 73.4 29.6 8.7 35.9 39.0 16.6 42.9 64.1 33.1 0.0 83.6 121.0 85.3 80.3 135.0 0.6 78.8 46.2 23.7 24.5 27.8 11.1 64.0 60.5 39.2 23.4 105.8 45.1 13.5 14.3 19.2 54.9 15.2 13.7 32.2 52.9 45.0 104.9 2.2 37.6 46.7 56.9 6.5 345.3 50.9 68.0 33.7 36.6 81.1 103.1 40.3 53.8 93.1 30.7 68.9 42.8 9.4 13.1 28.1 37.2 9.7 17.7 44.5 83.4 370.4 75.6 51.4 26.6 111.8 RAD23A "HHR23A, MGC111083" ENSG00000179262 "RAD23 homolog A, nucleotide excision repair protein" P54725 19 12945855-12953642 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "skeletal muscle: 984.0;tongue: 447.9" "Cell type enhanced" "Detected in all" "Erythroid cells: 901.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026418, HPA053901, HPA057003, HPA065599" Approved Supported Nucleoplasm,Cytosol NA NA 3400000 "Cluster 27: Non-specific - Gene expression" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 30: Epithelial cell lines - Translation" "Cluster 6: Erythroid cells - Oxygen transport" Nucleoplasm Cytosol "HPA026418: AB_2732430, HPA053901: AB_2682300, HPA057003: AB_2683309, HPA065599: AB_2685516" "unprognostic (2.09e-1)" "unprognostic (1.58e-3)" "unprognostic (1.23e-3)" "unprognostic (7.90e-3)" "unprognostic (1.45e-1)" "unprognostic (1.48e-1)" "unprognostic (3.78e-3)" "unprognostic (3.57e-3)" "unprognostic (3.13e-1)" "unprognostic (3.12e-3)" "unprognostic (1.09e-1)" "unprognostic (4.08e-2)" "unprognostic (2.09e-3)" "unprognostic (2.32e-3)" "unprognostic (9.99e-2)" "unprognostic (8.56e-2)" "unprognostic (6.59e-3)" 79.2 63.4 77.8 49.4 79.8 85.8 71.0 78.1 95.7 59.2 71.0 91.6 48.4 65.0 31.2 70.0 64.1 38.2 132.4 80.5 79.8 54.1 70.4 66.4 55.9 80.5 76.7 56.2 76.7 66.1 47.7 55.5 80.1 57.5 35.8 24.5 68.0 52.5 984.0 72.6 52.8 54.8 77.0 54.5 66.4 48.7 79.4 53.0 54.9 447.9 44.0 78.5 57.1 82.0 138.0 52.6 55.7 57.4 91.5 104.1 94.7 66.1 130.2 152.6 137.2 59.8 95.3 117.3 150.0 99.4 104.4 102.7 78.0 137.7 55.9 170.0 109.8 47.2 57.3 58.3 181.7 102.1 130.7 107.9 199.6 110.1 208.9 89.7 105.4 188.0 124.1 102.1 138.2 139.8 126.6 124.2 76.5 124.6 135.6 65.4 59.4 189.6 118.9 53.8 104.3 81.8 75.4 129.1 145.8 40.2 100.4 173.7 82.5 214.9 57.4 263.3 203.9 148.2 133.8 86.0 177.9 193.3 183.2 31.3 76.3 64.9 81.1 102.4 87.3 77.5 66.8 69.1 68.3 73.5 63.3 73.4 9.2 79.1 105.3 86.0 82.0 69.1 77.8 79.8 78.1 95.7 80.5 79.8 80.5 76.7 80.1 77.0 79.4 82.0 120.2 86.6 56.2 11.8 127.6 120.4 176.8 165.2 122.3 51.7 110.3 121.3 59.5 108.7 108.4 55.2 20.9 212.0 99.6 95.7 166.3 179.5 193.1 74.3 76.9 120.4 87.3 901.4 22.0 191.0 240.1 101.4 101.9 74.1 111.5 77.7 86.4 96.2 175.3 52.2 22.9 138.5 136.3 88.3 170.3 44.1 118.4 119.6 142.3 12.2 182.5 73.9 94.7 15.6 25.8 184.1 119.0 114.0 159.0 351.3 139.9 163.3 91.1 56.1 111.7 138.3 129.3 263.6 179.6 153.3 146.5 244.8 113.0 117.8 154.8 211.1 RAI14 "DKFZp564G013, KIAA1334, NORPEG, RAI13" ENSG00000039560 "Retinoic acid induced 14" Q9P0K7 5 34656328-34832612 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 208.2;Early spermatids: 210.1;Late spermatids: 364.3;Syncytiotrophoblasts: 156.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 267.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "spinal cord: 23.8" "HPA036949, HPA036950" Supported Supported "Nucleoplasm,Actin filaments,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 28: Placenta - Pregnancy" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 11: Alveolar cells - Smell perception" Nucleoplasm "Actin filaments, Cytosol" "HPA036949: AB_10670568, HPA036950: AB_10669721" "unprognostic (7.63e-2)" "unprognostic (9.86e-2)" "unprognostic (4.87e-2)" "unprognostic (1.40e-1)" "unprognostic (3.38e-2)" "unprognostic (4.75e-2)" "unprognostic (5.49e-2)" "unprognostic (6.18e-2)" "unprognostic (6.28e-2)" "unprognostic (2.62e-1)" "unprognostic (8.18e-2)" "unprognostic (4.58e-2)" "prognostic unfavorable (9.75e-4)" "prognostic unfavorable (2.05e-4)" "unprognostic (1.33e-1)" "unprognostic (4.81e-2)" "unprognostic (4.34e-2)" 10.6 9.0 10.1 21.6 14.5 2.4 9.8 13.3 9.8 51.2 17.5 22.1 7.0 53.6 6.2 10.0 13.8 18.7 6.8 8.0 9.4 18.9 27.5 26.2 14.7 18.1 13.9 9.5 7.9 10.8 4.9 34.6 17.1 11.4 10.3 10.2 16.5 25.4 1.9 19.5 7.5 58.0 15.6 39.4 10.8 39.2 12.7 6.3 10.1 2.3 10.2 43.0 14.3 20.0 12.5 48.5 55.2 37.1 29.0 100.9 70.3 147.0 118.3 83.3 83.0 36.7 15.6 2.9 57.0 72.5 90.5 8.2 64.0 109.0 179.2 0.2 30.5 20.6 43.3 22.9 90.0 0.5 1.9 94.8 34.0 149.4 118.1 136.7 267.4 4.6 29.4 1.0 110.1 10.0 2.3 0.7 43.3 7.8 47.0 18.2 84.1 0.6 97.4 70.1 14.4 7.9 86.8 12.8 39.5 80.5 14.9 2.3 173.2 134.1 71.7 33.5 65.1 3.1 0.1 0.4 113.5 0.4 53.5 0.9 0.2 0.1 0.9 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.4 0.8 0.0 0.1 0.0 0.0 10.1 14.5 13.3 9.8 8.0 9.4 18.1 13.9 17.1 15.6 12.7 20.0 16.2 105.8 208.2 33.3 0.9 12.0 32.2 46.7 23.9 3.2 27.8 9.9 5.2 7.2 81.8 35.0 68.8 32.3 0.6 17.9 7.9 36.1 210.1 35.7 36.1 96.1 1.8 2.7 6.6 28.5 75.3 25.0 11.2 36.1 3.8 22.7 17.2 23.0 7.2 15.2 6.0 1.1 16.2 1.6 4.3 364.3 72.1 4.6 5.4 15.0 1.0 19.3 0.0 31.2 60.1 53.3 5.1 31.6 0.1 26.6 6.3 25.3 24.8 5.1 0.0 6.0 33.4 9.0 9.2 6.4 15.8 156.1 3.4 11.4 2.6 61.5 RALGPS2 "FLJ10244, FLJ25604, KIAA0351" ENSG00000116191 "Ral GEF with PH domain and SH3 binding motif 2" Q86X27 1 178725147-178921841 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Alzheimer disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 56.2;testis: 77.0" "Cell type enhanced" "Detected in many" "B-cells: 263.1;Cone photoreceptor cells: 206.4;Late spermatids: 185.9;Rod photoreceptor cells: 397.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "memory B-cell: 26.7;naive B-cell: 21.0" "Lineage enriched" "Detected in many" 11 "B-cells: 26.7" "Cell line enhanced" "Detected in many" "U-266/84: 250.4;U-698: 194.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027143, HPA028328" Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 16: U-266 - Nucleosome" "Cluster 57: B-cells - Immune response" "Nucleoplasm, Cytosol" "HPA027143: AB_10602071, HPA028328: AB_10601889" "unprognostic (8.13e-2)" "unprognostic (1.46e-2)" "unprognostic (4.06e-3)" "unprognostic (2.71e-1)" "unprognostic (1.23e-1)" "unprognostic (1.50e-1)" "unprognostic (5.72e-2)" "unprognostic (6.63e-3)" "unprognostic (4.07e-2)" "unprognostic (1.33e-1)" "unprognostic (2.82e-2)" "unprognostic (7.77e-2)" "unprognostic (1.55e-1)" "unprognostic (3.45e-1)" "unprognostic (6.35e-2)" "unprognostic (4.37e-2)" "unprognostic (8.97e-2)" 5.5 8.5 3.5 24.0 5.0 13.2 8.1 4.9 4.6 6.5 3.3 13.4 11.5 9.4 5.4 16.3 8.0 8.1 4.6 7.1 5.8 6.7 32.0 2.8 52.4 3.0 2.4 18.3 5.7 7.8 2.9 9.2 2.6 7.3 12.1 52.5 5.4 5.5 1.4 19.6 16.4 11.8 3.4 28.3 13.7 77.0 5.5 15.2 6.8 4.8 56.2 12.6 7.6 2.1 39.9 12.7 38.7 0.4 42.3 61.6 15.2 34.0 74.8 27.1 24.3 15.1 38.3 83.7 11.2 100.8 13.5 32.2 17.2 8.6 35.4 0.1 10.3 0.0 8.7 14.6 7.1 11.1 0.4 27.5 7.5 35.1 24.6 18.8 23.7 15.3 20.6 3.1 17.8 6.3 17.0 3.5 26.5 15.3 13.4 23.5 39.9 0.7 9.3 24.9 6.0 17.2 22.2 24.5 48.4 26.3 29.3 5.6 17.9 12.4 11.8 45.4 16.4 91.8 250.4 194.3 7.2 5.7 14.2 0.8 0.1 2.4 0.3 0.1 0.3 26.7 0.2 0.1 0.4 21.0 0.7 0.2 1.3 0.4 0.1 0.8 0.0 1.1 3.5 5.0 4.9 4.6 7.1 5.8 3.0 2.4 2.6 3.4 5.5 2.1 5.4 12.8 6.9 29.4 263.1 14.8 16.3 5.4 14.8 97.4 27.9 15.1 17.5 15.7 8.7 14.7 206.4 7.5 11.6 39.5 21.5 15.2 123.0 23.3 25.6 4.9 35.9 22.7 84.0 12.0 10.1 18.7 48.9 33.0 8.8 60.3 2.9 55.2 6.3 13.5 92.3 22.5 0.0 8.5 4.8 185.9 50.1 7.3 8.8 41.2 5.1 27.8 10.3 107.5 4.0 31.0 52.4 46.6 105.2 26.0 22.7 9.7 23.9 397.3 19.7 41.5 18.6 146.6 34.8 29.1 34.1 3.3 10.3 20.7 15.6 72.0 RAPGEF3 "bcm910, cAMP-GEFI, EPAC" ENSG00000079337 "Rap guanine nucleotide exchange factor 3" O95398 12 47734363-47771040 "Predicted intracellular proteins" Angiogenesis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 130.6;Astrocytes: 143.0;Collecting duct cells: 69.9;Endothelial cells: 53.0;Oligodendrocytes: 45.7" "Cancer enhanced" "Detected in all" "thyroid cancer: 13.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 26.9;HUVEC TERT2: 12.1;NB-4: 14.3;RPTEC TERT1: 13.3;TIME: 12.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004386, HPA040365, HPA043518" Approved Uncertain "Endoplasmic reticulum,Cytosol" NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 38: EFO-21 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Cytosol "Endoplasmic reticulum" "CAB004386: AB_627521, HPA040365: AB_2676941, HPA043518: AB_2678524" "unprognostic (2.12e-1)" "unprognostic (2.88e-2)" "unprognostic (2.99e-2)" "unprognostic (1.81e-2)" "unprognostic (1.88e-1)" "unprognostic (1.82e-2)" "unprognostic (1.23e-4)" "unprognostic (9.35e-2)" "unprognostic (1.25e-2)" "unprognostic (5.32e-3)" "unprognostic (4.67e-2)" "unprognostic (4.37e-2)" "prognostic favorable (6.67e-7)" "unprognostic (9.16e-2)" "unprognostic (2.92e-1)" "unprognostic (2.61e-3)" "unprognostic (3.38e-2)" 44.6 2.8 29.2 2.6 35.0 1.4 44.0 30.3 29.2 26.0 12.5 9.9 4.0 16.4 6.9 13.2 24.1 13.2 21.1 31.4 21.3 40.0 1.9 11.9 4.4 33.6 29.6 38.2 4.7 5.8 6.4 8.9 28.0 13.5 2.4 0.9 21.2 11.0 11.4 9.8 8.8 5.1 22.4 16.2 11.5 3.5 28.9 1.6 32.4 9.0 2.1 14.9 21.3 39.7 2.3 0.6 0.7 2.4 0.3 2.3 0.9 1.7 1.5 0.7 0.4 0.3 6.1 0.1 26.9 3.0 1.1 2.4 0.8 4.5 0.3 3.0 0.4 0.2 2.6 0.2 0.2 0.4 0.3 0.9 0.3 1.3 0.8 3.4 12.1 0.6 0.1 2.9 0.5 1.5 0.0 14.3 0.6 1.0 3.7 0.4 0.1 1.0 13.3 2.5 0.2 0.3 0.2 1.7 0.4 0.8 6.7 0.6 12.0 6.6 1.1 1.5 0.6 1.0 0.4 0.2 4.1 3.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.2 35.0 30.3 29.2 31.4 21.3 33.6 29.6 28.0 22.4 28.9 39.7 130.6 0.0 11.7 143.0 0.7 2.7 5.8 2.6 13.1 0.5 4.5 4.8 15.7 2.8 3.6 69.9 0.0 0.2 1.4 1.7 7.9 1.1 1.6 11.8 2.4 53.0 0.0 0.0 1.5 0.7 0.4 6.3 18.3 21.2 3.8 1.5 20.7 0.2 0.9 0.0 2.9 6.6 4.1 0.6 2.6 3.7 24.2 1.5 5.4 12.2 0.0 1.5 2.1 10.6 45.7 5.8 6.3 8.6 4.4 11.6 0.8 41.3 1.9 0.5 6.6 2.7 5.1 1.2 1.6 1.4 3.3 0.3 1.3 6.6 0.8 17.2 RBL2 "p130, Rb2" ENSG00000103479 "RB transcriptional corepressor like 2" Q08999 16 53433977-53491648 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 468.3;Late spermatids: 209.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016547, HPA019703" Supported Supported "Nucleoplasm,Nucleoli rim,Mitotic chromosome,Cytosol" Yes No "Cluster 48: NK-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 58: T-cells - T-cell receptor" "Nucleoplasm, Nucleoli rim, Mitotic chromosome" Cytosol "CAB016547: AB_785011, HPA019703: AB_1856106" "unprognostic (1.51e-1)" "unprognostic (4.38e-2)" "unprognostic (4.00e-2)" "unprognostic (1.26e-1)" "unprognostic (6.88e-2)" "unprognostic (6.43e-2)" "unprognostic (5.03e-2)" "unprognostic (2.46e-2)" "unprognostic (1.04e-1)" "unprognostic (2.11e-1)" "unprognostic (4.70e-1)" "unprognostic (8.12e-2)" "prognostic favorable (3.57e-5)" "unprognostic (9.57e-3)" "unprognostic (1.02e-1)" "unprognostic (8.70e-2)" "unprognostic (7.51e-2)" 32.5 25.4 11.1 32.3 13.6 19.1 31.7 12.5 10.4 33.5 14.8 26.6 23.3 32.2 20.2 25.0 31.8 27.7 25.6 8.7 10.5 39.2 59.5 38.9 49.7 12.3 12.0 37.8 39.0 62.7 17.7 19.3 13.0 42.9 29.3 23.1 34.2 39.9 32.4 26.3 26.1 30.7 11.7 41.0 32.6 48.4 11.4 66.6 40.2 37.7 51.2 30.9 28.9 16.9 25.9 18.1 20.7 20.6 61.2 57.9 9.4 17.8 26.4 23.1 7.9 10.1 30.9 39.0 28.4 32.8 22.3 29.6 17.9 30.1 36.0 12.5 22.4 15.9 14.7 22.0 27.3 23.4 49.0 35.6 34.0 15.3 22.4 43.0 36.3 39.6 12.7 23.2 26.6 7.1 48.6 22.0 7.8 30.8 15.0 33.6 41.8 46.1 25.4 25.3 16.9 14.3 42.2 17.2 19.1 16.8 22.7 30.0 28.3 27.5 14.3 24.1 13.7 35.7 22.9 42.4 34.4 28.2 19.0 53.9 22.5 56.5 53.4 16.2 60.5 22.5 59.7 62.8 21.7 22.0 85.5 75.3 41.8 74.4 28.8 13.1 48.2 76.2 11.1 13.6 12.5 10.4 8.7 10.5 12.3 12.0 13.0 11.7 11.4 16.9 37.9 41.7 101.1 51.2 49.5 23.1 30.1 15.3 40.9 27.8 27.0 15.5 13.5 45.8 32.5 27.6 20.9 6.0 77.0 26.3 17.6 13.4 468.3 38.9 25.8 31.4 19.8 26.5 55.1 10.2 13.0 35.8 24.5 45.9 55.1 27.9 40.7 46.1 11.2 35.3 54.1 30.0 34.6 43.6 23.7 209.1 42.0 35.4 10.6 58.1 44.9 38.3 79.3 63.3 85.7 10.8 19.0 42.9 48.7 31.4 29.2 25.3 38.3 22.5 39.5 36.2 26.1 161.4 61.3 33.7 27.6 4.1 118.9 25.2 21.7 35.6 RBP7 CRBPIV ENSG00000162444 "Retinol binding protein 7" Q96R05 1 9997206-10016021 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 401.0;breast: 394.6" "Cell type enriched" "Detected in many" 7 "Adipocytes: 3631.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 311.5;neutrophil: 344.7" "Group enriched" "Detected in many" 31 "granulocytes: 344.7;monocytes: 311.5" "Group enriched" "Detected in some" 4 "EFO-21: 13.0;SK-MEL-30: 9.8;T-47d: 34.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" HPA034749 Enhanced Uncertain "Nuclear speckles,Cytosol" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 6: T47d - Mammary gland" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nuclear speckles, Cytosol" "HPA034749: AB_10602084" "unprognostic (1.93e-3)" "unprognostic (1.50e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (9.59e-2)" "unprognostic (2.31e-1)" "unprognostic (6.28e-2)" "unprognostic (1.39e-2)" "unprognostic (1.85e-1)" "unprognostic (1.05e-3)" "unprognostic (2.24e-1)" "unprognostic (1.46e-2)" "unprognostic (7.90e-2)" "unprognostic (5.07e-2)" "unprognostic (2.38e-2)" "unprognostic (2.93e-1)" "unprognostic (1.15e-1)" "unprognostic (1.61e-2)" 401.0 15.0 20.7 8.9 27.0 28.6 394.6 23.8 38.3 22.6 23.4 15.0 2.6 20.4 4.2 34.4 14.7 51.6 86.6 20.4 22.4 72.9 9.6 8.8 8.3 23.7 24.0 12.7 11.9 68.9 16.7 15.9 23.7 18.6 4.4 5.0 22.3 8.1 16.0 35.4 11.5 14.9 23.5 112.1 17.2 9.2 22.4 12.6 36.2 24.9 5.6 23.6 27.9 36.4 0.0 0.6 0.3 0.0 0.0 0.5 0.0 0.0 0.0 2.5 0.9 2.5 3.2 0.0 13.0 1.3 0.0 0.0 0.1 1.0 4.4 0.0 2.8 0.0 0.1 1.3 1.6 0.0 0.0 0.0 2.0 2.1 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 3.4 0.0 0.0 0.0 0.7 0.0 0.2 0.5 2.6 0.2 9.8 3.5 34.8 2.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.4 311.5 2.8 0.4 138.4 0.2 0.1 0.0 0.1 10.6 0.2 0.2 0.1 344.7 0.0 68.3 2.0 0.7 96.8 20.7 27.0 23.8 38.3 20.4 22.4 23.7 24.0 23.7 23.5 22.4 36.4 3631.8 0.0 1.3 0.7 9.5 20.6 9.5 2.6 9.1 0.2 43.0 73.9 22.9 10.0 1.2 1.8 0.0 5.0 16.2 0.1 23.5 2.0 3.2 2.5 15.8 349.2 0.0 5.7 0.4 2.8 1.9 36.1 0.0 4.8 3.8 7.1 69.7 3.7 63.7 0.0 0.4 0.4 2.0 502.5 14.1 6.1 6.2 42.5 21.4 1.0 149.7 2.1 3.1 0.0 13.4 2.7 0.1 0.7 2.7 20.7 0.0 1.4 0.9 1.5 0.0 3.9 20.5 1.8 2.8 26.2 17.6 6.2 3.8 3.6 0.6 6.3 RELB REL-B ENSG00000104856 "RELB proto-oncogene, NF-kB subunit" Q01201 19 45001449-45038198 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 108.5;monocytes: 112.5;Plasma cells: 108.8;Prostatic glandular cells: 145.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 15.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 61.9;HDLM-2: 79.5;U-698: 67.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB007753, HPA040506" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 37: B-cells - Transcription" "Cluster 2: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm Cytosol "CAB007753: AB_562340, HPA040506: AB_2677011" "prognostic favorable (1.55e-4)" "unprognostic (1.20e-1)" "unprognostic (7.13e-2)" "unprognostic (5.52e-2)" "unprognostic (1.12e-2)" "unprognostic (3.41e-2)" "unprognostic (1.71e-2)" "unprognostic (4.30e-2)" "unprognostic (5.81e-3)" "unprognostic (1.02e-3)" "unprognostic (6.01e-2)" "unprognostic (6.48e-2)" "prognostic unfavorable (2.99e-6)" "unprognostic (2.68e-2)" "unprognostic (4.69e-2)" "unprognostic (2.09e-1)" "unprognostic (2.20e-2)" 17.2 13.1 3.5 18.7 2.9 40.1 12.6 2.9 4.4 9.1 3.1 13.3 10.8 14.1 0.8 8.7 9.2 7.4 12.7 3.1 3.4 21.3 13.0 23.0 19.2 4.9 3.5 6.4 16.5 2.1 4.0 4.8 4.1 15.3 3.9 0.2 12.1 5.2 14.0 16.5 17.7 4.9 3.6 29.1 12.0 4.3 4.6 9.2 10.0 1.4 15.6 13.8 8.1 4.1 22.2 13.0 1.3 5.7 2.8 9.1 4.5 3.9 27.5 5.9 9.6 4.5 23.6 61.9 11.0 6.4 20.8 9.8 0.5 9.0 5.1 79.5 2.0 2.2 0.8 2.5 23.8 4.9 35.3 15.0 3.7 12.3 14.4 5.4 3.9 1.7 0.5 39.2 2.1 5.3 1.1 14.9 2.0 6.3 2.4 4.8 3.2 7.7 10.0 33.7 0.1 2.0 4.1 11.4 11.6 1.4 4.0 11.8 12.6 14.4 7.1 5.3 14.4 49.0 31.2 67.0 15.6 1.7 8.1 0.0 5.1 2.5 1.4 3.4 2.0 9.2 2.2 1.9 3.8 8.0 1.7 0.8 15.2 2.1 2.8 4.1 1.1 2.0 3.5 2.9 2.9 4.4 3.1 3.4 4.9 3.5 4.1 3.6 4.6 4.1 16.4 6.4 12.4 2.3 64.4 37.9 108.5 20.3 40.9 0.0 17.6 11.3 1.8 24.3 15.7 3.7 0.0 4.2 35.0 53.0 9.8 33.1 5.2 15.1 15.2 30.8 22.8 22.5 3.0 31.5 7.3 35.4 65.2 29.1 50.9 3.8 5.0 3.5 18.4 3.3 1.7 33.3 8.2 15.1 74.9 3.4 4.7 44.7 24.9 3.7 112.5 0.8 7.2 1.5 2.5 37.4 90.3 2.6 108.8 145.3 48.0 19.4 7.4 0.3 6.6 28.9 27.3 1.1 1.7 27.7 31.8 9.9 53.8 4.1 16.8 89.7 RGL3 FLJ32585 ENSG00000205517 "Ral guanine nucleotide dissociation stimulator like 3" Q3MIN7 19 11384341-11419328 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 41.1;parathyroid gland: 45.9;thyroid gland: 64.9" "Cell type enhanced" "Detected in many" "Astrocytes: 32.3;Collecting duct cells: 51.5;Gastric mucus-secreting cells: 48.4;Sertoli cells: 39.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 26.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 17.7;CACO-2: 10.4;RT4: 22.0;SK-BR-3: 9.7;T-47d: 15.9" "Region enriched" "Detected in many" 6 "cerebellum: 9.0" "Low region specificity" "Detected in many" "HPA042763, HPA043615, HPA064578" Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Cluster 1: Thyroid gland - Transcription" "Cluster 28: BEWO - Transcription regulation" "Cluster 44: Endometrium - Transcription" Nucleoplasm Cytosol "HPA042763: AB_10968569, HPA043615: AB_10959470, HPA064578: " "prognostic favorable (7.35e-4)" "unprognostic (3.12e-2)" "unprognostic (2.92e-1)" "unprognostic (5.69e-2)" "unprognostic (2.08e-1)" "unprognostic (6.60e-2)" "unprognostic (3.82e-2)" "unprognostic (5.31e-2)" "unprognostic (1.24e-2)" "unprognostic (1.48e-2)" "unprognostic (3.19e-3)" "unprognostic (5.99e-2)" "prognostic favorable (6.61e-4)" "unprognostic (4.17e-2)" "unprognostic (3.37e-1)" "unprognostic (3.21e-2)" "unprognostic (7.12e-3)" 7.3 11.5 1.8 0.7 1.6 0.0 7.4 1.9 2.5 13.3 6.9 2.9 1.4 4.8 9.5 1.1 9.5 2.1 9.2 2.2 2.2 41.1 10.6 8.9 0.6 2.7 2.4 2.5 21.0 45.9 15.4 5.6 2.8 6.5 1.3 0.8 5.9 9.4 2.0 1.3 1.8 0.8 1.7 8.2 13.8 0.6 2.9 0.2 64.9 0.6 0.3 5.3 5.7 2.3 0.0 0.6 0.0 0.1 1.1 0.2 17.7 1.1 1.4 0.6 2.0 10.4 7.4 0.0 6.5 1.3 2.6 4.6 0.0 0.0 0.1 0.0 0.0 0.1 4.2 3.3 2.7 0.0 0.0 0.0 0.1 0.1 0.0 4.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.9 1.4 0.0 0.7 2.2 6.3 22.0 1.0 5.2 0.2 9.7 3.3 3.7 15.9 0.0 0.0 3.3 0.0 2.5 0.9 0.0 0.6 1.0 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 1.6 1.9 2.5 2.2 2.2 2.7 2.4 2.8 1.7 2.9 2.3 3.1 19.2 21.0 32.3 1.1 0.1 2.1 0.4 1.8 0.3 3.3 4.6 4.6 12.8 12.4 51.5 0.0 12.9 0.0 2.2 11.7 8.6 0.0 14.8 9.6 5.8 10.3 0.0 0.5 4.2 11.9 4.1 48.4 18.4 1.3 3.1 26.0 5.8 3.0 0.0 0.6 7.7 2.0 7.4 0.3 0.2 3.7 1.5 5.4 4.7 0.0 16.9 0.0 1.5 0.5 5.7 5.3 0.4 0.6 1.4 0.0 4.6 1.7 0.6 39.5 9.9 18.7 0.6 1.7 0.0 0.0 12.0 0.2 0.8 2.4 2.0 RHOXF1 "OTEX, PEPP1" ENSG00000101883 "Rhox homeobox family member 1" Q8NHV9 X 120109051-120115913 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 15.1" "Cell type enriched" "Detected in some" 14 "Spermatogonia: 123.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "T-reg: 4.9" "Lineage enriched" "Detected in single" 33 "T-cells: 4.9" "Cell line enhanced" "Detected in single" "HEK 293: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052560, HPA056506" Approved Enhanced Nucleoplasm,Cytosol NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 43: Testis - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm Cytosol "HPA052560: , HPA056506: AB_2683157" "unprognostic (5.03e-3)" "unprognostic (1.22e-2)" "unprognostic (5.22e-2)" "unprognostic (2.31e-2)" "unprognostic (8.65e-2)" "unprognostic (1.07e-3)" "unprognostic (2.46e-1)" "unprognostic (3.15e-1)" "unprognostic (3.89e-1)" "unprognostic (2.15e-1)" "unprognostic (7.50e-4)" "unprognostic (1.97e-1)" "unprognostic (5.85e-4)" "unprognostic (3.00e-1)" "unprognostic (7.96e-2)" "unprognostic (2.26e-1)" "unprognostic (1.73e-3)" 1.7 1.2 2.3 0.1 2.3 0.1 1.4 3.7 3.4 1.5 2.7 1.7 0.0 0.8 0.0 0.5 2.4 0.2 0.6 2.3 2.7 1.8 0.9 0.5 0.3 2.7 2.7 3.5 0.3 0.1 1.7 0.0 2.7 1.4 0.0 2.5 0.6 0.2 0.2 1.2 1.0 0.1 2.4 1.3 0.7 15.1 2.6 0.2 1.1 0.0 0.1 1.0 0.8 2.7 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 4.9 0.0 2.3 2.3 3.7 3.4 2.3 2.7 2.7 2.7 2.7 2.4 2.6 2.7 0.2 0.0 0.0 0.0 0.1 0.4 0.1 0.2 0.0 1.3 0.3 0.5 1.3 0.0 0.0 0.0 4.2 0.1 0.2 0.1 1.9 0.2 1.5 0.2 0.1 0.5 0.0 0.0 0.8 0.4 0.4 0.2 0.0 0.1 0.0 8.3 0.0 0.2 0.1 0.0 1.5 0.3 0.0 0.0 0.0 3.8 0.6 0.2 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 1.5 0.1 0.1 0.0 0.1 2.4 1.3 0.0 0.0 0.3 3.3 123.8 0.0 0.3 0.0 0.2 0.7 0.2 0.0 RLIM "MGC15161, NY-REN-43, RNF12" ENSG00000131263 "Ring finger protein, LIM domain interacting" Q9NVW2 X 74582976-74614624 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018895 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 38: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 41: Macrophages - Immune response" Nucleoplasm Cytosol "HPA018895: AB_1856323" "unprognostic (1.17e-2)" "unprognostic (1.08e-1)" "unprognostic (1.72e-1)" "unprognostic (1.31e-3)" "unprognostic (1.25e-1)" "unprognostic (1.03e-1)" "unprognostic (8.98e-3)" "unprognostic (1.36e-1)" "unprognostic (1.03e-1)" "unprognostic (2.06e-1)" "unprognostic (1.12e-1)" "unprognostic (4.91e-2)" "unprognostic (2.25e-1)" "unprognostic (3.82e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (6.04e-4)" "unprognostic (1.20e-1)" 11.3 11.8 10.6 10.4 11.7 41.2 10.5 5.9 9.9 10.0 10.0 6.8 5.9 9.5 5.6 8.7 8.4 9.6 8.8 11.2 15.1 10.0 8.3 12.1 8.9 8.5 10.3 10.6 7.5 11.7 10.3 9.8 10.3 9.8 6.6 10.7 7.4 7.1 9.6 9.4 6.1 9.3 7.3 9.3 7.4 6.5 12.6 11.0 11.7 8.6 9.5 8.5 8.0 8.2 23.7 24.2 22.8 18.7 20.1 22.5 22.4 22.4 26.0 19.9 24.4 18.9 24.4 12.8 25.4 28.6 26.7 19.9 45.9 26.7 30.1 11.7 23.9 22.7 43.2 10.7 17.4 34.6 38.6 21.7 14.4 28.2 46.5 15.6 23.3 20.9 19.9 22.9 24.6 18.1 26.0 16.8 35.0 12.9 22.5 24.3 48.0 21.5 16.1 28.6 16.4 19.5 42.3 19.0 24.5 20.4 11.2 24.9 31.0 23.4 23.1 24.8 19.6 12.0 24.6 20.3 25.5 33.1 23.2 22.8 6.0 5.9 3.1 7.5 3.1 3.0 3.9 3.8 4.9 3.3 4.2 3.8 11.5 5.3 5.6 2.6 4.8 3.2 10.6 11.7 5.9 9.9 11.2 15.1 8.5 10.3 10.3 7.3 12.6 8.2 44.8 16.0 17.0 13.4 22.4 35.8 29.6 16.1 23.3 13.8 18.3 13.5 30.5 18.6 20.4 25.8 14.6 16.3 27.6 10.3 11.7 13.7 7.9 32.3 35.3 30.1 23.2 12.8 19.2 10.7 21.5 27.7 27.0 41.0 38.0 24.6 21.0 14.8 18.2 21.9 18.9 10.6 10.2 20.7 34.1 4.4 9.9 29.1 17.8 15.9 12.7 13.2 12.3 11.1 16.4 14.8 8.5 18.8 16.3 25.5 6.8 12.0 25.2 14.6 6.6 31.1 24.1 9.7 18.2 21.6 38.8 26.3 22.0 19.0 11.4 37.2 RMI2 "BLAP18, C16orf75, MGC24665" ENSG00000175643 "RecQ mediated genome instability 2" Q96E14 16 11249619-11381662 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 36.8" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 123.8;Erythroid cells: 38.5;Extravillous trophoblasts: 34.1;Peritubular cells: 42.5;Spermatocytes: 36.6;Spermatogonia: 51.8;Syncytiotrophoblasts: 47.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 4.2" "Group enriched" "Detected in many" 6 "B-cells: 4.2;T-cells: 1.4" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA040995 Uncertain Supported "Nuclear speckles,Cytosol" NA Yes "Cluster 37: B-cells - Transcription" "Cluster 3: T-cells - Adaptive immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 47: Cytotrophoblasts - Unknown function" "Nuclear speckles" Cytosol "HPA040995: AB_10795531" "unprognostic (2.76e-1)" "prognostic favorable (5.69e-5)" "unprognostic (1.17e-1)" "unprognostic (3.09e-3)" "unprognostic (1.69e-2)" "unprognostic (1.80e-3)" "prognostic unfavorable (2.77e-5)" "unprognostic (3.98e-1)" "unprognostic (1.16e-1)" "unprognostic (1.83e-1)" "unprognostic (3.44e-3)" "unprognostic (3.89e-1)" "unprognostic (2.18e-1)" "unprognostic (5.50e-2)" "unprognostic (3.68e-2)" "unprognostic (3.60e-3)" "unprognostic (1.03e-1)" 1.4 1.5 2.2 12.3 2.0 9.9 5.1 1.0 2.2 4.8 0.9 12.5 7.5 2.9 3.9 10.8 2.1 2.2 1.6 2.3 1.3 3.4 4.3 1.9 31.4 1.2 1.3 3.0 1.8 1.3 0.6 19.3 1.2 3.2 14.4 0.5 2.4 2.1 0.9 10.2 8.8 2.3 1.0 3.5 7.0 14.0 1.4 36.8 1.5 0.6 34.9 4.5 4.4 1.8 60.3 39.5 75.2 32.6 3.3 15.8 33.0 35.9 26.8 31.6 51.8 15.4 69.2 83.8 29.1 15.8 35.3 34.4 32.4 32.5 50.5 16.6 30.5 45.3 22.6 102.5 1.3 17.6 19.5 3.7 6.1 14.5 13.3 12.3 17.4 36.2 65.3 63.2 16.5 70.3 60.9 83.1 64.1 82.6 15.7 73.1 81.1 89.3 18.7 38.0 44.1 35.0 28.5 47.4 26.1 43.5 80.4 25.8 5.6 25.1 23.3 49.3 5.0 18.1 30.9 99.3 23.3 57.4 47.2 0.0 0.0 0.4 0.3 0.0 0.0 4.2 0.1 0.0 0.2 1.1 0.8 0.3 0.1 0.1 0.0 0.2 1.4 0.1 2.2 2.0 1.0 2.2 2.3 1.3 1.2 1.3 1.2 1.0 1.4 1.8 1.3 0.0 0.5 0.0 4.5 6.8 5.4 1.4 6.2 0.2 3.4 3.2 1.0 4.3 1.6 7.3 0.0 123.8 0.5 3.3 5.9 2.6 3.0 0.8 2.1 2.8 2.4 38.5 0.0 0.5 34.1 6.4 4.1 2.2 0.0 19.7 1.1 1.1 18.5 0.0 0.0 7.7 0.0 0.8 6.5 5.9 15.8 3.7 3.6 0.0 1.1 0.2 1.0 0.0 0.0 1.0 4.0 42.5 2.4 2.1 1.3 0.4 0.1 0.6 32.9 0.0 2.2 36.6 51.8 11.3 5.4 47.7 1.9 6.5 10.3 7.5 RNASEK-C17orf49 ENSG00000161939 "RNASEK-C17orf49 readthrough" 17 7012635-7017520 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 64.1;Alveolar cells type 2: 59.4;Club cells: 31.1;granulocytes: 60.5;Respiratory ciliated cells: 56.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HBEC3-KT: 2.9;THP-1: 3.7;U-87 MG: 3.7" "HPA022961, HPA024457" Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 11: Alveolar cells - Smell perception" Nucleoplasm Cytosol "HPA022961: AB_1845592, HPA024457: AB_1845593" "unprognostic (4.08e-2)" "unprognostic (3.30e-1)" "unprognostic (1.58e-1)" "unprognostic (9.37e-5)" "unprognostic (4.19e-1)" "unprognostic (1.71e-1)" "unprognostic (7.91e-2)" "unprognostic (3.01e-2)" "unprognostic (2.52e-1)" "unprognostic (2.87e-1)" "unprognostic (3.77e-3)" "unprognostic (8.26e-3)" "unprognostic (8.58e-3)" "unprognostic (3.00e-1)" "unprognostic (2.30e-1)" "unprognostic (1.19e-1)" "unprognostic (1.78e-1)" 1.9 4.1 0.0 0.2 0.0 0.6 1.6 0.1 0.2 2.4 0.0 1.7 0.0 1.4 0.0 2.1 1.4 0.0 2.4 0.2 0.0 5.5 2.1 2.5 0.0 0.1 0.0 1.6 1.5 0.1 3.5 0.0 0.0 1.5 0.0 0.0 1.8 0.1 2.2 1.9 1.6 0.1 0.0 2.7 1.9 1.7 0.0 0.0 1.8 0.0 0.1 1.2 1.6 0.0 0.7 2.0 0.2 0.3 0.0 0.0 0.6 1.3 1.0 1.5 1.1 1.3 0.6 1.0 0.1 0.0 0.1 0.3 0.4 2.9 0.4 0.0 2.4 0.0 1.3 0.5 1.4 0.0 0.3 0.0 0.0 0.9 0.0 0.2 0.3 0.1 0.3 0.0 0.0 0.7 1.1 1.3 1.2 0.3 0.6 0.8 0.0 0.0 0.4 0.4 0.2 1.0 0.0 0.0 0.2 0.1 0.3 3.7 0.0 0.0 0.1 1.9 0.5 0.0 0.4 0.2 3.7 0.3 0.0 2.4 2.3 1.9 0.5 1.6 0.8 1.0 0.7 0.4 2.0 0.9 0.6 0.6 3.8 0.5 1.8 2.1 0.5 1.7 0.0 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 64.1 59.4 0.0 2.6 0.4 0.0 0.3 0.6 0.0 0.9 0.3 0.0 0.0 31.1 0.0 0.0 0.3 0.7 3.2 3.9 8.3 0.0 0.3 0.2 6.5 5.4 1.3 0.0 8.2 0.2 5.3 0.0 0.3 60.5 0.0 0.7 0.1 0.6 0.0 0.0 3.2 0.0 1.2 0.8 0.0 0.3 14.8 0.0 0.0 4.8 0.0 0.0 0.0 0.0 7.7 6.1 0.4 2.8 0.1 3.9 0.5 56.2 0.0 0.0 0.1 1.3 0.2 0.1 2.0 1.0 0.8 5.9 0.1 2.6 0.1 RPS19BP1 "FLJ21770, MGC52010" ENSG00000187051 "Ribosomal protein S19 binding protein 1" Q86WX3 22 39529093-39532761 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042874 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA Yes "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli, Cytosol" Nucleoplasm "HPA042874: AB_10793988" "unprognostic (2.44e-1)" "unprognostic (1.67e-1)" "unprognostic (7.79e-2)" "unprognostic (5.07e-3)" "unprognostic (1.65e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (3.71e-4)" "unprognostic (1.65e-1)" "unprognostic (5.68e-2)" "unprognostic (8.31e-2)" "unprognostic (7.00e-2)" "unprognostic (6.73e-2)" "unprognostic (1.04e-1)" "unprognostic (6.11e-2)" "unprognostic (1.65e-1)" "unprognostic (2.34e-1)" "unprognostic (4.32e-2)" 98.5 123.0 122.2 43.1 124.5 61.7 94.6 126.7 159.0 73.5 115.9 117.1 43.5 65.5 31.5 94.2 65.6 19.3 114.6 121.2 119.7 123.1 158.5 80.4 48.0 126.5 124.2 68.9 109.6 47.1 66.5 30.2 123.7 108.1 19.2 23.9 94.4 42.8 104.7 80.0 78.3 19.7 124.8 100.5 101.5 65.8 128.4 40.5 96.7 45.4 34.6 99.9 73.7 123.9 94.8 117.6 54.5 80.4 60.7 39.7 110.8 102.0 87.3 92.5 74.0 131.1 62.1 118.9 107.4 64.5 74.8 73.8 87.8 111.3 32.2 163.8 261.5 110.0 105.5 118.0 88.2 166.8 142.3 60.1 83.1 80.3 96.8 49.4 64.9 87.6 128.0 83.8 61.0 108.0 80.6 164.1 95.1 210.9 209.5 127.3 70.0 182.0 99.7 95.8 121.2 66.9 85.8 137.3 203.1 33.6 98.8 134.8 74.0 77.5 168.8 85.7 141.7 140.3 145.4 188.4 103.3 116.8 183.1 126.8 147.4 187.3 133.0 141.6 123.5 159.7 135.1 140.6 122.4 173.9 129.9 132.8 168.7 128.9 119.4 193.1 165.1 138.3 122.2 124.5 126.7 159.0 121.2 119.7 126.5 124.2 123.7 124.8 128.4 123.9 113.6 44.8 51.4 13.1 109.5 137.1 94.3 124.3 84.2 98.0 178.6 205.7 73.8 105.8 83.0 97.5 52.1 152.9 114.7 205.5 217.2 174.9 23.6 68.6 69.8 121.0 142.6 83.5 8.7 192.2 231.9 92.0 76.0 81.6 69.8 62.0 116.0 184.8 204.3 35.3 10.9 207.5 130.2 116.4 233.3 40.3 137.0 110.8 108.5 8.4 147.8 139.1 162.7 5.5 18.7 233.5 202.2 126.0 193.3 206.8 274.9 362.2 54.0 103.7 78.9 74.4 100.9 61.6 138.0 87.6 147.9 131.6 115.2 103.1 165.9 132.4 RUNDC3B "RPIB9, RPIP9" ENSG00000105784 "RUN domain containing 3B" Q96NL0 7 87627548-87832296 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 7.3;brain: 6.3;liver: 5.6" "Group enriched" "Detected in many" 4 "Excitatory neurons: 167.5;Inhibitory neurons: 170.9;Microglial cells: 108.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.2;HEK 293: 1.0;SCLC-21H: 2.7;SH-SY5Y: 1.2;U-138 MG: 1.0;U-266/70: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056968, HPA057155, HPA075760" Uncertain Uncertain Vesicles,Cytosol NA NA "Cluster 45: Intestine - Brush border" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol Vesicles "HPA056968: AB_2683292, HPA057155: AB_2683353, HPA075760: " "unprognostic (2.49e-1)" "unprognostic (1.99e-1)" "unprognostic (2.12e-1)" "unprognostic (1.83e-1)" "unprognostic (2.20e-2)" "unprognostic (1.77e-3)" "unprognostic (1.19e-2)" "unprognostic (4.16e-2)" "unprognostic (2.56e-1)" "unprognostic (1.19e-1)" "unprognostic (9.42e-5)" "unprognostic (4.44e-1)" "prognostic favorable (2.62e-6)" "unprognostic (1.97e-2)" "unprognostic (2.41e-1)" "unprognostic (2.32e-1)" "unprognostic (9.55e-2)" 0.4 7.3 3.1 0.1 2.9 0.0 0.6 6.3 3.9 1.4 0.0 1.3 2.8 1.9 0.6 0.5 1.0 0.9 0.7 2.0 3.7 1.9 5.6 0.4 0.2 2.5 1.5 1.2 0.1 0.3 0.2 0.0 2.2 0.6 1.5 1.7 0.3 0.4 0.1 0.5 2.5 2.1 0.8 0.1 0.1 1.9 4.0 0.1 0.2 0.1 0.2 0.5 0.3 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 1.0 0.0 0.5 0.4 0.0 0.5 0.1 0.0 0.2 0.0 0.1 0.0 0.5 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.1 2.7 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.1 2.9 6.3 3.9 2.0 3.7 2.5 1.5 2.2 0.8 4.0 1.3 15.3 0.0 0.0 5.5 0.6 4.8 0.1 0.1 2.2 7.9 1.0 1.1 2.5 7.2 0.1 0.0 6.2 0.5 0.9 12.2 1.9 1.1 4.6 5.6 0.5 30.8 0.0 2.7 167.5 0.2 0.8 1.1 0.0 2.0 0.0 0.7 1.4 18.9 0.1 11.8 170.9 2.9 0.0 0.0 2.3 1.7 4.1 0.6 3.6 108.7 0.2 0.7 4.1 15.1 5.7 0.6 6.5 1.5 0.1 0.2 18.2 11.6 0.2 8.0 0.0 0.3 2.0 21.2 18.8 0.4 3.0 1.2 0.8 1.6 4.2 0.1 RYR2 "ARVC2, ARVD2, VTSIP" ENSG00000198626 "Ryanodine receptor 2" Q92736 1 237042184-237833988 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor" "Cardiomyopathy, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "heart muscle: 132.0" "Group enriched" "Detected in many" 10 "Cardiomyocytes: 2180.6;Excitatory neurons: 1320.5;Inhibitory neurons: 790.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 7.7;HEK 293: 8.5;K-562: 2.3;NB-4: 2.7;NTERA-2: 3.1;U-937: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020028 Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Plasma membrane, Cytosol" "HPA020028: AB_1856528" "unprognostic (5.23e-3)" "unprognostic (2.15e-2)" "unprognostic (5.02e-4)" "unprognostic (6.26e-2)" "unprognostic (8.74e-2)" "unprognostic (2.99e-3)" "unprognostic (5.28e-2)" "unprognostic (1.45e-3)" "unprognostic (2.69e-2)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-2)" "unprognostic (0.00e+0)" "unprognostic (2.36e-2)" "unprognostic (1.42e-1)" "unprognostic (3.13e-2)" "unprognostic (1.06e-2)" 0.7 0.7 9.1 0.8 15.9 0.0 0.6 8.7 24.0 1.5 0.0 2.0 0.2 0.7 0.4 2.9 0.7 1.9 132.0 10.5 0.0 0.1 0.1 1.8 0.1 0.0 0.0 2.9 8.4 0.0 1.8 1.2 0.0 2.9 0.5 6.5 0.5 1.7 0.1 0.3 0.5 0.7 0.0 1.3 1.5 1.1 0.0 0.1 4.4 0.3 0.0 1.2 0.4 13.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.0 0.9 0.3 0.0 0.0 7.7 8.5 2.2 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 2.3 0.4 0.0 0.0 0.0 2.7 3.1 0.6 0.3 0.0 0.1 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 4.9 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 9.1 15.9 8.7 24.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.2 0.0 0.5 17.0 0.0 0.4 0.0 0.0 0.0 74.2 0.3 0.1 2180.6 0.0 1.3 1.8 10.4 0.1 0.1 0.0 0.0 0.0 21.1 0.2 3.4 10.6 3.5 0.0 1320.5 2.9 0.1 53.6 0.0 0.5 0.0 0.5 1.1 0.0 0.1 1.7 790.6 0.0 0.0 0.0 0.2 15.3 1.2 1.3 8.8 48.7 0.0 1.3 0.0 29.7 140.6 0.4 0.0 0.0 0.1 0.0 1.0 0.2 0.7 5.3 0.0 0.5 21.6 5.8 2.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 S100A4 "18A2, 42A, CAPL, FSP1, MTS1, P9KA, PEL98" ENSG00000196154 "S100 calcium binding protein A4" P26447 1 153543613-153550136 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Kupffer cells: 2708.8;Langerhans cells: 5952.7;Macrophages: 2786.0;monocytes: 3172.6;NK-cells: 2130.8;Skeletal myocytes: 2034.0;T-cells: 2111.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 2614.3;ASC diff: 3300.1;BJ hTERT+: 6738.6;fHDF/TERT166: 4819.1;RPMI-8226: 2700.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 4 "spinal cord: 39.6" "CAB002618, HPA007486, HPA007973, CAB027387, CAB058698, CAB068227, CAB068228" Enhanced Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA 9600000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Nucleoplasm, Cytosol" "CAB002618: , CAB027387: , CAB058698: AB_2665603, CAB068227: AB_2665602, CAB068228: AB_2665601, HPA007486: , HPA007973: AB_1079858" "unprognostic (1.56e-1)" "unprognostic (6.10e-2)" "unprognostic (2.84e-2)" "unprognostic (8.20e-2)" "unprognostic (6.21e-2)" "prognostic favorable (4.03e-5)" "unprognostic (8.35e-2)" "unprognostic (4.81e-2)" "unprognostic (1.50e-1)" "unprognostic (2.20e-1)" "unprognostic (2.78e-2)" "unprognostic (3.39e-2)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.05e-1)" "unprognostic (3.05e-1)" "unprognostic (2.76e-2)" "unprognostic (3.16e-2)" 982.3 77.1 25.5 353.9 26.2 1090.8 561.9 27.5 53.1 566.3 32.0 301.7 91.7 177.8 124.5 224.0 217.6 167.6 268.5 24.7 27.4 247.0 64.3 874.2 221.0 31.7 26.4 51.0 53.8 18.1 24.8 182.9 29.8 223.7 331.5 10.0 245.4 155.8 163.0 371.5 234.3 297.7 27.8 443.0 133.3 32.2 33.7 112.6 191.9 424.6 315.4 391.6 455.2 34.1 11.8 2614.3 13.2 77.0 3300.1 2410.9 3.7 1664.4 6738.6 32.1 148.4 20.0 180.3 0.8 299.7 4819.1 3.5 65.3 8.8 20.9 23.6 405.2 2.3 1186.8 529.0 59.4 4.3 106.9 1924.6 364.2 21.5 62.2 13.0 4.9 2.6 0.7 9.9 4.2 2468.1 10.6 3.8 1273.9 7.2 189.7 1050.4 64.1 3.7 2700.2 103.5 71.3 108.5 11.6 24.9 1286.6 9.4 412.5 77.1 1493.7 3.1 8.5 13.7 2159.5 9.3 82.8 647.5 14.3 6.1 1367.9 127.2 2789.7 13536.2 1408.0 5800.5 9099.6 6077.0 761.6 5167.7 4700.0 9268.4 282.5 882.4 2641.3 12129.7 837.1 11862.4 1626.0 7406.7 24075.8 25.5 26.2 27.5 53.1 24.7 27.4 31.7 26.4 29.8 27.8 33.7 34.1 226.0 490.4 398.4 0.0 266.1 772.9 19.5 159.0 93.9 0.7 44.9 65.9 14.9 35.8 273.8 893.8 0.0 52.4 1345.4 8.9 111.6 21.9 7.3 53.0 473.0 209.1 4.8 730.9 0.0 23.5 255.5 1378.8 54.0 41.9 1395.8 0.6 96.4 18.6 1966.1 45.4 0.0 10.0 345.8 2708.8 5952.7 24.0 235.8 2786.0 1193.5 12.2 3172.6 3.6 2130.8 0.0 0.1 35.7 17.0 45.9 266.5 12.9 3.2 19.7 154.9 2.3 151.2 2034.0 1309.6 1.9 5.5 77.6 694.0 53.4 2111.1 32.5 11.3 73.1 S100A7 "PSOR1, S100A7c" ENSG00000143556 "S100 calcium binding protein A7" P31151 1 153457744-153460651 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 1065.7;lymphoid tissue: 1239.6;skin 1: 346.5;vagina: 1020.1" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 59.3;Club cells: 70.4;Ionocytes: 18.3;Suprabasal keratinocytes: 89.6;Syncytiotrophoblasts: 26.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 1201.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HaCaT: 7.2;SK-BR-3: 16.9" "CAB001453, HPA006997, CAB033766" Enhanced Uncertain Cytosol "Secreted in other tissues" NA NA 14000000 "Cluster 84: Esophagus - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Cytosol "CAB001453: AB_564004, CAB033766: AB_2269963, HPA006997: AB_1079860" "unprognostic (3.28e-1)" "unprognostic (9.85e-2)" "unprognostic (1.32e-2)" "unprognostic (2.16e-2)" "unprognostic (3.17e-1)" "unprognostic (2.94e-2)" "unprognostic (1.03e-2)" "unprognostic (4.00e-1)" "unprognostic (1.25e-1)" "unprognostic (1.27e-1)" "unprognostic (2.99e-1)" "unprognostic (5.41e-2)" "unprognostic (1.21e-2)" 1.0 0.2 0.9 0.0 0.8 0.8 15.6 1.4 2.1 174.8 0.7 0.3 0.0 1.2 27.6 1065.7 0.3 0.2 0.5 0.8 0.8 0.1 0.5 0.4 0.2 0.9 0.8 0.5 0.4 0.0 0.2 0.2 0.8 0.5 0.0 0.0 55.5 0.2 0.4 346.5 0.2 1.4 0.8 0.3 0.4 0.3 0.7 12.4 0.2 0.0 1239.6 1.2 1020.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 7.2 0.0 2.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.2 0.0 0.0 2.0 0.0 0.0 0.4 0.0 0.2 0.0 0.2 0.0 0.0 0.7 0.1 0.4 0.0 0.0 0.0 0.7 16.9 0.0 0.9 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.8 1.4 2.1 0.8 0.8 0.9 0.8 0.8 0.8 0.7 1.1 0.0 0.0 0.0 0.0 0.0 11.7 0.2 59.3 0.0 0.0 1.1 0.0 0.0 0.0 70.4 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.3 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 18.3 0.0 1.9 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 6.3 0.0 0.0 0.0 4.7 0.2 0.2 3.8 89.6 26.4 0.1 8.4 0.6 0.4 S100A7A "S100A15, S100A7f, S100A7L1" ENSG00000184330 "S100 calcium binding protein A7A" Q86SG5 1 153416520-153423222 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "esophagus: 5.6;lymphoid tissue: 5.9;skin 1: 1.6;vagina: 2.7" "Group enriched" "Detected in some" 8 "Early spermatids: 2.8;Late spermatids: 3.0;Suprabasal keratinocytes: 1.8" "Group enriched" "Detected in many" 4 "head and neck cancer: 25.6;melanoma: 12.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA006997 Supported Uncertain Cytosol NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 31: Spermatids - Spermatogenesis" Cytosol "HPA006997: AB_1079860" "unprognostic (2.18e-1)" "unprognostic (1.26e-1)" "unprognostic (3.73e-2)" "unprognostic (4.65e-2)" "unprognostic (1.40e-1)" "unprognostic (1.77e-1)" "unprognostic (1.17e-1)" "unprognostic (4.40e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 5.9 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 SCLT1 "FLJ30655, hCAP-1A" ENSG00000151466 "Sodium channel and clathrin linker 1" Q96NL6 4 128864921-129093600 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Astrocytes: 110.0;Excitatory neurons: 111.1;Inhibitory neurons: 116.0;Oligodendrocyte precursor cells: 109.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 66.0" "Group enriched" "Detected in all" 5 "granulocytes: 66.0;monocytes: 31.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036560, HPA036561" Approved Uncertain Microtubules,Cytosol NA Yes "Cluster 8: Neutrophils - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 2: Karpas-707 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Microtubules, Cytosol" "HPA036560: AB_2675190, HPA036561: AB_10673658" "unprognostic (2.15e-1)" "unprognostic (2.01e-1)" "unprognostic (1.62e-2)" "unprognostic (3.77e-2)" "unprognostic (5.05e-2)" "unprognostic (9.18e-2)" "unprognostic (1.33e-3)" "unprognostic (1.64e-2)" "unprognostic (1.94e-2)" "unprognostic (4.99e-2)" "unprognostic (3.86e-1)" "unprognostic (3.09e-2)" "unprognostic (5.34e-4)" "unprognostic (6.54e-2)" "unprognostic (2.70e-1)" "unprognostic (6.05e-2)" "unprognostic (8.92e-2)" 3.6 3.0 3.7 6.4 4.5 14.4 3.5 7.4 4.8 3.7 0.9 3.7 4.3 3.5 2.2 3.9 3.1 4.6 3.6 2.4 2.8 2.7 3.5 3.5 7.3 4.5 4.3 4.5 3.3 2.9 2.9 4.6 3.5 2.4 4.4 2.9 2.6 2.7 1.5 3.2 3.4 3.6 4.7 7.5 3.5 4.9 5.3 8.8 3.0 1.8 6.7 4.4 3.4 3.9 19.9 5.3 18.8 12.4 6.5 10.5 10.3 16.5 14.8 17.8 16.3 5.7 17.1 17.0 10.4 9.3 12.4 7.4 12.5 12.2 18.5 38.9 10.0 22.7 10.2 6.5 8.9 27.1 17.0 6.7 4.3 14.2 14.2 8.5 14.0 8.6 25.7 39.8 15.6 8.8 20.8 13.0 8.4 14.2 10.5 12.2 19.2 10.6 11.4 5.5 28.1 8.2 12.7 11.5 11.1 8.2 6.8 10.8 13.2 14.5 17.6 19.7 22.3 19.3 15.5 29.0 8.1 29.7 22.2 18.3 16.9 36.8 3.8 24.6 2.2 3.9 2.6 2.7 9.5 3.7 2.5 3.4 66.0 10.2 31.1 4.4 3.7 6.5 3.7 4.5 7.4 4.8 2.4 2.8 4.5 4.3 3.5 4.7 5.3 3.9 16.1 12.8 9.8 110.0 18.0 11.1 8.9 5.8 8.0 15.2 6.1 7.4 21.2 15.7 9.0 1.8 29.2 13.8 34.8 9.1 3.9 6.5 63.2 20.3 18.4 11.9 5.4 9.0 111.1 6.3 21.5 16.3 28.1 14.3 12.0 16.5 9.3 1.6 13.3 16.8 116.0 8.1 8.2 21.6 18.0 51.8 10.8 28.4 8.8 87.1 33.8 8.9 82.4 109.1 90.5 9.0 9.8 9.1 24.0 2.7 8.2 3.1 16.7 21.6 13.1 14.4 16.5 19.6 12.1 13.1 13.9 9.3 21.2 30.5 10.6 5.6 SDHAF2 "C11orf79, FLJ20487, PGL2, SDH5" ENSG00000167985 "Succinate dehydrogenase complex assembly factor 2" Q9NX18 11 61430042-61446733 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Chaperone "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039464, HPA039732" Supported Approved Nucleoli,Mitochondria,Cytosol NA NA "Cluster 35: T-regs - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Mitochondria, Cytosol" Nucleoli "HPA039464: AB_10962146, HPA039732: AB_10962868" "unprognostic (5.31e-2)" "unprognostic (1.12e-2)" "unprognostic (3.13e-1)" "unprognostic (1.30e-2)" "unprognostic (1.40e-1)" "unprognostic (6.71e-2)" "unprognostic (1.98e-3)" "unprognostic (9.06e-2)" "unprognostic (2.17e-1)" "unprognostic (2.09e-3)" "unprognostic (4.21e-3)" "unprognostic (1.50e-1)" "unprognostic (1.81e-2)" "unprognostic (3.61e-1)" "unprognostic (1.78e-1)" "unprognostic (1.45e-1)" "unprognostic (4.48e-2)" 27.5 37.1 36.2 26.4 37.4 45.6 28.9 37.9 38.2 23.8 37.4 27.2 24.7 23.8 34.8 28.8 28.7 25.5 40.4 35.9 40.2 36.5 46.4 23.8 39.9 37.9 37.6 26.9 24.0 32.9 41.0 24.9 37.9 29.0 29.1 23.4 26.3 20.9 38.9 26.3 27.0 26.9 37.7 34.7 27.6 22.1 38.0 38.0 28.6 44.7 41.6 32.8 21.7 39.2 45.0 58.4 36.5 25.1 57.2 52.2 27.0 33.3 58.0 48.9 41.8 52.8 46.8 42.3 58.4 55.6 62.8 45.4 45.4 51.4 56.6 60.4 39.7 33.2 35.5 71.9 52.8 41.4 48.1 55.6 58.7 50.2 45.8 35.3 80.8 43.5 42.2 50.9 63.5 86.0 49.2 89.3 56.1 47.0 78.6 45.9 45.9 76.6 63.7 57.9 36.9 40.6 46.9 53.5 99.0 38.5 83.0 40.2 53.3 45.0 32.7 54.3 37.5 31.2 51.2 54.7 43.4 37.3 46.0 125.3 68.8 126.6 82.5 64.5 103.1 89.7 93.0 91.7 55.9 84.8 101.5 97.5 97.9 97.9 53.3 63.3 126.7 78.6 36.2 37.4 37.9 38.2 35.9 40.2 37.9 37.6 37.9 37.7 38.0 39.2 32.8 35.3 33.2 11.1 28.9 20.6 34.6 53.7 10.2 14.0 27.9 35.1 22.3 14.3 33.5 29.5 6.2 77.0 41.9 29.5 54.8 55.3 15.8 19.3 21.7 36.5 34.2 30.3 13.2 60.3 51.4 28.4 16.8 19.0 32.3 22.2 42.5 42.3 52.7 15.2 13.3 31.4 59.0 36.5 22.8 17.8 31.4 29.7 44.4 8.4 66.4 49.4 69.0 16.6 18.1 62.9 34.9 30.9 16.3 30.8 34.0 51.9 31.5 19.7 32.9 17.3 27.2 23.1 25.8 10.9 22.4 99.6 41.5 45.1 27.6 38.8 SEC14L5 "KIAA0420, PRELID4B" ENSG00000103184 "SEC14 like lipid binding 5" O43304 16 4958330-5019157 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 78.7" "Group enriched" "Detected in some" 12 "Cone photoreceptor cells: 85.5;Excitatory neurons: 67.0;Oligodendrocytes: 189.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.5;RPMI-8226: 1.6;SCLC-21H: 2.5;T-47d: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041492, HPA041825" Uncertain "Golgi apparatus,Cytosol" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 70: Brain - Nervous system development" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus, Cytosol" "HPA041492: AB_10794519, HPA041825: AB_10794526" "unprognostic (1.90e-3)" "unprognostic (4.08e-2)" "unprognostic (5.93e-2)" "unprognostic (1.46e-1)" "unprognostic (1.99e-1)" "unprognostic (5.68e-2)" "unprognostic (7.33e-3)" "unprognostic (8.71e-4)" "unprognostic (6.87e-2)" "unprognostic (1.56e-4)" "unprognostic (1.01e-3)" "unprognostic (7.12e-2)" "unprognostic (1.07e-1)" "unprognostic (5.61e-2)" "unprognostic (1.56e-1)" "unprognostic (1.67e-1)" "unprognostic (1.45e-2)" 0.4 0.5 12.5 0.3 43.6 0.4 0.3 25.9 29.8 0.9 0.0 0.5 0.3 0.1 0.2 0.6 0.7 0.2 5.1 15.4 17.8 0.2 0.1 0.2 0.3 33.4 35.9 0.4 0.6 0.0 2.2 0.3 29.9 0.4 0.6 3.9 0.6 0.2 5.6 1.0 0.2 0.1 22.9 0.3 1.4 0.4 31.5 0.4 0.1 10.9 0.5 0.2 0.4 78.7 0.0 0.1 0.1 0.1 0.2 1.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.7 0.1 0.3 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.3 0.1 0.0 0.1 1.6 0.0 0.0 2.5 0.0 0.1 0.1 0.1 0.2 1.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 12.5 43.6 25.9 29.8 15.4 17.8 33.4 35.9 29.9 22.9 31.5 78.7 0.2 0.0 0.0 2.3 0.0 0.3 0.1 0.0 0.0 4.1 0.2 0.1 9.1 1.5 0.1 0.0 85.5 1.1 1.3 0.3 0.0 0.1 1.6 1.0 0.1 0.3 0.0 0.0 67.0 0.2 0.1 0.6 0.0 0.1 0.0 1.5 0.4 0.3 0.3 5.0 7.1 0.6 4.1 0.0 0.3 0.5 0.3 2.0 0.0 1.9 0.5 0.0 0.0 3.5 189.4 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.5 1.9 0.0 0.7 0.2 0.1 0.3 0.0 0.1 0.3 0.0 0.1 0.6 0.0 SELENON "MDRS1, RSMD1, RSS, SELN, SEPN1" ENSG00000162430 "Selenoprotein N" Q9NZV5 1 25800176-25818221 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Desmin-related myopathy, Disease variant, Myofibrillar myopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 99.2;Exocrine glandular cells: 42.3;Granulosa cells: 31.2;Hofbauer cells: 29.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058076 Approved Uncertain Cytosol "Intracellular and membrane" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 35: Non-specific - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA058076: AB_2683598" "unprognostic (2.65e-1)" "unprognostic (1.75e-1)" "unprognostic (4.11e-1)" "prognostic favorable (2.23e-4)" "unprognostic (1.93e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (3.40e-5)" "unprognostic (1.94e-1)" "unprognostic (4.72e-1)" "unprognostic (3.32e-3)" "unprognostic (6.01e-2)" "unprognostic (3.07e-1)" "unprognostic (1.64e-1)" "unprognostic (1.53e-1)" "unprognostic (1.10e-1)" "unprognostic (5.56e-3)" "unprognostic (5.89e-2)" 65.7 48.0 51.6 34.0 51.2 17.0 60.8 45.5 53.3 43.8 74.2 42.5 17.4 48.8 19.5 36.5 40.2 30.1 60.7 49.6 48.5 52.5 20.3 51.8 20.5 72.8 55.2 51.7 60.1 37.0 40.2 38.9 52.1 58.2 20.8 11.7 45.7 39.6 56.3 30.2 31.0 56.2 54.1 43.4 43.4 12.0 62.6 13.6 53.8 39.7 16.3 46.9 35.6 50.2 52.6 49.5 160.9 138.4 102.5 178.8 54.4 62.2 93.4 67.7 53.9 12.9 54.2 0.1 40.4 94.6 74.8 49.9 42.4 66.2 51.1 55.8 32.6 51.4 18.2 16.0 73.8 11.0 116.6 191.7 43.8 71.0 35.5 79.9 214.4 17.4 18.5 7.2 64.7 26.8 2.3 15.7 61.0 40.9 33.7 45.4 70.3 6.4 27.7 14.8 33.5 56.9 39.4 35.3 52.7 43.0 35.6 36.1 180.5 68.4 46.2 126.6 37.1 5.8 0.2 1.4 94.8 15.9 84.4 2.7 1.2 1.6 0.7 1.0 0.4 0.7 0.6 0.5 0.8 0.4 0.9 0.6 0.2 0.3 1.1 0.1 0.7 0.4 51.6 51.2 45.5 53.3 49.6 48.5 72.8 55.2 52.1 54.1 62.6 50.2 99.2 9.6 10.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 23.0 19.3 0.0 0.0 3.7 20.2 0.0 16.4 3.8 0.0 0.0 18.6 0.0 6.5 22.4 21.5 0.0 0.0 0.0 42.3 11.4 12.5 0.0 13.5 2.5 31.2 0.0 0.0 29.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 3.1 0.0 0.0 0.0 0.0 24.8 0.0 0.0 0.9 0.0 0.0 14.9 3.6 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 13.0 2.2 8.6 0.0 0.0 SELL "CD62L, hLHRc, LAM-1, LAM1, Leu-8, LNHR, LSEL, Lyam-1, LYAM1, PLNHR" ENSG00000188404 "Selectin L" P14151 1 169690665-169711702 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 150.4;lymphoid tissue: 231.4" "Group enriched" "Detected in many" 5 "B-cells: 221.4;dendritic cells: 206.0;Kupffer cells: 68.9;Macrophages: 86.3;monocytes: 208.7;NK-cells: 110.2;T-cells: 104.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 11.2;JURKAT: 29.4;MOLT-4: 21.2;U-266/70: 38.8;U-698: 19.4;U-937: 11.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB002144, HPA051972" Enhanced Uncertain Cytosol NA NA 4700000000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 16: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol "CAB002144: AB_563862, HPA051972: AB_2797242" "prognostic favorable (3.76e-4)" "prognostic favorable (2.25e-4)" "unprognostic (1.52e-2)" "unprognostic (2.89e-2)" "unprognostic (7.87e-3)" "prognostic favorable (6.43e-4)" "unprognostic (1.39e-3)" "unprognostic (3.43e-1)" "unprognostic (2.70e-3)" "prognostic favorable (3.14e-4)" "unprognostic (1.42e-1)" "unprognostic (4.21e-2)" "prognostic unfavorable (4.96e-5)" "unprognostic (4.76e-2)" "unprognostic (8.71e-3)" "unprognostic (9.57e-2)" "unprognostic (1.01e-1)" 29.3 2.3 2.8 118.8 4.5 150.4 2.6 8.4 6.2 3.7 2.7 6.8 3.2 2.6 1.7 5.5 4.7 24.1 3.1 3.2 4.0 3.0 12.1 19.4 231.4 7.4 4.5 1.0 3.7 28.0 13.9 11.2 6.1 3.7 7.1 1.0 3.8 1.9 3.4 0.6 17.0 14.5 6.4 166.8 5.6 1.1 3.9 132.2 2.8 13.6 202.0 37.9 1.4 8.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.2 0.2 0.7 0.0 0.3 11.2 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 7.7 1.3 0.5 0.0 0.0 0.0 0.0 1.8 29.4 0.1 1.4 0.0 1.8 21.2 0.3 0.1 0.4 0.3 7.8 0.2 0.7 6.1 0.3 0.0 0.0 0.0 1.4 0.0 0.8 0.0 0.0 0.0 0.6 0.2 0.0 0.0 38.8 0.0 19.4 2.0 11.1 0.3 3688.4 992.6 1696.7 284.3 211.6 78.1 613.0 528.9 294.2 756.3 734.4 1169.2 683.6 4201.4 2551.1 93.1 622.9 1011.2 2052.5 2.8 4.5 8.4 6.2 3.2 4.0 7.4 4.5 6.1 6.4 3.9 8.0 1.8 9.6 13.7 0.7 221.4 0.4 0.3 0.0 0.6 0.1 0.5 0.3 0.6 2.8 1.8 11.0 0.0 13.9 206.0 0.1 0.0 0.2 0.0 0.1 0.0 3.4 0.0 25.2 0.2 0.0 0.6 3.3 2.6 0.1 10.1 0.5 3.9 1.1 5.6 0.0 0.1 0.1 0.0 68.9 2.7 0.2 0.6 86.3 1.8 1.0 208.7 2.5 110.2 0.0 0.8 0.1 0.0 0.0 25.8 0.0 0.0 0.9 1.5 0.0 0.0 0.2 0.6 0.0 0.1 0.3 0.1 28.5 104.9 0.5 0.0 0.6 SERPINI1 PI12 ENSG00000163536 "Serpin family I member 1" Q99574 3 167735243-167825569 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 301.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 219.4;Excitatory neurons: 176.9;Inhibitory neurons: 228.8;Oligodendrocytes: 174.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 29.2;Karpas-707: 29.1;U-266/84: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001565, HPA056092" Enhanced Uncertain Cytosol "Secreted in brain" NA NA 750000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 65: Brain - Ion transport" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 56: Bipolar cells - Visual perception" Cytosol "HPA001565: AB_1079924, HPA056092: AB_2683036" "unprognostic (1.61e-1)" "unprognostic (1.06e-1)" "unprognostic (4.09e-3)" "unprognostic (1.35e-1)" "unprognostic (6.97e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (4.25e-4)" "unprognostic (2.48e-1)" "unprognostic (2.61e-1)" "unprognostic (6.07e-3)" "unprognostic (2.18e-2)" "unprognostic (1.01e-1)" "unprognostic (1.58e-3)" "unprognostic (1.41e-1)" "unprognostic (2.89e-1)" "unprognostic (1.22e-1)" "unprognostic (1.11e-1)" 13.1 15.8 138.8 4.1 157.7 2.3 11.7 115.9 301.4 8.4 82.1 5.1 2.2 8.6 8.2 5.5 7.9 6.3 14.0 162.0 129.1 32.1 4.1 6.4 4.6 122.8 153.6 6.9 39.5 6.9 42.8 6.7 123.9 11.8 4.4 84.4 23.0 7.4 3.2 3.1 4.4 6.1 134.6 8.7 10.8 15.8 134.5 4.4 11.2 8.1 8.2 4.9 6.0 164.8 0.8 3.5 5.5 0.4 10.3 2.2 0.3 1.9 2.7 1.3 2.2 1.5 5.9 29.2 9.5 1.3 4.5 1.3 3.9 3.8 1.5 7.7 6.5 8.9 22.5 10.7 0.7 1.4 1.1 3.8 1.4 0.8 1.3 2.9 0.4 10.5 18.9 29.1 1.2 2.7 0.8 1.9 3.3 4.2 4.5 2.7 0.4 3.2 11.2 1.0 2.2 13.4 3.6 6.8 8.3 12.4 10.6 4.4 1.0 5.5 0.5 0.5 10.3 23.0 28.4 18.8 4.2 7.7 3.2 1.5 0.3 0.8 9.3 0.7 6.9 22.1 9.7 10.2 0.5 25.2 6.9 8.1 0.9 9.5 0.5 7.2 27.2 5.2 138.8 157.7 115.9 301.4 162.0 129.1 122.8 153.6 123.9 134.6 134.5 164.8 49.8 6.4 1.5 43.1 10.7 3.7 13.2 6.4 14.2 219.4 3.6 14.1 8.2 1.5 6.7 5.5 14.6 6.1 6.2 0.7 7.9 1.8 0.4 2.0 1.0 16.0 4.8 7.4 176.9 18.0 6.0 8.9 2.6 1.7 2.5 2.3 3.9 0.6 2.3 5.0 228.8 0.3 73.2 0.6 3.2 2.4 4.1 0.9 7.2 25.3 1.2 78.0 2.1 31.2 174.7 3.0 0.0 2.6 14.6 6.7 0.0 39.9 13.6 35.4 26.3 5.2 54.7 3.0 27.4 0.5 1.7 5.1 6.2 1.1 0.3 2.3 SETBP1 "KIAA0437, SEB" ENSG00000152217 "SET binding protein 1" Q9Y6X0 18 44680173-45068510 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Excitatory neurons: 349.0;Inhibitory neurons: 548.3;Oligodendrocyte precursor cells: 170.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 11.6" "Immune cell enhanced" "Detected in some" "naive B-cell: 3.0;plasmacytoid DC: 2.8" "Group enriched" "Detected in many" 5 "B-cells: 3.0;dendritic cells: 2.8;monocytes: 1.0" "Cell line enhanced" "Detected in many" "AF22: 16.1;Karpas-707: 44.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049022, HPA057259" Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 66000 "Cluster 19: B-cells - Humoral immune response" "Cluster 46: Fibroblasts - ECM organization" "Cluster 2: Karpas-707 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Nuclear bodies, Cytosol" "HPA049022: AB_2680602, HPA057259: AB_2683384" "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" "unprognostic (1.11e-1)" "unprognostic (1.97e-2)" "unprognostic (4.63e-2)" "unprognostic (1.80e-1)" "unprognostic (1.91e-1)" "unprognostic (3.57e-2)" "unprognostic (3.49e-1)" "unprognostic (2.01e-2)" "unprognostic (2.71e-3)" "unprognostic (6.52e-2)" "prognostic favorable (6.34e-8)" "unprognostic (2.18e-2)" "unprognostic (2.29e-1)" "unprognostic (6.06e-2)" "unprognostic (7.81e-5)" 7.3 1.9 2.0 3.7 3.7 1.8 6.3 11.6 5.7 11.6 0.0 10.9 1.7 8.3 7.2 4.5 7.2 5.0 4.3 2.6 0.2 7.4 4.7 6.6 5.3 0.0 0.1 7.7 5.8 3.7 2.7 7.2 0.1 7.8 3.5 3.0 4.3 9.2 10.7 4.4 4.6 7.4 0.0 3.7 5.6 1.8 0.0 4.4 5.1 9.7 4.7 8.1 8.5 3.8 0.0 2.4 16.1 0.0 4.1 1.2 1.0 1.3 3.0 1.5 1.3 0.2 0.0 1.0 0.5 1.8 1.0 4.8 1.8 4.9 1.0 1.4 0.8 0.0 1.8 1.2 0.0 0.0 0.0 3.8 2.0 0.0 3.0 2.7 0.5 0.0 0.1 44.7 0.4 0.8 0.0 0.1 2.0 0.0 1.1 5.6 0.0 5.5 4.9 3.9 8.2 4.2 0.0 0.0 0.9 7.1 2.2 0.0 0.0 9.5 3.3 0.0 7.7 8.6 0.5 0.0 5.8 0.2 5.5 0.1 0.0 0.0 0.4 0.6 0.0 2.0 0.0 0.2 0.0 3.0 0.0 0.1 0.0 0.0 1.0 2.8 0.0 0.1 2.0 3.7 11.6 5.7 2.6 0.2 0.0 0.1 0.1 0.0 0.0 3.8 7.6 0.0 1.8 85.5 42.4 15.4 8.6 8.3 7.4 12.5 11.0 12.6 3.9 14.3 4.2 16.5 18.8 1.5 25.5 1.6 3.9 4.5 1.3 12.9 15.6 8.3 12.0 0.8 349.0 3.5 1.4 29.3 4.1 14.8 0.0 0.7 17.9 16.5 2.0 3.3 548.3 4.4 10.2 2.4 8.7 3.7 62.7 4.6 3.6 88.1 1.5 10.7 6.2 170.4 62.9 3.7 9.1 39.9 29.6 8.1 0.4 10.5 5.8 18.2 6.6 18.4 28.6 0.3 0.8 4.0 15.2 0.8 5.9 0.1 4.7 1.5 SETD6 FLJ21148 ENSG00000103037 "SET domain containing 6, protein lysine methyltransferase" Q8TBK2 16 58515479-58523842 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041481, HPA053546" Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm Cytosol "HPA041481: AB_10804004, HPA053546: AB_2682182" "unprognostic (1.32e-1)" "unprognostic (2.98e-3)" "unprognostic (3.35e-1)" "unprognostic (2.81e-1)" "unprognostic (7.90e-3)" "unprognostic (1.95e-1)" "unprognostic (1.93e-3)" "unprognostic (1.65e-1)" "unprognostic (3.65e-2)" "unprognostic (1.50e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (3.54e-4)" "unprognostic (3.74e-3)" "unprognostic (2.14e-1)" "unprognostic (3.73e-1)" "unprognostic (5.93e-3)" "unprognostic (1.55e-1)" 8.6 12.4 3.8 2.9 3.6 2.6 9.1 8.9 4.6 9.4 3.9 8.4 3.8 8.4 5.4 13.4 9.7 2.7 11.3 3.9 3.8 12.5 13.5 7.0 4.6 3.8 3.5 9.1 19.6 6.5 12.5 2.5 3.9 10.9 4.3 7.9 11.1 5.9 15.0 14.6 9.2 3.3 3.5 10.6 11.4 12.7 3.8 2.8 12.2 3.9 4.4 8.3 10.8 3.8 2.5 6.1 1.3 10.7 4.3 2.8 15.9 4.0 5.4 7.1 3.8 10.1 6.1 19.9 5.4 4.6 0.9 8.1 9.0 6.3 4.9 2.2 23.6 0.9 11.0 17.2 4.3 14.4 7.8 3.8 13.2 5.6 8.8 4.8 4.5 0.2 14.7 2.6 1.5 10.1 0.3 17.7 21.0 9.7 9.6 0.4 2.5 26.7 7.3 0.4 19.6 12.6 16.8 15.9 7.8 6.2 10.0 2.0 3.7 2.5 6.0 3.1 7.3 11.7 8.1 13.7 5.3 6.9 4.6 2.5 1.1 0.2 2.0 1.5 1.4 1.5 1.6 2.2 1.8 1.5 2.0 2.2 0.7 4.4 1.6 2.0 1.6 1.3 3.8 3.6 8.9 4.6 3.9 3.8 3.8 3.5 3.9 3.5 3.8 3.8 5.2 6.4 6.9 6.8 7.1 13.9 10.5 7.5 13.6 14.3 12.0 11.0 7.6 17.2 8.5 9.2 14.6 17.5 8.6 5.3 1.9 10.1 9.2 10.8 6.9 6.8 4.8 10.3 11.5 12.2 9.9 8.4 8.2 10.0 1.3 14.9 4.2 7.9 3.5 11.8 11.3 5.0 2.0 3.5 5.6 16.9 9.0 3.4 5.4 5.6 5.6 15.0 6.2 7.5 4.7 6.1 4.2 10.1 6.8 13.8 6.5 9.4 12.0 13.4 13.1 10.1 7.4 15.0 22.9 12.1 12.1 12.6 7.1 6.1 7.4 6.2 SGO1 "NY-BR-85, SGOL1" ENSG00000129810 "Shugoshin 1" Q5FBB7 3 20160593-20186206 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 8.7;lymphoid tissue: 13.0;testis: 6.7" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 16.5;Extravillous trophoblasts: 42.6;Granulosa cells: 20.3;Hofbauer cells: 10.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 5 "basophil: 10.0;memory B-cell: 8.8;naive B-cell: 8.9;plasmacytoid DC: 4.1;T-reg: 2.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035501, HPA069302, HPA069857" Enhanced Enhanced Nucleoplasm,Kinetochore,Cytosol Yes Yes "Cluster 37: B-cells - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Kinetochore, Cytosol" "HPA035501: AB_2732469, HPA069302: , HPA069857: AB_2686214" "unprognostic (6.87e-3)" "unprognostic (5.01e-2)" "unprognostic (2.25e-2)" "unprognostic (8.93e-3)" "unprognostic (2.51e-2)" "unprognostic (4.10e-2)" "unprognostic (2.55e-6)" "unprognostic (9.49e-3)" "unprognostic (2.45e-2)" "unprognostic (3.69e-2)" "unprognostic (1.65e-4)" "unprognostic (1.52e-2)" "unprognostic (0.00e+0)" "unprognostic (2.29e-2)" "unprognostic (4.95e-2)" "unprognostic (4.14e-1)" "unprognostic (1.64e-1)" 0.3 0.1 0.3 3.3 0.7 8.7 0.5 0.9 0.5 0.4 0.0 2.1 2.3 0.4 0.0 1.9 0.1 0.4 0.1 0.3 0.4 0.3 0.6 0.3 6.2 0.8 0.6 0.2 0.1 0.2 0.0 1.7 0.6 0.2 2.8 0.1 0.4 0.1 0.1 1.1 2.5 1.0 0.3 1.4 1.5 6.7 0.6 13.0 0.2 0.0 6.6 0.9 0.7 1.2 20.3 23.9 29.9 18.5 1.4 2.6 20.2 21.3 10.1 31.2 33.6 16.5 24.0 30.7 10.6 8.6 21.2 11.4 28.7 11.3 37.6 40.9 19.6 34.6 15.6 12.8 0.2 32.0 28.8 0.3 0.9 33.3 13.1 4.0 18.5 34.9 31.3 52.2 24.6 19.4 52.4 15.4 30.0 20.3 17.0 31.8 38.4 17.7 7.5 14.9 14.2 15.4 23.6 27.2 13.1 22.7 18.2 21.3 4.7 22.5 27.3 20.5 43.3 22.8 57.4 35.2 12.5 31.1 35.0 10.0 0.1 1.4 0.2 0.2 0.1 8.8 0.6 0.7 0.3 8.9 0.2 0.3 1.4 0.3 0.2 4.1 2.6 0.6 0.3 0.7 0.9 0.5 0.3 0.4 0.8 0.6 0.6 0.3 0.6 1.2 0.1 0.0 0.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.0 3.4 0.0 0.0 0.0 1.8 0.0 16.5 1.5 0.0 0.0 1.1 0.0 2.3 1.6 1.2 0.0 0.0 0.0 1.8 42.6 3.3 0.0 2.9 1.3 20.3 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 4.9 1.0 4.3 0.0 0.0 SHD ENSG00000105251 "Src homology 2 domain containing transforming protein D" Q96IW2 19 4279266-4290722 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 10.0;heart muscle: 17.8" "Cell type enhanced" "Detected in some" "Distal enterocytes: 137.5;Hepatocytes: 57.3;Intestinal goblet cells: 54.6;Paneth cells: 78.8;Proximal enterocytes: 43.1;Undifferentiated cells: 49.4" "Cancer enhanced" "Detected in some" "glioma: 11.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 178 "plasmacytoid DC: 17.8" "Lineage enriched" "Detected in single" 178 "dendritic cells: 17.8" "Group enriched" "Detected in some" 45 "RH-30: 58.4;SH-SY5Y: 193.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017955 Uncertain Uncertain "Centriolar satellite,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 53: Intestinal epithelial cells - Unknown function" "Centriolar satellite, Cytosol" "HPA017955: AB_1856828" "unprognostic (2.41e-3)" "unprognostic (7.68e-3)" "unprognostic (4.77e-3)" "unprognostic (3.67e-2)" "unprognostic (3.48e-2)" "unprognostic (3.42e-1)" "unprognostic (6.53e-2)" "unprognostic (1.43e-1)" "unprognostic (5.93e-2)" "unprognostic (3.73e-1)" "unprognostic (2.47e-2)" "unprognostic (3.76e-1)" "unprognostic (3.48e-1)" "unprognostic (1.21e-1)" "unprognostic (5.21e-2)" "unprognostic (9.69e-2)" "unprognostic (8.16e-4)" 0.0 0.1 4.2 0.6 3.6 0.7 0.0 7.0 8.6 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.1 17.8 2.4 9.6 0.0 1.5 0.0 0.6 7.4 6.4 0.0 0.0 0.1 0.2 0.0 5.6 0.0 0.3 0.6 0.1 0.0 0.4 0.0 0.2 0.0 4.6 0.1 0.0 0.1 10.0 0.1 0.0 1.7 0.3 0.1 0.0 6.0 0.0 0.0 0.7 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.4 0.0 0.0 0.2 58.4 0.1 0.0 0.0 0.5 193.2 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 4.2 3.6 7.0 8.6 2.4 9.6 7.4 6.4 5.6 4.6 10.0 6.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.9 0.0 0.0 6.9 0.0 0.0 0.0 0.0 1.8 21.7 137.5 1.9 0.0 0.1 0.1 0.0 0.2 13.2 5.3 2.8 0.0 0.6 0.4 0.0 0.1 8.9 0.0 0.7 57.3 0.4 10.1 4.2 54.6 0.0 0.6 0.0 0.4 0.0 0.6 0.0 1.0 0.2 0.9 0.0 9.0 0.3 0.0 78.8 0.0 0.0 0.0 43.1 0.0 0.0 0.4 0.0 2.5 0.1 0.0 2.9 0.0 0.0 4.4 0.8 0.0 49.4 0.0 SIGLEC8 "MGC59785, SAF2, SIGLEC-8, SIGLEC8L" ENSG00000105366 "Sialic acid binding Ig like lectin 8" Q9NYZ4 19 51450847-51458456 "CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.9;lymphoid tissue: 6.8" "Cell type enhanced" "Detected in some" "granulocytes: 44.9;Kupffer cells: 17.7;Microglial cells: 11.2" "Group enriched" "Detected in many" 4 "glioma: 7.2;renal cancer: 2.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 38 "eosinophil: 290.2" "Lineage enriched" "Detected in single" 719 "granulocytes: 290.2" "Cell line enriched" "Detected in some" 44 "HMC-1: 147.5" HPA012556 Uncertain Uncertain Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 3: HMC-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" Cytosol "HPA012556: AB_1856869" "unprognostic (1.27e-1)" "unprognostic (1.88e-4)" "unprognostic (1.28e-1)" "unprognostic (6.70e-2)" "unprognostic (2.97e-1)" "unprognostic (1.30e-2)" "unprognostic (7.84e-2)" "unprognostic (2.51e-2)" "unprognostic (2.72e-2)" "unprognostic (2.17e-1)" "unprognostic (1.10e-1)" "unprognostic (4.19e-1)" "unprognostic (8.62e-3)" "unprognostic (7.18e-2)" "unprognostic (6.02e-2)" "unprognostic (4.28e-3)" "unprognostic (3.29e-1)" 0.3 4.0 4.9 1.6 5.2 0.5 1.4 5.3 6.1 0.9 1.7 1.8 1.8 0.6 0.7 0.7 0.7 1.4 0.2 4.5 6.2 0.1 0.8 2.5 6.8 13.3 6.6 0.2 0.5 1.0 0.4 0.1 10.1 0.6 1.6 0.7 0.6 0.5 0.1 0.5 2.8 0.9 7.3 6.3 1.4 0.3 11.6 2.1 0.4 0.2 2.5 1.0 0.3 14.9 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 2.3 0.1 0.1 0.0 0.0 147.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.3 0.0 0.0 0.2 3.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.2 1.1 0.1 7.6 0.4 290.2 0.2 0.3 0.1 0.2 0.2 0.1 0.1 0.3 0.1 0.2 2.5 0.3 0.4 0.2 0.1 0.2 4.9 5.2 5.3 6.1 4.5 6.2 13.3 6.6 10.1 7.3 11.6 14.9 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 44.9 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 17.7 0.0 0.0 0.0 2.5 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SKA3 "C13orf3, MGC4832, RAMA1" ENSG00000165480 "Spindle and kinetochore associated complex subunit 3" Q8IX90 13 21153595-21176552 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 4.7;lymphoid tissue: 12.1;testis: 6.3" "Cell type enhanced" "Detected in many" "Erythroid cells: 12.8;Extravillous trophoblasts: 21.0;Spermatocytes: 21.7;Spermatogonia: 18.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA039272, HPA039356, HPA061534" Approved Supported "Mitotic spindle,Centrosome,Cytosol" Yes Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Mitotic spindle" "Centrosome, Cytosol" "HPA039272: AB_10805359, HPA039356: AB_10805475, HPA061534: " "unprognostic (3.46e-2)" "unprognostic (7.21e-2)" "unprognostic (2.15e-1)" "unprognostic (1.62e-2)" "unprognostic (2.04e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (9.73e-6)" "unprognostic (2.03e-3)" "prognostic unfavorable (8.71e-4)" "unprognostic (2.03e-1)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.39e-2)" "unprognostic (0.00e+0)" "unprognostic (2.24e-3)" "unprognostic (1.81e-1)" "unprognostic (1.22e-1)" "unprognostic (1.32e-1)" 0.2 0.1 0.2 2.5 0.2 4.7 0.8 0.1 0.3 0.2 0.0 1.7 1.0 0.5 0.0 1.9 0.2 0.4 0.0 0.5 0.2 0.1 0.2 0.2 4.3 0.2 0.2 0.0 0.0 0.0 0.0 1.6 0.2 0.0 3.0 0.0 0.2 0.0 0.0 1.8 2.1 1.1 0.2 0.7 1.0 6.3 0.3 12.1 0.1 0.1 3.7 0.4 0.5 0.2 26.1 13.0 25.8 20.5 0.9 5.1 19.1 35.0 14.8 42.1 28.7 23.4 27.8 35.6 10.0 19.3 18.5 24.4 34.4 15.2 54.7 30.3 15.9 47.3 7.7 12.7 0.0 39.5 17.7 1.5 1.0 34.9 15.4 4.2 20.7 30.6 26.3 14.2 33.9 21.0 60.7 37.8 27.9 42.8 23.8 36.5 50.3 15.8 12.2 9.9 30.1 11.1 11.8 17.1 8.1 17.9 15.3 33.5 8.7 16.0 23.8 17.0 43.9 9.0 19.7 34.5 4.4 31.1 51.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.5 0.1 0.2 0.2 0.1 0.3 0.5 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.4 0.0 0.0 0.0 2.6 2.0 0.7 2.4 0.0 0.1 0.9 0.8 0.8 0.0 1.8 0.0 0.0 8.7 1.0 2.1 0.0 1.2 6.3 2.8 0.9 1.4 0.0 12.8 0.8 1.3 21.0 2.1 1.5 1.6 0.0 5.8 1.8 0.4 5.5 0.0 0.6 1.8 2.0 1.9 2.9 7.7 1.5 1.6 0.0 1.9 0.8 0.3 3.1 0.0 0.2 1.0 1.6 1.2 8.5 0.3 0.4 0.6 2.0 0.4 0.0 0.3 2.3 21.7 18.2 5.8 2.8 2.2 1.2 0.5 5.0 0.7 SKIDA1 "C10orf140, FLJ45187" ENSG00000180592 "SKI/DACH domain containing 1" Q1XH10 10 21513475-21526368 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in many" "Bipolar cells: 19.1;Early spermatids: 17.9" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "cerebral cortex: 2.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 26.1;AN3-CA: 6.7;BEWO: 12.1;SH-SY5Y: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039208, HPA040439" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 45: Intestine - Brush border" "Cluster 12: NES - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA039208: AB_10795034, HPA040439: AB_10796122" "unprognostic (5.36e-2)" "unprognostic (1.84e-1)" "unprognostic (5.32e-3)" "unprognostic (6.45e-4)" "unprognostic (9.97e-2)" "unprognostic (3.23e-3)" "unprognostic (3.61e-2)" "unprognostic (1.12e-2)" "unprognostic (1.59e-2)" "unprognostic (4.23e-1)" "unprognostic (9.35e-3)" "unprognostic (5.93e-2)" "unprognostic (3.38e-6)" "unprognostic (8.13e-2)" "unprognostic (1.50e-1)" "unprognostic (8.20e-2)" "unprognostic (8.52e-3)" 0.3 0.6 0.4 0.1 0.6 0.6 0.2 0.4 2.3 0.5 0.0 0.6 0.1 0.2 0.2 0.2 0.5 0.1 1.2 0.5 0.0 1.3 1.4 0.3 0.1 0.1 0.0 1.3 0.5 1.1 0.5 0.8 0.0 0.3 0.2 1.5 0.5 0.6 0.2 1.0 0.2 0.3 0.0 0.1 0.2 1.7 0.0 0.2 1.2 0.2 0.1 0.3 0.3 0.9 0.5 1.1 26.1 6.7 0.5 0.3 12.1 0.5 0.4 0.0 0.1 2.5 0.2 0.2 1.0 0.4 0.2 1.6 2.4 0.5 0.0 0.0 2.9 0.1 1.3 0.3 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.7 0.2 0.4 0.2 0.2 0.1 1.1 0.9 0.1 1.6 0.0 0.0 0.4 0.8 0.0 0.5 0.7 2.9 6.0 0.9 4.5 0.1 2.1 0.4 5.4 0.4 0.2 0.8 0.2 0.6 0.1 0.0 0.3 1.6 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.4 2.3 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.9 1.0 0.0 1.5 5.2 0.2 1.5 1.0 0.6 6.8 19.1 1.8 2.2 6.9 4.3 1.4 1.8 0.0 5.3 0.0 0.1 7.9 0.1 17.9 0.4 1.3 4.3 0.0 0.0 2.8 0.6 3.4 2.1 0.0 0.3 1.3 3.3 4.6 10.3 3.2 1.7 2.2 0.0 0.0 2.2 0.3 10.2 1.5 0.6 0.0 1.0 0.0 6.1 0.0 3.5 2.1 0.3 0.0 2.2 0.1 0.7 0.0 8.5 0.6 4.7 6.6 1.5 1.2 6.5 5.1 4.2 1.8 3.4 0.1 5.2 0.0 0.2 SLC12A7 "DKFZP434F076, KCC4" ENSG00000113504 "Solute carrier family 12 member 7" Q9Y666 5 1050384-1112063 "Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 77.3" "Cell type enriched" "Detected in many" 4 "Horizontal cells: 281.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 43.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041652 Approved Uncertain Cytosol NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 18: Non-specific - Mitochondria" "Cluster 14: REH - Unknown function" "Cluster 62: Horizontal cells - Visual perception" Cytosol "HPA041652: AB_10793971" "unprognostic (2.22e-2)" "unprognostic (1.56e-1)" "unprognostic (8.92e-2)" "unprognostic (2.86e-1)" "unprognostic (1.69e-2)" "unprognostic (8.72e-2)" "prognostic unfavorable (2.12e-6)" "unprognostic (1.67e-1)" "unprognostic (1.71e-3)" "unprognostic (4.40e-2)" "unprognostic (4.50e-2)" "unprognostic (3.44e-2)" "unprognostic (1.65e-3)" "unprognostic (1.17e-3)" "unprognostic (1.26e-1)" "unprognostic (3.93e-2)" "prognostic favorable (3.16e-5)" 21.1 14.6 8.9 7.2 8.0 4.0 18.8 7.2 10.4 15.8 12.3 24.1 24.0 13.8 1.0 8.0 16.6 12.0 77.3 7.9 12.0 45.1 72.4 23.1 5.7 8.0 10.7 12.3 27.6 4.4 20.5 2.9 8.0 20.7 5.4 5.5 18.9 3.0 6.3 15.8 31.9 3.3 6.8 34.9 28.1 29.9 9.4 7.8 24.7 3.1 2.2 14.5 10.8 7.1 3.8 10.0 5.5 17.3 0.8 0.9 8.7 0.2 1.1 0.8 0.0 24.5 6.4 0.0 20.0 0.3 6.8 7.6 4.6 6.1 0.0 23.0 6.1 4.8 13.4 8.6 12.2 0.0 10.4 1.8 0.8 0.0 1.8 0.3 5.5 2.2 7.6 0.2 0.0 12.0 14.8 0.1 11.9 14.4 16.3 43.9 24.0 20.5 6.5 14.8 3.1 3.8 5.6 0.1 6.0 3.3 9.7 2.7 4.8 0.0 5.7 0.0 0.0 0.3 0.0 2.5 0.0 0.6 2.8 0.2 1.8 0.0 1.1 2.7 1.2 0.6 1.1 1.3 2.1 0.6 1.2 1.2 0.0 1.4 3.8 0.9 1.1 1.3 8.9 8.0 7.2 10.4 7.9 12.0 8.0 10.7 8.0 6.8 9.4 7.1 21.3 9.6 15.2 8.5 7.3 7.0 6.3 8.9 6.8 25.3 18.4 13.8 35.8 31.5 13.6 29.5 2.1 0.2 14.2 42.0 1.9 23.5 0.4 40.9 11.0 27.9 13.2 19.1 0.3 18.1 0.4 11.6 39.8 63.4 8.2 16.6 11.7 34.5 19.8 281.0 0.5 19.4 18.3 28.0 19.8 1.9 3.7 29.0 16.0 14.0 9.1 5.2 5.2 1.5 0.0 28.8 35.8 5.7 5.3 15.7 27.3 23.2 23.1 3.6 19.7 5.2 8.4 1.0 3.4 3.5 6.8 0.3 9.8 5.4 19.3 15.2 SLC25A12 Aralar ENSG00000115840 "Solute carrier family 25 member 12" O75746 2 171783405-171999859 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 97.0" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 97.7;Excitatory neurons: 148.5;Inhibitory neurons: 175.2;Oligodendrocyte precursor cells: 111.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035333, HPA035334" Enhanced Uncertain "Nuclear speckles,Cytosol" NA NA 9100 "Cluster 32: T-cells - Unknown function" "Cluster 38: Heart - Muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nuclear speckles" Cytosol "HPA035333: AB_10603028, HPA035334: AB_2674577" "unprognostic (3.24e-2)" "unprognostic (2.52e-2)" "unprognostic (4.07e-2)" "prognostic unfavorable (7.86e-4)" "unprognostic (2.65e-2)" "unprognostic (7.27e-2)" "unprognostic (4.21e-3)" "unprognostic (5.23e-2)" "unprognostic (1.39e-1)" "unprognostic (4.96e-2)" "unprognostic (7.76e-2)" "unprognostic (1.13e-1)" "prognostic favorable (2.91e-8)" "unprognostic (8.64e-3)" "unprognostic (2.08e-1)" "unprognostic (1.73e-1)" "unprognostic (2.70e-1)" 11.1 11.5 8.5 4.0 9.0 2.8 11.6 9.3 12.3 11.5 6.1 25.2 2.2 13.4 4.3 12.7 11.7 3.7 62.7 8.9 9.0 13.4 1.8 7.1 4.4 6.9 6.7 14.5 3.9 12.0 17.1 3.2 6.8 13.7 6.1 15.8 16.8 9.5 97.0 14.5 10.7 8.5 5.8 8.9 16.4 6.1 7.4 5.6 15.1 51.1 5.2 16.2 12.4 8.4 4.9 3.0 4.2 8.0 9.5 11.7 0.0 5.3 11.2 7.7 7.3 2.2 3.2 14.5 2.6 7.5 4.3 4.3 7.9 8.5 10.7 6.3 10.4 6.9 4.4 5.5 3.8 14.8 4.9 12.6 7.0 11.0 2.3 4.1 8.0 7.0 5.0 5.2 4.4 3.2 9.7 6.5 3.0 3.8 4.7 9.6 4.7 7.4 8.0 4.5 5.1 1.6 2.6 8.5 4.0 2.5 2.8 3.1 6.4 6.2 2.0 6.0 3.2 8.8 4.2 13.6 9.1 7.5 2.9 0.0 0.4 0.1 1.0 0.4 0.8 0.7 0.5 0.9 0.4 0.5 0.9 1.5 0.0 0.9 0.7 0.1 0.7 0.4 8.5 9.0 9.3 12.3 8.9 9.0 6.9 6.7 6.8 5.8 7.4 8.4 9.8 0.0 9.8 71.2 11.3 6.9 10.2 13.2 19.9 25.5 9.3 11.8 97.7 0.0 18.4 18.4 25.0 7.5 10.7 11.6 19.6 1.7 3.2 5.0 10.3 8.7 14.4 6.9 148.5 3.3 1.8 15.1 12.8 6.1 10.8 7.3 7.9 0.6 4.5 37.0 175.2 6.1 16.2 8.4 5.4 2.1 12.5 7.2 16.0 25.3 9.7 19.8 5.2 111.6 44.1 2.0 4.7 24.5 19.5 4.6 4.1 13.2 11.2 25.5 13.1 12.5 16.6 7.8 9.1 16.8 7.7 1.2 15.0 11.0 7.6 8.3 SLC25A20 "CAC, CACT" ENSG00000178537 "Solute carrier family 25 member 20" O43772 3 48856926-48898904 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 148.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 42.2;Hepatocytes: 64.2;Proximal enterocytes: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 96.1;RPMI-8226: 138.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016862, HPA029863" Approved Approved Mitochondria,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 25: RPMI-8226 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Mitochondria, Cytosol" "HPA016862: AB_1857028, HPA029863: AB_10602893" "unprognostic (1.02e-1)" "unprognostic (1.84e-1)" "unprognostic (2.20e-1)" "unprognostic (3.46e-2)" "unprognostic (5.18e-2)" "unprognostic (3.97e-2)" "unprognostic (1.03e-1)" "unprognostic (5.96e-3)" "unprognostic (4.06e-1)" "unprognostic (1.73e-1)" "unprognostic (1.36e-2)" "unprognostic (2.51e-1)" "unprognostic (3.71e-3)" "unprognostic (3.34e-1)" "unprognostic (5.12e-1)" "unprognostic (4.22e-2)" "unprognostic (3.49e-2)" 20.7 29.9 16.3 11.9 18.2 10.7 17.9 18.6 16.4 8.3 15.3 26.5 65.6 10.4 4.6 9.1 12.8 15.7 62.8 15.5 17.9 25.6 148.3 15.6 14.6 17.7 17.4 5.9 30.4 17.3 11.6 7.3 17.8 11.7 23.5 4.5 19.9 9.0 66.5 10.4 52.7 15.1 17.4 20.6 21.0 9.1 17.5 17.3 11.4 61.1 16.1 11.3 8.4 18.4 4.1 12.8 9.7 13.8 30.1 11.8 1.9 22.3 11.8 15.2 15.8 16.3 19.1 19.0 15.6 35.1 18.7 4.1 24.5 9.8 11.6 47.9 11.8 26.4 19.2 20.4 14.0 27.8 48.1 14.9 11.2 20.6 3.8 6.1 20.2 28.1 24.1 96.1 20.2 10.9 30.4 13.7 5.1 22.9 27.6 10.6 5.9 138.4 16.4 10.1 3.9 13.6 20.7 0.2 11.4 13.6 30.5 12.9 16.6 17.2 3.2 25.5 16.4 35.6 27.0 21.8 24.5 19.5 23.3 60.8 101.1 215.2 97.4 79.7 62.2 36.8 53.1 71.2 97.5 33.0 41.2 69.1 48.6 64.6 83.7 120.5 60.7 112.3 16.3 18.2 18.6 16.4 15.5 17.9 17.7 17.4 17.8 17.4 17.5 18.4 7.5 6.4 2.7 13.1 7.0 1.8 2.5 4.6 3.4 1.1 4.0 3.6 42.2 4.3 4.4 0.0 6.2 2.3 13.6 28.4 3.9 3.5 1.3 2.3 4.6 5.5 7.3 16.4 2.2 4.3 2.3 6.1 9.2 2.1 1.3 3.8 7.5 64.2 16.9 0.0 3.8 12.7 2.0 13.4 4.5 1.8 10.5 10.0 1.8 1.0 31.3 2.9 32.0 1.0 6.0 3.7 16.4 12.4 12.6 3.9 51.8 16.7 5.9 1.3 0.0 5.4 5.3 8.3 7.1 4.1 1.3 1.2 14.4 27.7 16.6 2.9 SLC28A1 CNT1 ENSG00000156222 "Solute carrier family 28 member 1" O00337 15 84884654-84945798 "Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "intestine: 49.1;kidney: 48.2;liver: 111.3" "Group enriched" "Detected in some" 5 "Hepatocytes: 38.6;Hofbauer cells: 54.3;Proximal enterocytes: 86.9;Proximal tubular cells: 93.4" "Group enriched" "Detected in some" 63 "liver cancer: 10.9;renal cancer: 33.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA019551, HPA056247" Enhanced Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Plasma membrane" "Nuclear speckles, Cytosol" "HPA019551: AB_2670187, HPA056247: " "unprognostic (3.81e-2)" "unprognostic (1.60e-1)" "unprognostic (2.22e-1)" "unprognostic (7.49e-2)" "unprognostic (5.08e-2)" "unprognostic (7.08e-2)" "unprognostic (8.68e-3)" "unprognostic (1.82e-1)" "unprognostic (1.98e-1)" "unprognostic (2.18e-2)" "unprognostic (1.63e-1)" "unprognostic (8.37e-2)" "unprognostic (1.35e-1)" "unprognostic (7.42e-2)" "unprognostic (7.72e-3)" "unprognostic (6.65e-2)" "unprognostic (1.55e-1)" 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.1 0.3 0.0 0.0 37.9 0.0 0.5 0.1 0.7 0.2 1.0 0.1 0.3 48.2 111.3 0.0 0.2 0.9 0.3 0.0 0.0 0.2 0.2 1.2 0.7 0.0 0.0 0.0 0.1 0.0 1.5 0.0 49.1 0.0 0.4 0.0 0.1 0.1 0.2 0.0 0.0 3.3 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.1 0.3 0.9 0.3 0.7 0.4 0.2 0.6 0.2 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.3 2.2 4.3 0.6 7.3 0.0 0.5 0.0 0.0 11.7 3.0 0.0 0.4 0.1 0.1 0.0 0.0 0.5 0.0 0.5 0.4 0.0 0.6 0.0 0.0 0.4 38.6 54.3 0.0 0.5 2.8 0.0 0.6 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.0 0.5 1.1 0.3 2.5 0.0 0.0 0.0 86.9 93.4 1.4 0.0 0.0 2.6 0.2 0.0 0.0 0.0 0.0 0.8 0.4 0.3 1.5 0.1 SLC34A1 "NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2" ENSG00000131183 "Solute carrier family 34 member 1" Q06495 5 177379235-177398848 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 54 "kidney: 155.4" "Cell type enriched" "Detected in some" 14 "Proximal tubular cells: 143.2" "Cancer enriched" "Detected in single" 12 "renal cancer: 1.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "HEL: 2.4;U-937: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA051255, HPA077175" Approved Approved "Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol" Yes NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 36: HEL - Hemostasis" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nuclear speckles, Plasma membrane" "Nucleoplasm, Mitotic spindle, Cytosol" "HPA051255: AB_2681409, HPA077175: " "unprognostic (1.17e-1)" "unprognostic (3.33e-3)" "unprognostic (1.49e-1)" "unprognostic (3.49e-2)" "unprognostic (1.56e-3)" "unprognostic (2.28e-1)" "unprognostic (4.50e-2)" "unprognostic (4.43e-3)" "unprognostic (1.91e-1)" "unprognostic (1.14e-1)" "unprognostic (5.95e-2)" "unprognostic (1.23e-3)" "unprognostic (1.38e-1)" "unprognostic (2.01e-1)" "unprognostic (1.28e-2)" "unprognostic (4.66e-2)" 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 155.4 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 7.3 0.0 0.0 0.2 0.0 9.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 143.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.1 SLC39A6 LIV-1 ENSG00000141424 "Solute carrier family 39 member 6" Q13433 18 36108531-36129385 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Breast glandular cells: 307.0;Prostatic glandular cells: 197.9" "Group enriched" "Detected in all" 4 "breast cancer: 361.9;prostate cancer: 127.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042377 Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 35: Glandular cells - Unknown function" Cytosol "Nucleoplasm, Plasma membrane" "HPA042377: AB_2677968" "unprognostic (7.60e-2)" "unprognostic (2.27e-2)" "unprognostic (5.50e-3)" "unprognostic (2.58e-3)" "unprognostic (1.02e-1)" "unprognostic (4.87e-3)" "prognostic unfavorable (5.33e-4)" "unprognostic (1.79e-1)" "unprognostic (2.00e-1)" "unprognostic (1.18e-1)" "unprognostic (3.19e-1)" "unprognostic (4.50e-2)" "unprognostic (7.63e-3)" "unprognostic (2.16e-1)" "unprognostic (4.74e-2)" "unprognostic (1.45e-1)" "unprognostic (1.30e-1)" 27.3 25.9 23.3 21.6 28.5 11.6 147.2 28.6 26.1 34.5 48.9 13.9 9.6 56.9 56.2 17.0 63.6 24.2 14.0 20.0 28.8 28.2 16.5 18.9 17.3 28.8 33.6 43.1 37.7 86.5 23.9 31.7 30.6 129.0 13.4 50.2 30.9 114.3 12.7 51.3 8.9 30.2 28.6 15.5 16.4 19.3 26.7 18.5 37.3 16.6 28.4 52.6 16.1 34.2 43.7 54.0 127.1 75.1 131.4 96.6 33.0 116.2 137.3 76.5 88.7 30.3 47.5 47.1 57.3 113.1 53.1 104.1 112.4 109.2 115.5 105.4 40.7 20.6 69.5 44.4 83.2 69.8 49.6 88.7 236.1 116.2 100.5 69.9 11.7 38.6 10.7 92.1 108.9 67.0 69.0 15.6 30.6 24.0 30.4 70.6 72.8 61.4 84.4 145.2 132.8 116.8 143.5 41.5 200.6 52.1 56.7 32.4 18.9 184.9 30.5 35.5 59.2 85.9 90.0 35.7 64.0 48.3 99.8 29.2 13.3 31.2 16.3 19.7 19.7 16.7 13.8 14.7 16.4 17.3 12.0 17.7 10.2 18.1 19.4 33.6 17.0 14.2 23.3 28.5 28.6 26.1 20.0 28.8 28.8 33.6 30.6 28.6 26.7 34.2 13.3 38.5 18.7 8.8 22.5 45.9 58.2 79.6 59.2 41.5 307.0 132.2 19.6 10.0 66.4 42.3 33.3 6.6 36.7 4.0 1.9 53.1 21.3 37.1 76.1 12.9 25.6 4.6 13.0 37.8 56.7 45.6 9.2 73.8 23.5 18.9 8.9 11.0 20.4 23.5 23.9 7.4 38.7 20.1 30.0 18.1 37.3 26.0 67.6 1.9 25.7 38.2 10.3 34.2 36.5 39.5 1.9 47.8 24.4 197.9 2.7 13.6 44.3 41.3 39.5 40.4 38.6 43.9 27.8 32.6 74.4 23.8 23.2 23.0 5.7 69.3 SLC40A1 "FPN1, HFE4, IREG1, MTP1, SLC11A3" ENSG00000138449 "Solute carrier family 40 member 1" Q9NP59 2 189560590-189583758 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 489.8;Kupffer cells: 1340.2;Syncytiotrophoblasts: 2463.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 326.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 509.0;CACO-2: 123.1;HEL: 430.0;HMC-1: 110.5;T-47d: 207.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065634 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 36: HEL - Hemostasis" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Plasma membrane, Cytosol" Nucleoplasm "HPA065634: AB_2685524" "unprognostic (1.28e-2)" "unprognostic (1.73e-2)" "unprognostic (9.41e-2)" "unprognostic (1.83e-2)" "unprognostic (8.00e-3)" "unprognostic (1.36e-2)" "unprognostic (1.66e-1)" "unprognostic (6.22e-2)" "unprognostic (6.65e-2)" "unprognostic (1.84e-1)" "unprognostic (6.43e-2)" "unprognostic (6.44e-2)" "prognostic favorable (8.55e-5)" "unprognostic (4.66e-1)" "unprognostic (1.61e-1)" "unprognostic (8.96e-2)" "unprognostic (4.11e-2)" 59.6 333.5 9.3 52.6 11.9 45.8 97.7 9.6 9.8 156.3 10.4 124.7 289.3 95.4 61.6 30.5 214.2 148.7 52.6 7.2 12.0 79.9 251.5 122.9 172.6 15.6 15.7 317.2 53.2 91.8 19.0 250.1 12.8 39.5 130.8 29.5 58.7 53.1 64.2 12.2 127.9 69.3 15.5 368.1 96.8 33.2 13.9 62.6 68.0 60.3 59.1 53.1 21.8 11.3 0.0 7.4 0.6 0.0 509.0 3.3 25.4 0.2 6.6 1.9 3.1 123.1 0.4 0.2 1.0 0.2 1.4 0.4 2.4 0.3 1.6 0.3 1.7 430.0 1.7 45.8 1.9 1.5 110.5 35.9 0.2 1.2 0.0 11.7 13.0 16.4 44.6 1.1 6.3 0.0 18.2 28.8 1.5 92.7 1.7 0.2 5.0 2.5 5.3 18.1 1.0 5.4 0.8 35.4 0.0 39.5 207.6 6.2 0.3 0.8 11.7 0.5 0.1 1.1 0.2 0.3 0.1 0.2 0.1 129.8 101.5 172.1 2.2 23.7 3.2 0.2 54.4 4.9 115.6 0.7 80.2 17.8 326.2 4.6 2.6 18.8 5.3 105.8 9.3 11.9 9.6 9.8 7.2 12.0 15.6 15.7 12.8 15.5 13.9 11.3 44.2 125.0 40.3 3.6 12.0 9.2 51.3 10.5 19.9 4.8 83.8 30.0 48.0 138.7 31.6 33.1 4.2 489.8 5.7 328.9 49.0 54.7 10.5 39.6 38.2 39.8 18.6 253.7 0.3 71.8 20.3 81.9 76.5 129.5 9.5 12.8 245.9 259.7 86.4 6.7 6.8 60.8 6.1 1340.2 26.8 9.2 121.2 172.7 8.8 34.7 41.7 17.5 2.1 14.6 0.2 71.5 86.2 58.6 4.1 26.2 163.0 150.0 34.4 48.4 65.7 13.7 49.1 7.4 3.9 12.5 8.1 2463.5 11.9 84.8 48.9 27.7 SLC4A2 "AE2, BND3L, EPB3L1, HKB3, NBND3" ENSG00000164889 "Solute carrier family 4 member 2" P04920 7 151057210-151076526 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "choroid plexus: 492.1" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 91.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019339 Enhanced Uncertain "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "Nuclear speckles, Plasma membrane" Cytosol "HPA019339: AB_1844825" "unprognostic (1.19e-1)" "unprognostic (3.33e-3)" "unprognostic (8.12e-3)" "unprognostic (1.10e-1)" "unprognostic (1.20e-1)" "unprognostic (1.49e-1)" "prognostic unfavorable (9.04e-6)" "unprognostic (1.24e-1)" "unprognostic (4.23e-1)" "unprognostic (3.30e-1)" "unprognostic (1.07e-1)" "unprognostic (3.21e-1)" "prognostic favorable (1.26e-4)" "unprognostic (4.67e-3)" "unprognostic (1.22e-1)" "unprognostic (1.28e-1)" "unprognostic (2.36e-2)" 28.4 34.8 16.9 19.2 29.4 12.7 23.7 29.1 21.9 38.9 492.1 45.0 22.5 40.3 4.9 21.0 31.1 19.7 31.3 39.4 23.2 38.6 52.3 33.2 13.1 32.8 27.9 31.9 52.5 72.4 13.8 27.0 32.0 28.2 7.1 4.7 23.1 14.0 18.8 21.7 29.3 16.5 20.2 27.0 82.2 13.7 32.7 12.4 25.4 12.3 6.3 31.9 25.8 40.2 60.9 196.9 37.8 78.9 37.6 17.9 87.1 72.9 37.0 56.9 48.0 113.0 91.6 35.8 154.1 35.0 84.6 58.2 38.2 31.4 9.8 105.3 59.1 48.5 91.9 57.5 59.6 25.2 147.0 29.0 27.4 65.6 15.7 60.9 31.3 50.6 151.8 27.1 44.3 118.0 69.2 43.3 90.4 80.7 73.2 55.2 21.2 42.2 44.6 41.0 31.5 113.9 67.0 118.4 62.0 27.3 51.2 46.7 72.0 78.1 39.1 77.5 106.5 31.2 47.7 20.5 118.7 61.4 160.6 0.0 1.6 0.4 0.8 1.6 0.7 0.9 0.7 0.7 1.0 0.3 0.7 0.8 0.2 0.1 1.0 2.1 0.2 0.9 16.9 29.4 29.1 21.9 39.4 23.2 32.8 27.9 32.0 20.2 32.7 40.2 15.6 9.6 8.2 9.8 7.2 11.1 5.9 13.6 15.4 7.7 14.5 11.9 4.0 18.6 9.6 20.2 25.0 36.1 14.2 17.6 17.6 35.7 1.0 21.9 18.9 13.6 27.6 2.5 0.4 35.8 9.4 13.6 30.1 17.0 47.1 62.1 17.9 34.6 26.0 15.2 1.4 12.1 16.2 16.1 12.0 1.6 13.7 17.0 26.6 4.7 11.6 21.6 3.1 3.0 16.8 43.8 14.0 19.9 9.9 5.9 24.9 19.1 11.4 8.2 13.1 12.8 17.6 3.1 7.9 10.6 7.0 91.5 8.5 11.2 22.1 4.5 SLC4A9 AE4 ENSG00000113073 "Solute carrier family 4 member 9" Q96Q91 5 140360194-140375141 "Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 24 "kidney: 35.5" "Cell type enhanced" "Detected in some" "Distal tubular cells: 1.9;Excitatory neurons: 2.4;Inhibitory neurons: 2.4;Ionocytes: 2.0;Oligodendrocyte precursor cells: 1.5;Oligodendrocytes: 6.4;Spermatocytes: 1.7;Spermatogonia: 1.9" "Cancer enriched" "Detected in single" 8 "renal cancer: 0.9" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA051307 Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Plasma membrane, Cytosol" Vesicles "HPA051307: AB_2681434" "unprognostic (1.68e-1)" "unprognostic (4.22e-2)" "unprognostic (2.20e-1)" "unprognostic (1.47e-1)" "unprognostic (1.10e-1)" "unprognostic (2.13e-1)" "unprognostic (1.02e-2)" "unprognostic (3.28e-3)" "unprognostic (2.78e-1)" "unprognostic (2.47e-1)" "unprognostic (4.78e-2)" "unprognostic (1.19e-1)" "unprognostic (4.24e-2)" "unprognostic (2.99e-2)" "unprognostic (3.06e-2)" "unprognostic (5.04e-2)" "unprognostic (1.82e-2)" 0.1 0.0 0.3 0.0 0.7 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.5 35.5 0.0 0.1 0.0 0.9 0.6 0.0 0.1 0.0 0.2 0.0 1.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.6 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.4 0.7 0.3 0.5 0.9 0.6 1.0 0.5 0.6 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.4 1.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 2.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.5 6.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.3 0.0 1.7 1.9 0.0 0.1 0.0 0.1 0.1 0.1 0.2 SLC5A1 "D22S675, NAGT, SGLT1" ENSG00000100170 "Solute carrier family 5 member 1" P13866 22 32043261-32113029 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "intestine: 528.1" "Cell type enriched" "Detected in many" 6 "Proximal enterocytes: 768.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 20.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 13 "OE19: 34.2" "Region enriched" "Detected in single" 26 "cerebellum: 7.6" "Low region specificity" "Detected in many" "CAB015467, HPA051805, HPA055106" Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol" NA NA "Cluster 56: Intestine - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 45: Enterocytes - Digestion" "Nucleoplasm, Golgi apparatus" "Nuclear membrane, Cytosol" "CAB015467: , HPA051805: AB_2681618, HPA055106: AB_2682695" "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" "unprognostic (2.24e-2)" "prognostic favorable (2.59e-4)" "unprognostic (3.85e-2)" "unprognostic (2.75e-2)" "unprognostic (1.60e-2)" "unprognostic (2.15e-1)" "unprognostic (9.22e-2)" "unprognostic (4.83e-2)" "unprognostic (6.21e-2)" "unprognostic (9.53e-2)" "prognostic favorable (6.97e-7)" "unprognostic (4.68e-3)" "unprognostic (1.98e-1)" "unprognostic (6.00e-2)" "unprognostic (1.45e-2)" 0.1 0.0 0.1 4.2 0.1 0.0 9.7 0.2 0.1 12.3 0.0 10.7 528.1 0.5 3.5 5.1 1.1 26.9 75.2 0.1 0.0 6.6 1.7 2.1 0.3 0.1 0.0 0.0 1.6 0.3 1.0 0.0 0.1 3.0 9.7 0.2 19.0 2.4 0.3 13.5 302.4 0.7 0.0 2.9 7.2 2.3 0.5 0.1 0.0 0.0 4.0 0.0 6.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.6 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 34.2 0.0 0.0 0.0 2.1 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.5 0.2 0.1 0.0 0.0 0.3 0.2 0.6 1.7 4.2 0.0 0.0 11.6 6.5 115.2 115.8 8.2 0.0 0.0 0.0 0.2 19.8 0.0 3.0 38.4 2.4 1.4 1.0 25.4 0.0 0.4 1.4 0.0 1.4 5.6 10.3 0.0 0.0 0.0 0.3 0.0 0.0 0.3 34.1 0.0 0.0 0.0 71.3 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 32.6 1.5 0.0 17.6 768.7 6.4 2.0 0.0 0.0 0.0 0.7 10.1 4.2 2.0 5.5 0.0 0.1 0.1 41.2 6.7 SLC6A13 GAT2 ENSG00000010379 "Solute carrier family 6 member 13" Q9NSD5 12 220621-262873 "Metabolic proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "kidney: 153.1" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 324.9" "Cancer enriched" "Detected in some" 18 "renal cancer: 32.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "RPTEC TERT1: 4.6;SuSa: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036449, HPA052726" Supported Nucleoplasm,Nucleoli,Mitochondria,Cytosol NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria "Nucleoplasm, Nucleoli, Cytosol" "HPA036449: AB_2675130, HPA052726: AB_2681927" "unprognostic (8.45e-3)" "unprognostic (4.20e-1)" "unprognostic (5.44e-2)" "unprognostic (1.64e-5)" "unprognostic (1.13e-1)" "unprognostic (8.02e-2)" "unprognostic (1.32e-2)" "unprognostic (1.30e-1)" "unprognostic (1.75e-1)" "unprognostic (2.15e-1)" "unprognostic (7.21e-4)" "unprognostic (2.93e-1)" "unprognostic (1.25e-3)" "unprognostic (3.79e-2)" "unprognostic (2.62e-1)" "unprognostic (6.23e-2)" "unprognostic (1.91e-1)" 0.2 0.3 13.4 0.0 16.5 0.1 0.1 11.0 20.1 0.1 13.9 0.1 2.6 0.1 0.3 0.0 7.1 0.0 2.6 12.2 11.9 153.1 36.8 0.8 0.0 11.6 12.6 0.2 0.0 0.0 3.0 0.0 11.7 0.5 0.0 1.1 0.1 0.1 0.5 0.2 0.6 0.0 12.1 0.3 0.1 3.1 13.8 0.1 6.3 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.4 1.6 0.0 0.0 0.1 0.0 0.5 0.0 0.2 0.6 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 16.5 11.0 20.1 12.2 11.9 11.6 12.6 11.7 12.1 13.8 11.7 0.0 0.0 0.6 1.3 1.9 0.0 0.0 0.4 0.0 0.4 0.1 0.1 1.5 0.0 0.1 18.4 2.1 0.0 0.1 0.0 49.0 0.0 1.4 0.6 0.1 0.2 0.0 5.3 3.6 0.0 0.0 0.3 0.0 0.6 0.0 0.0 1.8 27.0 0.0 0.0 1.2 0.0 2.0 1.6 0.0 0.6 0.3 1.7 0.0 17.8 0.0 0.0 0.0 1.5 1.3 0.0 0.0 0.0 0.0 0.1 0.5 324.9 0.7 0.7 0.0 0.4 0.1 0.6 0.4 0.0 0.0 0.3 0.9 0.0 0.0 0.0 SLC9A5 NHE5 ENSG00000135740 "Solute carrier family 9 member A5" Q14940 16 67237683-67272191 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 6.6;lymphoid tissue: 17.4" "Cell type enhanced" "Detected in some" "Excitatory neurons: 11.1;Horizontal cells: 16.8;Inhibitory neurons: 12.2;Oligodendrocyte precursor cells: 7.1;Spermatocytes: 17.2;Theca cells: 6.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-138 MG: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041004, HPA041329" Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Cytosol "Plasma membrane" "HPA041004: AB_10794433, HPA041329: AB_10794373" "unprognostic (8.90e-2)" "unprognostic (9.70e-2)" "unprognostic (3.39e-3)" "unprognostic (1.37e-1)" "unprognostic (1.44e-1)" "unprognostic (1.43e-1)" "unprognostic (2.24e-2)" "unprognostic (5.17e-2)" "unprognostic (1.50e-1)" "unprognostic (1.12e-1)" "unprognostic (2.50e-3)" "unprognostic (4.84e-2)" "unprognostic (9.85e-11)" "unprognostic (9.21e-2)" "unprognostic (1.95e-1)" "unprognostic (8.12e-3)" "unprognostic (9.07e-2)" 0.9 0.6 4.2 0.3 6.6 0.1 1.0 5.4 6.5 0.8 2.5 0.5 0.4 0.4 1.0 0.2 0.5 0.6 1.6 4.6 3.9 0.8 0.2 1.4 0.8 4.8 4.1 1.2 0.6 0.1 0.8 0.6 5.3 0.9 0.3 1.2 0.8 0.3 1.8 1.5 0.5 0.1 3.4 17.4 0.5 3.2 4.2 0.1 0.8 0.7 0.4 0.4 0.5 4.0 0.3 2.9 2.6 0.9 4.7 3.2 0.3 1.1 4.1 2.4 2.2 0.1 2.0 0.0 0.6 1.2 1.2 0.1 0.6 0.4 1.0 0.8 0.8 2.1 0.5 0.7 0.5 1.0 4.7 3.8 1.0 1.5 0.2 4.5 1.0 0.9 0.5 1.3 1.6 1.7 0.0 0.2 1.5 0.2 0.2 0.0 0.5 0.7 0.4 0.5 1.6 0.9 2.4 0.1 1.2 0.6 1.1 0.2 0.8 6.4 0.9 1.1 0.4 2.4 0.5 1.3 4.5 0.5 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 4.2 6.6 5.4 6.5 4.6 3.9 4.8 4.1 5.3 3.4 4.2 4.0 0.6 3.2 2.8 4.2 0.4 0.6 0.2 0.1 1.2 3.4 1.8 1.3 1.5 1.5 0.2 0.0 0.0 0.3 0.1 0.5 0.0 0.3 1.8 0.2 0.8 0.8 1.2 0.0 11.1 0.2 0.1 0.7 0.0 0.9 0.0 0.9 1.4 0.0 0.1 16.8 12.2 0.3 0.0 0.0 0.4 0.7 0.3 0.5 0.0 1.9 0.6 0.3 0.0 7.1 2.6 0.5 0.1 2.2 0.0 0.5 0.2 0.0 0.7 0.9 0.0 0.6 1.4 17.2 4.6 0.3 0.9 0.0 0.3 6.8 0.3 0.2 SLFN11 FLJ34922 ENSG00000172716 "Schlafen family member 11" Q7Z7L1 17 35350305-35373701 "Predicted intracellular proteins" "Antiviral defense, DNA damage, Immunity" "Helicase, Hydrolase, RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 70.6;dendritic cells: 39.9;Endothelial cells: 38.8;Langerhans cells: 53.0;Macrophages: 47.0;Smooth muscle cells: 38.8;T-cells: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 118.2" "Low region specificity" "Detected in many" "HPA023030, HPA062062" Uncertain Supported Nucleoplasm,Cytosol No NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 68: Epididymis - Unknown function" "Cluster 14: REH - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm Cytosol "HPA023030: AB_1856613, HPA062062: AB_2684673" "unprognostic (1.93e-2)" "unprognostic (2.56e-1)" "unprognostic (3.04e-2)" "unprognostic (1.03e-2)" "unprognostic (3.48e-3)" "unprognostic (1.01e-1)" "unprognostic (5.19e-2)" "unprognostic (1.31e-1)" "unprognostic (1.34e-1)" "unprognostic (1.08e-1)" "unprognostic (1.39e-1)" "unprognostic (2.54e-1)" "prognostic unfavorable (9.93e-10)" "unprognostic (1.65e-1)" "unprognostic (5.71e-3)" "unprognostic (6.33e-2)" "unprognostic (8.81e-3)" 31.7 8.2 5.6 20.0 6.1 12.8 17.1 6.4 5.2 21.1 8.2 10.2 6.2 12.1 42.2 8.4 20.6 18.3 20.0 6.0 8.0 6.4 6.8 37.7 21.2 9.5 6.3 23.1 5.4 6.1 6.5 10.5 9.7 9.1 11.1 1.4 11.8 12.3 7.3 5.2 13.9 19.1 7.6 23.3 9.0 2.7 11.0 22.9 24.1 19.0 20.9 17.9 12.6 9.4 29.3 25.6 0.1 0.0 25.4 72.0 0.4 35.3 25.2 59.9 103.9 0.0 0.0 0.2 0.6 46.4 18.8 13.9 78.8 0.0 72.1 16.6 94.2 63.0 0.3 0.0 33.0 82.4 0.1 29.5 0.9 66.5 0.2 0.0 99.4 46.8 0.1 0.3 10.1 0.0 118.2 66.4 0.6 0.0 0.1 98.9 73.3 0.2 0.7 13.8 0.2 0.1 0.0 13.0 0.1 0.0 20.7 58.6 52.1 16.3 0.4 61.9 53.7 2.3 1.0 0.2 12.2 70.3 36.0 0.5 18.2 2.1 6.1 27.6 8.4 4.6 3.8 5.5 14.0 1.5 2.8 4.1 1.4 3.1 18.2 19.4 6.3 8.7 5.6 6.1 6.4 5.2 6.0 8.0 9.5 6.3 9.7 7.6 11.0 9.4 70.6 0.0 5.2 0.3 19.5 7.5 1.1 1.1 5.7 0.4 6.7 2.8 9.2 1.5 2.7 1.8 0.0 1.4 39.9 0.1 0.0 0.0 1.4 5.9 16.0 38.8 0.0 9.9 0.3 0.6 0.5 29.2 6.6 2.2 3.8 0.3 15.0 0.4 32.8 0.0 2.6 0.1 0.0 36.5 53.0 1.7 10.2 47.0 12.4 17.8 17.2 0.3 3.1 0.0 0.1 0.1 1.2 3.0 24.7 1.3 0.1 0.2 13.3 0.1 6.6 7.9 38.8 0.0 0.2 1.9 8.5 0.8 37.3 7.7 0.1 0.7 SLX4 "BTBD12, FANCP, KIAA1784, KIAA1987" ENSG00000188827 "SLX4 structure-specific endonuclease subunit" Q8IY92 16 3581181-3611606 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 10.6" "Cell type enhanced" "Detected in many" "Spermatocytes: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049421, HPA066238" Approved Supported "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Cell Junctions, Cytosol" "HPA049421: AB_2680759, HPA066238: AB_2685642" "unprognostic (1.04e-1)" "unprognostic (1.23e-1)" "unprognostic (4.06e-2)" "unprognostic (2.65e-2)" "unprognostic (4.62e-1)" "unprognostic (6.08e-3)" "unprognostic (8.28e-5)" "unprognostic (6.52e-2)" "unprognostic (2.49e-1)" "unprognostic (1.56e-1)" "unprognostic (1.97e-2)" "unprognostic (1.50e-1)" "unprognostic (4.32e-2)" "unprognostic (8.39e-3)" "unprognostic (1.20e-1)" "unprognostic (1.43e-3)" "unprognostic (5.74e-2)" 1.8 2.1 2.1 2.9 1.9 3.0 1.6 7.1 2.7 2.1 0.4 2.3 2.2 2.1 1.3 2.4 2.0 1.1 1.9 2.3 2.1 1.9 1.9 2.1 4.1 2.3 2.0 1.6 1.7 1.1 3.9 1.1 1.8 2.3 0.9 1.7 1.6 1.0 2.7 1.8 2.8 1.2 1.1 3.4 2.2 10.6 1.9 2.7 1.8 1.3 2.9 2.1 2.0 2.1 2.7 8.4 5.3 6.7 2.0 2.1 5.6 4.3 2.2 4.9 5.4 4.2 3.3 10.0 4.2 2.2 3.8 6.0 3.6 3.0 2.9 8.4 4.6 6.8 6.5 2.7 1.8 6.7 9.3 1.5 2.2 4.6 2.6 1.2 3.6 5.6 6.7 5.3 3.9 4.7 4.2 5.9 4.5 1.7 3.1 8.2 8.9 2.8 1.9 1.9 4.5 4.1 3.8 2.6 1.3 2.8 6.5 5.2 4.3 5.6 7.8 4.9 5.1 4.8 4.0 11.4 1.8 6.7 5.7 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 2.1 1.9 7.1 2.7 2.3 2.1 2.3 2.0 1.8 1.1 1.9 2.1 2.7 0.0 2.3 4.6 4.5 0.8 0.8 1.1 4.0 8.7 2.0 1.4 1.7 1.5 3.2 0.0 2.1 1.7 3.4 2.0 0.0 1.5 6.5 5.5 4.2 1.8 0.0 6.5 9.5 2.4 1.6 2.4 3.6 4.6 0.0 4.8 1.1 1.4 2.9 0.0 9.3 2.4 2.0 2.9 1.6 2.3 2.1 5.1 0.0 4.7 2.2 2.7 4.1 7.1 5.5 2.0 0.3 1.9 4.0 0.4 2.3 0.6 2.3 10.1 0.0 4.9 2.5 20.0 9.1 2.3 0.6 1.0 4.4 3.0 2.1 0.6 SMPD4 "FLJ20297, FLJ20756, KIAA1418, NET13, nSMase-3, NSMASE3" ENSG00000136699 "Sphingomyelin phosphodiesterase 4" Q9NXE4 2 130151392-130182750 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046279, HPA049426" Approved Approved "Nuclear membrane,Cytosol" NA Yes "Cluster 39: Non-specific - mRNA processing" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 39: CACO-2 - Unknown function" "Cluster 44: Endometrium - Transcription" "Nuclear membrane" Cytosol "HPA046279: AB_2679611, HPA049426: AB_2680762" "unprognostic (5.02e-2)" "unprognostic (9.61e-3)" "unprognostic (6.31e-2)" "prognostic unfavorable (7.47e-5)" "unprognostic (1.69e-1)" "unprognostic (8.80e-2)" "prognostic unfavorable (8.37e-6)" "unprognostic (3.27e-2)" "unprognostic (1.72e-1)" "unprognostic (7.47e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (1.73e-4)" "prognostic unfavorable (8.16e-8)" "unprognostic (1.74e-1)" "unprognostic (2.28e-1)" "unprognostic (1.47e-3)" "unprognostic (2.09e-1)" 9.9 10.8 4.2 11.1 4.9 25.4 10.9 5.3 6.2 15.5 3.1 12.1 9.5 15.5 5.0 13.8 15.9 9.2 11.7 4.0 7.0 8.6 9.2 10.6 15.7 7.5 5.0 14.6 13.3 15.2 22.7 14.9 6.3 11.8 11.1 4.7 12.9 11.7 13.3 13.5 11.5 12.9 2.4 11.2 10.3 17.7 6.0 19.8 16.0 12.0 15.7 11.8 12.3 10.0 89.1 41.5 46.2 39.2 29.1 21.8 58.7 41.5 42.0 76.3 62.8 119.2 47.0 56.2 41.2 49.9 36.3 43.8 64.0 64.4 40.4 72.7 61.2 60.5 36.2 90.1 31.2 68.5 34.7 25.6 39.4 77.0 27.2 21.1 44.9 51.4 82.2 40.8 40.7 44.3 72.2 32.0 77.0 40.1 56.4 74.3 44.2 59.0 27.0 38.6 66.8 36.3 42.8 54.5 22.7 24.9 37.8 34.8 32.8 57.0 49.3 33.0 49.4 34.3 44.0 79.2 51.4 38.7 44.0 1.8 9.2 14.8 12.9 11.2 14.3 8.9 9.6 11.6 9.6 9.1 9.0 10.5 4.3 12.1 8.1 6.0 9.2 10.4 4.2 4.9 5.3 6.2 4.0 7.0 7.5 5.0 6.3 2.4 6.0 10.0 17.4 3.2 11.3 4.9 20.8 15.0 9.1 8.8 12.0 19.8 21.5 23.0 3.9 5.7 8.0 7.3 12.5 23.8 16.4 7.9 9.8 9.2 22.7 16.0 19.7 12.0 13.1 21.2 6.9 12.2 26.5 12.2 18.8 26.3 6.3 29.0 10.4 17.3 14.1 15.2 6.7 12.8 4.1 13.2 7.7 41.7 14.6 10.2 16.0 1.0 8.8 9.9 11.3 7.5 10.4 11.8 10.5 18.4 27.0 9.4 7.7 5.9 9.9 16.0 0.0 14.1 12.8 25.0 25.6 18.7 20.6 15.6 15.6 16.0 15.2 9.6 SNAP91 "AP180, CALM, KIAA0656" ENSG00000065609 "Synaptosome associated protein 91" O60641 6 83552880-83709691 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 80.8;pituitary gland: 25.8;retina: 91.8" "Cell type enhanced" "Detected in some" "Astrocytes: 91.1;Excitatory neurons: 336.6;Inhibitory neurons: 296.9;Oligodendrocyte precursor cells: 209.1;Oligodendrocytes: 89.0" "Cancer enhanced" "Detected in some" "glioma: 2.5;prostate cancer: 2.0" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 25 "plasmacytoid DC: 2.8" "Lineage enriched" "Detected in single" 25 "dendritic cells: 2.8" "Group enriched" "Detected in some" 10 "GAMG: 7.4;SCLC-21H: 23.7;SH-SY5Y: 14.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009745, HPA029632, HPA029633" Enhanced Uncertain Centrosome,Cytosol NA NA 28000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Centrosome, Cytosol" "CAB009745: AB_2302221, HPA029632: AB_10794614, HPA029633: AB_10794615" "unprognostic (1.07e-2)" "unprognostic (1.74e-1)" "unprognostic (7.55e-3)" "unprognostic (3.68e-2)" "unprognostic (1.03e-1)" "unprognostic (2.42e-1)" "unprognostic (2.56e-2)" "unprognostic (1.17e-1)" "unprognostic (4.54e-4)" "unprognostic (6.99e-2)" "unprognostic (1.75e-2)" "unprognostic (4.82e-2)" "unprognostic (2.15e-2)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" 0.3 7.9 42.1 1.0 52.0 0.0 0.6 61.2 80.8 1.1 0.0 1.2 0.3 0.7 0.1 0.1 0.7 1.0 0.7 51.3 31.6 0.1 0.0 0.3 3.0 40.9 11.1 2.1 1.5 1.1 25.8 0.5 41.1 3.1 0.6 91.8 0.5 0.6 0.2 0.1 0.8 0.7 7.2 1.4 0.9 12.1 23.0 0.3 0.9 1.5 1.9 0.4 0.4 40.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 7.4 0.3 1.0 0.0 0.0 0.4 1.4 0.6 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.1 0.2 0.3 23.7 14.7 0.0 0.1 0.0 0.2 0.0 0.6 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 42.1 52.0 61.2 80.8 51.3 31.6 40.9 11.1 41.1 7.2 23.0 40.8 0.0 0.0 0.0 91.1 0.0 0.0 0.0 0.0 0.0 49.8 0.1 0.0 1.3 0.0 0.0 0.0 62.6 1.5 0.1 0.1 0.0 0.0 23.9 0.2 1.4 0.3 0.0 0.0 336.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 32.0 296.9 0.0 0.0 0.0 0.0 12.8 0.9 0.0 0.0 31.9 0.0 10.9 0.0 209.1 89.0 0.4 0.0 1.2 0.0 0.5 0.0 0.0 0.0 59.8 0.0 0.0 0.1 29.6 4.8 0.0 0.0 4.4 0.0 0.1 0.0 0.0 SNIP1 PML1 ENSG00000163877 "Smad nuclear interacting protein 1" Q8TAD8 1 37534449-37554293 "Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing, RNA-mediated gene silencing" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 58.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036896 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 44: Endometrium - Transcription" Nucleoplasm Cytosol "HPA036896: AB_10670244" "unprognostic (1.37e-1)" "unprognostic (2.83e-1)" "unprognostic (1.65e-3)" "unprognostic (7.24e-2)" "unprognostic (5.83e-2)" "unprognostic (8.30e-3)" "unprognostic (3.26e-2)" "unprognostic (3.66e-2)" "unprognostic (7.74e-2)" "unprognostic (5.01e-2)" "unprognostic (9.30e-2)" "unprognostic (5.34e-3)" "unprognostic (3.06e-2)" "unprognostic (6.78e-3)" "unprognostic (2.63e-2)" "unprognostic (1.63e-1)" "unprognostic (1.86e-1)" 3.2 3.8 3.5 2.8 3.5 5.5 4.3 4.4 4.4 3.5 3.6 3.3 2.5 3.7 3.2 3.9 2.7 2.3 3.1 3.7 3.9 2.8 6.3 2.7 3.7 3.5 3.5 3.5 3.4 3.9 3.1 2.4 3.5 3.8 2.5 3.9 3.4 3.1 3.1 3.4 3.5 2.8 3.2 3.9 3.6 4.4 3.8 4.1 2.9 3.2 4.2 3.1 3.0 4.0 4.9 2.6 5.2 5.1 6.2 5.9 3.5 6.2 6.9 5.7 5.0 2.6 4.1 6.6 4.6 6.5 3.7 5.0 4.9 5.6 4.7 6.0 7.0 10.3 4.4 5.3 7.0 9.6 5.5 5.6 6.5 5.7 7.2 6.2 5.6 5.0 7.3 5.7 4.1 3.5 5.7 7.3 8.5 4.0 6.1 5.0 8.8 5.6 4.3 4.6 4.1 8.4 6.4 4.1 8.3 5.4 3.6 5.1 9.2 4.3 4.9 5.6 6.0 7.0 8.8 5.3 5.3 6.7 4.1 1.5 0.9 1.3 1.5 0.8 1.5 1.0 1.0 1.5 0.8 0.9 1.4 1.2 1.4 1.0 1.2 1.3 1.3 0.6 3.5 3.5 4.4 4.4 3.7 3.9 3.5 3.5 3.5 3.2 3.8 4.0 14.4 19.2 11.9 3.9 18.5 16.2 11.8 6.9 22.8 10.6 18.0 12.1 6.1 17.2 13.9 5.5 8.4 5.4 20.7 11.8 1.9 7.3 7.5 34.4 25.8 9.2 8.4 7.2 6.5 7.1 4.7 12.4 13.7 58.1 12.0 11.0 11.7 10.9 4.6 10.1 6.1 11.0 10.2 8.8 9.2 11.7 8.1 11.4 8.8 4.7 9.5 9.9 12.3 7.1 6.8 8.4 5.8 7.9 15.7 9.7 6.0 4.4 9.7 16.6 0.0 13.6 11.1 14.4 15.1 19.5 18.0 10.1 16.9 8.0 6.5 12.6 SNN ENSG00000184602 Stannin O75324 16 11668455-11679152 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 126.0;skeletal muscle: 114.9" "Cell type enhanced" "Detected in many" "Langerhans cells: 108.2;Macrophages: 64.7;Muller glia cells: 146.9" "Cancer enhanced" "Detected in all" "glioma: 62.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "AF22: 74.9;REH: 73.1" "Low region specificity" "Detected in all" HPA011055 Approved Uncertain Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 70: Brain - Nervous system development" "Cluster 12: NES - Nervous system development" "Cluster 51: Myeloid cells - Hemostasis" Cytosol "HPA011055: AB_1857326" "unprognostic (1.94e-1)" "unprognostic (7.26e-2)" "unprognostic (2.40e-1)" "unprognostic (1.84e-1)" "unprognostic (2.44e-1)" "unprognostic (1.48e-2)" "prognostic unfavorable (1.85e-6)" "unprognostic (4.51e-2)" "unprognostic (3.45e-1)" "unprognostic (2.82e-1)" "unprognostic (1.07e-2)" "unprognostic (2.14e-1)" "prognostic favorable (1.83e-5)" "unprognostic (4.91e-2)" "unprognostic (2.09e-1)" "unprognostic (3.58e-1)" "unprognostic (4.72e-2)" 57.4 29.4 114.1 19.8 126.0 24.5 24.3 91.6 101.7 18.3 49.4 16.9 9.1 14.0 20.2 19.1 12.8 22.0 28.4 117.4 87.9 14.5 9.3 21.6 30.8 92.8 102.9 17.0 8.7 9.9 15.4 8.2 83.6 14.3 5.7 40.5 18.3 21.9 114.9 14.8 14.4 10.5 93.3 34.6 14.1 3.9 108.9 28.6 17.3 36.9 27.5 18.5 14.6 89.0 7.6 7.2 74.9 20.5 48.7 13.8 7.2 3.2 6.8 9.0 9.1 11.7 5.2 7.8 30.6 10.6 15.9 14.6 22.7 9.1 6.9 2.1 5.1 25.8 8.1 15.3 12.9 1.8 14.9 12.1 40.7 4.8 10.0 12.7 16.8 22.4 4.1 12.0 8.4 12.7 21.0 5.8 39.0 9.5 5.2 73.1 10.0 53.8 8.5 21.9 44.4 18.0 17.4 22.6 11.5 29.1 9.1 15.2 15.1 10.4 21.3 61.2 3.3 4.8 3.3 18.1 6.2 22.0 13.4 0.1 21.0 16.0 0.6 36.2 0.6 15.2 3.3 1.5 19.9 15.5 6.1 4.5 53.0 0.7 48.6 8.0 2.2 17.1 114.1 126.0 91.6 101.7 117.4 87.9 92.8 102.9 83.6 93.3 108.9 89.0 27.5 0.0 6.1 11.8 46.8 18.4 19.9 9.5 18.8 7.5 7.3 10.0 16.6 14.3 6.9 5.5 0.0 1.3 16.8 0.4 25.4 16.7 0.7 6.8 7.8 17.9 5.3 0.0 28.6 18.3 23.1 9.4 3.1 8.4 13.4 5.7 27.1 3.0 20.7 6.7 11.6 0.5 14.2 39.5 108.2 0.5 5.0 64.7 21.4 11.2 58.2 146.9 4.1 8.5 5.0 14.6 0.3 15.4 2.9 14.6 0.9 5.2 6.7 6.5 6.6 17.7 16.9 0.4 3.8 15.3 19.0 1.4 12.1 1.1 0.4 13.2 SNRNP48 "C6orf151, dJ336K20B.1, dJ512B11.2, FLJ32234" ENSG00000168566 "Small nuclear ribonucleoprotein U11/U12 subunit 48" Q6IEG0 6 7590198-7611967 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029234 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Cytosol "HPA029234: AB_10604097" "prognostic unfavorable (8.30e-4)" "unprognostic (3.46e-2)" "unprognostic (2.65e-1)" "unprognostic (9.65e-2)" "unprognostic (1.07e-2)" "unprognostic (1.54e-1)" "unprognostic (9.46e-3)" "unprognostic (2.55e-1)" "unprognostic (9.87e-3)" "unprognostic (1.62e-2)" "unprognostic (1.57e-1)" "unprognostic (2.03e-1)" "prognostic unfavorable (4.16e-4)" "unprognostic (1.55e-1)" "unprognostic (8.70e-2)" "unprognostic (1.41e-2)" "unprognostic (1.03e-1)" 5.4 3.8 4.8 5.5 5.1 10.4 6.9 8.5 6.7 7.0 4.4 5.4 5.7 6.4 4.6 4.7 5.7 4.0 7.2 4.6 5.0 6.0 7.3 4.5 7.3 5.7 4.9 7.7 5.7 3.7 3.6 5.3 5.9 5.8 5.5 7.3 5.3 4.4 9.7 6.3 6.7 5.4 4.7 6.1 5.4 2.7 5.1 7.1 5.8 7.1 5.9 5.6 5.8 5.9 10.0 7.9 16.2 30.3 8.5 12.5 10.9 11.2 10.4 12.0 13.1 16.9 8.1 23.6 11.8 9.4 11.5 12.6 20.2 12.1 18.2 18.2 19.8 17.0 24.1 32.7 8.9 20.5 10.9 8.8 18.3 13.5 10.2 14.2 10.5 20.8 24.1 3.6 16.8 5.7 33.7 29.6 21.9 17.1 8.8 35.8 13.9 31.6 10.8 8.7 25.0 6.8 21.8 5.6 19.6 29.7 10.9 7.2 11.8 15.8 7.1 9.5 19.6 5.8 34.6 14.5 5.3 16.1 28.9 0.1 0.7 0.4 0.7 0.5 1.2 0.6 0.8 0.9 0.9 1.1 0.7 1.3 2.3 1.1 0.3 1.0 0.7 0.6 4.8 5.1 8.5 6.7 4.6 5.0 5.7 4.9 5.9 4.7 5.1 5.9 18.6 19.2 10.3 8.1 15.7 35.7 20.2 13.6 12.0 18.7 12.6 14.6 32.1 15.7 17.3 9.2 20.9 16.3 22.7 19.2 11.7 18.0 2.5 18.0 14.8 20.5 11.4 17.7 20.4 20.1 15.6 18.0 8.2 19.6 24.1 16.8 20.3 23.4 15.9 5.0 18.8 18.2 0.0 15.1 22.1 2.5 17.7 14.9 8.8 13.1 21.7 15.5 19.6 14.6 23.8 12.1 17.9 16.6 11.5 21.4 27.1 20.1 8.5 17.8 6.6 20.9 23.2 16.1 17.0 11.5 34.0 16.3 18.5 11.2 17.1 20.1 SORBS3 "SCAM-1, SH3D4, vinexin" ENSG00000120896 "Sorbin and SH3 domain containing 3" O60504 8 22544986-22575788 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 169.4;Late spermatids: 505.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015849 Approved Uncertain "Focal adhesion sites,Cytosol" NA NA 7700 "Cluster 16: MAIT-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 39: CACO-2 - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" Cytosol "Focal adhesion sites" "HPA015849: AB_1857365" "unprognostic (6.15e-3)" "unprognostic (2.09e-2)" "unprognostic (2.34e-1)" "unprognostic (3.90e-3)" "unprognostic (1.72e-1)" "unprognostic (9.30e-2)" "unprognostic (2.51e-2)" "unprognostic (2.44e-2)" "unprognostic (5.83e-3)" "unprognostic (1.70e-1)" "prognostic favorable (4.88e-4)" "unprognostic (4.21e-2)" "unprognostic (3.08e-3)" "unprognostic (7.41e-2)" "unprognostic (1.58e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (1.53e-5)" 173.3 65.3 59.3 26.2 59.7 5.1 129.0 67.6 72.6 156.9 49.9 105.2 29.9 124.0 23.6 65.5 118.8 38.7 105.8 53.0 55.3 84.8 121.2 111.9 21.1 85.0 60.6 125.6 49.3 35.7 73.3 66.6 65.6 127.2 34.9 11.4 88.7 48.5 64.7 106.8 71.2 53.7 61.7 80.0 63.7 128.2 65.7 7.6 93.8 37.3 13.4 103.5 133.9 57.6 83.0 101.8 54.6 61.9 86.4 114.4 55.7 83.0 127.8 95.0 58.8 103.6 36.2 0.7 55.3 130.1 38.3 69.7 82.5 75.7 48.9 58.1 36.2 6.9 58.3 48.4 98.2 0.8 0.5 72.6 55.6 33.3 48.4 105.2 74.6 42.7 18.4 2.6 68.4 32.8 7.1 2.4 19.3 14.1 42.5 79.0 36.8 7.7 43.7 15.8 3.1 48.9 40.4 9.8 52.7 56.8 16.7 29.2 116.9 83.8 59.8 61.9 59.3 1.7 2.5 11.5 49.0 19.4 58.3 0.0 2.5 0.6 11.4 4.7 23.4 0.8 12.6 13.4 8.1 1.3 12.7 7.6 0.5 5.8 1.1 2.7 0.6 5.2 59.3 59.7 67.6 72.6 53.0 55.3 85.0 60.6 65.6 61.7 65.7 57.6 89.6 19.2 7.2 27.1 5.8 29.2 24.6 23.3 39.9 2.7 29.0 27.8 12.2 31.5 18.3 12.9 0.0 24.1 4.7 53.5 9.8 21.3 169.4 10.9 39.5 51.9 14.6 2.1 3.8 19.2 30.5 48.8 8.6 20.5 17.2 19.3 79.9 49.5 35.3 5.0 4.5 35.2 8.2 39.0 31.5 505.8 61.2 23.8 24.9 13.1 5.7 21.9 3.1 19.6 7.6 26.2 53.2 58.6 3.7 38.8 65.1 26.0 10.7 3.5 59.2 23.1 84.1 7.0 8.0 25.3 21.3 20.5 19.7 7.1 31.3 23.7 SORCS2 KIAA1329 ENSG00000184985 "Sortilin related VPS10 domain containing receptor 2" Q96PQ0 4 7192538-7742836 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.9" "Cell type enhanced" "Detected in many" "Astrocytes: 107.1;Bipolar cells: 70.3;Excitatory neurons: 41.4;Muller glia cells: 33.0;Oligodendrocytes: 76.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 7.6;HaCaT: 19.6;HMC-1: 14.5;RPMI-8226: 9.1;SiHa: 14.1;THP-1: 8.4;U-937: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071818 Approved Vesicles,Cytosol NA NA "Cluster 45: Intestine - Brush border" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 56: Bipolar cells - Visual perception" "Vesicles, Cytosol" "HPA071818: " "unprognostic (1.38e-1)" "unprognostic (6.32e-2)" "unprognostic (1.91e-2)" "unprognostic (4.37e-2)" "unprognostic (4.91e-3)" "unprognostic (1.82e-2)" "unprognostic (4.60e-2)" "unprognostic (1.14e-2)" "unprognostic (1.49e-3)" "prognostic unfavorable (3.55e-4)" "unprognostic (1.52e-1)" "unprognostic (3.56e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (2.17e-3)" "unprognostic (5.37e-2)" "unprognostic (2.09e-1)" "unprognostic (7.27e-3)" 2.4 1.1 13.4 3.4 18.3 1.7 1.6 11.6 15.9 8.5 0.0 4.5 1.4 4.7 3.8 2.2 3.3 3.6 2.0 12.1 11.3 9.0 4.6 4.4 0.8 18.6 17.6 5.8 0.7 0.0 2.7 0.2 14.7 5.2 1.1 12.9 1.0 2.4 1.1 1.8 2.6 6.2 11.3 0.4 1.6 1.6 14.1 3.1 3.1 1.2 1.2 3.0 3.7 22.9 0.8 1.1 1.3 0.2 0.1 0.0 0.0 0.2 0.1 1.6 0.4 0.2 0.6 0.0 7.6 5.0 1.3 19.6 0.0 0.0 0.3 0.0 0.0 0.0 2.8 0.3 0.2 0.0 14.5 0.2 4.3 6.0 0.0 0.1 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.4 0.0 0.9 0.0 1.6 9.1 0.2 0.0 0.8 0.7 14.1 0.0 0.0 0.8 0.0 8.4 0.0 4.9 1.4 0.0 0.1 0.0 0.0 0.0 1.6 8.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 18.3 11.6 15.9 12.1 11.3 18.6 17.6 14.7 11.3 14.1 22.9 0.1 3.2 11.3 107.1 0.0 0.1 0.3 4.6 0.0 70.3 0.1 2.4 2.0 0.0 6.9 5.5 0.0 0.0 0.3 0.0 0.0 0.2 2.2 0.4 0.4 0.3 0.0 0.0 41.4 0.0 0.0 5.0 0.0 0.9 0.0 5.4 0.4 1.6 0.2 1.7 24.3 0.0 2.0 0.3 0.0 11.6 12.8 0.4 1.8 8.4 0.1 33.0 1.0 8.0 76.2 1.1 0.0 7.9 0.1 0.4 0.4 1.4 2.0 2.7 0.0 0.9 1.0 0.1 0.3 0.0 0.4 0.0 0.3 1.5 0.0 0.6 SP3 SPR-2 ENSG00000172845 "Sp3 transcription factor" Q02447 2 173880850-173965702 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004580, HPA032145, HPA032146" Supported Supported Supported Nucleoplasm,Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 59: Non-specific - Transcription" Nucleoplasm Cytosol "CAB004580: AB_628274, HPA032145: , HPA032146: AB_2732465" "unprognostic (1.94e-1)" "unprognostic (1.18e-1)" "unprognostic (1.85e-1)" "unprognostic (2.39e-3)" "unprognostic (2.50e-1)" "unprognostic (4.92e-2)" "unprognostic (5.54e-3)" "unprognostic (6.36e-2)" "unprognostic (2.76e-3)" "unprognostic (3.27e-1)" "unprognostic (5.01e-3)" "unprognostic (1.68e-1)" "prognostic unfavorable (2.46e-5)" "unprognostic (2.78e-1)" "unprognostic (2.07e-1)" "unprognostic (8.02e-2)" "unprognostic (1.69e-1)" 32.6 19.8 15.8 35.2 16.0 53.1 43.1 21.3 19.8 50.9 16.1 34.3 26.9 45.1 34.6 32.1 37.1 28.9 23.8 14.2 17.1 29.7 40.1 29.9 46.1 16.9 16.7 40.3 24.9 43.1 13.2 49.1 16.4 31.9 38.9 21.0 26.1 30.4 22.5 38.5 29.6 36.3 16.3 38.6 27.0 25.2 15.5 68.0 47.5 33.7 53.8 33.7 28.0 18.5 41.6 34.5 74.6 45.8 91.8 82.3 83.5 47.5 67.1 62.2 66.1 56.8 59.7 65.1 39.3 65.0 46.3 41.0 57.8 46.0 91.7 55.2 21.2 65.9 33.9 54.0 45.5 60.4 48.9 60.6 53.2 72.9 63.6 48.4 49.4 51.3 51.4 86.8 65.7 44.4 84.0 49.9 66.1 60.1 37.8 74.2 68.5 53.0 48.4 55.8 67.8 48.1 67.1 38.1 52.4 81.7 30.0 80.0 44.1 70.6 61.8 47.5 50.4 58.8 46.7 85.8 53.0 41.6 67.2 8.9 9.4 13.0 11.6 7.0 12.9 9.5 12.3 12.3 9.9 7.4 13.8 12.8 27.3 21.9 10.3 6.2 13.8 9.9 15.8 16.0 21.3 19.8 14.2 17.1 16.9 16.7 16.4 16.3 15.5 18.5 36.1 19.2 22.9 44.7 55.2 57.6 31.7 25.7 64.9 29.1 36.8 23.4 18.8 14.3 23.3 20.2 27.1 30.9 67.9 37.9 11.7 18.6 4.3 22.3 57.8 33.9 30.5 31.7 52.7 19.3 42.7 43.9 17.9 29.5 23.5 31.3 32.2 43.8 24.6 23.5 50.7 28.8 20.3 54.1 72.8 7.1 45.4 55.6 42.7 81.5 39.0 30.5 46.4 60.3 74.7 30.8 22.9 36.9 63.7 34.2 22.1 24.4 26.6 20.2 19.7 40.4 53.4 10.5 20.4 48.6 57.0 34.6 50.8 26.0 29.0 59.0 SPESP1 SP-ESP ENSG00000258484 "Sperm equatorial segment protein 1" Q6UW49 15 68818221-68946811 "Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 73.2" "Group enriched" "Detected in many" 4 "Early spermatids: 400.4;Spermatocytes: 455.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 17.8;BJ hTERT+ SV40 Large T+ RasG12V: 18.6;HBF TERT88: 21.7;HMC-1: 13.4;OE19: 15.9;RPTEC TERT1: 26.8;SCLC-21H: 19.9;WM-115: 31.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA045936, HPA051040" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Secreted in male reproductive system" NA NA 52000 "Cluster 46: Basophils - DNA binding" "Cluster 83: Testis - Spermatogenesis" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Vesicles" Cytosol "HPA045936: AB_2679504, HPA051040: AB_2681322" "unprognostic (1.14e-1)" "unprognostic (1.43e-1)" "unprognostic (1.73e-3)" "unprognostic (9.82e-2)" "unprognostic (1.59e-1)" "unprognostic (1.42e-2)" "unprognostic (1.06e-1)" "unprognostic (5.96e-2)" "unprognostic (2.79e-1)" "unprognostic (2.40e-1)" "unprognostic (8.99e-2)" "unprognostic (1.10e-2)" "unprognostic (1.16e-2)" "unprognostic (2.68e-2)" "unprognostic (1.15e-1)" "unprognostic (1.75e-1)" "unprognostic (9.67e-2)" 2.3 3.4 1.1 0.8 1.1 0.4 2.2 1.2 1.6 1.2 1.0 1.6 1.2 1.5 6.3 2.6 1.8 3.5 3.1 1.1 1.2 2.0 1.2 1.1 0.8 1.3 1.2 3.4 1.9 4.7 1.2 12.9 1.3 3.5 1.1 2.8 1.8 2.9 1.6 1.0 0.9 1.2 1.3 1.3 1.5 73.2 1.1 0.9 1.9 1.9 0.7 2.4 0.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 17.8 18.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 21.7 5.0 0.0 0.0 0.0 0.0 6.3 0.0 13.4 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 2.9 0.0 0.0 3.3 15.9 0.0 0.0 1.4 0.0 26.8 0.2 19.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 31.6 1.1 1.3 0.4 0.2 1.1 0.5 0.5 0.4 0.3 0.8 0.3 0.3 0.5 0.5 0.2 0.8 0.4 0.4 0.5 1.1 1.1 1.2 1.6 1.1 1.2 1.3 1.2 1.3 1.3 1.1 1.6 5.1 0.0 0.0 0.0 0.2 1.9 3.0 23.7 1.8 1.0 2.7 4.1 4.1 1.5 4.0 7.3 4.2 92.3 0.3 0.2 1.9 2.1 400.4 3.9 3.4 3.6 1.8 0.8 0.0 2.7 7.2 5.5 0.0 2.0 0.0 1.7 2.2 1.8 7.8 0.0 0.0 0.9 6.1 2.1 3.3 90.3 21.1 1.2 5.4 0.0 1.0 5.3 0.0 0.0 0.0 0.9 0.0 8.6 0.0 3.3 0.0 3.9 6.3 5.6 46.0 3.4 4.2 455.0 88.7 1.1 2.3 62.1 0.5 11.1 0.2 1.5 SPINT2 "HAI-2, Kop" ENSG00000167642 "Serine peptidase inhibitor, Kunitz type 2" O43291 19 38244035-38292615 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 1371.3;Syncytiotrophoblasts: 1413.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 852.5;CAPAN-2: 1219.1;OE19: 1500.4;RPTEC TERT1: 896.7;SK-BR-3: 789.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011101, CAB018969" Approved Uncertain "Plasma membrane,Intermediate filaments,Cytosol" No NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 47: Cytotrophoblasts - Unknown function" "Plasma membrane, Intermediate filaments, Cytosol" "CAB018969: , HPA011101: AB_1079039" "unprognostic (5.13e-2)" "unprognostic (1.06e-3)" "unprognostic (1.40e-1)" "unprognostic (6.25e-2)" "unprognostic (1.13e-1)" "unprognostic (1.91e-2)" "unprognostic (2.23e-1)" "unprognostic (2.03e-2)" "unprognostic (3.51e-1)" "unprognostic (1.67e-2)" "unprognostic (2.89e-2)" "unprognostic (2.04e-1)" "prognostic favorable (3.41e-4)" "unprognostic (3.59e-1)" "unprognostic (1.32e-1)" "unprognostic (6.94e-2)" "unprognostic (2.68e-2)" 10.5 44.6 56.9 65.3 57.3 81.1 178.5 47.2 66.3 145.6 80.0 297.0 247.4 44.6 269.6 351.9 189.7 105.1 13.6 58.9 92.9 216.1 14.3 138.3 37.4 52.0 54.8 83.3 234.2 252.9 435.9 156.4 56.2 181.8 251.7 23.6 503.9 111.3 1.8 257.0 267.0 19.0 47.6 50.2 219.4 215.7 70.3 82.6 321.3 0.9 101.3 140.1 157.6 51.0 852.5 603.0 3.0 3.4 0.4 0.0 387.4 16.2 1.7 1.2 2.6 426.8 1219.1 6.7 65.8 4.6 1.2 274.6 42.7 587.0 1.4 7.9 51.7 159.4 15.3 0.9 0.9 1.5 0.8 0.1 662.5 0.7 278.6 71.5 2.0 144.2 4.0 0.4 1.0 652.8 25.6 2.8 60.4 1500.4 172.1 87.9 0.6 386.2 896.7 707.4 222.2 3.4 246.5 789.2 2.1 231.0 353.7 104.5 0.7 1.2 4.7 3.4 3.2 56.1 76.4 47.6 1.0 11.2 1.0 515.9 127.4 531.9 3.8 91.1 7.9 143.2 44.2 21.5 297.7 160.4 86.1 80.4 56.4 19.0 64.4 523.5 19.1 142.8 56.9 57.3 47.2 66.3 58.9 92.9 52.0 54.8 56.2 47.6 70.3 51.0 8.0 368.6 233.9 10.4 90.9 376.9 563.9 954.0 278.9 14.3 487.2 518.2 2.8 316.0 655.6 559.1 6.2 1371.3 79.5 1028.3 101.8 866.9 61.8 401.4 47.3 24.3 360.5 83.9 20.7 659.8 502.0 34.6 234.5 490.4 115.5 371.8 32.5 2.0 230.3 3.3 39.8 672.8 734.5 55.5 139.0 55.6 19.0 133.6 88.9 24.4 364.3 129.6 1.0 4.5 9.0 910.4 889.4 17.0 61.3 684.9 918.6 208.8 495.1 17.2 52.6 1.2 76.7 545.2 264.1 507.7 428.3 1413.2 42.6 3.4 582.2 989.6 SPNS1 "HSpin1, LAT, nrs, PP2030, SLC62A1, SPIN1, SPINL" ENSG00000169682 "Sphingolipid transporter 1 (putative)" Q9H2V7 16 28974221-28984548 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041995, HPA042988" Enhanced Approved "Nucleoli fibrillar center,Golgi apparatus,Vesicles,Cytosol" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 51: Myeloid cells - Hemostasis" Vesicles "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA041995: AB_10959609, HPA042988: AB_10964587" "unprognostic (3.54e-2)" "unprognostic (4.57e-4)" "unprognostic (2.15e-1)" "unprognostic (2.49e-1)" "unprognostic (2.08e-1)" "unprognostic (3.66e-1)" "unprognostic (7.86e-5)" "unprognostic (1.01e-1)" "unprognostic (2.00e-1)" "unprognostic (1.27e-1)" "unprognostic (4.12e-2)" "unprognostic (3.02e-3)" "unprognostic (8.85e-7)" "unprognostic (1.48e-1)" "unprognostic (6.15e-2)" "unprognostic (1.26e-3)" "unprognostic (1.12e-2)" 26.8 30.8 17.0 19.3 17.4 37.0 24.8 17.1 26.3 27.7 18.6 32.5 22.4 30.9 6.6 25.9 23.0 18.0 27.5 16.9 15.7 32.1 33.9 31.5 20.1 19.1 16.6 22.0 24.4 20.8 21.1 19.8 17.2 26.5 10.0 6.5 24.4 14.9 25.0 35.7 27.8 15.1 15.8 33.9 28.2 20.3 19.8 20.8 27.8 14.9 10.5 30.5 25.2 18.3 25.9 59.6 22.2 51.9 41.5 22.8 62.9 28.2 28.9 46.1 40.9 55.0 60.4 16.4 67.8 25.5 38.2 53.3 36.4 31.2 16.4 19.0 61.6 23.8 57.1 69.3 70.4 26.7 49.2 38.4 40.9 49.7 21.0 26.8 42.9 30.0 54.4 28.7 23.4 68.8 29.3 75.8 52.6 20.8 39.1 36.7 26.7 73.6 24.9 24.8 39.5 51.3 20.1 59.3 44.9 18.5 59.2 31.9 36.6 37.3 28.2 52.7 22.0 43.2 36.7 15.6 47.7 40.4 30.8 13.4 32.8 13.5 9.9 42.1 8.3 5.7 9.8 13.0 27.6 4.3 10.0 6.8 5.6 7.7 28.8 11.5 12.1 18.1 17.0 17.4 17.1 26.3 16.9 15.7 19.1 16.6 17.2 15.8 19.8 18.3 24.4 6.4 7.2 8.8 14.9 21.3 21.3 29.8 14.8 31.0 17.2 15.7 0.3 20.0 20.1 20.2 29.2 63.3 26.5 10.5 13.7 58.1 2.1 15.3 19.2 24.1 12.2 21.8 10.2 45.7 72.3 24.6 16.8 18.9 22.7 40.9 19.2 14.3 98.7 26.9 10.3 13.8 46.8 45.6 28.4 3.7 22.7 61.8 33.8 15.0 32.7 28.5 24.7 7.1 8.6 37.3 16.0 16.6 18.6 14.4 41.5 18.2 26.2 38.6 6.6 17.4 23.8 24.8 33.5 16.4 22.7 87.3 20.7 37.8 20.0 19.4 SQLE ENSG00000104549 "Squalene epoxidase" Q14534 8 124998497-125022283 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018038, HPA020762" Enhanced Uncertain Vesicles,Cytosol NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 37: Intestine - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Vesicles, Cytosol" "HPA018038: AB_2669753, HPA020762: AB_2670512" "unprognostic (1.37e-2)" "unprognostic (6.26e-3)" "unprognostic (5.12e-2)" "unprognostic (9.51e-3)" "unprognostic (4.63e-1)" "prognostic unfavorable (7.42e-4)" "unprognostic (4.76e-3)" "prognostic unfavorable (4.67e-4)" "unprognostic (3.45e-2)" "unprognostic (7.21e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (7.51e-2)" "prognostic unfavorable (5.70e-4)" "unprognostic (9.71e-2)" "unprognostic (4.62e-2)" "unprognostic (1.19e-3)" "unprognostic (7.74e-3)" 8.6 31.1 17.5 19.6 27.0 23.0 22.1 26.8 24.0 30.7 25.4 21.6 31.0 16.4 9.1 78.7 18.6 10.7 7.2 18.6 24.4 17.1 72.3 30.9 17.7 47.3 27.7 14.3 10.7 22.7 16.5 47.5 35.1 25.0 18.6 17.8 19.1 7.6 1.4 49.4 14.0 12.3 27.6 9.7 21.8 59.4 21.8 14.2 10.5 1.6 29.4 14.7 46.2 34.6 135.5 51.5 301.6 87.2 91.7 154.1 30.5 34.9 106.3 46.5 84.7 70.6 192.3 92.7 49.2 43.2 186.0 101.0 127.3 192.4 53.6 77.1 268.3 265.2 32.6 181.1 134.6 31.5 74.6 106.1 201.4 138.8 113.3 29.8 51.5 64.2 153.8 174.8 38.1 223.7 109.6 39.3 125.2 92.6 35.2 47.5 55.4 126.6 329.3 153.3 93.9 47.6 71.6 226.3 74.1 96.5 60.7 81.3 50.8 19.2 66.0 22.9 31.6 31.6 69.6 126.6 32.0 93.7 33.8 1.5 6.3 0.7 10.6 10.8 5.0 16.6 6.0 9.5 15.2 17.1 8.2 8.6 0.2 12.6 12.7 10.8 7.1 7.7 17.5 27.0 26.8 24.0 18.6 24.4 47.3 27.7 35.1 27.6 21.8 34.6 13.2 60.9 97.9 21.5 34.7 22.9 64.0 199.9 16.5 41.8 35.6 27.3 6.1 31.5 129.6 53.3 50.1 99.7 20.6 81.6 7.9 60.3 21.0 95.9 23.3 39.7 31.7 22.3 14.3 83.6 133.7 35.3 51.0 80.5 41.3 77.1 9.7 127.9 61.1 148.0 18.8 58.0 126.1 10.9 30.1 13.2 23.9 22.2 21.4 13.1 91.0 24.3 8.2 20.1 77.9 98.6 38.4 10.9 30.6 118.0 17.3 3.7 123.0 61.1 26.3 12.5 42.0 179.5 128.6 69.5 89.1 217.1 21.1 171.8 35.0 114.8 SSH1 "KIAA1298, SSH1L" ENSG00000084112 "Slingshot protein phosphatase 1" Q8WYL5 12 108778191-108857590 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Actin-binding, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "WM-115: 63.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019845 Uncertain Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 17: WM-115 - Nervous system development" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA019845: AB_1857497" "unprognostic (1.18e-3)" "unprognostic (3.00e-1)" "unprognostic (2.49e-1)" "unprognostic (2.70e-2)" "unprognostic (9.40e-2)" "unprognostic (7.45e-2)" "prognostic unfavorable (5.80e-5)" "unprognostic (3.28e-2)" "unprognostic (3.69e-2)" "unprognostic (1.72e-3)" "unprognostic (7.12e-2)" "unprognostic (3.42e-1)" "unprognostic (1.71e-2)" "unprognostic (1.41e-1)" "unprognostic (8.66e-2)" "unprognostic (9.55e-2)" "unprognostic (6.22e-2)" 6.6 5.1 5.6 5.1 5.1 7.9 5.0 9.2 5.5 5.8 7.2 7.2 2.9 5.9 4.0 5.5 5.3 5.3 7.8 5.7 5.3 6.7 5.5 11.8 4.1 5.8 5.7 5.0 4.3 5.4 5.2 5.2 5.2 5.2 4.1 5.7 3.9 4.8 11.9 4.6 5.1 5.5 5.0 7.5 4.9 3.5 5.1 3.6 5.3 6.5 4.2 6.0 5.2 5.1 9.9 12.7 8.2 6.4 15.1 12.8 7.2 12.8 26.1 11.0 9.7 6.4 4.6 4.9 8.7 29.0 18.8 9.8 4.9 20.7 8.9 9.9 4.8 11.3 6.0 4.0 8.1 5.8 28.4 17.7 7.0 10.0 22.0 27.1 10.3 5.6 2.5 3.6 29.1 5.4 6.6 8.0 5.8 3.8 10.3 4.6 9.8 6.1 4.5 17.1 6.1 8.1 11.0 2.8 24.2 11.2 3.9 4.8 8.1 19.6 8.4 11.9 7.1 7.3 7.0 5.6 10.3 4.5 63.1 1.8 0.9 2.0 1.0 1.5 0.9 0.6 0.5 0.9 0.6 0.6 0.4 0.5 2.1 0.7 1.2 0.7 0.6 0.5 5.6 5.1 9.2 5.5 5.7 5.3 5.8 5.7 5.2 5.0 5.1 5.1 34.5 9.6 16.1 26.1 6.3 9.4 20.8 23.6 19.4 12.9 6.9 6.6 25.1 11.5 12.7 14.7 16.7 6.0 18.5 8.2 5.9 8.4 2.2 10.8 17.1 52.2 5.4 7.8 27.3 8.2 4.4 14.0 13.7 16.9 20.8 12.0 29.3 15.2 12.3 11.8 35.4 5.4 0.0 23.0 20.3 5.0 6.5 21.1 12.4 55.3 33.7 7.8 14.4 14.1 14.8 12.3 2.4 12.8 13.1 21.8 4.0 6.7 9.0 19.1 6.6 17.8 18.1 1.4 7.7 13.2 8.9 2.3 17.9 7.6 7.8 13.9 STK17B DRAK2 ENSG00000081320 "Serine/threonine kinase 17b" O94768 2 196133583-196176503 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 376.2;lymphoid tissue: 113.3" "Cell type enhanced" "Detected in many" "B-cells: 229.3;dendritic cells: 267.7;granulocytes: 195.1;Langerhans cells: 201.3;Macrophages: 198.9;Plasma cells: 191.8;T-cells: 342.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 122.3;HMC-1: 118.9;Karpas-707: 111.6;U-698: 132.1" "Region enriched" "Detected in all" 5 "cerebellum: 63.4" "Low region specificity" "Detected in all" HPA034858 Enhanced Uncertain "Plasma membrane,Cytosol" NA Yes "Cluster 5: Granulocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 24: Non-specific - Transcription regulation" "Plasma membrane, Cytosol" "HPA034858: AB_10670981" "unprognostic (2.14e-1)" "unprognostic (2.45e-3)" "unprognostic (3.68e-2)" "unprognostic (3.61e-2)" "unprognostic (3.63e-2)" "unprognostic (7.43e-3)" "unprognostic (1.75e-1)" "unprognostic (7.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.14e-1)" "unprognostic (9.90e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.72e-8)" "unprognostic (1.88e-1)" "unprognostic (1.19e-2)" "unprognostic (2.64e-2)" "unprognostic (5.80e-2)" 28.2 8.9 2.1 67.0 2.9 376.2 21.5 3.7 5.3 24.2 3.3 19.1 27.8 5.4 1.8 11.9 5.8 20.4 4.6 4.1 3.3 6.5 8.5 23.6 113.3 3.1 2.0 2.2 12.7 2.1 3.0 16.7 3.2 10.5 17.5 0.4 17.0 5.7 2.4 11.2 40.1 16.8 2.2 56.9 20.1 9.5 4.0 60.9 7.2 3.5 111.1 24.4 5.2 2.9 11.0 7.5 11.2 4.2 47.7 18.1 12.4 25.7 38.4 27.7 28.5 22.8 3.9 122.3 23.1 14.8 7.3 7.4 4.7 11.1 33.4 21.8 12.7 11.6 9.1 2.2 14.2 47.0 118.9 23.1 10.9 34.3 17.7 39.2 11.5 28.5 9.1 111.6 69.4 5.9 61.6 106.0 6.3 19.9 17.2 10.1 67.5 37.4 16.3 25.6 4.2 4.2 6.6 6.4 5.4 17.2 4.3 24.3 14.0 26.8 13.1 19.3 14.7 45.5 78.9 132.1 20.2 15.9 12.1 165.1 74.3 163.1 43.7 81.3 55.4 49.2 77.0 52.8 53.0 58.6 98.6 82.4 236.7 40.8 113.1 37.7 73.8 89.3 2.1 2.9 3.7 5.3 4.1 3.3 3.1 2.0 3.2 2.2 4.0 2.9 23.3 89.8 74.0 48.3 229.3 59.9 27.1 15.1 10.8 0.9 28.9 15.2 2.6 12.8 42.5 11.0 0.0 7.9 267.7 54.0 3.9 6.6 6.8 15.3 14.1 11.3 3.0 68.8 3.4 2.8 24.0 27.2 38.2 26.5 195.1 47.4 5.3 2.4 26.1 0.0 3.1 13.9 18.3 151.1 201.3 3.6 5.6 198.9 58.7 11.2 158.0 0.6 118.4 17.6 0.7 10.9 41.6 4.5 191.8 34.3 80.7 2.5 26.9 0.3 6.6 49.7 19.7 41.1 26.3 16.4 63.4 5.1 342.5 22.6 13.2 53.8 STRADB "ALS2CR2, CALS-21, ILPIP, ILPIPA, PAPK" ENSG00000082146 "STE20 related adaptor beta" Q9C0K7 2 201387858-201480846 "Enzymes, Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 412.8;Proximal enterocytes: 124.0;Proximal tubular cells: 217.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "LHCN-M2: 188.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026549, HPA028520" Approved Uncertain Aggresome,Cytosol NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 6: Erythroid cells - Oxygen transport" Cytosol Aggresome "HPA026549: AB_1844779, HPA028520: AB_10604100" "unprognostic (6.34e-2)" "unprognostic (2.48e-1)" "unprognostic (2.63e-1)" "unprognostic (3.56e-3)" "unprognostic (4.04e-2)" "unprognostic (7.64e-2)" "unprognostic (1.35e-1)" "unprognostic (1.58e-1)" "unprognostic (2.63e-3)" "unprognostic (2.65e-2)" "unprognostic (6.21e-2)" "unprognostic (2.74e-2)" "prognostic unfavorable (1.35e-4)" "unprognostic (1.08e-1)" "unprognostic (7.83e-2)" "prognostic favorable (4.45e-4)" "unprognostic (4.93e-2)" 29.9 53.2 24.1 8.9 26.3 80.9 16.8 26.2 30.8 10.6 22.4 27.6 37.0 13.2 17.4 17.0 10.4 14.3 38.0 25.3 26.2 73.3 104.9 10.6 14.5 27.7 25.9 14.1 17.6 6.2 17.4 19.7 27.3 11.1 30.3 40.5 13.9 7.7 109.0 8.4 42.9 10.2 26.7 13.7 9.1 15.8 25.6 11.4 17.9 69.5 11.6 9.7 9.3 30.2 12.6 21.5 36.2 47.0 58.5 73.8 25.6 25.6 43.4 34.9 51.6 29.6 11.9 0.1 16.0 40.7 42.4 12.6 35.8 23.9 62.7 14.9 30.1 15.2 9.6 62.9 43.9 18.4 16.7 62.5 21.6 43.7 39.0 63.5 26.5 28.5 33.4 5.3 188.5 6.8 17.2 31.1 49.2 11.7 22.6 22.8 14.5 9.6 29.2 9.9 6.0 29.3 17.6 13.1 76.8 66.0 6.7 34.4 25.7 20.6 16.1 26.6 19.3 21.1 39.0 5.8 35.8 8.2 20.5 5.5 12.9 16.3 9.2 14.4 8.3 28.8 12.2 13.4 17.2 35.8 15.5 15.6 2.6 29.0 13.1 7.7 16.4 15.8 24.1 26.3 26.2 30.8 25.3 26.2 27.7 25.9 27.3 26.7 25.6 30.2 5.0 9.6 4.2 17.0 20.2 2.2 6.8 6.5 11.4 13.8 24.9 10.8 27.8 28.6 6.1 14.7 83.4 51.0 6.3 40.9 39.2 12.4 3.9 7.5 7.4 5.6 16.9 412.8 20.8 15.4 27.6 13.6 6.6 10.2 5.7 12.0 7.9 94.6 19.2 11.8 19.8 22.6 8.2 16.9 5.2 8.1 10.8 13.5 16.0 15.0 14.8 19.6 7.2 26.7 26.0 9.0 35.2 3.8 10.9 10.2 124.0 217.8 5.3 19.1 6.6 21.7 6.6 45.0 46.7 15.2 1.4 27.9 8.9 26.8 25.0 9.1 STX17 FLJ20651 ENSG00000136874 "Syntaxin 17" P56962 9 99906654-99974534 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, ER-Golgi transport, Host-virus interaction, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001204 Approved Uncertain Nucleoli,Cytosol NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 16: U-266 - Nucleosome" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoli, Cytosol" "HPA001204: AB_1080118" "unprognostic (1.16e-1)" "unprognostic (2.50e-1)" "unprognostic (8.67e-2)" "unprognostic (2.93e-1)" "unprognostic (6.71e-2)" "unprognostic (1.88e-1)" "unprognostic (2.36e-1)" "unprognostic (1.70e-2)" "unprognostic (9.75e-2)" "unprognostic (1.62e-1)" "unprognostic (1.04e-2)" "unprognostic (1.08e-1)" "prognostic favorable (1.62e-5)" "unprognostic (9.48e-2)" "unprognostic (4.32e-2)" "unprognostic (5.70e-2)" "unprognostic (1.28e-1)" 9.3 9.4 7.6 9.3 8.3 11.3 12.3 12.9 8.9 9.5 10.2 9.5 8.9 10.8 10.9 12.0 8.0 8.5 8.1 7.6 7.8 9.7 18.3 9.3 9.2 7.6 7.1 10.9 12.1 11.0 7.6 10.7 7.7 12.4 9.8 10.9 12.8 11.3 16.7 17.6 9.4 10.5 6.7 10.5 10.9 7.9 7.9 11.4 13.2 13.0 10.3 7.7 9.8 10.9 12.9 12.4 11.2 13.0 14.0 13.2 22.3 9.7 13.1 10.1 8.4 14.1 15.8 25.2 9.2 9.5 17.7 14.1 9.6 13.6 7.1 21.3 7.7 16.0 16.3 8.3 15.9 22.5 5.3 12.2 15.9 10.9 15.7 11.7 12.0 21.9 22.4 12.5 8.2 15.4 14.5 8.4 10.0 15.3 8.8 10.8 20.3 10.5 13.7 15.5 6.2 11.9 19.1 13.3 10.2 7.0 13.8 6.9 9.1 6.5 9.9 11.1 8.3 18.5 24.4 4.8 9.2 9.5 6.9 18.6 3.6 7.3 6.4 3.9 9.1 6.3 7.7 7.2 4.6 5.1 8.8 8.4 4.0 14.5 8.2 2.8 4.6 4.6 7.6 8.3 12.9 8.9 7.6 7.8 7.6 7.1 7.7 6.7 7.9 10.9 25.1 16.0 32.6 35.6 26.2 10.6 19.2 13.9 34.7 14.9 20.1 20.6 19.1 14.3 19.4 23.9 20.9 24.7 21.5 10.7 29.4 19.0 67.2 13.5 21.6 18.7 25.2 26.9 41.9 19.4 19.5 18.0 28.1 15.6 26.0 24.0 18.5 25.0 10.4 10.1 40.5 15.7 20.3 12.7 10.6 36.7 25.7 17.1 8.8 45.0 24.8 21.8 24.7 48.7 47.4 15.7 18.1 18.0 24.4 30.9 17.8 21.1 19.6 13.5 39.5 19.6 20.2 33.6 18.1 27.3 12.1 27.4 26.6 27.0 16.2 18.3 SULT1E1 "EST, STE" ENSG00000109193 "Sulfotransferase family 1E member 1" P49888 4 69841212-69860145 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 27.5;liver: 37.2;skin 1: 19.3;vagina: 30.4" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 65.8;Glandular and luminal cells: 35.1;Hepatocytes: 51.4;Paneth cells: 66.3;Proximal enterocytes: 21.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "HHSteC: 71.1;HSkMC: 32.3;hTCEpi: 27.3;HUVEC TERT2: 20.4" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebral cortex: 7.8" "HPA028213, HPA028728, CAB047344" Enhanced Uncertain "Nuclear membrane,Cytosol" NA NA "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 30: Epithelial cell lines - Translation" "Cluster 44: Endometrium - Transcription" "Nuclear membrane, Cytosol" "CAB047344: , HPA028213: AB_10599848, HPA028728: AB_10601894" "unprognostic (5.60e-2)" "prognostic favorable (4.06e-4)" "unprognostic (2.48e-1)" "unprognostic (1.07e-3)" "unprognostic (2.42e-1)" "unprognostic (1.95e-1)" "unprognostic (1.70e-1)" "unprognostic (1.72e-1)" "unprognostic (1.41e-1)" "unprognostic (2.89e-1)" "unprognostic (3.22e-3)" "unprognostic (8.62e-2)" "unprognostic (6.48e-5)" "unprognostic (2.48e-1)" "unprognostic (4.11e-2)" "unprognostic (5.55e-2)" 0.1 14.5 0.1 0.0 0.1 0.1 0.1 0.1 0.2 13.5 4.1 0.2 27.5 0.3 1.0 0.8 0.2 0.2 0.0 0.1 0.0 0.3 37.2 2.3 0.0 0.1 0.1 0.0 0.2 0.0 0.6 0.1 0.1 0.7 0.1 0.0 6.6 0.4 0.0 19.3 27.3 0.1 0.0 0.0 2.1 0.1 0.1 0.5 0.0 0.0 1.5 0.7 30.4 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 71.1 0.0 0.0 32.3 27.3 0.0 0.9 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 11.9 1.0 8.7 0.0 0.0 0.1 0.0 0.1 1.5 2.8 1.8 0.0 0.2 0.0 0.2 0.0 0.0 0.0 65.8 1.3 0.3 0.0 0.0 0.1 1.3 0.1 0.2 0.0 35.1 0.0 0.0 2.5 51.4 0.3 0.0 0.0 4.7 0.0 0.8 0.7 0.0 0.3 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 66.3 0.0 0.0 0.0 21.5 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.1 0.0 3.4 1.5 0.1 0.0 13.8 0.2 SURF4 "ERV29, FLJ22993, MGC102753" ENSG00000148248 "Surfeit 4" O15260 9 133361450-133376166 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 325.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064613 Approved Supported "Nuclear membrane,Endoplasmic reticulum,Golgi apparatus,Cytosol" NA Yes 65000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "Nuclear membrane, Endoplasmic reticulum, Golgi apparatus" Cytosol "HPA064613: AB_2685299" "prognostic unfavorable (5.85e-4)" "unprognostic (1.38e-2)" "unprognostic (1.92e-1)" "unprognostic (2.04e-2)" "unprognostic (3.40e-2)" "prognostic unfavorable (1.47e-5)" "prognostic unfavorable (8.11e-4)" "unprognostic (1.10e-3)" "unprognostic (3.13e-2)" "unprognostic (1.90e-1)" "unprognostic (5.30e-3)" "unprognostic (1.23e-1)" "unprognostic (9.76e-3)" "unprognostic (7.58e-3)" "unprognostic (1.25e-1)" "unprognostic (2.29e-1)" "unprognostic (4.29e-3)" 97.0 106.4 20.3 38.8 22.5 66.5 76.5 22.1 23.4 70.5 27.9 72.1 79.2 78.5 40.6 77.6 71.1 39.0 74.1 21.5 22.3 67.1 223.8 84.2 29.6 23.6 22.2 61.0 150.4 35.4 88.6 55.4 22.2 69.2 37.9 14.0 86.4 39.5 60.1 63.2 82.2 43.4 22.9 59.6 88.5 49.4 25.8 27.8 68.2 23.3 31.4 62.7 59.4 25.9 59.8 96.4 65.3 90.3 134.8 140.2 127.4 184.1 178.4 127.0 124.7 145.9 84.8 41.1 70.6 254.2 122.9 152.7 75.7 94.4 97.0 86.5 46.3 72.1 87.1 156.5 156.2 124.8 94.1 150.4 85.8 109.3 120.2 101.6 118.6 62.9 89.0 109.8 164.5 131.8 60.1 115.4 72.7 162.8 96.2 41.2 89.9 156.5 100.4 56.3 53.8 65.5 136.4 100.4 95.2 61.5 106.6 75.8 127.5 179.4 64.5 137.3 119.6 56.1 86.4 46.4 166.7 66.6 137.5 43.9 40.8 36.2 51.9 32.8 56.9 15.1 36.3 48.4 32.9 12.1 22.0 34.6 28.4 29.4 31.7 38.9 46.9 68.8 20.3 22.5 22.1 23.4 21.5 22.3 23.6 22.2 22.2 22.9 25.8 25.9 53.5 44.8 48.1 18.9 43.0 60.8 65.8 72.5 46.1 21.9 55.5 43.2 42.6 31.5 47.5 35.0 39.6 167.9 80.4 106.9 19.6 95.7 38.6 28.6 72.8 54.8 75.2 31.1 23.2 118.1 254.4 84.8 78.5 67.7 24.7 49.5 47.5 207.3 85.9 33.7 15.6 107.9 30.5 52.3 50.5 19.7 68.3 50.8 40.9 17.8 53.7 53.3 52.5 22.6 23.8 115.1 65.5 53.0 114.8 106.8 151.3 48.5 23.2 26.9 78.9 51.9 80.6 84.4 47.3 46.1 62.4 325.2 90.5 81.8 81.2 84.2 SVIL ENSG00000197321 Supervillin O95425 10 29457338-29736959 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 808.1;tongue: 581.5" "Cell type enhanced" "Detected in all" "Basal squamous epithelial cells: 204.9;Cardiomyocytes: 469.6;Peritubular cells: 260.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "neutrophil: 259.3" "Lineage enriched" "Detected in all" 9 "granulocytes: 259.3" "Cell line enhanced" "Detected in many" "HaCaT: 146.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010878, HPA020095, HPA020138" Approved Supported "Plasma membrane,Actin filaments,Cytosol" NA NA 210000 "Cluster 1: Neutrophils - Mixed function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 54: Cardiomyocytes - Muscle contraction" "Plasma membrane" "Actin filaments, Cytosol" "CAB010878: AB_476685, HPA020095: AB_1857680, HPA020138: AB_1857681" "unprognostic (1.11e-1)" "unprognostic (2.94e-1)" "unprognostic (8.06e-2)" "unprognostic (1.15e-2)" "unprognostic (3.47e-3)" "unprognostic (2.26e-2)" "unprognostic (4.12e-1)" "unprognostic (1.49e-1)" "unprognostic (4.28e-1)" "unprognostic (3.42e-3)" "unprognostic (1.55e-1)" "unprognostic (9.20e-2)" "unprognostic (2.38e-3)" "unprognostic (7.11e-3)" "unprognostic (1.51e-1)" "unprognostic (2.50e-1)" "prognostic unfavorable (5.70e-5)" 26.4 13.4 3.7 22.7 3.9 37.2 22.6 1.3 8.9 45.8 2.5 314.5 14.8 116.2 24.1 92.1 55.5 52.0 165.0 2.2 2.7 15.4 10.4 22.9 12.6 7.0 4.1 83.3 18.5 31.8 8.5 17.9 4.4 70.3 37.1 10.3 40.6 100.0 808.1 26.9 60.1 107.0 4.4 7.6 77.6 11.7 4.9 19.1 35.0 581.5 10.8 173.2 40.3 5.2 71.4 27.9 12.4 5.4 32.1 84.4 22.1 12.6 24.1 4.3 4.7 34.4 63.1 2.4 43.0 4.9 31.9 146.8 8.6 25.6 5.2 1.4 17.6 0.1 33.6 19.9 21.4 8.0 1.5 72.7 24.5 44.2 19.1 71.9 69.6 14.7 0.1 0.4 6.7 19.9 7.7 4.0 7.0 27.8 15.1 15.5 32.1 0.9 40.2 20.1 18.1 14.1 12.3 1.4 34.3 39.8 12.9 7.9 46.3 21.9 23.4 94.4 34.4 0.6 0.8 0.3 64.5 14.0 65.4 43.4 12.1 58.2 11.1 14.0 10.9 0.6 11.2 7.6 7.3 1.0 17.1 10.9 259.3 14.6 29.6 3.0 4.3 3.7 3.7 3.9 1.3 8.9 2.2 2.7 7.0 4.1 4.4 4.4 4.9 5.2 31.3 48.1 30.5 2.3 3.7 70.2 108.0 41.1 204.9 11.7 36.6 67.1 469.6 18.6 53.5 38.6 25.0 29.7 11.3 39.7 7.9 94.1 4.0 26.3 65.8 61.1 23.9 1.7 8.3 42.3 18.5 68.1 7.7 43.6 10.1 35.7 32.2 11.8 10.4 5.0 43.9 31.3 28.5 7.5 45.7 6.8 109.6 25.3 28.4 146.1 16.7 30.6 13.4 28.1 6.6 63.4 40.2 260.7 3.3 131.8 18.4 10.8 42.2 15.0 46.0 90.6 92.9 6.5 11.1 103.8 60.0 24.8 14.6 27.9 39.2 98.3 SYCP2 SCP2 ENSG00000196074 "Synaptonemal complex protein 2" Q9BX26 20 59863564-59933655 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 43.2" "Cell type enriched" "Detected in many" 5 "Spermatocytes: 468.5" "Group enriched" "Detected in many" 6 "breast cancer: 6.7;cervical cancer: 11.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 25.9;JURKAT: 47.2;MOLT-4: 54.4;SiHa: 92.2;T-47d: 82.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA062401, HPA065613" Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 78: Testis - Spermatogenesis" "Cluster 6: T47d - Mammary gland" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "Plasma membrane, Cytosol" "HPA062401: AB_2684752, HPA065613: AB_2685519" "unprognostic (8.10e-3)" "unprognostic (8.28e-3)" "unprognostic (1.62e-1)" "unprognostic (2.48e-2)" "unprognostic (1.57e-1)" "unprognostic (1.19e-3)" "unprognostic (2.50e-2)" "unprognostic (2.18e-1)" "unprognostic (4.11e-2)" "unprognostic (1.44e-1)" "unprognostic (3.74e-1)" "unprognostic (7.02e-3)" "unprognostic (4.84e-3)" "unprognostic (8.48e-2)" "unprognostic (2.46e-1)" "unprognostic (7.87e-3)" "unprognostic (1.21e-1)" 3.2 0.8 2.2 1.4 2.8 2.4 13.9 9.7 4.9 2.4 0.0 1.3 1.6 1.6 1.2 0.9 1.3 2.4 2.5 2.2 1.1 4.3 1.1 2.2 2.6 1.8 1.8 0.7 6.6 0.7 1.9 3.9 2.2 3.8 1.1 1.5 4.4 1.0 1.3 2.7 2.4 0.7 1.4 3.1 6.1 43.2 2.5 1.3 2.4 1.0 1.7 1.8 1.5 4.1 0.3 1.3 0.2 1.4 0.6 0.8 1.4 4.1 1.1 1.8 0.2 25.9 2.6 0.1 4.0 1.8 0.8 0.6 0.5 0.1 1.0 8.5 0.6 0.2 6.1 0.4 0.2 0.4 19.0 0.4 0.4 0.4 0.0 0.9 0.0 47.2 0.2 0.0 0.9 12.5 54.4 2.9 0.4 1.5 0.3 0.0 0.1 0.2 2.1 6.1 0.2 4.5 92.2 13.3 3.3 1.6 82.6 4.7 0.5 0.1 2.8 11.2 0.0 0.0 0.0 0.0 0.0 1.7 5.2 0.7 0.1 0.7 0.8 0.0 0.8 0.2 0.4 0.5 0.0 0.2 0.2 0.4 0.7 0.0 0.0 0.0 0.3 0.2 2.2 2.8 9.7 4.9 2.2 1.1 1.8 1.8 2.2 1.4 2.5 4.1 11.5 0.0 1.1 24.5 1.4 1.0 1.1 1.0 0.0 1.9 12.7 9.4 3.6 2.8 6.3 1.8 2.1 0.8 3.0 0.1 1.9 0.9 82.3 0.4 5.0 6.5 0.0 0.0 27.5 3.6 0.4 2.1 2.6 0.5 2.5 1.2 2.9 0.0 0.5 0.0 14.6 0.1 0.0 1.2 0.8 21.8 4.7 1.6 5.4 13.1 1.4 2.3 5.2 28.6 11.1 1.2 1.2 1.9 0.4 1.8 0.3 5.4 8.6 1.1 52.6 1.7 3.8 468.5 92.4 0.6 0.0 0.4 4.1 0.2 0.3 1.2 TAOK2 "KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2" ENSG00000149930 "TAO kinase 2" Q9UL54 16 29973868-29992261 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010650 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Cytosol" Nucleoli "HPA010650: AB_1080204" "unprognostic (7.30e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.51e-4)" "prognostic favorable (3.87e-5)" "unprognostic (8.46e-2)" "unprognostic (2.14e-3)" "unprognostic (6.08e-2)" "unprognostic (1.12e-3)" "unprognostic (1.01e-2)" "unprognostic (1.60e-1)" "prognostic favorable (4.78e-4)" "unprognostic (3.85e-3)" "prognostic favorable (3.66e-4)" "unprognostic (7.42e-3)" "unprognostic (3.17e-1)" "unprognostic (7.47e-2)" "unprognostic (1.37e-1)" 31.4 36.0 23.4 14.7 21.2 12.7 30.8 18.0 26.1 24.8 11.9 21.8 17.3 25.9 11.1 20.8 22.6 12.0 32.6 23.0 18.9 22.7 17.6 34.0 14.4 21.0 20.0 24.1 19.5 17.4 29.4 19.4 18.9 22.5 8.5 14.3 20.5 13.3 23.4 22.4 24.4 13.3 15.3 33.8 21.8 34.8 20.8 13.2 25.4 12.7 10.5 22.4 21.6 19.0 22.2 41.8 22.4 35.1 25.8 17.1 34.2 40.0 21.1 26.4 24.4 33.6 28.7 23.8 32.8 28.8 18.0 33.9 20.4 20.0 14.1 37.5 43.3 25.8 46.2 34.8 18.7 25.5 47.5 20.0 17.1 28.1 11.2 18.5 44.7 22.4 23.5 23.6 25.8 41.0 29.8 36.0 21.5 16.4 27.6 54.2 32.5 22.2 16.6 20.5 26.1 20.8 22.8 30.2 12.1 14.4 37.5 28.5 62.9 45.0 20.7 32.4 23.6 34.2 23.7 22.1 27.6 28.8 33.7 0.3 0.7 0.4 0.7 0.7 0.8 0.5 0.7 0.6 0.4 0.6 0.4 0.3 1.2 0.5 0.4 0.8 0.9 0.6 23.4 21.2 18.0 26.1 23.0 18.9 21.0 20.0 18.9 15.3 20.8 19.0 52.0 9.6 11.5 21.9 6.3 10.7 4.6 7.5 7.4 14.6 10.5 5.7 9.8 7.2 9.1 9.2 39.6 7.8 7.6 27.0 1.9 8.5 3.9 8.7 9.5 35.3 13.1 3.4 7.9 12.0 6.2 9.7 14.3 8.9 3.8 16.0 47.2 11.8 9.8 10.1 10.7 16.8 12.2 11.2 11.1 4.4 12.5 8.2 7.2 7.5 9.0 8.4 11.3 9.0 12.7 16.1 14.8 12.8 5.9 7.4 27.2 8.0 10.0 21.4 6.6 8.7 8.7 19.7 21.6 9.1 9.7 12.0 9.2 16.0 14.7 7.4 TAPT1 FLJ90013 ENSG00000169762 "Transmembrane anterior posterior transformation 1" Q6NXT6 4 16160505-16227410 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Chondrogenesis, Cilium biogenesis/degradation, Differentiation, Host-virus interaction, Osteogenesis" "Developmental protein, Receptor" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 114.7;Late spermatids: 163.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "REH: 45.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042567 Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 39: Non-specific - Mitochondria" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" Centrosome "Nucleoplasm, Cytosol" "HPA042567: AB_2678055" "unprognostic (2.34e-1)" "unprognostic (5.84e-2)" "unprognostic (1.41e-2)" "prognostic favorable (9.75e-4)" "unprognostic (2.43e-1)" "unprognostic (2.56e-2)" "unprognostic (2.32e-3)" "unprognostic (3.15e-3)" "unprognostic (1.54e-1)" "unprognostic (6.30e-2)" "prognostic favorable (5.34e-4)" "unprognostic (7.07e-2)" "prognostic favorable (8.52e-4)" "unprognostic (9.00e-2)" "unprognostic (8.52e-2)" "unprognostic (7.25e-3)" "prognostic favorable (4.18e-4)" 7.4 15.1 17.5 6.0 18.6 25.7 10.0 17.3 22.3 8.2 15.1 8.9 6.4 10.0 9.2 6.1 9.5 6.7 9.1 17.1 17.0 12.4 30.5 11.9 9.6 18.6 17.4 8.1 8.1 13.0 8.5 6.8 18.4 7.4 8.2 24.7 7.6 6.4 35.5 7.7 7.5 9.3 17.4 8.5 7.9 11.1 17.5 12.2 11.5 19.9 8.1 7.6 6.9 19.5 4.9 3.6 6.0 7.0 8.9 6.8 2.5 7.8 6.0 7.4 8.1 4.9 8.5 31.7 8.3 5.0 10.8 4.0 5.2 4.0 9.3 2.9 6.3 6.2 5.0 5.2 8.4 12.6 6.2 4.2 7.7 7.3 5.3 9.1 3.8 19.3 9.7 14.5 7.2 3.5 18.7 10.1 4.0 9.3 8.4 45.0 8.4 5.8 12.0 5.1 10.0 8.0 7.4 6.2 9.5 4.1 11.5 12.3 7.1 6.2 4.1 4.2 10.3 13.9 12.2 24.2 12.4 30.9 7.3 1.1 0.3 0.0 0.2 0.2 0.0 1.0 0.7 0.4 0.5 2.5 0.9 0.7 0.6 0.3 0.3 0.8 0.5 0.3 17.5 18.6 17.3 22.3 17.1 17.0 18.6 17.4 18.4 17.4 17.5 19.5 12.0 32.1 62.6 47.3 20.2 9.1 6.3 4.2 4.0 24.5 15.0 9.9 14.3 10.0 8.7 7.3 114.7 4.2 16.2 11.1 3.9 6.7 79.0 14.2 12.6 12.8 14.4 16.6 42.6 8.2 3.1 10.2 8.6 12.0 2.5 17.5 8.6 46.0 4.2 70.7 43.6 9.8 4.1 10.3 18.9 163.1 9.9 11.1 16.0 45.0 6.5 33.1 8.2 60.8 68.2 9.5 9.4 15.1 8.9 7.1 10.7 8.7 14.4 62.4 6.6 17.0 11.5 33.3 5.7 7.1 8.0 7.0 10.8 16.5 9.0 6.6 TBC1D22B "C6orf197, dJ744I24.2, FLJ20337" ENSG00000065491 "TBC1 domain family member 22B" Q9NU19 6 37257772-37332970 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 80.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027908, HPA027909, HPA027910" Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 1: Pancreatic cells - Digestion" "Nucleoplasm, Cytosol" "HPA027908: AB_10602073, HPA027909: AB_10601857, HPA027910: AB_10602203" "unprognostic (9.83e-2)" "unprognostic (5.36e-2)" "unprognostic (2.17e-2)" "prognostic unfavorable (8.15e-5)" "unprognostic (2.70e-1)" "unprognostic (1.45e-1)" "unprognostic (2.29e-2)" "unprognostic (1.44e-1)" "unprognostic (9.48e-2)" "unprognostic (6.06e-3)" "unprognostic (3.10e-2)" "unprognostic (1.46e-1)" "unprognostic (3.53e-3)" "unprognostic (9.87e-2)" "unprognostic (2.71e-1)" "unprognostic (3.19e-1)" "unprognostic (9.73e-2)" 5.8 12.1 8.3 5.1 8.4 18.3 5.7 8.3 8.2 7.9 8.8 6.5 7.9 6.4 7.4 14.1 8.2 5.9 7.4 8.3 8.0 8.6 6.1 8.0 5.8 7.7 8.1 9.4 12.8 10.7 6.7 6.0 7.9 8.2 7.7 7.7 11.8 5.5 15.0 15.2 8.5 6.7 7.1 7.2 7.5 10.0 8.5 13.5 7.7 7.8 7.1 7.5 9.3 8.1 13.2 5.5 9.9 10.9 9.1 9.1 14.2 7.2 15.0 13.2 16.2 12.6 8.5 12.3 7.4 9.2 17.9 8.9 12.7 11.6 14.8 19.9 10.4 19.5 9.0 17.2 13.0 11.1 15.9 7.8 16.6 13.0 15.4 12.6 18.9 20.4 22.5 3.1 9.6 11.9 16.6 8.4 13.0 15.0 5.1 10.7 9.1 9.6 13.6 9.5 13.0 8.4 7.9 11.2 14.3 13.3 8.2 19.7 18.4 8.0 12.2 5.5 9.6 11.1 12.4 80.8 5.5 16.5 12.6 1.4 2.6 4.4 2.3 3.5 2.7 1.7 2.6 2.3 4.0 2.0 2.8 2.4 1.1 3.0 1.5 1.1 1.9 2.6 8.3 8.4 8.3 8.2 8.3 8.0 7.7 8.1 7.9 7.1 8.5 8.1 4.1 3.2 5.6 17.9 6.3 8.2 8.5 7.5 8.0 5.0 6.0 3.7 5.8 7.2 10.1 1.8 4.2 6.3 4.6 15.1 3.9 12.3 5.6 10.6 3.6 4.9 1.8 10.5 20.3 15.4 9.2 4.2 3.1 8.1 5.7 5.0 3.6 3.9 5.8 0.0 22.0 4.9 10.2 4.4 7.8 5.0 3.1 4.1 1.8 6.5 6.0 3.6 6.2 14.1 24.1 15.0 6.8 1.2 5.6 10.0 11.2 9.0 15.8 4.5 0.0 4.2 3.6 6.5 6.4 10.8 15.9 6.7 6.6 3.2 6.3 11.2 TBCEL "LRRC35, MGC10233" ENSG00000154114 "Tubulin folding cofactor E like" Q5QJ74 11 121024072-121090775 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 104.0;Oligodendrocytes: 39.4;Plasma cells: 42.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "HPA038593, HPA038594" Approved Uncertain Cytosol NA NA 22000 "Cluster 48: NK-cells - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 6: Erythroid cells - Oxygen transport" Cytosol "HPA038593: AB_10669647, HPA038594: AB_2676103" "unprognostic (9.06e-3)" "unprognostic (3.42e-2)" "unprognostic (2.65e-1)" "unprognostic (2.29e-1)" "unprognostic (5.80e-2)" "unprognostic (3.13e-1)" "unprognostic (1.22e-1)" "unprognostic (2.55e-2)" "unprognostic (1.27e-2)" "unprognostic (1.06e-2)" "unprognostic (4.20e-2)" "unprognostic (3.14e-1)" "unprognostic (8.55e-2)" "unprognostic (3.07e-3)" "unprognostic (1.86e-1)" "unprognostic (1.66e-2)" "unprognostic (1.02e-1)" 7.4 7.6 10.7 5.9 14.2 5.6 9.0 14.4 11.5 7.2 15.0 7.4 5.4 8.5 9.6 5.7 6.2 7.7 9.8 8.5 11.0 8.3 15.1 9.6 7.5 10.5 10.5 9.2 6.3 16.5 7.9 10.8 9.8 9.0 5.9 8.3 7.2 12.3 6.1 5.1 5.8 9.6 10.2 8.4 6.0 14.8 14.2 7.2 10.3 8.2 7.4 6.6 4.7 13.6 6.2 5.8 9.8 8.5 17.5 16.5 7.5 11.5 14.2 8.7 12.7 6.0 9.7 7.6 17.3 14.3 8.4 1.6 10.8 3.8 11.4 9.1 8.0 13.2 4.5 6.0 21.6 9.4 8.8 18.2 12.8 8.4 9.1 8.8 14.4 4.3 3.9 14.3 12.3 4.2 3.9 7.8 5.8 0.2 5.6 3.3 14.3 3.5 11.7 3.8 5.2 12.0 11.3 11.7 7.9 8.3 11.3 7.9 18.9 19.2 4.2 7.8 6.4 5.5 4.3 4.0 2.7 0.1 7.3 0.0 0.2 0.1 0.3 0.3 0.4 0.1 0.4 0.4 0.2 0.2 0.4 0.3 0.1 0.6 0.2 0.4 0.2 0.2 10.7 14.2 14.4 11.5 8.5 11.0 10.5 10.5 9.8 10.2 14.2 13.6 9.4 6.4 11.3 15.7 7.8 2.9 1.8 2.0 2.8 9.0 4.4 2.9 10.3 7.2 1.7 7.3 14.6 1.7 3.4 2.0 1.9 4.7 11.3 9.3 8.2 8.0 3.6 104.0 34.1 2.6 1.9 7.0 1.5 3.7 1.3 6.7 13.2 20.7 3.1 8.4 32.9 2.5 4.1 6.7 2.8 5.8 9.3 4.3 10.6 20.6 10.1 5.5 6.2 36.2 39.4 3.3 1.0 9.8 42.7 2.7 2.0 4.3 8.4 9.2 0.0 14.8 6.0 14.9 6.0 3.7 1.7 1.4 3.7 6.8 2.3 1.2 TBCEL-TECTA ENSG00000285509 "TBCEL-TECTA readthrough" 11 121024125-121113108 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEL: 1.3" "HPA038593, HPA038594" Uncertain Uncertain Cytosol NA NA "Cluster 36: HEL - Hemostasis" Cytosol "HPA038593: AB_10669647, HPA038594: AB_2676103" 0.1 0.0 0.4 0.1 0.6 0.0 0.1 0.3 0.6 0.2 0.5 0.1 0.1 0.2 0.0 0.1 0.0 0.2 0.2 0.4 1.1 0.3 0.1 0.2 0.0 0.7 0.6 0.2 0.6 0.4 0.2 0.7 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.5 1.1 0.1 0.0 0.0 0.0 0.1 0.6 0.1 0.2 0.5 0.1 0.0 0.1 0.0 0.6 0.7 0.7 0.1 0.3 0.4 0.2 0.2 0.2 0.3 0.0 0.2 0.1 0.7 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.3 0.0 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.8 0.2 0.0 0.2 0.7 0.9 0.2 0.0 0.0 0.7 0.4 0.0 0.0 0.6 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.3 0.6 0.4 1.1 0.7 0.6 0.7 0.3 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBXAS1 "CYP5, CYP5A1, THAS, TS, TXAS, TXS" ENSG00000059377 "Thromboxane A synthase 1" P24557 7 139777051-140020325 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Isomerase, Lyase, Monooxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 57.8" "Group enriched" "Detected in many" 4 "granulocytes: 71.0;Hofbauer cells: 88.8;Kupffer cells: 193.6;Macrophages: 132.9;Microglial cells: 191.1;monocytes: 63.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 14 "basophil: 324.3;classical monocyte: 322.4;eosinophil: 333.6;intermediate monocyte: 466.0;myeloid DC: 129.0;neutrophil: 271.1;non-classical monocyte: 423.1" "Group enriched" "Detected in all" 22 "dendritic cells: 129.0;granulocytes: 333.6;monocytes: 466.0" "Cell line enhanced" "Detected in many" "NB-4: 76.7;PC-3: 23.7;RPTEC TERT1: 21.0;U-937: 60.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA031257, HPA031258, HPA031259" Enhanced Approved "Endoplasmic reticulum,Cytosol" NA NA 890000 "Cluster 7: Monocytes - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 4: Macrophages - Innate immune response" "Endoplasmic reticulum, Cytosol" "HPA031257: AB_2673812, HPA031258: AB_2673813, HPA031259: AB_2673814" "unprognostic (4.46e-2)" "unprognostic (3.07e-1)" "unprognostic (8.80e-2)" "unprognostic (1.12e-1)" "unprognostic (2.72e-1)" "unprognostic (9.41e-2)" "unprognostic (5.10e-2)" "unprognostic (3.12e-1)" "unprognostic (2.38e-1)" "unprognostic (3.07e-2)" "unprognostic (1.11e-1)" "unprognostic (3.03e-2)" "prognostic unfavorable (1.14e-4)" "unprognostic (1.52e-1)" "unprognostic (5.00e-3)" "unprognostic (8.53e-2)" "unprognostic (5.34e-2)" 13.2 10.8 5.3 28.1 5.1 24.8 8.2 5.4 5.9 5.4 5.8 10.1 10.3 3.2 2.0 5.4 4.9 21.2 3.3 4.5 6.8 5.8 12.8 23.9 12.4 10.0 6.6 2.9 3.6 2.9 2.3 14.2 8.8 6.4 13.0 1.6 9.0 4.0 1.0 1.3 11.9 12.6 8.9 57.8 11.2 1.4 9.7 15.1 1.8 3.3 8.3 13.9 2.1 14.7 0.2 5.4 0.3 0.1 1.2 3.9 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 12.1 0.0 0.3 0.0 0.0 0.0 0.0 9.4 0.7 17.8 0.0 0.0 1.6 6.2 15.3 2.1 0.0 0.0 0.9 1.1 2.3 0.1 0.6 2.2 0.6 0.2 2.4 76.7 0.2 18.0 23.7 2.6 0.0 1.2 21.0 0.0 0.2 1.1 0.2 0.0 0.8 0.0 0.0 14.4 2.0 0.6 0.2 1.4 1.0 4.6 0.9 0.3 0.4 60.8 1.7 324.3 322.4 333.6 7.3 466.0 11.9 8.3 13.5 3.7 129.0 4.5 2.3 1.3 271.1 11.9 423.1 22.6 13.9 216.7 5.3 5.1 5.4 5.9 4.5 6.8 10.0 6.6 8.8 8.9 9.7 14.7 3.9 3.2 10.8 8.1 9.9 0.4 1.2 0.5 2.8 1.0 3.0 3.0 1.1 5.7 1.7 1.8 6.2 0.6 16.4 0.8 9.8 5.2 0.4 1.0 0.6 5.0 1.8 12.8 1.2 9.5 0.5 2.9 7.1 3.8 71.0 0.5 16.8 8.6 88.8 3.3 1.8 1.9 12.2 193.6 19.5 0.7 0.3 132.9 3.6 191.1 63.7 4.9 26.8 3.0 5.9 4.4 7.9 0.0 16.4 5.8 0.2 6.3 1.0 4.1 19.7 1.3 1.7 0.5 0.7 26.2 0.6 0.5 13.4 0.3 2.7 1.2 TCF7L2 "TCF-4, TCF4" ENSG00000148737 "Transcription factor 7 like 2" Q9NQB0 10 112950247-113167678 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "brain: 244.9" "Cell type enhanced" "Detected in many" "Astrocytes: 264.8;Distal enterocytes: 260.0;Extravillous trophoblasts: 231.4;Paneth cells: 211.1" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "thalamus: 244.9" "Group enriched" "Detected in many" 10 "intermediate monocyte: 28.9;non-classical monocyte: 86.6" "Lineage enriched" "Detected in many" 14 "monocytes: 86.6" "Low cell line specificity" "Detected in many" "Group enriched" "Detected in all" 9 "midbrain: 67.2;thalamus: 86.6" "Group enriched" "Detected in all" 5 "midbrain: 146.8;pons: 97.8;thalamus: 164.3" "CAB013535, HPA038800" Supported Approved "Nucleoplasm,Nuclear bodies,Cytosol" Yes No "Cluster 51: Monocytes - Innate immune response" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "Nuclear bodies, Cytosol" "CAB013535: AB_2533167, HPA038800: " "unprognostic (1.79e-2)" "unprognostic (3.36e-1)" "unprognostic (1.11e-1)" "unprognostic (2.31e-2)" "unprognostic (4.59e-3)" "unprognostic (1.72e-1)" "unprognostic (2.09e-1)" "unprognostic (9.84e-2)" "unprognostic (5.09e-1)" "unprognostic (7.10e-2)" "unprognostic (6.10e-3)" "unprognostic (3.46e-2)" "unprognostic (7.25e-3)" "unprognostic (1.60e-1)" "unprognostic (1.55e-1)" "unprognostic (3.64e-1)" "unprognostic (7.36e-3)" 28.1 9.4 47.4 8.6 6.3 7.6 25.0 0.2 12.1 18.9 1.0 22.9 20.4 25.1 6.7 9.9 18.1 9.4 11.3 4.3 46.9 9.9 22.4 13.9 5.4 5.1 98.0 22.9 12.4 11.1 9.6 17.7 1.7 12.3 21.3 4.6 14.5 13.1 8.4 17.2 19.3 16.4 1.6 22.2 23.3 7.6 244.9 5.8 12.9 6.9 3.7 13.8 14.3 3.2 15.0 37.8 40.7 39.6 20.8 13.7 48.5 10.3 20.0 7.1 8.5 24.9 45.3 0.1 11.3 19.4 9.6 10.5 14.0 17.6 9.1 1.7 13.1 10.4 25.2 23.6 22.0 4.2 3.7 24.4 6.3 11.0 18.2 29.7 12.0 8.8 11.0 0.7 8.2 28.0 6.7 2.5 29.2 16.6 21.6 19.0 29.8 6.9 15.2 20.4 0.8 12.4 15.7 15.4 17.0 31.5 10.0 2.2 27.9 6.8 18.7 16.9 21.3 2.6 0.3 0.4 6.5 8.7 14.9 0.4 4.5 0.4 1.5 28.9 0.9 0.0 0.4 1.2 4.1 0.0 0.4 0.6 6.0 0.0 86.6 0.2 0.0 3.5 47.4 6.3 0.2 12.1 4.3 46.9 5.1 98.0 1.7 1.6 244.9 3.2 62.0 22.4 26.5 264.8 3.3 42.6 27.3 35.8 64.9 2.8 53.0 54.9 13.6 52.9 35.5 40.5 6.2 44.2 9.1 260.0 11.7 39.3 8.8 40.1 140.6 46.1 19.8 4.8 35.1 43.6 231.4 90.8 90.2 64.2 0.0 37.6 52.8 74.2 17.5 5.0 16.6 87.7 16.2 99.9 20.6 5.0 59.0 54.6 32.0 107.7 22.4 34.4 5.2 192.5 34.9 59.0 211.1 48.5 6.0 38.4 75.3 16.2 26.8 6.1 92.1 37.3 51.3 9.4 28.9 61.1 39.8 28.5 6.7 13.1 73.9 49.0 TDGF1 "CR, CR-1, CRIPTO, Cripto-1" ENSG00000241186 "Teratocarcinoma-derived growth factor 1" P13385 3 46574534-46582457 "Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 23.4;lymphoid tissue: 20.9" "Cell type enriched" "Detected in some" 6 "Distal tubular cells: 121.3" "Cancer enriched" "Detected in many" 4 "testis cancer: 27.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 25.7;NTERA-2: 110.6;SuSa: 66.3" "Group enriched" "Detected in many" 5 "cerebellum: 11.2;pons and medulla: 8.7" "Low region specificity" "Detected in single" HPA051928 Uncertain Vesicles,Cytosol "Secreted in other tissues" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 5: NTERA-2 - Transcription" "Cluster 39: Non-specific - Basic cellular processes" Vesicles Cytosol "HPA051928: " "unprognostic (7.84e-3)" "unprognostic (2.00e-2)" "unprognostic (1.30e-2)" "unprognostic (1.17e-2)" "unprognostic (2.80e-2)" "unprognostic (1.14e-1)" "unprognostic (4.01e-2)" "unprognostic (1.93e-1)" "unprognostic (3.61e-1)" "unprognostic (1.72e-2)" "unprognostic (6.77e-2)" "unprognostic (1.74e-1)" "unprognostic (8.76e-3)" "unprognostic (2.01e-1)" "unprognostic (2.10e-2)" "unprognostic (1.75e-2)" "unprognostic (1.05e-1)" 0.4 3.4 2.4 0.5 1.9 0.3 0.3 2.1 4.8 0.7 1.4 2.6 0.7 1.0 2.0 0.1 0.1 0.6 0.6 1.8 1.7 23.4 1.3 0.4 0.4 2.1 1.8 7.7 0.4 0.1 0.1 0.2 2.2 0.4 4.6 0.4 1.0 0.3 1.5 0.3 0.5 1.2 1.7 20.9 2.7 0.5 3.1 15.1 0.8 1.5 0.1 0.2 0.1 1.9 0.1 0.2 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.0 1.8 0.0 0.2 0.0 0.0 25.7 0.2 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.2 110.6 4.0 0.0 0.2 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 66.3 0.1 0.1 1.8 0.2 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.7 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.9 0.3 0.1 0.1 0.0 0.0 2.4 1.9 2.1 4.8 1.8 1.7 2.1 1.8 2.2 1.7 3.1 1.9 0.9 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 5.5 0.0 0.0 0.0 0.9 121.3 0.2 5.0 0.3 0.1 8.2 2.4 0.0 0.0 0.0 0.0 0.3 8.2 0.2 0.0 14.3 0.4 1.4 0.1 0.0 0.0 5.5 0.0 0.0 0.0 1.0 0.3 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.0 0.0 0.0 0.3 0.6 0.0 0.2 0.0 0.1 0.3 0.1 0.3 0.0 0.0 0.0 0.1 17.7 6.1 0.0 TDO2 "TDO, TPH2" ENSG00000151790 "Tryptophan 2,3-dioxygenase" P48775 4 155854738-155920406 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Tryptophan catabolism" "Dioxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 47 "liver: 797.8" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 1174.2" "Cancer enriched" "Detected in many" 18 "liver cancer: 35.7" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "EFO-21: 9.6;HDLM-2: 22.0;U-87 MG: 11.3" "Group enriched" "Detected in some" 7 "cerebellum: 6.3;hippocampal formation: 5.3;white matter: 1.9" "Low region specificity" "Detected in all" HPA039611 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 44: HDLM-2 - Immune response" "Cluster 2: Hepatocytes - Metabolism" "Plasma membrane, Cytosol" "HPA039611: " "unprognostic (1.10e-1)" "unprognostic (3.00e-3)" "unprognostic (3.84e-2)" "unprognostic (1.95e-1)" "unprognostic (7.06e-2)" "unprognostic (3.50e-1)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (1.00e-1)" "unprognostic (2.13e-2)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (4.68e-8)" "unprognostic (7.99e-2)" "unprognostic (9.29e-3)" "unprognostic (1.28e-1)" "unprognostic (1.95e-2)" 0.3 1.6 0.3 16.8 0.5 0.0 0.1 0.2 1.2 0.2 0.2 1.2 3.5 0.4 0.6 0.7 0.3 1.9 0.0 0.5 0.3 0.6 797.8 3.2 3.1 0.2 1.1 0.1 0.3 0.1 4.0 0.6 0.2 0.2 1.4 0.0 0.4 0.2 0.2 0.0 5.9 2.5 0.3 1.9 1.6 0.4 0.3 0.2 0.2 0.0 2.6 7.6 0.1 0.7 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 9.6 0.0 0.2 0.0 0.1 0.0 0.0 22.0 0.0 0.1 0.0 0.0 0.3 0.3 0.0 1.1 0.0 0.0 0.0 0.9 0.0 0.0 0.1 3.5 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 1.6 0.0 0.3 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.2 0.0 1.2 0.4 0.5 0.0 3.4 0.0 0.0 11.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.2 1.2 0.5 0.3 0.2 1.1 0.2 0.3 0.3 0.7 0.8 0.0 0.0 0.7 2.7 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.6 158.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.5 0.1 1.1 2.4 0.0 32.0 4.1 0.0 0.0 1.7 3.6 0.1 0.0 0.0 29.6 1174.2 0.9 0.0 0.4 0.0 0.0 31.7 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.6 0.0 11.3 0.4 1.1 0.0 0.0 0.3 2.3 0.3 0.0 0.1 TERB1 "CCDC79, FLJ35894" ENSG00000249961 "Telomere repeat binding bouquet formation protein 1" Q8NA31 16 66754640-66801620 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 12.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "basophil: 1.9" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA079436 Supported "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 78: Testis - Spermatogenesis" "Cluster 11: Alveolar cells - Smell perception" Nucleoplasm "Cell Junctions, Cytosol" "HPA079436: " "unprognostic (2.15e-1)" "unprognostic (9.15e-2)" "unprognostic (1.30e-1)" "unprognostic (2.29e-1)" "unprognostic (3.91e-2)" "unprognostic (9.75e-2)" "unprognostic (5.79e-2)" "unprognostic (1.03e-1)" "unprognostic (7.57e-5)" "unprognostic (6.49e-2)" "unprognostic (3.23e-3)" "unprognostic (2.88e-2)" "unprognostic (6.81e-6)" "unprognostic (1.66e-1)" "unprognostic (2.56e-1)" "unprognostic (2.34e-1)" "unprognostic (6.14e-3)" 0.1 0.3 0.7 0.2 0.4 1.5 0.0 1.6 1.0 0.0 1.5 0.1 0.4 0.2 0.1 0.2 0.1 0.1 0.0 0.4 0.6 0.1 0.1 0.2 0.3 1.3 0.4 0.1 0.0 0.0 0.0 0.1 0.9 0.1 0.1 0.4 0.3 0.0 0.1 0.7 0.1 0.0 0.1 0.2 0.0 12.6 0.8 0.0 0.4 0.0 0.1 0.0 0.0 1.6 0.2 0.6 0.2 0.1 0.4 0.0 0.0 0.1 0.0 0.2 0.2 0.8 0.4 0.3 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.6 0.1 0.7 0.4 0.0 0.0 0.4 0.1 0.3 0.1 0.0 0.0 0.1 0.2 0.1 0.4 0.0 0.4 0.2 0.4 0.1 0.0 0.0 0.2 0.1 0.5 0.0 0.6 0.3 0.3 0.1 0.2 0.1 0.4 0.0 0.2 0.0 0.4 0.2 0.5 0.2 0.3 0.2 0.6 0.3 0.3 0.1 1.9 0.2 0.1 0.1 0.1 0.1 0.3 0.1 0.2 0.0 0.4 0.1 0.2 0.8 0.4 0.1 1.1 0.1 0.3 0.7 0.4 1.6 1.0 0.4 0.6 1.3 0.4 0.9 0.1 0.8 1.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 TFCP2 "CP2, LBP-1C, LSF, TFCP2C" ENSG00000135457 "Transcription factor CP2" Q12800 12 51093656-51173135 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 73.0;Inhibitory neurons: 75.9;Microglial cells: 69.3;Oligodendrocyte precursor cells: 79.4;Oligodendrocytes: 103.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070247 Supported Nucleoplasm,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 52: Non-specific - Ribosome" "Cluster 5: NTERA-2 - Transcription" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm Cytosol "HPA070247: AB_2686239" "unprognostic (6.27e-2)" "unprognostic (6.77e-2)" "unprognostic (6.90e-2)" "unprognostic (1.42e-1)" "unprognostic (4.68e-2)" "unprognostic (1.66e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (1.93e-1)" "prognostic unfavorable (1.18e-4)" "unprognostic (1.14e-1)" "unprognostic (1.32e-1)" "unprognostic (9.69e-2)" "unprognostic (4.91e-3)" "unprognostic (1.01e-1)" "unprognostic (3.20e-1)" "unprognostic (5.58e-2)" "unprognostic (5.31e-2)" 16.7 12.9 12.4 18.5 14.7 9.8 16.9 13.9 16.4 18.4 10.1 17.0 14.9 18.0 16.1 13.5 19.6 13.5 17.7 13.2 13.1 16.1 11.3 13.5 21.0 12.4 13.0 18.6 13.8 25.0 14.2 18.8 12.6 18.5 20.3 32.1 16.3 15.0 26.7 14.3 15.1 18.1 12.6 18.5 15.2 9.1 12.8 27.3 17.1 22.1 26.0 15.5 13.4 16.9 17.3 29.5 43.0 40.4 25.2 31.3 64.1 30.7 18.6 29.8 17.4 52.4 37.6 1.5 27.9 29.4 21.9 33.8 56.0 35.2 29.4 35.5 28.3 47.4 26.6 23.8 20.3 57.9 48.4 21.3 33.3 29.4 47.8 34.0 28.4 15.1 54.1 0.1 32.0 0.0 55.2 39.5 64.0 39.9 55.3 41.2 23.6 0.4 39.2 39.4 41.1 36.0 38.8 34.6 28.1 41.7 13.0 49.0 24.3 27.1 27.9 27.8 28.4 30.8 53.3 0.1 25.8 35.3 19.5 7.4 6.1 6.6 2.3 5.4 3.8 2.8 2.4 2.6 5.6 1.8 3.1 2.4 2.1 6.9 7.2 2.2 3.8 3.3 12.4 14.7 13.9 16.4 13.2 13.1 12.4 13.0 12.6 12.6 12.8 16.9 9.3 9.6 16.4 57.8 11.0 6.6 6.9 10.7 9.1 21.6 11.5 10.5 23.8 8.6 8.7 12.9 20.9 13.2 19.6 11.4 5.9 9.2 0.8 11.0 14.1 10.2 10.8 5.9 73.0 7.7 10.5 9.7 10.7 14.6 10.8 22.5 12.5 9.3 13.7 10.1 75.9 13.2 10.2 21.1 10.8 0.7 12.2 17.0 10.6 69.3 36.8 9.8 24.7 79.4 103.6 12.2 11.0 10.9 7.3 11.1 8.7 9.4 9.2 27.3 0.0 14.0 13.1 6.7 11.3 9.9 5.3 16.7 10.7 12.2 13.4 6.4 TFE3 "bHLHe33, TFEA" ENSG00000068323 "Transcription factor binding to IGHM enhancer 3" P19532 X 49028726-49043410 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Immunity, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 12.5" "Group enriched" "Detected in many" 4 "granulocytes: 12.5;monocytes: 6.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023881 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 30: Epithelial cell lines - Translation" "Cluster 41: Macrophages - Immune response" "Nucleoplasm, Cytosol" "HPA023881: AB_1857931" "unprognostic (2.68e-2)" "unprognostic (2.89e-3)" "unprognostic (2.40e-2)" "unprognostic (5.36e-2)" "unprognostic (2.71e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (6.03e-5)" "unprognostic (2.40e-1)" "unprognostic (1.26e-1)" "unprognostic (4.32e-2)" "unprognostic (5.41e-2)" "unprognostic (1.16e-1)" "prognostic unfavorable (2.19e-8)" "unprognostic (1.93e-1)" "unprognostic (8.77e-2)" "unprognostic (4.19e-2)" "unprognostic (6.25e-1)" 31.3 23.6 27.8 16.8 27.3 24.1 22.9 25.8 26.9 24.1 23.3 23.6 10.8 24.7 21.1 15.6 26.2 18.5 17.2 25.7 29.4 15.1 12.6 29.2 11.8 37.2 30.9 25.8 12.4 25.1 18.4 20.8 28.7 17.2 11.5 14.8 13.4 28.3 17.0 20.5 14.7 24.7 27.5 22.5 16.8 5.9 32.2 10.7 20.0 14.0 13.2 25.0 20.5 25.6 32.8 41.5 14.6 44.6 48.6 45.1 12.5 40.6 55.8 49.7 38.2 23.3 26.8 10.2 18.0 65.7 48.6 25.5 25.4 40.2 44.8 24.4 11.8 8.3 39.6 26.2 69.0 10.0 28.3 38.5 32.3 64.4 50.1 47.8 26.3 8.4 19.8 55.9 49.2 20.6 7.5 17.2 36.3 11.0 34.1 11.9 22.2 26.6 43.1 18.0 12.4 12.4 44.8 19.0 17.9 52.5 27.6 15.0 48.5 47.1 48.7 48.0 27.3 30.1 29.7 8.0 56.1 14.0 33.2 0.0 4.8 1.8 0.6 4.7 1.1 0.5 0.9 0.5 2.2 1.0 0.6 0.5 12.5 0.4 6.3 0.5 1.3 2.6 27.8 27.3 25.8 26.9 25.7 29.4 37.2 30.9 28.7 27.5 32.2 25.6 13.8 16.0 8.8 13.7 9.8 19.8 19.7 11.2 30.1 6.8 10.9 9.4 8.1 15.7 11.8 20.2 4.2 16.0 4.4 14.3 9.8 17.7 0.7 10.9 15.3 17.5 12.5 5.2 7.5 15.8 9.4 20.2 14.3 14.8 5.7 12.0 10.8 15.0 22.3 18.5 7.2 8.2 0.0 21.7 29.4 2.2 27.4 20.5 8.8 11.2 15.5 12.0 4.1 6.0 7.7 21.4 13.7 24.5 12.9 20.2 10.6 12.1 7.0 5.6 13.1 18.5 14.3 2.2 0.8 18.9 22.0 37.1 8.6 13.9 7.5 19.6 TGFB1 "CED, DPD1, TGFB, TGFbeta" ENSG00000105329 "Transforming growth factor beta 1" 19 41301587-41353922 "Human disease related genes, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "dendritic cells: 438.3;Extravillous trophoblasts: 452.1;Macrophages: 188.8;NK-cells: 223.5;T-cells: 221.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 3.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000361, HPA073356" Approved Approved "Golgi apparatus,Cytosol" "Secreted to blood" NA NA 1290000 "Cluster 52: Eosinophils - Transcription" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus" Cytosol "CAB000361: AB_2201910, HPA073356: " "unprognostic (1.49e-2)" "unprognostic (5.43e-3)" "unprognostic (3.29e-2)" "unprognostic (4.90e-2)" "unprognostic (3.75e-3)" "prognostic unfavorable (3.38e-4)" "unprognostic (8.51e-3)" "unprognostic (5.63e-3)" "unprognostic (2.47e-2)" "unprognostic (5.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.88e-1)" "prognostic unfavorable (1.19e-8)" "unprognostic (1.65e-3)" "unprognostic (2.79e-2)" "unprognostic (6.39e-2)" "unprognostic (4.86e-3)" 39.8 28.6 10.8 39.7 10.7 82.9 25.4 11.8 9.4 53.2 9.5 31.0 14.4 45.9 7.4 52.2 27.7 18.1 35.8 9.5 15.5 35.8 14.7 63.4 34.0 24.5 14.9 17.4 14.3 11.5 18.0 32.1 17.6 31.6 8.4 0.6 21.2 19.8 8.1 29.3 37.8 21.8 18.4 88.9 20.1 8.1 19.4 16.7 20.2 8.3 25.7 44.1 45.3 17.7 57.7 87.6 3.4 0.3 41.7 35.3 10.0 81.9 64.4 25.2 15.4 40.4 30.1 57.0 88.6 110.5 26.8 30.1 17.8 54.6 11.1 76.6 17.9 199.0 18.0 50.4 47.7 54.9 119.6 45.0 17.5 50.5 32.7 138.7 135.2 21.1 108.0 116.8 27.9 42.1 43.1 79.6 9.4 12.0 52.7 44.4 13.1 85.4 46.8 20.3 0.3 6.5 23.9 0.1 15.1 32.5 1.9 36.3 170.3 96.4 77.2 20.7 91.2 74.4 31.7 36.3 90.3 106.4 16.4 1.1 0.8 3.9 0.7 1.2 0.6 0.2 0.3 0.4 0.5 0.3 0.2 0.3 2.4 0.3 0.8 0.9 0.3 0.9 10.8 10.7 11.8 9.4 9.5 15.5 24.5 14.9 17.6 18.4 19.4 17.7 55.0 0.0 0.0 3.3 120.6 44.4 36.5 64.8 38.7 0.2 14.4 9.7 2.3 4.3 17.2 16.5 0.0 5.4 438.3 1.4 0.0 12.8 1.0 5.7 18.2 63.1 0.0 28.0 1.6 17.1 452.1 34.3 14.3 5.0 64.9 20.0 71.4 2.7 141.2 0.0 2.1 1.4 22.4 136.1 158.6 1.8 12.2 188.8 23.2 30.0 105.8 0.3 223.5 0.0 0.6 45.1 16.4 18.0 156.5 32.9 0.4 9.0 9.7 0.7 39.5 13.9 78.6 3.1 8.0 40.3 18.9 55.7 221.9 4.1 0.8 31.1 TMCO5A "MGC35118, TMCO5" ENSG00000166069 "Transmembrane and coiled-coil domains 5A" Q8N6Q1 15 37921939-37967724 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 141 "testis: 90.7" "Group enriched" "Detected in some" 104 "Early spermatids: 1153.9;Late spermatids: 3910.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA056530, HPA064017" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 31: Spermatids - Spermatogenesis" "Plasma membrane, Cytosol" "HPA056530: AB_2683167, HPA064017: " "unprognostic (2.60e-1)" "unprognostic (1.69e-4)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 90.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1153.9 0.2 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3910.6 13.4 1.1 0.0 0.0 0.0 0.0 0.0 1.0 1.4 0.0 0.0 10.9 0.0 0.0 0.0 0.0 1.1 0.0 6.6 0.0 0.0 24.2 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 TMEM35A "FLJ14084, NACHO, TMEM35, TUF-1" ENSG00000126950 "Transmembrane protein 35A" Q53FP2 X 101078879-101096367 "Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.9;intestine: 36.8;seminal vesicle: 50.9" "Cell type enriched" "Detected in some" 5 "Theca cells: 37.5" "Cancer enhanced" "Detected in many" "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 10.1;HUVEC TERT2: 52.5;SH-SY5Y: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048583 Enhanced Supported Supported "Vesicles,Focal adhesion sites,Cytosol" NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 52: Non-specific - Transcription" Vesicles "Focal adhesion sites, Cytosol" "HPA048583: AB_2680451" "unprognostic (7.98e-2)" "unprognostic (7.22e-2)" "unprognostic (1.21e-2)" "unprognostic (1.35e-2)" "unprognostic (3.02e-2)" "unprognostic (3.89e-3)" "unprognostic (2.77e-2)" "unprognostic (6.66e-3)" "unprognostic (1.05e-1)" "unprognostic (3.34e-3)" "unprognostic (9.20e-2)" "unprognostic (4.72e-2)" "unprognostic (3.49e-4)" "unprognostic (5.91e-2)" "unprognostic (1.85e-1)" "unprognostic (1.48e-2)" "unprognostic (9.37e-3)" 3.5 6.9 20.8 1.3 20.4 0.0 0.8 18.5 28.5 4.6 2.5 36.8 3.4 7.8 3.6 11.2 4.1 3.4 0.5 28.4 71.9 0.5 0.0 2.3 0.1 21.8 21.3 7.9 0.2 12.7 2.2 0.1 36.8 22.3 9.6 10.2 0.5 50.9 0.8 0.6 7.2 10.3 15.6 0.8 5.2 1.4 47.5 0.2 0.8 2.5 0.3 9.7 4.4 13.5 0.0 0.0 5.4 0.0 3.9 10.1 0.0 1.1 0.7 0.4 0.2 0.0 0.0 0.0 0.1 3.2 0.0 0.0 3.4 0.0 1.0 0.0 0.2 0.0 0.1 0.0 1.2 0.0 0.0 3.5 0.0 1.9 0.0 7.5 52.5 0.0 0.0 0.1 6.6 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.3 13.2 0.0 0.0 0.0 1.3 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.8 20.4 18.5 28.5 28.4 71.9 21.8 21.3 36.8 15.6 47.5 13.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 7.4 0.4 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.2 0.0 6.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 37.5 0.0 0.0 TMEM82 ENSG00000162460 "Transmembrane protein 82" A0PJX8 1 15742499-15747982 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 24.4;kidney: 11.5;liver: 52.7" "Cell type enhanced" "Detected in some" "Distal enterocytes: 42.8;Hepatocytes: 49.3;Paneth cells: 60.2;Proximal enterocytes: 173.6;Proximal tubular cells: 53.3" "Cancer enhanced" "Detected in some" "liver cancer: 10.2;renal cancer: 5.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "CACO-2: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA060282 Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 39: CACO-2 - Unknown function" "Cluster 45: Enterocytes - Digestion" Nucleoplasm Cytosol "HPA060282: AB_2684241" "unprognostic (2.46e-2)" "unprognostic (7.96e-2)" "unprognostic (4.88e-2)" "unprognostic (1.40e-2)" "unprognostic (6.45e-2)" "unprognostic (6.90e-2)" "unprognostic (4.80e-2)" "prognostic favorable (3.80e-7)" "unprognostic (1.41e-1)" "unprognostic (5.80e-2)" "unprognostic (4.75e-2)" "unprognostic (1.09e-1)" 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.6 24.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.5 52.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.0 1.6 0.0 42.8 7.9 0.0 0.0 0.0 0.0 0.0 2.4 2.7 0.0 0.2 2.9 0.0 1.5 0.1 0.0 0.0 0.4 49.3 0.1 0.0 0.0 9.2 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 60.2 0.0 0.0 0.0 173.6 53.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.0 12.5 0.0 TMIE DFNB6 ENSG00000181585 "Transmembrane inner ear" Q8NEW7 3 46694528-46710886 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.6;choroid plexus: 10.5;pituitary gland: 9.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 3.8;Spermatocytes: 2.6;Spermatogonia: 3.2" "Cancer enriched" "Detected in many" 5 "glioma: 6.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive CD4 T-cell: 2.4" "Lineage enriched" "Detected in single" 15 "T-cells: 2.4" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.1;EFO-21: 2.7;JURKAT: 10.7;SH-SY5Y: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038298 Uncertain Uncertain Vesicles,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 56: Bipolar cells - Visual perception" "Vesicles, Cytosol" "HPA038298: AB_10675792" "unprognostic (6.59e-2)" "unprognostic (1.11e-1)" "unprognostic (7.25e-3)" "unprognostic (2.48e-3)" "unprognostic (1.88e-2)" "unprognostic (5.40e-3)" "unprognostic (3.94e-2)" "unprognostic (8.80e-2)" "unprognostic (3.37e-2)" "unprognostic (6.65e-2)" "unprognostic (1.97e-1)" "unprognostic (5.35e-2)" "unprognostic (4.58e-2)" "unprognostic (1.23e-1)" "unprognostic (4.41e-2)" "unprognostic (5.29e-2)" "unprognostic (6.78e-2)" 0.7 6.2 14.2 0.5 14.1 0.0 0.4 14.0 18.0 0.7 10.5 1.0 0.4 0.5 0.7 1.5 0.6 0.2 0.7 14.1 19.3 2.3 0.8 1.0 0.8 19.6 15.7 1.5 0.2 0.1 9.9 0.4 19.2 0.5 0.3 0.7 0.5 1.0 3.6 0.7 0.5 0.4 16.0 0.7 0.3 1.5 18.7 0.5 0.9 1.2 0.8 0.6 0.9 14.9 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 3.1 0.0 2.7 0.0 0.5 0.1 0.1 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.8 0.0 0.0 0.0 1.8 0.0 1.2 0.0 0.5 10.7 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.7 0.1 1.2 0.0 0.3 0.1 0.1 0.3 2.3 0.3 0.3 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.1 0.0 2.4 0.4 0.0 0.0 0.0 0.0 0.4 0.4 14.2 14.1 14.0 18.0 14.1 19.3 19.6 15.7 19.2 16.0 18.7 14.9 1.9 0.0 0.0 0.3 0.0 0.8 0.2 0.5 0.0 3.8 0.2 0.6 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.9 0.4 0.5 0.2 0.0 0.7 0.0 0.0 1.7 0.4 0.1 0.4 0.0 0.1 0.0 0.1 0.4 0.1 0.6 0.0 0.8 0.0 0.0 0.0 0.4 1.5 0.6 0.3 0.0 1.9 0.1 1.4 0.0 0.0 0.3 1.2 0.0 0.4 0.0 0.3 0.0 0.0 0.6 0.5 0.0 1.1 1.0 2.6 3.2 0.0 0.9 0.1 0.2 0.1 0.0 0.2 TNFRSF11A "CD265, FEO, LOH18CR1, PDB2, RANK" ENSG00000141655 "TNF receptor superfamily member 11a" Q9Y6Q6 18 62325287-62391288 "CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Deafness, Disease variant, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 30.5;salivary gland: 25.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 35.6;Intestinal goblet cells: 24.0;Paneth cells: 42.3;Proximal enterocytes: 25.5;Undifferentiated cells: 42.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 8 "NK-cell: 5.3" "Lineage enriched" "Detected in single" 8 "NK-cells: 5.3" "Cell line enriched" "Detected in many" 6 "HDLM-2: 125.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB010391, HPA047976" Approved Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 110000 "Cluster 48: NK-cells - Unknown function" "Cluster 56: Intestine - Transmembrane transport" "Cluster 44: HDLM-2 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane" Cytosol "CAB010391: AB_2205352, HPA047976: AB_2680227" "unprognostic (4.08e-1)" "unprognostic (2.71e-1)" "unprognostic (3.23e-3)" "unprognostic (1.73e-1)" "unprognostic (6.03e-2)" "unprognostic (1.35e-1)" "unprognostic (9.96e-4)" "unprognostic (4.24e-3)" "unprognostic (7.79e-4)" "unprognostic (1.52e-1)" "unprognostic (4.05e-2)" "unprognostic (2.88e-1)" "unprognostic (4.69e-5)" "unprognostic (1.56e-1)" "unprognostic (1.78e-1)" "unprognostic (4.02e-2)" "unprognostic (7.07e-2)" 1.8 1.1 0.8 5.7 1.6 0.4 4.1 0.1 1.9 1.4 0.3 17.1 30.5 0.9 0.3 2.8 0.9 7.6 0.6 2.0 1.1 0.4 0.6 1.0 1.2 0.7 1.1 0.4 1.7 0.9 6.8 3.2 0.2 1.3 17.6 0.2 25.4 2.7 0.3 2.7 18.6 1.7 0.7 0.8 5.5 0.9 1.2 1.0 1.2 0.1 1.9 1.6 1.6 2.1 3.2 2.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 1.6 0.4 0.6 0.0 3.5 0.4 1.4 2.2 8.3 0.9 0.2 125.9 5.4 0.0 1.3 1.7 0.0 0.5 1.3 0.2 0.4 0.8 3.1 4.2 3.1 0.3 0.0 0.0 0.0 1.1 0.0 0.1 5.9 7.0 19.3 0.4 0.0 0.6 1.5 1.5 20.4 0.7 0.6 3.0 0.1 0.8 1.3 0.4 2.0 0.0 0.1 0.1 0.0 1.2 0.0 0.1 0.3 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 5.3 0.0 0.3 0.6 0.0 0.8 1.6 0.1 1.9 2.0 1.1 0.7 1.1 0.2 0.7 1.2 2.1 0.4 0.0 2.2 0.0 0.4 1.3 3.8 1.1 0.6 0.6 4.5 3.3 1.3 8.6 2.3 0.0 0.0 0.1 3.3 35.6 0.0 8.3 0.3 3.2 0.5 5.3 10.8 0.0 4.0 7.5 0.6 0.7 11.7 6.2 0.0 2.0 7.1 0.3 15.5 3.3 0.2 24.0 0.0 17.0 2.4 0.4 0.6 7.7 1.8 8.4 19.7 0.0 3.1 0.5 0.4 14.7 42.3 0.0 0.5 2.8 25.5 0.0 3.8 0.2 0.0 0.5 0.4 0.8 1.9 1.7 2.3 0.1 0.7 0.0 42.2 4.4 TOR1B "DQ1, MGC4386" ENSG00000136816 "Torsin family 1 member B" O14657 9 129803157-129811281 "Predicted intracellular proteins" "Chaperone, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013403, HPA013697, CAB022709" Approved Uncertain "Nuclear speckles,Cytosol" "Intracellular and membrane" NA NA 140000 "Cluster 5: Granulocytes - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Nuclear speckles" Cytosol "CAB022709: , HPA013403: AB_1858195, HPA013697: AB_1858196" "unprognostic (2.91e-3)" "unprognostic (1.73e-1)" "unprognostic (1.14e-1)" "unprognostic (8.55e-2)" "unprognostic (3.23e-1)" "unprognostic (3.72e-2)" "unprognostic (1.75e-1)" "unprognostic (5.73e-3)" "unprognostic (1.95e-1)" "unprognostic (7.47e-2)" "unprognostic (1.40e-1)" "unprognostic (2.13e-2)" "unprognostic (2.07e-3)" "unprognostic (4.09e-2)" "unprognostic (1.23e-1)" "unprognostic (5.40e-3)" "unprognostic (1.69e-3)" 11.1 10.0 8.6 13.1 8.4 14.3 8.7 12.0 8.7 8.4 9.5 20.3 11.3 9.1 7.0 10.3 7.7 13.3 8.9 8.2 9.2 8.6 18.5 11.7 11.0 8.8 8.6 7.5 12.6 11.7 7.3 14.2 8.7 11.0 22.6 5.9 10.3 9.2 10.6 11.8 14.1 12.6 8.6 9.3 11.9 10.2 9.5 10.7 10.7 9.9 9.4 15.8 8.5 8.4 11.7 26.5 10.9 29.0 53.2 39.4 25.0 40.8 26.7 27.6 27.2 22.0 26.1 8.3 25.2 40.7 43.0 46.4 11.9 16.9 28.2 30.4 12.3 7.2 21.5 15.8 22.8 13.8 31.1 22.6 29.3 39.6 19.4 20.4 24.9 21.5 25.6 18.8 26.2 32.9 19.2 21.8 22.9 54.8 20.1 7.8 18.9 25.3 21.3 12.1 15.0 17.2 26.0 30.4 16.6 19.5 43.7 13.5 22.7 51.9 24.5 62.4 35.7 13.6 53.9 7.0 28.6 17.9 36.0 8.7 13.3 20.2 12.6 16.0 13.0 4.0 10.0 11.2 6.9 4.7 7.3 7.3 16.4 8.8 10.1 4.2 10.5 9.9 8.6 8.4 12.0 8.7 8.2 9.2 8.8 8.6 8.7 8.6 9.5 8.4 9.5 9.6 2.4 6.5 11.7 6.5 5.9 7.3 12.5 2.7 6.9 5.6 5.5 5.7 6.1 5.5 4.2 10.8 16.1 15.3 0.0 9.7 13.3 5.0 6.7 8.2 19.2 3.4 13.9 13.7 17.7 10.5 17.9 5.7 4.5 4.0 9.7 13.3 12.0 6.7 15.6 16.2 4.1 5.4 5.0 15.1 4.4 12.1 3.6 4.7 12.3 4.7 16.5 14.6 10.5 12.6 6.7 5.7 14.5 10.1 10.7 3.7 9.4 2.7 19.7 6.8 13.0 22.7 5.4 10.4 5.4 15.2 12.2 4.6 10.5 11.2 TPH1 "TPH, TPRH" ENSG00000129167 "Tryptophan hydroxylase 1" P17752 11 18017564-18042426 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Serotonin biosynthesis" "Monooxygenase, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.0;intestine: 19.3;stomach 1: 15.0" "Cell type enriched" "Detected in many" 30 "Enteroendocrine cells: 1466.7" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.4" "Group enriched" "Detected in some" 5 "hypothalamus: 3.4;midbrain: 9.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 1.5" "Low region specificity" "Detected in some" "CAB010767, HPA022483" Uncertain Uncertain Cytosol NA NA "Cluster 9: Intestine - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 17: Intestinal endocrine cells - Hormone signaling" Cytosol "CAB010767: AB_261587, HPA022483: AB_1858378" "unprognostic (2.14e-4)" "unprognostic (9.97e-2)" "unprognostic (6.92e-2)" "unprognostic (6.78e-2)" "unprognostic (1.55e-1)" "unprognostic (6.26e-5)" "unprognostic (1.73e-1)" "unprognostic (5.33e-2)" "unprognostic (1.60e-1)" "unprognostic (2.12e-2)" "unprognostic (1.19e-4)" "unprognostic (6.72e-2)" "unprognostic (5.40e-8)" "unprognostic (3.76e-2)" "unprognostic (7.42e-2)" "unprognostic (3.10e-1)" "unprognostic (2.46e-5)" 0.6 0.1 0.2 1.2 0.3 1.1 1.3 0.3 0.3 0.6 4.7 9.0 10.2 0.9 0.9 0.2 0.9 0.1 0.3 0.4 3.4 0.5 0.2 0.8 0.5 0.2 9.0 0.7 0.5 0.1 3.0 0.2 1.1 1.4 19.3 1.8 0.5 0.1 0.4 1.4 11.2 0.2 0.2 0.7 15.0 0.9 0.4 0.3 0.5 0.1 0.7 0.4 0.4 0.3 0.1 0.0 0.5 0.4 0.0 0.0 0.2 0.1 0.1 0.0 0.3 0.6 0.0 0.4 0.1 0.0 0.0 0.2 0.1 0.5 0.2 0.4 1.0 0.7 0.3 1.1 0.0 1.5 0.3 0.0 0.6 0.0 0.2 0.1 0.2 0.8 0.3 0.2 0.0 0.1 0.3 0.2 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.3 0.4 0.3 0.0 0.1 0.2 0.0 0.0 0.9 0.0 0.1 0.4 0.1 0.5 0.0 0.1 0.3 0.0 0.3 0.4 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.3 0.3 0.3 0.4 3.4 0.2 9.0 1.1 0.2 0.4 0.3 1.4 0.0 0.0 1.0 1.1 0.4 0.4 0.5 0.0 14.9 1.9 1.0 0.8 0.0 0.1 5.5 2.1 0.2 0.6 1.7 0.0 0.2 0.8 0.1 0.6 0.7 1466.7 0.4 0.5 0.6 0.0 1.2 2.0 0.2 0.0 5.6 0.4 0.2 0.2 1.7 0.4 48.2 0.0 0.3 1.4 0.8 0.9 0.5 0.0 0.0 0.1 1.4 1.0 0.0 0.6 0.4 13.4 1.2 0.3 2.3 1.5 0.3 0.9 5.6 6.6 1.3 1.3 2.8 3.7 0.0 1.4 0.0 1.2 0.0 2.7 0.4 TRIM60 "FLJ35882, RNF129, RNF33" ENSG00000176979 "Tripartite motif containing 60" Q495X7 4 165016458-165041749 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "placenta: 1.5;testis: 1.5" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 5.1;Early spermatids: 3.0;Extravillous trophoblasts: 10.6;Spermatocytes: 9.6;Spermatogonia: 8.2;Syncytiotrophoblasts: 5.6" "Cancer enriched" "Detected in single" 103 "testis cancer: 5.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "BEWO: 14.2" "Not detected" "Not detected" "HPA035809, HPA035810, HPA061496" Uncertain Uncertain Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 28: Placenta - Pregnancy" "Cluster 28: BEWO - Transcription regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoli "Nucleoplasm, Cytosol" "HPA035809: AB_2674794, HPA035810: AB_10601827, HPA061496: AB_2684540" "unprognostic (1.10e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.3 0.2 0.3 0.2 0.3 0.0 0.4 0.5 0.9 0.7 0.0 0.1 0.0 0.0 5.1 0.6 0.0 0.0 0.0 3.0 0.8 0.9 0.7 0.0 0.0 0.2 0.0 10.6 0.3 0.0 1.5 0.0 0.2 0.0 1.1 0.5 0.0 0.3 0.0 0.0 1.3 0.0 0.5 0.9 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.4 0.7 0.3 0.0 0.1 0.8 0.5 0.0 0.0 0.3 9.6 8.2 0.0 0.3 5.6 0.7 0.2 0.0 0.1 TRIM73 TRIM50B ENSG00000178809 "Tripartite motif containing 73" Q86UV7 7 75395063-75410996 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 21.6" "Cell type enhanced" "Detected in many" "Granulosa cells: 41.9;Horizontal cells: 32.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 6.0;Hep G2: 10.5" "HPA047843, HPA051845" Uncertain Uncertain Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA047843: AB_2680176, HPA051845: AB_2681635" "unprognostic (1.01e-2)" "unprognostic (9.85e-5)" "unprognostic (4.72e-3)" "unprognostic (9.44e-3)" "unprognostic (2.49e-1)" "unprognostic (1.48e-2)" "unprognostic (1.25e-3)" "unprognostic (9.17e-3)" "unprognostic (1.41e-1)" "unprognostic (2.80e-1)" "unprognostic (5.46e-3)" "unprognostic (6.79e-2)" "unprognostic (4.18e-2)" "unprognostic (9.67e-2)" "unprognostic (1.15e-1)" "unprognostic (4.78e-2)" "unprognostic (2.73e-3)" 2.8 3.7 1.0 1.3 1.7 2.5 3.5 4.7 2.1 5.0 0.7 2.1 3.6 2.9 0.5 1.4 6.4 1.1 2.0 1.0 1.4 4.2 5.6 1.9 2.3 1.1 1.0 4.3 6.0 1.3 3.6 0.4 1.1 4.5 0.2 0.9 2.1 1.6 2.6 2.4 3.3 0.2 0.8 3.2 21.6 11.3 1.3 1.1 4.6 0.4 0.4 2.2 3.1 1.8 1.0 3.2 1.3 1.9 0.0 0.6 0.5 0.4 0.1 0.0 0.7 0.0 1.5 1.8 0.3 0.2 0.2 1.1 0.3 0.0 0.1 4.1 6.0 1.1 2.8 10.5 0.6 0.6 4.2 1.7 0.0 0.2 0.3 0.9 0.0 2.5 0.6 4.9 0.0 0.7 1.7 2.1 0.1 0.3 1.0 2.8 0.2 0.9 0.3 0.0 1.6 1.2 2.0 0.7 1.9 0.5 0.5 1.9 1.2 0.9 1.4 1.3 0.8 2.3 1.4 1.8 1.2 2.6 1.1 0.2 0.1 0.1 0.3 0.1 0.2 0.2 0.2 0.0 0.0 0.2 0.3 0.2 0.3 0.3 0.0 0.2 0.3 0.2 1.0 1.7 4.7 2.1 1.0 1.4 1.1 1.0 1.1 0.8 1.3 1.8 3.8 0.0 0.5 0.0 15.5 0.9 3.2 3.1 4.6 21.9 5.1 4.2 2.5 1.5 3.3 5.5 18.8 2.1 8.7 1.6 5.9 1.8 5.9 9.2 13.4 2.8 4.9 3.4 0.1 4.7 0.7 4.7 16.8 5.6 0.0 41.9 2.9 3.0 3.0 32.0 0.1 3.2 4.1 2.4 1.2 11.4 6.5 3.1 1.8 0.0 2.5 5.8 9.2 0.0 0.1 2.9 4.0 3.8 11.2 3.3 10.0 4.7 5.4 14.5 0.0 14.6 4.1 9.1 2.5 3.3 2.0 1.1 6.8 14.2 3.4 2.6 TRMT10A "MGC27034, RG9MTD2, TRM10" ENSG00000145331 "TRNA methyltransferase 10A" Q8TBZ6 4 99546709-99564039 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Methyltransferase, Transferase" "Diabetes mellitus, Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 99.5;Spermatogonia: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047601, HPA058241" Uncertain Supported "Nucleoplasm,Nucleoli,Actin filaments,Cytosol" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Nucleoli, Actin filaments" Cytosol "HPA047601: AB_2680099, HPA058241: AB_2683651" "unprognostic (5.24e-2)" "unprognostic (1.69e-1)" "unprognostic (1.34e-1)" "unprognostic (1.96e-3)" "unprognostic (2.10e-1)" "unprognostic (5.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.59e-2)" "unprognostic (3.65e-2)" "unprognostic (1.57e-1)" "unprognostic (3.51e-1)" "unprognostic (7.49e-3)" "unprognostic (3.32e-2)" "unprognostic (2.78e-2)" "prognostic unfavorable (2.14e-4)" "unprognostic (1.68e-2)" 4.3 3.7 2.0 3.1 2.6 2.2 4.4 2.6 2.9 1.9 1.5 3.6 4.3 2.7 3.9 3.6 5.8 3.4 2.3 1.8 2.5 4.9 9.8 2.4 4.4 2.6 2.5 3.3 5.9 3.7 2.3 3.7 2.9 4.1 3.6 2.8 3.9 2.2 3.9 3.7 4.5 2.7 2.7 3.5 4.4 9.9 2.4 4.3 6.1 2.7 4.4 2.9 2.0 4.3 8.2 5.4 10.1 5.7 6.0 8.4 7.8 9.6 3.7 5.8 4.1 4.9 9.4 10.9 3.7 5.6 5.9 4.4 10.9 5.1 8.6 13.7 5.4 8.0 4.4 7.6 5.5 19.6 7.8 5.4 14.4 5.7 14.0 3.0 6.4 10.0 17.5 9.4 4.5 9.4 16.4 3.5 6.5 13.8 5.0 9.5 10.2 7.2 8.5 6.8 6.3 5.8 5.3 28.3 9.9 8.5 9.3 7.8 4.9 6.9 7.2 5.5 11.1 7.0 12.4 10.0 4.9 10.9 4.7 2.7 3.9 2.1 1.8 3.8 1.7 3.5 3.3 3.3 5.2 5.8 3.5 3.2 4.9 3.3 3.4 3.0 3.9 1.9 2.0 2.6 2.6 2.9 1.8 2.5 2.6 2.5 2.9 2.7 2.4 4.3 7.2 3.2 10.3 8.8 8.7 8.2 5.6 8.4 10.2 4.3 12.1 8.6 6.4 11.5 6.6 11.0 4.2 16.8 6.1 10.6 43.0 13.8 46.8 33.5 12.1 7.2 7.2 2.1 5.3 19.3 16.4 6.9 8.6 21.6 8.2 11.0 8.2 32.6 8.5 5.0 4.6 11.1 12.2 8.1 4.1 17.0 6.5 5.0 5.4 1.9 8.4 8.7 5.2 3.5 19.7 14.1 11.0 7.5 10.4 4.8 19.0 31.9 20.6 5.9 13.1 5.7 8.1 99.5 55.0 10.2 9.5 17.5 5.5 8.1 10.6 6.6 TRMT61B FLJ20628 ENSG00000171103 "TRNA methyltransferase 61B" Q9BVS5 2 28849821-28870309 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026747, HPA026751" Enhanced Uncertain Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Cytosol "HPA026747: AB_1848782, HPA026751: AB_1848784" "unprognostic (1.01e-2)" "unprognostic (1.32e-2)" "unprognostic (1.63e-3)" "unprognostic (2.05e-2)" "unprognostic (3.32e-2)" "unprognostic (4.14e-2)" "prognostic unfavorable (3.61e-4)" "unprognostic (2.36e-2)" "unprognostic (2.55e-2)" "unprognostic (2.77e-1)" "unprognostic (2.52e-2)" "unprognostic (2.52e-2)" "prognostic favorable (9.61e-5)" "unprognostic (2.19e-1)" "unprognostic (1.43e-1)" "unprognostic (5.38e-2)" "unprognostic (2.34e-1)" 8.8 13.1 9.8 8.5 9.9 9.2 13.1 12.1 17.0 9.4 12.0 8.4 14.1 10.1 14.0 8.6 8.1 7.2 15.2 9.8 9.9 14.4 12.6 6.6 11.0 9.7 9.8 9.4 7.0 15.1 9.0 8.9 10.0 10.6 9.3 9.4 8.7 7.9 13.8 8.7 14.1 10.3 9.8 8.7 9.2 7.4 9.7 10.2 9.1 16.6 9.1 10.7 7.5 10.6 28.5 16.7 16.7 29.6 22.3 19.0 20.1 16.5 20.3 20.6 19.2 19.3 15.0 29.9 14.8 14.5 24.7 21.7 23.5 20.1 21.3 22.6 15.8 9.1 13.6 25.7 25.2 19.4 10.0 19.5 22.0 16.4 22.2 15.2 20.0 19.1 18.9 11.2 17.2 11.3 17.3 29.6 31.0 33.6 26.7 12.7 26.9 26.1 18.2 18.2 28.1 29.8 17.8 27.8 28.5 13.9 14.2 6.7 15.8 13.7 23.1 13.6 21.0 13.7 24.2 46.6 18.1 28.9 18.8 0.0 8.0 3.5 11.2 8.5 13.8 14.5 12.4 12.0 7.8 14.1 13.7 9.9 1.1 17.7 7.1 8.3 14.7 7.4 9.8 9.9 12.1 17.0 9.8 9.9 9.7 9.8 10.0 9.8 9.7 10.6 10.2 16.0 8.7 18.3 17.7 18.1 11.0 23.7 17.1 10.8 9.9 10.2 2.8 11.5 14.7 9.2 6.2 22.1 11.8 4.5 15.6 14.5 9.3 9.4 11.8 8.5 4.8 10.9 38.0 10.2 13.8 10.8 21.4 7.7 9.5 15.8 7.5 11.5 9.2 6.7 34.8 9.8 20.3 7.3 8.2 3.6 8.7 7.0 7.2 7.5 11.0 10.3 8.2 36.2 32.2 10.3 8.5 10.5 13.5 7.6 23.6 30.3 15.0 21.6 6.6 12.2 10.6 24.1 9.7 15.3 15.8 8.8 12.4 15.9 12.1 7.3 TSPAN15 "NET-7, TM4SF15" ENSG00000099282 "Tetraspanin 15" O95858 10 69451465-69507666 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 125.8;Ductal cells: 125.2;Exocrine glandular cells: 189.3;Pancreatic endocrine cells: 193.4;Paneth cells: 120.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "MAIT T-cell: 19.5" "Lineage enriched" "Detected in many" 6 "T-cells: 19.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 154.7;EFO-21: 211.3;MCF7: 168.0;OE19: 153.2;PC-3: 266.8;SK-BR-3: 134.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044657, HPA071160" Approved Approved "Nuclear bodies,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 38: EFO-21 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "Nuclear bodies, Plasma membrane" "Vesicles, Cytosol" "HPA044657: AB_10967927, HPA071160: " "unprognostic (2.03e-1)" "unprognostic (1.28e-1)" "unprognostic (1.43e-1)" "unprognostic (1.48e-2)" "unprognostic (9.44e-3)" "unprognostic (6.81e-3)" "prognostic unfavorable (8.00e-4)" "unprognostic (2.23e-1)" "unprognostic (3.65e-1)" "unprognostic (2.76e-1)" "unprognostic (8.22e-3)" "unprognostic (2.36e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (8.49e-2)" "unprognostic (4.66e-2)" "unprognostic (6.34e-2)" "unprognostic (3.78e-3)" 70.1 5.3 22.8 15.3 37.6 1.0 61.0 35.0 34.1 16.4 14.9 62.5 38.8 32.6 8.5 10.8 24.6 27.4 16.9 23.6 25.4 25.9 4.6 34.4 8.7 36.9 33.4 3.4 20.0 3.2 6.6 28.1 33.7 34.5 39.4 3.1 26.6 24.7 17.9 10.6 38.8 31.3 30.0 26.7 75.3 9.5 34.5 3.6 14.5 5.6 7.5 46.0 14.9 62.4 51.3 103.9 2.1 0.3 2.3 0.0 12.0 0.2 1.9 2.6 6.8 45.1 154.7 0.0 211.3 2.3 9.2 101.2 7.2 11.5 3.0 42.1 20.4 2.9 3.5 10.0 1.1 0.1 1.8 2.2 3.1 1.4 1.5 7.5 39.4 20.5 1.1 0.0 1.2 168.0 0.6 0.9 2.6 153.2 266.8 4.0 2.1 2.0 29.7 92.9 34.5 13.2 0.6 134.8 17.9 17.3 59.3 2.2 34.5 0.2 0.8 0.1 17.5 1.2 6.1 1.0 1.1 0.1 0.2 0.0 0.0 0.0 2.3 0.0 19.5 0.0 3.1 2.8 3.3 0.0 1.0 0.2 0.0 0.1 0.0 0.2 1.1 0.5 22.8 37.6 35.0 34.1 23.6 25.4 36.9 33.4 33.7 30.0 34.5 62.4 108.8 32.1 6.9 4.9 1.5 3.6 10.9 59.6 2.2 2.9 45.1 15.6 1.7 31.5 29.5 29.5 6.2 2.0 1.6 125.8 3.9 125.2 27.9 25.5 3.8 48.4 40.2 8.0 1.7 189.3 11.9 8.2 71.4 36.6 1.3 2.5 10.4 0.1 25.3 1.7 1.0 106.7 36.7 8.5 16.1 6.6 0.6 9.8 28.4 15.0 15.6 44.7 0.0 11.1 75.3 193.4 120.9 0.0 0.2 50.4 68.3 1.8 27.6 1.5 13.1 39.7 26.8 4.3 18.5 2.9 3.1 3.0 3.9 7.5 66.3 29.6 TSPO "BZRP, DBI, IBP, MBR, mDRC, PBR, pk18, PKBS" ENSG00000100300 "Translocator protein" "B1AH88, P30536" 22 43151547-43163242 "Cancer-related genes, FDA approved drug targets, Predicted membrane proteins" "Lipid transport, Transport" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 690.1" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 1429.2;Pancreatic endocrine cells: 1442.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 516.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011232, HPA046260, HPA072304" Uncertain Supported Vesicles,Mitochondria,Cytosol NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 16: Pancreatic endocrine cells - Mixed function" Mitochondria "Vesicles, Cytosol" "CAB011232: , HPA046260: , HPA072304: " "unprognostic (5.29e-3)" "unprognostic (1.41e-1)" "unprognostic (3.31e-1)" "unprognostic (4.02e-3)" "unprognostic (3.95e-1)" "unprognostic (1.46e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (2.16e-1)" "unprognostic (1.17e-1)" "unprognostic (3.75e-2)" "unprognostic (1.07e-2)" "unprognostic (1.33e-1)" "unprognostic (1.69e-1)" "unprognostic (1.53e-2)" "unprognostic (3.03e-1)" "unprognostic (1.04e-1)" "unprognostic (2.34e-3)" 249.3 164.5 42.3 65.3 46.3 488.7 204.3 50.9 61.1 217.3 45.8 189.7 73.6 91.8 8.7 690.1 108.5 39.4 174.7 39.9 51.0 120.5 81.9 181.5 44.3 61.9 48.8 72.3 93.4 22.4 50.8 30.5 57.4 126.6 33.9 4.2 244.9 28.9 84.0 388.0 116.9 26.6 58.0 206.9 216.9 21.4 59.5 22.2 77.4 27.5 39.9 135.7 355.5 69.0 300.0 143.3 10.2 134.4 54.7 175.3 10.8 216.6 107.0 109.4 115.7 28.8 222.4 0.3 147.8 175.7 52.2 242.2 27.9 171.7 13.9 49.5 111.4 28.9 150.4 10.1 193.4 66.4 145.0 137.5 276.4 65.9 58.2 125.8 262.9 0.2 24.0 53.6 114.2 244.5 1.1 188.5 11.6 154.0 355.7 67.0 0.0 516.2 139.3 173.8 14.0 65.4 103.9 200.4 263.5 0.1 76.3 256.6 269.7 132.6 96.9 135.5 92.9 21.7 4.1 2.7 170.0 218.3 171.4 656.8 1678.5 931.0 314.7 1051.6 247.7 199.2 429.9 309.2 1170.2 266.9 325.9 264.3 1052.3 365.0 713.1 209.0 539.5 1585.6 42.3 46.3 50.9 61.1 39.9 51.0 61.9 48.8 57.4 58.0 59.5 69.0 225.5 160.3 140.0 3.6 88.9 366.8 392.3 1429.2 554.3 2.8 269.3 360.2 92.1 323.1 555.7 206.0 2.1 10.0 140.3 680.7 369.8 578.5 2.4 170.8 143.6 220.4 194.9 239.9 0.3 586.4 284.9 205.1 440.9 309.5 268.6 124.3 187.1 110.5 758.5 3.3 0.8 636.8 478.1 644.7 524.7 11.7 82.6 611.6 723.9 10.3 776.9 180.5 207.0 6.0 20.1 1442.1 705.9 157.6 76.3 526.2 471.9 180.7 283.2 19.4 105.2 108.2 197.8 2.8 4.5 1067.4 536.0 20.0 180.0 30.5 664.1 786.1 TTC3 "DCRR1, RNF105, TPRD, TPRDI, TPRDII, TPRDIII" ENSG00000182670 "Tetratricopeptide repeat domain 3" P53804 21 37073226-37203112 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016810, HPA023964, HPA036304" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol No No "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Nucleoli" Cytosol "HPA016810: AB_1858434, HPA023964: AB_1858435, HPA036304: AB_2675049" "unprognostic (3.90e-2)" "unprognostic (1.65e-1)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "unprognostic (1.53e-1)" "unprognostic (1.37e-2)" "unprognostic (8.52e-2)" "unprognostic (9.29e-2)" "unprognostic (8.71e-2)" "unprognostic (1.61e-1)" "unprognostic (2.05e-2)" "unprognostic (1.99e-1)" "unprognostic (9.10e-2)" "unprognostic (1.02e-1)" "unprognostic (1.60e-1)" "unprognostic (1.39e-1)" "unprognostic (6.74e-2)" 45.8 29.3 28.1 27.1 25.0 26.4 43.1 36.3 35.3 59.3 45.7 34.6 24.7 38.9 58.6 27.9 34.9 35.4 28.0 38.9 15.5 37.7 31.7 24.4 29.4 10.0 11.1 60.6 42.9 39.1 35.6 29.0 11.8 51.2 36.3 63.0 50.0 41.4 27.7 30.7 30.3 34.6 6.7 27.3 40.9 27.4 15.3 38.0 64.8 30.6 29.2 30.6 9.4 21.4 72.9 25.4 115.3 22.2 108.9 156.8 40.0 77.5 96.0 34.2 46.1 34.0 35.8 62.3 26.6 130.9 32.1 23.3 35.3 47.9 48.2 66.3 25.0 125.6 38.0 44.1 39.6 70.9 39.1 81.9 28.8 35.0 31.0 68.8 51.6 54.1 77.3 71.1 65.2 56.0 69.4 18.8 33.3 48.0 42.6 91.6 55.3 33.2 39.4 55.3 87.7 67.6 97.2 55.2 49.1 26.5 62.2 27.3 68.3 49.2 19.5 61.2 30.4 71.1 55.1 60.6 80.7 69.9 37.9 4.8 6.2 6.8 11.5 6.4 17.1 13.0 13.3 15.8 10.8 15.1 23.2 14.4 1.0 12.8 8.6 17.3 10.0 4.8 28.1 25.0 36.3 35.3 38.9 15.5 10.0 11.1 11.8 6.7 15.3 21.4 78.3 125.0 142.7 161.3 144.8 65.9 94.8 102.7 86.0 347.7 175.8 140.1 134.7 68.6 118.2 75.4 227.2 50.1 129.5 67.8 166.3 91.1 192.7 115.0 217.4 78.9 190.2 65.4 424.5 75.3 93.5 171.0 131.5 132.0 64.6 256.8 99.6 94.4 61.4 329.7 396.0 163.1 99.7 95.2 83.7 192.4 210.0 86.8 211.7 111.5 87.4 196.5 93.7 321.7 261.9 73.3 96.5 261.1 167.6 121.4 72.8 96.1 108.6 233.9 52.6 245.8 127.9 400.0 258.4 91.7 62.8 52.7 109.7 204.1 148.1 103.9 TXNRD2 "SELZ, TR, TR3, TRXR2" ENSG00000184470 "Thioredoxin reductase 2" Q9NNW7 22 19875517-19941820 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2 OS: 139.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002007, HPA003323" Supported Approved Mitochondria,Cytosol NA NA 2800000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 1: K-562 - Erythropoiesis" "Cluster 47: Cytotrophoblasts - Unknown function" "Mitochondria, Cytosol" "CAB002007: , HPA003323: AB_1080396" "unprognostic (3.17e-2)" "unprognostic (8.72e-2)" "unprognostic (4.30e-1)" "unprognostic (9.71e-3)" "unprognostic (7.25e-2)" "unprognostic (6.35e-2)" "unprognostic (3.21e-1)" "unprognostic (1.12e-1)" "unprognostic (2.78e-1)" "unprognostic (2.83e-1)" "unprognostic (4.94e-3)" "unprognostic (2.49e-1)" "prognostic favorable (1.10e-7)" "unprognostic (2.47e-1)" "unprognostic (5.99e-2)" "unprognostic (1.69e-1)" "unprognostic (1.10e-1)" 10.5 44.4 11.9 8.9 12.0 14.5 12.3 18.1 19.3 11.7 21.2 14.9 10.3 10.6 6.2 10.2 10.6 6.2 30.0 12.9 11.9 24.8 65.4 13.6 9.1 11.8 12.1 16.5 15.9 13.5 14.4 9.8 11.5 26.8 4.6 4.4 15.4 8.2 23.0 10.9 12.0 5.1 11.3 16.9 26.4 14.6 12.4 4.9 15.2 16.1 6.1 11.8 10.4 11.8 19.4 39.2 3.5 14.9 6.9 9.6 8.8 18.8 21.1 31.8 23.4 36.7 19.4 10.9 43.2 19.0 32.7 33.2 17.8 25.2 12.1 21.6 46.5 18.8 34.4 22.4 12.9 21.1 8.4 9.2 18.5 16.2 13.8 12.9 91.3 2.2 106.4 17.4 24.8 47.1 7.2 30.1 17.7 46.9 27.6 10.5 85.2 10.0 19.3 21.0 19.1 16.4 32.0 39.9 21.8 5.8 33.7 27.6 52.2 23.0 139.5 19.8 38.4 17.6 14.0 6.9 22.4 15.5 30.3 2.7 10.5 5.8 3.5 8.2 2.6 3.9 3.0 3.2 7.8 2.6 3.9 3.2 0.9 3.8 7.9 2.9 2.1 4.6 11.9 12.0 18.1 19.3 12.9 11.9 11.8 12.1 11.5 11.3 12.4 11.8 5.6 16.0 23.6 11.1 10.3 4.2 23.1 15.1 3.4 22.1 11.4 9.1 16.7 15.7 15.7 20.2 10.4 60.7 8.8 14.7 58.7 22.0 26.4 9.8 8.4 14.4 1.2 33.1 9.2 32.0 24.3 12.4 23.4 10.0 1.3 27.6 8.9 49.5 25.9 10.1 8.5 16.9 20.3 22.0 7.8 18.2 15.5 14.6 5.4 10.3 27.2 18.7 10.3 8.5 7.2 22.3 13.9 9.1 12.2 17.8 15.6 52.0 16.6 11.0 6.6 11.3 13.3 10.9 14.0 6.4 5.3 42.0 11.4 36.4 16.4 15.7 TYSND1 "MGC34695, NET41" ENSG00000156521 "Trypsin like peroxisomal matrix peptidase 1" Q2T9J0 10 70137981-70146700 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Early spermatids: 120.7;Late spermatids: 227.4;Spermatocytes: 124.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 27.5;PC-3: 41.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030304 Approved Uncertain Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Centrosome" Cytosol "HPA030304: AB_10670560" "unprognostic (4.75e-3)" "unprognostic (4.30e-2)" "unprognostic (2.44e-2)" "unprognostic (7.69e-2)" "unprognostic (1.84e-1)" "unprognostic (4.53e-2)" "unprognostic (2.02e-2)" "unprognostic (1.55e-1)" "unprognostic (1.33e-1)" "unprognostic (1.10e-1)" "unprognostic (1.59e-2)" "unprognostic (2.80e-1)" "unprognostic (1.37e-1)" "unprognostic (9.26e-3)" "unprognostic (1.91e-1)" "unprognostic (1.30e-1)" "unprognostic (1.69e-2)" 5.7 6.0 1.4 1.9 1.3 0.9 5.4 1.7 1.8 5.8 1.1 4.9 3.3 4.1 0.6 11.8 4.5 0.6 2.9 1.0 0.9 5.2 6.4 2.8 1.8 2.1 0.7 4.2 6.2 1.3 3.4 1.3 0.8 5.7 0.6 0.2 5.7 1.5 3.2 11.4 5.0 0.3 0.6 5.4 3.9 14.2 0.9 1.2 4.6 0.5 0.9 4.8 6.5 1.4 16.0 10.2 0.8 6.2 1.0 0.9 3.7 2.2 1.4 2.0 1.8 6.2 9.6 13.8 6.0 0.5 0.6 27.5 1.0 3.9 0.4 8.9 9.5 0.7 2.9 3.3 2.4 1.2 0.1 2.0 7.6 1.7 3.1 1.2 1.4 4.9 0.1 4.3 0.8 6.3 5.3 5.6 3.3 3.5 41.7 8.9 2.6 6.2 0.9 2.6 7.4 3.8 6.7 14.8 6.1 0.2 9.4 1.1 2.6 2.5 1.7 4.8 8.7 14.9 9.9 7.0 2.9 6.2 1.8 0.0 0.8 0.7 3.8 1.2 2.4 3.0 2.2 2.8 0.9 3.3 3.0 2.6 0.3 2.0 0.7 0.7 2.6 1.4 1.4 1.3 1.7 1.8 1.0 0.9 2.1 0.7 0.8 0.6 0.9 1.4 6.1 9.6 5.3 4.9 12.6 14.3 14.5 13.3 14.8 6.9 14.8 16.9 4.2 27.1 7.8 11.0 0.0 35.2 15.5 14.6 17.6 7.8 120.7 5.5 6.8 6.3 14.3 5.0 6.7 9.5 9.8 7.5 5.1 6.3 13.4 9.3 6.8 16.5 12.1 0.0 6.0 12.1 16.2 10.7 6.6 227.4 9.3 8.2 12.4 6.5 6.1 7.0 12.3 11.6 5.5 5.5 11.6 7.9 7.5 14.5 19.2 16.5 3.9 4.4 6.6 6.9 6.1 124.7 12.5 22.4 18.5 16.7 14.0 10.6 21.0 8.8 UBE2D3 UbcH5C ENSG00000109332 "Ubiquitin conjugating enzyme E2 D3" P61077 4 102794383-102868896 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003920 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 10: Non-specific - Unknown function" "Plasma membrane, Cytosol" "HPA003920: AB_1858519" "unprognostic (7.43e-2)" "unprognostic (3.19e-1)" "unprognostic (1.27e-2)" "unprognostic (5.78e-2)" "unprognostic (6.44e-2)" "unprognostic (4.96e-2)" "unprognostic (1.17e-1)" "unprognostic (8.44e-3)" "unprognostic (1.14e-1)" "unprognostic (1.95e-1)" "unprognostic (5.75e-2)" "unprognostic (3.31e-2)" "prognostic favorable (4.51e-4)" "unprognostic (5.08e-2)" "unprognostic (2.79e-1)" "unprognostic (4.54e-2)" "unprognostic (1.34e-2)" 182.7 171.7 85.7 172.0 92.6 478.3 141.9 101.1 120.6 127.1 93.4 154.9 154.0 125.3 113.8 173.4 125.9 142.5 149.4 92.1 103.9 172.2 251.4 175.3 189.6 102.5 96.0 131.5 154.2 133.5 98.4 159.0 99.8 106.8 144.4 129.0 116.7 102.1 243.6 136.4 158.3 129.9 101.4 149.5 144.4 127.0 95.6 198.5 159.2 197.9 197.0 185.6 128.0 113.7 301.6 169.1 275.4 223.4 286.2 408.0 235.9 301.2 395.1 260.1 243.6 257.4 416.4 319.3 190.6 304.4 336.8 168.6 294.7 400.8 352.5 299.6 149.8 292.0 165.8 209.6 300.3 415.5 240.4 314.0 247.9 288.6 398.9 334.3 343.4 258.7 372.9 316.4 350.9 243.1 613.4 235.1 200.2 341.0 167.1 318.4 269.9 231.5 261.5 283.7 275.6 232.1 183.5 464.8 349.6 318.2 193.0 241.0 318.4 270.0 231.1 179.2 276.3 277.9 389.8 491.3 288.2 227.2 297.0 614.9 253.7 394.0 163.5 256.0 216.3 165.9 203.4 194.4 217.6 139.2 205.8 190.5 817.2 215.7 271.9 149.8 229.6 422.1 85.7 92.6 101.1 120.6 92.1 103.9 102.5 96.0 99.8 101.4 95.6 113.7 303.4 166.7 193.1 98.9 291.7 844.0 693.9 408.2 233.9 133.7 251.5 166.9 229.8 193.0 242.3 139.8 125.1 311.5 317.4 336.1 547.8 361.0 779.4 257.1 246.7 344.0 240.8 348.7 159.7 382.2 561.6 286.0 202.3 371.3 224.9 154.8 193.1 235.7 392.9 122.8 145.8 283.8 303.2 403.0 825.6 635.1 164.7 415.1 357.5 111.5 399.4 160.0 280.2 104.5 185.0 454.4 347.2 149.0 296.4 612.3 335.8 428.8 242.4 170.6 105.2 270.6 531.9 217.2 180.7 258.2 813.3 638.4 382.5 172.3 268.2 784.3 UBE2L5 UBE2L5P ENSG00000236444 "Ubiquitin conjugating enzyme E2 L5" A0A1B0GUS4 13 30422488-30429758 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Ligase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 55 "testis: 46.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA045609, HPA062415" Approved Uncertain Nucleoplasm,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 83: Testis - Spermatogenesis" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoplasm, Cytosol" "HPA045609: AB_10961322, HPA062415: AB_2684756" "unprognostic (2.09e-1)" "unprognostic (1.18e-2)" "unprognostic (8.01e-3)" "unprognostic (6.41e-4)" "unprognostic (1.78e-1)" "unprognostic (7.13e-2)" "unprognostic (2.20e-1)" "unprognostic (1.65e-1)" "unprognostic (1.19e-1)" "unprognostic (6.49e-3)" "unprognostic (1.78e-1)" "unprognostic (8.00e-2)" "unprognostic (3.50e-2)" "unprognostic (9.37e-2)" "unprognostic (2.60e-1)" "unprognostic (2.44e-2)" "unprognostic (8.75e-2)" 0.5 0.2 0.2 0.2 0.1 0.3 0.4 0.4 0.4 0.4 0.0 0.3 0.2 0.8 0.2 0.2 0.5 0.1 0.2 0.2 0.0 0.1 0.2 0.2 0.3 0.0 0.0 0.2 0.2 0.0 0.2 0.1 0.0 0.4 0.1 0.2 0.2 0.2 0.4 0.7 0.2 0.4 0.0 0.2 0.2 46.5 0.0 0.2 0.2 0.0 0.2 0.3 0.3 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.2 0.2 0.1 0.1 0.0 0.0 0.4 0.5 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.5 0.0 0.1 0.1 0.1 0.1 0.2 0.0 0.3 0.1 0.2 0.0 0.4 0.2 0.3 0.2 0.7 0.2 0.6 0.2 0.3 0.3 0.4 0.2 0.3 0.4 0.4 0.3 0.3 0.4 0.7 0.2 0.1 0.4 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 UBE2R2 "CDC34B, FLJ20419, MGC10481, UBC3B" ENSG00000107341 "Ubiquitin conjugating enzyme E2 R2" Q712K3 9 33817160-33920399 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 311.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061000, HPA074334" Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 12: NES - Nervous system development" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Nucleoli" Cytosol "HPA061000: AB_2684408, HPA074334: " "unprognostic (1.51e-1)" "unprognostic (1.50e-1)" "unprognostic (7.08e-2)" "unprognostic (1.53e-1)" "unprognostic (6.55e-2)" "unprognostic (5.15e-2)" "prognostic unfavorable (4.37e-4)" "unprognostic (1.82e-3)" "unprognostic (4.61e-3)" "unprognostic (3.05e-3)" "unprognostic (2.22e-2)" "unprognostic (4.19e-1)" "unprognostic (2.01e-2)" "unprognostic (4.18e-2)" "unprognostic (1.22e-1)" "unprognostic (5.72e-2)" "unprognostic (1.43e-1)" 32.0 20.6 25.4 20.2 27.3 15.4 27.1 24.8 28.0 30.8 20.8 31.4 28.0 28.5 16.3 29.2 23.9 18.6 32.4 24.8 24.6 22.1 33.3 28.2 21.7 27.2 25.8 30.1 53.4 14.5 15.0 23.9 26.7 20.9 19.6 25.0 21.5 18.4 63.1 34.5 24.8 25.9 24.5 23.1 22.1 44.8 25.0 30.1 18.3 44.8 25.4 26.6 28.7 30.2 41.2 42.0 78.7 35.0 42.0 68.2 25.1 34.7 46.5 38.7 38.3 34.0 28.7 33.9 14.4 47.2 28.3 17.8 41.5 38.5 41.8 58.3 22.7 28.7 43.7 43.3 60.1 34.6 31.0 58.4 55.6 31.8 59.2 61.5 65.8 39.8 28.0 35.0 38.7 22.6 68.0 91.4 46.2 33.1 34.7 63.2 24.0 17.6 41.1 28.9 37.6 45.4 40.1 35.2 27.0 49.5 31.3 41.9 50.3 37.8 35.4 26.8 32.9 23.5 23.0 46.5 36.0 19.7 83.5 22.6 10.9 6.3 2.8 11.1 1.7 4.6 2.6 2.2 6.1 4.8 2.5 2.3 31.7 7.4 18.7 3.7 3.3 4.0 25.4 27.3 24.8 28.0 24.8 24.6 27.2 25.8 26.7 24.5 25.0 30.2 73.7 22.4 30.7 39.8 38.6 105.5 46.3 26.1 32.5 65.8 57.8 60.8 134.8 57.2 26.8 22.0 14.6 69.5 46.4 64.7 15.6 49.7 311.1 65.7 84.9 74.9 72.0 36.6 67.8 69.4 82.0 57.4 25.5 81.8 13.3 99.2 84.9 88.3 76.6 60.6 67.0 55.4 32.6 123.5 112.2 257.4 67.1 110.6 35.6 40.3 116.4 124.3 42.2 45.2 127.8 84.7 49.1 76.0 24.0 83.9 79.1 59.8 25.0 31.2 59.2 48.3 55.6 94.4 64.6 41.8 120.5 82.8 34.9 68.0 48.7 121.2 UGGT1 "HUGT1, UGCGL1" ENSG00000136731 "UDP-glucose glycoprotein glucosyltransferase 1" Q9NYU2 2 128091200-128195677 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012761, HPA015127" Enhanced Uncertain Cytosol NA NA 4000000 "Cluster 24: B-cells - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 52: Non-specific - Transcription" Cytosol "HPA012761: AB_1858597, HPA015127: AB_1858596" "unprognostic (1.57e-1)" "unprognostic (1.80e-1)" "unprognostic (6.14e-2)" "unprognostic (1.87e-1)" "unprognostic (4.63e-2)" "unprognostic (6.45e-2)" "unprognostic (7.03e-3)" "unprognostic (3.13e-2)" "unprognostic (3.02e-2)" "unprognostic (1.05e-1)" "unprognostic (4.09e-3)" "unprognostic (7.05e-2)" "prognostic unfavorable (6.37e-4)" "unprognostic (3.86e-1)" "unprognostic (1.50e-1)" "unprognostic (2.23e-2)" "unprognostic (8.38e-3)" 8.1 8.5 4.2 13.7 4.6 21.8 7.6 4.8 6.5 9.1 5.0 12.4 9.0 7.3 19.9 8.0 6.5 6.5 8.0 4.3 4.6 8.2 14.9 8.4 12.3 4.7 4.4 5.1 14.8 8.7 6.5 8.7 5.0 8.7 10.0 9.7 8.6 6.2 13.2 8.8 10.2 6.2 4.0 9.4 10.7 6.4 4.8 11.7 10.4 13.0 12.6 7.5 6.6 5.6 34.8 11.8 22.0 47.6 28.0 22.3 34.3 39.4 16.7 12.7 11.3 26.0 24.9 49.4 15.4 28.3 11.3 25.3 16.8 16.8 25.5 31.5 8.2 43.4 14.9 82.3 28.0 58.6 25.9 16.3 13.0 25.4 23.0 25.0 29.8 19.8 28.4 25.6 26.9 24.4 23.5 33.5 39.5 24.0 12.4 19.2 21.3 20.9 23.8 25.2 11.7 17.4 27.3 36.0 24.4 22.5 14.4 40.2 43.1 34.6 24.4 20.1 28.4 27.3 40.4 22.3 29.3 31.4 32.6 3.8 2.5 2.5 2.3 2.5 2.3 1.6 1.9 2.1 1.9 3.3 1.6 2.3 3.7 1.9 2.5 3.1 1.6 1.4 4.2 4.6 4.8 6.5 4.3 4.6 4.7 4.4 5.0 4.0 4.8 5.6 14.6 35.3 24.7 24.8 14.3 8.2 6.4 11.1 5.7 19.8 11.2 7.1 16.7 12.8 20.7 3.7 22.9 10.5 22.1 21.5 1.9 14.0 9.2 18.4 27.7 16.5 22.8 31.5 40.6 19.5 20.1 16.6 21.9 22.2 11.4 20.8 17.9 39.7 16.6 20.2 37.6 21.9 8.2 25.4 16.4 2.3 14.9 20.0 14.2 32.8 26.0 7.5 15.5 31.2 46.5 19.4 10.4 13.5 31.5 13.3 25.3 8.4 12.7 20.2 6.6 18.5 13.3 10.0 8.5 9.4 10.7 10.8 18.9 16.0 22.8 10.1 UQCC3 "C11orf83, UNQ655" ENSG00000204922 "Ubiquinol-cytochrome c reductase complex assembly factor 3" Q6UW78 11 62670273-62673686 "Disease related genes, Human disease related genes, Predicted membrane proteins" "ATP synthesis" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 209.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 82.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046851 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Mitochondria" Cytosol "HPA046851: AB_2679839" "unprognostic (5.89e-2)" "unprognostic (1.95e-1)" "unprognostic (1.60e-1)" "unprognostic (3.42e-2)" "unprognostic (3.91e-1)" "unprognostic (7.41e-2)" "prognostic unfavorable (2.55e-4)" "unprognostic (2.18e-1)" "unprognostic (1.67e-1)" "unprognostic (8.70e-3)" "unprognostic (7.84e-2)" "unprognostic (8.96e-2)" "unprognostic (7.07e-2)" "unprognostic (7.21e-3)" "unprognostic (1.48e-1)" "unprognostic (3.20e-1)" "unprognostic (1.36e-1)" 7.5 12.2 7.4 3.7 7.5 5.7 7.5 8.2 9.7 7.6 9.3 9.9 8.1 6.5 1.7 12.3 6.1 1.2 10.2 7.1 7.1 10.7 11.9 4.7 4.2 7.6 7.3 6.5 9.0 3.5 6.7 2.2 7.7 9.4 1.9 3.9 11.5 3.3 15.7 9.0 8.3 1.5 7.0 7.4 9.6 3.4 7.4 2.4 6.3 5.0 1.6 6.3 8.1 8.1 26.9 52.9 7.7 12.0 4.7 4.6 6.5 10.4 3.5 7.7 7.6 31.4 22.8 17.4 21.1 3.6 10.4 26.1 7.4 12.3 2.4 8.8 27.4 9.8 28.7 20.3 6.3 16.0 7.6 4.4 10.3 6.8 7.6 4.8 6.0 8.1 21.3 12.2 4.3 82.4 15.7 39.2 8.6 10.6 29.8 17.9 11.7 31.1 6.1 13.2 15.5 15.7 11.5 41.7 16.2 2.4 39.7 14.9 7.9 16.8 19.7 17.6 23.6 18.7 11.0 18.3 13.8 13.7 12.3 14.6 25.0 20.1 21.3 19.1 20.4 30.8 21.1 19.0 20.0 29.9 19.2 15.3 11.0 19.6 17.2 26.7 25.8 20.0 7.4 7.5 8.2 9.7 7.1 7.1 7.6 7.3 7.7 7.0 7.4 8.1 49.0 44.8 25.0 3.6 32.3 0.0 42.2 0.0 47.3 21.8 77.5 86.4 35.8 70.1 16.1 64.4 16.7 53.1 22.9 65.2 140.8 56.6 1.7 50.3 40.6 32.9 35.2 32.2 2.4 78.4 53.1 32.4 54.6 41.1 5.1 28.0 44.6 125.4 54.8 18.5 4.2 75.2 0.0 39.7 0.0 3.7 48.4 29.2 0.0 7.5 47.2 59.7 66.9 5.0 5.2 67.4 66.9 36.1 38.4 85.1 209.3 170.6 12.4 37.0 39.5 28.3 31.8 4.2 32.0 91.0 0.0 29.0 25.3 35.1 79.0 57.0 USP26 ENSG00000134588 "Ubiquitin specific peptidase 26" Q9BXU7 X 133024631-133097109 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "Spermatogonia: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000424, HPA027310, HPA079124" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm Cytosol "HPA000424: , HPA027310: , HPA079124: " "unprognostic (7.92e-4)" "unprognostic (3.59e-2)" "unprognostic (1.99e-2)" "unprognostic (2.08e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 UTP14A "NY-CO-16, SDCCAG16, Utp14" ENSG00000156697 "UTP14A small subunit processome component" Q9BVJ6 X 129906121-129929761 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047217, HPA054023, CAB079950" Uncertain Supported Nucleoli,Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli Cytosol "CAB079950: , HPA047217: AB_2679987, HPA054023: AB_2682346" "unprognostic (6.75e-2)" "unprognostic (2.20e-1)" "unprognostic (1.10e-1)" "unprognostic (7.84e-3)" "unprognostic (2.95e-1)" "prognostic unfavorable (7.67e-4)" "unprognostic (3.00e-3)" "unprognostic (8.24e-2)" "unprognostic (4.09e-3)" "unprognostic (2.81e-1)" "unprognostic (2.28e-2)" "unprognostic (6.99e-3)" "prognostic unfavorable (8.12e-8)" "unprognostic (4.77e-2)" "unprognostic (1.13e-1)" "unprognostic (5.06e-2)" "unprognostic (9.99e-2)" 11.5 7.8 5.9 11.9 7.7 9.8 13.2 6.2 8.1 10.5 5.6 10.1 7.2 11.2 11.1 11.6 10.7 7.6 7.8 5.9 7.6 9.0 8.2 7.5 13.7 6.7 7.0 12.7 16.1 9.5 5.2 10.1 6.6 8.2 11.9 5.1 8.6 8.3 12.5 10.0 8.2 11.7 5.8 9.5 10.1 2.2 7.0 12.7 9.2 6.3 17.1 14.2 9.8 7.1 34.7 38.0 19.9 52.9 32.7 33.2 33.5 37.6 28.5 37.0 29.4 39.0 33.5 81.6 73.7 27.3 40.2 43.4 80.6 40.8 45.1 27.2 40.1 46.6 32.9 29.8 36.9 66.7 34.5 40.9 35.1 50.2 52.6 23.7 29.5 29.9 47.3 25.0 32.1 57.1 48.4 50.6 41.6 65.5 42.1 37.5 30.1 56.0 25.4 26.1 20.8 54.7 21.3 38.9 45.2 26.1 21.0 38.4 25.8 16.2 21.2 45.8 73.2 30.8 38.4 71.1 24.4 81.2 37.4 29.2 9.4 5.0 13.9 16.8 16.1 12.3 11.5 13.1 13.8 14.1 14.4 13.5 1.1 18.5 15.4 11.0 17.6 8.8 5.9 7.7 6.2 8.1 5.9 7.6 6.7 7.0 6.6 5.8 7.0 7.1 10.1 12.8 15.6 3.6 11.2 8.4 17.0 11.1 17.6 5.3 10.2 13.2 10.5 11.5 20.6 0.0 4.2 24.1 16.8 7.2 13.7 16.8 0.2 12.7 24.0 10.1 7.7 12.2 7.8 12.6 20.0 11.9 9.7 15.7 14.0 10.6 6.8 5.1 13.6 1.7 7.2 10.4 12.2 9.5 5.5 0.5 6.2 11.1 5.4 3.7 17.8 6.5 16.5 3.5 8.4 13.0 9.7 7.2 14.7 12.2 4.9 9.1 8.1 5.2 13.1 17.9 13.2 1.3 2.2 18.9 8.0 40.6 13.1 13.1 13.8 11.4 UTP14C "2700066J21Rik, KIAA0266" ENSG00000253797 "UTP14C small subunit processome component" Q5TAP6 13 52024691-52033600 "Predicted intracellular proteins" "Differentiation, Meiosis, Ribosome biogenesis, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.2;JURKAT: 2.2;MOLT-4: 1.3;NB-4: 5.7;RPTEC TERT1: 2.1;THP-1: 2.9" "HPA047217, HPA054023" Uncertain Approved Nucleoli,Cytosol NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 50: Fibroblasts - ECM organization" Nucleoli Cytosol "HPA047217: AB_2679987, HPA054023: AB_2682346" "unprognostic (7.89e-2)" "unprognostic (5.98e-2)" "unprognostic (4.47e-1)" "unprognostic (1.25e-1)" "unprognostic (2.33e-3)" "unprognostic (2.51e-1)" "unprognostic (2.02e-1)" "unprognostic (3.30e-1)" "unprognostic (7.16e-2)" "prognostic unfavorable (7.52e-4)" "unprognostic (7.35e-2)" "unprognostic (1.23e-1)" "prognostic favorable (1.46e-5)" "unprognostic (2.44e-2)" "unprognostic (3.43e-1)" "unprognostic (1.74e-1)" "unprognostic (3.04e-2)" 5.7 5.2 3.8 0.0 3.5 0.0 5.2 3.6 4.4 5.9 4.0 6.1 0.3 7.1 0.0 4.4 5.9 0.0 6.2 3.4 3.5 5.9 7.7 4.7 0.6 3.3 3.9 5.5 6.8 1.2 5.5 0.0 3.3 5.3 0.0 2.2 6.6 0.0 6.7 3.7 5.6 0.2 3.3 5.1 5.9 3.2 3.7 1.8 6.1 2.4 0.0 5.5 5.1 3.8 0.0 0.0 1.2 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.2 1.3 5.7 0.0 0.0 0.0 0.5 0.0 0.0 2.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 3.5 3.6 4.4 3.4 3.5 3.3 3.9 3.3 3.3 3.7 3.8 9.9 6.4 17.5 8.5 8.2 5.9 5.6 10.8 9.6 13.9 13.7 7.9 23.8 12.8 15.8 16.5 4.2 10.1 5.1 21.2 0.0 7.3 0.4 9.1 13.9 13.9 18.6 19.9 8.9 7.6 9.6 13.9 5.1 12.4 11.4 14.4 14.6 33.6 9.3 25.2 9.0 14.7 8.2 13.5 3.9 0.8 10.5 8.1 8.8 5.6 8.2 14.1 10.3 6.6 10.7 7.7 11.3 14.3 8.4 12.7 9.9 6.4 14.8 11.6 6.6 20.2 12.6 7.2 13.3 14.0 8.4 7.0 7.2 9.4 14.1 6.7 VENTX "HPX42B, VENTX2" ENSG00000151650 "VENT homeobox" O95231 10 133237855-133241928 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Kupffer cells: 6.2;Langerhans cells: 7.9;Macrophages: 7.8;monocytes: 5.0" "Cancer enriched" "Detected in some" 15 "testis cancer: 30.4" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 7 "dendritic cells: 1.8;granulocytes: 1.9;monocytes: 3.2" "Group enriched" "Detected in some" 10 "NB-4: 18.2;NTERA-2: 10.9" HPA050955 Uncertain Uncertain "Nucleoli fibrillar center,Cytosol" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 41: Macrophages - Immune response" "Nucleoli fibrillar center" Cytosol "HPA050955: AB_2681288" "unprognostic (9.41e-2)" "unprognostic (8.89e-2)" "unprognostic (2.34e-1)" "unprognostic (4.26e-1)" "unprognostic (3.22e-2)" "unprognostic (2.01e-1)" "unprognostic (2.54e-1)" "unprognostic (9.62e-3)" "unprognostic (2.22e-1)" "unprognostic (3.00e-3)" "unprognostic (3.70e-4)" "unprognostic (4.22e-1)" "unprognostic (2.51e-3)" "unprognostic (3.43e-2)" "unprognostic (3.48e-1)" "unprognostic (7.54e-2)" "unprognostic (3.14e-1)" 4.8 2.3 1.6 3.6 1.1 2.8 1.9 1.6 1.5 1.5 1.9 1.9 0.4 1.6 0.5 0.5 1.8 1.5 1.5 1.5 1.5 1.7 0.5 3.8 0.5 1.9 1.7 1.5 1.2 0.5 1.4 0.5 1.5 1.3 0.4 0.2 1.3 0.8 0.9 1.2 1.0 1.2 0.9 5.7 0.9 1.0 2.5 0.2 0.8 0.1 0.4 1.4 1.0 1.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 18.2 10.9 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 1.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 1.9 2.6 0.3 0.1 3.2 0.0 0.3 0.1 0.0 1.8 0.2 0.1 0.1 0.9 0.3 2.4 0.1 0.0 0.7 1.6 1.1 1.6 1.5 1.5 1.5 1.9 1.7 1.5 0.9 2.5 1.8 0.0 0.0 1.1 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 6.2 7.9 0.2 0.0 7.8 0.0 0.0 5.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 VPS50 "CCDC132, DKFZp313I2429, FLJ20097, KIAA1861, VPS54L" ENSG00000004766 "VPS50 subunit of EARP/GARPII complex" Q96JG6 7 93232340-93361123 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026679 Approved Uncertain "Plasma membrane,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Cytosol "Plasma membrane" "HPA026679: AB_1846135" "unprognostic (2.09e-1)" "unprognostic (1.44e-1)" "unprognostic (1.46e-1)" "unprognostic (3.12e-2)" "unprognostic (7.43e-2)" "unprognostic (4.97e-2)" "prognostic unfavorable (7.21e-5)" "unprognostic (1.05e-1)" "unprognostic (4.79e-2)" "unprognostic (1.37e-1)" "unprognostic (3.69e-1)" "unprognostic (5.17e-2)" "prognostic favorable (1.35e-6)" "unprognostic (2.08e-1)" "unprognostic (3.46e-2)" "unprognostic (1.18e-1)" "unprognostic (1.35e-1)" 7.4 9.0 4.2 3.4 4.6 2.6 8.2 5.7 5.3 7.3 4.6 8.9 1.9 8.2 4.2 9.2 6.8 2.7 7.7 4.4 4.0 7.1 6.1 6.1 4.9 4.1 4.0 7.6 7.8 6.0 7.7 4.8 4.2 6.4 5.2 5.1 8.8 3.2 12.0 8.8 8.2 3.5 4.2 9.5 7.8 6.5 3.8 4.3 7.3 4.9 4.8 7.9 7.8 5.0 6.5 2.2 2.6 5.0 8.2 7.9 6.3 5.5 5.0 9.1 6.1 5.5 9.0 5.5 5.1 4.2 13.6 3.6 10.4 7.0 11.3 5.8 4.6 14.6 3.1 2.4 4.9 3.4 4.5 3.8 8.7 9.9 9.5 5.9 11.5 3.9 10.2 8.2 11.3 4.7 5.3 4.6 6.2 8.7 5.9 3.5 6.3 8.1 5.1 2.9 3.7 7.8 4.8 13.5 4.4 7.5 6.3 2.8 5.8 12.4 4.4 16.3 4.5 3.3 8.0 9.1 6.9 6.1 6.8 3.1 3.2 2.1 2.6 3.5 4.6 2.4 2.7 2.7 4.5 2.4 2.0 2.5 1.1 1.4 2.5 2.8 2.9 2.0 4.2 4.6 5.7 5.3 4.4 4.0 4.1 4.0 4.2 4.2 3.8 5.0 10.9 12.8 11.3 0.0 13.5 0.0 3.4 0.0 6.8 14.1 11.7 6.3 0.0 2.8 5.0 5.5 16.7 7.5 11.0 5.5 3.9 6.2 27.9 7.6 10.8 7.9 2.4 10.8 0.0 5.5 11.7 6.4 11.2 8.2 7.6 12.6 9.7 6.1 10.7 10.1 0.0 7.1 0.0 13.7 0.0 14.2 9.0 10.0 0.0 0.0 9.4 10.3 6.2 0.0 0.0 6.9 9.4 7.2 10.2 2.7 6.1 8.3 5.8 14.3 6.6 11.2 6.3 18.1 12.8 7.9 0.0 9.4 8.5 13.9 5.1 2.8 VSIG4 "CRIg, Z39IG" ENSG00000155659 "V-set and immunoglobulin domain containing 4" Q9Y279 X 66021738-66040125 "Plasma proteins, Predicted membrane proteins" "Complement alternate pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 166.0" "Group enriched" "Detected in many" 5 "Hofbauer cells: 989.8;Kupffer cells: 590.9;Macrophages: 328.4" "Cancer enriched" "Detected in all" 5 "glioma: 88.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 27 "classical monocyte: 18.7;intermediate monocyte: 11.1;myeloid DC: 17.8" "Group enriched" "Detected in many" 31 "dendritic cells: 17.8;monocytes: 18.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA003903, CAB026000" Enhanced Uncertain "Nucleoli,Plasma membrane,Cytosol" NA NA 59000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 19: Lung - Lung function" "Cluster 4: Macrophages - Innate immune response" "Plasma membrane, Cytosol" Nucleoli "CAB026000: , HPA003903: AB_1858776" "unprognostic (6.87e-3)" "unprognostic (4.79e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (3.19e-1)" "unprognostic (1.30e-2)" "unprognostic (1.53e-2)" "unprognostic (9.37e-3)" "unprognostic (1.24e-1)" "unprognostic (3.10e-1)" "unprognostic (1.37e-3)" "unprognostic (1.06e-1)" "unprognostic (2.77e-1)" "prognostic unfavorable (1.95e-6)" "unprognostic (3.70e-2)" "unprognostic (5.45e-2)" "unprognostic (3.37e-2)" "unprognostic (3.47e-2)" 137.1 68.8 17.9 44.2 18.8 7.8 44.2 17.0 36.6 14.1 21.5 40.9 22.5 15.5 5.3 15.4 66.8 39.6 30.0 18.2 18.3 17.9 51.0 166.0 27.8 25.1 23.6 12.9 14.3 6.8 7.0 139.6 25.8 10.6 31.7 2.2 24.5 9.3 8.2 10.8 43.9 108.3 18.9 69.3 22.9 7.3 37.6 5.4 12.3 12.5 1.8 61.5 11.6 26.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 18.7 0.1 0.0 11.1 0.0 0.0 0.0 0.2 17.8 0.1 0.0 0.0 0.5 0.0 0.4 0.1 0.0 5.6 17.9 18.8 17.0 36.6 18.2 18.3 25.1 23.6 25.8 18.9 37.6 26.7 1.3 3.2 16.1 0.0 1.2 2.3 0.3 0.0 0.0 0.0 2.6 0.5 1.8 7.2 3.1 0.0 0.0 5.3 0.3 0.0 0.0 0.1 7.9 0.0 0.0 10.4 0.0 0.0 0.0 0.0 4.9 2.7 0.0 0.0 3.8 0.0 5.0 3.2 989.8 0.0 0.0 0.0 0.0 590.9 111.8 16.6 1.5 328.4 3.6 12.2 1.5 0.5 0.0 0.5 0.0 0.0 0.1 0.4 0.3 0.3 0.0 0.1 4.4 0.0 6.6 0.6 2.0 0.3 0.9 0.5 1.7 12.3 1.5 0.0 0.0 0.2 WASHC2A "bA56A21.1, bA98I6.1, FAM21A, FAM21B, FLJ10824" ENSG00000099290 "WASH complex subunit 2A" Q641Q2 10 50067888-50133509 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 38.5;Alveolar cells type 2: 28.5;Endometrial ciliated cells: 45.7;Respiratory ciliated cells: 41.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047844, HPA060975, HPA061022" Supported Supported Nucleoli,Vesicles,Cytosol NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 18: U-2197 - ECM organization" "Cluster 7: Non-specific - Mitochondria" Vesicles "Nucleoli, Cytosol" "HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656" "unprognostic (2.46e-1)" "unprognostic (1.11e-3)" "unprognostic (8.82e-2)" "unprognostic (3.28e-1)" "unprognostic (2.75e-1)" "unprognostic (6.51e-3)" "prognostic unfavorable (6.75e-5)" "unprognostic (4.60e-2)" "unprognostic (2.85e-2)" "unprognostic (2.37e-2)" "unprognostic (9.04e-2)" "unprognostic (2.73e-2)" "unprognostic (1.18e-1)" "unprognostic (2.57e-1)" "unprognostic (2.95e-1)" "unprognostic (1.85e-2)" "unprognostic (4.40e-2)" 25.3 25.9 19.9 22.1 20.7 37.5 24.0 23.4 24.8 24.7 18.3 28.9 25.2 22.5 19.2 20.2 19.7 18.0 58.6 19.9 19.9 22.9 15.5 26.0 28.8 21.1 21.2 26.7 17.7 23.3 21.5 22.9 21.1 20.6 28.9 19.9 21.9 20.0 22.3 25.7 28.9 21.2 18.6 26.6 21.5 12.5 22.6 24.2 23.3 15.6 26.9 23.8 22.1 23.9 26.1 12.5 21.1 24.3 83.2 46.0 16.9 29.8 64.0 43.7 46.6 28.8 37.8 22.5 18.1 44.8 41.3 28.0 31.2 25.3 43.2 22.2 22.0 15.9 25.6 29.7 58.6 28.0 27.2 47.8 31.2 47.6 30.5 46.2 33.1 19.2 26.6 22.2 53.9 19.1 15.5 48.0 17.1 16.7 58.4 23.1 30.1 13.7 30.5 29.3 7.3 22.4 27.8 25.9 40.9 30.9 31.6 19.2 49.4 22.0 18.5 62.7 25.0 23.4 48.3 19.1 48.9 51.4 9.0 1.0 9.1 9.9 9.1 11.6 10.1 5.1 8.0 8.8 7.3 4.9 7.7 6.0 4.1 8.2 6.9 4.6 9.2 7.9 19.9 20.7 23.4 24.8 19.9 19.9 21.1 21.2 21.1 18.6 22.6 23.9 16.2 38.5 28.5 0.0 3.3 0.0 0.0 0.0 0.0 0.0 10.6 11.0 0.0 0.0 22.9 14.7 0.0 7.4 10.0 0.0 0.0 16.7 0.0 45.7 19.9 7.9 0.0 0.0 0.0 15.6 6.9 8.9 0.0 20.3 15.2 13.5 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 5.7 0.0 0.0 0.0 0.0 15.1 0.0 0.0 2.6 0.0 0.0 11.7 41.5 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 7.7 7.8 9.4 0.0 0.0 WASHC2C "Em:AC012044.3, FAM21C, KIAA0592" ENSG00000172661 "WASH complex subunit 2C" Q9Y4E1 10 45727200-45792964 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 35.3;Alveolar cells type 2: 35.2;Collecting duct cells: 23.9;granulocytes: 30.3;Respiratory ciliated cells: 24.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047844, HPA060975, HPA061022" Supported Supported Nucleoli,Vesicles,Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 32: U-937 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" Vesicles "Nucleoli, Cytosol" "HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656" "unprognostic (7.50e-2)" "unprognostic (2.32e-2)" "unprognostic (1.13e-1)" "unprognostic (1.06e-1)" "unprognostic (4.51e-2)" "unprognostic (5.98e-3)" "prognostic unfavorable (1.35e-5)" "prognostic favorable (4.69e-4)" "unprognostic (1.26e-1)" "unprognostic (5.02e-2)" "unprognostic (1.00e-3)" "unprognostic (1.51e-1)" "unprognostic (2.24e-1)" "unprognostic (1.48e-1)" "unprognostic (1.09e-1)" "unprognostic (1.73e-1)" "unprognostic (2.00e-2)" 19.4 15.7 10.9 17.3 11.8 42.5 17.5 14.8 14.9 19.1 13.5 20.3 15.2 16.8 12.4 13.5 14.9 16.5 22.0 11.3 11.4 18.0 15.9 17.7 20.2 12.5 12.2 21.6 11.6 21.4 13.9 13.7 12.7 15.6 22.0 14.2 15.3 14.6 17.1 17.6 19.7 19.0 9.6 19.3 15.0 12.9 14.1 21.2 17.1 9.8 18.7 17.7 14.6 14.0 24.5 25.9 20.7 23.5 52.1 45.8 12.4 28.4 45.8 32.4 30.8 16.0 23.3 20.1 18.8 41.7 30.8 21.6 23.2 13.0 32.6 18.9 19.2 20.9 32.3 12.3 55.0 21.4 24.6 43.4 30.4 35.4 26.1 31.6 33.7 16.5 33.9 15.7 40.1 12.8 14.0 35.9 14.8 14.7 3.9 17.4 30.5 10.5 23.8 38.2 10.0 22.3 32.8 16.1 39.4 21.0 22.1 20.6 58.1 16.8 18.0 44.7 19.1 21.5 36.3 19.6 23.5 49.4 9.2 14.1 17.1 11.7 12.2 17.9 11.8 9.9 10.1 12.7 11.7 9.2 10.0 8.9 16.8 12.5 22.8 8.1 10.4 13.3 10.9 11.8 14.8 14.9 11.3 11.4 12.5 12.2 12.7 9.6 14.1 14.0 16.2 35.3 35.2 0.0 3.0 0.0 0.0 0.0 0.0 0.0 11.3 8.8 0.0 0.0 11.8 23.9 0.0 6.8 11.8 0.0 3.9 13.5 0.0 11.3 17.9 6.1 0.0 0.0 0.0 14.0 6.4 7.9 0.0 13.9 30.3 13.7 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 10.3 0.0 0.0 0.0 0.0 11.9 0.0 0.0 3.8 0.0 0.0 12.8 24.8 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 7.8 7.0 12.1 0.0 0.0 WEE2 "FLJ16107, WEE1B" ENSG00000214102 "WEE2 oocyte meiosis inhibiting kinase" P0C1S8 7 141708353-141731271 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Meiosis "Kinase, Transferase, Tyrosine-protein kinase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Distal tubular cells: 1.9;Proximal tubular cells: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "CACO-2: 3.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA027418, HPA054280" Uncertain Enhanced Nucleoplasm,Cytosol NA NA "Cluster 39: CACO-2 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm Cytosol "HPA027418: AB_10603144, HPA054280: " "unprognostic (6.35e-2)" "unprognostic (1.47e-1)" "unprognostic (1.89e-1)" "unprognostic (3.18e-1)" "unprognostic (2.33e-1)" "unprognostic (4.00e-2)" "unprognostic (2.90e-1)" "unprognostic (1.97e-2)" "unprognostic (3.23e-2)" "unprognostic (3.02e-2)" "unprognostic (2.61e-1)" "unprognostic (1.76e-2)" "unprognostic (1.73e-1)" "unprognostic (3.25e-2)" "unprognostic (2.66e-1)" "unprognostic (6.07e-2)" "unprognostic (2.88e-3)" 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.4 0.3 0.0 0.0 0.3 0.0 0.1 0.4 0.1 0.1 0.3 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.2 0.6 0.1 0.0 0.2 0.1 0.2 0.3 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.4 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZBTB4 "KAISO-L1, KIAA1538, ZNF903" ENSG00000174282 "Zinc finger and BTB domain containing 4" Q9P1Z0 17 7459366-7484263 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008980, HPA064763" Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 56: Bipolar cells - Visual perception" "Nuclear bodies" "Nucleoplasm, Cytosol" "CAB008980: , HPA064763: AB_2685347" "unprognostic (2.23e-1)" "unprognostic (3.95e-1)" "unprognostic (7.17e-2)" "unprognostic (2.92e-2)" "unprognostic (5.32e-2)" "unprognostic (7.62e-3)" "unprognostic (2.43e-1)" "unprognostic (1.67e-2)" "unprognostic (1.28e-1)" "unprognostic (1.63e-3)" "prognostic favorable (2.53e-4)" "unprognostic (1.73e-1)" "prognostic favorable (1.65e-9)" "unprognostic (1.10e-1)" "unprognostic (4.86e-2)" "unprognostic (1.88e-1)" "unprognostic (6.04e-3)" 34.8 36.1 22.1 7.4 20.6 3.0 31.4 19.9 23.1 41.9 11.7 47.2 6.3 40.3 16.2 26.4 40.5 9.6 38.8 21.2 21.0 24.1 7.8 30.0 8.3 27.1 21.7 48.4 23.1 36.1 28.6 10.8 27.0 33.1 6.6 23.1 28.0 21.4 32.4 27.2 23.0 16.4 19.7 22.1 27.3 15.9 23.3 9.5 43.9 14.8 9.0 42.3 33.9 21.5 10.7 14.4 3.6 6.9 37.1 19.1 6.5 14.7 21.0 13.0 12.9 4.8 5.1 1.1 11.4 28.0 9.5 16.7 3.6 20.6 9.5 17.0 6.2 5.3 12.3 3.4 10.4 1.0 12.2 13.4 21.1 12.5 15.9 30.6 11.5 4.0 1.8 3.4 14.5 7.1 3.7 2.2 1.5 4.3 6.8 6.8 6.2 1.6 15.9 8.9 2.1 5.3 6.5 4.6 6.9 6.3 8.6 2.4 16.1 14.6 5.7 13.9 12.3 6.1 4.5 0.7 15.7 3.3 7.7 0.4 0.3 0.5 1.0 0.5 1.0 0.5 0.8 0.8 0.2 0.5 1.0 1.0 0.2 0.6 1.7 0.4 0.4 0.6 22.1 20.6 19.9 23.1 21.2 21.0 27.1 21.7 27.0 19.7 23.3 21.5 27.4 51.3 53.1 33.6 14.6 30.7 16.3 18.4 18.8 86.6 23.6 20.6 92.6 20.0 24.8 20.2 68.8 10.3 24.5 4.6 3.9 14.4 40.8 21.1 25.2 26.1 17.4 9.5 36.9 14.4 2.2 24.8 7.1 26.0 13.9 25.7 23.9 8.1 13.5 74.0 37.3 10.1 14.2 30.0 34.6 57.0 51.9 18.6 17.8 15.9 12.0 27.0 24.7 21.6 26.7 19.0 5.3 70.0 9.5 16.2 8.2 11.2 32.2 39.9 32.9 37.8 27.4 7.3 4.3 17.3 23.4 5.2 21.1 16.3 9.0 14.7 ZBTB48 "HKR3, TZAP, ZNF855" ENSG00000204859 "Zinc finger and BTB domain containing 48" P10074 1 6579994-6589280 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 61.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030417 Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 3: HMC-1 - Innate immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Cytosol "HPA030417: AB_10603145" "unprognostic (6.66e-2)" "prognostic favorable (1.04e-4)" "unprognostic (7.15e-3)" "unprognostic (9.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.92e-2)" "unprognostic (2.71e-1)" "unprognostic (8.15e-3)" "unprognostic (6.43e-2)" "unprognostic (1.70e-1)" "prognostic favorable (5.19e-6)" "unprognostic (7.73e-2)" "unprognostic (1.82e-2)" "unprognostic (1.23e-1)" "unprognostic (2.77e-2)" "unprognostic (2.84e-1)" "unprognostic (1.91e-3)" 10.1 10.9 6.7 13.3 7.3 14.2 10.8 6.9 8.6 15.4 9.3 10.7 11.8 11.0 11.9 11.9 13.1 11.2 8.5 7.2 7.2 11.5 21.2 11.1 14.1 7.1 7.7 16.5 11.6 13.3 11.9 10.5 7.2 15.5 12.4 6.9 11.5 10.0 10.2 14.1 11.5 10.6 6.5 16.0 12.4 25.5 7.8 16.9 14.2 14.2 15.0 12.0 13.0 8.5 6.5 7.2 12.1 17.8 13.0 10.1 6.1 6.3 7.5 12.2 12.8 8.1 14.8 20.8 11.1 5.7 8.1 12.4 18.3 12.8 9.3 21.6 16.5 17.0 24.1 7.9 15.1 28.0 45.2 10.0 9.5 11.9 18.9 16.1 8.9 16.0 17.5 13.2 9.0 12.0 14.0 20.0 9.2 12.7 12.9 15.5 11.3 23.4 10.6 5.3 23.4 10.7 9.7 22.3 15.1 12.1 12.7 22.2 9.9 8.3 5.3 9.1 8.3 14.7 13.8 33.2 7.7 22.0 5.1 20.0 10.5 42.3 8.3 6.5 8.5 9.1 6.5 8.1 11.5 10.5 8.7 7.8 14.6 10.6 10.7 7.7 5.9 8.4 6.7 7.3 6.9 8.6 7.2 7.2 7.1 7.7 7.2 6.5 7.8 8.5 7.7 3.2 12.3 10.4 13.0 4.7 9.3 13.3 3.4 8.0 7.8 8.0 5.8 11.5 10.0 11.0 6.2 6.1 12.5 15.1 11.7 4.7 61.8 10.1 7.1 6.1 15.5 3.4 7.5 3.6 5.1 6.8 23.4 6.5 26.6 10.1 7.1 15.1 10.8 10.1 6.6 15.5 14.2 7.6 5.4 19.1 8.7 11.2 5.4 4.7 9.2 11.1 9.2 4.0 5.5 3.1 14.6 5.7 6.6 5.6 22.6 12.6 18.3 7.8 19.7 10.5 8.2 34.5 14.8 5.3 5.5 5.1 9.9 13.6 10.0 6.5 ZEB2 "KIAA0569, SIP-1, SIP1, ZFHX1B" ENSG00000169554 "Zinc finger E-box binding homeobox 2" O60315 2 144364364-144521057 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease variant, Epilepsy, Hirschsprung disease, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 363.7" "Cell type enhanced" "Detected in many" "Horizontal cells: 662.9;Inhibitory neurons: 539.3;Oligodendrocytes: 1489.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 154.0;THP-1: 181.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003456 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 43: THP-1 - Innate immune response" "Cluster 41: Macrophages - Immune response" Nucleoli "Nucleoplasm, Cytosol" "HPA003456: AB_10603840" "unprognostic (1.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" "unprognostic (2.42e-1)" "unprognostic (4.12e-1)" "unprognostic (4.17e-2)" "unprognostic (3.69e-1)" "unprognostic (3.77e-2)" "unprognostic (5.83e-2)" "unprognostic (7.90e-2)" "unprognostic (1.33e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (6.04e-5)" "unprognostic (1.11e-2)" "unprognostic (1.73e-2)" "unprognostic (7.45e-2)" "unprognostic (1.32e-2)" 61.3 45.2 185.6 56.8 258.3 127.5 29.5 138.3 165.5 52.4 3.0 24.5 21.9 29.6 9.6 27.9 20.3 43.9 45.7 132.5 155.4 18.2 23.3 41.2 43.2 238.3 214.5 70.5 5.7 6.7 3.3 62.1 222.8 18.5 29.9 35.5 9.6 22.7 20.8 12.8 25.9 33.3 183.2 69.4 18.0 16.2 249.6 10.6 13.3 18.8 24.2 46.6 24.1 363.7 1.6 2.0 83.4 0.1 98.9 49.7 0.3 35.1 35.1 38.5 37.1 0.0 0.8 6.6 0.1 37.4 10.6 0.4 14.5 0.1 47.6 37.6 11.2 154.0 6.3 0.2 23.0 26.4 113.2 42.1 0.9 48.9 22.9 33.7 29.4 0.0 43.0 4.1 45.2 0.2 0.4 79.9 12.3 0.0 1.9 44.1 63.5 0.2 0.4 0.6 0.7 22.1 4.2 0.2 97.3 27.5 0.2 181.4 45.9 42.9 0.7 87.5 11.0 47.1 0.3 7.5 66.7 78.4 122.6 27.8 47.7 12.2 21.0 42.6 1.9 9.2 2.7 10.7 27.0 9.4 1.9 7.7 15.2 7.3 43.9 21.5 0.6 19.0 185.6 258.3 138.3 165.5 132.5 155.4 238.3 214.5 222.8 183.2 249.6 363.7 32.6 6.4 19.2 121.8 92.4 24.9 1.2 0.6 3.4 158.6 2.2 4.3 71.0 1.5 10.1 5.5 4.2 1.7 426.2 0.1 1.9 0.7 2.2 2.1 84.7 29.2 0.0 127.0 228.2 0.8 2.0 123.0 13.3 2.5 157.5 99.3 79.2 4.6 144.5 662.9 539.3 0.0 0.0 435.0 276.3 7.2 120.5 435.0 103.2 343.8 233.6 69.3 223.5 381.0 1489.6 0.2 1.1 66.5 132.3 1.8 0.0 10.3 4.0 11.9 184.1 185.0 198.7 2.9 11.3 3.4 19.6 4.7 136.7 108.8 0.4 2.2 ZHX1-C8orf76 ENSG00000259305 "ZHX1-C8orf76 readthrough" Q96EF9 8 123226189-123274284 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 10.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 26.0" HPA023708 Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm Cytosol "HPA023708: AB_1845785" "unprognostic (1.06e-1)" "unprognostic (2.11e-1)" "unprognostic (1.37e-2)" "unprognostic (1.83e-3)" "unprognostic (1.13e-1)" "unprognostic (1.16e-1)" "unprognostic (2.49e-3)" "unprognostic (7.10e-2)" "unprognostic (1.91e-2)" "unprognostic (9.34e-3)" "unprognostic (2.29e-1)" "unprognostic (3.09e-2)" "unprognostic (5.64e-11)" "unprognostic (1.79e-1)" "unprognostic (2.09e-1)" "unprognostic (1.98e-1)" "unprognostic (1.06e-2)" 2.7 2.4 1.4 1.1 1.8 8.5 2.5 2.1 1.8 2.3 1.3 1.8 2.0 1.8 1.8 2.8 2.1 1.1 2.5 1.3 1.4 2.3 2.6 2.9 2.4 1.8 1.7 2.3 1.6 1.1 3.6 1.7 1.6 2.5 2.4 2.9 2.5 1.3 4.1 2.5 1.9 1.6 1.2 3.0 1.8 1.4 1.9 2.2 2.1 1.9 2.7 1.9 2.3 2.3 3.4 4.3 3.1 2.2 1.9 2.1 2.0 1.5 1.5 3.6 2.7 3.5 2.6 2.0 1.3 2.5 2.1 2.2 3.5 1.9 5.4 3.5 7.3 5.9 3.1 4.2 1.9 1.2 3.1 2.8 2.8 2.9 1.8 1.5 4.2 5.9 4.9 2.8 3.2 10.6 5.0 3.9 0.8 6.8 4.7 3.9 2.0 2.8 2.5 3.4 4.8 3.4 3.0 26.0 1.6 1.7 3.9 1.1 0.3 1.5 3.0 2.5 3.4 3.9 5.2 4.3 2.1 3.2 1.1 1.7 2.9 4.8 2.0 4.1 1.9 2.7 2.6 1.8 2.5 2.9 2.1 1.8 1.0 2.7 2.9 2.3 4.9 2.0 1.4 1.8 2.1 1.8 1.3 1.4 1.8 1.7 1.6 1.2 1.9 2.3 2.5 0.0 1.1 4.6 2.0 3.1 5.3 2.5 0.0 0.4 2.2 2.0 1.1 1.5 2.7 3.7 0.0 1.9 5.2 0.9 1.9 1.8 1.4 1.0 1.0 1.7 3.0 0.0 2.0 1.8 2.6 1.8 0.0 0.8 0.0 1.7 2.2 0.8 2.7 10.1 2.8 2.2 4.1 1.3 2.1 1.4 0.9 2.0 1.8 0.0 2.4 0.9 3.1 4.5 4.9 2.2 0.5 1.2 0.7 2.9 1.6 1.3 4.3 1.4 0.0 1.6 1.4 2.7 2.5 0.4 1.4 1.0 1.3 0.8 1.4 7.0 ZMYND15 DKFZp434N127 ENSG00000141497 "Zinc finger MYND-type containing 15" Q9H091 17 4739833-4746119 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 28.3" "Cell type enriched" "Detected in many" 6 "Early spermatids: 191.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.1;CAPAN-2: 1.9;HaCaT: 1.6;T-47d: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA023286 Uncertain "Nuclear speckles,Cytosol" NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nuclear speckles" Cytosol "HPA023286: AB_1859076" "unprognostic (2.30e-3)" "unprognostic (1.63e-2)" "unprognostic (1.61e-2)" "unprognostic (7.49e-3)" "unprognostic (3.62e-2)" "unprognostic (7.86e-2)" "unprognostic (4.97e-2)" "unprognostic (1.59e-2)" "unprognostic (1.33e-2)" "unprognostic (3.49e-1)" "unprognostic (6.72e-3)" "unprognostic (4.02e-1)" "unprognostic (5.47e-2)" "unprognostic (4.62e-2)" "unprognostic (9.24e-3)" "unprognostic (2.69e-1)" "unprognostic (2.07e-1)" 1.8 1.3 1.6 2.4 1.6 1.0 1.7 1.6 2.5 0.9 1.7 0.8 4.0 0.6 0.5 0.9 1.1 2.8 0.6 1.6 1.8 1.9 3.1 4.6 1.7 2.4 2.0 0.7 1.2 5.5 1.4 1.2 2.0 1.7 0.7 0.3 3.1 0.8 0.4 1.4 3.0 0.7 2.0 5.5 1.9 28.3 2.4 0.8 1.1 0.1 0.4 1.8 0.7 2.6 2.1 0.3 0.0 0.9 0.0 0.1 0.1 0.0 0.5 0.5 1.1 0.9 1.9 0.0 0.0 0.0 0.2 1.6 0.4 0.1 0.0 0.2 0.7 0.0 0.2 0.5 0.3 0.0 0.6 0.1 0.2 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.2 0.2 0.0 0.0 0.6 0.6 0.9 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.6 1.6 1.6 2.5 1.6 1.8 2.4 2.0 2.0 2.0 2.4 2.6 0.8 0.0 2.0 1.3 0.6 0.9 8.0 1.8 0.6 0.3 4.4 3.7 0.7 2.8 3.1 1.8 0.0 0.1 0.2 3.3 0.0 1.6 191.4 2.8 0.3 1.4 1.2 0.0 0.0 3.9 0.0 0.7 4.6 2.7 0.0 0.3 3.9 0.6 5.2 0.0 0.1 2.9 0.0 11.9 7.3 30.9 0.6 12.9 1.8 1.9 21.9 2.0 0.0 1.0 0.5 3.5 1.4 2.2 0.1 6.7 3.8 0.8 3.7 0.3 0.0 0.2 1.0 24.3 2.0 0.5 0.9 0.0 0.2 0.3 1.3 8.5 ZNF208 "PMIDP, ZNF95" ENSG00000160321 "Zinc finger protein 208" O43345 19 21932958-22010949 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 15.4;Late spermatids: 14.1;Oligodendrocytes: 26.3" "Group enriched" "Detected in some" 4 "ovarian cancer: 0.6;testis cancer: 1.9;thyroid cancer: 0.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 9.3;NTERA-2: 33.1;SuSa: 6.9;U-266/84: 11.2" HPA077100 Uncertain "Golgi apparatus,Cytosol" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" Cytosol "HPA077100: " "unprognostic (4.06e-3)" "unprognostic (2.90e-1)" "unprognostic (1.09e-1)" "unprognostic (1.75e-1)" "unprognostic (7.46e-2)" "unprognostic (1.66e-1)" "unprognostic (2.87e-1)" "unprognostic (6.23e-2)" "unprognostic (1.64e-2)" "unprognostic (1.73e-1)" "unprognostic (1.29e-2)" "unprognostic (1.66e-1)" "unprognostic (4.94e-2)" "unprognostic (7.21e-3)" "unprognostic (1.70e-1)" "unprognostic (1.47e-2)" "unprognostic (2.73e-3)" 4.2 1.1 4.0 1.9 6.5 1.5 3.4 2.8 4.5 4.0 2.4 4.9 1.4 6.6 4.6 2.2 4.9 3.5 11.4 6.0 7.0 4.6 0.7 1.3 2.8 8.9 7.3 3.4 2.6 13.3 7.1 2.7 8.7 3.5 1.5 2.4 2.8 3.2 0.9 4.0 2.2 6.0 3.0 2.7 1.7 8.6 6.2 0.5 7.9 1.3 1.7 3.2 2.6 6.9 0.4 0.3 0.5 1.1 0.0 0.2 1.5 0.3 0.1 0.2 0.1 1.8 0.6 0.6 0.3 0.3 9.3 0.7 1.2 0.2 0.4 0.2 0.2 0.6 1.5 0.8 0.0 0.4 0.2 1.0 0.3 0.0 0.2 0.7 0.4 0.4 0.5 1.6 0.0 0.5 0.4 0.6 33.1 0.0 1.1 0.2 0.0 1.9 1.1 1.8 0.8 1.6 0.2 0.8 0.3 6.9 0.9 0.8 0.0 0.5 0.3 1.9 0.1 1.0 11.2 0.2 0.1 0.4 0.7 2.4 0.6 0.7 0.8 0.4 0.4 1.3 1.5 0.5 0.3 1.6 0.6 0.9 2.6 1.0 0.3 1.6 1.5 0.3 4.0 6.5 2.8 4.5 6.0 7.0 8.9 7.3 8.7 3.0 6.2 6.9 6.7 0.0 0.0 11.4 4.3 0.0 1.0 0.0 0.6 6.6 4.2 2.5 11.4 0.0 1.3 5.5 0.0 6.8 0.5 0.0 3.9 6.6 15.4 0.2 3.7 3.4 0.0 1.3 11.5 0.2 3.1 5.9 0.5 0.1 0.0 2.7 1.1 0.5 0.7 3.3 1.7 0.0 0.0 0.0 0.7 14.1 1.5 0.2 0.0 9.4 0.0 0.8 1.0 11.1 26.3 0.7 0.0 1.2 0.4 1.2 0.0 2.6 0.0 0.4 0.0 2.5 1.7 8.7 6.2 0.9 0.3 5.3 2.2 0.3 0.0 2.0 ZNF232 ZSCAN11 ENSG00000167840 "Zinc finger protein 232" Q9UNY5 17 5105541-5123116 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatocytes: 18.1;Spermatogonia: 21.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027309, HPA028611" Uncertain Supported Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 37: B-cells - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "Vesicles, Cytosol" "HPA027309: AB_10603464, HPA028611: AB_2672700" "unprognostic (4.20e-2)" "unprognostic (2.06e-3)" "unprognostic (3.69e-1)" "unprognostic (5.59e-3)" "unprognostic (5.21e-2)" "unprognostic (5.90e-3)" "prognostic unfavorable (4.66e-4)" "unprognostic (3.12e-2)" "unprognostic (5.46e-3)" "unprognostic (2.49e-2)" "prognostic favorable (6.55e-4)" "unprognostic (3.28e-2)" "unprognostic (3.49e-3)" "unprognostic (2.22e-2)" "unprognostic (2.28e-1)" "unprognostic (1.11e-1)" "unprognostic (8.61e-3)" 1.8 1.2 3.0 1.1 3.5 0.4 1.9 3.4 4.3 2.7 3.1 2.7 1.0 2.4 2.4 1.6 2.3 1.3 2.0 3.1 3.5 2.3 2.1 1.5 1.9 3.6 3.1 3.4 2.8 1.9 1.6 1.5 3.5 2.1 1.3 2.3 1.9 1.3 2.0 1.4 1.8 1.9 3.1 1.9 2.2 2.6 3.5 1.6 2.4 1.8 1.4 1.8 1.8 4.2 5.8 4.3 6.9 7.0 2.4 1.0 3.7 2.8 1.4 2.7 3.7 6.7 1.4 11.5 3.4 1.0 4.0 3.9 4.9 2.8 1.6 4.6 7.4 2.0 10.0 6.0 3.5 0.0 3.4 1.9 3.0 2.9 2.5 1.9 2.0 13.7 10.0 4.1 3.3 2.8 10.1 4.0 13.5 4.9 4.6 8.5 4.4 7.8 2.2 0.8 7.2 4.7 5.4 2.1 4.6 5.2 1.1 2.8 3.2 2.7 4.6 2.1 5.5 5.5 9.3 3.0 6.9 0.3 4.6 1.3 1.9 1.9 4.2 2.0 5.2 12.5 4.7 5.8 3.9 11.4 7.0 6.5 0.1 5.7 1.2 7.4 4.3 3.5 3.0 3.5 3.4 4.3 3.1 3.5 3.6 3.1 3.5 3.1 3.5 4.2 4.2 0.0 2.6 2.0 5.2 4.2 2.9 4.0 5.7 5.7 3.8 6.6 5.6 0.0 3.9 5.5 0.0 3.9 3.5 3.1 3.9 7.0 8.6 5.5 6.8 5.2 1.2 2.1 3.4 4.0 5.0 3.4 1.5 2.2 0.0 4.0 3.6 3.9 6.1 0.0 3.3 2.4 0.0 3.8 1.3 6.9 3.7 2.9 0.0 3.7 1.8 4.2 0.0 3.0 8.1 3.7 7.6 5.3 1.4 4.1 2.6 3.2 6.5 3.9 0.0 4.4 4.4 18.1 21.7 3.3 4.7 2.1 3.2 3.4 3.8 1.8 ZNF260 "ozrf1, Zfp260" ENSG00000254004 "Zinc finger protein 260" Q3ZCT1 19 36510687-36528271 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028806 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 1: Thyroid gland - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Cytosol" "HPA028806: AB_10795285" "unprognostic (1.34e-1)" "unprognostic (6.31e-2)" "unprognostic (8.35e-3)" "unprognostic (1.11e-3)" "unprognostic (3.55e-2)" "unprognostic (1.29e-3)" "unprognostic (7.83e-3)" "unprognostic (3.91e-1)" "unprognostic (1.13e-2)" "unprognostic (8.36e-2)" "unprognostic (1.06e-1)" "unprognostic (1.81e-2)" "prognostic favorable (1.44e-4)" "unprognostic (7.73e-2)" "unprognostic (2.17e-1)" "unprognostic (1.06e-1)" "unprognostic (7.89e-3)" 4.5 5.0 4.9 4.1 5.7 1.7 7.9 5.5 5.8 6.7 4.4 3.9 4.1 7.2 5.2 5.1 5.3 5.4 5.0 4.5 5.5 7.4 5.8 4.9 6.3 5.2 5.5 8.4 3.9 11.7 3.2 6.8 5.3 6.6 4.6 8.9 4.8 4.7 2.4 6.8 4.2 5.2 5.2 5.9 5.5 3.1 5.6 7.6 9.7 4.1 6.7 6.1 3.4 6.9 11.2 11.2 25.1 19.1 7.7 11.5 10.9 9.6 10.1 8.6 11.0 5.1 6.2 7.3 15.2 7.8 6.6 4.1 12.8 5.9 13.2 9.7 5.6 10.8 8.6 5.8 10.7 5.5 8.7 10.6 9.8 8.9 13.7 12.5 11.7 10.7 8.7 7.9 17.4 6.1 20.6 3.6 15.9 7.0 4.8 13.5 15.5 5.5 9.8 19.6 18.1 19.9 21.3 11.4 8.0 15.3 9.5 10.5 10.2 15.0 15.5 8.9 8.7 10.0 20.4 16.7 0.4 5.9 20.7 4.6 1.3 1.4 1.7 1.2 1.8 2.4 2.3 1.4 1.5 2.9 3.1 2.4 0.6 1.9 1.9 1.0 2.2 1.4 4.9 5.7 5.5 5.8 4.5 5.5 5.2 5.5 5.3 5.2 5.6 6.9 10.9 9.6 6.2 9.4 14.1 10.3 8.2 7.2 18.2 7.9 12.3 9.8 8.9 1.5 11.1 0.0 8.4 6.4 8.9 2.7 5.9 8.2 18.0 9.3 12.7 9.7 12.0 10.7 13.2 4.4 7.0 9.3 7.7 9.2 8.2 15.9 10.8 4.0 4.6 21.9 13.4 5.1 12.2 5.7 3.3 4.1 5.9 5.4 1.8 9.4 6.0 7.9 5.2 24.1 27.7 6.6 3.5 8.2 3.7 7.1 3.4 8.3 6.3 7.9 6.6 6.4 9.1 8.0 3.8 16.2 13.1 4.1 10.4 9.2 4.6 11.9 ZNF318 "HRIHFB2436, ZFP318" ENSG00000171467 "Zinc finger protein 318" Q5VUA4 6 43307134-43369647 "Predicted intracellular proteins" "Meiosis, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 82.9;Spermatogonia: 46.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 2.1" "Lineage enriched" "Detected in single" 4 "B-cells: 2.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027022, HPA027031" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 34: Non-specific - Transcription" "Cluster 21: OE19 - Mitochondria" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm Cytosol "HPA027022: AB_1859189, HPA027031: AB_1859190" "unprognostic (1.64e-1)" "unprognostic (3.80e-1)" "unprognostic (1.13e-1)" "unprognostic (4.11e-3)" "unprognostic (1.97e-2)" "unprognostic (3.02e-2)" "unprognostic (2.53e-3)" "unprognostic (1.93e-1)" "unprognostic (1.80e-2)" "unprognostic (3.37e-2)" "unprognostic (8.24e-2)" "unprognostic (3.47e-1)" "unprognostic (4.61e-3)" "unprognostic (3.61e-1)" "unprognostic (3.00e-1)" "unprognostic (2.82e-1)" "unprognostic (1.54e-2)" 8.1 6.4 6.4 12.4 5.5 11.4 7.9 11.7 8.8 14.2 1.9 9.3 7.2 11.5 10.6 6.4 9.7 7.0 7.0 6.3 5.3 6.4 8.1 7.5 25.6 3.7 4.6 11.9 8.2 10.8 7.3 8.0 3.6 9.7 8.0 21.2 7.5 8.1 8.5 12.0 9.7 9.0 3.1 14.4 6.3 26.2 4.8 13.3 12.5 6.3 25.0 8.9 10.0 6.9 26.4 6.2 18.0 29.9 15.4 13.7 9.3 11.6 14.3 12.8 11.1 6.6 3.2 41.5 6.4 14.4 15.0 11.4 20.0 9.5 16.6 11.8 10.7 11.4 8.1 10.7 7.7 20.2 9.2 8.8 9.8 10.8 9.6 10.8 10.2 11.3 15.6 19.3 13.8 9.0 6.4 12.8 8.1 42.9 5.9 7.6 17.9 6.4 7.1 5.9 16.6 10.2 8.6 7.2 9.0 13.8 9.1 27.6 10.6 17.9 9.2 12.2 11.4 12.4 10.9 28.2 5.6 15.1 10.2 0.0 0.3 0.0 0.5 0.2 0.1 0.6 0.4 0.3 0.3 2.1 0.3 0.3 0.1 0.3 0.1 0.3 0.5 0.2 6.4 5.5 11.7 8.8 6.3 5.3 3.7 4.6 3.6 3.1 4.8 6.9 7.8 9.6 14.5 10.7 29.9 9.7 4.4 5.6 12.0 18.1 6.5 6.9 9.5 8.6 6.4 9.2 8.4 5.8 6.8 5.2 3.9 5.2 30.7 9.2 13.3 7.8 5.4 8.2 19.9 4.7 4.4 10.4 5.1 6.3 6.3 20.6 11.7 19.4 6.6 25.2 18.9 5.1 6.1 11.1 7.2 16.5 6.2 10.7 3.6 4.7 9.7 9.4 16.5 15.6 17.5 4.2 8.2 9.8 5.1 3.0 11.4 3.9 6.8 11.8 26.3 13.6 8.7 82.9 46.3 9.0 5.1 1.8 8.8 8.9 8.3 2.0 ZNF354A "EZNF, HKL1, KID-1, KID1, TCF17" ENSG00000169131 "Zinc finger protein 354A" O60765 5 178711512-178730659 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 49.6" "Low region specificity" "Detected in all" HPA052043 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 28: BEWO - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Nucleoli" Cytosol "HPA052043: AB_2681706" "unprognostic (2.79e-1)" "unprognostic (3.44e-2)" "unprognostic (7.06e-3)" "unprognostic (1.78e-3)" "unprognostic (1.38e-1)" "unprognostic (1.32e-1)" "unprognostic (3.25e-2)" "unprognostic (1.41e-1)" "unprognostic (7.66e-3)" "prognostic favorable (8.28e-4)" "unprognostic (4.06e-2)" "unprognostic (4.55e-2)" "prognostic unfavorable (3.45e-6)" "unprognostic (8.71e-2)" "unprognostic (4.13e-1)" "unprognostic (1.13e-1)" "unprognostic (1.07e-2)" 8.3 5.3 7.8 7.7 7.6 9.4 8.3 7.4 9.3 9.5 6.8 12.4 4.3 8.6 7.6 6.9 8.8 5.8 7.7 7.8 6.9 11.7 4.8 8.1 8.4 7.1 7.3 7.6 11.1 8.1 6.5 8.5 7.3 9.7 5.8 8.5 6.3 8.4 7.5 7.5 8.2 8.0 6.7 12.6 7.9 10.5 7.7 8.4 10.8 8.1 8.8 9.9 8.3 7.9 7.6 5.8 12.0 31.9 20.4 16.4 49.6 8.6 11.4 11.7 12.5 8.7 12.5 10.1 11.1 7.9 21.5 14.9 4.5 37.6 17.8 13.7 13.8 3.1 8.0 1.1 15.4 0.0 8.3 12.9 22.9 10.3 20.8 15.1 11.3 13.5 2.5 0.0 17.2 15.4 15.5 10.2 10.5 7.0 15.0 11.6 2.1 6.5 10.9 7.6 13.1 14.3 10.9 12.3 17.0 15.7 10.1 14.9 8.8 13.2 8.6 7.5 7.4 3.3 7.2 6.3 0.5 2.3 16.9 4.5 6.0 15.6 4.9 4.0 6.1 5.4 4.3 5.5 5.4 3.5 4.8 3.6 15.8 6.1 4.1 2.0 4.4 3.6 7.8 7.6 7.4 9.3 7.8 6.9 7.1 7.3 7.3 6.7 7.7 7.9 10.7 12.8 7.4 8.8 7.5 5.0 11.7 14.1 4.0 9.0 8.2 9.3 6.6 4.3 11.3 7.3 14.6 12.8 12.6 3.7 13.7 11.3 18.8 5.9 9.0 9.0 4.8 7.8 18.6 7.6 14.6 9.5 3.6 5.7 6.3 14.3 4.6 1.5 8.9 6.7 10.9 2.7 8.2 7.7 8.2 4.7 6.8 8.2 10.6 10.3 7.6 9.2 16.5 12.5 13.3 7.2 1.4 10.5 3.2 10.7 4.1 17.0 9.5 10.5 6.6 10.1 9.4 36.2 12.0 4.8 5.5 12.2 9.2 10.9 4.3 7.7 ZNF480 MGC32104 ENSG00000198464 "Zinc finger protein 480" Q8WV37 19 52297169-52325922 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA042218 Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm Cytosol "HPA042218: AB_10794791" "unprognostic (1.50e-2)" "unprognostic (1.43e-1)" "unprognostic (1.56e-1)" "unprognostic (1.35e-1)" "unprognostic (3.01e-2)" "unprognostic (5.22e-2)" "unprognostic (2.01e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.65e-4)" "unprognostic (4.22e-2)" "unprognostic (7.81e-3)" "unprognostic (4.97e-2)" "prognostic favorable (2.03e-4)" "unprognostic (3.05e-1)" "unprognostic (1.11e-2)" "unprognostic (2.54e-1)" "unprognostic (1.82e-3)" 7.6 7.3 4.8 10.4 5.9 9.5 6.6 7.7 6.9 7.5 5.3 10.4 9.8 6.0 3.3 6.5 5.6 4.5 11.1 4.8 6.0 8.7 8.6 6.2 12.6 6.0 5.1 6.9 4.5 7.4 5.9 5.7 6.0 6.2 10.1 10.4 7.2 5.2 10.8 5.5 8.2 6.0 4.2 9.8 9.1 3.3 5.9 15.2 7.2 14.9 15.5 11.1 5.4 8.3 7.2 28.4 18.2 21.2 21.1 19.7 14.1 18.3 26.7 12.8 14.9 12.9 10.0 36.0 11.2 15.1 23.4 15.3 19.9 18.5 18.5 0.3 33.1 37.0 15.2 12.5 20.3 52.7 29.0 18.1 23.4 17.8 20.7 26.7 18.8 31.0 27.0 12.0 29.0 11.7 48.3 10.5 13.7 23.7 22.8 24.5 19.5 30.0 18.8 51.0 17.2 15.0 26.6 18.9 7.4 37.3 15.7 38.1 32.4 12.7 15.8 7.3 28.6 28.4 56.9 74.3 5.7 28.2 23.1 10.1 9.6 11.2 12.6 9.4 14.5 19.7 12.8 15.1 11.9 19.1 12.0 16.3 3.6 17.8 11.4 19.3 15.9 7.8 4.8 5.9 7.7 6.9 4.8 6.0 6.0 5.1 6.0 4.2 5.9 8.3 13.1 35.3 11.8 8.5 20.1 5.5 15.3 22.1 5.7 4.7 6.7 6.1 43.0 8.6 18.2 3.7 2.1 8.7 17.8 11.7 17.6 18.6 2.5 12.7 11.9 17.0 12.6 14.9 1.7 27.6 16.8 11.1 9.7 14.1 12.6 15.4 14.3 15.4 17.6 6.7 4.7 18.0 20.3 15.8 14.3 2.4 9.0 12.3 7.2 6.5 19.0 6.1 26.8 9.5 10.2 36.3 11.8 8.2 9.2 25.4 13.5 24.2 16.8 7.4 0.0 10.6 12.0 1.9 6.1 10.5 8.4 14.8 19.7 12.1 16.1 22.6 ZNF660 FLJ36870 ENSG00000144792 "Zinc finger protein 660" Q6AZW8 3 44578223-44599694 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 27.9;Muller glia cells: 28.1;Rod photoreceptor cells: 25.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.4;HEL: 3.4;NTERA-2: 5.2;RH-30: 3.4;SuSa: 2.8" "Low region specificity" "Detected in all" HPA029705 Uncertain Uncertain "Nucleoli fibrillar center,Cytosol" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 21: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 5: Muller glia cells - Visual perception" "Nucleoli fibrillar center, Cytosol" "HPA029705: AB_10602592" "unprognostic (5.43e-2)" "unprognostic (3.58e-2)" "unprognostic (1.07e-1)" "unprognostic (9.52e-3)" "unprognostic (1.25e-1)" "unprognostic (6.34e-2)" "unprognostic (1.22e-1)" "unprognostic (3.73e-2)" "unprognostic (2.46e-2)" "unprognostic (1.36e-2)" "unprognostic (2.91e-3)" "unprognostic (8.56e-2)" "unprognostic (2.79e-3)" "unprognostic (4.87e-3)" "unprognostic (1.60e-1)" "unprognostic (7.21e-2)" "unprognostic (1.94e-2)" 1.1 0.8 0.7 0.4 0.6 0.8 0.9 2.3 0.7 2.2 0.1 1.4 0.1 2.1 0.6 0.3 1.8 0.7 1.0 0.6 0.9 1.1 0.3 0.9 0.9 0.9 0.8 3.4 0.8 0.7 2.4 0.7 0.8 1.6 0.3 4.6 0.6 0.9 0.4 0.3 0.9 0.9 0.6 1.0 0.8 1.7 0.9 0.8 1.5 0.4 0.6 1.3 1.2 0.8 0.0 0.0 3.4 0.8 0.0 0.0 0.5 0.4 0.8 0.5 0.5 0.0 0.0 0.0 0.7 0.3 0.0 0.0 1.1 0.0 0.6 0.0 0.0 3.4 0.3 0.5 0.8 0.0 0.0 1.3 0.0 1.2 0.0 0.1 0.8 0.0 0.0 0.1 1.8 0.0 0.0 2.0 5.2 0.0 0.0 0.0 3.4 0.0 0.1 0.1 0.8 2.2 0.0 0.0 0.0 2.8 0.0 1.3 0.2 0.9 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.7 0.6 2.3 0.7 0.6 0.9 0.9 0.8 0.8 0.6 0.9 0.8 3.2 0.0 6.0 11.8 1.4 0.1 1.1 0.5 0.0 27.9 1.0 1.0 2.2 4.3 3.2 0.0 6.2 0.0 2.3 0.2 0.0 1.2 10.3 1.9 7.8 4.0 4.2 3.0 7.6 0.5 0.0 4.4 0.5 1.1 6.3 12.4 3.6 0.2 2.0 11.8 11.5 0.3 0.0 1.0 0.5 2.0 5.0 1.3 0.0 11.2 2.9 28.1 6.2 15.6 13.7 0.5 0.0 3.4 0.3 0.8 0.0 0.2 1.0 25.6 0.0 7.9 5.1 7.7 3.9 0.1 0.0 0.0 0.7 7.0 0.4 0.3 ZSCAN22 "HKR2, ZNF50" ENSG00000182318 "Zinc finger and SCAN domain containing 22" P10073 19 58326994-58342332 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEK 293: 14.7" "Low region specificity" "Detected in all" HPA006471 Uncertain Uncertain "Plasma membrane,Actin filaments,Cytosol" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 15: Liver - Metabolism" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 51: Myeloid cells - Hemostasis" "Plasma membrane, Cytosol" "Actin filaments" "HPA006471: AB_2221026" "unprognostic (5.55e-3)" "unprognostic (2.24e-1)" "unprognostic (6.56e-2)" "unprognostic (1.13e-1)" "unprognostic (1.93e-1)" "unprognostic (3.82e-2)" "unprognostic (2.47e-3)" "unprognostic (1.52e-1)" "unprognostic (2.91e-1)" "unprognostic (1.15e-1)" "unprognostic (2.15e-3)" "unprognostic (5.00e-2)" "unprognostic (7.59e-2)" "unprognostic (2.59e-2)" "unprognostic (1.74e-1)" "unprognostic (5.22e-3)" "unprognostic (1.07e-1)" 1.2 1.5 1.4 1.3 1.7 0.7 1.1 2.9 1.6 1.7 1.0 1.5 1.2 1.5 0.8 1.8 1.3 0.7 1.2 1.3 1.4 1.3 2.4 1.1 1.2 1.4 1.2 1.5 1.4 1.6 2.6 1.2 1.4 1.4 0.9 0.8 1.2 1.0 1.1 2.3 1.3 1.2 0.8 1.4 1.4 1.2 1.2 1.1 1.3 1.0 1.4 1.5 1.5 2.8 2.4 4.2 2.3 3.5 2.6 1.6 2.4 2.0 1.0 1.2 1.1 2.3 1.7 1.9 1.3 1.6 1.5 1.8 3.3 2.2 1.3 3.0 14.7 4.1 4.2 2.1 2.1 3.3 4.2 1.8 2.2 2.6 2.7 2.2 1.8 1.9 4.1 3.6 2.1 1.9 1.6 1.5 2.0 3.0 4.8 2.2 3.6 3.3 1.2 3.1 3.6 2.6 3.0 4.0 2.0 1.8 1.9 2.3 1.8 6.5 1.9 1.6 3.5 3.6 5.3 1.4 2.6 2.2 2.3 0.0 0.8 1.0 2.0 0.7 1.3 0.8 1.1 1.6 1.1 1.0 0.9 1.0 0.2 1.2 0.9 0.5 0.9 1.0 1.4 1.7 2.9 1.6 1.3 1.4 1.4 1.2 1.4 0.8 1.2 2.8 1.1 0.0 4.1 1.6 1.5 1.8 0.6 1.0 0.0 0.7 1.3 0.9 0.6 1.5 1.6 1.8 0.0 0.9 0.8 0.4 1.9 0.9 0.3 1.1 1.2 0.9 0.0 1.7 2.1 0.6 0.9 1.1 1.1 1.6 0.0 1.1 0.0 1.3 0.5 1.7 2.1 0.5 0.0 0.8 0.8 0.0 2.1 2.3 1.8 0.0 1.3 0.5 0.0 1.0 2.2 1.1 1.6 0.4 1.1 0.9 0.8 0.6 1.1 0.7 0.0 1.7 0.8 4.3 1.9 1.1 3.7 0.7 1.2 0.9 1.0 0.4 ZSWIM7 SWS1 ENSG00000214941 "Zinc finger SWIM-type containing 7" Q19AV6 17 15976560-15999717 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054681 Uncertain Uncertain Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Cytosol "HPA054681: AB_2682572" "unprognostic (3.07e-2)" "unprognostic (5.51e-2)" "unprognostic (1.58e-1)" "prognostic favorable (3.54e-5)" "unprognostic (1.58e-1)" "unprognostic (1.15e-1)" "unprognostic (1.75e-2)" "unprognostic (8.28e-2)" "unprognostic (4.61e-2)" "unprognostic (3.82e-2)" "prognostic favorable (1.77e-4)" "unprognostic (4.23e-2)" "unprognostic (1.84e-2)" "unprognostic (8.56e-2)" "unprognostic (2.45e-3)" "unprognostic (8.80e-3)" "unprognostic (1.70e-1)" 12.5 18.0 6.9 6.0 7.2 4.3 12.6 6.8 10.4 11.8 6.2 12.9 7.3 11.7 4.8 8.5 10.9 4.4 18.2 7.3 7.8 14.5 13.8 10.1 7.2 7.4 7.1 15.7 12.6 6.6 16.2 5.4 7.5 10.8 4.6 5.6 9.3 4.7 32.7 10.9 10.1 5.4 6.8 13.9 10.2 5.8 7.7 4.6 11.7 10.2 3.7 10.4 10.4 7.5 17.2 24.5 12.4 30.1 5.1 4.8 15.1 11.3 4.4 11.7 8.6 4.6 4.9 8.1 9.8 12.2 3.5 5.5 4.1 8.9 5.5 8.7 14.1 9.3 11.5 9.7 12.1 7.5 15.1 11.7 15.4 6.4 11.0 1.7 15.1 21.2 5.9 4.5 6.1 23.2 26.2 17.4 8.1 25.0 14.4 16.2 31.7 13.1 10.6 9.0 4.4 18.9 17.5 17.4 12.4 33.2 12.5 1.8 21.5 18.9 6.4 4.9 9.9 2.3 6.3 9.8 16.2 9.3 16.3 28.0 27.2 12.0 13.6 27.5 14.6 26.8 15.9 13.1 42.0 24.6 18.8 18.0 1.6 18.0 19.8 25.9 12.6 19.7 6.9 7.2 6.8 10.4 7.3 7.8 7.4 7.1 7.5 6.8 7.7 7.5 42.4 35.3 54.5 16.6 35.7 25.6 33.7 50.0 37.0 38.4 56.0 65.0 65.0 67.2 32.7 40.5 62.6 99.9 39.2 35.0 86.1 56.5 13.6 32.9 40.0 33.9 50.8 24.0 16.1 52.0 58.9 29.5 21.9 27.6 55.2 52.3 37.5 55.2 49.7 18.5 13.4 37.1 59.0 55.4 37.8 14.4 45.4 53.0 55.2 15.0 46.9 60.1 53.5 14.6 21.9 50.6 35.7 39.9 24.5 37.0 50.0 134.5 35.8 56.9 26.3 33.9 30.6 87.1 74.1 28.8 27.6 72.8 29.1 71.2 36.3 28.8